0001493152-23-008631.txt : 20230323 0001493152-23-008631.hdr.sgml : 20230323 20230323070107 ACCESSION NUMBER: 0001493152-23-008631 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 89 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230323 DATE AS OF CHANGE: 20230323 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AYRO, Inc. CENTRAL INDEX KEY: 0001086745 STANDARD INDUSTRIAL CLASSIFICATION: COMMUNICATION SERVICES, NEC [4899] IRS NUMBER: 980204758 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-34643 FILM NUMBER: 23754421 BUSINESS ADDRESS: STREET 1: 900 E. OLD SETTLERS BOULEVARD, SUITE 100 CITY: ROUND ROCK STATE: TX ZIP: 78664 BUSINESS PHONE: 512-994-4917 MAIL ADDRESS: STREET 1: 900 E. OLD SETTLERS BOULEVARD, SUITE 100 CITY: ROUND ROCK STATE: TX ZIP: 78664 FORMER COMPANY: FORMER CONFORMED NAME: DropCar, Inc. DATE OF NAME CHANGE: 20180201 FORMER COMPANY: FORMER CONFORMED NAME: WPCS INTERNATIONAL INC DATE OF NAME CHANGE: 20020612 FORMER COMPANY: FORMER CONFORMED NAME: PHOENIX STAR VENTURES INC DATE OF NAME CHANGE: 20010424 10-K 1 form10-k.htm
0001086745 false FY 0001086745 2022-01-01 2022-12-31 0001086745 2022-06-30 0001086745 2023-03-22 0001086745 2021-01-01 2021-12-31 0001086745 2022-12-31 0001086745 2021-12-31 0001086745 AYRO:ConvertiblePreferredStockSeriesHMember 2022-12-31 0001086745 AYRO:ConvertiblePreferredStockSeriesHMember 2021-12-31 0001086745 AYRO:ConvertiblePreferredStockSeriesHThreeMember 2022-12-31 0001086745 AYRO:ConvertiblePreferredStockSeriesHThreeMember 2021-12-31 0001086745 AYRO:ConvertiblePreferredStockSeriesHSixMember 2022-12-31 0001086745 AYRO:ConvertiblePreferredStockSeriesHSixMember 2021-12-31 0001086745 us-gaap:SeriesHPreferredStockMember us-gaap:PreferredStockMember 2020-12-31 0001086745 AYRO:SeriesHThreePreferredStockMember us-gaap:PreferredStockMember 2020-12-31 0001086745 AYRO:SeriesHSixPreferredStockMember us-gaap:PreferredStockMember 2020-12-31 0001086745 us-gaap:CommonStockMember 2020-12-31 0001086745 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001086745 us-gaap:RetainedEarningsMember 2020-12-31 0001086745 2020-12-31 0001086745 us-gaap:SeriesHPreferredStockMember us-gaap:PreferredStockMember 2021-12-31 0001086745 AYRO:SeriesHThreePreferredStockMember us-gaap:PreferredStockMember 2021-12-31 0001086745 AYRO:SeriesHSixPreferredStockMember us-gaap:PreferredStockMember 2021-12-31 0001086745 us-gaap:CommonStockMember 2021-12-31 0001086745 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001086745 us-gaap:RetainedEarningsMember 2021-12-31 0001086745 us-gaap:SeriesHPreferredStockMember us-gaap:PreferredStockMember 2021-01-01 2021-12-31 0001086745 AYRO:SeriesHThreePreferredStockMember us-gaap:PreferredStockMember 2021-01-01 2021-12-31 0001086745 AYRO:SeriesHSixPreferredStockMember us-gaap:PreferredStockMember 2021-01-01 2021-12-31 0001086745 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001086745 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001086745 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001086745 us-gaap:SeriesHPreferredStockMember us-gaap:PreferredStockMember 2022-01-01 2022-12-31 0001086745 AYRO:SeriesHThreePreferredStockMember us-gaap:PreferredStockMember 2022-01-01 2022-12-31 0001086745 AYRO:SeriesHSixPreferredStockMember us-gaap:PreferredStockMember 2022-01-01 2022-12-31 0001086745 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001086745 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001086745 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001086745 us-gaap:SeriesHPreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001086745 AYRO:SeriesHThreePreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001086745 AYRO:SeriesHSixPreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001086745 us-gaap:CommonStockMember 2022-12-31 0001086745 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001086745 us-gaap:RetainedEarningsMember 2022-12-31 0001086745 AYRO:FleetInventoryMember 2022-01-01 2022-12-31 0001086745 AYRO:CenntroAutomotiveGroupLtdMember 2022-01-01 2022-12-31 0001086745 AYRO:ClubCarDiscountMember 2022-01-01 2022-12-31 0001086745 AYRO:ClubCarDiscountMember 2022-12-31 0001086745 srt:MinimumMember 2022-01-01 2022-12-31 0001086745 srt:MaximumMember 2022-01-01 2022-12-31 0001086745 us-gaap:ComputerEquipmentMember srt:MinimumMember 2022-01-01 2022-12-31 0001086745 us-gaap:ComputerEquipmentMember srt:MaximumMember 2022-01-01 2022-12-31 0001086745 us-gaap:FurnitureAndFixturesMember srt:MinimumMember 2022-01-01 2022-12-31 0001086745 us-gaap:FurnitureAndFixturesMember srt:MaximumMember 2022-01-01 2022-12-31 0001086745 us-gaap:MachineryAndEquipmentMember srt:MinimumMember 2022-01-01 2022-12-31 0001086745 us-gaap:MachineryAndEquipmentMember srt:MaximumMember 2022-01-01 2022-12-31 0001086745 us-gaap:LeaseholdImprovementsMember 2022-01-01 2022-12-31 0001086745 AYRO:OptionsToPurchaseCommonStockMember 2022-01-01 2022-12-31 0001086745 AYRO:OptionsToPurchaseCommonStockMember 2021-01-01 2021-12-31 0001086745 AYRO:RestrictedStockUnvestedMember 2022-01-01 2022-12-31 0001086745 AYRO:RestrictedStockUnvestedMember 2021-01-01 2021-12-31 0001086745 AYRO:RestrictedStockVestedUnissuedMember 2022-01-01 2022-12-31 0001086745 AYRO:RestrictedStockVestedUnissuedMember 2021-01-01 2021-12-31 0001086745 AYRO:WarrantsOutstandingMember 2022-01-01 2022-12-31 0001086745 AYRO:WarrantsOutstandingMember 2021-01-01 2021-12-31 0001086745 AYRO:PreferredStockOutstandingMember 2022-01-01 2022-12-31 0001086745 AYRO:PreferredStockOutstandingMember 2021-01-01 2021-12-31 0001086745 us-gaap:ProductMember 2022-01-01 2022-12-31 0001086745 us-gaap:ProductMember 2021-01-01 2021-12-31 0001086745 AYRO:ShippingRevenueMember 2022-01-01 2022-12-31 0001086745 AYRO:ShippingRevenueMember 2021-01-01 2021-12-31 0001086745 AYRO:MiscellaneousIncomeMember 2022-01-01 2022-12-31 0001086745 AYRO:MiscellaneousIncomeMember 2021-01-01 2021-12-31 0001086745 AYRO:ServiceIncomeMember 2022-01-01 2022-12-31 0001086745 AYRO:ServiceIncomeMember 2021-01-01 2021-12-31 0001086745 AYRO:FleetInventoryMember 2021-01-01 2021-12-31 0001086745 AYRO:CenntroAutomotiveGroupLtdMember 2021-12-31 0001086745 AYRO:ComputerAndEquipmentMember 2022-12-31 0001086745 AYRO:ComputerAndEquipmentMember 2021-12-31 0001086745 us-gaap:FurnitureAndFixturesMember 2022-12-31 0001086745 us-gaap:FurnitureAndFixturesMember 2021-12-31 0001086745 us-gaap:LeaseholdImprovementsMember 2022-12-31 0001086745 us-gaap:LeaseholdImprovementsMember 2021-12-31 0001086745 AYRO:PrototypesMember 2022-12-31 0001086745 AYRO:PrototypesMember 2021-12-31 0001086745 AYRO:ComputerSoftwareMember 2022-12-31 0001086745 AYRO:ComputerSoftwareMember 2021-12-31 0001086745 AYRO:RetiringLegacyAssetsMember 2022-01-01 2022-12-31 0001086745 us-gaap:BondsMember 2022-12-31 0001086745 us-gaap:BondsMember 2022-01-01 2022-12-31 0001086745 us-gaap:USTreasurySecuritiesMember 2022-12-31 0001086745 us-gaap:USTreasurySecuritiesMember 2022-01-01 2022-12-31 0001086745 AYRO:JanuaryTwentyTwentyOneOfferingMember AYRO:SecuritiesPurchaseAgreementMember AYRO:AdditionalSharesMember 2021-01-24 2021-01-25 0001086745 AYRO:AdditionalSharesMember AYRO:SecuritiesPurchaseAgreementMember AYRO:JanuaryTwentyTwentyOneOfferingMember 2021-01-25 0001086745 AYRO:SecuritiesPurchaseAgreementMember AYRO:AdditionalSharesMember 2021-02-10 2021-02-11 0001086745 AYRO:AdditionalSharesMember AYRO:SecuritiesPurchaseAgreementMember 2021-02-11 0001086745 us-gaap:InvestorMember AYRO:SecuritiesPurchaseAgreementMember AYRO:AdditionalSharesMember 2021-02-10 2021-02-11 0001086745 us-gaap:InvestorMember AYRO:AdditionalSharesMember AYRO:SecuritiesPurchaseAgreementMember 2021-02-11 0001086745 AYRO:AdditionalSharesMember AYRO:SecuritiesPurchaseAgreementMember 2021-03-16 2021-03-17 0001086745 AYRO:SecuritiesPurchaseAgreementMember us-gaap:InvestorMember 2020-07-20 2020-07-21 0001086745 AYRO:AdditionalSharesMember AYRO:SecuritiesPurchaseAgreementMember 2020-07-21 0001086745 AYRO:SecuritiesPurchaseAgreementMember 2020-07-20 2020-07-21 0001086745 AYRO:SecuritiesPurchaseAgreementMember us-gaap:WarrantMember 2021-02-01 2021-02-28 0001086745 AYRO:SecuritiesPurchaseAgreementMember 2021-02-01 2021-02-28 0001086745 AYRO:SecuritiesPurchaseAgreementMember 2021-01-01 2021-12-31 0001086745 us-gaap:RestrictedStockMember 2021-01-01 2021-12-31 0001086745 us-gaap:RestrictedStockMember 2022-01-01 2022-12-31 0001086745 srt:DirectorMember us-gaap:RestrictedStockMember AYRO:TwoThousandAndTwentyLongTermIncentivePlanMember 2021-02-20 2021-02-24 0001086745 srt:DirectorMember us-gaap:RestrictedStockMember AYRO:TwoThousandAndTwentyLongTermIncentivePlanMember 2021-02-24 0001086745 us-gaap:RestrictedStockMember us-gaap:CommonStockMember 2021-12-31 0001086745 srt:DirectorMember us-gaap:RestrictedStockMember AYRO:TwoThousandAndTwentyLongTermIncentivePlanMember 2022-01-29 2022-02-01 0001086745 srt:DirectorMember us-gaap:RestrictedStockMember AYRO:TwoThousandAndTwentyLongTermIncentivePlanMember 2022-02-01 0001086745 srt:DirectorMember us-gaap:RestrictedStockMember AYRO:TwoThousandAndTwentyLongTermIncentivePlanMember 2022-01-01 2022-12-31 0001086745 us-gaap:PreferredStockMember 2022-01-01 2022-12-31 0001086745 us-gaap:SeriesHPreferredStockMember 2022-12-31 0001086745 us-gaap:SeriesHPreferredStockMember 2022-01-01 2022-12-31 0001086745 us-gaap:SeriesHPreferredStockMember AYRO:AffiliatesMember 2022-12-31 0001086745 AYRO:SeriesHThreePreferredStockMember 2022-12-31 0001086745 AYRO:SeriesHThreeWarrantsMember 2022-12-31 0001086745 AYRO:SeriesHThreePreferredStockMember AYRO:AffiliatesMember 2022-12-31 0001086745 AYRO:SeriesHSixConvertibePreferredStockMember 2020-02-05 0001086745 AYRO:SeriesHSixConvertibePreferredStockMember 2020-02-04 2020-02-05 0001086745 AYRO:SeriesHSixConvertibePreferredStockMember 2022-01-01 2022-12-31 0001086745 AYRO:SeriesHSixConvertibePreferredStockMember AYRO:AffiliatesMember 2020-02-05 0001086745 us-gaap:PreferredStockMember 2022-12-31 0001086745 AYRO:SeedWarrantsMember 2022-12-31 0001086745 AYRO:SeriesIWarrantsMember 2022-12-31 0001086745 AYRO:SeriesIWarrantsMember 2022-01-01 2022-12-31 0001086745 AYRO:SeriesIWarrantsMember 2021-12-31 0001086745 AYRO:SeriesHFourWarrantsMember 2022-12-31 0001086745 AYRO:SeriesJWarrantsMember 2022-12-31 0001086745 AYRO:SeriesJWarrantsMember 2022-01-01 2022-12-31 0001086745 AYRO:SeriesHFiveWarrantsMember 2022-12-31 0001086745 AYRO:SeriesHFiveWarrantsMember 2022-01-01 2022-12-31 0001086745 AYRO:SeriesHFiveWarrantsMember srt:MinimumMember 2022-12-31 0001086745 AYRO:SeriesHFiveWarrantsMember srt:MaximumMember 2022-12-31 0001086745 AYRO:SeriesHFiveWarrantsMember srt:MaximumMember 2022-01-01 2022-12-31 0001086745 AYRO:JuneFinderWarrantsMember 2020-06-19 0001086745 AYRO:JunePlacementAgentWarrantsMember 2020-06-19 0001086745 AYRO:JunePlacementAgentWarrantsMember 2020-12-31 0001086745 AYRO:JuneFinderWarrantsMember 2022-12-31 0001086745 AYRO:JulyEightFinderWarrantsMember 2020-07-08 0001086745 AYRO:JulyEightPlacementAgentWarrantsMember 2020-07-08 0001086745 AYRO:JulyEightFinderWarrantsMember 2022-12-31 0001086745 AYRO:JulyEightPlacementAgentWarrantsMember 2022-12-31 0001086745 AYRO:JulyTwentyTwoPlacementAgentWarrantsMember 2020-07-22 0001086745 AYRO:JulyTwentyTwoPlacementAgentWarrantsMember 2022-12-31 0001086745 AYRO:SeptemberWarrantMember 2020-09-25 0001086745 AYRO:SeptemberWarrantMember 2020-09-24 2020-09-25 0001086745 AYRO:SeptemberWarrantMember 2020-10-01 2020-12-31 0001086745 AYRO:SeptemberWarrantMember 2022-12-31 0001086745 AYRO:SeriesAWarrantsAndSeriesBMember AYRO:SecuritiesPurchaseAgreementMember 2020-11-21 2020-11-22 0001086745 AYRO:SeriesAWarrantsMember AYRO:SecuritiesPurchaseAgreementMember 2020-11-22 0001086745 AYRO:SeriesBWarrantsMember AYRO:SecuritiesPurchaseAgreementMember 2020-11-22 0001086745 AYRO:SeriesAWarrantsMember AYRO:SecuritiesPurchaseAgreementMember 2022-12-31 0001086745 AYRO:SeriesBWarrantsMember AYRO:SecuritiesPurchaseAgreementMember 2022-12-31 0001086745 AYRO:NovemberFinderWarrantsMember 2020-11-22 0001086745 AYRO:NovemberPlacementAgentWarrantsMember 2020-11-22 0001086745 AYRO:NovemberPlacementAgentWarrantsMember 2020-11-21 2020-11-22 0001086745 AYRO:JanuaryTwentyTwentyOneOfferingMember AYRO:SecuritiesPurchaseAgreementMember 2021-01-24 2021-01-25 0001086745 AYRO:AdditionalSharesMember AYRO:SecuritiesPurchaseAgreementMember 2021-01-25 0001086745 AYRO:SecuritiesPurchaseAgreementMember 2021-01-24 2021-01-25 0001086745 AYRO:JanuaryTwentyTwentyOneOfferingMember AYRO:SecuritiesPurchaseAgreementMember 2021-01-25 0001086745 AYRO:SecuritiesPurchaseAgreementMember 2021-01-25 0001086745 AYRO:SecuritiesPurchaseAgreementMember 2022-12-31 0001086745 AYRO:FebruaryFinderWarrantsMember 2021-02-11 0001086745 AYRO:FebruaryFinderWarrantsMember us-gaap:CommonStockMember 2021-02-11 0001086745 AYRO:FebruaryPlacementAgentWarrantsMember 2021-02-11 0001086745 AYRO:FebruaryFinderWarrantsMember 2022-12-31 0001086745 AYRO:FebruaryPlacementAgentWarrantsMember 2022-12-31 0001086745 AYRO:SeriesHConvertiblePreferredStockMember 2022-01-01 2022-12-31 0001086745 AYRO:ConvertiblePreferredStockSeriesHThreeMember 2022-01-01 2022-12-31 0001086745 AYRO:SeriesHSixConvertiblePreferredStockMember 2022-01-01 2022-12-31 0001086745 AYRO:TwoThousandTwentyLongTermIncentivePlanMember 2022-12-31 0001086745 AYRO:TwoThousandTwentyLongTermIncentivePlanMember 2022-01-01 2022-12-31 0001086745 AYRO:TwoThousandSeventeenLongTermIncentivePlanMember 2022-12-31 0001086745 AYRO:TwoThousandFourteenEquityIncentivePlanMember AYRO:DropCarIncMember 2022-12-31 0001086745 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0001086745 us-gaap:EmployeeStockOptionMember 2022-12-31 0001086745 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-12-31 0001086745 us-gaap:EmployeeStockOptionMember 2022-05-05 2022-05-06 0001086745 AYRO:DirectorsMember us-gaap:RestrictedStockMember 2020-09-01 2020-09-30 0001086745 AYRO:DirectorsMember us-gaap:RestrictedStockMember 2022-01-01 2022-12-31 0001086745 AYRO:DirectorsMember us-gaap:RestrictedStockMember 2021-01-01 2021-12-31 0001086745 AYRO:KellerAwardMember us-gaap:RestrictedStockMember 2020-12-01 2020-12-31 0001086745 AYRO:KellerAwardMember us-gaap:RestrictedStockMember 2021-09-01 2021-09-30 0001086745 AYRO:KellerAwardMember us-gaap:RestrictedStockMember 2022-01-01 2022-12-31 0001086745 AYRO:KellerAwardMember us-gaap:RestrictedStockMember 2021-01-01 2021-12-31 0001086745 AYRO:DirectorsMember us-gaap:RestrictedStockMember AYRO:TwoThousandAndTwentyLongTermIncentivePlanMember 2021-02-23 2021-02-24 0001086745 AYRO:DirectorsMember us-gaap:RestrictedStockMember AYRO:TwoThousandAndTwentyLongTermIncentivePlanMember 2021-02-24 0001086745 AYRO:DirectorsMember us-gaap:RestrictedStockMember AYRO:TwoThousandAndTwentyLongTermIncentivePlanMember 2021-01-01 2021-12-31 0001086745 AYRO:ThomasMWittenschlaegerMember us-gaap:RestrictedStockMember 2021-09-01 2021-09-30 0001086745 AYRO:ThomasMWittenschlaegerMember us-gaap:RestrictedStockMember 2021-09-30 0001086745 AYRO:ThomasMWittenschlaegerMember us-gaap:RestrictedStockMember 2022-01-01 2022-12-31 0001086745 AYRO:ThomasMWittenschlaegerMember us-gaap:RestrictedStockMember 2021-01-01 2021-12-31 0001086745 AYRO:ThomasMWittenschlaegerMember us-gaap:RestrictedStockMember 2022-12-31 0001086745 srt:DirectorMember us-gaap:RestrictedStockMember 2022-01-29 2022-02-01 0001086745 srt:DirectorMember us-gaap:RestrictedStockMember 2022-02-01 0001086745 us-gaap:RestrictedStockMember 2022-12-31 0001086745 AYRO:DavidEHollingsworthMember us-gaap:RestrictedStockMember 2022-08-23 2022-08-23 0001086745 AYRO:DavidEHollingsworthMember us-gaap:RestrictedStockMember 2022-08-23 0001086745 us-gaap:RestrictedStockMember AYRO:DavidEHollingsworthMember 2022-01-01 2022-12-31 0001086745 us-gaap:RestrictedStockMember AYRO:DavidEHollingsworthMember 2021-01-01 2021-12-31 0001086745 AYRO:ResearchAndDevelopmentMember 2022-01-01 2022-12-31 0001086745 AYRO:ResearchAndDevelopmentMember 2021-01-01 2021-12-31 0001086745 AYRO:SalesAndMarketingMember 2022-01-01 2022-12-31 0001086745 AYRO:SalesAndMarketingMember 2021-01-01 2021-12-31 0001086745 AYRO:GeneralAndAdministrativeMember 2022-01-01 2022-12-31 0001086745 AYRO:GeneralAndAdministrativeMember 2021-01-01 2021-12-31 0001086745 us-gaap:RestrictedStockUnitsRSUMember 2020-12-31 0001086745 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-12-31 0001086745 us-gaap:RestrictedStockUnitsRSUMember 2021-12-31 0001086745 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0001086745 us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001086745 AYRO:SalesRevenueMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001086745 AYRO:OneCustomerMember AYRO:SalesRevenueMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001086745 AYRO:TwoCustomerMember AYRO:SalesRevenueMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001086745 AYRO:OneCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001086745 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember AYRO:OneSupplierMember 2022-01-01 2022-12-31 0001086745 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember AYRO:OneSupplierMember 2021-01-01 2021-12-31 0001086745 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember AYRO:TwoSupplierMember 2022-01-01 2022-12-31 0001086745 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember AYRO:TwoSupplierMember 2021-01-01 2021-12-31 0001086745 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember AYRO:ThreeSupplierMember 2022-01-01 2022-12-31 0001086745 srt:BoardOfDirectorsChairmanMember 2022-12-31 0001086745 AYRO:MasterManufacturingServicesAgreementMember AYRO:KarmaAutomotiveLLCMember 2020-09-24 2020-09-25 0001086745 AYRO:FirstProductionLevelBuildsMember AYRO:MasterManufacturingServicesAgreementMember AYRO:KarmaAutomotiveLLCMember 2020-09-24 2020-09-25 0001086745 AYRO:SetupCostsMember AYRO:MasterManufacturingServicesAgreementMember AYRO:KarmaAutomotiveLLCMember 2020-09-24 2020-09-25 0001086745 AYRO:AdvisorMember AYRO:MasterManufacturingServicesAgreementMember AYRO:KarmaAutomotiveLLCMember 2020-09-24 2020-09-25 0001086745 AYRO:MasterManufacturingServicesAgreementMember AYRO:FirstProductionLevelBuildsMember AYRO:KarmaAutomotiveLLCMember 2021-01-01 2021-12-31 0001086745 AYRO:MasterManufacturingServicesAgreementMember AYRO:FirstProductionLevelBuildsMember AYRO:KarmaAutomotiveLLCMember 2022-01-01 2022-12-31 0001086745 AYRO:MasterManufacturingServicesAgreementMember AYRO:FirstProductionLevelBuildsMember AYRO:KarmaAutomotiveLLCMember 2022-12-31 0001086745 AYRO:CenntroAutomotiveGroupLtdMember 2022-12-31 0001086745 2021-03-01 2021-03-31 0001086745 AYRO:NewLeaseAgreementMember 2021-03-01 2021-03-31 0001086745 AYRO:NewLeaseAgreementMember 2022-12-31 0001086745 AYRO:NewLeaseAgreementMember 2021-12-31 0001086745 AYRO:DropCarOperatingIncMember 2019-01-01 2019-01-02 0001086745 AYRO:DropCarOperatingIncMember 2021-12-31 0001086745 AYRO:DropCarOperatingIncMember 2022-01-01 2022-12-31 0001086745 us-gaap:DomesticCountryMember 2022-12-31 0001086745 us-gaap:DomesticCountryMember 2021-12-31 0001086745 us-gaap:StateAndLocalJurisdictionMember 2022-12-31 0001086745 us-gaap:StateAndLocalJurisdictionMember 2021-12-31 0001086745 AYRO:TaxCutsAndJobsActMember 2022-01-01 2022-12-31 0001086745 us-gaap:DomesticCountryMember 2022-01-01 2022-12-31 0001086745 country:GE 2022-01-01 2022-12-31 0001086745 us-gaap:RestrictedStockMember us-gaap:SubsequentEventMember 2023-01-26 2023-01-27 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-K

 

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended December 31, 2022

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ______ to _______

 

Commission file number: 001-34643

 

AYRO, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   98-0204758

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

900 E. Old Settlers Boulevard, Suite 100

Round Rock, Texas

  78664
(Address of principal executive offices)   (Zip Code)

 

(512) 994-4917
(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Exchange Act:

 

Title of each Class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.0001 per share   AYRO   The NASDAQ Stock Market, LLC

 

Securities registered pursuant to Section 12(g) of the Act: None

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.:

 

Large accelerated filer Accelerated filer
       
Non-accelerated filer Smaller reporting company
       
    Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. 

 

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐ *

 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐ *

 

*The registrant has included these items on the cover page but, in accordance with Release No. 33-11126, is not completing the relevant check boxes as it is not yet required to have a policy under an applicable exchange listing standard.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

 

The aggregate market value of voting stock held by nonaffiliates of the registrant as of June 30, 2022, the last business day of the registrant’s most recently completed second quarter, was $30,220,995, based on a closing price of $0.84 on June 30, 2022.

 

As of March 22, 2023 the registrant had 37,352,203 shares of common stock outstanding.

 

DOCUMENTS INCORPORATED BY REFERENCE

 

Portions of the definitive Proxy Statement of AYRO, Inc., relating to the Annual Meeting of Stockholders to be filed within 120 days after the end of the fiscal year covered by this Form 10-K, are incorporated into Part III of this Form 10-K by reference.

 

 

 

 
 

 

TABLE OF CONTENTS

 

    PAGE
     
Forward-Looking Statements; Risk Factor Summary  
PART I.    
Item 1. Business 5
Item 1A. Risk Factors 16
Item 1B. Unresolved Staff Comments 37
Item 2. Properties 37
Item 3. Legal Proceedings 37
Item 4. Mine Safety Disclosures 37
     
PART II    
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 38
Item 6. [Reserved] 38
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations 39
Item 7A. Quantitative and Qualitative Disclosures About Market Risk 51
Item 8. Financial Statements and Supplementary Data 51
Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosures 51
Item 9A. Controls and Procedures 52
Item 9B. Other Information 52
Item 9C. Disclosure Regarding Foreign Jurisdictions That Prevent Inspections 52
     
PART III    
Item 10. Directors, Executive Officers and Corporate Governance 53
Item 11. Executive Compensation 53
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 53
Item 13. Certain Relationships and Related Transactions, and Director Independence 53
Item 14. Principal Accountant Fees and Services 53
     
PART IV    
Item 15. Exhibits and Financial Statement Schedules 54
Item 16. Form 10-K Summary 54
     
Signatures   60

 

2
 

 

FORWARD-LOOKING STATEMENTS; RISK FACTOR SUMMARY

 

This Annual Report on Form 10-K contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of forward-looking terms such as “anticipates,” “assumes,” “believes,” “can,” “could,” “estimates,” “expects,” “forecasts,” “guides,” “intends,” “is confident that,” “may,” “plans,” “seeks,” “projects,” “targets,” and “would” or the negative of such terms or other variations on such terms or comparable terminology. Such forward-looking statements include, but are not limited to, future financial and operating results, the company’s plans, objectives, expectations and intentions, statements concerning the strategic review of our product development strategy and other statements that are not historical facts. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition, and results of operations. These forward-looking statements speak only as of the date of this Annual Report on Form 10-K and are subject to a number of risks, uncertainties, and assumptions that could cause actual results to differ materially from our historical experience and our present expectations, or projections described under the section in this Annual Report on Form 10-K entitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

 

A summary of the principal risk factors that make investing in our securities risky and might cause our actual results to differ materially from those projected in these forward-looking statements is set forth below. If any of the following risks occur, our business, financial condition, results of operations, cash flows, cash available for distribution, ability to service our debt obligations and prospects could be materially and adversely affected.

 

we may be acquired by a third party;
   
we have a history of losses and have never been profitable, and we expect to incur additional losses in the future and may never be profitable;
   
our failure to meet the continued listing requirements of The Nasdaq Capital Market could result in a delisting of our common stock;
   
if our Master Procurement Agreement with Club Car is terminated, we will need to identify new strategic channel partners to support the sales of our vehicles;
   
we rely on a single third-party supplier and manufacturer located in Canada for certain sub-assembly and assembly parts for the Vanish and any disruption in the operations of this third-party supplier could adversely affect our business and results of operations;
   
If we lose our exclusive license to manufacture the AYRO 411x model in North America, Cenntro could sell identical or similar products through other companies or directly to our customers;
   
we may be unable to replace lost manufacturing capacity on a timely and cost-effective basis, which could adversely impact our operations and ability to meet delivery timelines;
   
we may experience delays in the development and introduction of new products;
   
the market for our products is developing and may not develop as expected;
   
we are currently evaluating our product development strategy, which may result in significant changes and have a material impact on our business, results of operations and financial condition;
   
our business is subject to general economic and market conditions, including trade wars and tariffs;
   
our business, results of operations and financial condition may be adversely impacted by public health epidemics, including the COVID-19 outbreak;
   
if disruptions in our transportation network continue to occur or our shipping costs continue to increase, we may be unable to sell or timely deliver our products, and our gross margin could decrease;
   
our limited operating history makes evaluating our business and future prospects difficult and may increase the risk of any investment in our securities;
   
if we are unable to effectively implement or manage our growth strategy, our operating results and financial condition could be materially and adversely affected;
   
developments in alternative technologies or improvements in the internal combustion engine may have a materially adverse effect on the demand for our electric vehicles;
   
the markets in which we operate are highly competitive, and we may not be successful in competing in these industries;
   
a significant portion of our revenues is derived from a single customer and the anticipated loss of this customer could cause our sales to decrease significantly;
   
our future growth depends on customers’ willingness to adopt electric vehicles;
   
we may experience lower-than-anticipated market acceptance of our current models and the vehicles in development;
   
if we are unable to manage our growth and expand our operations successfully, our business and operating results will be harmed, and our reputation may be damaged;
   
if we fail to include key feature sets relative to the target markets for our electric vehicles, our business will be harmed;
   
unanticipated changes in industry standards could render our vehicles incompatible with such standards and adversely affect our business;
   
our future success depends on our ability to identify additional market opportunities and develop and successfully introduce new and enhanced products that address such markets and meet the needs of customers in such markets;
   
unforeseen or recurring operational problems at our facilities, or a catastrophic loss of our manufacturing facilities, may cause significant lost or delayed production and adversely affect our results of operations;
   
we may become subject to product liability claims, which could harm our financial condition and liquidity if we are not able to successfully defend or insure against such claims;
   
if our vehicles fail to perform as expected due to defects, our ability to develop, market and sell our electric vehicles could be seriously harmed
   
we depend on key personnel to operate our business, and the loss of one or more members of our management team, or our failure to attract, integrate and retain other highly qualified personnel in the future, could harm our business;
   
transitioning from an offshoring to an onshoring business model carries risk;
   
we currently have limited electric vehicles marketing and sales experience, and if we are unable to establish sales and marketing capabilities or enter into dealer agreements to market and sell our vehicles, we may be unable to generate any revenue;
   
failure to maintain the strength and value of our brand could have a material adverse effect on our business, financial condition and results of operations;
   
the range of our electric vehicles on a single charge declines over time, which may negatively influence potential customers’ decisions whether to purchase our vehicles;
   
an unexpected change in failure rates of our products could have a material adverse impact on our business, financial condition and operating results;

 

3
 

 

increases in costs, disruption of supply or shortage of raw materials, in particular lithium-ion battery cells, chipsets and displays, could harm our business;
   
customer financing and insuring our vehicles may prove difficult because retail lenders are unfamiliar with our vehicles and our vehicles have a limited loss history determining residual values within the insurance industry;
   
our electric vehicles make use of lithium-ion battery cells, which, if not appropriately managed and controlled, have occasionally been observed to catch fire or vent smoke and flames;
   
our business may be adversely affected by labor and union activities;
   
we rely on our dealers for the service of our vehicles and have limited experience servicing our vehicles, and if we are unable to address the service requirements of our future customers, our business will be materially and adversely affected;
   
if we fail to deliver vehicles and accessories to market as scheduled, our business will be harmed;
   
failure in our information technology and storage systems could significantly disrupt the operation of our business;
   
we may be required to raise additional capital to fund our operations, and such capital raising may be costly or difficult to obtain, and could dilute our stockholders’ ownership interests
   
our long-term capital requirements are subject to numerous risks
   
we may invest in or acquire other businesses, and our business may suffer if we are unable to successfully integrate acquired businesses into our company or otherwise manage the growth associated with multiple acquisitions;
   
increased safety, emissions, fuel economy or other regulations may result in higher costs, cash expenditures, and/or sales restrictions;
   
our vehicles are subject to multi-jurisdictional motor vehicle standards;
   
we may fail to comply with evolving environmental and safety laws and regulations;
   
changes in regulations could render our vehicles incompatible with federal, state or local regulations, or use cases;
   
unusual or significant litigation, governmental investigations or adverse publicity arising out of alleged defects in our vehicles, or otherwise, may derail our business;
   
we are required to comply with state-specific regulations regarding the sale of vehicles by a manufacturer;
   
we have identified a material weakness in our internal control over financial reporting, and if we are unable to remediate the material weakness, or if we experience additional material weaknesses in the future, our business may be harmed;
   
if we are unable to adequately protect our proprietary designs and intellectual property rights, our competitive position could be harmed;
   
we may need to obtain rights to intellectual property from third parties in the future, and if we fail to obtain licenses or fail to comply with our obligations in existing agreements under which we have licensed intellectual property and other rights from third parties, we could lose our ability to manufacture our vehicles;
   
many of our proprietary designs are in digital form, and a breach of our computer systems could result in these designs being stolen;
   
our proprietary designs are susceptible to reverse engineering by our competitors;
   
if we are unable to protect the confidentiality of our trade secrets or know-how, such proprietary information may be used by others to compete against us;
   
legal proceedings or third-party claims of intellectual property infringement and other challenges may require us to spend substantial time and money and could harm our business;
   
we are generally obligated to indemnify our sales channel partners, customers, suppliers and contractors for certain expenses and liabilities resulting from intellectual property infringement claims regarding our products, which could force us to incur substantial costs;
   
we are subject to exposure from changes in the exchange rates of local currencies; and
   
we are subject to governmental export and import controls that could impair our ability to compete in international markets due to licensing requirements and subject us to liability if we are not in compliance with applicable laws.

 

For a more detailed discussion of these and other factors that may affect our business and that could cause our actual results to differ materially from those projected in these forward-looking statements, see the risk factors and uncertainties set forth in Part I, Item 1A of this Annual Report on Form 10-K. Any one or more of these uncertainties, risks and other influences could materially affect our results of operations and whether forward-looking statements made by us ultimately prove to be accurate. We undertake no obligation to publicly update or revise any forward-looking statements, whether from new information, future events or otherwise, except as required by law.

 

4
 

 

PART I

 

ITEM 1. BUSINESS.

 

On May 28, 2020, pursuant to the previously announced Agreement and Plan of Merger, dated December 19, 2019 (the “Merger Agreement”), by and among AYRO, Inc., a Delaware corporation previously known as DropCar, Inc. (“DropCar”), ABC Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Company (“Merger Sub”), and AYRO Operating Company, Inc., a Delaware corporation previously known as AYRO, Inc. (“AYRO Operating”), Merger Sub was merged with and into AYRO Operating, with AYRO Operating continuing after the merger as the surviving entity and a wholly owned subsidiary of the Company (the “Merger”). In this Annual Report on Form 10-K, unless the context otherwise requires, references to “we,” “us,” “our,” “our company,” “AYRO” and “Company” refer to AYRO, Inc. and its subsidiaries.

 

Overview

 

We design and manufacture compact, sustainable electric vehicles for closed campus mobility, low speed urban and community transport, local on-demand and last mile delivery and government use. Our four-wheeled purpose-built electric vehicles are geared toward commercial customers, including universities, business and medical campuses, last mile delivery services and food service providers. We are currently updating our model year 2023 vehicle lineup in support of the aforementioned markets.

 

Strategic Review

 

Following the hiring of our current Chief Executive Officer in the third quarter of 2021, we initiated a strategic review of our product development strategy, as we focus on creating value within the electric vehicle, last-mile delivery, smart payload and enabling infrastructure markets. In connection with our strategic review, we have cancelled all material research and development activity and expenditures, associated with our planned next-generation three-wheeled high speed vehicle.

 

For the past several years, our primary supplier has been Cenntro Automotive Group, Ltd. (“Cenntro”), which operates a large electric vehicle factory in the automotive district in Hangzhou, China. As a result of rising shipping costs, quality issues with certain components and persistent delays, we ceased production of the AYRO 411x from Cenntro in September 2022 in order to focus our resources on the development and launch of the new 411 fleet vehicle model year 2023 refresh, the Vanish.

 

Products

 

Our vehicles provide the end user an environmentally friendly alternative to internal combustion engine vehicles (cars powered by gasoline or diesel oil), for light duty uses, including low-speed logistics, maintenance services, cargo services, and personal/group transport in a quiet, zero emissions vehicle with a lower total cost of ownership.

 

AYRO 411x

 

The AYRO 411x is an electric, four-wheel, compact, light-duty utility trucks sold exclusively through our contracted partner, Club Car, as part of a global multi-year sustainability solution development, sales and marketing agreement.

 

AYRO Vanish

 

In December 2021, we began design and development of the Vanish, including updates to our supply chain evolution, the offshoring/onshoring mix, our manufacturing strategy and our annual model year refresh program. We unveiled the first Vanish prototype in the fourth quarter of 2022. Pre-production was completed in December 2022 and we expect to begin accepting pre-orders in the second quarter of 2023.

 

There will be three members of the AYRO Vanish fleet of vehicles (the “AYRO Vanish Fleet”):

 

The Vanish Cargo Van Box, a fully enclosed cargo box, which may be internally tailored for use;
The Vanish Flatbed truck, which provides users with considerable versatility; and
The Vanish Pickup truck, generally utilized for open air hauling.

 

5
 

 

Each member of the AYRO Vanish Fleet will be classified as a street legal low speed vehicle (“LSV”) or non-LSV variant, defined as a four wheeled motor vehicle, other than an all-terrain vehicle, that is capable of reaching speeds of at least 20 miles per hour (“mph”) but not greater than 25 mph. The AYRO Vanish Fleet is expected to have a maximum payload capacity of 1,500 pounds. The AYRO Vanish is 13 feet long and can use either a conventional 120V or 240V wall outlet or can be configured for a J1772 charger. The “non-LSV” variant has a higher payload capacity of 1,800 pounds.

 

All three platforms will share identical components on common chassis architectures
Spare and maintenance parts will identical for all three platforms
Communication, application, and web-enabled software
Allows for conversion into an autonomous platform
Cost savings from reduced fleet size, reduced insurance overhang, common logistics, and application-enabled operational efficiencies.

 

The AYRO Vanish Fleet will have an expected range of over 50 miles and an expected maximum speed of 25 mph. in line with the United States Department of Transportation regulations for LSVs and with most state statutes, which typically limit the speed of LSVs to 25 mph or 35 mph posted roads.

 

The Company estimates that the AYRO Vanish Fleet’s operating costs will be approximately 50% lower per year compared to similarly sized gas-powered trucks and vans. The vehicles are primarily sourced from North America and Europe, with vehicle final assembly and integration occurring in our Round Rock, Texas facility, thus ameliorating concerns regarding rising costs of trans-Pacific shipping, shipping times, import duties and quality.

 

Additional Models, Vehicles, Payloads and Infrastructure

 

We continue to invest in expanding our existing all-electric vehicle technologies, reconfigurable cargo subsystems, onboard and web-based fleet support applications, driver support systems and applications, as well as architectural innovations that maximize subsystem commonality across the AYRO vehicle fleet. Our product line roadmap contemplates growing our fleet of purpose-engineered vehicles and services with every passing model year, with a focus on the low-speed vehicle segment, last mile delivery of a plurality of payloads, and potential line extension into efficient, safe micro-mobility platforms.

 

We are also currently in discussions with a key supply partner on positioning the model year 2023 Vanish for sale on the General Services Administration schedule (“GSA Schedule”). The GSA Schedule is a long-term government-wide contract with commercial companies that provides access to millions of commercial products and services at pre-negotiated prices. This would represent an increase of the total addressable market for the Company and further represent a demand hedge to the cyclicality of markets currently addressed.

 

6
 

 

Manufacturing and Supply Chain

 

Manufacturing Agreement with Cenntro

 

In 2017, AYRO Operating partnered with Cenntro in a supply chain agreement to provide sub-assembly manufacturing services. Cenntro owns the design of the AYRO Club Car 411 and 411x (“AYRO 411 Fleet”) vehicles and has granted us an exclusive license to purchase the AYRO 411 Fleet vehicles for sale in North America.

 

Under our Manufacturing License Agreement with Cenntro (the “Cenntro MLA”), in order for us to maintain our exclusive territorial rights pursuant to the Cenntro MLA, we must meet certain minimum purchase requirements.

 

We imported semi-knocked-down vehicle kits from Cenntro for the AYRO 411x models comprising our model year 2022 lineup. The vehicle kits were received through shipping containers at the assembly facility of Karma Automotive LLC (“Karma”), our previous manufacturing partner in southern California, as well as at our customization, service and integration facility in Round Rock, Texas. The vehicles were then assembled with tailored customization requirements per order.

 

On May 31, 2022, we received a letter from Cenntro purporting to terminate all agreements and contracts between the Company and Cenntro. Although we do not believe Cenntro’s termination of the Cenntro MLA is valid, we have determined to cease production of the AYRO 411x and focus our resources on the development and launch of the Vanish. We have canceled all purchase orders and future builds with Cenntro and currently intend to only order replacement parts for vehicles from Cenntro in the future. Cenntro inventory remaining on hand as of December 31, 2022 was $244,902. We expect to lose our exclusive license under the Cenntro MLA, in which case Cenntro could sell identical or similar products through other companies or directly to our customers, which could have a material adverse effect on our results of operations and financial condition.

 

We intend for the new Vanish to utilize assemblies and products that will largely eliminate our dependency on Chinese imports and optimize the supply chain to rely primarily upon North American and European sources. Final assembly of the Vanish will occur in our Round Rock, Texas facilities.

 

Manufacturing Agreement with Linamar

 

On July 28, 2022, we partnered with Linamar Corporation (“Linamar”), a Canadian manufacturer, in a manufacturing agreement (the “Linamar MLA”) to provide certain sub assembly and assembly parts, including the cabin frame and skate for the Vanish (collectively, the “Products”). During the term of the Linamar MLA, Linamar has the exclusive right to supply the Products to the Company, subject to certain exceptions. The Linamar MLA has an initial term of three years and will automatically renew for successive two-year terms unless either party has given at least 12 months’ written notice of nonrenewal. Either party may terminate the Linamar MLA at any time upon 12 months’ written notice, and in the event of a change in control of the Company prior to the end of the initial term, we may terminate upon written notice within three days of completion of such change in control.

 

In the event we terminate the Linamar MLA prior to its expiration, whether following a change in control or otherwise, we must purchase any remaining raw material inventory, finished goods inventory and work in progress and any unamortized capital equipment used in production and testing of the Products and pay a termination fee of $750,000, subject to certain adjustments. We are dependent on the Linamar MLA, and in the event of its termination our manufacturing operations and customer deliveries would be materially impacted.

 

Under the Linamar MLA, we must commit to certain minimum purchases, to be determined by AYRO on a quarterly basis.

 

We import the Products from Linamar in Canada, and we manufacture and assemble the Vanish at our customization, service, and integration facility in Round Rock, Texas. Over 98% of the vehicle assemblies, components, and products are from North American and European sources.

 

Assembly and Integration

 

For assembly, tailoring, diagnostics testing and service of the Vanish, we currently occupy 24,000 square feet of office and manufacturing space configured in a “U”-shaped assembly line with multiple stations per vehicle in our Round Rock, Texas facility. The chart below indicates the estimated number of vehicles that can be assembled per month and the assembly time required for each. Assembly time also includes USDOT quality checks and testing as the final step of the assembly process. The number of vehicles indicated below assumes a single shift.

 

Vehicle  Assembly time
(Man-Hours)
   Vehicle Assembly
Capacity per month
 
AYRO Vanish   20    170 

 

7
 

 

Supply Agreement with Gallery Carts

 

During 2020, we entered into a supply agreement with Gallery Carts, a leading provider of food and beverage kiosks, carts, and mobile storefront solutions. Joint development efforts have led to the launch of the parties’ first all-electric configurable mobile hospitality vehicle for “on-the-go” venues across the United States. This innovative solution permits food, beverage and merchandising operators to bring goods directly to consumers.

 

The configurable Powered Vendor Box, in the rear of the vehicle, features long-life lithium batteries that power the preconfigured hot/cold beverage and food equipment is directly integrated with the 411x and will be directly integrated with the Vanish. The canopy doors, as well as the full vehicle, can be customized with end-user logos and graphics to enhance the brand experience. Gallery, with 40 years of experience delivering custom food kiosk solutions, has expanded into electric mobile delivery vehicles, as customers increasingly want food, beverages and merchandise delivered to where they are gathering. For example, a recent study conducted by Technomic found that a large majority of students, 77%, desired alternative mobile and to-go food options on campuses.

 

Gallery, a premier distributor of AYRO vehicles, has a diverse clientele throughout mobile food, beverage and merchandise distribution markets for key customer applications such as university, corporate and government campuses, major league and amateur-level stadiums and arenas, resorts, airports and event centers. In addition to finding innovative and safe ways to deliver food and beverages to their patrons, reducing and ultimately eliminating their carbon footprint is a top priority for many of these customers.

 

Business Strategy

 

Our goal is to continue to develop and commercialize automotive-grade, sustainable electric transportation solutions for the markets and use cases that we believe can be well served by our purpose-built, street legal low speed electric vehicles. Our business strategy includes the following:

 

8
 

 

  Scale up our operations to achieve growth. We intend to direct resources to scale up our operations, which we believe is needed to increase our revenue, including expanding and optimizing our automotive component supply chain and our flow-based assembly operations in Round Rock, Texas. Further, we plan to expand sales territories and add distribution channels, forming strategic partnerships to build out our whole product offering across multiple segments and to access additional sales channels or to accelerate product adoption for particular vertical markets, building our brand, and increasing manufacturing capacity to produce higher volumes of electric vehicles. Importantly, we are pursuing a strategy to increase our North American content in our vehicle platforms, starting with the AYRO Vanish Fleet.

 

  Identify defined markets and use cases which are currently under-served but represent sizable market opportunity sub-sets of the electric vehicle market and focus development efforts on purpose-built electric vehicles to address such markets. We are currently developing a new series of modular, highly reconfigurable payload systems affording operators the maximum flexibility in the use of their fleet for a plurality of payloads. We intend to direct resources to advance the development of such reconfigurable payload solutions which we believe will afford customers the option of sharing transportation assets or configuring those assets differently for differing time of day or time of season use cases.

 

  Invest in research and development and qualification of sensors, cameras, software and mobility services, seeking to enhance the value of using our electric vehicles and to derive incremental potential revenue streams for us and our partner ecosystem. We intend to offer a web-based application to accompany every vehicle sold or leased beginning with the AYRO Vanish Fleet to enhance the use cases for those vehicles and optimize driver routing, user scheduling, and customer communication. We intend for onboard sensors will collect vehicle health, location data, route data, payload data and environmental data to provide us, the customer and fleet operators the ability to do post-hoc analysis of forecast versus observed delivery efficiency. A subscription service could later be offered even to delivery operators operating vehicles other than ours, creating the potential for an additional revenue stream.

 

Trends Driving the Need for Electric Vehicles

 

The U.S. electric vehicle market is forecasted to grow substantially in the years ahead, driven by factors such as the country’s increasingly urbanized population, escalating gas prices and increased desirability of non-emissive transportation alternatives.

 

A segment of the electric vehicle market, low speed electric vehicles (“LSEVs”)—which are LSVs but cannot be powered by gas or diesel fuel—are growing increasingly popular as eco-friendly options for consumers and commercial entities. LSEVs run on electric motors fueled by a variety of different batteries, such as lithium ion, molten salt, zinc-air and various nickel-based designs.

 

Trends such as increasingly stringent government regulations aimed toward reducing vehicle emissions, growing urban populations and social pressure to adopt sustainable lifestyles all create a demand for more ecologically and economically sustainable methods of transportation. This demand continues to spur technological advancements and LSEV market growth.

 

Expanding rules and regulations governing vehicle emissions have contributed to growth in the LSEV market. In particular, the U.S., Germany, France, and China have implemented stringent laws and regulations governing vehicular emissions, requiring automobile manufacturers to use advanced technologies to combat high-emission levels in vehicles. To incentivize clean-energy use, many governments are increasingly instituting substantial incentives for consumers to purchase electric vehicles, such as:

 

tax credits, rebates, and exemptions;
   
reduced utility rates; and
   
parking incentives.

 

Further, governments are establishing infrastructure benchmarks to support the growth of the electric vehicle industry.

 

9
 

 

Competition and Market Opportunities

 

The worldwide automotive market, particularly for economy and alternative fuel vehicles, exhibits a high competitive intensity, especially amongst tier 1 competitors. The relatively modest LSEV market, being smaller in overall size, engenders a more modest competitive intensity. A few notable companies in the global LSEV market include HDK Electric Vehicles, Bradshaw Electric Vehicles, Textron Inc., Polaris Industries, Yamaha Motors Co. Ltd., Ingersoll Rand, Inc., Speedway Electric, AGT Electric Cars, Bintelli Electric Vehicles and Ligier Group.

 

When compared to internal combustion engine vehicle costs, our vehicles are significantly more attractive based on tax, title and license fees. Compared to a standard Ford F150 (gasoline) pickup truck (2.7 liter), the AYRO Vanish Fleet is expected to provide an approximate 49% reduction in operating expenses and an approximate 100% reduction in CO2 emissions (if renewed energy is used to charge the AYRO vehicles, an increasing trend for most higher education campuses and government facilities).

 

Our closest competitor in the LSEV industry is the WAEV, Inc. (formerly Polaris) Gem (“Gem”). WAEV offers multiple passenger vehicle models and multiple utility vehicle models under the WAEV and Taylor-Dunn brands. While the GEM el XD model, which is similar to vehicles in the AYRO 411x Fleet, has a lower starting MSRP than the AYRO 411x, the GEM el XD requires reconfiguration to match the standard AYRO 411x features, raising the final MSRP of each vehicle above that of the AYRO 411x Fleet alternative and above the expected MSRP of the Vanish. The AYRO 411x Fleet has, and the Vanish is expected to have, a greater bed and box capacity, 13% more horsepower and a 48% better turning radius, allowing use of our in tighter spaces than are possible using the GEM el XD.

 

We expect competition in our industry to intensify over time. Factors affecting competition include product quality and features, innovation and development time, pricing, reliability, safety, customer service and financing terms. Increased competition may lead to lower vehicle unit sales and increased inventory, which may result in downward price pressure and may adversely affect our business, financial condition, operating results and prospects. Our ability to successfully compete in our industry will be fundamental to our future success in both existing and new markets and our market share. There can be no assurances that we will be able to compete successfully in our markets. If our competitors introduce new cars or services that compete with or surpass the quality, price or performance of our vehicles or services, we may be unable to satisfy existing customers or attract new customers at the prices and levels that would allow us to generate attractive rates of return on our investment. Increased competition could result in price reductions and revenue shortfalls, loss of customers and loss of market share, which could harm our business, prospects, financial condition and operating results.

 

Factors that are anticipated to boost the demand of LSV markets in North America include: rising elderly population, commuters, students and government fleets seeking mobility solutions beyond automobiles, and projections of lower vehicle mils and greenhouse gas emissions in the U.S.

 

Target Markets

 

Our target market segment straddles the range of a converted golf cart to a small pickup truck. This “hybrid” market allows for cannibalization of both adjacent markets by AYRO. The multipurpose applications and clean energy use of LSEVs make them popular across a wide array of industries and customers, including college and university campuses, resorts and hotels, corporate parks, hospitals, warehouses, individual consumers, last mile delivery service providers, municipalities, and the food service industry. A number of these market segments, and our competitive position within them, are discussed in greater detail below.

 

Universities. LSEVs are growing increasingly common on university and college campuses due to a number of factors. LSEVs fulfil the versatile needs of campuses better than golf carts or standard combustion vehicles because not only do LSEVs’ low speed thresholds promote safer driving among pedestrians, but the vehicles are also street legal with on-road safety features, enabling drivers to drive on roads and free up pedestrian space along sidewalks and smaller pathways. Additionally, the significantly reduced carbon imprint of LSEVs compared to internal combustion engine vehicles appeals to environmentally aware students and professors looking to promote environmental sustainability on campus. By transitioning from internal combustion engine vehicles to LSEVs, campuses should be able to reduce significantly the costs spent on fuel, oil, parts, and maintenance. We believe the AYRO Vanish Fleet will provide all of these benefits to university and college campuses. We estimate that in the U.S., there are over 1,800 higher education campuses with over 10,000 students each with over 400 on-campus vehicles that are ideal targets for the AYRO Vanish Fleet as campuses transition from fossil-fueled campus fleet vehicles to LSEVs.

 

Food Delivery Services. As the millennial generation assumes a more substantial portion of the consumer population, customers increasingly favor convenience and timeliness, spurring dramatic growth in online ordering and delivery services across a wide swath of industries, including food delivery and restaurant ordering services. Food delivery sales are anticipated to increase over 20% per year, culminating in an expected $365 billion worldwide by 2030, according to Upserve. Upserve further estimates that approximately 60% of U.S. consumers report that they order delivery or takeout at least once a week. Within the next decade, potentially over 40% of restaurant sales will be attributable to delivery services, according to Morgan Stanley. Every major urban environment having a 35mph or less speed limit is a target market for our current and future LSV fleet.

 

10
 

 

Last Mile Delivery Service. Retail focus on last mile delivery—the movement of goods from a transportation hub to the final delivery destination—has grown exponentially over the past few years due to the rise in online ordering and e-commerce. Consumers’ ability to pick and choose products based on delivery speed and availability makes last mile delivery a key differentiator among retailers. Last mile delivery provides retailers timelier and more convenient delivery options not offered by the main three shipping services in the U.S. (the U.S. Postal Service, FedEx, and UPS). Additionally, given the increasing designation of low emission zones in urban centers, retailers will need to continue to deploy eco-friendly vehicles. Retailers will likely expand the use of LSEV fleets to make deliveries in low emission zones due to their zero gas emissions and lower price than competing electric vehicles.

 

Municipalities. As more city governments adopt regulations geared toward reducing pollution from vehicles, cities are increasingly looking to replace their municipal vehicles with zero-emission fleets. Such fleet overhauls, however, can be costly. LSEVs are a cheaper and more practical option for cities daunted by the cost of standard electronic vehicles. Our LSEVs have both on and off-road capabilities, making them particularly versatile for municipalities.

 

On-Road and Personal Transportation. LSEVs offer a feasible and practical method of transportation, especially in urban centers. Because our LSEVs are street-legal, they offer city dwellers a more sustainable, cost-efficient, easily maneuverable, compact and light weight option compared to internal combustion engine vehicles. Our LSEVs also offer a variety of specifications and equipment, meaning that consumers do not have to sacrifice comfort or convenience.

 

We primarily focus on the LSEV North American market, which is highly competitive and constitutes 28% of the global LSEV market according to WiseGuy Reports. We have examined various considerations with regard to our market impact, including cost comparisons to existing vehicles in the market, market validation and target commercial markets.

 

Resources

 

We sourced our semi-knocked-down kits for the model year 2022 AYRO 411 and 411x from Cenntro. While many of their components are commercial off-the-shelf (“COTS”) parts, many are specific to the 411 product and are subject to raw material limitations. However, for AYRO Vanish, we have endeavored to reduce our supply risk by migrating our vehicle supply chain to the North American continent and by embracing parts and sub-assembly standardization, reducing discrete stock keeping units and simplifying logistical complexity.

 

11
 

 

Intellectual Property

 

As we expand our vehicle and service roadmaps, and integrated technologies, our focus on identifying specific market and customer needs continues to drive purpose-built engineering efforts.

 

Leveraging the all-electric AYRO 411x and Vanish Fleet LSVs, we intend to develop applications or use case solutions optimized for the logistics of storing and delivering food, beverages, merchandise, equipment, tools and related goods. This is accomplished by integrating application-specific appliances, storage facilities, vehicle wraps and related items. We will leverage either integrated traction or a separate battery power system to provide AC power to the various appliances and solution elements. We are filing and have filed a number of provisional utility and/or design patents associated with the aforementioned verticalization development, and we have filed for both domestic and international trademarks to cover the company name, company logo, and certain other key product and service marks. We continue to focus on innovative and applicable electric vehicle optimization designs that serve an expanding customer and application use base.

 

Patents

 

We currently have United States registrations for two design patents. Both were issued on February 11, 2020 and will expire on February 11, 2035. In addition to these issued patents, we have numerous non-public patent applications on file with the United States Patent and Trademark Office (“USPTO”).

 

We currently have United States applications for two design patents and two utility patents awaiting examination. Reference number 58929.11US01 was filed on March 10, 2022 for Electric Vehicle Structure. Reference number 58929.12US01 was filed on April 12, 2022 for Electric Vehicle Control Systems, Apparatus, and Methods. Reference number 58929.23US01 was filed on May 20, 2022 for Reconfigurable Vehicle Payload Architecture. Reference number 58929.25US01 was filed on June 21, 2022 for Systems and Methods for Residual Tire Track Shaping and Elimination.

 

All patents have been filed under accelerated consideration criteria due to the age (65) of the named inventor.

 

Trademarks

 

We have two granted trademark applications in the United States and abroad. We registered the word “AYRO” as United States Registration No. 88431321 on June 23, 2020. This registration was also filed in Canada, Mexico, and the European Union under the Madrid Protocol as Registration No. 1507096. Our Company logo was registered as United States Registration No. 88859276 on October 13, 2020. This logo was also registered in Canada, Mexico, and the European Union under the Madrid Protocol as Registration No. 1554092. Our application for the color version of our Company logo was filed in the United States on October 9, 2020 as Serial No. 90245135 and is currently in prosecution with the USPTO.

 

Currently, we have eight trademarks pending, including a logo refresh and the AYRO Valet, Vapor, and Vanish trademarks.

 

Government Regulations

 

Many governmental standards and regulations relating to safety, fuel economy, emissions control, noise control, vehicle recycling, substances of concern, vehicle damage, and theft prevention are applicable to new motor vehicles, engines, and equipment manufactured for sale in the United States, Europe, and elsewhere. In addition, manufacturing and other automotive assembly facilities in the United States, Europe, and elsewhere are subject to stringent standards regulating air emissions, water discharges, and the handling and disposal of hazardous substances. The most significant standards and regulations affecting AYRO are discussed below.

 

12
 

 

Mobile Source Emissions Control

 

The federal Clean Air Act imposes stringent limits on the amount of regulated pollutants that may be lawfully emitted by new vehicles and engines produced for sale in the United States. The current (“Tier 2”) emissions regulations promulgated by the Environmental Protection Agency (the “EPA”) set standards for motorcycles. Tier 2 emissions standards also establish durability requirements for emissions components up to 5 years or 30,000 kilometers.

 

California has received a waiver from the EPA to establish its own unique emissions control standards for certain regulated pollutants. New vehicles and engines sold in California must be certified by the California Air Resources Board (“CARB”). CARB’s emissions standards for motorcycles are in line with those of the EPA. We currently expect that our vehicles will meet and exceed both the EPA’s and CARB’s standards.

 

Motor Vehicle Safety

 

The National Traffic and Motor Vehicle Safety Act of 1966, or “Safety Act,” regulates vehicles and vehicle equipment in two primary ways. First, the Safety Act prohibits the sale in the United States of any new vehicle or equipment that does not conform to applicable vehicle safety standards established by the National Highway Traffic Safety Administration (“NHTSA”). Meeting or exceeding NHTSA safety standards is costly, in part because the standards tend to conflict with the need to reduce vehicle weight in order to meet emissions and fuel economy standards. Second, the Safety Act requires that defects related to motor vehicle safety be remedied through safety recall campaigns. A manufacturer is obligated to recall vehicles if it determines the vehicles do not comply with a safety standard. If we or NHTSA determine that either a safety defect or noncompliance exists with respect to any of our vehicles, the cost of such recall campaigns could be substantial.

 

U.S. Environmental Protection Agency (“EPA”) Certification

 

Our product programs are built on plug-in electric, zero emissions platforms. We report federal and state emissions data consistent with 10 CFR 474 and CARB requirements for Zero-Emission Vehicle certification.

 

Electromagnetic Compatibility

 

The Federal Communications Commission is the federal agency responsible for implementing and enforcing communications law and regulations, including Part 15 of Title 47 of the Code of Federal Regulations which regulates unlicensed radio-frequency transmissions, both intentional and unintentional. With very few exceptions, all electronic devices must be reviewed to comply with Part 15 before they can be advertised or sold in the U.S. market.

 

Motor Vehicle Manufacturer and Dealer Regulation

 

As with helmet laws and driver’s license requirements, state laws that regulate the manufacture, distribution, and sale of motor vehicles are a patchwork. For our electric vehicles, outside of our collaboration with a third-party sales/distribution white label partner, we plan on a multi-faceted approach to sales, including exploring the following: (i) developing an expanded network of channel partners; (ii) entering into direct sales via a national leasing company that will in turn consummate sales with end users in a variety of states; and/or (iii) opening facilities in high growth states and delivering the vehicle to the end user via a common carrier. On December 20, 2022, we completed pre-production on our Model Year 2023 refresh vehicle, the AYRO Vanish. The Vanish will share no commonality with the legacy 411 platform and will be the product of a supply chain evolution from Asian suppliers to North America.

 

We are registered as a manufacturer in Texas, California, Colorado, Louisiana, Florida and Arizona.

 

Pollution Control Costs

 

We are required to comply with stationary source air pollution, water pollution, and hazardous waste control standards that are now in effect or are scheduled to come into effect with respect to our manufacturing operations.

 

Research and Development

 

Our product development and engineering efforts align with the Society of Automotive Engineering (“SAE”) J2258_201611 standards for Light Utility Vehicles. The J2258 standard provides key compliance criteria for Gross Vehicle Weight Rating (“GVWR”), occupant protection and safety restraint systems, lateral and longitudinal stability, center of gravity and operating controls, among others. Our test validation and inspection standards follow Federal Motor Vehicle Safety Standards (“FMVSS”) 49 CFR 571.500 for LSVs with the additions of SAE J585 and FMVSS 111 for rear visibility, lighting, signaling, reflectors, changes in direction of movement, back-up camera response timing and field of view.

 

Our development standards and test compliance validation processes are supported by a variety of test documentation, including supplier self-reporting, third party laboratory test reports and regional compliance validation with CARB for speed, range and environmental performance.

 

13
 

 

Our production system follows a lean, cell-based manufacturing model. The process involves the following five sequential cells: (1) cab preparation, (2) chassis preparation, (3) system integration and testing, (4) final assembly and integration test, and (5) quality assurance and FMVSS Compliance. Assembly quality and shift efficiency metrics are measured daily by our production staff at the end of every shift.

 

We maintain a certification and compliance checklist for each vehicle. Our vehicles use an automotive style steering wheel, turn signal stalk, headlight, running light and reverse light controls, a multi-speed windshield wiper and washer, and an accelerator and brake pedal consistent with controls employed in standard passenger cars.

 

Segment Information

 

We operate as one reportable segment, which is the design, development, manufacturing and sales of electric vehicles.

 

Employees

 

As of December 31, 2022, we had 44 full-time employees. None of our employees are represented by a labor union, and we maintain good relations with our employees. We have not furloughed employees due to the COVID-19 pandemic. In an effort to attract and retain quality employees, we offer industry-standard compensation and benefits packages to our employees and prospective employees.

 

Geographic Areas

 

We operate in the United States, and all our revenue was generated in the United States during the fiscal year ended December 31, 2022.

 

Corporate Information

 

Our corporate headquarters is located at 900 E. Old Settlers Blvd, Round Rock, Texas 78664. Our phone number is 512-994-4917. Our website address is www.ayro.com. The information on, or that can be accessed through, our website is not incorporated by reference into this Annual Report. We currently lease approximately 23,927 square feet of office and warehouse space under a lease that expires on February 28, 2027.

 

Available Information

 

We are required to file Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q with the Securities and Exchange Commission (“SEC”) on a regular basis, and are required to disclose certain material events in Current Reports on Form 8-K. The SEC maintains an Internet website that contains reports, proxy and information statements and other information regarding issuers that file electronically with the SEC. The SEC’s Internet website is located at http://www.sec.gov. We also make available, free of charge, our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to these reports on our website at www.ayro.com as soon as reasonably practicable after those reports and other information is electronically filed with, or furnished to, the SEC.

 

14
 

 

ITEM 1A. RISK FACTORS

 

Our business, financial condition and operating results can be affected by a number of factors, whether currently known or unknown, including but not limited to those described below, any one or more of which could, directly or indirectly, cause our actual financial condition and operating results to vary materially from past, or from anticipated future, financial condition and operating results. Any of these factors, in whole or in part, could materially and adversely affect our business, financial condition, operating results and stock price. The following discussion of risk factors contains forward-looking statements. See “Forward-Looking Statements; Risk Factor Summary.” These risk factors may be important to understanding other statements in this Annual Report on Form 10-K.

 

Risks Related to Our Business

 

We may be acquired by a third party.

 

Pursuant to a five-year Master Procurement Agreement with Club Car (the “MPA”), we granted Club Car a right of first refusal for sales of 51% or more of AYRO Operating’s assets or equity interests, which right of first refusal is exercisable for a period of 45 days following delivery of an acquisition notice to Club Car.

 

We have a history of losses and have never been profitable. We expect to incur additional losses in the future and may never be profitable.

 

We have never been profitable or generated positive cash flow from our operations. We have incurred a net loss in each year since our inception in 2016 and have generated limited revenues since inception, principally as a result of our investments in building infrastructure in support of our manufacturing and business operations and plans for growth. We experienced net losses of approximately $22.9 million and $33.1 million for the years ended December 31, 2022 and 2021, respectively. As of December 31, 2022, we had an accumulated deficit of approximately $81.1 million. We may incur significant additional losses as we continue to focus our resources on scaling up our operations for growth and incur significant future expenditures for research and development, sales and marketing, and general and administrative expenses, capital expenses and working capital fluctuations.

 

Our ability to generate revenue and achieve profitability depends mainly upon our ability, alone or with others, to successfully market our products to meet the market demand and maintain compliance with the rules, regulations and laws of federal, state, local and international governmental bodies. We may be unable to achieve any or all of these goals with regard to our products. Our future vehicle roadmap requires significant investment prior to commercial introduction, but these vehicles may never be successfully designed, engineered, manufactured or sold. Moreover, scaling up of our operations, launching additional products and expanding our sales territories will require significant additional investment. We will continue to incur losses until such time that our vehicle sales volume supports our underlying overhead costs. As a result, we may never be profitable or achieve significant and/or sustained revenues. Even if we are successful in generating revenue and increasing our customer base, we may not become profitable in the future or may be unable to maintain any profitability achieved if we fail to increase our revenue and manage our operating expenses or if we incur unanticipated liabilities.

 

Our failure to meet the continued listing requirements of The Nasdaq Capital Market could result in a delisting of our common stock.

 

As previously reported, on October 3, 2022, we received a letter from Nasdaq indicating that, based upon the closing bid price of the Company’s common stock for the 30 consecutive business day period between August 19, 2022 and September 30, 2022, we did not meet the minimum bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2). In order to regain compliance with Nasdaq’s minimum bid price requirement, our common stock must maintain a minimum closing bid price of $1.00 for at least ten consecutive business days during the Compliance Period. In the event that we do not regain compliance by the end of the Compliance Period, we may be eligible for additional time to regain compliance. To qualify, we will be required to meet the continued listing requirement for the market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the bid price requirement, and will need to provide written notice of our intention to cure the deficiency during the second compliance period by effecting a reverse stock split, if necessary. If we meet these requirements, we may be granted an additional 180 calendar days to regain compliance. However, if it appears to Nasdaq that we will be unable to cure the deficiency, or if we are not otherwise eligible for the additional cure period, Nasdaq will provide notice that our common stock will be subject to delisting.

 

To resolve the noncompliance, we may consider available options including a reverse stock split, which may not result in a permanent increase in the market price of our common stock, which is dependent on many factors, including general economic, market and industry conditions and other factors detailed from time to time in the reports we file with the SEC. It is not uncommon for the market price of a company’s shares to decline in the period following a reverse stock split.

 

Although we expect to take actions intended to restore our compliance with the listing requirements, we can provide no assurance that any action taken by us would be successful, or that any such action would stabilize the market price or improve the liquidity of our common stock. Should a delisting occur, an investor would likely find it significantly more difficult to dispose of, or to obtain accurate quotations as to the value of our common stock, and our ability to raise future capital through the sale of our common stock could be severely limited.

 

15
 

 

If the MPA is terminated, we will need to identify new strategic channel partners to support the sales of our vehicles.

 

The majority of our sales have historically been comprised of sales to Club Car pursuant to the MPA. We are evaluating our relationship with Club Car and currently do not expect them to remain a customer going forward. If the MPA is terminated, we will need to identify new strategic channel partners to support the sales of our vehicles. It may take time to identify and add these partners and to train new personnel to market and support our vehicles. We may be unable to identify suitable partners, or such partners may not successfully market and sell our vehicles and may not devote sufficient time and resources to enable our vehicles to develop, achieve or sustain market acceptance. Failure to enter into arrangements with and retain a sufficient number of high-quality strategic channel partners could increase our marketing costs, adversely impact buying and inventory patterns, payment terms or other contractual terms, sell-through or delivery of our vehicles or curtail our routes-to-market, and could have a material adverse effect on our prospects, business, financial condition or results of operations. Club Car is not expected to be a customer in 2023.

 

We rely upon a single third-party supplier and manufacturer located in Canada for certain sub-assembly and assembly parts for the Vanish. Any disruption in the operations of this third-party supplier could adversely affect our business and results of operations.

 

As part of our strategy to minimize our capital expenditures on manufacturing infrastructure, we currently rely on Linamar for certain sub-assembly and assembly parts for the Vanish. Our dependence on a single supplier and manufacturer for the Products and the challenges we may face in obtaining adequate supplies required to assemble our vehicles, involve several risks, including limited control over pricing, availability, quality and delivery schedules.

 

We cannot be certain that Linamar will continue to provide us with the quantities of the Products that we require or satisfy our anticipated specifications and quality requirements. If Linamar experiences unanticipated delays, disruptions or shutdowns or is unable to ship the Products, replacement or warranty parts for any reason, within or outside of Linamar’s control, our manufacturing operations and customer deliveries would be seriously impacted. Although we believe we could locate alternative suppliers to fulfill our needs, we may be unable to find a sufficient alternative supply channel in a reasonable time or on commercially reasonable terms or develop our own replacements. Any performance failure on the part of Linamar or any other of our significant suppliers could interrupt production of our vehicles, which would have a material adverse effect on our business, financial condition and operating results.

 

If we lose our exclusive license to manufacture the AYRO 411x model in North America, Cenntro could sell identical or similar products through other companies or directly to our customers.

 

Cenntro, which has historically been our largest supplier, owns the design of the AYRO 411x model and granted us an exclusive license to manufacture the AYRO 411 and 411x models for sale in North America, subject to certain minimum purchase requirements. On May 31, 2022, we received a letter from Cenntro purporting to terminate all agreements and contracts between the Company and Cenntro, which would result in the termination of our exclusive license. We are in discussions with Cenntro concerning the winding up of our relationship with Cenntro. We have canceled all purchase orders and future builds with Cenntro and currently intend to only order replacement parts for vehicles from Cenntro in the future. We expect to lose our exclusive license. If we lose our exclusive license, Cenntro could sell identical or similar products through other companies or directly to our customers, which could have a material adverse effect on our results of operations and financial condition.

 

Since the expiration of the Karma Agreement in September 2022, we have assembled all vehicles at our own facilities, and we intend to continue doing so in the future. We may be unable to replace this lost manufacturing capacity on a timely and cost-effective basis, which could adversely impact our operations and ability to meet delivery timelines.

 

Prior to the expiration of the Karma Agreement in September 2022, we depended on Karma for a significant portion of our vehicle assembly operations. Since the expiration of the Karma Agreement, we have assembled all vehicles at our own facilities, and intend to continue doing so in the future. We may be unable to replace this lost manufacturing capacity on a timely and cost-effective basis, which could adversely impact our operations and ability to meet delivery timelines.

 

We do not know whether we will be able to develop efficient, automated, low-cost manufacturing capabilities and processes that will enable us to meet the quality, price, engineering, design and manufacturing standards, as well as the manufacturing volumes, required to successfully mass market our vehicles. Even if we are successful in developing high-volume manufacturing capability and processes, we do not know whether we will be able to do so in a manner that avoids significant delays and cost overruns, including as a result of factors beyond our control such as problems with suppliers and vendors or force majeure events, meets our product commercialization and manufacturing schedules and satisfies the requirements of customers and potential customers.

 

If we are unable to develop such manufacturing capabilities and processes, we may need to find a third party manufacturer, which may not be cost-effective and could expose us to a number of additional risks that are outside our control, including:

 

unexpected increases in manufacturing costs;
interruptions in shipments if a third-party contract manufacturing partner is unable to complete production in a timely manner;
reduced control over delivery schedules;
reduced control over manufacturing levels and our ability to meet minimum volume commitments to our customers;
reduced control over manufacturing yield; and
reduced control over manufacturing capacity.

 

If we or a manufacturing partner were to experience delays, disruptions, capacity constraints or quality control problems in manufacturing operations, product shipments could be delayed or rejected, and our customers could consequently elect to change product demand. These disruptions could have a material adverse effect on our revenues, competitive position and reputation.

 

The market for our products is developing and may not develop as expected.

 

The market for our electric vehicles is developing and may not develop as expected. The market for alternative fuel vehicles is relatively new, rapidly evolving, characterized by rapidly changing technologies, price competition, additional competitors, evolving multi-level government regulations and industry standards, frequent new vehicle announcements and changing consumer demands and behaviors. The electric vehicle market is in its early stage where many standards and best practices have not been established or are constantly evolving, and it may take many years for the market to fully mature.

 

16
 

 

We believe our future success will depend in large part on our ability to quickly and efficiently adapt to both the market demand for products and features, as well as adapt to newly created statutory laws at federal, state, local and international levels. Due to the nature of the electronic vehicle market still in development, it is difficult to predict the demands for our electric vehicles and ancillary services and products, as well as the size and growth rate for this market, the entry of competitive products, or the success of existing competitive products. If a meaningful market for our vehicles does not develop, we will not be successful.

 

We are currently evaluating our product development strategy, which may result in significant changes and have a material impact on our business, results of operations and financial condition.

 

In connection with the hiring of our current Chief Executive Officer, we are currently undertaking a strategic review of our product development strategy. This process may result in us modifying or discontinuing current or planned products, reallocating time and resources among existing products, exploring new products or making other operational changes, including adjusting our reliance on internal and external resources. Any decisions on advancing, reprioritizing or eliminating any of our products will be based on an evaluation of a number of factors, including our assessment of internal and external resources, the potential market for such products, the costs and complexities of manufacturing, the potential of competing products, as well as the likelihood of any challenges to our intellectual property, regardless of merit. Additionally, as of December 20, 2022 we completed pre-production on the new AYRO Vanish, including updates on our supply chain evolution, the offshoring/onshoring mix, our manufacturing strategy, and our annual model year refresh program.

 

Our business, results of operations and financial condition may be materially and adversely impacted by public health epidemics, including COVID-19.

 

Our business, results of operations and financial condition may be materially adversely impacted if a public health epidemic, including the recent coronavirus outbreak, interferes with our ability, or the ability of our employees, workers, contractors, suppliers and other business partners to perform our and their respective responsibilities and obligations relative to the conduct of our business. A public health epidemic, including the coronavirus, poses the risk of disruptions from the temporary closure of third-party suppliers and manufacturers, restrictions on our employees’ and other service providers’ ability to travel, the decreased willingness or ability of our customers to test drive or purchase our vehicles and shutdowns that may be requested or mandated by governmental authorities. Our business, results of operations and financial condition have been adversely impacted by the former coronavirus outbreak both in China and the United States. This has delayed our ability to timely procure raw materials from our supplier in China, which, in turn, has delayed shipments to and corresponding revenue from customers. The pandemic and social distancing directives have interfered with our ability, or the ability of our employees, workers, contractors, suppliers and other business partners, to perform our and their respective responsibilities and obligations relative to the conduct of our business. The COVID-19 pandemic has posed restrictions on our employees’ and other service providers’ ability to travel on pre-sales meetings, customers’ abilities to physically meet with our employees and the ability of our customers to test drive or purchase our vehicles and shutdowns that may be requested or mandated by governmental authorities. The extent to which the coronavirus may continue to impact our results will depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity of the coronavirus and the actions to contain the coronavirus or treat its impact, among others.

 

If disruptions in our transportation network continue to occur or our shipping costs continue to increase, we may be unable to sell or timely deliver our products, and our gross margin could decrease.

 

A majority of our raw materials have historically been shipped via container from overseas vendors in China, such as Cenntro, which has historically been our largest supplier. Although we have reduced our reliance on offshore suppliers by primarily sourcing components for the Vanish from vendors in North America and Europe, our vendors may be reliant on offshore suppliers. We rely heavily on third parties, including ocean carriers and truckers, in that process. The global shipping industry recently experienced a shortage of shipping capacity, trucking shortages, increased ocean shipping rates and increased trucking and fuel costs. As a result, our receipt of imported products has been, and may continue to be, disrupted or delayed.

 

We recently experienced business disruptions due to multiple factors brought about by the COVID-19 pandemic, such as supply and demand imbalance, a shortage of warehouse workers, truck drivers, transport equipment (tractors and trailers) and other causes, which have resulted in heightened congestion, bottlenecks and gridlock, leading to abnormally high transportation delays. This has materially and adversely affected our business and financial results for the fiscal year ended December 31, 2022 and could continue to materially and adversely affect our business and financial results throughout 2023. If significant disruptions along these lines continue, this could lead to further significant disruptions in our business, delays in shipments to us and our vendors, and revenue and profitability shortfalls, which could adversely affect our business, prospects, financial condition and operating results.

 

The global shipping industry is also experiencing unprecedented increases in shipping rates from the trans-Pacific ocean carriers due to various factors, including limited availability of shipping capacity. We may find it necessary to rely on an increasingly expensive spot market and other alternative sources to make up any shortfall in shipping needs. Additionally, if increases in fuel prices occur, our transportation costs would likely further increase. Similarly, supply chain disruptions such as those described in the preceding paragraphs may lead to an increase in transportation costs. Such cost increases have adversely affected our business and could have additional adverse effects on our business, prospects, financial condition and operating results.

 

17
 

 

Our limited operating history makes evaluating our business and prospects difficult and may increase the risk of any investment in our securities.

 

Our limited operating history makes evaluating our business and prospects difficult and may increase the risk of investment. Our operating results have fluctuated in the past and may fluctuate significantly in the future, which makes it difficult to predict our future operating results. Any substantial adjustment to overhead expenses to account for lower levels of sales is difficult and takes time, thus we may not be able to reduce our costs sufficiently to compensate for a shortfall in net sales, and even a small shortfall in net sales could disproportionately and adversely affect our operating margin and operating results for a given period.

 

Our operating results may also fluctuate due to a variety of other factors, many of which are outside our control, including the changing and volatile local, national, and international economic environments. Besides the other risks in this “Risk Factors” section, factors that may affect our operations include:

 

  fluctuations in demand for our products;
     
  the inherent complexity, length, and associated unpredictability of product development windows and product lifecycles;
     
  changes in customers’ budgets for technology purchases and delays in their purchasing cycles;
     
  changes in customer preferences;
     
  changing market conditions;
     
  any significant changes in the competitive dynamics of our markets, including new entrants or further consolidation;
     
  our ability to continue to broaden our customer and dealer base beyond our traditional customers and dealers;
     
  our ability to broaden our geographical markets;
     
  the timing of product releases or upgrades by us or our competitors; and
     
  our ability to develop, introduce, and ship in a timely manner new products and product enhancements and anticipate future market demands that meet customers’ requirements.

 

Each of these factors individually, or the cumulative effect of two or more of these factors, could result in large fluctuations in our quarterly and annual operating results. As a result, comparing our operating results on a period-to-period basis may not be meaningful, and our operating results for any given period may fall below expectations or our guidance. You should not rely on our past results as an indication of future performance.

 

If we are unable to effectively implement or manage our growth strategy, our operating results and financial condition could be materially and adversely affected.

 

Our ability to generate and grow revenue will depend, in part, on our ability to execute our business plan, expand our business model and develop new products in a timely manner. As part of our growth strategy, we may modify our distribution channels, engage in strategic transactions with third parties to access additional sales and distribution channels, accelerate product adoption for particular vertical markets, open new manufacturing, research or engineering facilities or expand our existing facilities. We also plan to add additional product lines and expand our businesses into new geographical markets. There is a range of risks inherent in such a strategy that could adversely affect our ability to successfully achieve these objectives, including, but not limited to, the following:

 

  the potential failure to successfully operate our dealer-distribution channels;

 

18
 

 

  an inability to attract and retain customers, employees, suppliers and/or marketing partners;
     
  the uncertainty that we may not be able to generate, anticipate or meet consumer demand;
     
  the potential disruption of our business;
     
  the increased scope and complexity of our operations could require significant attention from management and impose constraints on our operations or other projects;
     
  inconsistencies between our standards, procedures and policies and those of new points of sale or dealerships, and costs or inefficiencies associated with the integration of our operational and administrative systems, if necessary;
     
  unforeseen expenses, delays or conditions, including the potential for increased regulatory compliance or other third-party approvals or consents, or provisions in contracts with third parties that could limit our flexibility to take certain actions;
     
  the costs of compliance with local laws and regulations and the implementation of compliance processes, as well as the assumption of unexpected labilities, litigation, penalties or other enforcement actions;
     
  the uncertainty that new product lines or ancillary services will generate anticipated sales;
     
  the uncertainty that the expanded operations will achieve anticipated operating results;
     
  the difficulty of managing the operations of a larger company;
     
  the difficulty of competing for growth opportunities with companies that have greater financial resources than us; and
     
  the ability of our suppliers to support consumer demand.

 

Any one of these factors could impair our growth strategy, result in delays, increased costs or decreases in the amount of expected revenues derived from our growth strategy and could adversely impact our prospects, business, financial condition or results of operations.

 

Developments in alternative technologies or improvements in the internal combustion engine may have a materially adverse effect on the demand for our electric vehicles.

 

Significant developments related to ethanol or compressed natural gas, or improvements in the fuel economy of the internal combustion engine or hybrids may materially and adversely affect our business and prospects in ways we do not currently anticipate. For example, types of fuel that are abundant and relatively inexpensive in North America, such as compressed natural gas, may emerge as consumers’ preferred alternative to petroleum-based propulsion. If alternative energy engines or low gasoline prices make existing four-wheeled vehicles with greater passenger and cargo capacities less expensive to operate, we may not be able to compete with manufacturers of such vehicles. Furthermore, given the rapidly changing nature of the electric vehicle market, there can be no assurance that our vehicles and technology will not be rendered obsolete by alternative or competing technologies. Any material change in the existing technologies may cause delays in our development and introduction of new or upgraded vehicles, which could result in the loss of competitiveness of our vehicles, decreased revenue and a loss of market share to competitors.

 

The markets in which we operate are highly competitive, and we may not be successful in competing in these industries. We currently face competition from new and established domestic and international competitors and expect to face competition from others in the future, including competition from companies with new technology.

 

We face significant competition, and there is no assurance that our vehicles will be successful in the respective markets in which they compete. The worldwide vehicle market, particularly for alternative fuel vehicles, is highly competitive today and we expect it will become even more so in the future. Established automobile manufacturers such as General Motors, Ford, Nissan and Toyota, as well as other newer companies such as Tesla, Arcimoto and Electrameccanica, have entered or are reported to have plans to enter the alternative fuel vehicle market, including hybrid, plug-in hybrid and fully electric vehicles. In some cases, such competitors have announced an intention to now or at some point in the future produce electric vehicles exclusively.

 

As the LSEV market grows increasingly saturated, we expect to experience significant competition. The most competitive companies in the global LSEV market include HDK Electric Vehicles, Bradshaw Electric Vehicles, Textron Inc., Polaris Industries, Yamaha Motors Co. Ltd., Ingersoll Rand, Inc., Speedway Electric, AGT Electric Cars, Bintelli Electric Vehicles and Ligier Group. Many of our existing or potential competitors have substantially greater financial, technical and human resources than us, and significantly greater experience in manufacturing, designing and selling electric vehicles, as well as in clearing regulatory requirements for those vehicles in the United States and in foreign countries. Many of our current and potential future competitors also have significantly more experience designing, building and selling electric vehicles at the commercial, or fleet, scale. Large automobile or equipment manufacturers with greater purchasing power allow them to acquire raw materials at a much lower cost. Additionally, the large traditional manufacturer has more ready access to efficient design, testing and service facilities. We do not have the company history, facilities or capital to properly compete with large traditional manufacturers should they decide to enter our market. Mergers and acquisitions in the electric vehicle market could result in even more resources being concentrated among a smaller number of our competitors.

 

Increased competition could result in lower vehicle unit sales, price reductions, revenue shortfalls, loss of customers and loss of market share, which could harm our business, prospects, financial condition and operating results. Additionally, industry overcapacity has resulted in many manufacturers offering marketing incentives on vehicles in an attempt to maintain and grow market share. These incentives historically have included a combination of subsidized financing or leasing programs, price rebates, and other incentives. As a result, we are not necessarily able to set our prices to offset higher costs. Continuation of or increased excess capacity could have a substantial adverse effect on our financial condition and results of operations.

 

19
 

 

New entrants seeking to gain market share by introducing new technology, attractive feature sets, new products and development of longer-life power packs may make it more difficult for us to sell our vehicles and earn design wins which could create increased pricing pressure, reduced profit margins, increased sales and marketing expenses, or the loss of market share or expected market share, any of which may significantly harm our business, operating results and financial condition.

 

A significant portion of our revenues is derived from a single customer. The anticipated loss of this customer could cause our sales to decrease significantly.

 

For the year ended December 31, 2022, revenues from Club Car constituted approximately 100% of our revenues as compared to 79% in 2021. Club Car is not expected to be a customer in 2023. The anticipated loss of Club Car as a customer, or any significant reduction in purchases by Club Car, could have a material adverse effect on our sales, financial condition and results of operations.

 

Our future growth depends on customers’ willingness to adopt electric vehicles.

 

If there is lower market demand for our electric vehicles than we expect in the target markets, which include universities, food delivery services, last mile delivery service, municipalities and on-road and personal transportation, our business, prospects, financial condition and operating results will be negatively impacted. Potential customers may be reluctant to adopt electric vehicles as an alternative to traditional internal combustion engine vehicles or other electric vehicles due to various factors, which include but are not limited to:

 

  perceptions or negative publicity about electric vehicle quality, dependability, safety, stability of lithium-ion battery packs, utility, performance and cost regarding our vehicles or electric vehicles sold by other manufacturers, especially if accidents or certain events create a negative public perception;
     
  local, regional, national and international investment in charging infrastructure, standardization of electric vehicle charging systems and cost of charging that may impact adaptability for the overall electric vehicle market;
     
  the limited range of the vehicle on a single battery charge cycle;
     
  the impact of driving habits and terrain on the battery life, especially the differences with internal combustion engines;
     
  the deterioration rate of the battery packs, which are impacted by many external factors, including, but not limited to, overall life, environmental conditions, dormant time, the number of lifetime charge cycles and these factors’ impacts on the batteries’ ability to maintain an adequate charge;
     
  the access to knowledgeable service locations to support our electric vehicles;
     
  the price of alternative fuel sources, such as gasoline, as an alternative to the cost of charging electricity; and
     
  the availability of governmental incentives, including tax deductions and credits offered to consumers for purchasing and using electric vehicles.

 

Any of the above factors may hinder widespread adoption of electric vehicles and influence prospective customers and dealers to decide not to purchase our electric vehicles. Such issues would have an adverse material effect on our consolidated financial statements of operations, financial conditions, ability to develop strategic partnerships and ability to raise additional funding. Moreover, the COVID-19 pandemic may negatively impact the transportation and automotive industries and consumer behavior long-term.

 

We may experience lower-than-anticipated market acceptance of our current models and the vehicles in development.

Our projected growth depends upon the end-consumers’ mass adoption of our purpose-built electric vehicles. Although we have conducted some market research regarding our electric vehicles we currently sell or are developing, many factors both within and outside our control affect the success of our vehicles in the marketplace. At this time, it is difficult to measure consumers’ willingness to adopt purpose-built electric vehicles, particularly two-passenger electric vehicles. Offering fuel-efficient vehicles that consumers want and value can mitigate the risks of increasing price competition and declining demand, but vehicles that are perceived to be less desirable (whether in terms of price, quality, styling, safety, overall value, or other attributes) can exacerbate these risks. For example, if a new vehicle encountered quality issues at the time of launch, the vehicle’s perceived quality could be affected even after the issues had been corrected, resulting in lower than anticipated sales volumes, market share, and profitability. Moreover, if a new vehicle is not accepted by consumers based on size, styling, or other attributes, we would experience lower than anticipated sales volumes, market share, and profitability. If our vehicles are not adopted or there is a reduction in demand for our products caused by a lack of customer acceptance, a slowdown in demand for electronic transportation solutions, battery safety concerns, technological challenges, battery life issues, competing technologies and products, decreases in discretionary spending, weakening economic conditions, or otherwise, the reduction in demand could result in reduced customer orders, early order cancellations, the loss of customers, or decreased sales, any of which would adversely affect our business, operating results, and financial condition.

 

20
 

 

If we are unable to manage our growth and expand our operations successfully, our business and operating results will be harmed, and our reputation may be damaged.

 

We have been expanding our operations significantly since our inception and anticipate that further significant expansion will be required to achieve our business objectives. The growth and expansion of our business and product offerings places a continuous and significant strain on our management, operational and financial resources. Any such future growth would also add complexity to and require effective coordination throughout our organization. Our future operating results depend to a large extent on our ability to manage this expansion and growth successfully. Risks that we face in undertaking this expansion include:

 

  establishing sufficient sales, service and service facilities in a timely manner;
     
  forecasting production and revenue;
     
  training new personnel;
     
  controlling expenses and investments in anticipation of expanded operations;
     
  establishing or expanding design, manufacturing, sales and service facilities;
     
  implementing and enhancing administrative infrastructure, systems and processes;
     
  addressing new markets;
     
  expanding operations and finding and hiring a significant number of additional personnel, including manufacturing personnel, design personnel, engineers and service technicians; and
     
  securing sub-assemblies and other raw materials from our suppliers to support growth.

 

In this regard, we will be required to continue to improve our operational, financial and management controls and our reporting procedures, and we may not be able to successfully implement improvements to these systems and processes in a timely or efficient manner, which could result in additional operating inefficiencies and could cause our costs to increase more than planned. If we do increase our operating expenses in anticipation of the growth of our business and this growth does not meet our expectations, our operating results and gross margin will be negatively impacted. If we are unable to manage future expansion, our ability to provide high quality products could be harmed, damage our reputation and brand, and may have a material adverse effect on our business, operating results and financial condition.

 

If we fail to include key feature sets relative to the target markets for our electric vehicles, our business will be harmed.

 

Achieving design wins to support the needs of our target markets is an important success factor for our business. In order to achieve design wins, we must:

 

  anticipate the features and functionality that OEMs, customers and consumers will demand;
     
  successfully incorporate those features and functionalities into products that meet the exacting design requirements of our customers; and
     
  price our products competitively.

 

Failure to maintain our expertise and inability to deliver custom, specific design systems could harm our business.

 

21
 

 

Unanticipated changes in industry standards could render our vehicles incompatible with such standards and adversely affect our business.

 

The emergence of new industry standards and technical requirements could render our vehicles incompatible with vehicles developed by competitors or make it difficult for our products to meet the requirements of our end-customers. Moreover, the introduction of new industry standards, or changes to existing industry standards, could cause us to incur substantial development costs to adapt to these new or changed standards, particularly if we were to achieve, or be perceived as likely to achieve, greater penetration in the marketplace. If our vehicles are not in compliance with prevailing industry standards and technical requirements for a significant period of time, we could miss opportunities to achieve crucial design wins, our revenue may decline, and we may incur significant expenses to redesign our vehicles to meet the relevant standards, which could adversely affect our business, results of operations and prospects.

 

Our future success depends on our ability to identify additional market opportunities and develop and successfully introduce new and enhanced products that address such markets and meet the needs of customers in such markets.

 

We may not be able to successfully develop new electric vehicles, address new market segments or develop a broader customer base. We currently sell one four-wheeled truck, service parts, and payload options from which all our revenues are derived. Our future success will be dependent on our ability to address additional markets, anticipate our existing and prospective customers’ needs and develop new vehicle models that meet those needs. We will have to incorporate the latest technological improvements and enhancements into our future vehicles to be able to compete in the rapidly evolving electric vehicle industry and the target markets. There can be no assurance that we will be able to design future models of vehicles, or develop future services, that will meet the expectations of our customers or address market demands, or that our future models will achieve market acceptance or become commercially viable.

 

In order to introduce new products and product enhancements, we will have to coordinate with our suppliers and other third parties to design a new model or an enhanced version of an existing model that offer features desired by our customers and a level of performance, functionality, or cost-effectiveness superior to the vehicles offered by our competitors. If we fail to coordinate these efforts and achieve market introduction and acceptance of new or upgraded vehicle models that address the needs of our customers in a timely manner, our operating results will be materially and adversely affected, and our business and prospects will be harmed.

 

Furthermore, we will need to address additional markets and expand our customer demographic to further grow our business. Our failure to address additional market opportunities could materially harm our business, financial condition, operating results and prospects.

 

22
 

 

Unforeseen or recurring operational problems at our facilities, or a catastrophic loss of our manufacturing facilities, may cause significant lost or delayed production and adversely affect our results operations.

 

We import sub-assemblies from Linamar and perform final assembly, testing and safety qualifications in our facility in Round Rock, Texas in an assembly line process. Our manufacturing process could be affected by operational problems that could impair our production capability and the timeframes within which we expect to produce our vehicles. Disruptions or shutdowns at our assembly facility could be caused by

 

  maintenance outages to conduct maintenance activities that cannot be performed safely during operations;

 

  pandemics, including the COVID-19 pandemic, and related governmental responses that may restrict our ability to operate;
     
  prolonged power failures or reductions;
     
  breakdown, failure or substandard performance of any of our machines or other equipment;
     
  noncompliance with, and liabilities related to, environmental requirements or permits;
     
  disruptions in the transportation infrastructure, including railroad tracks, bridges, tunnels or roads;
     
  fires, floods, snow or ice storms, earthquakes, tornadoes, hurricanes, microbursts or other catastrophic disasters, national emergencies, political unrest, economic sanctions, war or terrorist activities;
     
  other operational problems; or
     
  availability of parts, including both batteries and semiconductors, which are used to produce many components of our vehicles.

 

If our manufacturing facility is compromised or shut down, we may experience prolonged startup periods, regardless of the reason for the compromise or shutdown. Those startup periods could range from several days to several weeks or longer, depending on the reason for the compromise or shutdown and other factors. Any disruption in operations at our facility could cause a significant loss of production, delays in our ability to produce our vehicles and adversely affect our results of operations and negatively impact our customers. Further, a catastrophic event could result in the loss of the use of all or a portion of our manufacturing facility. Although we carry property insurance, our coverage may not be adequate to compensate us for all losses that may occur. Any of these events individually or in the aggregate could have a material adverse effect on our business, financial condition and operating results.

 

We may become subject to product liability claims, which could harm our financial condition and liquidity if we are not able to successfully defend or insure against such claims.

 

We may become subject to product liability claims, which could harm our business, prospects, operating results and financial condition. The automobile industry experiences significant product liability claims, and we face an inherent risk of exposure to claims in the event our vehicles do not perform as expected or malfunction resulting in personal injury or death. Our risks in this area are particularly pronounced given that our vehicles have a limited commercial history. A successful product liability claim against us that exceeds our product liability insurance limits could require us to pay a substantial monetary award. Moreover, a product liability claim could generate substantial negative publicity about our vehicles and business and inhibit or prevent commercialization of other future vehicles, which would have a material adverse effect on our brand, business, prospects and operating results. We maintain product liability insurance for all of our vehicles with annual limits of $10.0 million on a claims-made basis, but any such insurance might not be sufficient to cover all potential product liability claims. Any lawsuit seeking significant monetary damages either in excess of our coverage, or outside of our coverage, may have a material adverse effect on our reputation, business and financial condition. We may not be able to secure additional product liability insurance coverage on commercially acceptable terms or at reasonable costs when needed, particularly if we do face liability for our vehicles and are forced to make a claim under our policy.

 

23
 

 

If our vehicles fail to perform as expected due to defects, our ability to develop, market and sell our electric vehicles could be seriously harmed.

 

Our vehicles have in the past and may in the future contain defects in design and manufacturing that may cause them not to perform as expected or that may require repair, including a result of defective parts received from our former supplier. The discovery of defects in our vehicles would result in delays in new model launches, recall campaigns, reputational damage, or increased warranty costs that may negatively affect our business. Moreover, if one of our vehicles is a cause, or perceived to be the cause, of injury or death to an operator, passenger or bystander, we would likely be subject to a claim. If we were found responsible, we could incur substantial liability which could interrupt or even cause us to terminate some or all of our operations.

 

Meeting or exceeding many government-mandated safety standards is costly and often technologically challenging. Government safety standards also require manufacturers to remedy defects related to vehicle safety through safety recall campaigns, and a manufacturer is obligated to recall vehicles if it determines that the vehicles do not comply with a safety standard. The costs of recall campaigns or warranty costs to remedy such defects in vehicles that have been sold could be substantial. Further, adverse publicity surrounding actual or alleged safety-related or other defects could damage our reputation and confidence in our vehicles, which would adversely affect sales of our vehicles.

 

We depend on key personnel to operate our business, and the loss of one or more members of our management team, or our failure to attract, integrate and retain other highly qualified personnel in the future, could harm our business.

 

We believe our future success will depend in large part upon our ability to attract and retain highly skilled managerial, technical, finance and sales and marketing personnel. We have only one line of business and are highly dependent upon the continued service of our key executive officers and other employees. The loss of and failure to replace key management and personnel could have a serious adverse effect on sales bookings, strategic relationships, manufacturing operations, order fulfilment and customer service, and may adversely impact the achievement of our objectives. Despite our efforts to retain valuable employees, members of our management may terminate their employment with us at any time. Although we have written employment agreements with our executive officers, these employment agreements do not bind these executives for any specific term and allow executive officers to leave at any time, for any reason, with or without cause. We do not maintain any “key-man” insurance policies on any of the key employees nor do we intend to obtain such insurance.

 

Recruiting and retaining qualified employees, consultants, and advisors for our business, including sales or technical personnel, is crucial to continue to execute our growth strategy. Because the pool of qualified personnel with engineering or manufacturing experience and/or experience working in the electric vehicle market is limited overall, recruitment and retention of senior management and skilled technical, sales and other personnel is very competitive. Many of the companies with which we compete for experienced personnel have greater resources than us. We are also at a disadvantage in recruiting and retaining key personnel, as our small size and limited resources may be viewed as providing a less stable environment with fewer opportunities than would be offered at one of our larger competitors. As a result, we may not be successful in either attracting or retaining such personnel and/or on acceptable terms given the competition and may be required to increase the level of compensation paid to existing and new employees, which could materially increase our operating expenses. In addition, failure to succeed in expansion of our operations may make it more challenging to recruit and retain qualified personnel.

 

Transitioning from an offshoring to an onshoring business model carries risks.

 

We are in the process of transitioning from a supply chain that is heavily reliant on Chinese imports to a supply chain that relies primarily upon North American and European sources. If our new materials suppliers are not managed properly to support vehicle demand, our results of operations and working capital can be adversely affected. If we are unable to implement our business plans in the timeframe estimated by management and successfully transition into a mass-producing electric vehicle manufacturing business, we will not be able to scale up our operations to generate greater profit. As a result, our business, prospects, operating results and financial condition will be negatively impacted and our ability to grow our business will be harmed.

 

Furthermore, as the scale of our vehicle production increases, we will need to accurately forecast, purchase, warehouse and transport to our manufacturing facilities components at much higher volumes than we have done in the past. If we are unable to accurately match the timing and quantities of component purchases to our actual production plans or capabilities, or successfully implement automation, inventory management and other systems to accommodate the increased complexity in our supply chain, we may have to incur unexpected storage, transportation and write-off costs, which could have a material adverse effect on our financial condition and operating results.

 

24
 

 

We currently have limited electric vehicles marketing and sales experience, and if we are unable to establish sales and marketing capabilities or enter into dealer agreements to market and sell our vehicles, we may be unable to generate any revenue.

 

We have limited experience selling and marketing our vehicles, and we currently have minimal marketing or sales organization. To successfully expand our operations, we will need to invest in and develop these capabilities, either on our own or with others, which would be expensive, difficult and time consuming. Any failure or delay in the timely development of our internal sales and marketing capabilities could adversely impact the potential for success of our products.

 

Further, given our lack of prior experience in marketing and selling electric vehicles, we rely on third-party dealers to market our vehicles. If these dealers do not commit sufficient resources to market our vehicles and we are unable to develop the necessary marketing and sales capabilities on our own, including developing a direct sales channel with our end-customers, we will be unable to generate sufficient revenue from the sale of our vehicles to sustain or grow our business. We may be competing with companies that currently have extensive and well-funded marketing and sales operations, particularly in the markets we are targeting. Without appropriate capabilities, whether directly or through third-party dealerships, we may be unable to compete successfully against these more established companies.

 

Failure to maintain the strength and value of our brand could have a material adverse effect on our business, financial condition and results of operations.

 

Our success depends, in part, on the value and strength of our brand. Maintaining, enhancing, promoting and positioning our brand, particularly in new markets where we have limited brand recognition, will depend largely on the success of our marketing and merchandising efforts and our ability to provide high-quality services, warranty plans, products and resources and a consistent, high-quality customer experience. Our brand could be adversely affected if we fail to achieve these objectives, if we fail to comply with laws and regulations, if we are subject to publicized litigation or if our public image or reputation were to be tarnished by negative publicity. Some of these risks may be beyond our ability to control, such as the effects of negative publicity regarding our suppliers or third-party providers of services or other electric transportation companies or their products or negative publicity related to members of management. Any of these events could hurt our image, resulting in reduced demand for our products and a decrease in sales. Further, maintaining, enhancing, promoting and positioning our brands’ images may require us to make substantial investments in marketing and employee training, which could adversely affect our cash flow, and which may ultimately be unsuccessful. These factors could have a material adverse effect on our business, financial condition and results of operations.

 

The range of our electric vehicles on a single charge declines over time, which may negatively influence potential customers’ decisions whether to purchase our vehicles.

 

The range of our electric vehicles on a single charge declines principally as a function of usage, time and charging patterns. For example, a customer’s use of their vehicle, as well as the frequency with which they charge the battery of their vehicle, can result in additional deterioration of the battery’s ability to hold a charge. Additionally, over time, a battery’s ability to hold its initial charge will degrade. While expected in electric vehicle applications, such battery deterioration and the related decrease in range may negatively influence potential customer decisions as to whether to purchase our vehicles, which may harm our ability to market and sell our vehicles.

 

We offer a product warranty to cover defective products at no cost to the customer. An unexpected change in failure rates of our products could have a material adverse impact on our business, financial condition and operating results.

 

We offer product warranties that generally extend for two years from date of sale that require us to repair or replace defective products returned by the customer during the warranty period at no cost to the customer. While defects in the individual parts for our vehicles are currently reimbursed by our supply chain, warranty labor is our responsibility. We record an estimate for anticipated warranty-related costs at the time of sale based on historical and estimated future product return rates and expected repair or replacement costs. While such costs and failure rates have historically been within management’s expectations and the provisions established and we receive warranty coverage from our vendors, unexpected changes in failure rates could have a material adverse impact on our business requiring additional warranty reserves. These failures could adversely impact our operating results.

 

25
 

 

Increases in costs, disruption of supply or shortage of raw materials, including but not limited to lithium-ion battery cells, chipsets and displays, could harm our business

 

We may experience increases in the cost or a sustained interruption in the supply or shortage of raw materials, including lithium-ion battery cells, semiconductors, and integrated circuits. Any such increase or supply interruption could materially negatively impact our business, prospects, financial condition and operating results. Currently, we are experiencing supply chain shortages, including with respect to lithium-ion battery cells, integrated circuits, vehicle control chips, and displays. Certain production-ready components such as chipsets and displays may be delayed en route to our facilities, which has and may continue to cause delays in validation and testing for these components, which would in turn create a delay in the availability of saleable vehicles.

 

We use various raw materials, including aluminum, steel, carbon fiber, non-ferrous metals (such as copper), and cobalt. The prices for these raw materials fluctuate depending on market conditions, and global demand, and could adversely affect our business and operating results. For instance, we are exposed to multiple risks relating to price fluctuations for lithium-ion cells. These risks include:

 

  the inability or unwillingness of current battery manufacturers to build or operate battery cell manufacturing plants to supply the numbers of lithium-ion cells required to support the growth of the electric vehicle industry as demand for such cells increases;
     
  disruption in the supply of cells due to quality issues or recalls by the battery cell manufacturers; and
     
  an increase in the cost of raw materials, such as cobalt, used in lithium-ion cells.

 

Any disruption in the supply of lithium-ion battery cells, semiconductors, or integrated circuits could temporarily disrupt production of our vehicles until a different supplier is fully qualified. Moreover, battery cell manufacturers may refuse to supply electric vehicle manufacturers if they determine that the vehicles are not sufficiently safe. Furthermore, fluctuations or shortages in petroleum and other economic conditions may cause us to experience significant increases in freight charges and raw material costs. Substantial increases in the prices for our raw materials would increase our operating costs and could reduce our margins if the increased costs cannot be recouped through increased electric vehicle prices. There can be no assurance that we will be able to recoup increasing costs of raw materials by increasing vehicle prices.

 

Customer financing and insuring our vehicles may prove difficult because retail lenders are unfamiliar with our vehicles and our vehicles have a limited loss history determining residual values within the insurance industry.

 

Retail lenders are unfamiliar with our vehicles and may be hesitant to provide financing to our customers. Our vehicles do not have a loss history in the insurance industry, which may cause our customers difficulty in securing insurance coverage.

 

Our electric vehicles make use of lithium-ion battery cells, which, if not appropriately managed and controlled, have occasionally been observed to catch fire or vent smoke and flames. If such events occur in our electric vehicles, we could face liability associated with our warranty, for damage or injury, adverse publicity and a potential safety recall, any of which would adversely affect our business, prospects, financial condition and operating results.

 

The battery packs in our electric vehicles use lithium-ion cells. On occasion, if not appropriately managed and controlled, lithium-ion cells can rapidly release the energy they contain by venting smoke and flames in a manner that can ignite nearby materials. Highly publicized incidents of laptop computers and cell phones bursting into flames have focused consumer attention on the safety of these cells. These events also have raised questions about the suitability of these lithium-ion cells for automotive applications. There can be no assurance that a field failure of our battery packs will not occur, which could damage the vehicle or lead to personal injury or death and may subject us to lawsuits. Furthermore, there is some risk of electrocution if individuals who attempt to repair battery packs on our vehicles do not follow applicable maintenance and repair protocols. Any such damage or injury would likely lead to adverse publicity and potentially a safety recall. Any such adverse publicity could adversely affect our business, prospects, financial condition and operating results.

 

26
 

 

Our business may be adversely affected by labor and union activities.

 

Although none of our employees are currently represented by a labor union, it is common throughout the automobile industry generally for many employees at automobile companies to belong to a union, which can result in higher employee costs and increased risk of work stoppages. We rely on other companies in the supply chain with work forces that may or may not be unionized and are thus subject to work stoppages or strikes organized by such unions, which could have a material adverse impact on our business, financial condition or operating results. If a work stoppage occurs within our business, or within that of our key suppliers’ businesses, it could delay the manufacturing, sale and shipment of our electric vehicles and have a material adverse effect on our business, prospects, operating results or financial condition.

 

We rely on our dealers for the service of our vehicles and have limited experience servicing our vehicles. If we are unable to address the service requirements of our future customers, our business will be materially and adversely affected.

 

Currently, our vehicles are serviced by the selling dealer. If the dealer is unable to successfully address the service requirements of our customers, customer confidence in both the vehicles and our brand will erode and our prospects and operating results will be materially and adversely affected. In addition, we anticipate the level and quality of service the dealers will provide to our customers will have a direct impact on the success of our future vehicles. If our dealers are unable to satisfactorily service our customers, our ability to generate customer loyalty, grow our business and sell additional vehicles could be significantly impaired.

 

Our dealers have very limited experience servicing our vehicles. Servicing electric vehicles is different than servicing vehicles with internal combustion engines and requires specialized skills, including high voltage training and servicing techniques.

 

If we fail to deliver vehicles and accessories to market as scheduled, our business will be harmed.

 

A significant amount of our revenue is seasonal. By missing product delivery schedules, we may miss that year’s opportunity to bring and sell a new product to market. Seasonality could be affected by many factors including, but not limited to, governmental fiscal years, as municipalities tend to order vehicles either at the end of their fiscal year when they know they have funds remaining, and tourist season for geographically diverse destination fleet operators, as such customers tend to place their entire orders for delivery in time for the beginning of that season. Any change in fleet replacement timing, average fleet age, or fleet maintenance demands may have a material impact on the business.

 

27
 

 

Failure in our information technology and storage systems could significantly disrupt the operation of our business.

 

Our ability to execute our business plan and maintain operations depends on the continued and uninterrupted performance of our information technology (“IT”) systems. We must routinely update our IT infrastructure and our various IT systems throughout the organization, or we may not continue to meet our current and future business needs. Modification, upgrade or replacement of such systems may be costly. Furthermore, IT systems are vulnerable to risks and damages from a variety of sources, including telecommunications or network failures, malicious human acts and natural disasters. Moreover, despite network security and back-up measures, some of our and our vendors’ servers are potentially vulnerable to physical or electronic break-ins, computer viruses and similar disruptive problems. Despite precautionary measures to prevent unanticipated problems that could affect our IT systems, sustained or repeated system failures that interrupt our ability to generate and maintain data could adversely affect our ability to operate our business.

 

Risks Relating to Our Financial Position and Need for Additional Capital

 

We may be required to raise additional capital to fund our operations, and such funding may be costly or difficult to obtain and could dilute our stockholders’ ownership interests.

 

The design, manufacture, sale and servicing of vehicles is a capital-intensive business, and we may need to raise additional funds to expand our operations and reach vehicle production goals. At December 31, 2022, we had working capital of approximately $49.8 million. Based upon our current expectations, we believe that our existing capital resources will enable us to continue planned operations through at least March 23, 2024. However, we cannot assure you that our plans will not change or that changed circumstances will not result in the depletion of our capital resources more rapidly than we currently anticipate. If our cash on hand and our sales revenue are not sufficient to cover our cash requirements, we will need to raise additional capital, whether through the sale of equity or debt securities, the entry into strategic business collaborations, the establishment of other funding facilities, licensing arrangements, or asset sales or other means, in order to support our business plan. In addition, we may need to raise additional capital for strategic acquisitions or transactions. Such additional capital may not be available on reasonable terms or at all.

 

Our ability to obtain the necessary financing to carry out our business plan is subject to a number of factors, including general market conditions, performance of our vehicles, market demand for our vehicles and investor acceptance of our business plan. These factors may make the timing, amount, terms and conditions of such financing unattractive or unavailable to us. If we are unable to obtain additional financing on a timely basis, we may have to curtail, delay or eliminate our development activities and growth plans, and/or be forced to sell some or all assets, perhaps on unfavorable terms, which would have a material adverse effect on our business, financial condition and results of operations, and ultimately we could be forced to discontinue our operations and liquidate, in which event it is unlikely that stockholders would receive any distribution on their shares. Further, we may not be able to continue operating if we do not generate sufficient revenues from operations to stay in business.

 

We have raised capital in the past primarily through public offerings, as well as debt and private placements of our convertible preferred stock. We may in the future pursue the sale of additional equity and/or debt securities, or the establishment of other funding facilities including asset-based borrowings. There can be no assurances, however, that we will be able to raise additional capital through such an offering on acceptable terms, or at all. Issuances of additional debt or equity securities could impact the rights of the holders of our common stock and may dilute their ownership percentage. The terms of any securities issued by us in future capital transactions may be more favorable to new investors, and may include preferences, superior voting rights and the issuance of warrants or other derivative securities, which may have a further dilutive effect on the holders of any of our securities then outstanding.

 

The terms of debt securities we may have to issue or future borrowings we may have to incur to fund our operations could impose significant restrictions on our operations. The incurrence of indebtedness or the issuance of certain equity securities could result in increased fixed payment obligations and could also result in restrictive covenants, such as limitations on our ability to incur additional debt or issue additional equity, limitations on our ability to acquire or license intellectual property rights, and other operating restrictions that could adversely affect our ability to conduct our business.

 

28
 

 

If we raise additional funds through collaboration and licensing arrangements with third parties, it may be necessary to relinquish some rights to our technologies or our products, to grant licenses on terms that are not favorable to us, or to issue equity instruments that may be dilutive to our stockholders.

 

In addition, we may incur substantial costs in pursuing future capital financing, including investment banking fees, legal fees, accounting fees, securities law compliance fees, printing and distribution expenses and other costs. We may also be required to recognize non-cash expenses in connection with certain securities we issue, such as convertible notes and warrants, which may adversely impact our financial condition.

 

Our long-term capital requirements are subject to numerous risks.

 

Our long-term capital requirements are expected to depend on many potential factors, including, among others:

 

  the number of vehicles being manufactured and future models in development;
     
  the regulatory compliance and clarity of each of our vehicles;
     
  the progress, success and cost of our development programs, including manufacturing;
     
  the costs of manufacturing, developing sales, marketing and distribution channels;
     
  the costs of enforcing our issued patents and defending intellectual property-related claims;
     
  our ability to successfully grow sales, including securing strategic partner and distribution agreements and favorable pricing and market share; and
     
  our consumption of available resources more rapidly than currently anticipated, resulting in the need for additional funding sooner than anticipated.

 

We may invest in or acquire other businesses, and our business may suffer if we are unable to successfully integrate acquired businesses into our company or otherwise manage the growth associated with multiple acquisitions.

 

As part of our business strategy, we may make acquisitions as opportunities arise to add new or complementary businesses, products, brands or technologies. In some cases, the costs of such acquisitions may be substantial, including as a result of professional fees and due diligence efforts. There is no assurance that the time and resources expended on pursuing a particular acquisition will result in a completed transaction, or that any completed transaction will ultimately be successful. In addition, we may be unable to identify suitable acquisition or strategic investment opportunities or may be unable to obtain any required financing or regulatory approvals, and therefore may be unable to complete such acquisitions or strategic investments on favorable terms, if at all. We may decide to pursue acquisitions with which our investors may not agree and we cannot assure investors that any acquisition or investment will be successful or otherwise provide a favorable return on investment. In addition, acquisitions and the integration thereof require significant time and resources and place significant demands on our management, as well as on our operational and financial infrastructure. In addition, if we fail to successfully close transactions or integrate new teams, or integrate the products and technologies associated with these acquisitions into our company, our business could be seriously harmed. Acquisitions may expose us to operational challenges and risks, including:

 

  the ability to profitably manage acquired businesses or successfully integrate the acquired businesses’ operations, personnel, financial reporting, accounting and internal controls, technologies and products into our business;
     
  increased indebtedness and the expense of integrating acquired businesses, including significant administrative, operational, economic, geographic or cultural challenges in managing and integrating the expanded or combined operations;
     
  entry into jurisdictions or acquisition of products or technologies with which we have limited or no prior experience, and the potential of increased competition with new or existing competitors as a result of such acquisitions;
     
  diversion of management’s attention and the over-extension of our operating infrastructure and our management systems, information technology systems, and internal controls and procedures, which may be inadequate to support growth;
     
  the ability to fund our capital needs and any cash flow shortages that may occur if anticipated revenue is not realized or is delayed, whether by general economic or market conditions, or unforeseen internal difficulties; and
     
  the ability to retain or hire qualified personnel required for expanded operations.

 

29
 

 

Our acquisition strategy may not succeed if we are unable to remain attractive to target companies or expeditiously close transactions. Issuing shares of our common stock to fund an acquisition would cause economic dilution to existing stockholders. If we develop a reputation for being a difficult acquirer or having an unfavorable work environment, or target companies view our common stock unfavorably, we may be unable to consummate key acquisition transactions essential to our corporate strategy and our business may be seriously harmed.

 

Risks Related to Regulatory Matters

 

Increased safety, emissions, fuel economy, or other regulations may result in higher costs, cash expenditures, and/or sales restrictions.

 

The motorized vehicle industry is governed by a substantial amount of government regulation, which often differs by state and region. Government regulation has arisen, and proposals for additional regulation are advanced, primarily out of concern for the environment, vehicle safety, and energy independence. In addition, many governments regulate local product content and/or impose import requirements as a means of creating jobs, protecting domestic producers, and influencing the balance of payments. The cost to comply with existing government regulations is substantial, and future additional regulations could have a substantial adverse impact on our financial condition.

 

Our vehicles are subject to multi-jurisdictional motor vehicle standards.

 

All vehicles sold must comply with federal, state and country-specific motor vehicle safety standards. Rigorous testing and the use of approved materials and equipment are among the requirements for achieving federal certification. Failure of the AYRO Vanish Fleet or future vehicle models to satisfy motor vehicle standards would have a material adverse effect on our business and operating results.

 

If we fail to comply with evolving environmental and safety laws and regulations, we could become subject to fines or penalties or incur costs that could have a material adverse effect on the success of our business.

 

We are subject to numerous environmental and health and safety laws, including statutes, regulations, bylaws and other legal requirements. These laws relate to the generation, use, handling, storage, transportation and disposal of regulated substances, including hazardous substances (such as batteries), dangerous goods and waste, emissions or discharges into soil, water and air, including noise and odors (which could result in remediation obligations), and occupational health and safety matters, including indoor air quality. These legal requirements vary by location and can arise under federal, provincial, state or municipal laws. Any breach of such laws and/or requirements would have a material adverse effect on our company and our operating results.

 

30
 

 

Changes in regulations could render our vehicles incompatible with federal, state or local regulations, or use cases.

 

Many governmental standards and regulations relating to safety, fuel economy, emissions control, noise control, vehicle recycling, substances of concern, vehicle damage, and theft prevention are applicable to new motor vehicles, engines, and equipment manufactured for sale in the United States, Europe, and elsewhere, including our electric vehicles. In addition, manufacturing and other automotive assembly facilities in the United States, Europe, and elsewhere are subject to stringent standards regulating air emissions, water discharges, and the handling and disposal of hazardous substances. Therefore, any unanticipated changes in regulations applicable to our electric vehicles could render our vehicles incompatible, which may prevent us from selling such vehicles and, as a result, we could lose market share.

 

Unusual or significant litigation, governmental investigations or adverse publicity arising out of alleged defects in our vehicles, or otherwise, may derail our business.

 

Although we plan to comply with governmental safety regulations, mobile and stationary source emissions regulations, and other standards, compliance with governmental standards does not necessarily prevent individual or class action lawsuits, which can entail significant cost and risk. In certain circumstances, courts may permit tort claims even when our vehicles comply with federal law and/or other applicable law. Furthermore, simply responding to actual or threatened litigation or government investigations of our compliance with regulatory standards, whether related to our vehicles, business or commercial relationships, may require significant expenditures of time and other resources. Litigation also is inherently uncertain, and we could experience significant adverse results if litigation is ever brought against us. In addition, adverse publicity surrounding an allegation of a defect, regulatory violation or other matter (with or without corresponding litigation or governmental investigation) may cause significant reputational harm that could have a significant adverse effect on our sales.

 

In order for us to sell directly to end customers, we are required to comply with state-specific regulations regarding the sale of vehicles by a manufacturer.

 

We sold approximately 1% of our vehicles directly to our end customers in the year ended December 31, 2022. Going forward, we intend to focus on leveraging volume sales through dealers; however, we will continue to sell vehicles directly to end customers. Sales to both dealers and end customers require us to comply with state-specific regulations regarding the sale of vehicles by a manufacturer, including licensing and registration requirements. State laws that regulate the distribution and sale of motor vehicles by the manufacturer vary, and ensuring compliance is time-consuming and costly. Moreover, for customers living in states where we are prohibited from selling directly from within the state, we will have to consummate sales at facilities in a state that allows direct manufacturer-to-consumer sales and deliver the vehicle to the end user via a common carrier. As such, we may be required to either acquire and maintain a facility in multiple states, or incur additional costs of delivery of the vehicle, which consequently increases the cost and/or sales price of our vehicles and makes our vehicles less desirable to end-customers.

 

31
 

 

We have identified a material weakness in our internal control over financial reporting. If we are unable to remediate the material weakness, or if we experience additional material weaknesses in the future, our business may be harmed.

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting and for evaluating and reporting on the effectiveness of our system of internal control. Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external reporting purposes in accordance with Generally Accepted Accounting Principles in the United States (“GAAP”). As a public company, we are required to comply with the Sarbanes-Oxley Act and other rules that govern public companies. In particular, we are required to certify our compliance with Section 404 of the Sarbanes-Oxley Act, which requires us to furnish annually a report by management on the effectiveness of our internal control over financial reporting.

 

Our management performed an assessment of the effectiveness of our internal control over financial reporting as of December 31, 2022 and concluded our internal control over financial reporting was not effective as of December 31, 2022 due to the material weakness related to segregation of duties. Specifically, due to limited resources and headcount we did not have multiple people in the accounting function for a full segregation of duties. We have taken and continue to take remedial steps to improve our internal control over financial reporting by hiring additional personnel with added expertise in public company reporting and expect to conclude that the material weakness has been remediated as these individuals progress through the onboarding process.

 

Remediation efforts place a significant burden on management and add increased pressure to our financial resources and processes. If we are unable to successfully remediate our existing material weakness or any additional material weaknesses in our internal control over financial reporting that may be identified in the future in a timely manner, the accuracy and timing of our financial reporting may be adversely affected; our liquidity, our access to capital markets, the perceptions of our creditworthiness may be adversely affected; we may be unable to maintain or regain compliance with applicable securities laws, the listing requirements of the Nasdaq Stock Market; we may be subject to regulatory investigations and penalties; investors may lose confidence in our financial reporting; our reputation may be harmed; and our stock price may decline.

 

32
 

 

Risks Related to Our Intellectual Property

 

If we are unable to adequately protect our proprietary designs and intellectual property rights, our competitive position could be harmed.

 

Our ability to compete effectively is dependent in part upon our ability to obtain patent protection for our designs, products, methods, processes and other technologies, to preserve our trade secrets, to prevent third parties from infringing on our proprietary rights and to operate without infringing the proprietary rights of third parties. We rely on design patents, trademarks, trade secret laws, confidentiality procedures and licensing arrangements to protect our intellectual property rights. There can be no assurance these protections will be available in all cases or will be adequate to prevent our competitors from copying, reverse engineering or otherwise obtaining and using our designs, technology, proprietary rights or products. For example, the laws of certain countries in which our products, components and sub-assemblies are manufactured or licensed do not protect our proprietary rights to the same extent as the laws of the United States.

 

To prevent substantial unauthorized use of our intellectual property rights, it may be necessary to prosecute actions for infringement and/or misappropriation of our trade secrets and/or proprietary rights against third parties. Any such action could result in significant costs and diversion of our resources and management’s attention, and there can be no assurance we will be successful in such action. Furthermore, our current and potential competitors may have the ability to dedicate substantially greater resources to enforce their intellectual property rights than we do. Accordingly, despite our efforts, we may not be able to prevent third parties from infringing upon or misappropriating our trade secrets and/or intellectual property.

 

In addition, third parties may seek to challenge, invalidate or circumvent our patents, trademarks, copyrights and trade secrets, or applications for any of the foregoing. There can be no assurance that our competitors or customers will not independently develop technologies that are substantially equivalent or superior to our technology or design around our proprietary rights. In each case, our ability to compete could be significantly impaired.

 

We may need to license intellectual property from third parties in the future. If we fail to obtain licenses we need or fail to comply with our obligations in agreements under which we license intellectual property and other rights from third parties, we could lose our ability to manufacture our vehicles.

 

We may need to license intellectual property from third parties in the future for new vehicle models. No assurance can be given that we will be able to obtain such license or meet our obligations to maintain the licenses we may have to obtain from third parties in the future. If we were to lose or otherwise be unable to maintain these licenses for any reason, it would halt our ability to manufacture and sell our vehicles or may prohibit development of our future models, which could result in a material adverse effect on our business or results of operations.

 

33
 

 

In addition, if we do not own the patents or patent applications that we license, as is the case with the AYRO 411x’s patents, we may need to rely upon our licensors to properly prosecute and maintain those patent applications and prevent infringement of those patents. If our licensors are unable to adequately protect their proprietary intellectual property we license from legal challenges, or if we are unable to enforce such licensed intellectual property against infringement or alternative technologies, we will not be able to compete effectively in the electric vehicle markets we are targeting.

 

Many of our proprietary designs are in digital form, and a breach of our computer systems could result in these designs being stolen.

 

If our security measures are breached or unauthorized access to private or proprietary data is otherwise obtained, our proprietary designs could be stolen. Because we hold many of these designs in digital form on our servers, there exists an inherent risk that an unauthorized third party could conduct a security breach resulting in the theft of our proprietary information. While we have taken steps to protect our proprietary information, because techniques used to obtain unauthorized access or sabotage systems change frequently and generally are not identified until they are launched against a target, we may be unable to anticipate these techniques or to implement adequate preventative measures. Any or all of these issues could negatively impact our competitive advantage and our ability to obtain new customers, thereby adversely affecting our financial results.

 

Our proprietary designs are susceptible to reverse engineering by our competitors.

 

Much of the value of our proprietary rights is derived from our vast library of design specifications. While we consider our design specifications to be protected by various proprietary, trade secret and intellectual property laws, such information is susceptible to reverse engineering by our competitors. We may not be able to prevent our competitors from developing competing design specifications, and the cost of enforcing these rights may be significant. If we are unable to adequately protect our proprietary designs, our financial condition and operating results could suffer.

 

If we are unable to protect the confidentiality of our trade secrets or know-how, such proprietary information may be used by others to compete against us.

 

We consider trade secrets, including confidential and unpatented know-how and designs important to the maintenance of our competitive position. We protect trade secrets and confidential and unpatented know-how, in part, by customarily entering into non-disclosure and confidentiality agreements with parties who have access to such knowledge, such as our employees, outside technical and commercial collaborators, consultants, advisors and other third parties. We also enter into confidentiality and invention or patent assignment agreements with our employees and consultants that obligate them to maintain confidentiality and assign their inventions to us. Despite these efforts, any of these parties may breach the agreements and disclose our proprietary information, including our trade secrets, and we may not be able to obtain adequate remedies for such breaches.

 

34
 

 

Legal proceedings or third-party claims of intellectual property infringement and other challenges may require us to spend substantial time and money and could harm our business.

 

The vehicle design and manufacturing industry is characterized by vigorous protection and pursuit of intellectual property rights, which has resulted in protracted and expensive litigation for many companies. We may become subject to lawsuits alleging that we have infringed the intellectual property rights of others. The nature of claims contained in unpublished patent filings around the world is unknown to us, and it is not possible to know which countries patent holders may choose for the extension of their filings under the Patent Cooperation Treaty, or other mechanisms. To the extent that we have previously incorporated third-party technology and/or know-how into certain products for which we do not have sufficient license rights, we could incur substantial litigation costs, be forced to pay substantial damages or royalties, or even be forced to cease sales in the event any owner of such technology or know-how were to challenge our subsequent sale of such products (and any progeny thereof). In addition, to the extent that we discover or have discovered third-party patents that may be applicable to products or processes in development, we may need to take steps to avoid claims of possible infringement, including obtaining non-infringement or invalidity opinions and, when necessary, re-designing or re-engineering products. However, we cannot assure you that these precautions will allow us to successfully avoid infringement claims. We may also be subject to claims based on the actions of employees and consultants with respect to the usage or disclosure of intellectual property learned from other employers. Third parties may in the future assert claims of infringement of intellectual property rights against us or against our customers or channel partners for which we may be liable.

 

Our involvement in intellectual property litigation could result in significant expense to us, adversely affect the development of sales of the challenged product or intellectual property and divert the efforts of our technical and management personnel, whether or not such litigation is resolved in our favor. Uncertainties resulting from the initiation and continuation or defense of intellectual property litigation or other proceedings could have a material adverse effect on our ability to compete in the marketplace. In the event of an adverse outcome in any such litigation, we may, among other things, be required to:

 

  pay substantial damages;
     
 

cease the development, manufacture, use, sale or importation of products that infringe upon other patented intellectual property;

     
  expend significant resources to develop or acquire non-infringing intellectual property;
     
  discontinue processes incorporating infringing technology; or
     
 

obtain licenses to the infringing intellectual property, which licenses may not be available on acceptable terms, or at all.

 

We are generally obligated to indemnify our sales channel partners, customers, suppliers and contractors for certain expenses and liabilities resulting from intellectual property infringement claims regarding our products, which could force us to incur substantial costs.

 

We have agreed, and expect to continue to agree, to indemnify our sales channel partners and customers for certain intellectual property infringement claims regarding our products. As a result, in the case of infringement claims against these sales channel partners and end-customers, we could be required to indemnify them for losses resulting from such claims or to refund amounts they have paid to us. Our sales channel partners and other end-customers in the future may seek indemnification from us in connection with infringement claims brought.

 

35
 

 

Risks Related to Our International Operations

 

We are subject to governmental export and import controls that could impair our ability to compete in international markets due to licensing requirements and subject us to liability if we are not in compliance with applicable laws.

 

Our products are subject to export control and import laws and regulations, including the U.S. Export Administration Regulations, U.S. Customs regulations and various economic and trade sanctions regulations administered by the U.S. Treasury Department’s Office of Foreign Assets Controls. Exports of our products must be made in compliance with these laws and regulations. If we violate these laws and regulations, we and certain of our employees could be subject to substantial civil or criminal penalties, including the possible loss of export or import privileges, fines which may be imposed on us and responsible employees or managers, and, in extreme cases, the incarceration of responsible employees or managers. In addition, if our channel partners, agents or consultants fail to obtain appropriate import, export or re-export licenses or authorizations, we may also be adversely affected through reputational harm and penalties. Obtaining the necessary authorizations, including any required license, for a particular sale may be time-consuming, is not guaranteed and may result in the delay or loss of sales opportunities. Changes in our products or changes in applicable export or import laws and regulations may also create delays in the introduction and sale of our products in international markets, prevent our end-customers with international operations from deploying our products or, in some cases, prevent the export or import of our products to certain countries, governments or persons altogether. Any change in export or import laws and regulations, shift in the enforcement or scope of existing laws and regulations, or change in the countries, governments, persons or technologies targeted by such laws and regulations, could also result in decreased use of our products, or in our decreased ability to export or sell our products to existing or potential end-customers with international operations. Any decreased use of our products or limitation on our ability to export or sell our products would likely adversely affect our business, financial condition and operating results.

 

New regulations or standards or changes in existing regulations or standards in the United States or internationally related to our suppliers’ products may result in unanticipated costs or liabilities, which could have a material adverse effect on our business, operating results and future sales, and could place additional burdens on the operations of our business.

 

Our suppliers’ products are subject to governmental regulations in many jurisdictions. To achieve and maintain market acceptance, our suppliers’ products must continue to comply with these statutory regulations and many industry standards. As these regulations and standards evolve, and if new regulations or standards are implemented, our suppliers may have to modify their products. The failure of their products to comply, or delays in compliance, with the existing and evolving industry regulations and standards could prevent or delay introduction of our vehicles, which could harm our business. Supplier uncertainty regarding future policies may also affect demand for electric vehicles, including our vehicles. Moreover, channel partners or customers may require us, or we may otherwise deem it necessary or advisable, to alter our products to address actual or anticipated changes in the regulatory environment. Our inability to alter our products to address these requirements and any regulatory changes may have a material adverse effect on our business, operating results and financial condition.

 

36
 

 

ITEM 1B. UNRESOLVED STAFF COMMENTS.

 

None.

 

ITEM 2. PROPERTIES.

 

Our corporate headquarters are located at 900 E. Old Settlers Blvd., Suite 100, Round Rock, Texas. We currently lease approximately 23,927 square feet of office space in Round Rock, Texas under a lease that expires in February 2027. The lease agreement provides for a base monthly rent, and we are also responsible for real estate taxes, maintenance and other operating expenses applicable to the leased premises.

 

We believe that this facility is adequate for our present operations.

 

ITEM 3. LEGAL PROCEEDINGS.

 

On February 12, 2021, the Company entered into an agreement with Arcimoto, Inc. to settle certain patent infringement claims (the “Arcimoto Settlement”), pursuant to which the Company agreed to cease the production, importation and sale of the AYRO 311 Autocycle, a compact, three-wheeled electric vehicle previously manufactured by the Company (the “AYRO 311”), among other things. Accordingly, AYRO would not be contractually permitted to resume production of the AYRO 311.

 

As of January 1, 2019, DropCar Operating, Inc. (“DropCar Operating”) had accrued approximately $0.23 million for the settlement of multiple employment disputes. As of December 31, 2022, the accrual has been paid.

 

On March 23, 2018, DropCar Operating was made aware of an audit being conducted by the New York State Department of Labor (“DOL”) regarding a claim filed by an employee. The DOL is investigating whether DropCar Operating properly paid overtime for which DropCar Operating has raised several defenses. In addition, the DOL is conducting its audit to determine whether DropCar Operating owes spread of hours pay (an hour’s pay for each day an employee worked or was scheduled for a period over ten hours in a day). If the DOL determines that monies are owed, the DOL will seek a backpay order, which management believes will not, either individually or in the aggregate, have a material adverse effect on our business, consolidated financial position, results of operations or cash flows. Management believes the case has no merit.

 

DropCar was a defendant in a class action lawsuit which resulted in a judgement entered whereby the Company is required to pay legal fees in the amount of $0.05 million to the plaintiff’s counsel. As of December 31, 2022, there is no remaining balance.

 

We are subject to various legal proceedings and claims, either asserted or unasserted, which arise in the ordinary course of business, that we believe are incidental to the operation of our business. While the outcome of these claims cannot be predicted with certainty, management does not believe that the outcome of any of these legal matters will have a material adverse effect on our results of operations, financial positions or cash flows.

 

ITEM 4. MINE SAFETY DISCLOSURES.

 

Not applicable.

 

37
 

 

PART II

 

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES.

 

Market Information

 

Our common stock trades on the Nasdaq Capital Market under the symbol “AYRO.”

 

Stockholders

 

As of March 22, 2023, there were approximately [79] stockholders of record of our common stock.

 

Dividends

 

We have not paid any cash dividends to our stockholders since inception and do not plan to pay cash dividends in the foreseeable future. Any future declaration of dividends will depend on our earnings, capital requirements, financial condition, prospects and any other factors that our board of directors deems relevant, as well as compliance with the requirements of state law. In general, as a Delaware corporation, we may pay dividends out of surplus capital or, if there is no surplus capital, out of net profits for the fiscal year in which a dividend is declared and/or the preceding fiscal year. We currently intend to retain earnings, if any, for reinvestment in our business.

 

Recent Sales of Unregistered Securities

 

None.

 

Issuer Purchases of Equity Securities

 

None.

 

ITEM 6. [Reserved]

 

38
 

 

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following management’s discussion and analysis should be read in conjunction with our historical financial statements and the related notes thereto. This management’s discussion and analysis contains forward-looking statements, such as statements of our plans, objectives, expectations and intentions. Any statements that are not statements of historical fact are forward-looking statements. When used, the words “believe,” “plan,” “intend,” “anticipate,” “target,” “estimate,” “expect” and the like, and/or future tense or conditional constructions (“will,” “may,” “could,” “should,” etc.), or similar expressions, identify certain of these forward-looking statements. These forward-looking statements are subject to risks and uncertainties, including those under “Risk Factors” in our filings with the Securities and Exchange Commission (“SEC”) that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. Our actual results and the timing of events could differ materially from those anticipated in these forward-looking statements as a result of several factors. See “Forward-Looking Statements; Risk Factor Summary.”

 

References in this management’s discussion and analysis to “we,” “us,” “our,” “the Company,” “our Company” or “AYRO” refer to AYRO, Inc. and its subsidiaries.

 

Overview

 

Business

 

We design and manufacture compact, sustainable electric vehicles for closed campus mobility, low speed urban and community transport, local on-demand and last mile delivery and government use. Our four-wheeled purpose-built electric vehicles are geared toward commercial customers, including universities, business and medical campuses, last mile delivery services and food service providers.

 

Products

 

AYRO vehicles provide the end user an environmentally friendly alternative to internal combustion engine vehicles (cars powered by gasoline or diesel oil), for light duty uses, including low-speed logistics, maintenance and cargo services, at a lower total cost. The majority of our sales have historically been comprised of sales of AYRO 411 Fleet (as defined below) vehicles to Club Car, LLC (“Club Car”).

 

Strategic Review

 

Following the hiring of our current Chief Executive Officer in the third quarter of 2021, we initiated a strategic review of our product development strategy as we focus on creating value within the electric vehicle, last-mile delivery, smart payload and enabling infrastructure markets. In connection with the strategic review, we canceled development of our planned next-generation three-wheeled high-speed vehicle.

 

For the past several years, our primary supplier has been Cenntro Automotive Group, Ltd. (“Cenntro”), which operates a large electric vehicle factory in the automotive district in Hangzhou, China. As a result of rising shipping costs, quality issues with certain components and persistent delays, we ceased production of the AYRO 411x from Cenntro in September 2022 in order to focus our resources on the development and launch of our model year 2023 refresh, the Vanish.

 

We began design and development on the Vanish in December 2021, including updates to our supply chain, the offshoring/onshoring mix, our manufacturing strategy and our annual model year refresh program. We unveiled the first Vanish prototype in the fourth quarter of 2022. Pre-production of the Vanish was completed in December 2022 and preorders are expected to be available in the second quarter of 2023.

 

39
 

 

Nasdaq Minimum Bid Price Requirement

 

On October 3, 2022, we received a letter from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) indicating that, based upon the closing bid price of the Company’s common stock for the 30 consecutive business day period between August 19, 2022 and September 30, 2022, we did not meet the minimum bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2). The letter also indicated that we will be provided with a compliance period of 180 calendar days, or until April 3, 2023 (the “Compliance Period”), in which to regain compliance pursuant to Nasdaq Listing Rule 5810(c)(3)(A).

 

In order to regain compliance with Nasdaq’s minimum bid price requirement, our common stock must maintain a minimum closing bid price of $1.00 for at least ten consecutive business days during the Compliance Period. In the event we do not regain compliance by the end of the Compliance Period, we may be eligible for additional time to regain compliance. To qualify, we will be required to meet the continued listing requirement for the market value of our publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the bid price requirement, and will need to provide written notice of its intention to cure the deficiency during the second compliance period, by effecting a reverse stock split, if necessary. If we meet these requirements, we may be granted an additional 180 calendar days to regain compliance. However, if it appears to Nasdaq that we will be unable to cure the deficiency, or if we are not otherwise eligible for the additional cure period, Nasdaq will provide notice that our common stock will be subject to delisting. We have not regained compliance as of the date of this report.

 

Manufacturing Agreement with Linamar

 

On July 28, 2022, we partnered with Linamar Corporation (“Linamar”), a Canadian manufacturer, in a manufacturing agreement (the “Linamar MLA”) to provide certain sub assembly and assembly parts, including the cabin frame and skate for the Vanish (collectively, the “Products”). During the term of the Linamar MLA, Linamar has the exclusive right to supply the Products to the Company, subject to certain exceptions. The Linamar MLA has an initial term of three years and will automatically renew for successive two-year terms unless either party has given at least 12 months’ written notice of nonrenewal. Either party may terminate the Linamar MLA at any time upon 12 months’ written notice, and in the event of a change in control of the Company prior to the end of the initial term, we may terminate upon written notice within three days of completion of such change in control.

 

In the event we terminate the Linamar MLA prior to its expiration, whether following a change in control or otherwise, we must purchase any remaining raw material inventory, finished goods inventory and work in progress and any unamortized capital equipment used in production and testing of the Products and pay a termination fee of $750,000, subject to certain adjustments. We are dependent on the Linamar MLA, and in the event of its termination our manufacturing operations and customer deliveries would be materially impacted.

 

Under the Linamar MLA, we must commit to certain minimum purchases, to be determined by AYRO on a quarterly basis.

 

We import the Products from Linamar in Canada, and we manufacture and assemble the Vanish at our customization, service, and integration facility in Round Rock, Texas. Over 98% of the vehicle assemblies, components, and products are from North American and European sources.

 

Manufacturing Agreement with Cenntro

 

In 2017, AYRO Operating Company, Inc. (“AYRO Operating”) our wholly owned subsidiary previously known as AYRO, Inc. partnered with Cenntro in a supply chain agreement to provide sub-assembly manufacturing services. Cenntro owns the design of the AYRO Club Car 411 and 411x (“AYRO 411 Fleet”) vehicles and has granted us an exclusive license to purchase the AYRO 411 Fleet vehicles for sale in North America.

 

40
 

 

Under our Manufacturing License Agreement with Cenntro (the “Cenntro MLA”), in order for us to maintain our exclusive territorial rights pursuant to the Cenntro MLA, we must meet certain minimum purchase requirements.

 

We imported semi-knocked-down vehicle kits from Cenntro for the AYRO 411x models comprising our model year 2022 lineup. The vehicle kits were received through shipping containers at the assembly facility of Karma Automotive LLC (“Karma”), our then-manufacturing partner, in southern California, as well as at our customization, service and integration facility in Round Rock, Texas. The vehicles were then assembled with tailored customization requirements per order.

 

On May 31, 2022, we received a letter from Cenntro purporting to terminate all agreements and contracts between the Company and Cenntro. Although we do not believe Cenntro’s termination of the Cenntro MLA is valid, we have determined to cease production of the AYRO 411x and focus our resources on the development and launch of the Vanish. We have canceled all purchase orders and future builds with Cenntro and currently intend to only order replacement parts for vehicles from Cenntro in the future. We expect to lose our exclusive license under the Cenntro MLA, in which case Cenntro could sell identical or similar products through other companies or directly to our customers, which could have a material adverse effect on our results of operations and financial condition.

 

The new Vanish utilizes assemblies and products that will largely eliminate our dependency on Chinese imports and optimize the supply chain to rely primarily upon North American and European sources. Final assembly of the Vanish is expected to occur in our Round Rock, Texas facilities, which we are currently building out in anticipation of Vanish production.

 

Master Procurement Agreement with Club Car

 

In March 2019, we entered into a five-year Master Procurement Agreement (the “MPA”) with Club Car for the sale of our four-wheeled vehicles. The MPA grants Club Car the exclusive right to sell our four-wheeled vehicles in North America, provided that Club Car orders at least 500 vehicles per year.

 

Although Club Car did not meet the volume threshold for 2020 or 2021, we have not sold our model year 2022 411x vehicles commercially other than through Club Car. Under the terms of the MPA, we receive orders from Club Car dealers for vehicles of specific configurations, and we invoice Club Car once the vehicle has shipped. The MPA has an initial term of five (5) years commencing January 1, 2019 and may be renewed by Club Car for successive one-year periods upon 60 days’ prior written notice, so long as those minimums are met. Pursuant to the MPA, we granted Club Car a right of first refusal for sales of 51% or more of AYRO Operating’s assets or equity interests, which right of first refusal is exercisable for a period of 45 days following delivery of an acquisition notice to Club Car. We also agreed to collaborate with Club Car on new products similar to our four-wheeled vehicle and improvements to existing products and granted Club Car a right of first refusal to purchase similar commercial utility vehicles which AYRO Operating may develop during the term of the MPA. For the fiscal year ended December 31, 2022, revenues from Club Car constituted approximately 100% of our revenues.

 

In connection with the forthcoming introduction of the Vanish, we are reevaluating our channel strategy with an eye towards distributing our next-generation platform and payloads in a manner that maximizes visibility, moderates channel costs and creates value. Accordingly, we are seeking additional business partners and channel partners to sell our products beginning with the Vanish. We do not expect Club Car to remain a customer going forward. The anticipated loss of Club Car as a customer, or any significant reduction in purchases by Club Car, could have a material adverse effect on our sales, financial condition and results of operations.

 

41
 

 

Manufacturing Services Agreement with Karma

 

On September 25, 2020, we entered into a Master Manufacturing Services Agreement (the “Karma Agreement”) with Karma, pursuant to which Karma agreed to provide certain manufacturing services for the production of our vehicles. The initial statement of work provided that Karma would perform assembly of a certain quantity of the AYRO 411 vehicles and provide testing, materials management and outbound logistics services. For such services in the initial statement of work, we agreed to pay $1.2 million to Karma, of which (i) $0.52 million was paid at closing and (ii) $0.64 million was due and payable five months following the satisfaction of certain production requirements. This second payment was accrued for as of December 31, 2021 and paid February 3, 2022.

 

On February 24, 2021, the Karma Agreement was amended to allow Karma to assemble a certain number of units of the AYRO 411x vehicle. The Karma Agreement expired in September 2022.

 

In late September 2022, we retired the 411x assembly line in connection with our transition to production of the Vanish.

 

Supply Agreement with Gallery Carts

 

During 2020, we entered into a supply agreement with Gallery Carts (“Gallery”), a leading provider of food and beverage kiosks, carts, and mobile storefront solutions. Joint development efforts have led to the launch of the parties’ first all-electric configurable mobile hospitality vehicle for “on-the-go” venues across the United States. This innovative solution permits food, beverage and merchandising operators to bring goods directly to consumers.

 

The configurable Powered Vendor Box, in the rear of the vehicle, features long-life lithium batteries that power the preconfigured hot/cold beverage and food equipment and is directly integrated with the AYRO 411x and will be directly integrated with the Vanish. The canopy doors, as well as the full vehicle, can be customized with end-user logos and graphics to enhance the brand experience. Gallery, with 40 years of experience delivering custom food kiosk solutions, has expanded into electric mobile delivery vehicles, as customers increasingly want food, beverages and merchandise delivered to where they are gathering. For example, a recent study conducted by Technomic found that a large majority of students, 77%, desired alternative mobile and to-go food options on campus.

 

Gallery, a premier distributor of AYRO vehicles, has a diverse clientele throughout mobile food, beverage and merchandise distribution markets for key customer applications such as university, corporate and government campuses, major league and amateur-level stadiums and arenas, resorts, airports, and event centers. In addition to finding innovative and safe ways to deliver food and beverages to their patrons, reducing and ultimately eliminating their carbon footprint is a top priority for many of these customers.

 

42
 

 

Factors Affecting Results of Operations

 

Master Procurement Agreement

 

In March 2019, we entered into the MPA with Club Car. In partnership with Club Car and in interaction with its substantial dealer network, we have redirected our business development resources towards supporting Club Car’s enterprise and fleet sales function as Club Car proceeds in its new product introduction initiatives. We are evaluating our relationship with Club Car and may seek to replace Club Car with new business partners for selling our products beginning with the Vanish. We do not expect Club Car to remain a customer going forward.

 

COVID-19 Pandemic

 

Our business, results of operations and financial condition have been adversely impacted by the coronavirus outbreak both in China and the United States. This has delayed our ability to timely procure raw materials from Cenntro, which in turn delayed shipments to, and corresponding revenue from, customers. The pandemic and social distancing directives have interfered with our ability, and the ability of our employees, workers, contractors, suppliers and other business partners to perform our and their respective responsibilities and obligations relative to the conduct of our business. The COVID-19 pandemic poses restrictions on our employees’ and other service providers’ ability to travel on pre-sales meetings, customers’ abilities to physically meet with our employees and the ability of our customers to test drive or purchase our vehicles, and shutdowns that may be requested or mandated by governmental authorities. The pandemic adversely impacted our sales and the demand for our products in 2021 and 2022.

 

Tariffs

 

Countervailing tariffs on certain goods from China continued to have an adverse impact on raw material costs throughout 2021 and 2022.

 

Shipping Costs and Delays

 

A majority of our raw materials have historically been shipped via container from overseas vendors in China, such as Cenntro, which was formerly our largest supplier. Although we intend to reduce our reliance on offshore suppliers by primarily sourcing components for the Vanish from vendors in North America and Europe, our vendors may be reliant on offshore suppliers. We rely heavily on third parties, including ocean carriers and truckers, in that process. The global shipping industry is experiencing a shortage of shipping capacity, trucking shortages, increased ocean shipping rates and increased trucking and fuel costs. As a result, our receipt of imported products has been, and may continue to be, disrupted or delayed.

 

A port worker strike, work slow-down or other transportation disruption in domestic ports could significantly disrupt our business or that of our vendors. This has materially and adversely affected our business and financial results for the fiscal year ended December 31, 2022 and could continue to materially and adversely affect our business and financial results in 2023. If significant disruptions along these lines continue, this could lead to further significant disruptions in our business, delays in shipments to us and to our vendors and revenue and profitability shortfalls, which could adversely affect our business, prospects, financial condition and operating results.

 

The global shipping industry is also experiencing unprecedented increases in shipping rates from the trans-Pacific ocean carriers due to various factors, including limited availability of shipping capacity. Additionally, if further increases in fuel prices occur, our transportation costs would likely further increase.

 

43
 

 

Supply Chain

 

Beginning in the second quarter of 2021, we offered a configuration of our 411x powered by lithium-ion battery technology. Additionally, our powered food box offerings are currently powered by lithium-ion battery technology. Our business depends on the continued supply of battery cells and other parts for our vehicles. During 2021 and 2022, we at times experienced supply chain shortages of both lithium-ion battery cells and other critical components used to produce our vehicles, which has slowed our planned production of vehicles. In addition, we could be impacted by shortages of other products or raw materials, including silicon chips that we or our suppliers use in the production of our vehicles or parts sourced for our vehicles.

 

We intend for the Vanish to utilize assemblies and products that will eliminate our dependency on Chinese imports and optimize the supply chain to North American and European sources.

 

Inventory Obsolescence

 

At June 30, 2022, we determined that testing of obsolescence was required for inventory due to the quality of certain purchased components from Cenntro’s lithium-ion (“NCM”) line. 17 vehicles tested in the second quarter of 2022 were determined to have 49 unique failures. An inspection of the remaining NCM units revealed a 100% failure rate. As a result, all inventory associated with Cenntro’s NCM line was written off for $1,317,289 to cost of goods sold. As of December 31, 2021 the balance of prepaid expenses and accrued expenses, net with Cenntro was $602,016. As of December 31, 2022, there was no longer a balance. Impairments of prepaid expenses led to a write-down, netted with the balance in accrued expenses. The remainder of the balance was expensed through cost of goods sold for $621,097. During the year ended December 31, 2022, a $413,561 net realizable value adjustment was recorded due to the Club Car Discount (as defined below), spare inventory for the 411x was written off, net with the inventory reserve of $124,375, and $2,476,322 was expensed for impairment of inventory.

 

Components of Statements of Operations

 

Revenue

 

We derive revenue from the sale of our four-wheeled electric vehicles, and, to a lesser extent, shipping, parts and service fees. In the past we also derived rental revenue from vehicle revenue sharing agreements with tourist destination fleet operators, and, to a lesser extent, shipping, parts and service fees. Provided that all other revenue recognition criteria have been met, we typically recognize revenue upon shipment, as title and risk of loss are transferred to customers and channel partners at that time. Products are typically shipped to dealers or directly to end customers, or in some cases to our international distributors. These international distributors assist with import regulations, currency conversions and local language. Our vehicle product sales revenues vary from period to period based on, among other things, the customer orders received and our ability to produce and deliver the ordered products. Customers often specify requested delivery dates that coincide with their need for our vehicles.

 

Because these customers may use our products in connection with a variety of projects of different sizes and durations, a customer’s orders for one reporting period generally do not indicate a trend for future orders by that customer. Additionally, order patterns do not necessarily correlate amongst customers. In September 2022, Club Car required a discount of $2,000 per vehicle, to be applied to all past and future 2022 sales (the “Club Car Discount”). Revenue was reduced by $0.13 million as a result of the Club Car Discount for the year ended December 31, 2022.

 

44
 

 

Cost of Goods Sold

 

Cost of goods sold primarily consists of costs of materials and personnel costs associated with manufacturing operations, and an accrual for post-sale warranty claims. Personnel costs consist of wages and associated taxes and benefits. Cost of goods sold also includes freight and changes to our warranty reserves. Allocated overhead costs consist of certain facilities and utility costs. We expect cost of revenue to increase in absolute dollars as product revenue increases. At June 30, 2022, we determined that testing of obsolescence was required for inventory due to the quality of NCM components received from Cenntro. 17 vehicles tested in the second quarter of 2022 were determined to have 49 unique failures. An inspection of the remaining NCM units revealed a 100% failure rate. As a result, all inventory associated with Cenntro’s NCM line was written off to cost of goods sold for $1,317,289. Impairments of prepaid expenses led to a write-down, netted with the balance in accrued expenses. The remainder of the balance was expensed through cost of goods sold for $621,097. During years ended December 31, 2022, the Club Car Discount required a $413,561 net realizable value adjustment, necessitating a write down of the value of inventory. During the year ended December 31, 2022, $2,476,322 was expensed for impairment of inventory.

 

Operating Expenses

 

Our operating expenses consist of general and administrative, sales and marketing and research and development expenses. Salaries and personnel-related costs, benefits, and stock-based compensation expense are the most significant components of each category of operating expenses. Operating expenses also include allocated overhead costs for facilities and utility costs.

 

Stock-based compensation

 

We account for stock-based compensation expense in accordance with Accounting Standards Codification (“ASC”) 718, Compensation—Stock Compensation, which requires the measurement and recognition of compensation expense for share-based awards based on the estimated fair value on the date of grant.

 

The fair value of each stock option granted to employees is estimated on the date of the grant using the Black-Scholes option-pricing model, and the related stock-based compensation expense is recognized over the vesting period during which an employee is required to provide service in exchange for the award. The fair value of the options granted to non-employees is measured and expensed as the options vest.

 

Restricted stock grants are stock awards that entitle the holder to receive shares of our common stock as the award vests over time. The fair value of each restricted stock grant is based on the fair market value price of common stock on the date of grant, and it is measured and expensed as it vests.

 

We estimate the fair value of stock-based and cash unit awards containing a market condition using a Monte Carlo simulation model. Key inputs and assumptions used in the Monte Carlo simulation model include the stock price of the award on the grant date, the expected term, the risk-free interest rate over the expected term, the expected annual dividend yield and the expected stock price volatility. The expected volatility is based on a combination of the historical and implied volatility of our publicly traded, near-the-money stock options, and the valuation period is based on the vesting period of the awards. The risk-free interest rate is derived from the U.S. Treasury yield curve in effect at the time of grant and, since we do not currently pay or plan to pay a dividend on its common stock, the expected dividend yield was zero.

 

Research and Development Expense

 

Research and development expense consists primarily of employee compensation and related expenses, prototype expenses, depreciation associated with assets acquired for research and development, amortization of product development costs, product strategic advisory fees, third-party engineering and contractor support costs, and allocated overhead. We expect our research and development expenses to increase in absolute dollars as we continue to invest in new and existing products.

 

Sales and Marketing Expense

 

Sales and marketing expense consists primarily of employee compensation and related expenses, sales commissions, marketing programs, travel and entertainment expenses and allocated overhead. Marketing programs consist of advertising, tradeshows, events, corporate communications and brand-building activities. We expect sales and marketing expenses to increase modestly in absolute dollars as we expand our market segments addressed, refresh and expand our product lines, provide event support for our channel partners, and further develop potential sales channels.

 

General and Administrative Expense

 

General and administrative expense consists primarily of employee compensation and related expenses for administrative functions including finance, legal, human resources and fees for third-party professional services, and allocated overhead. We expect our general and administrative expense to increase in absolute dollars as we continue to invest in growing our business.

 

45
 

 

Other (Expense) Income

 

Other (expense) income consists of income received or expenses incurred for activities outside of our core business. Other expense consists primarily of interest expense and unrealized gain/loss on marketable securities.

 

Provision for Income Taxes

 

Provision for income taxes consists of estimated income taxes due to the United States government and to the state tax authorities in jurisdictions in which we conduct business. In the case of a tax deferred asset, we reserve the entire value for future periods.

 

Results of Operations

 

Year Ended December 31, 2022 Compared with Year ended December 31, 2021

 

The following table sets forth our results of operations for each of the periods set forth below:

 

   For the Years ended December 31, 
   2022   2021   Change 
Revenue  $2,990,497   $2,683,597   $306,900 
Cost of goods sold   6,043,506    4,774,784    1,268,722 
Gross loss   (3,053,009)   (2,091,187)   (961,822)
Operating expenses:               
Research and development   6,845,451    11,449,617    (4,604,166)
Sales and marketing   1,874,658    2,419,168    (544,510)
General and administrative   11,503,788    17,168,898    (5,665,110)
Total operating expenses   20,223,897    31,037,683    (10,813,786)
Loss from operations   (23,276,906)   (33,128,870)   9,851,964 
Other income and (expense):               
Interest Income   182,276    51,768    130,508 
Interest expense   -    (2,312)   2,312 
Realized gain on marketable securities   160,990    -    160,990 
Unrealized loss on marketable securities   (1,713)   -    (1,713)
Net loss  $(22,935,353)  $(33,079,414)  $10,144,061 

 

Revenue

 

Revenue was $2.99 million for the year ended December 31, 2022, as compared to $2.68 million for the year ended December 31, 2021, an increase of 11.4%, or $0.31 million. The increase in revenue was the result of an increase in volume of sales of our vehicles, powered-food box sales and other vehicle options for the year ended December 31, 2022.

 

Cost of goods sold and gross loss

 

Cost of goods sold increased by $1.27 million, or 26.6%, to $6.04 million for the year ended December 31, 2022, as compared to the year ended December 31, 2021. The increase in cost of goods sold was primarily due to a $1.32 million write-off of NCM inventory due to a 100% failure rate, and $0.62 million of Cenntro prepaid and accrued balances, as well as an increase in vehicles sales, and an increase in time-of-order options for our vehicles and specialty products. The company recorded a $0.41 million net realizable value adjustment due to the Club Car discount.

 

Gross margin percentage was (102.1)% for the year ended December 31, 2022, as compared to (77.9)% for the year ended December 31, 2021. The decrease in gross margin percentage was primarily due to the write-off of NCM inventory, the write down of Cenntro balances, and the issuance of credit memos in connection with the Club Car Discount, and the corresponding net realizable value adjustment.

 

46
 

 

Research and development expenses

 

Research and development expense was $6.85 million for the year ended December 31, 2022, as compared to $11.45 million for the year ended December 31, 2021, a decrease of $4.6 million, or 41%. The decrease was primarily due to a repositioning of expenses related to personnel costs for our engineering, design, and research teams from the initiated development of our planned next-generation three-wheeled vehicle to the Vanish. We had a decrease in R&D contracting for professional service and design costs of $3.95 million, and a decrease in salaries and related expenses of $0.47 million.

 

Sales and marketing expense

 

Sales and marketing expense decreased by $0.54 million, or 22.5%, for the year ended December 31, 2022, as compared to the year ended December 31, 2021, as we reduced the cost of marketing-related initiatives surrounding the Vanish. Salaries and related expenses decreased by $0.12 due to the restructuring of our sales and marketing resources. Stock based compensation decreased by $0.2 million. Expenses related to consultants for professional marketing services decreased by $0.07 million.

 

General and administrative expenses

 

The majority of our operating losses from continuing operations resulted from general and administrative expenses. General and administrative expenses consist primarily of costs associated with our overall operations and with being a public company. These costs include personnel, legal and financial professional services, insurance, investor relations, and compliance-related fees. General and administrative expense was $11.5 million for the year ended December 31, 2022, compared to $17.17 million for 2021, a decrease of $5.67 million, primarily due to a $6.07 million decrease in stock-based compensation expense. Salaries and related expenses excluding stock-based compensation increased by $1.52 million. Fulfillment and rent expense increased by $0.12 million and $0.12 million, respectively. Depreciation increased by $0.27 million.

 

47
 

 

Other income and expense

 

We recorded $0.18 million in interest income on cash accounts, a realized gain of $0.16 million on marketable securities and an unrealized loss of $.001 million.

 

Liquidity and Capital Resources

 

As of December 31, 2022, we had $39.10 million in cash, $9.85 million in marketable securities and working capital of $49.67 million. As of December 31, 2021, we had $69.16 million in cash and working capital of $72.31 million. The decrease in cash and working capital was primarily a result of our inventory write down and our operating loss, respectively. Our sources of cash since inception have been predominantly from the sale of equity and debt.

 

Our business is capital-intensive, and future capital requirements will depend on many factors, including our growth rate, the timing and extent of spending to support development efforts, the results of our strategic review, the expansion of our sales and marketing teams, the timing of new product introductions and the continuing market acceptance of our products and services. We are working to control expenses and deploy our capital in the most efficient manner.

 

We are evaluating other options for the strategic deployment of capital beyond our ongoing strategic initiatives, including potentially entering other segments of the electric vehicle market. We anticipate being opportunistic with our capital, and we intend to explore potential partnerships and acquisitions that could be synergistic with our competitive stance in the market.

 

We are subject to a number of risks similar to those of earlier stage commercial companies, including dependence on key individuals and products, the difficulties inherent in the development of a commercial market, the potential need to obtain additional capital, competition from larger companies, other technology companies and other technologies. Based on the foregoing, management believes that the existing cash at December 31, 2022, will be sufficient to fund operations for at least the next twelve months following the date of this report.

 

As discussed above under “Strategic Review,” we suspended all material research and development activity and expenditures, including expenses associated with our planned next-generation three-wheeled vehicle, while we conducted a strategic review of our product development strategy. In December of 2022 we completed pre-production on the new 411 fleet vehicle model refresh, the Vanish.

 

48
 

 

Summary of Cash Flows

 

The following table summarizes our cash flows:

   Years Ended December 31, 
   2022   2021 
Cash Flows:          
Net cash used in operating activities  $(18,728,643)  $(26,631,485)
Net cash used in investing activities  $(11,335,261)  $(600,363)
Net cash provided by financing activities  $-   $59,855,217 

 

Operating Activities

 

During the year ended December 31, 2022, we used $18.73 million in cash in operating activities, a decrease of $7.90 million compared to cash used in operating activities of $26.63 million during the same period in 2021. The decrease in cash used in operating activities was primarily a result of reduced consultant expenditures, increased collections on accounts receivable, and reduced cash used for purchasing inventory.

 

Our ability to generate cash from operations in future periods will depend in large part on profitability, the rate and timing of collections of our accounts receivable, inventory turns and our ability to manage other areas of working capital.

 

Investing Activities

 

During the year ended December 31, 2022, we used cash of $11.34 million in investing activities, as compared to $0.6 million cash used in investing activities during 2021, an increase of $10.73 million. The net increase was primarily due to our investment in marketable securities.

 

Financing Activities

 

During the year ended December 31, 2022, we had no financing activities of note.

 

During the year ended December 31, 2021, we received net proceeds of an aggregate of $58.30 million from the issuance of common stock, net of fees and expenses, $0.10 million from the exercise of warrants for cash. In addition, we issued 555,004 shares of common stock from the exercise of stock options and received cash proceeds of $1.5 million.

 

49
 

 

Critical Accounting Estimates

 

Our management’s discussion and analysis of our financial condition and results of operations is based on our consolidated financial statements, which have been prepared in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”). The preparation of our consolidated financial statements and related disclosures requires us to make estimates, assumptions and judgments that affect the reported amount of assets, liabilities, revenue, costs and expenses and related disclosures. We base our assumptions, estimates and judgments on historical experience, current trends and other factors that management believes to be relevant at the time our consolidated financial statements are prepared. Accordingly, we evaluate our estimates and assumptions on an ongoing basis. Our actual results may differ from these estimates under different assumptions and conditions.

 

We have identified certain accounting estimates which involve a significant level of estimation uncertainty and have had, or are reasonably likely to have, a material impact on our financial conditions or results of operations.

 

We believe that the following accounting estimates are the most critical to aid in fully understanding and evaluating our reported financial results. There have been no changes to estimates during the periods presented in the filing. Historically, changes in management estimates have not been material.

 

Use of Estimates

 

The preparation of the consolidated financial statements, in conformity with GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenue and expenses during the reporting period. Our most significant estimates include inventory valuation and the measurement of stock-based compensation expenses. Actual results could differ from these estimates.

 

Inventory Valuation

 

The accounting of inventory in accordance with GAAP recognizes the value of inventory at the lower of cost or net realizable value based upon assumptions about future demand and market conditions. Inventories are assessed regularly for impairment, and valuation reserves are established, when necessary, based upon a number of factors. The determination of events and assumptions utilized in our inventory valuation requires judgment. Transportation costs are included in net realizable value.

 

Revenue Recognition

 

We recognize revenue in accordance with ASC 606, Revenue from Contracts with Customers, the core principle of which is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to receive in exchange for those goods or services. To achieve this core principle, five basic criteria must be met before revenue can be recognized: (i) identify the contract with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to performance obligations in the contract; and (v) recognize revenue when or as we satisfy a performance obligation.

 

50
 

 

Stock-Based Compensation

 

The Company accounts for stock-based compensation in accordance with ASC 718, Compensation-Stock Compensation (“ASC 718”). The Company recognizes all employee share-based compensation as an expense in the financial statements on a straight-line basis over the requisite service period, based on the terms of the awards. Equity-classified awards principally related to stock options, restricted stock awards (“RSAs”) and equity-based compensation, are measured at the grant date fair value of the award. The Company determines grant date fair value of stock option awards using the Black-Scholes option-pricing model. The fair value of RSAs is determined using the closing price of the Company’s common stock on the grant date. For service based vesting grants, expense is recognized ratably over the requisite service period based on the number of options or shares. For value-based vesting grants, expense is recognized via straight line expense over the expected period per grant as determined by outside valuation experts. Stock-based compensation is reversed for forfeitures in the period of forfeiture.

 

We estimate the fair value of stock-based and cash unit awards containing a market condition using a Monte Carlo simulation model. Key inputs and assumptions used in the Monte Carlo simulation model include the stock price of the award on the grant date, the expected term, the risk-free interest rate over the expected term, the expected annual dividend yield and the expected stock price volatility. The expected volatility is based on a combination of the historical and implied volatility of the Company’s publicly traded, near-the-money stock options, and the valuation period is based on the vesting period of the awards. The risk-free interest rate is derived from the U.S. Treasury yield curve in effect at the time of grant and, since the Company does not currently pay or plan to pay a dividend on its common stock, the expected dividend yield was zero.

 

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

 

Not applicable.

 

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA.

 

The information required by this Item 8 is included at the end of this Annual Report on Form 10-K beginning on page F-1.

 

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE.

 

Based on information provided by Friedman LLP (“Friedman”), the Company’s independent registered public accounting firm, effective September 1, 2022, certain assets of Friedman LLP were acquired by Marcum LLP and continued to operate as an independent registered public accounting firm. As previously disclosed, on September 21, 2022, the Company dismissed Friedman and engaged Marcum to serve as the independent registered public accounting firm of the Company for the fiscal year ended December 31, 2022, which actions were ratified by the Audit Committee of the Board of Directors of the Company. The services previously provided by Friedman are now provided by Marcum.

 

The reports of Friedman on the Company’s consolidated financial statements for the two most recent fiscal years, ended December 31, 2021 and 2020, did not contain an adverse opinion or a disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope, or accounting principles.

 

During the fiscal years ended December 31, 2022 and 2021, and the subsequent interim period through September 21, 2021, (i) there were no disagreements, as defined in Item 304(a)(1)(iv) of Regulation S-K, with Friedman on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to the satisfaction of Friedman, would have caused Friedman to make reference to the subject matter of the disagreements in connection with its reports on the Company’s consolidated financial statements for such period, and (ii) there were no “reportable events,” as defined in Item 304(a)(1)(v) of Regulation S-K, except that the Company identified a material weakness in its internal control over financial reporting related to segregation of duties, which was described in Item 4 of the Company’s Quarterly Reports on Form 10-Q for the quarters ended September 30, 2022, June 30, 2022, March 31, 2022, September 30, 2021, June 30, 2021 and March 31, 2021 and Item 9A of the Company’s Annual Reports on Form 10-K for the years ended December 31, 2021 and 2020. The Audit Committee discussed the subject matter of the reportable events with Friedman LLP, and notwithstanding these material weaknesses in internal control over financial reporting, the Company has concluded that, based on its knowledge, the consolidated financial statements, and other financial information included in its Quarterly Reports on Form 10-Q for the quarters ended September 30, 2022, June 30, 2022, March 31, 2022, September 30, 2021, June 30, 2021 and March 31, 2021 and its Annual Reports on Form 10-K for the years ended December 31, 2021 and 2020 present fairly, in all material respects, the Company’s financial condition, results of operations and cash flows for the periods presented in conformity with accounting principles generally accepted in the United States.

 

During the Company’s fiscal years ended December 31, 2021 and 2020 and the subsequent interim period through September 21, 2022, neither the Company nor anyone on its behalf has consulted with Marcum regarding either (i) the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company’s financial statements, and neither a written report nor oral advice was provided to the Company that Marcum concluded was an important factor considered by the Company in reaching a decision as to any accounting, auditing or financial reporting issue, or (ii) any matter that was either the subject of a “disagreement” or a “reportable event,” as such terms are defined in Regulation S-K Item 304(a)(1)(iv) and (v), respectively.

 

51
 

 

ITEM 9A – CONTROLS AND PROCEDURES

 

Disclosure Controls and Procedures

 

Under the supervision and with the participation of management, including our principal executive and principal financial officers, we evaluated the effectiveness of our disclosure controls and procedures as of December 31, 2022. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”), as amended, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that we file or submit under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, as appropriate, to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives, and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

 

Based on the evaluation of our disclosure controls and procedures as of December 31, 2022, our Chief Executive Officer and Chief Financial Officer concluded that, as of such date, our disclosure controls and procedures were ineffective due to the material weakness in internal control over financial reporting discussed below.

 

Management’s Report on Internal Control Over Financial Reporting

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act as a process designed by, or under the supervision of, our Chief Executive Officer and Chief Financial Officer and effected by our board of directors, management and other personnel to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles and includes those policies and procedures that:

 

  pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of our assets;
     
  provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorization of our management and directors; and
     
  provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risks that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

Management assessed the effectiveness of our internal control over financial reporting as of December 31, 2022. In making this assessment, management used the criteria set forth in Internal Control—Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”). A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of annual or interim financial statements will not be prevented or detected on a timely basis. In its assessment of the effectiveness of internal control over financing reporting as of December 31, 2022, management identified a material weakness related to segregation of duties. Specifically, due to limited resources and headcount we did not have multiple people in the accounting function for a full segregation of duties.

 

Based on this assessment, management concluded that we did not maintain effective internal control over financial reporting as of December 31, 2022, based on the criteria in Internal Control – Integrated Framework (2013).

 

Plan for Remediation of Material Weakness

 

We have engaged a third party to conduct a full assessment of our controls and procedures. In the fourth quarter of 2022 we completed our full assessment and are now in the process of testing those controls.

 

Changes in Internal Control over Financial Reporting

 

Except as disclosed above, there were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

ITEM 9B. OTHER INFORMATION.

 

None.

 

Item 9C. Disclosure Regarding Foreign Jurisdictions That Prevent Inspections.

 

Not applicable.

 

52
 

 

PART III

 

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS, AND CORPORATE GOVERNANCE

 

The information required under this item is incorporated herein by reference to our definitive proxy statement pursuant to Regulation 14A, which proxy statement will be filed with the SEC not later than 120 days after the close of our fiscal year ended December 31, 2022. Information relating to this item will be included in an amendment to this Annual Report on Form 10-K if the Company’s definitive proxy statement is not filed within such time.

 

ITEM 11. EXECUTIVE COMPENSATION

 

The information required under this item is incorporated herein by reference to our definitive proxy statement pursuant to Regulation 14A, which proxy statement will be filed with the SEC not later than 120 days after the close of our fiscal year ended December 31, 2022. Information relating to this item will be included in an amendment to this Annual Report on Form 10-K if the Company’s definitive proxy statement is not filed within such time.

 

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

 

The information required under this item is incorporated herein by reference to our definitive proxy statement pursuant to Regulation 14A, which proxy statement will be filed with the SEC not later than 120 days after the close of our fiscal year ended December 31, 2022. Information relating to this item will be included in an amendment to this Annual Report on Form 10-K if the Company’s definitive proxy statement is not filed within such time.

 

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE

 

The information required under this item is incorporated herein by reference to our definitive proxy statement pursuant to Regulation 14A, which proxy statement will be filed with the SEC not later than 120 days after the close of our fiscal year ended December 31, 2022. Information relating to this item will be included in an amendment to this Annual Report on Form 10-K if the Company’s definitive proxy statement is not filed within such time.

 

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES

 

The Company’s independent registered public accounting firm is Marcum LLP (PCAOB Firm ID No.: 688) located in Melville, New York. The information required under this item is incorporated herein by reference to our definitive proxy statement pursuant to Regulation 14A, which proxy statement will be filed with the SEC not later than 120 days after the close of our fiscal year ended December 31, 2022. Information relating to this item will be included in an amendment to this Annual Report on Form 10-K if the Company’s definitive proxy statement is not filed within such time.

 

53
 

 

PART IV

 

ITEM 15. EXHIBITS, AND FINANCIAL STATEMENT SCHEDULES.

 

(a) The following documents are filed as part of this Annual Report on Form 10-K:

 

(1) Financial Statements:

 

Reports of Independent Registered Public Accounting Firms F-1-2
Consolidated Balance Sheets as of December 31, 2022 and 2021 F-3
Consolidated Statements of Operations for the years ended December 31, 2022 and 2021 F-4
Consolidated Statements of Stockholders’ Equity for the years ended December 31, 2022 and 2021 F-5
Consolidated Statements of Cash Flows for the years ended December 31, 2022 and 2021 F-6
Notes to Consolidated Financial Statements F-7

 

(2) Financial Statement Schedules:

 

None. Financial statement schedules have not been included because they are not applicable, or the information is included in the consolidated financial statements or notes thereto.

 

(3) Exhibits:

 

See “Index to Exhibits” for a description of our exhibits.

 

Item 16. FORM 10-K SUMMARY

 

Not applicable.

 

54
 

 

Exhibit No.   Description
     
2.1   Agreement and Plan of Merger and Reorganization by and among DropCar, Inc., ABC Merger Sub, Inc. and AYRO, Inc. dated December 19, 2019 (incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on December 20, 2019)
     
2.2   Asset Purchase Agreement, by and among DropCar, Inc., DropCar Operating Company, Inc., DC Partners Acquisition, LLC, Spencer Richardson and David Newman, dated December 19, 2019 (incorporated by reference to Exhibit 2.5 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on December 20, 2019)
     
2.3   Amendment to Asset Purchase Agreement, by and among DropCar, Inc., DropCar Operating Company, Inc., DC Partners Acquisition, LLC, Spencer Richardson and David Newman, dated May 28, 2020 (incorporated by reference to Exhibit 2.3 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on May 29, 2020)
     
3.1   Certificate of Amendment to the Certificate of Designations, Preferences and Rights of Series H-4 Convertible Preferred Stock (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on May 29, 2020)
     
3.2   Amended and Restated Certificate of Incorporation, effective May 28, 2020 (incorporated by reference to Exhibit 3.2 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on May 29, 2020)
     
3.3   Certificate of Amendment to Amended and Restated Certificate of Incorporation, effective May 28, 2020 (incorporated by reference to Exhibit 3.3 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on May 29, 2020)
     
3.4   Amended and Restated Bylaws, effective May 28, 2020 (incorporated by reference to Exhibit 3.4 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on May 29, 2020)
     
3.5   First Amendment to the Amended and Restated Bylaws (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on July 8, 2020)
     
3.6   Second Amendment to the Amended and Restated Bylaws (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on October 19, 2021)
     
4.1   Palladium Holdings, LLC Finder’s Warrant issued in connection with the June 2020 Registered Direct Offering (incorporated by reference to Exhibit 4.1 to the Company’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 14, 2020)
     
4.2   Form of Spartan Capital Securities, LLC Finder’s Warrant issued in connection with the June 2020 Registered Direct Offering (incorporated by reference to Exhibit 4.2 to the Company’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 14, 2020)
     
4.3   Palladium Holdings, LLC Advisor’s Warrant issued in connection with the July 2020 Registered Direct Offering (incorporated by reference to Exhibit 4.3 to the Company’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 14, 2020)

 

55
 

 

4.4   Form of Spartan Capital Securities, LLC Advisor’s Warrant issued in connection with the July 2020 Registered Direct Offering (incorporated by reference to Exhibit 4.4 to the Company’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 14, 2020)
     
4.5   Palladium Holdings, LLC Advisor’s Warrant issued in connection with the July 23, 2020 Registered Direct Offering (incorporated by reference to Exhibit 4.5 to the Company’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 14, 2020)
     
4.6   Form of Pre-Funded Warrant issued in connection with the AYRO Private Placements (incorporated by reference to Exhibit 4.6 to the Company’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 14, 2020)
     
4.7   Form of Warrant issued in connection with the $850K AYRO Private Placement (incorporated by reference to Exhibit 4.7 to the Company’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 14, 2020)
     
4.8   Form of Warrant issued in connection with the $1.15M AYRO Private Placement (incorporated by reference to Exhibit 4.8 to the Company’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 14, 2020)
     
4.9   Form of Warrant issued in connection with the AYRO Bridge Loan (incorporated by reference to Exhibit 4.9 to the Company’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 14, 2020)
     
4.10   Form of Penny Warrant issued in connection with the Secured Loan (incorporated by reference to Exhibit 4.10 to the Company’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 14, 2020)
     
4.11   Form of Series B Warrant (incorporated by reference to Exhibit 4.2 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on November 23, 2020)
     
4.12   Form of Investor Warrant issued in connection with the January 2021 Offering (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on January 26, 2021)
     
4.13   Form of Palladium Warrant issued in connection with the January 2021 Offering (incorporated by reference to Exhibit 4.2 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on January 26, 2021)

 

56
 

 

4.14   Form of Placement Agent Common Stock Purchase Warrant issued in connection with the February 2021 Offering (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on February 16, 2021)
     
4.15   Description of Capital Stock (incorporated by reference to Exhibit 4.16 to the Company’s Annual Report on Form 10-K for the year ended December 31, 2020, filed with the SEC on March 31, 2020)
     
4.16   Form of Spartan Common Stock Purchase Warrant issued in connection with the February 2021 Offering (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on February 16, 2021)
     
10.1   Mark Adams Secured Promissory Note, dated as of October 14, 2019 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on May 29, 2020)
     
10.2   Amendment to Mark Adams Secured Promissory Note, dated December 31, 2019 (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on May 29, 2020)
     
10.3   April Bridge Financing, by and among AYRO Operating Company, Inc., and the lenders party thereto, dated April 14, 2020 (incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on May 29, 2020)
     
10.4   Form of Bridge Loan Registration Rights Agreement, dated May 28, 2020 (incorporated by reference to Exhibit 10.4 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on May 29, 2020)
     
10.5   Form of AYRO Operating Private Placement Registration Rights Agreement, dated May 28, 2020 (incorporated by reference to Exhibit 10.5 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on May 29, 2020)
     
10.6†   Employment Agreement, by and between the Company and Rodney Keller, dated May 28, 2020 (incorporated by reference to Exhibit 10.6 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on May 29, 2020)

 

57
 

 

10.7†   Employment Agreement, by and between AYRO Operating Company, Inc., and Curtis Smith, dated March 8, 2018 (incorporated by reference to Exhibit 10.7 to the Company’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 14, 2020)
     
10.8†   Amendment to Employment Agreement, by and between AYRO Operating Company, Inc., and Curtis Smith, dated May 28, 2020 (incorporated by reference to Exhibit 10.7 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on May 29, 2020)
     
10.9†   AYRO, Inc. 2020 Long-Term Equity Incentive Plan (incorporated by reference to Exhibit 99.1 to the Company’s Registration Statement on Form S-8 filed with the Securities and Exchange Commission on August 3, 2020)
     
10.10†   Form of ISO Award Agreement (incorporated by reference to Exhibit 10.9 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on May 29, 2020)
     
10.11†   Form of NQSO Award Agreement (incorporated by reference to Exhibit 10.10 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on May 29, 2020)
     
10.12†   Form of RSU Award Agreement (incorporated by reference to Exhibit 10.11 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on May 29, 2020)
     
10.13   Form of Securities Purchase Agreement, dated June 17, 2020, by and among the Company and the purchasers thereto (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on June 19, 2020)
     
10.14   Form of Securities Purchase Agreement, dated July 6, 2020, by and among the Company and the purchasers thereto (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on July 8, 2020)
     
10.15   Form of Securities Purchase Agreement, dated July 21, 2020, by and among the Company and the purchasers thereto (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on July 23, 2020)
     
10.16+   Master Procurement Agreement, dated March 5, 2019, by and among the Company and Club Car LLC (incorporated by reference to Exhibit 10.16 to the Company’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 14, 2020)
     
10.17†   AYRO Operating, Inc. 2017 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.17 to the Company’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 14, 2020)
     
10.18†   Form of NQSO Award Agreement under the AYRO Operating, Inc. 2017 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.18 to the Company’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 14, 2020)
     
10.19   Advisory Agreement, dated January 1, 2019, by and among the Company and Sustainability Consultants, LLC (incorporated by reference to Exhibit 10.19 to the Company’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 14, 2020)

 

58
 

 

10.20   Form of Addendum to the Securities Purchase Agreement, dated October 16, 2020 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on October 16, 2020)
     
10.21†   First Amendment to Employment Agreement, by and between AYRO, Inc., and Rodney C. Keller, Jr., dated September 29, 2020 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on October 1, 2020)
     
10.22   Form of Securities Purchase Agreement, dated November 22, 2020, by and among the Company and the purchasers thereto (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on November 23, 2020
     
10.23†   First Amendment to the AYRO, Inc. 2020 Long-Term Incentive Plan, dated December 17, 2020 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on December 22, 2020)
     
10.24   Form of Securities Purchase Agreement, dated January 25, 2021, by and among the Company and the purchasers thereto (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on January 26, 2021)
     
10.25   Form of Securities Purchase Agreement, dated February 11, 2021, by and among the Company and the purchasers thereto (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on February 16, 2021)
     
10.26†   Voluntary Separation Agreement, Release and Consulting Agreement, by and between the Company and Rodney Keller, Jr., dated as of September 20, 2021 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on September 24, 2021)
     
10.27†   Restricted Stock Award Agreement, by and between the Company and Thomas M. Wittenschlaeger, dated as of September 23, 2021 (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on September 24, 2021)
     
10.28†   Employment Agreement, by and between the Company and Thomas M. Wittenschlaeger, effective as of September 23, 2021 (incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on September 24, 2021)
     
10.29†   General Release and Severance Agreement, by and between the Company and Curtis Smith, dated as of January 14, 2022 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on January 14, 2022)
     
10.30†   General Release Agreement, by and between the Company and Brian Groh, dated as of January 14, 2022 (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on January 14, 2022)
     
10.31†   General Release Agreement, by and between the Company and Richard Perley, dated as of January 14, 2022 (incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on January 14, 2022)
     
10.32   Employment Agreement, by and between the Company and David E. Hollingsworth, effective as of August 23, 2022 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on August 26, 2022)
     
16.1   Letter from Friedman LLP to the Securities and Exchange Commission, dated September 21, 2022 (incorporated by reference to Exhibit 16.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on September 21, 2022)
     
23.1**   Consent of Marcum LLP
     
23.2**   Consent of Friedman LLP
     
31.1**   Certification of the Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
     
31.2**   Certification of the Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
     
32.1***   Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
     
101 INS**   Inline XBRL Instance Document
101 SCH**   Inline XBRL Taxonomy Extension Schema Document
101 CAL**   Inline XBRL Taxonomy Calculation Linkbase Document
101 DEF**   Inline XBRL Taxonomy Extension Definition Linkbase Document
101 LAB**   Inline XBRL Taxonomy Extension Label Linkbase Document
101 PRE**   Inline XBRL Taxonomy Presentation Linkbase Document
104   Cover Page Interactive Data File - The cover page iXBRL tags are embedded within the inline XBRL document.

 

**   Filed herewith.
     
***   Furnished herewith.
     
+   Certain portions of this exhibit have been redacted pursuant to Item 601(b)(10)(iv) of Regulation S-K. The omitted information is (i) not material and (ii) would likely cause competitive harm to the Company if publicly disclosed. The Company agrees to furnish supplementally an unredacted copy of the exhibit to the SEC upon its request.
     
  Management or compensatory plan or arrangement.

 

59
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  AYRO, INC.
     
Dated: March 23, 2023 By: /s/ Thomas M. Wittenschlaeger
    Thomas M. Wittenschlaeger
    President, Chief Executive Officer, and Director
    (Principal Executive Officer)

 

Pursuant to the requirements of the Securities and Exchange Act of 1934, this report has been signed by the following persons in the capacities and on the dates indicated below.

 

Name   Title   Date
         
/s/ Thomas M. Wittenschlaeger  

President, Chief Executive Officer and Director

(Principal Executive Officer)

  March 23, 2023
Thomas M. Wittenschlaeger        
         
/s/ David E. Hollingsworth  

Chief Financial Officer

(Principal Financial Officer and Principal Accounting Officer)

  March 23, 2023
David E. Hollingsworth        
         
/s/ Joshua Silverman   Chairman of the Board of Directors   March 23, 2023
Joshua Silverman        
         
/s/ George Devlin   Director   March 23, 2023
George Devlin        
         
/s/ Sebastian Giordano   Director   March 23, 2023
Sebastian Giordano        
         
/s/ Zvi Joseph   Director   March 23, 2023
Zvi Joseph        
         
/s/ Greg Schiffman   Director   March 23, 2023
Greg Schiffman        
         
/s/ Wayne R. Walker   Director   March 23, 2023
Wayne R. Walker        

 

60
 

 

AYRO, INC. AND SUBSIDIARIES

CONSOLIDATED FINANCIAL STATEMENTS

Table of Contents

 

Reports of Independent Registered Public Accounting Firms Marcum LLP (PCAOB ID Number 688) and Friedman LLP (PCAOB ID Number 711) F-1-2
   
Consolidated Balance Sheets as of December 31, 2022 and 2021 F-3
   
Consolidated Statements of Operations for the years ended December 31, 2022 and 2021 F-4
   
Consolidated Statements of Stockholders’ Equity for the years ended December 31, 2022 and 2021 F-5
   
Consolidated Statements of Cash Flows for the years ended December 31, 2022 and 2021 F-6
   
Notes to Consolidated Financial Statements F-7

 

 
 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Shareholders and Board of Directors of

AYRO Inc.,

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheet of AYRO Inc. (the “Company”) as of December 31, 2022, and the related consolidated statements of operations, stockholders’ equity and cash flows for each of the year ended December 31, 2022, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022, and the results of its operations and its cash flows for year ended December 31, 2022, in conformity with accounting principles generally accepted in the United States of America.

 

Basis for Opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.

 

Critical Audit Matters

 

Critical audit matters are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. We determined that there are no critical audit matters.

 

/s/ Marcum llp

 

Marcum LLP

 

We have served as the Company’s auditor since 2020 (such date takes into account the acquisition of certain assets of Friedman LLP effective September 1, 2022)

 

East Hanover, New Jersey

March 23, 2023

 

F-1

 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Board of Directors and Stockholders of 

AYRO, Inc.

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheet of AYRO, Inc. (the “Company”) as of December 31, 2021 , and the related consolidated statement of operations, stockholder’s equity, and cash flows for the year ended December 31, 2021 , and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021, and the results of its operations and its cash flows for the year ended December 31, 2021, in conformity with accounting principles generally accepted in the United States of America.

 

Basis for Opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.

 

/s/ Friedman LLP

 

We have served as the Company’s auditor from 2020 through 2022.

 

East Hanover, New Jersey

 

March 23, 2022

 

F-2

 

 

AYRO, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

 

   2022   2021 
   As of December 31, 
   2022   2021 
ASSETS        
Current assets:          
Cash  $39,096,562   $69,160,466 
Marketable securities   9,848,804    - 
Accounts receivable, net   510,071    969,429 
Inventory   970,381    3,744,037 
Prepaid expenses and other current assets   1,478,845    2,276,178 
Total current assets   51,904,663    76,150,110 
Property and equipment, net   2,192,337    835,160 
Operating lease – right-of-use asset   819,401    1,012,884 
Deposits and other assets   73,683    129,610 
Total assets  $54,990,084   $78,127,764 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY          
           
Current liabilities:          
Accounts payable  $1,107,215   $647,050 
Accrued expenses   964,937    2,990,513 
Current portion lease obligation – operating lease   165,767    206,426 
Total current liabilities   2,237,919    3,843,989 
Lease obligation - operating lease, net of current portion   693,776    859,543 
Total liabilities   2,931,695    4,703,532 
           
Commitments and contingencies   -     -  
           
Stockholders’ equity:          
Preferred Stock, (authorized – 20,000,000 shares)   -    - 
Convertible Preferred Stock Series H, ($0.0001 par value; authorized – 8,500 shares; issued and outstanding – 8 shares as of December 31, 2022 and 2021, respectively)   -    - 
Convertible Preferred Stock Series H-3, ($0.0001 par value; authorized – 8,461 shares; issued and outstanding – 1,234 as of December 31, 2022 and 2021, respectively)   -    - 
Convertible Preferred Stock Series H-6, ($0.0001 par value; authorized – 50,000 shares; issued and outstanding – 50 as of December 31, 2022 and 2021, respectively)   -    - 
Common Stock, ($0.0001 par value; authorized – 100,000,000 shares; issued and outstanding – 37,241,642 and 36,866,956 as of December 31, 2022 and 2021, respectively)   3,724    3,687 
Additional paid-in capital   133,224,249    131,654,776 
Accumulated deficit   (81,169,584)   (58,234,231)
Total stockholders’ equity   52,058,389    73,424,232 
Total liabilities and stockholders’ equity  $54,990,084   $78,127,764 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-3
 

 

AYRO, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

 

   2022   2021 
   For the years ended December 31, 
   2022   2021 
Revenue  $2,990,497   $2,683,597 
Cost of goods sold   6,043,506    4,774,784 
Gross loss   (3,053,009)   (2,091,187)
           
Operating expenses:          
Research and development   6,845,451    11,449,617 
Sales and marketing   1,874,658    2,419,168 
General and administrative   11,503,788    17,168,898 
Total operating expenses   20,223,897    31,037,683 
           
Loss from operations   (23,276,906)   (33,128,870)
           
Other income (expense):          
Interest income   182,276    51,768 
Interest expense   -    (2,312)
Realized gain on marketable securities   160,990    - 
Unrealized loss on marketable securities   (1,713)   - 
Total other income (expense), net   341,553    49,456 
Net loss prior to provision for income taxes  $(22,935,353)  $(33,079,414)
           
Provision for income taxes   -    - 
           
           
Net loss  $(22,935,353)  $(33,079,414)
           
Net loss per share, basic and diluted  $(0.62)  $(0.94)
           
Basic and diluted weighted average Common Stock outstanding   37,048,975    35,171,935 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-4
 

 

AYRO, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

 

   Shares   Amount   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Deficit   Total 
                             
   Series H   Series H-3   Series H-6       Additional         
   Preferred Stock   Preferred Stock   Preferred Stock   Common Stock  

Paid-in

   Accumulated     
   Shares   Amount   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Deficit   Total 
Balance, January 1, 2021   8   $-    1,234   $--    50   $-    27,088,584   $2,709   $64,509,724   $(25,154,817)  $39,357,616 
Issuance of common stock for services                                 15,000    2    42,298         42,300 
Sale of common stock, net of fees                                 8,035,835    804    58,269,025         58,269,829 
Exercise of warrants, net of fees                                 13,642    1    99,999         100,000 
Exercise of stock options                                 555,004    55    1,506,944         1,506,999 
Stock based compensation                                           7,226,902         7,226,902 
Vested Restricted Stock                                 1,158,891    116    (116)        - 
Net Loss        -          -          -                    (33,079,414)   (33,079,414)
December 31, 2021   8    -    1,234    -    50    -    36,866,956    3,687    131,654,776    (58,234,231)   73,424,232 
                                                        
Stock based compensation                                           65,291         65,291 
Vested Restricted Stock                                 374,686    37    1,504,182         1,504,219 
Net Loss        -          -          -                    (22,935,353)   (22,935,353)
Balance, December 31, 2022   8    -    1,234    -    50    -    37,241,642    3,724    133,224,249    (81,169,584)   52,058,389 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-5
 

 

AYRO, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

 

   2022   2021 
  For the years ended 
   December 31, 
   2022   2021 
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net loss  $(22,935,353)  $(33,079,414)
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization   762,206    527,584 
Stock-based compensation   1,240,129    7,556,282 
Amortization of right-of-use asset   193,483    206,375 
Bad debt expense   4,485    99,309 
Realized gain on marketable securities   (160,990)   - 
Unrealized loss on marketable securities   1,713    - 
Impairment of inventory and prepaid   2,476,322    - 
Change in operating assets and liabilities:          
Accounts receivable   454,873    (302,887)
Inventory   830,845    (2,666,327)
Prepaid expenses and other current assets   (581,846)   (667,416)
Deposits   18,797    (18,797)
Accounts payable   445,165    (120,155)
Accrued expenses   (1,272,046)   2,038,365 
Contract liability   -    (24,000)
Lease obligations - operating leases   (206,426)   (180,404)
Net cash used in operating activities   (18,728,643)   (26,631,485)
           
CASH FLOWS FROM INVESTING ACTIVITIES:          
Purchase of property and equipment   (1,588,689)   (538,012)
Purchase of marketable securities, net   (9,689,526)   - 
Purchase of intangible assets   (57,046)   (62,351)
Net cash used in investing activities   (11,335,261)   (600,363)
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Repayments of debt   -    (21,611)
Proceeds from exercise of warrants, net of fees   -    100,000 
Proceeds from exercise of stock options   -    1,506,999 
Proceeds from issuance of Common Stock, net of fees and expenses   -    58,269,829 
Net cash provided by financing activities   -    59,855,217 
           
Net change in cash   (30,063,904)   32,623,369 
           
Cash, beginning of year   69,160,466    36,537,097 
           
Cash, end of year  $39,096,562   $69,160,466 
           
Supplemental disclosure of cash and non-cash transactions:          
Cash paid for interest  $-   $1,971 
Restricted Stock issued previously accrued   329,380    329,380 
Accrued Fixed Assets   348,932      
Supplemental non-cash amounts of lease liabilities arising from obtaining right of use assets  $-   $120,440 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-6
 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 1. ORGANIZATION AND NATURE OF OPERATIONS

 

AYRO, Inc. (“AYRO” or the “Company”), a Delaware corporation formerly known as DropCar, Inc. (“DropCar”), a corporation headquartered outside Austin, Texas, is the merger successor discussed below of AYRO Operating Company, Inc., which was formed under the laws of the State of Texas on May 17, 2016 as Austin PRT Vehicle, Inc. and subsequently changed its name to Austin EV, Inc. under an Amended and Restated Certificate of Formation filed with the State of Texas on March 9, 2017. On July 24, 2019, the Company changed its name to AYRO, Inc. and converted its corporate domicile to Delaware. The Company was founded on the basis of promoting resource sustainability. The Company, and its wholly-owned subsidiaries, are principally engaged in manufacturing and sales of environmentally-conscious, minimal-footprint electric vehicles. The all-electric vehicles are typically sold both directly to customers and to dealers in the United States.

 

Merger

 

On May 28, 2020, pursuant to the previously announced Agreement and Plan of Merger, dated December 19, 2019 (the “Merger Agreement”), by and among AYRO, Inc., a Delaware corporation previously known as DropCar, Inc., ABC Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Company (“Merger Sub”), and AYRO Operating Company (“AYRO Operating”), a Delaware corporation previously known as AYRO, Inc., Merger Sub was merged with and into AYRO Operating, with AYRO Operating continuing after the merger as the surviving entity and a wholly owned subsidiary of the Company (the “Merger”).

 

Strategic Review

 

Following the hiring of the Company’s current Chief Executive Officer in the third quarter of 2021, the Company initiated a strategic review of their product development strategy, as they focus on creating value within the electric vehicle, last-mile delivery, and smart payload and enabling infrastructure markets. In connection with the strategic review, the Company canceled development of its planned next-generation three-wheeled high speed vehicle.

In December of 2021 the Company began research and development on the Vanish, including updates on their supply chain evolution, offshoring/onshoring mix, manufacturing strategy, and annual model year refresh program.

 

NOTE 2. LIQUIDITY AND OTHER UNCERTAINTIES

 

Liquidity and Other Uncertainties

 

The consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States (“GAAP”), which contemplates continuation of the Company as a going concern. The Company is subject to a number of risks similar to those of earlier stage commercial companies, including dependence on key individuals and products, the difficulties inherent in the development of a commercial market, the potential need to obtain additional capital, competition from larger companies, other technology companies and other technologies. The Company has a limited operating history and the sales and income potential of its business and market are unproven. The Company incurred net losses of $22,935,353 for the year ended December 31, 2022, and negative cash flows from operations of $18,728,643 for the year ended December 31, 2022. At December 31, 2022, the Company had cash balances totaling $39,096,562 and $9,848,804 in marketable securities. In addition, overall working capital decreased by $22,639,376 during the year ended December 31, 2022. Management believes that the existing cash at December 31, 2022 will be sufficient to fund operations for at least the next twelve months following the issuance of these consolidated financial statements.

 

F-7
 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

The Company may experience increases in the cost or a sustained interruption in the supply or shortage of raw materials, including lithium-ion battery cells, semiconductors, and integrated circuits. Any such increase or supply interruption could materially negatively impact the business, prospects, financial condition and operating results. Currently, the Company is experiencing supply chain shortages, including with respect to lithium-ion battery cells, integrated circuits, vehicle control chips, and displays. Certain production-ready components may be delayed in shipment to company facilities which has and may continue to cause delays in validation and testing for these components, which would in turn create a delay in the availability of saleable vehicles.

 

The Company uses various raw materials, including aluminum, steel, carbon fiber, non-ferrous metals (such as copper), and cobalt. The prices for these raw materials fluctuate depending on market conditions, and global demand and could adversely affect business and operating results. For instance, the Company is exposed to multiple risks relating to price fluctuations for lithium-ion cells. These risks include:

 

 

the inability or unwillingness of current battery manufacturers to build or operate battery cell manufacturing plants to supply the numbers of lithium-ion cells required to support the growth of the electric vehicle industry as demand for such cells increases;

 

 

disruption in the supply of cells due to quality issues or recalls by the battery cell manufacturers; and

 

  an increase in the cost of raw materials, such as cobalt, used in lithium-ion cells.

 

Any disruption in the supply of lithium-ion battery cells, semiconductors, or integrated circuits could temporarily disrupt production of the Company’s vehicles until a different supplier is fully qualified. Moreover, battery cell manufacturers may refuse to supply electric vehicle manufacturers if they determine that the vehicles are not sufficiently safe. Furthermore, fluctuations or shortages in petroleum and other economic conditions may cause the Company to experience significant increases in freight charges and raw material costs. Substantial increases in the prices for our raw materials would increase operating costs and could reduce our margins if the increased costs cannot be recouped through increased electric vehicle prices. There can be no assurance that the Company will be able to recoup increasing costs of raw materials by increasing vehicle prices.

 

We have made certain indemnities, under which we may be required to make payments to an indemnified party, in relation to certain transactions. We indemnify our directors and officers to the maximum extent permitted under the laws of the State of Delaware. In connection with our facility leases, we have indemnified our lessors for certain claims arising from the use of the facilities. The duration of the indemnities vary and, in many cases, are indefinite. These indemnities do not provide for any limitation of the maximum potential future payments we could be obligated to make. Historically, we have not been obligated to make any payments for these obligations and no liabilities have been recorded for these indemnities.

 

On October 3, 2022, AYRO, Inc. (the “Company”) received a letter from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) indicating that, based upon the closing bid price of the Company’s common stock for the 30 consecutive business day period between August 19, 2022 and September 30, 2022, the Company did not meet the minimum bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2). The letter also indicated that the Company will be provided with a compliance period of 180 calendar days, or until April 3, 2023 (the “Compliance Period”), in which to regain compliance pursuant to Nasdaq Listing Rule 5810(c)(3)(A).

 

F-8
 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation and Principles of Consolidation

 

The consolidated financial statements represent the consolidation of the accounts of the Company and its subsidiary in conformity with GAAP. All intercompany accounts and transactions have been eliminated in consolidation.

 

Reclassification

 

Certain 2021 amounts were classified to conform to the current year presentation. Intangible assets were included into other assets on the consolidated balance sheet for current and prior year.

 

Use of Estimates

 

The preparation of the consolidated financial statements, in conformity with GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenue and expenses during the reporting period.

 

Cash and Cash Equivalents

 

The Company considers all highly-liquid investments purchased with a maturity of three months or less at the time of purchase to be cash equivalents. The Company maintains total cash balances in one account which exceeds the federally insured limits. Management does not believe this results in any significant credit risk. The Company has no cash equivalents as of December 31, 2022 and 2021.

 

Marketable Securities

 

Marketable securities include investment in fixed income bonds and U.S. Treasury securities that are considered to be highly liquid and easily tradeable. The marketable securities are considered trading securities and are measured at fair value and are accounted for in accordance with ASC 320. The marketable securities are valued using inputs observable in active markets for identical securities and are therefore classified as Level 1 within the Company’s fair value hierarchy. The Company held $9,848,804 in marketable securities as of December 31, 2022.

 

Fair Value Measurements

 

The Company applies Accounting Standards Codification (“ASC”) 820, Fair Value Measurement (“ASC 820”), which establishes a framework for measuring fair value and clarifies the definition of fair value within that framework. ASC 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company’s principal or most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established in ASC 820 generally requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity’s own assumptions based on market data and the entity’s judgments about the assumptions that market participants would use in pricing the asset or liability and are to be developed based on the best information available in the circumstances.

 

The carrying amounts of financial instruments reported in the accompanying consolidated financial statements for current assets and current liabilities approximate the fair value because of the immediate or short-term maturities of the financial instruments.

 

F-9
 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

The valuation hierarchy is composed of three levels. The classification within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The levels within the valuation hierarchy are described below:

 

Level 1 — Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities.

 

Level 2 — Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals.

 

Level 3 — Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities.

 

The marketable securities are considered trading securities and are measured at fair value and are accounted for in accordance with ASC 320. The marketable securities are valued using inputs observable in active markets for identical securities and are therefore classified as Level 1 within the Company’s fair value hierarchy.

 

Accounts Receivable, Net

 

In the normal course of business, the Company extends credit to customers. Accounts receivable, less the allowance for doubtful accounts, reflect the net realizable value of receivables and approximate fair value. An allowance for doubtful accounts is maintained and reflects the best estimate of probable losses determined principally on the basis of historical experience and specific allowances for known troubled accounts. All accounts or portions thereof that are deemed to be uncollectible or that require an excessive collection cost are written off to the allowance for doubtful accounts. As of December 31, 2022 and 2021, the Company had reserved an allowance for doubtful accounts of $2,349 and $173,138, respectively. All account receivables are made on an unsecured basis.

 

Inventory

 

Inventory consists of purchased chassis, cabs, batteries, truck beds and component parts which includes cost of raw materials, freight, direct labor, and related production overhead and are stated at the lower of cost or net realizable value, as determined using a first-in, first-out method. Inventory also includes a fleet of internally manufactured vehicles that serve demonstration and other purposes, the balance of which is being depreciated over their useful lives. Management compares the cost of inventory with the net realizable value and, if applicable, an allowance is made for writing down the inventory to its net realizable value, if lower than cost. On an ongoing basis, inventory is reviewed for potential write-down for estimated obsolescence or unmarketable inventory based upon forecasts for future demand and market conditions. At June 30, 2022, we determined that testing of obsolescence was required for inventory due to the quality of certain purchased components from Cenntro’s lithium-ion (“NCM”) line. 17 vehicles tested in the second quarter of 2022 were determined to have 49 unique failures. An inspection of the remaining NCM units revealed a 100% failure rate. As a result, all inventory associated with Cenntro’s NCM line was written off for $1,317,289 to cost of goods sold. As of December 31, 2022, there was no longer a balance. The remainder of the balance was expensed through cost of goods sold for $621,097. During the year ended December 31, 2022, a $413,561 net realizable value adjustment was recorded due to the Club Car Discount (as defined below), spare inventory for the 411x was written off, net with the inventory reserve of $124,375, and $2,476,322 was expensed for impairment of inventory.

 

Property and Equipment, Net

 

Property and equipment, net, are stated at cost, less accumulated depreciation. Depreciation is recorded over the shorter of the estimated useful life, of one to ten years, or the lease term of the applicable assets using the straight-line method beginning on the date an asset is placed in service. The Company regularly evaluates the estimated remaining useful lives of the Company’s property and equipment, net, to determine whether events or changes in circumstances warrant a revision to the remaining period of depreciation. Maintenance and repairs are charged to expense when incurred.

 

F-10
 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

The estimated useful lives for significant property and equipment categories are as follows:

 

Computer Equipment and Software 13 years
Furniture and Fixtures 27 years
Machinery and Equipment 310 years
Leasehold Improvements Shorter of useful or lease life

 

Long-Lived Assets, Including Definite-Lived Intangible Assets

 

Intangible assets are stated at cost less accumulated amortization. Amortization is generally recorded on a straight-line basis over estimated useful life of 3-10 years. The Company periodically reviews the estimated useful lives of intangible assets and makes adjustments when events indicate that a shorter life is appropriate.

 

Long-lived assets are evaluated for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable through the estimated undiscounted future cash flows derived from such assets.

 

Factors that the Company considers in deciding when to perform an impairment review include significant changes in the Company’s forecasted projections for the asset or asset group for reasons including, but not limited to, significant under-performance of a product in relation to expectations, significant changes, or planned changes in the Company’s use of the assets, significant negative industry or economic trends, and new or competing products that enter the marketplace. The impairment test is based on a comparison of the undiscounted cash flows expected to be generated from the use of the asset group. If impairment is indicated, the asset is written down by the amount by which the carrying value of the asset exceeds the related fair value of the asset with the related impairment charge recognized within the statements of operations.

 

Leases

 

Operating lease assets are included within operating lease right-of-use assets, and the corresponding operating lease obligation on the consolidated balance sheets as of December 31, 2022 and 2021 in accordance with ASC 842, Leases. The Company has elected not to present short-term leases as these leases have a lease term of 12 months or less at lease inception and do not contain purchase options or renewal terms that the Company is reasonably certain to exercise. All other lease assets and lease liabilities are recognized based on the present value of lease payments over the lease term at commencement date. Because most of the Company’s leases do not provide an implicit rate of return, the Company used an incremental borrowing rate based on the information available at adoption date in determining the present value of lease payments.

 

Revenue Recognition

 

The Company recognizes revenue in accordance with ASC 606, Revenue from Contracts with Customers, the core principle of which is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to receive in exchange for those goods or services.

 

To achieve this core principle, five basic criteria must be met before revenue can be recognized: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to performance obligations in the contract; and (5) recognize revenue when or as the Company satisfies a performance obligation.

 

Nature of goods and services

 

The following is a description of the Company’s products and services from which the Company generates revenue, as well as the nature, timing of satisfaction of performance obligations, and significant payment terms for each:

 

Product revenue

 

Product revenue from customer contracts is recognized on the sale of each electric vehicle as vehicles are shipped to customers. The majority of the Company’s vehicle sales orders generally have only one performance obligation: sale and delivery of complete vehicles. Ownership and risk of loss transfers to the customer based on FOB shipping point and freight charges are the responsibility of the customer. Revenue is typically recognized at the point control transfers or in accordance with payment terms customary to the business. The Company provides product warranties to assure that the product assembly complies with agreed upon specifications. The Company’s product warranty is similar in all material respects to the product warranties provided by the Company’s suppliers, therefore minimizing the warranty liability to the standard labor rates associated with the defective part replacement. Customers do not have the option to purchase a warranty separately; as such, warranty is not accounted for as a separate performance obligation. The Company’s policy is to exclude taxes collected from a customer from the transaction price of automotive contracts.

 

F-11
 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Shipping revenue

 

Amounts billed to customers related to shipping and handling are classified as shipping revenue. The Company has elected to recognize the cost for freight and shipping when control over vehicles has transferred to the customer as an operating expense. The Company has reported shipping expenses of $442,932 and $393,231 for years ended December 31, 2022 and 2021, respectively, included in General and Administrative Expenses.

 

Services and other revenue

 

Services and other revenue consist of non-warranty after-sales vehicle services. Revenue is typically recognized at a point in time when services and replacement parts are provided.

 

Miscellaneous income

 

Miscellaneous income consists of late fees charged for receivables not paid within the terms of the customer agreement based upon the outstanding customer receivable balance. This revenue is earned when a customer’s receivable balance becomes delinquent and its collection is reasonably assured and is calculated using a stated late fee rate multiplied by the outstanding balance that is subject to a late fee charge.

 

Segment Reporting

 

The Company operates in one business segment which focuses on the manufacturing and sales of environmentally-conscious, minimal-footprint electric vehicles. The Company’s business offerings have similar economic and other characteristics, including the nature of products, manufacturing, types of customers, and distribution methods. The chief operating decision maker (CODM) reviews profit and loss information on a consolidated basis to assess performance and make overall operating decisions. The consolidated financial statements reflect the financial results of the Company’s one reportable operating segment. The Company has no significant revenues or tangible assets outside of the United States.

 

Income Taxes

 

The Company accounts for income tax using an asset and liability approach, which allows for the recognition of deferred tax benefits in future years. Under the asset and liability approach, deferred taxes are provided for the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The accounting for deferred income tax calculation represents management’s best estimate on the most likely future tax consequences of events that have been recognized in the consolidated financial statements or tax returns and related future anticipation. A valuation allowance is provided for deferred tax assets if it is more likely than not these items will either expire before the Company is able to realize their benefits, or that future realization is uncertain. As of December 31, 2022 and 2021, there were no accruals for uncertain tax positions.

 

Warrants and Preferred Shares

 

The accounting treatment of warrants and preferred share series issued is determined pursuant to the guidance provided by ASC 470, Debt, ASC 480, Distinguishing Liabilities from Equity, and ASC 815, Derivatives and Hedging, as applicable. Each feature of a freestanding financial instruments including, without limitation, any rights relating to subsequent dilutive issuances, dividend issuances, equity sales, rights offerings, forced conversions, optional redemptions, automatic monthly conversions, dividends and exercise are assessed with determinations made regarding the proper classification in the Company’s consolidated financial statements.

 

Stock-Based Compensation

 

The Company accounts for stock-based compensation in accordance with ASC 718, Compensation-Stock Compensation (“ASC 718”). The Company recognizes all employee and non-employee share-based compensation as an expense in the financial statements on a straight-line basis over the requisite service period, based on the terms of the awards. Equity-classified awards principally related to stock options, restricted stock awards (“RSAs”) and equity-based compensation, are measured at the grant date fair value of the award. The Company determines grant date fair value of stock option awards using the Black-Scholes option-pricing model. The fair value of RSAs is determined using the closing price of the Company’s common stock on the grant date. For service based vesting grants, expense is recognized ratably over the requisite service period based on the number of options or shares. For value-based vesting grants, expense is recognized via straight line expense over the expected period per grant as determined by outside valuation experts. Stock-based compensation is reversed for forfeitures in the period of forfeiture.

 

We estimate the fair value of stock-based and cash unit awards containing a market condition using a Monte Carlo simulation model. Key inputs and assumptions used in the Monte Carlo simulation model include the stock price of the award on the grant date, the expected term, the risk-free interest rate over the expected term, the expected annual dividend yield and the expected stock price volatility. The expected volatility is based on a combination of the historical and implied volatility of the Company’s publicly traded, near-the-money stock options, and the valuation period is based on the vesting period of the awards. The risk-free interest rate is derived from the U.S. Treasury yield curve in effect at the time of grant and, since the Company does not currently pay or plan to pay a dividend on its common stock, the expected dividend yield was zero.

 

Stock options and warrants issued as compensation for services provided to the Company are accounted for based upon the fair value of the underlying equity instrument. The attribution of the fair value of the equity instrument is charged directly to compensation expense over the period during which services are rendered.

 

F-12
 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Basic and Diluted Loss Per Share

 

Basic and diluted net loss per share is determined by dividing net loss by the weighted average ordinary shares outstanding during the period. For all periods presented with a net loss, the shares underlying the ordinary share options and warrants have been excluded from the calculation because their effect would be anti-dilutive. Therefore, the weighted-average shares outstanding used to calculate both basic and diluted loss per share are the same for periods with a net loss.

 

The following potentially dilutive securities have been excluded from the computation of diluted weighted average shares outstanding as they would be anti-dilutive:

 

   For the Years Ended December 31, 
   2022   2021 
Options to purchase common stock   777,922    1,338,675 
Restricted stock unvested   660,562    450,000 
Restricted stock vested - unissued   -    43,000 
Warrants outstanding   6,106,023    6,108,823 
Preferred stock outstanding   2,475    2,475 
Totals   7,546,982    7,942,973 

 

Research and development costs

 

Costs are incurred in connection with research and development programs that are expected to contribute to future earnings. Such costs include labor, stock-based compensation, training, software subscriptions, and consulting. These amounts are charged to the consolidated statement of operations as incurred. Total research and development expenses included were $6,845,451 and $11,449,617 for the years ended December 31, 2022 and 2021, respectively.

 

Recent Accounting Pronouncements

 

In June 2016, the FASB issued ASU 2016-13 “Financial Instruments -Credit Losses” (ASC 326) “Measurement of Credit Losses on Financial Instruments: and subsequent amendment to the guidance, ASU 2018-19 in November 2018. The standard significantly changes how entities will measure credit losses for most financial assets, including trade receivables. The standard will replace historic incurred loss” approach with an “expected loss” model for instruments measured at amortized cost. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements.

 

F-13
 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 4. REVENUES

 

Disaggregation of Revenue

 

Revenue by type consists of the following:

 

           
   Years Ended December 31, 
   2022   2021 
Revenue type          
Product revenue  $2,716,583   $2,419,821 
Shipping revenue   229,027    227,089 
Miscellaneous Income   44,887    - 
Service income   -    36,687 
 Total Revenue  $2,990,497   $2,683,597 

 

Contract Liabilities

 

The Company recognizes a contract liability when a consideration is received, or if the Company has the unconditional right to receive consideration, in advance of satisfying the performance obligation. A contract liability is the Company’s obligation to transfer goods or services to a customer for which the Company has received consideration, or an amount of consideration is due from the customer. The table below details the activity in the Company’s contract liabilities as of December 31, 2022 and 2021. The balance at the end of each period is reported as contract liability in the Company’s consolidated balance sheet.

 

   December 31,   December 31, 
   2022   2021 
Balance, beginning of period  $-   $24,000 
Additions   -    - 
Transfer to revenue   -    (24,000)
Balance, end of period  $        -   $- 

 

Warranty Reserve

 

The Company records a reserve for warranty repairs upon the initial delivery of vehicles to its dealer network. The Company provides a product warranty on each vehicle including powertrain, battery pack and electronics package. Such warranty matches the product warranty provided by its supply chain for warranty parts for all unaltered vehicles and is not considered a separate performance obligation. The supply chain warranty does not cover warranty-based labor needed to replace a part under warranty. Warranty reserves include management’s best estimate of the projected cost of labor to repair/replace all items under warranty. The Company reserves a percentage of all dealer-based sales to cover an industry-standard warranty fund to support dealer labor warranty repairs. Such percentage is recorded as a component of cost of revenues in the statement of operations. As of December 31, 2022 and 2021, warranty reserves were recorded within accrued expenses of $410,017 and $240,517, respectively.

 

F-14
 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 5. ACCOUNTS RECEIVABLE, NET

 

Accounts receivable, net consists of amounts due from invoiced customers and product deliveries and were as follows:

 

   December 31,   December 31, 
   2022   2021 
Trade receivables  $512,420   $1,142,567 
Less: Allowance for doubtful accounts   (2,349)   (173,138)
 Accounts receivable, net  $510,071   $969,429 

 

The Company reduced allowance for doubtful accounts by $170,789 for the year ended December 31, 2022, due to collecting on past due accounts, and recorded $4,485 of bad debt expense of direct write off for the year ended December 31, 2022.

 

NOTE 6. INVENTORY, NET

 

Inventory, net consisted of the following:

 

   December 31,   December 31, 
   2022   2021 
Raw materials  $330,931   $3,481,614 
Work-in-progress   -    51,441 
Finished goods   639,450    210,982 
 Total  $970,381   $3,744,037 

 

For the years ended December 31, 2022 and 2021, depreciation recorded for fleet inventory was $87,586 and $95,544. The Company determined that testing of obsolescence was required for inventory due to the quality of certain purchased components from Cenntro’s lithium-ion line (“NCM”). 17 vehicles tested in the second quarter of 2022 were determined to have 49 unique failures. An inspection of the remaining NCM units discovered a 100% failure rate. As a result, all inventory associated with Cenntro’s NCM line was written off to cost of goods sold for $1,317,289. The Club Car Discount during the years ended December 31, 2022 required a $413,561 net realizable value adjustment, necessitating the value of inventory to be written down, spare inventory for the 411x was written off, net with the inventory reserve of $124,375.

 

NOTE 7. PREPAID EXPENSES AND OTHER CURRENT ASSETS

 

   December 31,   December 31, 
   2022   2021 
Prepaid final assembly services  $-   $439,660 
Prepayments for inventory   1,174,466    1,622,617 
Prepayments for insurance   118,434    - 
Prepayments on advances on design   75,000    - 
Prepayments on software   103,851    - 
Prepaid other   7,094    213,901 
Total Prepaid Expenses and Other Current Assets  $1,478,845   $2,276,178 

 

As of December 31, 2021 the balance of prepaid expenses and accrued expenses, net with Cenntro was $602,016. As of December 31, 2022, there was no longer a balance. Impairments of prepaid expenses led to a write-down, netted with the balance in accrued expenses. The remainder of the balance was expensed through cost of goods sold for $621,097.

 

F-15
 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 8. PROPERTY AND EQUIPMENT, NET

 

Property and equipment, net consisted of the following:

 

   December 31,   December 31, 
   2022   2021 
Computer and equipment  $1,970,001   $853,695 
Furniture and fixtures   323,789    173,155 
Lease improvements   952,952    282,271 
Prototypes   -    300,376 
Computer software   455,875    455,875 
Property and equipment, gross   3,702,617    2,065,372 
Less: Accumulated depreciation   (1,510,280)   (1,230,212)
Property and equipment, net  $2,192,337   $835,160 

 

Depreciation expense for the years ended December 31, 2022 and 2021 was $580,445, of which $101,581 was related to retiring legacy assets, and $314,164, respectively.

 

F-16
 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 9. MARKETABLE SECURITIES

 

Marketable securities purchased in 2022 consisted of the following:

 

December 31, 2022
       Realized   Unrealized   Transferred     
   Cost Basis   Gains   Loss   to Cash   Total 
Bonds  $12,235,258   $160,990   $(1,713)  $(10,310,473)  $2,084,062 
US Treasury securities   7,764,742    -    -    -    7,764,742 
   $20,000,000   $160,990   $(1,713)  $(10,310,473)  $9,848,804 

 

F-17
 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 10. STOCKHOLDERS’ EQUITY

 

Common Stock

 

On January 25, 2021, AYRO entered into a Securities Purchase Agreement with certain institutional and accredited investors, pursuant to which AYRO agreed to issue and sell in a registered direct offering (the “January 2021 Offering”) an aggregate of 3,333,334 shares of common stock of AYRO, par value $0.0001 per share, at an offering price of $6.00 per share, for gross proceeds of $20,000,004 before the deduction of fees and offering expenses of $1,648,608.

 

On February 11, 2021, AYRO entered into a Securities Purchase Agreement with certain institutional and accredited investors, pursuant to which AYRO agreed to issue and sell in a registered direct offering (the “February 2021 Offering”) an aggregate of 4,400,001 shares of common stock of AYRO, par value $0.0001 per share, at an offering price of $9.50 per share, for gross proceeds of $41,800,008 before the deduction of fees and offering expenses of $3,394,054. Each purchaser was also granted an option to purchase, on or before February 16, 2022, additional shares of common stock equal to the full amount of 75% of the common stock it purchased at the initial closing, or an aggregate of 3,300,001 shares, at an exercise price of $11.50 per share.

 

On March 17, 2021, in connection with that certain Agreement and Plan of Merger dated December 19, 2019, whereby certain former stockholders of AYRO Operating entered into lock-up agreements (collectively, the “May Lock-Up Agreements”) pursuant to which they agreed to certain restrictions on the transfer or sale of shares of the Company’s common stock for the one-year period following the Merger, AYRO modified the May Lock-Up Agreements to allow each stockholder party to a May Lock-Up Agreement to (i) sell up to 5% of such stockholder’s holdings in the Company’s common stock on any trading day (with such 5% limitation to be measured as of the date of each sale) and (ii) allow for unlimited sales of the Company’s common stock for any sales made at $10.00 per share or greater. As of May 28, 2021, all of the May Lock-up Agreements were expired.

 

Pursuant to the Securities Purchase Agreement dated July 21, 2020, during the year ended December 31, 2021 investors purchased 302,500 of the Additional Shares of common stock of AYRO, par value $0.0001 per share, at an offering price of $5.00 per share, for gross proceeds of $1,512,500.

 

During February 2021, the Company issued 13,642 shares of common stock upon the exercise of warrants and received cash proceeds of $100,000.

 

During the year ended December 31, 2021, the Company issued 555,004 shares of common stock upon the exercise of stock options and received cash proceeds of $1,506,999.

 

F-18
 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

During the year ended December 31, 2021, the Company issued 1,158,891 shares of common stock upon the vesting of restricted stock.

 

During the year ended December 31, 2022, the Company issued 374,686 shares of common stock upon the vesting of restricted stock.

 

Restricted Stock

 

On February 24, 2021, pursuant to the AYRO, Inc. 2020 Long-Term Incentive Plan, the Company granted 172,000 shares of restricted stock to non-executive directors at a value of $7.66 per share. 43,000 shares of common stock remained unissued as of December 31, 2021; these shares were issued during the years ended December 31, 2022.

 

On February 1, 2022, pursuant to the AYRO, Inc. 2020 Long-Term Incentive Plan, the Company granted 442,249 shares of restricted stock to non-executive directors at a value of $1.29 per share. During the years ended December 31, 2022, 331,686 shares were issued and vested.

 

Preferred Stock

 

Upon closing of the Merger, the Company assumed the Series H, H-3 and H-6 preferred stock of DropCar, Inc., which respective conversion prices have been adjusted to reflect the May 2020 one-for-five reverse split.

 

Series H Convertible Preferred Stock

 

Under the terms of the Series H Certificate of Designation, each share of the Company’s Series H Convertible Preferred Stock (the “Series H Preferred Stock”) has a stated value of $154.00 and is convertible into shares of the Company’s Common Stock, equal to the stated value divided by the conversion price of $184.80 per share (subject to adjustment in the event of stock splits or dividends). The Company is prohibited from effecting the conversion of the Series H Preferred Stock to the extent that, as a result of such conversion, the holder would beneficially own more than 9.99%, in the aggregate, of the issued and outstanding shares of the Company’s common stock calculated immediately after giving effect to the issuance of shares of common stock upon such conversion. In the event of liquidation, the holders of the Series H Preferred Stock are entitled, pari passu with the holders of common stock, to receive a payment in the amount the holder would receive if such holder converted the Series H Preferred Stock into common stock immediately prior to the date of such payment. As of December 31, 2022, such payment would be calculated as follows:

 

      
Number of Series H Preferred Stock outstanding as of December 31, 2022   8 
Multiplied by the stated value  $154 
Equals the gross stated value  $1,232 
Divided by the conversion price  $184.8 
Equals the convertible shares of Company Common Stock   6.66 
Multiplied by the fair market value of Company Common Stock as of December 31, 2022  $0.38 
Liquidation Value  $2.66 

 

F-19
 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Series H-3 Convertible Preferred Stock

 

Pursuant to the Series H-3 Certificate of Designation (as defined below), the holders of the Company’s Series H-3 Convertible Preferred Stock (the “Series H-3 Preferred Stock”) are entitled to elect up to two members of a seven-member Board, subject to certain step downs; pursuant to the Series H-3 securities purchase agreement, the Company agreed to effectuate the appointment of the designees specified by the Series H-3 investors as directors of the Company.

 

Under the terms of the Series H-3 Certificate of Designation, each share of the Series H-3 Preferred Stock has a stated value of $138.00 and is convertible into shares of common stock, equal to the stated value divided by the conversion price of $165.60 per share (subject to adjustment in the event of stock splits and dividends). The Company is prohibited from effecting the conversion of the Series H-3 Preferred Stock to the extent that, as a result of such conversion, the holder or any of its affiliates would beneficially own more than 9.99%, in the aggregate, of the issued and outstanding shares of common stock calculated immediately after giving effect to the issuance of shares of common stock upon the conversion of the Series H-3 Preferred Stock.

 

In the event of liquidation, the holders of the Series H-3 Preferred Stock are entitled, pari passu with the holders of common stock, to receive a payment in the amount the holder would receive if such holder converted the Series H-3 Preferred Stock into common stock immediately prior to the date of such payment. As of December 31, 2022, such payment would be calculated as follows:

 

      
Number of Series H-3 Preferred Stock outstanding as of December 31, 2022   1,234 
Multiplied by the stated value  $138 
Equals the gross stated value  $170,292 
Divided by the conversion price  $165.6 
Equals the convertible shares of Company Common Stock   1,028 
Multiplied by the fair market value of Company Common Stock as of December 31, 2022  $0.38 
Liquidation Value  $391 

 

Series H-6 Convertible Preferred Stock

 

On February 5, 2020, the Company filed the Certificate of Designations, Preferences and Rights of the Series H-6 Preferred Stock (the “Series H-6 Certificate of Designation”) with the Secretary of State of the State of Delaware, establishing and designating the rights, powers and preferences of the Series H-6 Preferred Stock. The Company designated up to 50,000 shares of Series H-6 Preferred Stock and each share has a stated value of $72.00 (the “H-6 Stated Value”). Each share of Series H-6 Preferred Stock is convertible at any time at the option of the holder thereof, into a number of shares of common stock of the Company determined by dividing the H-6 Stated Value by the initial conversion price of $3.60 per share, which was then further reduced to $2.50 under the anti-dilution adjustment provision, subject to a 9.99% blocker provision. The Series H-6 Preferred Stock has the same dividend rights as the common stock, except as provided for in the Series H-6 Certificate of Designation or as otherwise required by law. The Series H-6 Preferred Stock also has the same voting rights as the common stock, except that in no event shall a holder of Series H-6 Preferred Stock be permitted to exercise a greater number of votes than such holder would have been entitled to cast if the Series H-6 Preferred Stock had immediately been converted into shares of common stock at a conversion price equal to $3.60. In addition, a holder (together with its affiliates) may not be permitted to vote Series H-6 Preferred Stock held by such holder to the extent that such holder would beneficially own more than 9.99% of our common stock. In the event of any liquidation or dissolution, the Series H-6 Preferred Stock ranks senior to the common stock in the distribution of assets, to the extent legally available for distribution.

 

F-20
 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

The holders of Series H-6 Preferred Stock are entitled to certain anti-dilution adjustments if the Company issues shares of its common stock at a lower price per share than the applicable conversion price of the Series H-6 Preferred Stock. If any such dilutive issuance occurs prior to the conversion of the Series H-6 Preferred Stock, the conversion price will be adjusted downward to a price that cannot be less than 20% of the exercise price of $3.60.

 

In the event of liquidation, the holders of the Series H-6 Preferred Stock are entitled, pari passu with the holders of common stock, to receive a payment in the amount the holder would receive if such holder converted the Series H-6 Preferred Stock into common stock immediately prior to the date of such payment. As of December 31, 2022, such payment would be calculated as follows:

 

      
Number of Series H-6 Preferred Stock outstanding as of December 31, 2022   50 
Multiplied by the stated value  $72 
Equals the gross stated value  $3,600 
Divided by the conversion price  $2.5 
Equals the convertible shares of Company Common Stock   1,440 
Multiplied by the fair market value of Company Common Stock as of December 31, 2022  $0.38 
Liquidation Value  $547 

 

AYRO Series Seed Preferred Stock

 

Prior to the Merger, the Company was authorized to issue 8,472,500 shares of preferred stock, no par value, of which all were designated as Series Seed Preferred Stock. As of December 31, 2022 and 2021, no shares of Series Seed Preferred Stock were issued and outstanding. In conjunction with the Merger, all 7,360,985 shares of AYRO Series Seed Preferred Stock were converted into approximately 2,007,193 shares of the Company Common Stock after taking into account the Exchange Ratio, Reverse Stock Split and Stock Dividend.

 

F-21
 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Warrants

 

AYRO Seed Warrants

 

Prior to the Merger, the Company issued 461,647 warrants (the “AYRO Seed Warrants”) with an exercise price $7.33. The AYRO Seed Warrants terminate five years from the grant date. As of December 31, 2022, there were 448,005 AYRO Seed Warrants outstanding.

 

Series I Warrants

 

As a result of the Merger, 14,636 Series I Warrants transferred to AYRO and have an exercise price of $69.00 per share. If at any time (i) the volume weighted average price (“VWAP”) of the Common Stock exceeds $138.00 for not less than the mandatory exercise measuring period; (ii) the daily average number of shares of Common Stock traded during the mandatory exercise measuring period equals or exceeds 25,000; and (iii) no equity conditions failure has occurred as of such date, then the Company shall have the right to require the holder to exercise all or any portion of the Series I Warrants still unexercised for a cash exercise. During the year ended December 31, 2021, all 14,636 Series I Warrants expired.

 

Series H-3 Warrants

 

As a result of the Merger, 2,800 Series H-3 Warrants transferred to AYRO and have an exercise price of $165.60 per share, subject to adjustments (the “Series H-3 Warrants”). Subject to certain ownership limitations, the Series H-3 Warrants are immediately exercisable from the issuance date and will be exercisable for a period of five (5) years from the issuance date. As of December 31, 2022, all 2,800 Series H-3 Warrants expired.

 

Series H-4 Warrants

 

As a result of the Merger, 37,453 Series H-4 Warrants transferred to AYRO and have an exercise price of $15.60. The Series H-4 Warrants contain an anti-dilution price protection and the warrants cannot be less than $15.60 per share. As of December 31, 2022, there were 37,453 Series H-4 Warrants outstanding.

 

F-22
 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Series J Warrants

 

As a result of the Merger, 52,023 Series J Warrants transferred to AYRO. The terms of the Series J Warrants are substantially identical to the terms of the Series H-4 Warrants except that (i) the exercise price is equal to $30.00 per share, (ii) the Series J Warrants may be exercised at all times beginning on the 6-month anniversary of the issuance date on a cash basis and also on a cashless basis, (iii) the Series J Warrants do not contain any provisions for anti-dilution adjustment and (iv) the Company has the right to require the Holders to exercise all or any portion of the Series J Warrants still unexercised for a cash exercise if the volume-weighted average price (VWAP) (as defined in the Series J Warrant) for the Company’s common stock equals or exceeds $45.00 for not less than ten consecutive trading days.

 

If at any time (i) the VWAP of the Common Stock exceeds $9.00 for not less than the mandatory exercise measuring period; (ii) the daily average number of shares of Common Stock traded during the mandatory exercise measuring period equals or exceeds 25,000; and (iii) no equity conditions failure has occurred as of such date, then the Company shall have the right to require the holder to exercise all or any portion of the Series J Warrants still unexercised for a cash exercise. As of December 31, 2022, there were 52,023 Series J Warrants outstanding.

 

Series H-5 Warrants

 

As a result of the Merger, 296,389 Series H-5 Warrants were transferred to AYRO and have an exercise price of $2.50 per share. Subject to certain ownership limitations, the H-5 Warrants will be exercisable beginning six months from the issuance date and will be exercisable for a period of five years from the initial issuance date.

 

The H-5 Warrants are entitled to certain anti-dilution adjustments if the Company issues shares of its common stock at a lower price per share than the applicable exercise price (subject to a floor of $0.792 per share). An anti-dilution adjustment was triggered resulting in an adjusted exercise price per share from $3.96 to $2.50, resulting in an issuance of an additional 173,091 warrants that are exercisable at $2.50 per share. As of December 31, 2022, there were 348,476 Series H-5 Warrants outstanding.

 

The Series H-1, H-4, J and H-5 Warrants expire through the years 2023-2024.

 

F-23
 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Other AYRO Warrants

 

On June 19, 2020, the Company agreed to issue finder warrants (the “June Finder Warrants”) to purchase 27,273 shares of the Company’s common stock at an exercise price of $2.75 per share to a finder or its designees, and the Company agreed to issue warrants to Palladium (the “June Placement Agent Warrants”) to purchase 126,000 shares of the Company’s common stock at an exercise price of $2.875 per share. The June Finder Warrants and June Placement Agent Warrants terminate after a period of 5 years on June 19, 2025. As of December 31, 2020, 126,000 of the June Placement Agent Warrants had been exercised. As of December 31, 2022, the 27,273 June Finder Warrants were outstanding.

 

On July 8, 2020, the Company agreed to issue finder warrants (the “July 8 Finder Warrants”) to purchase 71,770 shares of the Company’s common stock at an exercise price of $5.225 per share to a finder or its designees, and the Company agreed to issue warrants to Palladium (the “July 8 Placement Agent Warrants”) to purchase 147,368 shares of the Company’s common stock at an exercise price of $5.4625 per share.

 

The July 8 Finder Warrants and July 8 Placement Agent Warrants terminate after a period of 5 years on July 8, 2025. As of December 31, 2022, there were 71,770 July 8 Finder Warrants and 147,368 July 8 Placement Agent Warrants were outstanding.

 

On July 22, 2020, the Company agreed to issue warrants to Palladium (the “July 22 Placement Agent Warrants”) to purchase 129,500 shares of the Company’s common stock at an exercise price of $5.750 per share. The July 22 Placement Agent Warrants terminate after a period of 5 years on July 22, 2025. As of December 31, 2022, there were 129,500 July 22 Placement Agent Warrants outstanding.

 

F-24
 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

On September 25, 2020, the Company issued a warrant (the “September Warrant”) to purchase 31,348 shares of the Company’s common stock at an exercise price of $3.19 per share to a vendor for facilitating a manufacturing agreement. The September Warrant is immediately exercisable and expires on September 25, 2025. The September Warrant was classified as equity and the estimated fair value of $2.13 per share was computed as of September 25, 2020, using the Black-Scholes model. The Company recorded $66,845 as stock-based compensation expense during the fourth quarter of 2020 for the total fair value of the September Warrant. As of December 31, 2022, there were 31,348 September Warrants outstanding.

 

On November 22, 2020, the Company entered into a Securities Purchase Agreement with new and current stockholders of the Company, pursuant to which such stockholders agreed to purchase shares of AYRO’s Common Stock, Series A Warrants and Series B Warrants to purchase AYRO’s Common Stock for an aggregate purchase price of $9,999,997. Each purchaser additionally purchased and received Series A Warrants and Series B Warrants equal to 75% and 50% of the purchased shares, for a total of 1,237,624 Series A Warrants and 825,084 Series B Warrants. The Series A Warrants were immediately exercisable, in whole or in part at a strike price of $8.09 and expired on May 24, 2021. The Series B Warrants are immediately exercisable, in whole or in part, at a strike price of $8.90, and terminate five years from the date issuance on November 24, 2025. As of December 31, 2022, there were no Series A Warrants and 825,084 Series B Warrants outstanding.

 

On November 22, 2020, the Company agreed to issue finder warrants (the “November Finder Warrants”) to purchase 56,256 shares of the Company’s common stock at an exercise price of $6.6660 per share to a finder or its designees, and the Company agreed to issue warrants to Palladium (the “November Placement Agent Warrants”) to purchase 57,756 shares of the Company’s common stock at an exercise price of $6.9690 per share.

 

The November Finder Warrants and November Placement Agent Warrants terminate after a period of 5 years on November 22, 2025. As of December 31, 2022, there were 56,256 November Finder Warrants and 57,756 November Placement Agent Warrants outstanding.

 

On January 25, 2021, AYRO entered into a Securities Purchase Agreement with certain institutional and accredited investors, pursuant to which AYRO agreed to issue and sell in the January 2021 Offering an aggregate of 3,333,334 shares of common stock of AYRO, par value $0.0001 per share, at an offering price of $6.00 per share, for gross proceeds of approximately $20.0 million before the deduction of fees and offering expenses.

 

Each purchaser was also granted a warrant to purchase, between July 26, 2021 and July 26, 2023, additional shares of common stock equal to the full amount of the common stock it purchased at the initial closing, or an aggregate of 3,333,334 shares at an exercise price of $6.93 per share.

 

On January 25, 2021, the Company agreed to issue warrants to Palladium, the placement agent for the January 2021 offering to purchase 233,334 shares of the Company’s common stock at an exercise price of $6.93 per share. The warrants are exercisable six months following issuance and terminate on July 23, 2023. As of December 31, 2022 all 3,566,668 warrants are outstanding.

 

On February 11, 2021, the Company agreed to issue warrants to Spartan Capital Securities, LLC and its affiliates (the “February Finder Warrants”) to purchase 15,574 shares of the Company’s common stock at an exercise price of $10.925 per share and to purchase 35,885 shares of the Company’s common stock at an exercise price of $10.45 per share to a finder or its designees. In addition, the Company agreed to issue warrants to Palladium (the “February Placement Agent Warrants”) to purchase 255,584 shares of the Company’s common stock at an exercise price of $10.925 per share. The February Finder Warrants and February Placement Agent Warrants terminate after a period of 5 years on February 26, 2026. As of December 31, 2022, there were 51,459 February Finder Warrants and 255,584 February Placement Agent Warrants were outstanding.

 

A summary of the Company’s warrants to purchase common stock activity is as follows:

 

   Shares Underlying Warrants  

Weighted

Average Exercise

Price

  

Weighted

Average

Remaining Contractual

Term (in years)

 
Outstanding at December 31, 2020   3,501,014   $8.03    2.87 
Granted   3,873,711   $7.24      
Exercised   (13,642)  $7.33      
Expired   (1,252,260)  $8.80      
Outstanding at December 31, 2021   6,108,823   $7.37    2.31 
Expired   (2,800)   165.60      
Outstanding at December 31,2022   6,106,023   $7.30    1.32 

 

F-25
 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 11. STOCK BASED COMPENSATION

 

AYRO 2020 Long Term Incentive Plan

 

On May 28, 2020, the Company’s shareholders approved the AYRO, Inc. 2020 Long Term Incentive Plan for future grants of incentive stock options, nonqualified stock, stock appreciation rights, restricted stock, restricted stock units, performance and other awards.

 

The Company has reserved a total of 4,089,650 shares of its common stock pursuant to the AYRO, Inc. 2020 Long-Term Incentive Plan, including shares of restricted stock that have been issued. The Company has 1,158,899 stock options, restricted stock and warrants remaining under this plan as of December 31, 2022.

 

AYRO 2017 Long Term Incentive Plan

 

The Company has reserved a total of 477,983 shares of its common stock pursuant to the AYRO, Inc. 2017 Long-Term Incentive Plan. The Company had 128,606 shares of common stock outstanding under the plan at December 31, 2022. At December 31, 2022, no shares remained available for grant under future awards under the 2017 Long-Term Incentive Plan. In conjunction with the 2020 incentive plan, the remaining unissued amounts were cancelled.

 

DropCar Amended and Restated 2014 Equity Incentive Plan

 

The Company’s equity incentive plan created in 2014 (the “2014 Plan”) was amended in 2018 to increase the number of shares of Company common stock available for issuance. Pursuant to the 2014 Plan, 141,326 shares of common stock were reserved for issuance. As of December 31, 2022, there were no shares available for grant under the 2014 Plan.

 

Stock-based compensation, including stock options, and restricted stock, expense is included in the consolidated statement of operations as follows:

 

   2022   2021 
   Years Ended December 31, 
   2022   2021 
Research and development  $21,922   $73,447 
Sales and marketing   25,811    224,076 
General and administrative   1,192,396    7,258,760 
Total  $1,240,129   $7,556,282 

 

F-26
 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Options

 

The following table reflects the stock option activity:

 

  

Number of

Shares

  

Weighted

Average

Exercise

Price

  

Contractual

Life (Years)

 
Outstanding at December 31, 2020   1,920,269   $4.40    8.66 
Exercised   (555,004)  $(2.72)     
Forfeitures   (26,590)  $(2.52)     
Outstanding at December 31, 2021   1,338,675   $5.14    8.26 
Granted   173,500    0.97      
Exercised   -    -      
Forfeitures   (734,253)   3.13      
Outstanding at December 31, 2022   777,922    6.15    7.56 

 

Of the outstanding options, 612,963 were vested and exercisable as of December 31, 2022. At December 31, 2022 the aggregate intrinsic value of stock options vested and exercisable was $0.

 

The Company recognized $65,291 and $1,232,402 of stock option expense for the years ended December 31, 2022 and 2021, respectively. Total compensation cost related to non-vested stock option awards not yet recognized as of December 31, 2022 was $142,648 and will be recognized on a straight-line basis through the end of the vesting periods through April 2025. The amount of future stock option compensation expense could be affected by any future option grants or by any forfeitures.

 

Determining the appropriate fair value of the stock-based awards requires the input of subjective assumptions, including the fair value of the Company’s common stock, and for stock options, the expected life of the option, and the expected stock price volatility. The Company uses the Black-Scholes option pricing model to value its stock option awards. The assumptions used in calculating the fair value of stock-based awards represent management’s best estimates and involve inherent uncertainties and the application of management’s judgment. The Company granted 173,000 shares on May 6, 2022, at a grant date fair value of $0.97. As a result, if factors change and management uses different assumptions, stock-based compensation expense could be materially different for future awards.

 

F-27
 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

The Company uses the following inputs when valuing stock-based awards.

 

   For the Years Ended December 31, 
   2022   2021 
Expected life (years)   6    n/a 
Risk-free interest rate   3.04%   n/a 
Expected volatility   128.67%   n/a 
Stock Price  $0.84    n/a 
Exercise Price  $0.97    n/a 

 

The expected life of the employee stock options was estimated using the “simplified method,” as the Company has no historical information to develop reasonable expectations about future exercise patterns and employment duration for its stock option grants. The simplified method is based on the average of the vesting tranches and the contractual life of each grant. The expected life of awards that vest immediately use the contractual maturity since they are vested when issued. For stock price volatility, the Company uses public company comparable data and in periods prior to the Merger historical private placement data as a basis for its expected volatility to calculate the fair value of option grants. The risk-free interest rate is based on U.S. Treasury notes with a term approximating the expected life of the option at the grant-date.

 

Restricted Stock

 

The following table reflects the restricted stock activity:

 

   Number of Shares  

Weighted

Average Grant

Price

 
Outstanding at December 31, 2020   1,072,503   $5.30 
Granted   622,000   $3.91 
Vested   (1,201,891)  $5.71 
Forfeitures   (42,612)  $3.17 
Outstanding at December 31, 2021   450,000   $2.48 
Granted   542,248   $1.06 
Vested   (331,686)  $1.29 
Outstanding at December 31, 2022   660,562   $1.91 

 

In September 2020, the Company issued 436,368 shares of restricted stock to current directors, of which 15,115 immediately vested and the remainder to vest in December 2020, which was subsequently modified to vest in full in May 2021. The Company recognized compensation expense during the year ended December 31, 2022 and 2021 of $0 and $699,527, respectively.

 

In December 2020, based on objectives achieved, the Company issued 651,250 shares of restricted stock to Rodney C. Keller, Jr. that vest according to the following vesting schedule: one-third vested on May 28, 2021, one-third was to vest on December 4, 2021 and one-third was to vest on December 4, 2022. In September 2021 all 434,166 unvested shares of Keller Restricted Stock vested pursuant to Mr. Keller’s separation agreement. Compensation expense recognized for the Keller Restricted Stock for the years ended December 31, 2022 and 2021 was $0 and $4,126,618, respectively.

 

F-28
 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

On February 24, 2021, pursuant to the AYRO, Inc. 2020 Long-Term Incentive Plan, the Company issued 172,000 shares of restricted stock to non-executive directors at a value of $7.66 per share. All awards vested during the year ended December 31, 2021. The Company recognized compensation expense during the year ended December 31, 2021 of $329,380.

 

In September 2021, pursuant to the employment agreement with Thomas M. Wittenschlaeger, the Company issued 450,000 shares of restricted stock at a value of $2.48 per share. Vesting will occur as predetermined value-based targets are met. We estimate the fair value of stock-based and cash unit awards containing a market condition using a Monte Carlo simulation model. Key inputs and assumptions used in the Monte Carlo simulation model include the stock price of the award on the grant date, the expected term, the risk-free interest rate over the expected term, the expected annual dividend yield and the expected stock price volatility. The Company does not currently pay or plan to pay a dividend on its common stock, the expected dividend yield was zero. Volatility was determined using a three-year lookback with a 110% determination. The expected term is December 27, 2023 for the fifth and final tranche. During the year ended December 31, 2022 and 2021 the Company recognized $646,771 and $180,215 respectively. Total compensation cost related to non-vested restricted stock not yet recognized as of December 31, 2022 was $290,118 and will be recognized on a straight-line basis per target through the end of each vesting period through December 2023.

 

On February 1, 2022, pursuant to the AYRO, Inc. 2020 Long-Term Incentive Plan, the Company issued 442,248 shares of restricted stock to non-executive directors at a value of $1.29 per share. 331,686 shares vested during the year ended December 31, 2022. The remainder vested in full in January 2023. The Company recognized compensation expense during the year ended December 31, 2022 and 2021 of $522,958 and $0 respectively. $42,788 remained unrecognized as of December 31, 2022.

 

On August 23, 2022, pursuant to the employment agreement with David E. Hollingsworth, the Company issued 100,000 shares of restricted stock at a value of $0.03 per share. Vesting will occur as predetermined value-based targets are met. We estimate the fair value of stock-based and cash unit awards containing a market condition using a Monte Carlo simulation model. During the year ended December 31, 2022 and 2021 the Company recognized $1,001 and $0 respectively.

 

F-29
 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 12. CONCENTRATIONS AND CREDIT RISK

 

Revenues

 

One customer accounted for approximately 100% , respectively, of the Company’s revenues for the year ended December 31, 2022 and for two customers 79% and 20%, respectively, for the year ended December 31, 2021.

 

Accounts Receivable

 

As of December 31, 2022 one customer accounted for 100% of the Company’s net accounts receivable. As of December 31, 2021 two customers accounted for more than 10% of the Company’s net accounts receivable. One customer accounted for approximately 87% of the Company’s gross account receivable and a second customer accounted for approximately 10% of the Company’s gross account receivable.

 

Purchasing

 

The Company places orders with various suppliers. During the years ended December 31, 2022 and 2021, three suppliers accounted for more than 10% of the Company’s raw materials. One supplier, Cenntro Automotive Group (“Cenntro”), a related party – see Note 14 – accounted for approximately 50% and 62%, respectively, of the Company’s purchases of raw materials during the years ended December 31, 2022 and 2021. The second supplier accounted for 19% and 9%, respectively, of the Company’s purchases of raw materials during the years ended December 31, 2022 and 2021. The third supplier accounted for 10% of the Company’s purchases of raw materials during the year ended December 31, 2022.

 

Manufacturing

 

On May 31, 2022, the Company received a letter from Cenntro purporting to terminate all agreements and contracts between the Company and Cenntro. Although the Company does not believe Cenntro’s termination of the Cenntro MLA is valid, the Company has determined to cease production of the AYRO 411x and focus its resources on the development and launch of the Vanish. The Company has canceled all purchase orders and future builds with Cenntro and currently intends to only order replacement parts for vehicles from Cenntro in the future. The Company is in discussions with Cenntro concerning the potential repurchase by Cenntro of unsaleable inventory due to quality concerns. AYRO expects to lose its exclusive license under the Cenntro MLA, in which case Cenntro could sell similar products through other companies or directly to the Company’s customers, which could have a material adverse effect on its results of operations and financial condition.

 

F-30
 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 13. RELATED PARTY TRANSACTIONS

 

The Company had received short-term expense advances from its founders. For the years ended December 31, 2022 and 2021, the amounts outstanding were $15,000 for each year and recorded as a component of accounts payable on the accompanying consolidated balance sheets.

 

During the year ended December 31, 2022, the Company paid $60,000 to a member of the Board of Directors for approved consulting services.

 

NOTE 14. COMMITMENTS AND CONTINGENCIES

 

Manufacturing Agreements

 

On September 25, 2020, AYRO entered into a Master Manufacturing Services Agreement (the “Karma Agreement”) with Karma Automotive, LLC (“Karma”). The Karma Agreement expired in September 2022. Pursuant to the agreement Karma agreed to provide certain manufacturing services, starting in 2021, under an attached statement of work including final assembly, raw material storage and logistical support of our vehicles in return for compensation of $1,160,800.

 

The Company paid Karma an amount of $440,000 for the first production level builds and $80,000 for setup costs. In addition, the Company issued warrants to an advisor to the transaction with a fair value of $66,845 due at signing of the contract, which amount was expensed in the prior year. The payment was recorded as prepaid expense as of December 31, 2020. For the year ended December 31, 2021, the Company recorded expense of $641,140 related to the Karma Agreement for the assembly of the AYRO 411 and 411x vehicles (the “AYRO 411 Fleet”), of which $468,480 was recorded to reduce the total remaining prepaid expense to match the expected number of 411x vehicles to be built in 2022. This amount was recorded against cost of goods for direct labor as part of the first production level builds, and $73,333 was recorded for pre-production costs. No prepaid balance remained as of December 31, 2022.

 

On July 28, 2022, the Company partnered with Linamar Corporation (“Linamar”) a Canadian manufacturer, in a manufacturing agreement (the “Linamar MLA”) to provide certain sub assembly and assembly parts, including the cabin frame and skate for the Vanish (collectively, the “Products”). During the term of the Linamar MLA, Linamar has the exclusive right to supply the Products to the Company, subject to certain exceptions. The Linamar MLA has an initial term of three years and will automatically renew for successive two-year terms unless either party has given at least 12 months’ written notice of nonrenewal. Either party may terminate the Linamar MLA at any time upon 12 months’ written notice, and in the event of a change in control of the Company prior to the end of the initial term, the Company may terminate upon written notice within three days of completion of such change in control.

 

In the event the Company terminates the Linamar MLA prior to its expiration, whether following a change in control or otherwise, the Company must purchase any remaining raw material inventory, finished goods inventory and work in progress and any unamortized capital equipment used in production and testing of the Products and pay a termination fee of $750,000, subject to certain adjustments. The Company is dependent on the Linamar MLA, and in the event of its termination the Company’s manufacturing operations and customer deliveries would be materially impacted.

 

Under the Linamar MLA, the Company must commit to certain minimum purchase requirements, to be determined by AYRO on a quarterly basis.

 

Supply Chain Agreements

 

In 2017, the Company executed a supply chain contract with Cenntro, which has historically been the Company’s primary supplier. Prior to the Merger, Cenntro was a significant shareholder in AYRO Operating. Cenntro owns the design of the AYRO 411 Fleet vehicles and has granted the Company an exclusive license to purchase the AYRO 411 Fleet vehicles for sale in North America. The Company purchased 100% of its vehicle chassis, cabs and wheels for AYRO 411 Fleet Vehicles through this supply chain relationship with Cenntro. The Company must sell a minimum number of units in order to maintain its exclusive supply chain contract. See Note 12 for concentration amounts.

 

As of December 31, 2021 the net balance between prepaid expenses and accrued expenses with Cenntro was a prepaid balance of $602,016. As of December 31, 2022 the balance was zero. Impairments of prepaid expenses led to a write-down, netted with the balance in accrued expenses. The remainder of the balance was expensed through cost of goods sold for $621,097. Additionally, all inventory associated with Cenntro’s NCM line was written off to cost of goods sold for $1,317,289.

 

The Company has canceled all purchase orders and future builds with Cenntro and currently intends to only order replacement parts from Cenntro in the future.

 

Lease Agreements

 

In 2019 the Company entered into a new lease agreement for office and manufacturing space. The lease commencement date was January 16, 2020. Prior to the commencement date of the new lease agreement, the Company leased other office and manufacturing space on a short-term basis. The Company determined if an arrangement is a lease at inception of the contract and whether a contract is or contains a lease by determining whether it conveys the right to control the use of identified asset for a period of time. The contact provides the right to substantially all the economic benefits from the use of the identified asset and the right to direct use of the identified asset, as such, the contract is, or contains, a lease. In connection with the adoption of ASC 842, Leases, the Company has elected to treat the lease and non-lease components as a single component.

 

During March 2021, the Company subleased additional office space to support the Company’s expansion plan. The term is for 16 months with no lease obligation remaining as of December 31, 2022. In connection with the adoption of ASC 842, Leases, the Company has elected to treat the lease and non-lease components as a single component.

 

Leases were classified as an operating lease at inception. An operating lease results in the recognition of a Right-of-Use (“ROU”) assets and lease liability on the balance sheet. ROU assets and operating lease liabilities are recognized based on the present value of lease payments over the lease term as of the commencement date. Because the lease does not provide an explicit or implicit rate of return, the Company determines an incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments on an individual lease basis.

 

The incremental borrowing rate for a lease is the rate of interest the Company would have to pay on a collateralized basis to borrow an amount equal to the lease payments for the asset under similar term, which is 10.41%. Lease expense for the lease is recognized on a straight-line basis over the lease term.

 

F-31
 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

The Company’s leases do not contain any residual value guarantees or material restrictive covenants. Leases with a lease term of 12 months or less are not recorded on the balance sheet and lease expense is recognized on a straight-line basis over the lease term. The remaining term for the Company’s lease as of December 31, 2022 is 4.25 years. The Company currently has no finance leases.

 

During the years ended December 31, 2022 and 2021, cash paid for amounts included in the measurement of lease liabilities- operating cash flows from operating lease was $306,689 and $180,404 respectively.

 

The components of lease expense consist of the following:

   2022   2021 
   Years Ended December 31, 
   2022   2021 
Operating lease expense  $409,543   $462,105 
Short-term lease expense   153,572    8,296 
Total lease cost  $563,115   $470,401 

 

Balance sheet information related to leases consists of the following:

 

   December 31, 2022   December 31, 2021 
Assets          
Operating lease – right-of-use asset  $819,401   $1,012,884 
Total lease assets  $819,401   $1,012,884 
           
Liabilities          
Current liabilities:          
Lease obligation – operating lease  $165,767   $206,426 
Noncurrent liabilities:          
Lease obligation - operating lease, net of current portion   693,776    859,543 
Total lease liability  $859,543   $1,065,969 

 

The weighted-average remaining lease term and discount rate is as follows:

 

Weighted average remaining lease term (in years) – operating lease   4.25 
Weighted average discount rate – operating lease   10.41%

 

F-32
 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Cash flow information related to leases consists of the following:

 

   December 31, 2022   December 31, 2021 
Operating cash flows for operating leases  $306,689   $180,404 
Supplemental non-cash amounts of lease liabilities arising from obtaining right of use assets  $-   $120,440 

  

Future minimum lease payment under non-cancellable lease as of December 31, 2022 are as follows:

 

As of December 31, 2022  Operating Leases 
2023   247,533 
2024   254,277 
2025   261,223 
2026   268,378 
2027   44,929 
Total minimum lease payments   1,076,340 
Less effects of discounting   (216,797)
Present value of future minimum lease payments  $859,543 

 

Litigation

 

The Company is subject to various legal proceedings and claims, either asserted or unasserted, which arise in the ordinary course of business, that it believes are incidental to the operation of its business. While the outcome of these claims cannot be predicted with certainty, management does not believe that the outcome of any of these legal matters will have a material adverse effect on its results of operations, financial positions or cash flows.

 

F-33
 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

On February 12, 2021, the Company entered into an agreement with Arcimoto, Inc. to settle certain patent infringement claims (the “Arcimoto Settlement”) for a de minimis amount, pursuant to which the Company agreed to cease the production, importation and sale of the AYRO 311, among other things. Accordingly, the Company would not be contractually permitted to resume production of the AYRO 311.

 

As of January 1, 2019, DropCar had accrued approximately $232,000 for the settlement of multiple employment disputes. As of December 31, 2021 the accrual balance was $3,500, as of December 31, 2022 the remainder has been paid.

 

On March 23, 2018, DropCar was made aware of an audit being conducted by the New York State Department of Labor (“DOL”) regarding a claim filed by an employee. The DOL is investigating whether DropCar properly paid overtime for which DropCar has raised several defenses. In addition, the DOL is conducting its audit to determine whether the Company owes spread of hours pay (an hour’s pay for each day an employee worked or was scheduled for a period over ten hours in a day). Management believes the case has no merit.

 

DropCar was a defendant in a class action lawsuit which resulted in a judgement entered into whereby the Company is required to pay legal fees in the amount of $45,000 to the plaintiff’s counsel. As of December 31, 2022 there is no balance due.

 

DropCar was audited by the New York State Department of Taxation and Finance (“DOTF”) for its sales tax paid over the period of 2017 – 2020. The DOTF believes DropCar owes additional sales tax plus interest. Management is investigating the details this audit. As of December 31, 2021, the Company has accrued $476,280 in expense for such additional sales tax and interest and paid as of December 31, 2022.

 

F-34
 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 15. INCOME TAXES

 

The following is a reconciliation of the statutory federal income tax rate applied to pre-tax net loss compared to the income taxes in the statement of operations as of December 31, 2022 and 2021.

 

   December 31, 2022   December 31, 2021 
Income tax benefit at statutory U.S. federal rate  $(4,816,424)  $(6,946,677)
Permanent differences - equity based compensation   51,381    310,384 
Income tax benefit attributable to U.S. states   (936,810)   (965,708
Permanent difference - non-deductible compensation   -    765,339 
           
Basis adjustments   -    70,544 
Change in valuation allowance   5,701,853    6,766,118 
Total income tax expense  $-   $- 

 

Deferred income taxes reflect the net effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The following table sets forth deferred income tax assets and liabilities as of the date shown:

 

   December 31, 2022   December 31, 2021 
Deferred tax assets:          
Net operating losses  $15,843,010   $11,733,274 
Intangible assets   99,566    85,758 
Capitalized research and development expense   1,490,870    - 
Equity based compensation   743,567    569,350 
Warrants   156,851    156,851 
Accrued compensation   1,467    33,147 
Property and equipment   1,492    73,646 
Lease liability   210,195    260,674 
Other   113,487    93,268 
Deferred tax assets   18,660,505    13,005,968 
Deferred tax liabilities          
ROU asset   (200,379)   (247,695)
           
Deferred tax liabilities   (200,379)   (247,695)
           
Valuation allowance   18,460,126    12,758,273 
Net deferred tax asset/(liability)  $-   $- 

 

In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income, and projections for future taxable income over periods in which the deferred tax assets are deductible. Management believes it is more likely than not that the Company will not realize the benefits of these deductible differences. A valuation allowance has been applied to the amount of deferred tax assets Management expects will be unrealized.

 

Management does not believe that there are significant uncertain tax positions in 2022. There are no interest and penalties related to uncertain tax positions in 2022. The Company has federal net operating loss carryforwards of $64,332,435 and $48,152,539 as of December 31, 2022 and 2021, respectively. $995,801 of the federal net operating loss is subject to a 20-year carry forward, with a portion beginning to expire in 2036. $63,336,634 of the federal net operating loss has an indefinite carry forward period subjected to 80% of taxable income. The Company had state net operating loss carryforwards totaling $48,091,426 and $34,824,332 at December 31, 2022 and 2021. The Company has various state net operating loss carryforwards. The determination of the state net operating loss carryforwards is dependent upon apportionment percentages and state laws that can change from year to year and impact the amount of such carryforwards. If such net operating loss carryforwards are not utilized, they will begin to expire in 2031.

 

F-35
 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

The following table sets for the tax years subject to examination for the major jurisdictions where the Company conducts business as of December 31, 2022.

 

Federal 2016 to 2022
Georgia 2019 to 2022

 

Federal and state laws impose substantial restrictions on the utilization of NOL carryforwards in the event of an ownership change for income tax purposes, as defined in Section 382 of the Internal Revenue Code (“IRC”). Pursuant to IRC Section 382, annual use of the Company’s NOL carryforwards may be limited in the event a cumulative change in ownership of more than 50% occurs within a three-year period. The Company has not completed an IRC Section 382 analysis regarding the limitation of NOL carryforwards.

 

However, it is possible that past ownership changes will result in the inability to utilize a significant portion of the Company’s NOL carryforward that was generated prior to any change of control. The Company’s ability to use its remaining NOL carryforwards may be further limited if the Company experiences an IRC Section 382 ownership change in connection with future changes in the Company’s stock ownership.

 

Certain deferred tax assets from DropCar, such as NOL carryforwards and capital loss carryforwards are not included in the Company’s deferred tax assets as they are expected to be fully limited under IRC Section 382 as a result of the merger.

 

The Tax Cuts and Jobs Act (“TCJA”) requires taxpayers to capitalize and amortize research and experimental expenditures under IRC Section 174 for tax years beginning after December 31, 2021. This rule became effective for this Company during the year ended December 31, 2022 and resulted in the capitalization of research and development costs of $6,729,353. Before the TCJA, businesses have had the option of deducting Section 174 expenses in the year incurred or capitalizing and amortizing the costs over five years. The Company will amortize these costs for tax purposes over five years if the research and development was performed in the U.S. and over 15 years if research and development was performed outside the U.S.

 

On August 16, 2022, the Inflation Reduction Act was enacted into law. This Act includes a 15.0 percent book minimum tax on the adjusted financial statement income of applicable corporations, a number of clean-energy tax credits, and a 1.0 percent excise tax on certain stock buybacks. The Company does not expect these changes to have a material impact on the provision for income taxes or the financial statements.

 

NOTE 16. SUBSEQUENT EVENTS

 

The Company issued 110,562 shares of common stock upon the vesting of restricted stock on January 27, 2023.

 

F-36

EX-23.1 2 ex23-1.htm

 

Exhibit 23.1

 

Independent Registered Public Accounting Firm’s Consent

 

We consent to the incorporation by reference in the Registration Statements of AYRO Inc. on Form S-3 (File No.’s 333-236330, 333-136618, 333-140546, 333-142846, 333-146106, 333-149788, 333-165927, 333-207205, 333-215729, 333-217768, 333-224300, 333-227858, 333-240314, 333-248543 and 333-251001) and Form S-8 (File No.’s 333-128488, 333-158232, 333-216145, 333-225790, 333-240316 and 333-251029) of our report dated March 23, 2023, with respect to our audit of the consolidated financial statements of AYRO Inc. as of and for the year ended December 31, 2022 which report is included in this Annual Report on Form 10-K of AYRO Inc. for the year ended December 31, 2022.

 

/s/ Marcum llp

 

Marcum llp

East Hanover, NJ

March 23, 2023

 

 
EX-23.2 3 ex23-2.htm

 

Exhibit 23.2

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We hereby consent to the incorporation by reference in the Registration Statements of AYRO, Inc. on Form S-3 (File No.’s 333-236330, 333-136618, 333-140546, 333-142846, 333-146106, 333-149788, 333-165927, 333-207205, 333-215729, 333-217768, 333-224300, 333-227858, 333-240314, 333-248543 and 333-251001) and Form S-8 (File No.’s 333-128488, 333-158232, 333-216145, 333-225790, 333-240316 and 333-251029) of our report dated March 23, 2022, with respect to our audit of the consolidated financial statements as of and for the year ended December 31, 2021 which report is included in this Annual Report on Form 10-K of AYRO Inc. for the year ended December 31, 2022. We were dismissed as auditors on September 21, 2022 and, accordingly, we have not performed any audit or review procedures with respect to any financial statements incorporated by reference for the periods after the date of our dismissal.

 

/s/ Friedman LLP  
   
FRIEDMAN LLP  
East Hanover, NJ  
March 23, 2023  

 

 
EX-31.1 4 ex31-1.htm

 

Exhibit 31.1

 

CERTIFICATION UNDER SECTION 302

 

I, Thomas M. Wittenschlaeger, certify that:

 

1. I have reviewed this Annual Report on Form 10-K of AYRO, Inc.;
   
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
   
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
   
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: March 23, 2023  
   
/s/ Thomas M. Wittenschlaeger  
Thomas M. Wittenschlaeger  

President and Chief Executive Officer

(Principal Executive Officer)

 

 

 
EX-31.2 5 ex31-2.htm

 

Exhibit 31.2

 

CERTIFICATIONS UNDER SECTION 302

 

I, David E. Hollingsworth, certify that:

 

1. I have reviewed this Annual Report on Form 10-K of AYRO, Inc.;
   
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
   
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
   
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
   
  a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
     
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
   
  a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: March 23, 2023  
   
/s/ David E. Hollingsworth  
David E. Hollingsworth  
Chief Financial Officer  
(Principal Financial Officer and Principal Accounting Officer)  

 

 
EX-32.1 6 ex32-1.htm

 

Exhibit 32.1

 

CERTIFICATIONS UNDER SECTION 906

 

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of AYRO, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge and in the capacity of an officer, that:

 

The Annual Report for the year ended December 31, 2022 (the “Form 10-K”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company as of, and for, the periods presented in the Form 10-K.

 

Date: March 23, 2023 By: /s/ Thomas M. Wittenschlaeger
    Thomas M. Wittenschlaeger
   

President and Chief Executive Officer

(Principal Executive Officer)

     
Date: March 23, 2023 By: /s/ David E. Hollingsworth
    David E. Hollingsworth
   

Chief Financial Officer

(Principal Financial Officer and Principal Accounting Officer)

 

 

EX-101.SCH 7 ayro-20221231.xsd INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated Statements of Changes in Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - ORGANIZATION AND NATURE OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - LIQUIDITY AND OTHER UNCERTAINTIES link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - REVENUES link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - ACCOUNTS RECEIVABLE, NET link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - INVENTORY, NET link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - PROPERTY AND EQUIPMENT, NET link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - MARKETABLE SECURITIES link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - STOCKHOLDERS’ EQUITY link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - STOCK BASED COMPENSATION link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - CONCENTRATIONS AND CREDIT RISK link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - REVENUES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - ACCOUNTS RECEIVABLE, NET (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - INVENTORY, NET (Tables) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - MARKETABLE SECURITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - STOCKHOLDERS’ EQUITY (Tables) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - STOCK BASED COMPENSATION (Tables) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - INCOME TAXES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - LIQUIDITY AND OTHER UNCERTAINTIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIVES (Details) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE (Details) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - SCHEDULE OF DISAGGREGATION OF REVENUE (Details) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - SCHEDULE OF CONTRACT LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - REVENUES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - SCHEDULE OF ACCOUNTS RECEIVABLE (Details) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - ACCOUNTS RECEIVABLE, NET (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - SCHEDULE OF INVENTORY (Details) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - INVENTORY, NET (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - SCHEDULE OF PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT, NET (Details) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - SCHEDULE OF MARKETABLE SECURITIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000051 - Disclosure - SCHEDULE OF PAYMENT OF PREFERRED STOCK (Details) link:presentationLink link:calculationLink link:definitionLink 00000052 - Disclosure - SCHEDULE OF WARRANT ACTIVITY (Details) link:presentationLink link:calculationLink link:definitionLink 00000053 - Disclosure - STOCKHOLDERS’ EQUITY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000054 - Disclosure - SCHEDULE OF STOCK-BASED COMPENSATION (Details) link:presentationLink link:calculationLink link:definitionLink 00000055 - Disclosure - SCHEDULE OF STOCK-BASED COMPENSATION, STOCK OPTIONS, ACTIVITY (Details) link:presentationLink link:calculationLink link:definitionLink 00000056 - Disclosure - SCHEDULE OF STOCK-BASED PAYMENT AWARD, STOCK OPTIONS, VALUATION ASSUMPTIONS (Details) link:presentationLink link:calculationLink link:definitionLink 00000057 - Disclosure - SCHEDULE OF RESTRICTED STOCK ACTIVITY (Details) link:presentationLink link:calculationLink link:definitionLink 00000058 - Disclosure - STOCK BASED COMPENSATION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000059 - Disclosure - CONCENTRATIONS AND CREDIT RISK (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000060 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000061 - Disclosure - SCHEDULE OF COMPONENTS OF LEASE EXPENSES (Details) link:presentationLink link:calculationLink link:definitionLink 00000062 - Disclosure - SCHEDULE OF OPERATING LEASES RIGHT OF USE ASSETS AND LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000063 - Disclosure - SCHEDULE OF WEIGHTED- AVERAGE REMAINING LEASE TERM AND DISCOUNT RATE (Details) link:presentationLink link:calculationLink link:definitionLink 00000064 - Disclosure - SCHEDULE OF CASH FLOW INFORMATION (Details) link:presentationLink link:calculationLink link:definitionLink 00000065 - Disclosure - SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES (Details) link:presentationLink link:calculationLink link:definitionLink 00000066 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000067 - Disclosure - SCHEDULE OF RECONCILIATION STATUTORY FEDERAL INCOME TAX RATE (Details) link:presentationLink link:calculationLink link:definitionLink 00000068 - Disclosure - SCHEDULE OF DEFERRED TAX (Details) link:presentationLink link:calculationLink link:definitionLink 00000069 - Disclosure - SCHEDULE OF INCOME TAX EXAMINATION (Details) link:presentationLink link:calculationLink link:definitionLink 00000070 - Disclosure - INCOME TAXES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000071 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 ayro-20221231_cal.xml INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 9 ayro-20221231_def.xml INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 10 ayro-20221231_lab.xml INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Class of Stock [Axis] Convertible Preferred Stock Series H [Member] Convertible Preferred Stock Series H-3 [Member] Convertible Preferred Stock Series H-6 [Member] Series H Preferred Stock [Member] Equity Components [Axis] Preferred Stock [Member] Series H-3 Preferred Stock [Member] Series H-6 Preferred Stock [Member] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Inventory [Axis] Fleet Inventory [Member] Legal Entity [Axis] Cenntro Automotive Group Ltd [Member] Club Car Discount [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Long-Lived Tangible Asset [Axis] Computer Equipment [Member] Furniture and Fixtures [Member] Machinery and Equipment [Member] Leasehold Improvements [Member] Antidilutive Securities [Axis] Options to Purchase Common Stock [Member] Restricted Stock Unvested [Member] Restricted Stock Vested Unissued [Member] Warrants Outstanding [Member] Preferred Stock Outstanding [Member] Product and Service [Axis] Product [Member] Shipping Revenue [Member] Miscellaneous Income [Member] Service Income [Member] Computer And Equipment [Member] Prototypes [Member] Computer Software [Member] Retiring Legacy Assets [Member] Investment Type [Axis] Bonds [Member] US Treasury Securities [Member] Award Type [Axis] January 2021 Offering [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Securities Purchase Agreement [Member] Additional Shares [Member] Related Party [Axis] Investor [Member] Warrant [Member] Restricted Stock [Member] Title of Individual [Axis] Director [Member] Plan Name [Axis] 2020 Long-Term Incentive Plan [Member] Investment, Name [Axis] Affiliates [Member] Series H-3 Warrants [Member] Series H-6 Convertible Preferred Stock [Member] Seed Warrants [Member] Series I Warrants [Member] Series H-4 Warrants [Member] Series J Warrants [Member] Series H-5 Warrants [Member] June Finder Warrants [Member] June Placement Agent Warrants [Member] July 8 Finder Warrants [Member] July 8 Placement Agent Warrants [Member] July 22 Placement Agent Warrants [Member] September Warrant [Member] Series A Warrants and Series B [Member] Series A Warrants [Member] Series B Warrants [Member] November Finder Warrants [Member] November Placement Agent Warrants [Member] February Finder Warrants [Member] February Placement Agent Warrants [Member] Series H Convertible Preferred Stock [Member] Series H Six Convertible Preferred Stock [Member] 2020 Long Term Incentive Plan [Member] 2017 Long Term Incentive Plan [Member] 2014 Equity Incentive Plan [Member] DropCar Inc [Member] Share-Based Payment Arrangement, Option [Member] Directors [Member] Keller Award [Member] ThomasM Wittens Chlaeger [Member] David E. Hollingsworth [Member] Income Statement Location [Axis] Research And Development [Member] Sales And Marketing [Member] General And Administrative [Member] Restricted Stock Units (RSUs) [Member] Concentration Risk Benchmark [Axis] Sales Revenue [Member] Concentration Risk Type [Axis] Customer Concentration Risk [Member] Customer [Axis] Customer One [Member] Customer Two [Member] Accounts Receivable [Member] Cost of Goods and Service, Product and Service Benchmark [Member] Supplier Concentration Risk [Member] Supplier One [Member] Supplier Two [Member] Three Supplier [Member] Board of Directors Chairman [Member] Master Manufacturing Services Agreement [Member] Karma Automotive, LLC [Member] Related Party Transaction [Axis] First Production Level Builds [Member] Setup Costs [Member] Advisor [Member] New Lease Agreement [Member] DropCar Operating, Inc. [Member] Income Tax Authority [Axis] Domestic Tax Authority [Member] State and Local Jurisdiction [Member] Income Tax Authority, Name [Axis] Tax Cuts And Jobs Act [Member] Geographical [Axis] GEORGIA, REPUBLIC OF Subsequent Event Type [Axis] Subsequent Event [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] ICFR Auditor Attestation Flag Auditor Firm ID Auditor Name Auditor Location Statement [Table] Statement [Line Items] ASSETS Current assets: Cash Marketable securities Accounts receivable, net Inventory Prepaid expenses and other current assets Total current assets Property and equipment, net Operating lease – right-of-use asset Deposits and other assets Total assets LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities: Accounts payable Accrued expenses Current portion lease obligation – operating lease Total current liabilities Lease obligation - operating lease, net of current portion Total liabilities Commitments and contingencies Stockholders’ equity: Preferred stock, value Common Stock, ($0.0001 par value; authorized – 100,000,000 shares; issued and outstanding – 37,241,642 and 36,866,956 as of December 31, 2022 and 2021, respectively) Additional paid-in capital Accumulated deficit Total stockholders’ equity Total liabilities and stockholders’ equity Preferred stock, shares authorized Preferred stock, par value Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Revenue Cost of goods sold Gross loss Operating expenses: Research and development Sales and marketing General and administrative Total operating expenses Loss from operations Other income (expense): Interest income Interest expense Realized gain on marketable securities Unrealized loss on marketable securities Total other income (expense), net Net loss prior to provision for income taxes Provision for income taxes Net loss Net loss per share, basic and diluted Basic and diluted weighted average Common Stock outstanding Beginning balance Beginning balance, shares Issuance of common stock for services Issuance of common stock for services, shares Sale of common stock, net of fees Sale of common stock, net of fees, shares Exercise of warrants, net of fees Exercise of Warrants net , shares Exercise of stock options Exercise of stock options, shares Stock based compensation Vested Restricted Stock Vested restricted stock , shares Net Loss Ending balance, Ending balance, shares Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Net loss Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization Stock-based compensation Amortization of right-of-use asset Bad debt expense Realized gain on marketable securities Unrealized loss on marketable securities Impairment of inventory and prepaid Change in operating assets and liabilities: Accounts receivable Inventory Prepaid expenses and other current assets Deposits Accounts payable Accrued expenses Contract liability Lease obligations - operating leases Net cash used in operating activities CASH FLOWS FROM INVESTING ACTIVITIES: Purchase of property and equipment Purchase of marketable securities, net Purchase of intangible assets Net cash used in investing activities CASH FLOWS FROM FINANCING ACTIVITIES: Repayments of debt Proceeds from exercise of warrants, net of fees Proceeds from exercise of stock options Proceeds from issuance of Common Stock, net of fees and expenses Net cash provided by financing activities Net change in cash Cash, beginning of year Cash, end of year Supplemental disclosure of cash and non-cash transactions: Cash paid for interest Restricted Stock issued previously accrued Accrued Fixed Assets Supplemental non-cash amounts of lease liabilities arising from obtaining right of use assets Organization, Consolidation and Presentation of Financial Statements [Abstract] ORGANIZATION AND NATURE OF OPERATIONS Liquidity And Other Uncertainties LIQUIDITY AND OTHER UNCERTAINTIES Accounting Policies [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Revenue from Contract with Customer [Abstract] REVENUES Credit Loss [Abstract] ACCOUNTS RECEIVABLE, NET Inventory Disclosure [Abstract] INVENTORY, NET Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] PREPAID EXPENSES AND OTHER CURRENT ASSETS Property, Plant and Equipment [Abstract] PROPERTY AND EQUIPMENT, NET Cash and Cash Equivalents [Abstract] MARKETABLE SECURITIES Equity [Abstract] STOCKHOLDERS’ EQUITY Share-Based Payment Arrangement [Abstract] STOCK BASED COMPENSATION Risks and Uncertainties [Abstract] CONCENTRATIONS AND CREDIT RISK Related Party Transactions [Abstract] RELATED PARTY TRANSACTIONS Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES Income Tax Disclosure [Abstract] INCOME TAXES Subsequent Events [Abstract] SUBSEQUENT EVENTS Basis of Presentation and Principles of Consolidation Reclassification Use of Estimates Cash and Cash Equivalents Marketable Securities Fair Value Measurements Accounts Receivable, Net Inventory Property and Equipment, Net Long-Lived Assets, Including Definite-Lived Intangible Assets Leases Revenue Recognition Segment Reporting Income Taxes Warrants and Preferred Shares Stock-Based Compensation Basic and Diluted Loss Per Share Research and development costs Recent Accounting Pronouncements SCHEDULE OF ESTIMATED USEFUL LIVES SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE SCHEDULE OF DISAGGREGATION OF REVENUE SCHEDULE OF CONTRACT LIABILITIES SCHEDULE OF ACCOUNTS RECEIVABLE SCHEDULE OF INVENTORY SCHEDULE OF PREPAID EXPENSES AND OTHER CURRENT ASSETS SCHEDULE OF PROPERTY AND EQUIPMENT, NET SCHEDULE OF MARKETABLE SECURITIES Schedule of Stock by Class [Table] Class of Stock [Line Items] SCHEDULE OF PAYMENT OF PREFERRED STOCK SCHEDULE OF WARRANT ACTIVITY SCHEDULE OF STOCK-BASED COMPENSATION SCHEDULE OF STOCK-BASED COMPENSATION, STOCK OPTIONS, ACTIVITY SCHEDULE OF STOCK-BASED PAYMENT AWARD, STOCK OPTIONS, VALUATION ASSUMPTIONS SCHEDULE OF RESTRICTED STOCK ACTIVITY SCHEDULE OF COMPONENTS OF LEASE EXPENSES SCHEDULE OF OPERATING LEASES RIGHT OF USE ASSETS AND LIABILITIES SCHEDULE OF WEIGHTED- AVERAGE REMAINING LEASE TERM AND DISCOUNT RATE SCHEDULE OF CASH FLOW INFORMATION SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES SCHEDULE OF RECONCILIATION STATUTORY FEDERAL INCOME TAX RATE SCHEDULE OF DEFERRED TAX SCHEDULE OF INCOME TAX EXAMINATION Net losses Net cash provided by (used in) operating activities Cash and cash equivalents, at carrying value Marketable securities, current Working capital Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Property plant and equipment, estimated useful lives Property plant and equipment, estimated useful lives Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Totals Allowance for doubtful accounts Inventory write down Inventory reserves Impairment of inventory Estimated useful life of intangible assets Shipping expenses Research and development expenses Disaggregation of Revenue [Table] Disaggregation of Revenue [Line Items]  Total Revenue Balance, beginning of period Additions Transfer to revenue Balance, end of period Warranty reserves Trade receivables Less: Allowance for doubtful accounts  Accounts receivable, net Changes in allowance for doubtful accounts receivable Raw materials Work-in-progress Finished goods  Total Inventory, Current [Table] Inventory [Line Items] Depreciation expenses Inventory reserve Prepaid final assembly services Prepayments for inventory Prepayments for insurance Prepayments on advances on design Prepayments on software Prepaid other Total Prepaid Expenses and Other Current Assets Prepaid expenses and accrued expenses, net Property and equipment, gross Less: Accumulated depreciation Property and equipment, net Depreciation Investment Income [Table] Net Investment Income [Line Items] Cost Basis Gross Realized Gains Gross Unrealized Losses Transferred to Cash Fair Value Number of Series H Preferred Stock outstanding as of December 31, 2022 Multiplied by the stated value Equals the gross stated value Divided by the conversion price Equals the convertible shares of Company Common Stock Multiplied by the fair market value of Company Common Stock as of December 31, 2022 Liquidation Value Liquidation Value Shares Underlying Warrants Outstanding Weighted Average Exercise Price Outstanding Weighted Average Remaining Contractual Life Shares Underlying Warrants Granted Weighted Average Exercise Price Granted Shares Underlying Warrants Exercised Weighted Average Exercise Price Exercised Shares Underlying Warrants Expired Weighted Average Exercise Price Expired Shares underlying warrants outstanding Weighted Average Exercise Price Outstanding Weighted Average Remaining Contractual Life Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Line Items] Number of shares issued Offering price Proceeds from sale of common stock Offering expenses Purchase of additional shares description Number of additional shares purchased Shares issued for exercised stock options, shares Shares issued for exercised stock options Number of shares vested Number of restricted shares Share price Common Stock, Shares Subscribed but Unissued Number of restricted shares issued and vested Reverse stock split, description Preferred stock stated value Convertible conversion price increase Aggregate issued and outstanding shares percentage Conversion price per share Preferred stock, conversion price description Conversion of stock shares Conversion of stock shares issued Warrants to purchase common stock Warrant exercise price Warrants outstanding Warrants description Warrant weighted average exercise price Warrants and rights outstanding term Anti-dilution price protection price per share Exceeds warrant price per share Number of warrants issued Warrant expiration description Decrease in exercise price Share based compensation expenses Value of common stock issued Warrant expiration date Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Total Number of Stock options outstanding, Beginning balance Weighted Average Exercise Price Outstanding, Beginning balance Weighted average remaining contractual life Number of Stock options, Exercised Weighted Average Exercise Price Outstanding, Exercised Number of Stock options, Forfeitures Weighted Average Exercise Price Outstanding, Forfeitures Number of Stock options, Granted Weighted Average Exercise Price Outstanding, Granted Number of Stock options outstanding, Ending balance Weighted Average Exercise Price Outstanding, Ending balance Weighted average remaining contractual life Expected life (years) Risk-free interest Expected volatility Share price Exercise price Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Number of shares, Outstanding, Beginning balance Weighted Average Grant Price, Outstanding, Beginning balance Number of shares, Granted Weighted Average Grant Price, Granted Number of shares, Vested Weighted Average Grant Price, Vested Number of shares, Forfeited Weighted Average Grant Price, Forfeited Number of shares, Outstanding, Ending balance Weighted Average Grant Price, Outstanding, Ending balance Number of shares reserved Number of options granted Options to purchase shares outstanding Number of stock options available for grants Aggregate intrinsic value of stock options vested and exercisable Compensation expenses Cost not yet recognized Grant date fair value Number of restricted stock units Restricted stock vesting description Restricted stock shares vested but not issued Volatility rate Concentration Risk [Table] Concentration Risk [Line Items] Concentration risk percentage Schedule of Related Party Transactions, by Related Party [Table] Related Party Transaction [Line Items] Due to related parties Operating lease expense Short-term lease expense Total lease cost Operating lease – right-of-use asset Total lease assets Lease obligation – operating lease Total lease liability Weighted average remaining lease term (in years) - operating lease Weighted average discount rate - operating lease Operating cash flows for operating leases Supplemental non-cash amounts of lease liabilities arising from obtaining right of use assets 2023 2024 2025 2026 2027 Total minimum lease payments Less effects of discounting Present value of future minimum lease payments Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Share based compensation Repayments of related party debt Operating expense Settlement of multiple employment disputes Pre-production costs Termination fee Prepaid balance Inventory written-off Operating sub lease, expansion description Incremental borrowing rate for the lease Remaining term of lease Lease liabilities Remaning accounts payable and accrued liabilities Legal fees Other accrued liabilities, current Income tax benefit at statutory U.S. federal rate Permanent differences - equity based compensation Income tax benefit attributable to U.S. states Permanent difference - non-deductible compensation Basis adjustments Change in valuation allowance Total income tax expense Net operating losses Intangible assets Capitalized research and development expense Equity based compensation Warrants Accrued compensation Property and equipment Lease liability Other Deferred tax assets ROU asset Deferred tax liabilities Valuation allowance Net deferred tax asset/(liability) Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Line Items] Income tax examiation year Deferred tax assets, operating loss carryforward Net operating loss carryforwards Operating loss carryforwards maturity description Operating loss indefinite carryforwards Capitalization of research and development costs Subsequent Event [Table] Subsequent Event [Line Items] Issuance of common stock upon vesting of restrcited stock Liquidity and other uncertainities [text block] Working capital. Warrants and preferred shares [Policy text block] Fleet Inventory [Member] Cenntro Automotive Group Ltd [Member] Convertible Preferred Stock Series H [Member] Club Car Discount [Member] Convertible Preferred Stock Series H-3 [Member] Schedule of estimated useful lives [Table text block] Shipping expenses. Convertible Preferred Stock Series H-6 [Member] Options to Purchase Common Stock [Member] Restricted Stock Unvested [Member] Restricted Stock Vested Unissued [Member] Warrants Outstanding [Member] Preferred Stock Outstanding [Member] Shipping Revenue [Member] Miscellaneous Income [Member] Service Income [Member] Additions. Transfer to revenue. Warranty reserves. Prepaid final assembly services. Prepayments for inventory. Prepayments on software. Series H-3 Preferred Stock [Member] Series H-6 Preferred Stock [Member] Computer And Equipment [Member] Prototypes [Member] Computer Software [Member] Impairment of inventory and prepaid. Retiring Legacy Assets [Member] Accrued fixed assets. Marketable securities transferred to cash. Stock issued during period value exercise of warrants. Prepayments on advances on design. Stock issued during period share exercise of warrants. January 2021 Offering [Member] Securities Purchase Agreement [Member] Additional Shares [Member] 2020 Long-Term Incentive Plan [Member] Schedule Of Payment Of Preferred Stock [Table Text Block] Multiplied by the stated value. Equals the gross stated value. Conversion Price of Share. Series H-3 Warrants [Member] Series H-6 Convertible Preferred Stock [Member] Series I Warrants [Member] Warrant weighted average exercise price. Series H-4 Warrants [Member] Anti-dilution price protection price per share. Series J Warrants [Member] Exceeds warrant price per share. Series H-5 Warrants [Member] June Finder Warrants [Member] June Placement Agent Warrants [Member] July 8 Finder Warrants [Member] July 8 Placement Agent Warrants [Member] July 22 Placement Agent Warrants [Member] September Warrant [Member] Warrant expiration description. Series A Warrants and Series B [Member] Series A Warrants [Member] Series B Warrants [Member] November Finder Warrants [Member] November Placement Agent Warrants [Member] February Finder Warrants [Member] February Placement Agent Warrants [Member] Number of warrants or rights granted. Number of warrants or rights exercised. Class of warrant or right expired. Exercise price per share or per unit of warrants or rights granted. Exercise price per share or per unit of warrants or rights exercised. Class of warrant or right expired erercise price expired. Weighted Average Remaining Contractual Life, Beginning. Weighted Average Remaining Contractual Life, Ending. 2020 Long Term Incentive Plan [Member] 2017 Long Term Incentive Plan [Member] Two Thousand Fourteen Equity Incentive Plan [Member] DropCar Inc [Member] Stock issued during period shares stock options granted. Share based compensation arrangements by share based payment award options exercises in period weighted average granted. Share based compensation arrangement by share based payment award options outstanding weighted average remaining contractual term1. Share based compensation arrangement by share based payment award options vested weighted average grant date fairvalue1. Directors [Member] Keller Award [Member] Restricted stock for service vested not issued. ThomasM Wittens Chlaeger [Member] David E. Hollingsworth [Member] Customer One [Member] Sales Revenue [Member] Customer Two [Member] Supplier One [Member] Supplier Two [Member] Three Supplier [Member] Master Manufacturing Services Agreement [Member] Karma Automotive, LLC [Member] First Production Level Builds [Member] Setup Costs [Member] Advisor [Member] Incremental borrowing rate for the lease. New Lease Agreement [Member] Schedule of operating leases right of use assets and liabilities [Table Text Block]. Amount of lessee's right to use underlying asset under operating lease. Schedule of weighted average remaining lease term and discount rate [Table Text Block]. Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in five fiscal year and thereafter following current fiscal year. DropCar Operating, Inc. [Member] Remaning accounts payable and accrued liabilities. Income tax reconciliation equity based compensation expense Deferred tax assets warrants. Deferred tax assets compensation. Deferred tax assets depreciation. Deferred tax assets capitalized research and development expense. Operating loss indefinite carry forwards. Prepaid expense and other accrued expenses, net. Operating loss carryforwards maturity description. Tax Cuts And Jobs Act [Member] Seed Warrants [Member] Affiliates [Member] Assets, Current Assets Liabilities, Current Liabilities Stockholders' Equity Attributable to Parent Liabilities and Equity Gross Profit Operating Income (Loss) Interest Expense Nonoperating Income (Expense) Shares, Outstanding Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Deposit Assets Increase (Decrease) in Accounts Payable Increase (Decrease) in Accrued Liabilities Net Cash Provided by (Used in) Operating Activities Payments to Acquire Property, Plant, and Equipment Payments to Acquire Marketable Securities Payments to Acquire Intangible Assets Net Cash Provided by (Used in) Investing Activities Repayments of Debt Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Inventory, Policy [Policy Text Block] Property, Plant and Equipment, Estimated Useful Lives Contract with Customer, Liability, Current Weighted average exercise price exercised/forfeited Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Preferred Stock, Liquidation Preference, Value Weighted Average Remaining Contractual Life, Ending Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price StockIssuedDuringPeriodSharesStockOptionsGranted Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Lease, Cost Operating lease - right-of-use asset, net Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Lessee, Operating Lease, Liability, to be Paid Lessee, Operating Lease, Liability, Undiscounted Excess Amount Deferred Tax Assets, Gross Deferred Tax Liabilities, Leasing Arrangements Deferred Tax Liabilities, Gross Deferred Tax Liabilities, Net EX-101.PRE 11 ayro-20221231_pre.xml INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 12 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Cover - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Mar. 22, 2023
Jun. 30, 2022
Cover [Abstract]        
Document Type 10-K      
Amendment Flag false      
Document Annual Report true      
Document Transition Report false      
Document Period End Date Dec. 31, 2022      
Document Fiscal Period Focus FY      
Document Fiscal Year Focus 2022      
Current Fiscal Year End Date --12-31      
Entity File Number 001-34643      
Entity Registrant Name AYRO, INC.      
Entity Central Index Key 0001086745      
Entity Tax Identification Number 98-0204758      
Entity Incorporation, State or Country Code DE      
Entity Address, Address Line One 900 E. Old Settlers Boulevard      
Entity Address, Address Line Two Suite 100      
Entity Address, City or Town Round Rock      
Entity Address, State or Province TX      
Entity Address, Postal Zip Code 78664      
City Area Code (512)      
Local Phone Number 994-4917      
Title of 12(b) Security Common Stock, par value $0.0001 per share      
Trading Symbol AYRO      
Security Exchange Name NASDAQ      
Entity Well-known Seasoned Issuer No      
Entity Voluntary Filers No      
Entity Current Reporting Status Yes      
Entity Interactive Data Current Yes      
Entity Filer Category Non-accelerated Filer      
Entity Small Business true      
Entity Emerging Growth Company false      
Entity Shell Company false      
Entity Public Float       $ 30,220,995
Entity Common Stock, Shares Outstanding     37,352,203  
Documents Incorporated by Reference [Text Block] Portions of the definitive Proxy Statement of AYRO, Inc., relating to the Annual Meeting of Stockholders to be filed within 120 days after the end of the fiscal year covered by this Form 10-K, are incorporated into Part III of this Form 10-K by reference.      
ICFR Auditor Attestation Flag false      
Auditor Firm ID 688 711    
Auditor Name Marcum LLP Friedman LLP    
Auditor Location East Hanover, New Jersey East Hanover, New Jersey    
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Current assets:    
Cash $ 39,096,562 $ 69,160,466
Marketable securities 9,848,804
Accounts receivable, net 510,071 969,429
Inventory 970,381 3,744,037
Prepaid expenses and other current assets 1,478,845 2,276,178
Total current assets 51,904,663 76,150,110
Property and equipment, net 2,192,337 835,160
Operating lease – right-of-use asset 819,401 1,012,884
Deposits and other assets 73,683 129,610
Total assets 54,990,084 78,127,764
Current liabilities:    
Accounts payable 1,107,215 647,050
Accrued expenses 964,937 2,990,513
Current portion lease obligation – operating lease 165,767 206,426
Total current liabilities 2,237,919 3,843,989
Lease obligation - operating lease, net of current portion 693,776 859,543
Total liabilities 2,931,695 4,703,532
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, value
Common Stock, ($0.0001 par value; authorized – 100,000,000 shares; issued and outstanding – 37,241,642 and 36,866,956 as of December 31, 2022 and 2021, respectively) 3,724 3,687
Additional paid-in capital 133,224,249 131,654,776
Accumulated deficit (81,169,584) (58,234,231)
Total stockholders’ equity 52,058,389 73,424,232
Total liabilities and stockholders’ equity 54,990,084 78,127,764
Convertible Preferred Stock Series H [Member]    
Stockholders’ equity:    
Preferred stock, value
Convertible Preferred Stock Series H-3 [Member]    
Stockholders’ equity:    
Preferred stock, value
Convertible Preferred Stock Series H-6 [Member]    
Stockholders’ equity:    
Preferred stock, value
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Balance Sheets (Parenthetical) - $ / shares
Dec. 31, 2022
Dec. 31, 2021
Preferred stock, shares authorized 20,000,000 20,000,000
Common stock, par value $ 0.0001 $ 0.0001
Common stock, shares authorized 100,000,000 100,000,000
Common stock, shares issued 37,241,642 36,866,956
Common stock, shares outstanding 37,241,642 36,866,956
Convertible Preferred Stock Series H [Member]    
Preferred stock, shares authorized 8,500 8,500
Preferred stock, par value $ 0.0001 $ 0.0001
Preferred stock, shares issued 8 8
Preferred stock, shares outstanding 8 8
Convertible Preferred Stock Series H-3 [Member]    
Preferred stock, shares authorized 8,461 8,461
Preferred stock, par value $ 0.0001 $ 0.0001
Preferred stock, shares issued 1,234 1,234
Preferred stock, shares outstanding 1,234 1,234
Convertible Preferred Stock Series H-6 [Member]    
Preferred stock, shares authorized 50,000 50,000
Preferred stock, par value $ 0.0001 $ 0.0001
Preferred stock, shares issued 50 50
Preferred stock, shares outstanding 50 50
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]    
Revenue $ 2,990,497 $ 2,683,597
Cost of goods sold 6,043,506 4,774,784
Gross loss (3,053,009) (2,091,187)
Operating expenses:    
Research and development 6,845,451 11,449,617
Sales and marketing 1,874,658 2,419,168
General and administrative 11,503,788 17,168,898
Total operating expenses 20,223,897 31,037,683
Loss from operations (23,276,906) (33,128,870)
Other income (expense):    
Interest income 182,276 51,768
Interest expense (2,312)
Realized gain on marketable securities 160,990
Unrealized loss on marketable securities (1,713)
Total other income (expense), net 341,553 49,456
Net loss prior to provision for income taxes (22,935,353) (33,079,414)
Provision for income taxes
Net loss $ (22,935,353) $ (33,079,414)
Net loss per share, basic and diluted $ (0.62) $ (0.94)
Basic and diluted weighted average Common Stock outstanding 37,048,975 35,171,935
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Series H Preferred Stock [Member]
Preferred Stock [Member]
Series H-3 Preferred Stock [Member]
Preferred Stock [Member]
Series H-6 Preferred Stock [Member]
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance at Dec. 31, 2020 $ 2,709 $ 64,509,724 $ (25,154,817) $ 39,357,616
Beginning balance, shares at Dec. 31, 2020 8 1,234 50 27,088,584      
Issuance of common stock for services       $ 2 42,298   42,300
Issuance of common stock for services, shares       15,000      
Sale of common stock, net of fees       $ 804 58,269,025   58,269,829
Sale of common stock, net of fees, shares       8,035,835      
Exercise of warrants, net of fees       $ 1 99,999   100,000
Exercise of Warrants net , shares       13,642      
Exercise of stock options       $ 55 1,506,944   1,506,999
Exercise of stock options, shares       555,004      
Stock based compensation         7,226,902   7,226,902
Vested Restricted Stock       $ 116 (116)  
Vested restricted stock , shares       1,158,891      
Net Loss     (33,079,414) (33,079,414)
Ending balance, at Dec. 31, 2021 $ 3,687 131,654,776 (58,234,231) 73,424,232
Ending balance, shares at Dec. 31, 2021 8 1,234 50 36,866,956      
Exercise of stock options, shares            
Stock based compensation         65,291   65,291
Vested Restricted Stock       $ 37 1,504,182   1,504,219
Vested restricted stock , shares       374,686      
Net Loss     (22,935,353) (22,935,353)
Ending balance, at Dec. 31, 2022 $ 3,724 $ 133,224,249 $ (81,169,584) $ 52,058,389
Ending balance, shares at Dec. 31, 2022 8 1,234 50 37,241,642      
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (22,935,353) $ (33,079,414)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 762,206 527,584
Stock-based compensation 1,240,129 7,556,282
Amortization of right-of-use asset 193,483 206,375
Bad debt expense 4,485 99,309
Realized gain on marketable securities (160,990)
Unrealized loss on marketable securities 1,713
Impairment of inventory and prepaid 2,476,322
Change in operating assets and liabilities:    
Accounts receivable 454,873 (302,887)
Inventory 830,845 (2,666,327)
Prepaid expenses and other current assets (581,846) (667,416)
Deposits 18,797 (18,797)
Accounts payable 445,165 (120,155)
Accrued expenses (1,272,046) 2,038,365
Contract liability (24,000)
Lease obligations - operating leases (206,426) (180,404)
Net cash used in operating activities (18,728,643) (26,631,485)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchase of property and equipment (1,588,689) (538,012)
Purchase of marketable securities, net (9,689,526)
Purchase of intangible assets (57,046) (62,351)
Net cash used in investing activities (11,335,261) (600,363)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Repayments of debt (21,611)
Proceeds from exercise of warrants, net of fees 100,000
Proceeds from exercise of stock options 1,506,999
Proceeds from issuance of Common Stock, net of fees and expenses 58,269,829
Net cash provided by financing activities 59,855,217
Net change in cash (30,063,904) 32,623,369
Cash, beginning of year 69,160,466 36,537,097
Cash, end of year 39,096,562 69,160,466
Supplemental disclosure of cash and non-cash transactions:    
Cash paid for interest 1,971
Restricted Stock issued previously accrued 329,380 329,380
Accrued Fixed Assets 348,932  
Supplemental non-cash amounts of lease liabilities arising from obtaining right of use assets $ 120,440
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.23.1
ORGANIZATION AND NATURE OF OPERATIONS
12 Months Ended
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
ORGANIZATION AND NATURE OF OPERATIONS

NOTE 1. ORGANIZATION AND NATURE OF OPERATIONS

 

AYRO, Inc. (“AYRO” or the “Company”), a Delaware corporation formerly known as DropCar, Inc. (“DropCar”), a corporation headquartered outside Austin, Texas, is the merger successor discussed below of AYRO Operating Company, Inc., which was formed under the laws of the State of Texas on May 17, 2016 as Austin PRT Vehicle, Inc. and subsequently changed its name to Austin EV, Inc. under an Amended and Restated Certificate of Formation filed with the State of Texas on March 9, 2017. On July 24, 2019, the Company changed its name to AYRO, Inc. and converted its corporate domicile to Delaware. The Company was founded on the basis of promoting resource sustainability. The Company, and its wholly-owned subsidiaries, are principally engaged in manufacturing and sales of environmentally-conscious, minimal-footprint electric vehicles. The all-electric vehicles are typically sold both directly to customers and to dealers in the United States.

 

Merger

 

On May 28, 2020, pursuant to the previously announced Agreement and Plan of Merger, dated December 19, 2019 (the “Merger Agreement”), by and among AYRO, Inc., a Delaware corporation previously known as DropCar, Inc., ABC Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Company (“Merger Sub”), and AYRO Operating Company (“AYRO Operating”), a Delaware corporation previously known as AYRO, Inc., Merger Sub was merged with and into AYRO Operating, with AYRO Operating continuing after the merger as the surviving entity and a wholly owned subsidiary of the Company (the “Merger”).

 

Strategic Review

 

Following the hiring of the Company’s current Chief Executive Officer in the third quarter of 2021, the Company initiated a strategic review of their product development strategy, as they focus on creating value within the electric vehicle, last-mile delivery, and smart payload and enabling infrastructure markets. In connection with the strategic review, the Company canceled development of its planned next-generation three-wheeled high speed vehicle.

In December of 2021 the Company began research and development on the Vanish, including updates on their supply chain evolution, offshoring/onshoring mix, manufacturing strategy, and annual model year refresh program.

 

XML 19 R8.htm IDEA: XBRL DOCUMENT v3.23.1
LIQUIDITY AND OTHER UNCERTAINTIES
12 Months Ended
Dec. 31, 2022
Liquidity And Other Uncertainties  
LIQUIDITY AND OTHER UNCERTAINTIES

NOTE 2. LIQUIDITY AND OTHER UNCERTAINTIES

 

Liquidity and Other Uncertainties

 

The consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States (“GAAP”), which contemplates continuation of the Company as a going concern. The Company is subject to a number of risks similar to those of earlier stage commercial companies, including dependence on key individuals and products, the difficulties inherent in the development of a commercial market, the potential need to obtain additional capital, competition from larger companies, other technology companies and other technologies. The Company has a limited operating history and the sales and income potential of its business and market are unproven. The Company incurred net losses of $22,935,353 for the year ended December 31, 2022, and negative cash flows from operations of $18,728,643 for the year ended December 31, 2022. At December 31, 2022, the Company had cash balances totaling $39,096,562 and $9,848,804 in marketable securities. In addition, overall working capital decreased by $22,639,376 during the year ended December 31, 2022. Management believes that the existing cash at December 31, 2022 will be sufficient to fund operations for at least the next twelve months following the issuance of these consolidated financial statements.

 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

The Company may experience increases in the cost or a sustained interruption in the supply or shortage of raw materials, including lithium-ion battery cells, semiconductors, and integrated circuits. Any such increase or supply interruption could materially negatively impact the business, prospects, financial condition and operating results. Currently, the Company is experiencing supply chain shortages, including with respect to lithium-ion battery cells, integrated circuits, vehicle control chips, and displays. Certain production-ready components may be delayed in shipment to company facilities which has and may continue to cause delays in validation and testing for these components, which would in turn create a delay in the availability of saleable vehicles.

 

The Company uses various raw materials, including aluminum, steel, carbon fiber, non-ferrous metals (such as copper), and cobalt. The prices for these raw materials fluctuate depending on market conditions, and global demand and could adversely affect business and operating results. For instance, the Company is exposed to multiple risks relating to price fluctuations for lithium-ion cells. These risks include:

 

 

the inability or unwillingness of current battery manufacturers to build or operate battery cell manufacturing plants to supply the numbers of lithium-ion cells required to support the growth of the electric vehicle industry as demand for such cells increases;

 

 

disruption in the supply of cells due to quality issues or recalls by the battery cell manufacturers; and

 

  an increase in the cost of raw materials, such as cobalt, used in lithium-ion cells.

 

Any disruption in the supply of lithium-ion battery cells, semiconductors, or integrated circuits could temporarily disrupt production of the Company’s vehicles until a different supplier is fully qualified. Moreover, battery cell manufacturers may refuse to supply electric vehicle manufacturers if they determine that the vehicles are not sufficiently safe. Furthermore, fluctuations or shortages in petroleum and other economic conditions may cause the Company to experience significant increases in freight charges and raw material costs. Substantial increases in the prices for our raw materials would increase operating costs and could reduce our margins if the increased costs cannot be recouped through increased electric vehicle prices. There can be no assurance that the Company will be able to recoup increasing costs of raw materials by increasing vehicle prices.

 

We have made certain indemnities, under which we may be required to make payments to an indemnified party, in relation to certain transactions. We indemnify our directors and officers to the maximum extent permitted under the laws of the State of Delaware. In connection with our facility leases, we have indemnified our lessors for certain claims arising from the use of the facilities. The duration of the indemnities vary and, in many cases, are indefinite. These indemnities do not provide for any limitation of the maximum potential future payments we could be obligated to make. Historically, we have not been obligated to make any payments for these obligations and no liabilities have been recorded for these indemnities.

 

On October 3, 2022, AYRO, Inc. (the “Company”) received a letter from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) indicating that, based upon the closing bid price of the Company’s common stock for the 30 consecutive business day period between August 19, 2022 and September 30, 2022, the Company did not meet the minimum bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2). The letter also indicated that the Company will be provided with a compliance period of 180 calendar days, or until April 3, 2023 (the “Compliance Period”), in which to regain compliance pursuant to Nasdaq Listing Rule 5810(c)(3)(A).

 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

XML 20 R9.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation and Principles of Consolidation

 

The consolidated financial statements represent the consolidation of the accounts of the Company and its subsidiary in conformity with GAAP. All intercompany accounts and transactions have been eliminated in consolidation.

 

Reclassification

 

Certain 2021 amounts were classified to conform to the current year presentation. Intangible assets were included into other assets on the consolidated balance sheet for current and prior year.

 

Use of Estimates

 

The preparation of the consolidated financial statements, in conformity with GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenue and expenses during the reporting period.

 

Cash and Cash Equivalents

 

The Company considers all highly-liquid investments purchased with a maturity of three months or less at the time of purchase to be cash equivalents. The Company maintains total cash balances in one account which exceeds the federally insured limits. Management does not believe this results in any significant credit risk. The Company has no cash equivalents as of December 31, 2022 and 2021.

 

Marketable Securities

 

Marketable securities include investment in fixed income bonds and U.S. Treasury securities that are considered to be highly liquid and easily tradeable. The marketable securities are considered trading securities and are measured at fair value and are accounted for in accordance with ASC 320. The marketable securities are valued using inputs observable in active markets for identical securities and are therefore classified as Level 1 within the Company’s fair value hierarchy. The Company held $9,848,804 in marketable securities as of December 31, 2022.

 

Fair Value Measurements

 

The Company applies Accounting Standards Codification (“ASC”) 820, Fair Value Measurement (“ASC 820”), which establishes a framework for measuring fair value and clarifies the definition of fair value within that framework. ASC 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company’s principal or most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established in ASC 820 generally requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity’s own assumptions based on market data and the entity’s judgments about the assumptions that market participants would use in pricing the asset or liability and are to be developed based on the best information available in the circumstances.

 

The carrying amounts of financial instruments reported in the accompanying consolidated financial statements for current assets and current liabilities approximate the fair value because of the immediate or short-term maturities of the financial instruments.

 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

The valuation hierarchy is composed of three levels. The classification within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The levels within the valuation hierarchy are described below:

 

Level 1 — Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities.

 

Level 2 — Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals.

 

Level 3 — Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities.

 

The marketable securities are considered trading securities and are measured at fair value and are accounted for in accordance with ASC 320. The marketable securities are valued using inputs observable in active markets for identical securities and are therefore classified as Level 1 within the Company’s fair value hierarchy.

 

Accounts Receivable, Net

 

In the normal course of business, the Company extends credit to customers. Accounts receivable, less the allowance for doubtful accounts, reflect the net realizable value of receivables and approximate fair value. An allowance for doubtful accounts is maintained and reflects the best estimate of probable losses determined principally on the basis of historical experience and specific allowances for known troubled accounts. All accounts or portions thereof that are deemed to be uncollectible or that require an excessive collection cost are written off to the allowance for doubtful accounts. As of December 31, 2022 and 2021, the Company had reserved an allowance for doubtful accounts of $2,349 and $173,138, respectively. All account receivables are made on an unsecured basis.

 

Inventory

 

Inventory consists of purchased chassis, cabs, batteries, truck beds and component parts which includes cost of raw materials, freight, direct labor, and related production overhead and are stated at the lower of cost or net realizable value, as determined using a first-in, first-out method. Inventory also includes a fleet of internally manufactured vehicles that serve demonstration and other purposes, the balance of which is being depreciated over their useful lives. Management compares the cost of inventory with the net realizable value and, if applicable, an allowance is made for writing down the inventory to its net realizable value, if lower than cost. On an ongoing basis, inventory is reviewed for potential write-down for estimated obsolescence or unmarketable inventory based upon forecasts for future demand and market conditions. At June 30, 2022, we determined that testing of obsolescence was required for inventory due to the quality of certain purchased components from Cenntro’s lithium-ion (“NCM”) line. 17 vehicles tested in the second quarter of 2022 were determined to have 49 unique failures. An inspection of the remaining NCM units revealed a 100% failure rate. As a result, all inventory associated with Cenntro’s NCM line was written off for $1,317,289 to cost of goods sold. As of December 31, 2022, there was no longer a balance. The remainder of the balance was expensed through cost of goods sold for $621,097. During the year ended December 31, 2022, a $413,561 net realizable value adjustment was recorded due to the Club Car Discount (as defined below), spare inventory for the 411x was written off, net with the inventory reserve of $124,375, and $2,476,322 was expensed for impairment of inventory.

 

Property and Equipment, Net

 

Property and equipment, net, are stated at cost, less accumulated depreciation. Depreciation is recorded over the shorter of the estimated useful life, of one to ten years, or the lease term of the applicable assets using the straight-line method beginning on the date an asset is placed in service. The Company regularly evaluates the estimated remaining useful lives of the Company’s property and equipment, net, to determine whether events or changes in circumstances warrant a revision to the remaining period of depreciation. Maintenance and repairs are charged to expense when incurred.

 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

The estimated useful lives for significant property and equipment categories are as follows:

 

Computer Equipment and Software 13 years
Furniture and Fixtures 27 years
Machinery and Equipment 310 years
Leasehold Improvements Shorter of useful or lease life

 

Long-Lived Assets, Including Definite-Lived Intangible Assets

 

Intangible assets are stated at cost less accumulated amortization. Amortization is generally recorded on a straight-line basis over estimated useful life of 3-10 years. The Company periodically reviews the estimated useful lives of intangible assets and makes adjustments when events indicate that a shorter life is appropriate.

 

Long-lived assets are evaluated for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable through the estimated undiscounted future cash flows derived from such assets.

 

Factors that the Company considers in deciding when to perform an impairment review include significant changes in the Company’s forecasted projections for the asset or asset group for reasons including, but not limited to, significant under-performance of a product in relation to expectations, significant changes, or planned changes in the Company’s use of the assets, significant negative industry or economic trends, and new or competing products that enter the marketplace. The impairment test is based on a comparison of the undiscounted cash flows expected to be generated from the use of the asset group. If impairment is indicated, the asset is written down by the amount by which the carrying value of the asset exceeds the related fair value of the asset with the related impairment charge recognized within the statements of operations.

 

Leases

 

Operating lease assets are included within operating lease right-of-use assets, and the corresponding operating lease obligation on the consolidated balance sheets as of December 31, 2022 and 2021 in accordance with ASC 842, Leases. The Company has elected not to present short-term leases as these leases have a lease term of 12 months or less at lease inception and do not contain purchase options or renewal terms that the Company is reasonably certain to exercise. All other lease assets and lease liabilities are recognized based on the present value of lease payments over the lease term at commencement date. Because most of the Company’s leases do not provide an implicit rate of return, the Company used an incremental borrowing rate based on the information available at adoption date in determining the present value of lease payments.

 

Revenue Recognition

 

The Company recognizes revenue in accordance with ASC 606, Revenue from Contracts with Customers, the core principle of which is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to receive in exchange for those goods or services.

 

To achieve this core principle, five basic criteria must be met before revenue can be recognized: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to performance obligations in the contract; and (5) recognize revenue when or as the Company satisfies a performance obligation.

 

Nature of goods and services

 

The following is a description of the Company’s products and services from which the Company generates revenue, as well as the nature, timing of satisfaction of performance obligations, and significant payment terms for each:

 

Product revenue

 

Product revenue from customer contracts is recognized on the sale of each electric vehicle as vehicles are shipped to customers. The majority of the Company’s vehicle sales orders generally have only one performance obligation: sale and delivery of complete vehicles. Ownership and risk of loss transfers to the customer based on FOB shipping point and freight charges are the responsibility of the customer. Revenue is typically recognized at the point control transfers or in accordance with payment terms customary to the business. The Company provides product warranties to assure that the product assembly complies with agreed upon specifications. The Company’s product warranty is similar in all material respects to the product warranties provided by the Company’s suppliers, therefore minimizing the warranty liability to the standard labor rates associated with the defective part replacement. Customers do not have the option to purchase a warranty separately; as such, warranty is not accounted for as a separate performance obligation. The Company’s policy is to exclude taxes collected from a customer from the transaction price of automotive contracts.

 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Shipping revenue

 

Amounts billed to customers related to shipping and handling are classified as shipping revenue. The Company has elected to recognize the cost for freight and shipping when control over vehicles has transferred to the customer as an operating expense. The Company has reported shipping expenses of $442,932 and $393,231 for years ended December 31, 2022 and 2021, respectively, included in General and Administrative Expenses.

 

Services and other revenue

 

Services and other revenue consist of non-warranty after-sales vehicle services. Revenue is typically recognized at a point in time when services and replacement parts are provided.

 

Miscellaneous income

 

Miscellaneous income consists of late fees charged for receivables not paid within the terms of the customer agreement based upon the outstanding customer receivable balance. This revenue is earned when a customer’s receivable balance becomes delinquent and its collection is reasonably assured and is calculated using a stated late fee rate multiplied by the outstanding balance that is subject to a late fee charge.

 

Segment Reporting

 

The Company operates in one business segment which focuses on the manufacturing and sales of environmentally-conscious, minimal-footprint electric vehicles. The Company’s business offerings have similar economic and other characteristics, including the nature of products, manufacturing, types of customers, and distribution methods. The chief operating decision maker (CODM) reviews profit and loss information on a consolidated basis to assess performance and make overall operating decisions. The consolidated financial statements reflect the financial results of the Company’s one reportable operating segment. The Company has no significant revenues or tangible assets outside of the United States.

 

Income Taxes

 

The Company accounts for income tax using an asset and liability approach, which allows for the recognition of deferred tax benefits in future years. Under the asset and liability approach, deferred taxes are provided for the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The accounting for deferred income tax calculation represents management’s best estimate on the most likely future tax consequences of events that have been recognized in the consolidated financial statements or tax returns and related future anticipation. A valuation allowance is provided for deferred tax assets if it is more likely than not these items will either expire before the Company is able to realize their benefits, or that future realization is uncertain. As of December 31, 2022 and 2021, there were no accruals for uncertain tax positions.

 

Warrants and Preferred Shares

 

The accounting treatment of warrants and preferred share series issued is determined pursuant to the guidance provided by ASC 470, Debt, ASC 480, Distinguishing Liabilities from Equity, and ASC 815, Derivatives and Hedging, as applicable. Each feature of a freestanding financial instruments including, without limitation, any rights relating to subsequent dilutive issuances, dividend issuances, equity sales, rights offerings, forced conversions, optional redemptions, automatic monthly conversions, dividends and exercise are assessed with determinations made regarding the proper classification in the Company’s consolidated financial statements.

 

Stock-Based Compensation

 

The Company accounts for stock-based compensation in accordance with ASC 718, Compensation-Stock Compensation (“ASC 718”). The Company recognizes all employee and non-employee share-based compensation as an expense in the financial statements on a straight-line basis over the requisite service period, based on the terms of the awards. Equity-classified awards principally related to stock options, restricted stock awards (“RSAs”) and equity-based compensation, are measured at the grant date fair value of the award. The Company determines grant date fair value of stock option awards using the Black-Scholes option-pricing model. The fair value of RSAs is determined using the closing price of the Company’s common stock on the grant date. For service based vesting grants, expense is recognized ratably over the requisite service period based on the number of options or shares. For value-based vesting grants, expense is recognized via straight line expense over the expected period per grant as determined by outside valuation experts. Stock-based compensation is reversed for forfeitures in the period of forfeiture.

 

We estimate the fair value of stock-based and cash unit awards containing a market condition using a Monte Carlo simulation model. Key inputs and assumptions used in the Monte Carlo simulation model include the stock price of the award on the grant date, the expected term, the risk-free interest rate over the expected term, the expected annual dividend yield and the expected stock price volatility. The expected volatility is based on a combination of the historical and implied volatility of the Company’s publicly traded, near-the-money stock options, and the valuation period is based on the vesting period of the awards. The risk-free interest rate is derived from the U.S. Treasury yield curve in effect at the time of grant and, since the Company does not currently pay or plan to pay a dividend on its common stock, the expected dividend yield was zero.

 

Stock options and warrants issued as compensation for services provided to the Company are accounted for based upon the fair value of the underlying equity instrument. The attribution of the fair value of the equity instrument is charged directly to compensation expense over the period during which services are rendered.

 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Basic and Diluted Loss Per Share

 

Basic and diluted net loss per share is determined by dividing net loss by the weighted average ordinary shares outstanding during the period. For all periods presented with a net loss, the shares underlying the ordinary share options and warrants have been excluded from the calculation because their effect would be anti-dilutive. Therefore, the weighted-average shares outstanding used to calculate both basic and diluted loss per share are the same for periods with a net loss.

 

The following potentially dilutive securities have been excluded from the computation of diluted weighted average shares outstanding as they would be anti-dilutive:

 

   For the Years Ended December 31, 
   2022   2021 
Options to purchase common stock   777,922    1,338,675 
Restricted stock unvested   660,562    450,000 
Restricted stock vested - unissued   -    43,000 
Warrants outstanding   6,106,023    6,108,823 
Preferred stock outstanding   2,475    2,475 
Totals   7,546,982    7,942,973 

 

Research and development costs

 

Costs are incurred in connection with research and development programs that are expected to contribute to future earnings. Such costs include labor, stock-based compensation, training, software subscriptions, and consulting. These amounts are charged to the consolidated statement of operations as incurred. Total research and development expenses included were $6,845,451 and $11,449,617 for the years ended December 31, 2022 and 2021, respectively.

 

Recent Accounting Pronouncements

 

In June 2016, the FASB issued ASU 2016-13 “Financial Instruments -Credit Losses” (ASC 326) “Measurement of Credit Losses on Financial Instruments: and subsequent amendment to the guidance, ASU 2018-19 in November 2018. The standard significantly changes how entities will measure credit losses for most financial assets, including trade receivables. The standard will replace historic incurred loss” approach with an “expected loss” model for instruments measured at amortized cost. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements.

 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

XML 21 R10.htm IDEA: XBRL DOCUMENT v3.23.1
REVENUES
12 Months Ended
Dec. 31, 2022
Revenue from Contract with Customer [Abstract]  
REVENUES

NOTE 4. REVENUES

 

Disaggregation of Revenue

 

Revenue by type consists of the following:

 

           
   Years Ended December 31, 
   2022   2021 
Revenue type          
Product revenue  $2,716,583   $2,419,821 
Shipping revenue   229,027    227,089 
Miscellaneous Income   44,887    - 
Service income   -    36,687 
 Total Revenue  $2,990,497   $2,683,597 

 

Contract Liabilities

 

The Company recognizes a contract liability when a consideration is received, or if the Company has the unconditional right to receive consideration, in advance of satisfying the performance obligation. A contract liability is the Company’s obligation to transfer goods or services to a customer for which the Company has received consideration, or an amount of consideration is due from the customer. The table below details the activity in the Company’s contract liabilities as of December 31, 2022 and 2021. The balance at the end of each period is reported as contract liability in the Company’s consolidated balance sheet.

 

   December 31,   December 31, 
   2022   2021 
Balance, beginning of period  $-   $24,000 
Additions   -    - 
Transfer to revenue   -    (24,000)
Balance, end of period  $        -   $- 

 

Warranty Reserve

 

The Company records a reserve for warranty repairs upon the initial delivery of vehicles to its dealer network. The Company provides a product warranty on each vehicle including powertrain, battery pack and electronics package. Such warranty matches the product warranty provided by its supply chain for warranty parts for all unaltered vehicles and is not considered a separate performance obligation. The supply chain warranty does not cover warranty-based labor needed to replace a part under warranty. Warranty reserves include management’s best estimate of the projected cost of labor to repair/replace all items under warranty. The Company reserves a percentage of all dealer-based sales to cover an industry-standard warranty fund to support dealer labor warranty repairs. Such percentage is recorded as a component of cost of revenues in the statement of operations. As of December 31, 2022 and 2021, warranty reserves were recorded within accrued expenses of $410,017 and $240,517, respectively.

 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

XML 22 R11.htm IDEA: XBRL DOCUMENT v3.23.1
ACCOUNTS RECEIVABLE, NET
12 Months Ended
Dec. 31, 2022
Credit Loss [Abstract]  
ACCOUNTS RECEIVABLE, NET

NOTE 5. ACCOUNTS RECEIVABLE, NET

 

Accounts receivable, net consists of amounts due from invoiced customers and product deliveries and were as follows:

 

   December 31,   December 31, 
   2022   2021 
Trade receivables  $512,420   $1,142,567 
Less: Allowance for doubtful accounts   (2,349)   (173,138)
 Accounts receivable, net  $510,071   $969,429 

 

The Company reduced allowance for doubtful accounts by $170,789 for the year ended December 31, 2022, due to collecting on past due accounts, and recorded $4,485 of bad debt expense of direct write off for the year ended December 31, 2022.

 

XML 23 R12.htm IDEA: XBRL DOCUMENT v3.23.1
INVENTORY, NET
12 Months Ended
Dec. 31, 2022
Inventory Disclosure [Abstract]  
INVENTORY, NET

NOTE 6. INVENTORY, NET

 

Inventory, net consisted of the following:

 

   December 31,   December 31, 
   2022   2021 
Raw materials  $330,931   $3,481,614 
Work-in-progress   -    51,441 
Finished goods   639,450    210,982 
 Total  $970,381   $3,744,037 

 

For the years ended December 31, 2022 and 2021, depreciation recorded for fleet inventory was $87,586 and $95,544. The Company determined that testing of obsolescence was required for inventory due to the quality of certain purchased components from Cenntro’s lithium-ion line (“NCM”). 17 vehicles tested in the second quarter of 2022 were determined to have 49 unique failures. An inspection of the remaining NCM units discovered a 100% failure rate. As a result, all inventory associated with Cenntro’s NCM line was written off to cost of goods sold for $1,317,289. The Club Car Discount during the years ended December 31, 2022 required a $413,561 net realizable value adjustment, necessitating the value of inventory to be written down, spare inventory for the 411x was written off, net with the inventory reserve of $124,375.

 

XML 24 R13.htm IDEA: XBRL DOCUMENT v3.23.1
PREPAID EXPENSES AND OTHER CURRENT ASSETS
12 Months Ended
Dec. 31, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
PREPAID EXPENSES AND OTHER CURRENT ASSETS

NOTE 7. PREPAID EXPENSES AND OTHER CURRENT ASSETS

 

   December 31,   December 31, 
   2022   2021 
Prepaid final assembly services  $-   $439,660 
Prepayments for inventory   1,174,466    1,622,617 
Prepayments for insurance   118,434    - 
Prepayments on advances on design   75,000    - 
Prepayments on software   103,851    - 
Prepaid other   7,094    213,901 
Total Prepaid Expenses and Other Current Assets  $1,478,845   $2,276,178 

 

As of December 31, 2021 the balance of prepaid expenses and accrued expenses, net with Cenntro was $602,016. As of December 31, 2022, there was no longer a balance. Impairments of prepaid expenses led to a write-down, netted with the balance in accrued expenses. The remainder of the balance was expensed through cost of goods sold for $621,097.

 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

XML 25 R14.htm IDEA: XBRL DOCUMENT v3.23.1
PROPERTY AND EQUIPMENT, NET
12 Months Ended
Dec. 31, 2022
Property, Plant and Equipment [Abstract]  
PROPERTY AND EQUIPMENT, NET

NOTE 8. PROPERTY AND EQUIPMENT, NET

 

Property and equipment, net consisted of the following:

 

   December 31,   December 31, 
   2022   2021 
Computer and equipment  $1,970,001   $853,695 
Furniture and fixtures   323,789    173,155 
Lease improvements   952,952    282,271 
Prototypes   -    300,376 
Computer software   455,875    455,875 
Property and equipment, gross   3,702,617    2,065,372 
Less: Accumulated depreciation   (1,510,280)   (1,230,212)
Property and equipment, net  $2,192,337   $835,160 

 

Depreciation expense for the years ended December 31, 2022 and 2021 was $580,445, of which $101,581 was related to retiring legacy assets, and $314,164, respectively.

 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

XML 26 R15.htm IDEA: XBRL DOCUMENT v3.23.1
MARKETABLE SECURITIES
12 Months Ended
Dec. 31, 2022
Cash and Cash Equivalents [Abstract]  
MARKETABLE SECURITIES

NOTE 9. MARKETABLE SECURITIES

 

Marketable securities purchased in 2022 consisted of the following:

 

December 31, 2022
       Realized   Unrealized   Transferred     
   Cost Basis   Gains   Loss   to Cash   Total 
Bonds  $12,235,258   $160,990   $(1,713)  $(10,310,473)  $2,084,062 
US Treasury securities   7,764,742    -    -    -    7,764,742 
   $20,000,000   $160,990   $(1,713)  $(10,310,473)  $9,848,804 

 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

XML 27 R16.htm IDEA: XBRL DOCUMENT v3.23.1
STOCKHOLDERS’ EQUITY
12 Months Ended
Dec. 31, 2022
Equity [Abstract]  
STOCKHOLDERS’ EQUITY

NOTE 10. STOCKHOLDERS’ EQUITY

 

Common Stock

 

On January 25, 2021, AYRO entered into a Securities Purchase Agreement with certain institutional and accredited investors, pursuant to which AYRO agreed to issue and sell in a registered direct offering (the “January 2021 Offering”) an aggregate of 3,333,334 shares of common stock of AYRO, par value $0.0001 per share, at an offering price of $6.00 per share, for gross proceeds of $20,000,004 before the deduction of fees and offering expenses of $1,648,608.

 

On February 11, 2021, AYRO entered into a Securities Purchase Agreement with certain institutional and accredited investors, pursuant to which AYRO agreed to issue and sell in a registered direct offering (the “February 2021 Offering”) an aggregate of 4,400,001 shares of common stock of AYRO, par value $0.0001 per share, at an offering price of $9.50 per share, for gross proceeds of $41,800,008 before the deduction of fees and offering expenses of $3,394,054. Each purchaser was also granted an option to purchase, on or before February 16, 2022, additional shares of common stock equal to the full amount of 75% of the common stock it purchased at the initial closing, or an aggregate of 3,300,001 shares, at an exercise price of $11.50 per share.

 

On March 17, 2021, in connection with that certain Agreement and Plan of Merger dated December 19, 2019, whereby certain former stockholders of AYRO Operating entered into lock-up agreements (collectively, the “May Lock-Up Agreements”) pursuant to which they agreed to certain restrictions on the transfer or sale of shares of the Company’s common stock for the one-year period following the Merger, AYRO modified the May Lock-Up Agreements to allow each stockholder party to a May Lock-Up Agreement to (i) sell up to 5% of such stockholder’s holdings in the Company’s common stock on any trading day (with such 5% limitation to be measured as of the date of each sale) and (ii) allow for unlimited sales of the Company’s common stock for any sales made at $10.00 per share or greater. As of May 28, 2021, all of the May Lock-up Agreements were expired.

 

Pursuant to the Securities Purchase Agreement dated July 21, 2020, during the year ended December 31, 2021 investors purchased 302,500 of the Additional Shares of common stock of AYRO, par value $0.0001 per share, at an offering price of $5.00 per share, for gross proceeds of $1,512,500.

 

During February 2021, the Company issued 13,642 shares of common stock upon the exercise of warrants and received cash proceeds of $100,000.

 

During the year ended December 31, 2021, the Company issued 555,004 shares of common stock upon the exercise of stock options and received cash proceeds of $1,506,999.

 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

During the year ended December 31, 2021, the Company issued 1,158,891 shares of common stock upon the vesting of restricted stock.

 

During the year ended December 31, 2022, the Company issued 374,686 shares of common stock upon the vesting of restricted stock.

 

Restricted Stock

 

On February 24, 2021, pursuant to the AYRO, Inc. 2020 Long-Term Incentive Plan, the Company granted 172,000 shares of restricted stock to non-executive directors at a value of $7.66 per share. 43,000 shares of common stock remained unissued as of December 31, 2021; these shares were issued during the years ended December 31, 2022.

 

On February 1, 2022, pursuant to the AYRO, Inc. 2020 Long-Term Incentive Plan, the Company granted 442,249 shares of restricted stock to non-executive directors at a value of $1.29 per share. During the years ended December 31, 2022, 331,686 shares were issued and vested.

 

Preferred Stock

 

Upon closing of the Merger, the Company assumed the Series H, H-3 and H-6 preferred stock of DropCar, Inc., which respective conversion prices have been adjusted to reflect the May 2020 one-for-five reverse split.

 

Series H Convertible Preferred Stock

 

Under the terms of the Series H Certificate of Designation, each share of the Company’s Series H Convertible Preferred Stock (the “Series H Preferred Stock”) has a stated value of $154.00 and is convertible into shares of the Company’s Common Stock, equal to the stated value divided by the conversion price of $184.80 per share (subject to adjustment in the event of stock splits or dividends). The Company is prohibited from effecting the conversion of the Series H Preferred Stock to the extent that, as a result of such conversion, the holder would beneficially own more than 9.99%, in the aggregate, of the issued and outstanding shares of the Company’s common stock calculated immediately after giving effect to the issuance of shares of common stock upon such conversion. In the event of liquidation, the holders of the Series H Preferred Stock are entitled, pari passu with the holders of common stock, to receive a payment in the amount the holder would receive if such holder converted the Series H Preferred Stock into common stock immediately prior to the date of such payment. As of December 31, 2022, such payment would be calculated as follows:

 

      
Number of Series H Preferred Stock outstanding as of December 31, 2022   8 
Multiplied by the stated value  $154 
Equals the gross stated value  $1,232 
Divided by the conversion price  $184.8 
Equals the convertible shares of Company Common Stock   6.66 
Multiplied by the fair market value of Company Common Stock as of December 31, 2022  $0.38 
Liquidation Value  $2.66 

 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Series H-3 Convertible Preferred Stock

 

Pursuant to the Series H-3 Certificate of Designation (as defined below), the holders of the Company’s Series H-3 Convertible Preferred Stock (the “Series H-3 Preferred Stock”) are entitled to elect up to two members of a seven-member Board, subject to certain step downs; pursuant to the Series H-3 securities purchase agreement, the Company agreed to effectuate the appointment of the designees specified by the Series H-3 investors as directors of the Company.

 

Under the terms of the Series H-3 Certificate of Designation, each share of the Series H-3 Preferred Stock has a stated value of $138.00 and is convertible into shares of common stock, equal to the stated value divided by the conversion price of $165.60 per share (subject to adjustment in the event of stock splits and dividends). The Company is prohibited from effecting the conversion of the Series H-3 Preferred Stock to the extent that, as a result of such conversion, the holder or any of its affiliates would beneficially own more than 9.99%, in the aggregate, of the issued and outstanding shares of common stock calculated immediately after giving effect to the issuance of shares of common stock upon the conversion of the Series H-3 Preferred Stock.

 

In the event of liquidation, the holders of the Series H-3 Preferred Stock are entitled, pari passu with the holders of common stock, to receive a payment in the amount the holder would receive if such holder converted the Series H-3 Preferred Stock into common stock immediately prior to the date of such payment. As of December 31, 2022, such payment would be calculated as follows:

 

      
Number of Series H-3 Preferred Stock outstanding as of December 31, 2022   1,234 
Multiplied by the stated value  $138 
Equals the gross stated value  $170,292 
Divided by the conversion price  $165.6 
Equals the convertible shares of Company Common Stock   1,028 
Multiplied by the fair market value of Company Common Stock as of December 31, 2022  $0.38 
Liquidation Value  $391 

 

Series H-6 Convertible Preferred Stock

 

On February 5, 2020, the Company filed the Certificate of Designations, Preferences and Rights of the Series H-6 Preferred Stock (the “Series H-6 Certificate of Designation”) with the Secretary of State of the State of Delaware, establishing and designating the rights, powers and preferences of the Series H-6 Preferred Stock. The Company designated up to 50,000 shares of Series H-6 Preferred Stock and each share has a stated value of $72.00 (the “H-6 Stated Value”). Each share of Series H-6 Preferred Stock is convertible at any time at the option of the holder thereof, into a number of shares of common stock of the Company determined by dividing the H-6 Stated Value by the initial conversion price of $3.60 per share, which was then further reduced to $2.50 under the anti-dilution adjustment provision, subject to a 9.99% blocker provision. The Series H-6 Preferred Stock has the same dividend rights as the common stock, except as provided for in the Series H-6 Certificate of Designation or as otherwise required by law. The Series H-6 Preferred Stock also has the same voting rights as the common stock, except that in no event shall a holder of Series H-6 Preferred Stock be permitted to exercise a greater number of votes than such holder would have been entitled to cast if the Series H-6 Preferred Stock had immediately been converted into shares of common stock at a conversion price equal to $3.60. In addition, a holder (together with its affiliates) may not be permitted to vote Series H-6 Preferred Stock held by such holder to the extent that such holder would beneficially own more than 9.99% of our common stock. In the event of any liquidation or dissolution, the Series H-6 Preferred Stock ranks senior to the common stock in the distribution of assets, to the extent legally available for distribution.

 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

The holders of Series H-6 Preferred Stock are entitled to certain anti-dilution adjustments if the Company issues shares of its common stock at a lower price per share than the applicable conversion price of the Series H-6 Preferred Stock. If any such dilutive issuance occurs prior to the conversion of the Series H-6 Preferred Stock, the conversion price will be adjusted downward to a price that cannot be less than 20% of the exercise price of $3.60.

 

In the event of liquidation, the holders of the Series H-6 Preferred Stock are entitled, pari passu with the holders of common stock, to receive a payment in the amount the holder would receive if such holder converted the Series H-6 Preferred Stock into common stock immediately prior to the date of such payment. As of December 31, 2022, such payment would be calculated as follows:

 

      
Number of Series H-6 Preferred Stock outstanding as of December 31, 2022   50 
Multiplied by the stated value  $72 
Equals the gross stated value  $3,600 
Divided by the conversion price  $2.5 
Equals the convertible shares of Company Common Stock   1,440 
Multiplied by the fair market value of Company Common Stock as of December 31, 2022  $0.38 
Liquidation Value  $547 

 

AYRO Series Seed Preferred Stock

 

Prior to the Merger, the Company was authorized to issue 8,472,500 shares of preferred stock, no par value, of which all were designated as Series Seed Preferred Stock. As of December 31, 2022 and 2021, no shares of Series Seed Preferred Stock were issued and outstanding. In conjunction with the Merger, all 7,360,985 shares of AYRO Series Seed Preferred Stock were converted into approximately 2,007,193 shares of the Company Common Stock after taking into account the Exchange Ratio, Reverse Stock Split and Stock Dividend.

 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Warrants

 

AYRO Seed Warrants

 

Prior to the Merger, the Company issued 461,647 warrants (the “AYRO Seed Warrants”) with an exercise price $7.33. The AYRO Seed Warrants terminate five years from the grant date. As of December 31, 2022, there were 448,005 AYRO Seed Warrants outstanding.

 

Series I Warrants

 

As a result of the Merger, 14,636 Series I Warrants transferred to AYRO and have an exercise price of $69.00 per share. If at any time (i) the volume weighted average price (“VWAP”) of the Common Stock exceeds $138.00 for not less than the mandatory exercise measuring period; (ii) the daily average number of shares of Common Stock traded during the mandatory exercise measuring period equals or exceeds 25,000; and (iii) no equity conditions failure has occurred as of such date, then the Company shall have the right to require the holder to exercise all or any portion of the Series I Warrants still unexercised for a cash exercise. During the year ended December 31, 2021, all 14,636 Series I Warrants expired.

 

Series H-3 Warrants

 

As a result of the Merger, 2,800 Series H-3 Warrants transferred to AYRO and have an exercise price of $165.60 per share, subject to adjustments (the “Series H-3 Warrants”). Subject to certain ownership limitations, the Series H-3 Warrants are immediately exercisable from the issuance date and will be exercisable for a period of five (5) years from the issuance date. As of December 31, 2022, all 2,800 Series H-3 Warrants expired.

 

Series H-4 Warrants

 

As a result of the Merger, 37,453 Series H-4 Warrants transferred to AYRO and have an exercise price of $15.60. The Series H-4 Warrants contain an anti-dilution price protection and the warrants cannot be less than $15.60 per share. As of December 31, 2022, there were 37,453 Series H-4 Warrants outstanding.

 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Series J Warrants

 

As a result of the Merger, 52,023 Series J Warrants transferred to AYRO. The terms of the Series J Warrants are substantially identical to the terms of the Series H-4 Warrants except that (i) the exercise price is equal to $30.00 per share, (ii) the Series J Warrants may be exercised at all times beginning on the 6-month anniversary of the issuance date on a cash basis and also on a cashless basis, (iii) the Series J Warrants do not contain any provisions for anti-dilution adjustment and (iv) the Company has the right to require the Holders to exercise all or any portion of the Series J Warrants still unexercised for a cash exercise if the volume-weighted average price (VWAP) (as defined in the Series J Warrant) for the Company’s common stock equals or exceeds $45.00 for not less than ten consecutive trading days.

 

If at any time (i) the VWAP of the Common Stock exceeds $9.00 for not less than the mandatory exercise measuring period; (ii) the daily average number of shares of Common Stock traded during the mandatory exercise measuring period equals or exceeds 25,000; and (iii) no equity conditions failure has occurred as of such date, then the Company shall have the right to require the holder to exercise all or any portion of the Series J Warrants still unexercised for a cash exercise. As of December 31, 2022, there were 52,023 Series J Warrants outstanding.

 

Series H-5 Warrants

 

As a result of the Merger, 296,389 Series H-5 Warrants were transferred to AYRO and have an exercise price of $2.50 per share. Subject to certain ownership limitations, the H-5 Warrants will be exercisable beginning six months from the issuance date and will be exercisable for a period of five years from the initial issuance date.

 

The H-5 Warrants are entitled to certain anti-dilution adjustments if the Company issues shares of its common stock at a lower price per share than the applicable exercise price (subject to a floor of $0.792 per share). An anti-dilution adjustment was triggered resulting in an adjusted exercise price per share from $3.96 to $2.50, resulting in an issuance of an additional 173,091 warrants that are exercisable at $2.50 per share. As of December 31, 2022, there were 348,476 Series H-5 Warrants outstanding.

 

The Series H-1, H-4, J and H-5 Warrants expire through the years 2023-2024.

 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Other AYRO Warrants

 

On June 19, 2020, the Company agreed to issue finder warrants (the “June Finder Warrants”) to purchase 27,273 shares of the Company’s common stock at an exercise price of $2.75 per share to a finder or its designees, and the Company agreed to issue warrants to Palladium (the “June Placement Agent Warrants”) to purchase 126,000 shares of the Company’s common stock at an exercise price of $2.875 per share. The June Finder Warrants and June Placement Agent Warrants terminate after a period of 5 years on June 19, 2025. As of December 31, 2020, 126,000 of the June Placement Agent Warrants had been exercised. As of December 31, 2022, the 27,273 June Finder Warrants were outstanding.

 

On July 8, 2020, the Company agreed to issue finder warrants (the “July 8 Finder Warrants”) to purchase 71,770 shares of the Company’s common stock at an exercise price of $5.225 per share to a finder or its designees, and the Company agreed to issue warrants to Palladium (the “July 8 Placement Agent Warrants”) to purchase 147,368 shares of the Company’s common stock at an exercise price of $5.4625 per share.

 

The July 8 Finder Warrants and July 8 Placement Agent Warrants terminate after a period of 5 years on July 8, 2025. As of December 31, 2022, there were 71,770 July 8 Finder Warrants and 147,368 July 8 Placement Agent Warrants were outstanding.

 

On July 22, 2020, the Company agreed to issue warrants to Palladium (the “July 22 Placement Agent Warrants”) to purchase 129,500 shares of the Company’s common stock at an exercise price of $5.750 per share. The July 22 Placement Agent Warrants terminate after a period of 5 years on July 22, 2025. As of December 31, 2022, there were 129,500 July 22 Placement Agent Warrants outstanding.

 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

On September 25, 2020, the Company issued a warrant (the “September Warrant”) to purchase 31,348 shares of the Company’s common stock at an exercise price of $3.19 per share to a vendor for facilitating a manufacturing agreement. The September Warrant is immediately exercisable and expires on September 25, 2025. The September Warrant was classified as equity and the estimated fair value of $2.13 per share was computed as of September 25, 2020, using the Black-Scholes model. The Company recorded $66,845 as stock-based compensation expense during the fourth quarter of 2020 for the total fair value of the September Warrant. As of December 31, 2022, there were 31,348 September Warrants outstanding.

 

On November 22, 2020, the Company entered into a Securities Purchase Agreement with new and current stockholders of the Company, pursuant to which such stockholders agreed to purchase shares of AYRO’s Common Stock, Series A Warrants and Series B Warrants to purchase AYRO’s Common Stock for an aggregate purchase price of $9,999,997. Each purchaser additionally purchased and received Series A Warrants and Series B Warrants equal to 75% and 50% of the purchased shares, for a total of 1,237,624 Series A Warrants and 825,084 Series B Warrants. The Series A Warrants were immediately exercisable, in whole or in part at a strike price of $8.09 and expired on May 24, 2021. The Series B Warrants are immediately exercisable, in whole or in part, at a strike price of $8.90, and terminate five years from the date issuance on November 24, 2025. As of December 31, 2022, there were no Series A Warrants and 825,084 Series B Warrants outstanding.

 

On November 22, 2020, the Company agreed to issue finder warrants (the “November Finder Warrants”) to purchase 56,256 shares of the Company’s common stock at an exercise price of $6.6660 per share to a finder or its designees, and the Company agreed to issue warrants to Palladium (the “November Placement Agent Warrants”) to purchase 57,756 shares of the Company’s common stock at an exercise price of $6.9690 per share.

 

The November Finder Warrants and November Placement Agent Warrants terminate after a period of 5 years on November 22, 2025. As of December 31, 2022, there were 56,256 November Finder Warrants and 57,756 November Placement Agent Warrants outstanding.

 

On January 25, 2021, AYRO entered into a Securities Purchase Agreement with certain institutional and accredited investors, pursuant to which AYRO agreed to issue and sell in the January 2021 Offering an aggregate of 3,333,334 shares of common stock of AYRO, par value $0.0001 per share, at an offering price of $6.00 per share, for gross proceeds of approximately $20.0 million before the deduction of fees and offering expenses.

 

Each purchaser was also granted a warrant to purchase, between July 26, 2021 and July 26, 2023, additional shares of common stock equal to the full amount of the common stock it purchased at the initial closing, or an aggregate of 3,333,334 shares at an exercise price of $6.93 per share.

 

On January 25, 2021, the Company agreed to issue warrants to Palladium, the placement agent for the January 2021 offering to purchase 233,334 shares of the Company’s common stock at an exercise price of $6.93 per share. The warrants are exercisable six months following issuance and terminate on July 23, 2023. As of December 31, 2022 all 3,566,668 warrants are outstanding.

 

On February 11, 2021, the Company agreed to issue warrants to Spartan Capital Securities, LLC and its affiliates (the “February Finder Warrants”) to purchase 15,574 shares of the Company’s common stock at an exercise price of $10.925 per share and to purchase 35,885 shares of the Company’s common stock at an exercise price of $10.45 per share to a finder or its designees. In addition, the Company agreed to issue warrants to Palladium (the “February Placement Agent Warrants”) to purchase 255,584 shares of the Company’s common stock at an exercise price of $10.925 per share. The February Finder Warrants and February Placement Agent Warrants terminate after a period of 5 years on February 26, 2026. As of December 31, 2022, there were 51,459 February Finder Warrants and 255,584 February Placement Agent Warrants were outstanding.

 

A summary of the Company’s warrants to purchase common stock activity is as follows:

 

   Shares Underlying Warrants  

Weighted

Average Exercise

Price

  

Weighted

Average

Remaining Contractual

Term (in years)

 
Outstanding at December 31, 2020   3,501,014   $8.03    2.87 
Granted   3,873,711   $7.24      
Exercised   (13,642)  $7.33      
Expired   (1,252,260)  $8.80      
Outstanding at December 31, 2021   6,108,823   $7.37    2.31 
Expired   (2,800)   165.60      
Outstanding at December 31,2022   6,106,023   $7.30    1.32 

 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

XML 28 R17.htm IDEA: XBRL DOCUMENT v3.23.1
STOCK BASED COMPENSATION
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
STOCK BASED COMPENSATION

NOTE 11. STOCK BASED COMPENSATION

 

AYRO 2020 Long Term Incentive Plan

 

On May 28, 2020, the Company’s shareholders approved the AYRO, Inc. 2020 Long Term Incentive Plan for future grants of incentive stock options, nonqualified stock, stock appreciation rights, restricted stock, restricted stock units, performance and other awards.

 

The Company has reserved a total of 4,089,650 shares of its common stock pursuant to the AYRO, Inc. 2020 Long-Term Incentive Plan, including shares of restricted stock that have been issued. The Company has 1,158,899 stock options, restricted stock and warrants remaining under this plan as of December 31, 2022.

 

AYRO 2017 Long Term Incentive Plan

 

The Company has reserved a total of 477,983 shares of its common stock pursuant to the AYRO, Inc. 2017 Long-Term Incentive Plan. The Company had 128,606 shares of common stock outstanding under the plan at December 31, 2022. At December 31, 2022, no shares remained available for grant under future awards under the 2017 Long-Term Incentive Plan. In conjunction with the 2020 incentive plan, the remaining unissued amounts were cancelled.

 

DropCar Amended and Restated 2014 Equity Incentive Plan

 

The Company’s equity incentive plan created in 2014 (the “2014 Plan”) was amended in 2018 to increase the number of shares of Company common stock available for issuance. Pursuant to the 2014 Plan, 141,326 shares of common stock were reserved for issuance. As of December 31, 2022, there were no shares available for grant under the 2014 Plan.

 

Stock-based compensation, including stock options, and restricted stock, expense is included in the consolidated statement of operations as follows:

 

   2022   2021 
   Years Ended December 31, 
   2022   2021 
Research and development  $21,922   $73,447 
Sales and marketing   25,811    224,076 
General and administrative   1,192,396    7,258,760 
Total  $1,240,129   $7,556,282 

 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Options

 

The following table reflects the stock option activity:

 

  

Number of

Shares

  

Weighted

Average

Exercise

Price

  

Contractual

Life (Years)

 
Outstanding at December 31, 2020   1,920,269   $4.40    8.66 
Exercised   (555,004)  $(2.72)     
Forfeitures   (26,590)  $(2.52)     
Outstanding at December 31, 2021   1,338,675   $5.14    8.26 
Granted   173,500    0.97      
Exercised   -    -      
Forfeitures   (734,253)   3.13      
Outstanding at December 31, 2022   777,922    6.15    7.56 

 

Of the outstanding options, 612,963 were vested and exercisable as of December 31, 2022. At December 31, 2022 the aggregate intrinsic value of stock options vested and exercisable was $0.

 

The Company recognized $65,291 and $1,232,402 of stock option expense for the years ended December 31, 2022 and 2021, respectively. Total compensation cost related to non-vested stock option awards not yet recognized as of December 31, 2022 was $142,648 and will be recognized on a straight-line basis through the end of the vesting periods through April 2025. The amount of future stock option compensation expense could be affected by any future option grants or by any forfeitures.

 

Determining the appropriate fair value of the stock-based awards requires the input of subjective assumptions, including the fair value of the Company’s common stock, and for stock options, the expected life of the option, and the expected stock price volatility. The Company uses the Black-Scholes option pricing model to value its stock option awards. The assumptions used in calculating the fair value of stock-based awards represent management’s best estimates and involve inherent uncertainties and the application of management’s judgment. The Company granted 173,000 shares on May 6, 2022, at a grant date fair value of $0.97. As a result, if factors change and management uses different assumptions, stock-based compensation expense could be materially different for future awards.

 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

The Company uses the following inputs when valuing stock-based awards.

 

   For the Years Ended December 31, 
   2022   2021 
Expected life (years)   6    n/a 
Risk-free interest rate   3.04%   n/a 
Expected volatility   128.67%   n/a 
Stock Price  $0.84    n/a 
Exercise Price  $0.97    n/a 

 

The expected life of the employee stock options was estimated using the “simplified method,” as the Company has no historical information to develop reasonable expectations about future exercise patterns and employment duration for its stock option grants. The simplified method is based on the average of the vesting tranches and the contractual life of each grant. The expected life of awards that vest immediately use the contractual maturity since they are vested when issued. For stock price volatility, the Company uses public company comparable data and in periods prior to the Merger historical private placement data as a basis for its expected volatility to calculate the fair value of option grants. The risk-free interest rate is based on U.S. Treasury notes with a term approximating the expected life of the option at the grant-date.

 

Restricted Stock

 

The following table reflects the restricted stock activity:

 

   Number of Shares  

Weighted

Average Grant

Price

 
Outstanding at December 31, 2020   1,072,503   $5.30 
Granted   622,000   $3.91 
Vested   (1,201,891)  $5.71 
Forfeitures   (42,612)  $3.17 
Outstanding at December 31, 2021   450,000   $2.48 
Granted   542,248   $1.06 
Vested   (331,686)  $1.29 
Outstanding at December 31, 2022   660,562   $1.91 

 

In September 2020, the Company issued 436,368 shares of restricted stock to current directors, of which 15,115 immediately vested and the remainder to vest in December 2020, which was subsequently modified to vest in full in May 2021. The Company recognized compensation expense during the year ended December 31, 2022 and 2021 of $0 and $699,527, respectively.

 

In December 2020, based on objectives achieved, the Company issued 651,250 shares of restricted stock to Rodney C. Keller, Jr. that vest according to the following vesting schedule: one-third vested on May 28, 2021, one-third was to vest on December 4, 2021 and one-third was to vest on December 4, 2022. In September 2021 all 434,166 unvested shares of Keller Restricted Stock vested pursuant to Mr. Keller’s separation agreement. Compensation expense recognized for the Keller Restricted Stock for the years ended December 31, 2022 and 2021 was $0 and $4,126,618, respectively.

 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

On February 24, 2021, pursuant to the AYRO, Inc. 2020 Long-Term Incentive Plan, the Company issued 172,000 shares of restricted stock to non-executive directors at a value of $7.66 per share. All awards vested during the year ended December 31, 2021. The Company recognized compensation expense during the year ended December 31, 2021 of $329,380.

 

In September 2021, pursuant to the employment agreement with Thomas M. Wittenschlaeger, the Company issued 450,000 shares of restricted stock at a value of $2.48 per share. Vesting will occur as predetermined value-based targets are met. We estimate the fair value of stock-based and cash unit awards containing a market condition using a Monte Carlo simulation model. Key inputs and assumptions used in the Monte Carlo simulation model include the stock price of the award on the grant date, the expected term, the risk-free interest rate over the expected term, the expected annual dividend yield and the expected stock price volatility. The Company does not currently pay or plan to pay a dividend on its common stock, the expected dividend yield was zero. Volatility was determined using a three-year lookback with a 110% determination. The expected term is December 27, 2023 for the fifth and final tranche. During the year ended December 31, 2022 and 2021 the Company recognized $646,771 and $180,215 respectively. Total compensation cost related to non-vested restricted stock not yet recognized as of December 31, 2022 was $290,118 and will be recognized on a straight-line basis per target through the end of each vesting period through December 2023.

 

On February 1, 2022, pursuant to the AYRO, Inc. 2020 Long-Term Incentive Plan, the Company issued 442,248 shares of restricted stock to non-executive directors at a value of $1.29 per share. 331,686 shares vested during the year ended December 31, 2022. The remainder vested in full in January 2023. The Company recognized compensation expense during the year ended December 31, 2022 and 2021 of $522,958 and $0 respectively. $42,788 remained unrecognized as of December 31, 2022.

 

On August 23, 2022, pursuant to the employment agreement with David E. Hollingsworth, the Company issued 100,000 shares of restricted stock at a value of $0.03 per share. Vesting will occur as predetermined value-based targets are met. We estimate the fair value of stock-based and cash unit awards containing a market condition using a Monte Carlo simulation model. During the year ended December 31, 2022 and 2021 the Company recognized $1,001 and $0 respectively.

 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

XML 29 R18.htm IDEA: XBRL DOCUMENT v3.23.1
CONCENTRATIONS AND CREDIT RISK
12 Months Ended
Dec. 31, 2022
Risks and Uncertainties [Abstract]  
CONCENTRATIONS AND CREDIT RISK

NOTE 12. CONCENTRATIONS AND CREDIT RISK

 

Revenues

 

One customer accounted for approximately 100% , respectively, of the Company’s revenues for the year ended December 31, 2022 and for two customers 79% and 20%, respectively, for the year ended December 31, 2021.

 

Accounts Receivable

 

As of December 31, 2022 one customer accounted for 100% of the Company’s net accounts receivable. As of December 31, 2021 two customers accounted for more than 10% of the Company’s net accounts receivable. One customer accounted for approximately 87% of the Company’s gross account receivable and a second customer accounted for approximately 10% of the Company’s gross account receivable.

 

Purchasing

 

The Company places orders with various suppliers. During the years ended December 31, 2022 and 2021, three suppliers accounted for more than 10% of the Company’s raw materials. One supplier, Cenntro Automotive Group (“Cenntro”), a related party – see Note 14 – accounted for approximately 50% and 62%, respectively, of the Company’s purchases of raw materials during the years ended December 31, 2022 and 2021. The second supplier accounted for 19% and 9%, respectively, of the Company’s purchases of raw materials during the years ended December 31, 2022 and 2021. The third supplier accounted for 10% of the Company’s purchases of raw materials during the year ended December 31, 2022.

 

Manufacturing

 

On May 31, 2022, the Company received a letter from Cenntro purporting to terminate all agreements and contracts between the Company and Cenntro. Although the Company does not believe Cenntro’s termination of the Cenntro MLA is valid, the Company has determined to cease production of the AYRO 411x and focus its resources on the development and launch of the Vanish. The Company has canceled all purchase orders and future builds with Cenntro and currently intends to only order replacement parts for vehicles from Cenntro in the future. The Company is in discussions with Cenntro concerning the potential repurchase by Cenntro of unsaleable inventory due to quality concerns. AYRO expects to lose its exclusive license under the Cenntro MLA, in which case Cenntro could sell similar products through other companies or directly to the Company’s customers, which could have a material adverse effect on its results of operations and financial condition.

 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

XML 30 R19.htm IDEA: XBRL DOCUMENT v3.23.1
RELATED PARTY TRANSACTIONS
12 Months Ended
Dec. 31, 2022
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

NOTE 13. RELATED PARTY TRANSACTIONS

 

The Company had received short-term expense advances from its founders. For the years ended December 31, 2022 and 2021, the amounts outstanding were $15,000 for each year and recorded as a component of accounts payable on the accompanying consolidated balance sheets.

 

During the year ended December 31, 2022, the Company paid $60,000 to a member of the Board of Directors for approved consulting services.

 

XML 31 R20.htm IDEA: XBRL DOCUMENT v3.23.1
COMMITMENTS AND CONTINGENCIES
12 Months Ended
Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES

NOTE 14. COMMITMENTS AND CONTINGENCIES

 

Manufacturing Agreements

 

On September 25, 2020, AYRO entered into a Master Manufacturing Services Agreement (the “Karma Agreement”) with Karma Automotive, LLC (“Karma”). The Karma Agreement expired in September 2022. Pursuant to the agreement Karma agreed to provide certain manufacturing services, starting in 2021, under an attached statement of work including final assembly, raw material storage and logistical support of our vehicles in return for compensation of $1,160,800.

 

The Company paid Karma an amount of $440,000 for the first production level builds and $80,000 for setup costs. In addition, the Company issued warrants to an advisor to the transaction with a fair value of $66,845 due at signing of the contract, which amount was expensed in the prior year. The payment was recorded as prepaid expense as of December 31, 2020. For the year ended December 31, 2021, the Company recorded expense of $641,140 related to the Karma Agreement for the assembly of the AYRO 411 and 411x vehicles (the “AYRO 411 Fleet”), of which $468,480 was recorded to reduce the total remaining prepaid expense to match the expected number of 411x vehicles to be built in 2022. This amount was recorded against cost of goods for direct labor as part of the first production level builds, and $73,333 was recorded for pre-production costs. No prepaid balance remained as of December 31, 2022.

 

On July 28, 2022, the Company partnered with Linamar Corporation (“Linamar”) a Canadian manufacturer, in a manufacturing agreement (the “Linamar MLA”) to provide certain sub assembly and assembly parts, including the cabin frame and skate for the Vanish (collectively, the “Products”). During the term of the Linamar MLA, Linamar has the exclusive right to supply the Products to the Company, subject to certain exceptions. The Linamar MLA has an initial term of three years and will automatically renew for successive two-year terms unless either party has given at least 12 months’ written notice of nonrenewal. Either party may terminate the Linamar MLA at any time upon 12 months’ written notice, and in the event of a change in control of the Company prior to the end of the initial term, the Company may terminate upon written notice within three days of completion of such change in control.

 

In the event the Company terminates the Linamar MLA prior to its expiration, whether following a change in control or otherwise, the Company must purchase any remaining raw material inventory, finished goods inventory and work in progress and any unamortized capital equipment used in production and testing of the Products and pay a termination fee of $750,000, subject to certain adjustments. The Company is dependent on the Linamar MLA, and in the event of its termination the Company’s manufacturing operations and customer deliveries would be materially impacted.

 

Under the Linamar MLA, the Company must commit to certain minimum purchase requirements, to be determined by AYRO on a quarterly basis.

 

Supply Chain Agreements

 

In 2017, the Company executed a supply chain contract with Cenntro, which has historically been the Company’s primary supplier. Prior to the Merger, Cenntro was a significant shareholder in AYRO Operating. Cenntro owns the design of the AYRO 411 Fleet vehicles and has granted the Company an exclusive license to purchase the AYRO 411 Fleet vehicles for sale in North America. The Company purchased 100% of its vehicle chassis, cabs and wheels for AYRO 411 Fleet Vehicles through this supply chain relationship with Cenntro. The Company must sell a minimum number of units in order to maintain its exclusive supply chain contract. See Note 12 for concentration amounts.

 

As of December 31, 2021 the net balance between prepaid expenses and accrued expenses with Cenntro was a prepaid balance of $602,016. As of December 31, 2022 the balance was zero. Impairments of prepaid expenses led to a write-down, netted with the balance in accrued expenses. The remainder of the balance was expensed through cost of goods sold for $621,097. Additionally, all inventory associated with Cenntro’s NCM line was written off to cost of goods sold for $1,317,289.

 

The Company has canceled all purchase orders and future builds with Cenntro and currently intends to only order replacement parts from Cenntro in the future.

 

Lease Agreements

 

In 2019 the Company entered into a new lease agreement for office and manufacturing space. The lease commencement date was January 16, 2020. Prior to the commencement date of the new lease agreement, the Company leased other office and manufacturing space on a short-term basis. The Company determined if an arrangement is a lease at inception of the contract and whether a contract is or contains a lease by determining whether it conveys the right to control the use of identified asset for a period of time. The contact provides the right to substantially all the economic benefits from the use of the identified asset and the right to direct use of the identified asset, as such, the contract is, or contains, a lease. In connection with the adoption of ASC 842, Leases, the Company has elected to treat the lease and non-lease components as a single component.

 

During March 2021, the Company subleased additional office space to support the Company’s expansion plan. The term is for 16 months with no lease obligation remaining as of December 31, 2022. In connection with the adoption of ASC 842, Leases, the Company has elected to treat the lease and non-lease components as a single component.

 

Leases were classified as an operating lease at inception. An operating lease results in the recognition of a Right-of-Use (“ROU”) assets and lease liability on the balance sheet. ROU assets and operating lease liabilities are recognized based on the present value of lease payments over the lease term as of the commencement date. Because the lease does not provide an explicit or implicit rate of return, the Company determines an incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments on an individual lease basis.

 

The incremental borrowing rate for a lease is the rate of interest the Company would have to pay on a collateralized basis to borrow an amount equal to the lease payments for the asset under similar term, which is 10.41%. Lease expense for the lease is recognized on a straight-line basis over the lease term.

 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

The Company’s leases do not contain any residual value guarantees or material restrictive covenants. Leases with a lease term of 12 months or less are not recorded on the balance sheet and lease expense is recognized on a straight-line basis over the lease term. The remaining term for the Company’s lease as of December 31, 2022 is 4.25 years. The Company currently has no finance leases.

 

During the years ended December 31, 2022 and 2021, cash paid for amounts included in the measurement of lease liabilities- operating cash flows from operating lease was $306,689 and $180,404 respectively.

 

The components of lease expense consist of the following:

   2022   2021 
   Years Ended December 31, 
   2022   2021 
Operating lease expense  $409,543   $462,105 
Short-term lease expense   153,572    8,296 
Total lease cost  $563,115   $470,401 

 

Balance sheet information related to leases consists of the following:

 

   December 31, 2022   December 31, 2021 
Assets          
Operating lease – right-of-use asset  $819,401   $1,012,884 
Total lease assets  $819,401   $1,012,884 
           
Liabilities          
Current liabilities:          
Lease obligation – operating lease  $165,767   $206,426 
Noncurrent liabilities:          
Lease obligation - operating lease, net of current portion   693,776    859,543 
Total lease liability  $859,543   $1,065,969 

 

The weighted-average remaining lease term and discount rate is as follows:

 

Weighted average remaining lease term (in years) – operating lease   4.25 
Weighted average discount rate – operating lease   10.41%

 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Cash flow information related to leases consists of the following:

 

   December 31, 2022   December 31, 2021 
Operating cash flows for operating leases  $306,689   $180,404 
Supplemental non-cash amounts of lease liabilities arising from obtaining right of use assets  $-   $120,440 

  

Future minimum lease payment under non-cancellable lease as of December 31, 2022 are as follows:

 

As of December 31, 2022  Operating Leases 
2023   247,533 
2024   254,277 
2025   261,223 
2026   268,378 
2027   44,929 
Total minimum lease payments   1,076,340 
Less effects of discounting   (216,797)
Present value of future minimum lease payments  $859,543 

 

Litigation

 

The Company is subject to various legal proceedings and claims, either asserted or unasserted, which arise in the ordinary course of business, that it believes are incidental to the operation of its business. While the outcome of these claims cannot be predicted with certainty, management does not believe that the outcome of any of these legal matters will have a material adverse effect on its results of operations, financial positions or cash flows.

 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

On February 12, 2021, the Company entered into an agreement with Arcimoto, Inc. to settle certain patent infringement claims (the “Arcimoto Settlement”) for a de minimis amount, pursuant to which the Company agreed to cease the production, importation and sale of the AYRO 311, among other things. Accordingly, the Company would not be contractually permitted to resume production of the AYRO 311.

 

As of January 1, 2019, DropCar had accrued approximately $232,000 for the settlement of multiple employment disputes. As of December 31, 2021 the accrual balance was $3,500, as of December 31, 2022 the remainder has been paid.

 

On March 23, 2018, DropCar was made aware of an audit being conducted by the New York State Department of Labor (“DOL”) regarding a claim filed by an employee. The DOL is investigating whether DropCar properly paid overtime for which DropCar has raised several defenses. In addition, the DOL is conducting its audit to determine whether the Company owes spread of hours pay (an hour’s pay for each day an employee worked or was scheduled for a period over ten hours in a day). Management believes the case has no merit.

 

DropCar was a defendant in a class action lawsuit which resulted in a judgement entered into whereby the Company is required to pay legal fees in the amount of $45,000 to the plaintiff’s counsel. As of December 31, 2022 there is no balance due.

 

DropCar was audited by the New York State Department of Taxation and Finance (“DOTF”) for its sales tax paid over the period of 2017 – 2020. The DOTF believes DropCar owes additional sales tax plus interest. Management is investigating the details this audit. As of December 31, 2021, the Company has accrued $476,280 in expense for such additional sales tax and interest and paid as of December 31, 2022.

 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

XML 32 R21.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAXES
12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
INCOME TAXES

NOTE 15. INCOME TAXES

 

The following is a reconciliation of the statutory federal income tax rate applied to pre-tax net loss compared to the income taxes in the statement of operations as of December 31, 2022 and 2021.

 

   December 31, 2022   December 31, 2021 
Income tax benefit at statutory U.S. federal rate  $(4,816,424)  $(6,946,677)
Permanent differences - equity based compensation   51,381    310,384 
Income tax benefit attributable to U.S. states   (936,810)   (965,708
Permanent difference - non-deductible compensation   -    765,339 
           
Basis adjustments   -    70,544 
Change in valuation allowance   5,701,853    6,766,118 
Total income tax expense  $-   $- 

 

Deferred income taxes reflect the net effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The following table sets forth deferred income tax assets and liabilities as of the date shown:

 

   December 31, 2022   December 31, 2021 
Deferred tax assets:          
Net operating losses  $15,843,010   $11,733,274 
Intangible assets   99,566    85,758 
Capitalized research and development expense   1,490,870    - 
Equity based compensation   743,567    569,350 
Warrants   156,851    156,851 
Accrued compensation   1,467    33,147 
Property and equipment   1,492    73,646 
Lease liability   210,195    260,674 
Other   113,487    93,268 
Deferred tax assets   18,660,505    13,005,968 
Deferred tax liabilities          
ROU asset   (200,379)   (247,695)
           
Deferred tax liabilities   (200,379)   (247,695)
           
Valuation allowance   18,460,126    12,758,273 
Net deferred tax asset/(liability)  $-   $- 

 

In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income, and projections for future taxable income over periods in which the deferred tax assets are deductible. Management believes it is more likely than not that the Company will not realize the benefits of these deductible differences. A valuation allowance has been applied to the amount of deferred tax assets Management expects will be unrealized.

 

Management does not believe that there are significant uncertain tax positions in 2022. There are no interest and penalties related to uncertain tax positions in 2022. The Company has federal net operating loss carryforwards of $64,332,435 and $48,152,539 as of December 31, 2022 and 2021, respectively. $995,801 of the federal net operating loss is subject to a 20-year carry forward, with a portion beginning to expire in 2036. $63,336,634 of the federal net operating loss has an indefinite carry forward period subjected to 80% of taxable income. The Company had state net operating loss carryforwards totaling $48,091,426 and $34,824,332 at December 31, 2022 and 2021. The Company has various state net operating loss carryforwards. The determination of the state net operating loss carryforwards is dependent upon apportionment percentages and state laws that can change from year to year and impact the amount of such carryforwards. If such net operating loss carryforwards are not utilized, they will begin to expire in 2031.

 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

The following table sets for the tax years subject to examination for the major jurisdictions where the Company conducts business as of December 31, 2022.

 

Federal 2016 to 2022
Georgia 2019 to 2022

 

Federal and state laws impose substantial restrictions on the utilization of NOL carryforwards in the event of an ownership change for income tax purposes, as defined in Section 382 of the Internal Revenue Code (“IRC”). Pursuant to IRC Section 382, annual use of the Company’s NOL carryforwards may be limited in the event a cumulative change in ownership of more than 50% occurs within a three-year period. The Company has not completed an IRC Section 382 analysis regarding the limitation of NOL carryforwards.

 

However, it is possible that past ownership changes will result in the inability to utilize a significant portion of the Company’s NOL carryforward that was generated prior to any change of control. The Company’s ability to use its remaining NOL carryforwards may be further limited if the Company experiences an IRC Section 382 ownership change in connection with future changes in the Company’s stock ownership.

 

Certain deferred tax assets from DropCar, such as NOL carryforwards and capital loss carryforwards are not included in the Company’s deferred tax assets as they are expected to be fully limited under IRC Section 382 as a result of the merger.

 

The Tax Cuts and Jobs Act (“TCJA”) requires taxpayers to capitalize and amortize research and experimental expenditures under IRC Section 174 for tax years beginning after December 31, 2021. This rule became effective for this Company during the year ended December 31, 2022 and resulted in the capitalization of research and development costs of $6,729,353. Before the TCJA, businesses have had the option of deducting Section 174 expenses in the year incurred or capitalizing and amortizing the costs over five years. The Company will amortize these costs for tax purposes over five years if the research and development was performed in the U.S. and over 15 years if research and development was performed outside the U.S.

 

On August 16, 2022, the Inflation Reduction Act was enacted into law. This Act includes a 15.0 percent book minimum tax on the adjusted financial statement income of applicable corporations, a number of clean-energy tax credits, and a 1.0 percent excise tax on certain stock buybacks. The Company does not expect these changes to have a material impact on the provision for income taxes or the financial statements.

 

XML 33 R22.htm IDEA: XBRL DOCUMENT v3.23.1
SUBSEQUENT EVENTS
12 Months Ended
Dec. 31, 2022
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 16. SUBSEQUENT EVENTS

 

The Company issued 110,562 shares of common stock upon the vesting of restricted stock on January 27, 2023.

XML 34 R23.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Basis of Presentation and Principles of Consolidation

Basis of Presentation and Principles of Consolidation

 

The consolidated financial statements represent the consolidation of the accounts of the Company and its subsidiary in conformity with GAAP. All intercompany accounts and transactions have been eliminated in consolidation.

 

Reclassification

Reclassification

 

Certain 2021 amounts were classified to conform to the current year presentation. Intangible assets were included into other assets on the consolidated balance sheet for current and prior year.

 

Use of Estimates

Use of Estimates

 

The preparation of the consolidated financial statements, in conformity with GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenue and expenses during the reporting period.

 

Cash and Cash Equivalents

Cash and Cash Equivalents

 

The Company considers all highly-liquid investments purchased with a maturity of three months or less at the time of purchase to be cash equivalents. The Company maintains total cash balances in one account which exceeds the federally insured limits. Management does not believe this results in any significant credit risk. The Company has no cash equivalents as of December 31, 2022 and 2021.

 

Marketable Securities

Marketable Securities

 

Marketable securities include investment in fixed income bonds and U.S. Treasury securities that are considered to be highly liquid and easily tradeable. The marketable securities are considered trading securities and are measured at fair value and are accounted for in accordance with ASC 320. The marketable securities are valued using inputs observable in active markets for identical securities and are therefore classified as Level 1 within the Company’s fair value hierarchy. The Company held $9,848,804 in marketable securities as of December 31, 2022.

 

Fair Value Measurements

Fair Value Measurements

 

The Company applies Accounting Standards Codification (“ASC”) 820, Fair Value Measurement (“ASC 820”), which establishes a framework for measuring fair value and clarifies the definition of fair value within that framework. ASC 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company’s principal or most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established in ASC 820 generally requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity’s own assumptions based on market data and the entity’s judgments about the assumptions that market participants would use in pricing the asset or liability and are to be developed based on the best information available in the circumstances.

 

The carrying amounts of financial instruments reported in the accompanying consolidated financial statements for current assets and current liabilities approximate the fair value because of the immediate or short-term maturities of the financial instruments.

 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

The valuation hierarchy is composed of three levels. The classification within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The levels within the valuation hierarchy are described below:

 

Level 1 — Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities.

 

Level 2 — Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals.

 

Level 3 — Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities.

 

The marketable securities are considered trading securities and are measured at fair value and are accounted for in accordance with ASC 320. The marketable securities are valued using inputs observable in active markets for identical securities and are therefore classified as Level 1 within the Company’s fair value hierarchy.

 

Accounts Receivable, Net

Accounts Receivable, Net

 

In the normal course of business, the Company extends credit to customers. Accounts receivable, less the allowance for doubtful accounts, reflect the net realizable value of receivables and approximate fair value. An allowance for doubtful accounts is maintained and reflects the best estimate of probable losses determined principally on the basis of historical experience and specific allowances for known troubled accounts. All accounts or portions thereof that are deemed to be uncollectible or that require an excessive collection cost are written off to the allowance for doubtful accounts. As of December 31, 2022 and 2021, the Company had reserved an allowance for doubtful accounts of $2,349 and $173,138, respectively. All account receivables are made on an unsecured basis.

 

Inventory

Inventory

 

Inventory consists of purchased chassis, cabs, batteries, truck beds and component parts which includes cost of raw materials, freight, direct labor, and related production overhead and are stated at the lower of cost or net realizable value, as determined using a first-in, first-out method. Inventory also includes a fleet of internally manufactured vehicles that serve demonstration and other purposes, the balance of which is being depreciated over their useful lives. Management compares the cost of inventory with the net realizable value and, if applicable, an allowance is made for writing down the inventory to its net realizable value, if lower than cost. On an ongoing basis, inventory is reviewed for potential write-down for estimated obsolescence or unmarketable inventory based upon forecasts for future demand and market conditions. At June 30, 2022, we determined that testing of obsolescence was required for inventory due to the quality of certain purchased components from Cenntro’s lithium-ion (“NCM”) line. 17 vehicles tested in the second quarter of 2022 were determined to have 49 unique failures. An inspection of the remaining NCM units revealed a 100% failure rate. As a result, all inventory associated with Cenntro’s NCM line was written off for $1,317,289 to cost of goods sold. As of December 31, 2022, there was no longer a balance. The remainder of the balance was expensed through cost of goods sold for $621,097. During the year ended December 31, 2022, a $413,561 net realizable value adjustment was recorded due to the Club Car Discount (as defined below), spare inventory for the 411x was written off, net with the inventory reserve of $124,375, and $2,476,322 was expensed for impairment of inventory.

 

Property and Equipment, Net

Property and Equipment, Net

 

Property and equipment, net, are stated at cost, less accumulated depreciation. Depreciation is recorded over the shorter of the estimated useful life, of one to ten years, or the lease term of the applicable assets using the straight-line method beginning on the date an asset is placed in service. The Company regularly evaluates the estimated remaining useful lives of the Company’s property and equipment, net, to determine whether events or changes in circumstances warrant a revision to the remaining period of depreciation. Maintenance and repairs are charged to expense when incurred.

 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

The estimated useful lives for significant property and equipment categories are as follows:

 

Computer Equipment and Software 13 years
Furniture and Fixtures 27 years
Machinery and Equipment 310 years
Leasehold Improvements Shorter of useful or lease life

 

Long-Lived Assets, Including Definite-Lived Intangible Assets

Long-Lived Assets, Including Definite-Lived Intangible Assets

 

Intangible assets are stated at cost less accumulated amortization. Amortization is generally recorded on a straight-line basis over estimated useful life of 3-10 years. The Company periodically reviews the estimated useful lives of intangible assets and makes adjustments when events indicate that a shorter life is appropriate.

 

Long-lived assets are evaluated for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable through the estimated undiscounted future cash flows derived from such assets.

 

Factors that the Company considers in deciding when to perform an impairment review include significant changes in the Company’s forecasted projections for the asset or asset group for reasons including, but not limited to, significant under-performance of a product in relation to expectations, significant changes, or planned changes in the Company’s use of the assets, significant negative industry or economic trends, and new or competing products that enter the marketplace. The impairment test is based on a comparison of the undiscounted cash flows expected to be generated from the use of the asset group. If impairment is indicated, the asset is written down by the amount by which the carrying value of the asset exceeds the related fair value of the asset with the related impairment charge recognized within the statements of operations.

 

Leases

Leases

 

Operating lease assets are included within operating lease right-of-use assets, and the corresponding operating lease obligation on the consolidated balance sheets as of December 31, 2022 and 2021 in accordance with ASC 842, Leases. The Company has elected not to present short-term leases as these leases have a lease term of 12 months or less at lease inception and do not contain purchase options or renewal terms that the Company is reasonably certain to exercise. All other lease assets and lease liabilities are recognized based on the present value of lease payments over the lease term at commencement date. Because most of the Company’s leases do not provide an implicit rate of return, the Company used an incremental borrowing rate based on the information available at adoption date in determining the present value of lease payments.

 

Revenue Recognition

Revenue Recognition

 

The Company recognizes revenue in accordance with ASC 606, Revenue from Contracts with Customers, the core principle of which is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to receive in exchange for those goods or services.

 

To achieve this core principle, five basic criteria must be met before revenue can be recognized: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to performance obligations in the contract; and (5) recognize revenue when or as the Company satisfies a performance obligation.

 

Nature of goods and services

 

The following is a description of the Company’s products and services from which the Company generates revenue, as well as the nature, timing of satisfaction of performance obligations, and significant payment terms for each:

 

Product revenue

 

Product revenue from customer contracts is recognized on the sale of each electric vehicle as vehicles are shipped to customers. The majority of the Company’s vehicle sales orders generally have only one performance obligation: sale and delivery of complete vehicles. Ownership and risk of loss transfers to the customer based on FOB shipping point and freight charges are the responsibility of the customer. Revenue is typically recognized at the point control transfers or in accordance with payment terms customary to the business. The Company provides product warranties to assure that the product assembly complies with agreed upon specifications. The Company’s product warranty is similar in all material respects to the product warranties provided by the Company’s suppliers, therefore minimizing the warranty liability to the standard labor rates associated with the defective part replacement. Customers do not have the option to purchase a warranty separately; as such, warranty is not accounted for as a separate performance obligation. The Company’s policy is to exclude taxes collected from a customer from the transaction price of automotive contracts.

 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Shipping revenue

 

Amounts billed to customers related to shipping and handling are classified as shipping revenue. The Company has elected to recognize the cost for freight and shipping when control over vehicles has transferred to the customer as an operating expense. The Company has reported shipping expenses of $442,932 and $393,231 for years ended December 31, 2022 and 2021, respectively, included in General and Administrative Expenses.

 

Services and other revenue

 

Services and other revenue consist of non-warranty after-sales vehicle services. Revenue is typically recognized at a point in time when services and replacement parts are provided.

 

Miscellaneous income

 

Miscellaneous income consists of late fees charged for receivables not paid within the terms of the customer agreement based upon the outstanding customer receivable balance. This revenue is earned when a customer’s receivable balance becomes delinquent and its collection is reasonably assured and is calculated using a stated late fee rate multiplied by the outstanding balance that is subject to a late fee charge.

 

Segment Reporting

Segment Reporting

 

The Company operates in one business segment which focuses on the manufacturing and sales of environmentally-conscious, minimal-footprint electric vehicles. The Company’s business offerings have similar economic and other characteristics, including the nature of products, manufacturing, types of customers, and distribution methods. The chief operating decision maker (CODM) reviews profit and loss information on a consolidated basis to assess performance and make overall operating decisions. The consolidated financial statements reflect the financial results of the Company’s one reportable operating segment. The Company has no significant revenues or tangible assets outside of the United States.

 

Income Taxes

Income Taxes

 

The Company accounts for income tax using an asset and liability approach, which allows for the recognition of deferred tax benefits in future years. Under the asset and liability approach, deferred taxes are provided for the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The accounting for deferred income tax calculation represents management’s best estimate on the most likely future tax consequences of events that have been recognized in the consolidated financial statements or tax returns and related future anticipation. A valuation allowance is provided for deferred tax assets if it is more likely than not these items will either expire before the Company is able to realize their benefits, or that future realization is uncertain. As of December 31, 2022 and 2021, there were no accruals for uncertain tax positions.

 

Warrants and Preferred Shares

Warrants and Preferred Shares

 

The accounting treatment of warrants and preferred share series issued is determined pursuant to the guidance provided by ASC 470, Debt, ASC 480, Distinguishing Liabilities from Equity, and ASC 815, Derivatives and Hedging, as applicable. Each feature of a freestanding financial instruments including, without limitation, any rights relating to subsequent dilutive issuances, dividend issuances, equity sales, rights offerings, forced conversions, optional redemptions, automatic monthly conversions, dividends and exercise are assessed with determinations made regarding the proper classification in the Company’s consolidated financial statements.

 

Stock-Based Compensation

Stock-Based Compensation

 

The Company accounts for stock-based compensation in accordance with ASC 718, Compensation-Stock Compensation (“ASC 718”). The Company recognizes all employee and non-employee share-based compensation as an expense in the financial statements on a straight-line basis over the requisite service period, based on the terms of the awards. Equity-classified awards principally related to stock options, restricted stock awards (“RSAs”) and equity-based compensation, are measured at the grant date fair value of the award. The Company determines grant date fair value of stock option awards using the Black-Scholes option-pricing model. The fair value of RSAs is determined using the closing price of the Company’s common stock on the grant date. For service based vesting grants, expense is recognized ratably over the requisite service period based on the number of options or shares. For value-based vesting grants, expense is recognized via straight line expense over the expected period per grant as determined by outside valuation experts. Stock-based compensation is reversed for forfeitures in the period of forfeiture.

 

We estimate the fair value of stock-based and cash unit awards containing a market condition using a Monte Carlo simulation model. Key inputs and assumptions used in the Monte Carlo simulation model include the stock price of the award on the grant date, the expected term, the risk-free interest rate over the expected term, the expected annual dividend yield and the expected stock price volatility. The expected volatility is based on a combination of the historical and implied volatility of the Company’s publicly traded, near-the-money stock options, and the valuation period is based on the vesting period of the awards. The risk-free interest rate is derived from the U.S. Treasury yield curve in effect at the time of grant and, since the Company does not currently pay or plan to pay a dividend on its common stock, the expected dividend yield was zero.

 

Stock options and warrants issued as compensation for services provided to the Company are accounted for based upon the fair value of the underlying equity instrument. The attribution of the fair value of the equity instrument is charged directly to compensation expense over the period during which services are rendered.

 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Basic and Diluted Loss Per Share

Basic and Diluted Loss Per Share

 

Basic and diluted net loss per share is determined by dividing net loss by the weighted average ordinary shares outstanding during the period. For all periods presented with a net loss, the shares underlying the ordinary share options and warrants have been excluded from the calculation because their effect would be anti-dilutive. Therefore, the weighted-average shares outstanding used to calculate both basic and diluted loss per share are the same for periods with a net loss.

 

The following potentially dilutive securities have been excluded from the computation of diluted weighted average shares outstanding as they would be anti-dilutive:

 

   For the Years Ended December 31, 
   2022   2021 
Options to purchase common stock   777,922    1,338,675 
Restricted stock unvested   660,562    450,000 
Restricted stock vested - unissued   -    43,000 
Warrants outstanding   6,106,023    6,108,823 
Preferred stock outstanding   2,475    2,475 
Totals   7,546,982    7,942,973 

 

Research and development costs

Research and development costs

 

Costs are incurred in connection with research and development programs that are expected to contribute to future earnings. Such costs include labor, stock-based compensation, training, software subscriptions, and consulting. These amounts are charged to the consolidated statement of operations as incurred. Total research and development expenses included were $6,845,451 and $11,449,617 for the years ended December 31, 2022 and 2021, respectively.

 

Recent Accounting Pronouncements

Recent Accounting Pronouncements

 

In June 2016, the FASB issued ASU 2016-13 “Financial Instruments -Credit Losses” (ASC 326) “Measurement of Credit Losses on Financial Instruments: and subsequent amendment to the guidance, ASU 2018-19 in November 2018. The standard significantly changes how entities will measure credit losses for most financial assets, including trade receivables. The standard will replace historic incurred loss” approach with an “expected loss” model for instruments measured at amortized cost. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements.

XML 35 R24.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
SCHEDULE OF ESTIMATED USEFUL LIVES

The estimated useful lives for significant property and equipment categories are as follows:

 

Computer Equipment and Software 13 years
Furniture and Fixtures 27 years
Machinery and Equipment 310 years
Leasehold Improvements Shorter of useful or lease life
SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE

The following potentially dilutive securities have been excluded from the computation of diluted weighted average shares outstanding as they would be anti-dilutive:

 

   For the Years Ended December 31, 
   2022   2021 
Options to purchase common stock   777,922    1,338,675 
Restricted stock unvested   660,562    450,000 
Restricted stock vested - unissued   -    43,000 
Warrants outstanding   6,106,023    6,108,823 
Preferred stock outstanding   2,475    2,475 
Totals   7,546,982    7,942,973 
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.23.1
REVENUES (Tables)
12 Months Ended
Dec. 31, 2022
Revenue from Contract with Customer [Abstract]  
SCHEDULE OF DISAGGREGATION OF REVENUE

Revenue by type consists of the following:

 

           
   Years Ended December 31, 
   2022   2021 
Revenue type          
Product revenue  $2,716,583   $2,419,821 
Shipping revenue   229,027    227,089 
Miscellaneous Income   44,887    - 
Service income   -    36,687 
 Total Revenue  $2,990,497   $2,683,597 
SCHEDULE OF CONTRACT LIABILITIES
   December 31,   December 31, 
   2022   2021 
Balance, beginning of period  $-   $24,000 
Additions   -    - 
Transfer to revenue   -    (24,000)
Balance, end of period  $        -   $- 
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.23.1
ACCOUNTS RECEIVABLE, NET (Tables)
12 Months Ended
Dec. 31, 2022
Credit Loss [Abstract]  
SCHEDULE OF ACCOUNTS RECEIVABLE

Accounts receivable, net consists of amounts due from invoiced customers and product deliveries and were as follows:

 

   December 31,   December 31, 
   2022   2021 
Trade receivables  $512,420   $1,142,567 
Less: Allowance for doubtful accounts   (2,349)   (173,138)
 Accounts receivable, net  $510,071   $969,429 
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.23.1
INVENTORY, NET (Tables)
12 Months Ended
Dec. 31, 2022
Inventory Disclosure [Abstract]  
SCHEDULE OF INVENTORY

Inventory, net consisted of the following:

 

   December 31,   December 31, 
   2022   2021 
Raw materials  $330,931   $3,481,614 
Work-in-progress   -    51,441 
Finished goods   639,450    210,982 
 Total  $970,381   $3,744,037 
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.23.1
PREPAID EXPENSES AND OTHER CURRENT ASSETS (Tables)
12 Months Ended
Dec. 31, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
SCHEDULE OF PREPAID EXPENSES AND OTHER CURRENT ASSETS
   December 31,   December 31, 
   2022   2021 
Prepaid final assembly services  $-   $439,660 
Prepayments for inventory   1,174,466    1,622,617 
Prepayments for insurance   118,434    - 
Prepayments on advances on design   75,000    - 
Prepayments on software   103,851    - 
Prepaid other   7,094    213,901 
Total Prepaid Expenses and Other Current Assets  $1,478,845   $2,276,178 
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.23.1
PROPERTY AND EQUIPMENT, NET (Tables)
12 Months Ended
Dec. 31, 2022
Property, Plant and Equipment [Abstract]  
SCHEDULE OF PROPERTY AND EQUIPMENT, NET

Property and equipment, net consisted of the following:

 

   December 31,   December 31, 
   2022   2021 
Computer and equipment  $1,970,001   $853,695 
Furniture and fixtures   323,789    173,155 
Lease improvements   952,952    282,271 
Prototypes   -    300,376 
Computer software   455,875    455,875 
Property and equipment, gross   3,702,617    2,065,372 
Less: Accumulated depreciation   (1,510,280)   (1,230,212)
Property and equipment, net  $2,192,337   $835,160 
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.23.1
MARKETABLE SECURITIES (Tables)
12 Months Ended
Dec. 31, 2022
Cash and Cash Equivalents [Abstract]  
SCHEDULE OF MARKETABLE SECURITIES

Marketable securities purchased in 2022 consisted of the following:

 

December 31, 2022
       Realized   Unrealized   Transferred     
   Cost Basis   Gains   Loss   to Cash   Total 
Bonds  $12,235,258   $160,990   $(1,713)  $(10,310,473)  $2,084,062 
US Treasury securities   7,764,742    -    -    -    7,764,742 
   $20,000,000   $160,990   $(1,713)  $(10,310,473)  $9,848,804 
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.23.1
STOCKHOLDERS’ EQUITY (Tables)
12 Months Ended
Dec. 31, 2022
Class of Stock [Line Items]  
SCHEDULE OF WARRANT ACTIVITY

A summary of the Company’s warrants to purchase common stock activity is as follows:

 

   Shares Underlying Warrants  

Weighted

Average Exercise

Price

  

Weighted

Average

Remaining Contractual

Term (in years)

 
Outstanding at December 31, 2020   3,501,014   $8.03    2.87 
Granted   3,873,711   $7.24      
Exercised   (13,642)  $7.33      
Expired   (1,252,260)  $8.80      
Outstanding at December 31, 2021   6,108,823   $7.37    2.31 
Expired   (2,800)   165.60      
Outstanding at December 31,2022   6,106,023   $7.30    1.32 
Series H Convertible Preferred Stock [Member]  
Class of Stock [Line Items]  
SCHEDULE OF PAYMENT OF PREFERRED STOCK
      
Number of Series H Preferred Stock outstanding as of December 31, 2022   8 
Multiplied by the stated value  $154 
Equals the gross stated value  $1,232 
Divided by the conversion price  $184.8 
Equals the convertible shares of Company Common Stock   6.66 
Multiplied by the fair market value of Company Common Stock as of December 31, 2022  $0.38 
Liquidation Value  $2.66 
Convertible Preferred Stock Series H-3 [Member]  
Class of Stock [Line Items]  
SCHEDULE OF PAYMENT OF PREFERRED STOCK
      
Number of Series H-3 Preferred Stock outstanding as of December 31, 2022   1,234 
Multiplied by the stated value  $138 
Equals the gross stated value  $170,292 
Divided by the conversion price  $165.6 
Equals the convertible shares of Company Common Stock   1,028 
Multiplied by the fair market value of Company Common Stock as of December 31, 2022  $0.38 
Liquidation Value  $391 
Series H Six Convertible Preferred Stock [Member]  
Class of Stock [Line Items]  
SCHEDULE OF PAYMENT OF PREFERRED STOCK
      
Number of Series H-6 Preferred Stock outstanding as of December 31, 2022   50 
Multiplied by the stated value  $72 
Equals the gross stated value  $3,600 
Divided by the conversion price  $2.5 
Equals the convertible shares of Company Common Stock   1,440 
Multiplied by the fair market value of Company Common Stock as of December 31, 2022  $0.38 
Liquidation Value  $547 
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.23.1
STOCK BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
SCHEDULE OF STOCK-BASED COMPENSATION

Stock-based compensation, including stock options, and restricted stock, expense is included in the consolidated statement of operations as follows:

 

   2022   2021 
   Years Ended December 31, 
   2022   2021 
Research and development  $21,922   $73,447 
Sales and marketing   25,811    224,076 
General and administrative   1,192,396    7,258,760 
Total  $1,240,129   $7,556,282 
SCHEDULE OF STOCK-BASED COMPENSATION, STOCK OPTIONS, ACTIVITY

The following table reflects the stock option activity:

 

  

Number of

Shares

  

Weighted

Average

Exercise

Price

  

Contractual

Life (Years)

 
Outstanding at December 31, 2020   1,920,269   $4.40    8.66 
Exercised   (555,004)  $(2.72)     
Forfeitures   (26,590)  $(2.52)     
Outstanding at December 31, 2021   1,338,675   $5.14    8.26 
Granted   173,500    0.97      
Exercised   -    -      
Forfeitures   (734,253)   3.13      
Outstanding at December 31, 2022   777,922    6.15    7.56 
SCHEDULE OF STOCK-BASED PAYMENT AWARD, STOCK OPTIONS, VALUATION ASSUMPTIONS

The Company uses the following inputs when valuing stock-based awards.

 

   For the Years Ended December 31, 
   2022   2021 
Expected life (years)   6    n/a 
Risk-free interest rate   3.04%   n/a 
Expected volatility   128.67%   n/a 
Stock Price  $0.84    n/a 
Exercise Price  $0.97    n/a 
SCHEDULE OF RESTRICTED STOCK ACTIVITY

The following table reflects the restricted stock activity:

 

   Number of Shares  

Weighted

Average Grant

Price

 
Outstanding at December 31, 2020   1,072,503   $5.30 
Granted   622,000   $3.91 
Vested   (1,201,891)  $5.71 
Forfeitures   (42,612)  $3.17 
Outstanding at December 31, 2021   450,000   $2.48 
Granted   542,248   $1.06 
Vested   (331,686)  $1.29 
Outstanding at December 31, 2022   660,562   $1.91 
XML 44 R33.htm IDEA: XBRL DOCUMENT v3.23.1
COMMITMENTS AND CONTINGENCIES (Tables)
12 Months Ended
Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
SCHEDULE OF COMPONENTS OF LEASE EXPENSES

The components of lease expense consist of the following:

   2022   2021 
   Years Ended December 31, 
   2022   2021 
Operating lease expense  $409,543   $462,105 
Short-term lease expense   153,572    8,296 
Total lease cost  $563,115   $470,401 
SCHEDULE OF OPERATING LEASES RIGHT OF USE ASSETS AND LIABILITIES

Balance sheet information related to leases consists of the following:

 

   December 31, 2022   December 31, 2021 
Assets          
Operating lease – right-of-use asset  $819,401   $1,012,884 
Total lease assets  $819,401   $1,012,884 
           
Liabilities          
Current liabilities:          
Lease obligation – operating lease  $165,767   $206,426 
Noncurrent liabilities:          
Lease obligation - operating lease, net of current portion   693,776    859,543 
Total lease liability  $859,543   $1,065,969 
SCHEDULE OF WEIGHTED- AVERAGE REMAINING LEASE TERM AND DISCOUNT RATE

The weighted-average remaining lease term and discount rate is as follows:

 

Weighted average remaining lease term (in years) – operating lease   4.25 
Weighted average discount rate – operating lease   10.41%
SCHEDULE OF CASH FLOW INFORMATION

Cash flow information related to leases consists of the following:

 

   December 31, 2022   December 31, 2021 
Operating cash flows for operating leases  $306,689   $180,404 
Supplemental non-cash amounts of lease liabilities arising from obtaining right of use assets  $-   $120,440 
SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES

Future minimum lease payment under non-cancellable lease as of December 31, 2022 are as follows:

 

As of December 31, 2022  Operating Leases 
2023   247,533 
2024   254,277 
2025   261,223 
2026   268,378 
2027   44,929 
Total minimum lease payments   1,076,340 
Less effects of discounting   (216,797)
Present value of future minimum lease payments  $859,543 
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAXES (Tables)
12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
SCHEDULE OF RECONCILIATION STATUTORY FEDERAL INCOME TAX RATE

The following is a reconciliation of the statutory federal income tax rate applied to pre-tax net loss compared to the income taxes in the statement of operations as of December 31, 2022 and 2021.

 

   December 31, 2022   December 31, 2021 
Income tax benefit at statutory U.S. federal rate  $(4,816,424)  $(6,946,677)
Permanent differences - equity based compensation   51,381    310,384 
Income tax benefit attributable to U.S. states   (936,810)   (965,708
Permanent difference - non-deductible compensation   -    765,339 
           
Basis adjustments   -    70,544 
Change in valuation allowance   5,701,853    6,766,118 
Total income tax expense  $-   $- 
SCHEDULE OF DEFERRED TAX

Deferred income taxes reflect the net effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The following table sets forth deferred income tax assets and liabilities as of the date shown:

 

   December 31, 2022   December 31, 2021 
Deferred tax assets:          
Net operating losses  $15,843,010   $11,733,274 
Intangible assets   99,566    85,758 
Capitalized research and development expense   1,490,870    - 
Equity based compensation   743,567    569,350 
Warrants   156,851    156,851 
Accrued compensation   1,467    33,147 
Property and equipment   1,492    73,646 
Lease liability   210,195    260,674 
Other   113,487    93,268 
Deferred tax assets   18,660,505    13,005,968 
Deferred tax liabilities          
ROU asset   (200,379)   (247,695)
           
Deferred tax liabilities   (200,379)   (247,695)
           
Valuation allowance   18,460,126    12,758,273 
Net deferred tax asset/(liability)  $-   $- 
SCHEDULE OF INCOME TAX EXAMINATION

The following table sets for the tax years subject to examination for the major jurisdictions where the Company conducts business as of December 31, 2022.

 

Federal 2016 to 2022
Georgia 2019 to 2022
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.23.1
LIQUIDITY AND OTHER UNCERTAINTIES (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Liquidity And Other Uncertainties    
Net losses $ 22,935,353 $ 33,079,414
Net cash provided by (used in) operating activities 18,728,643 26,631,485
Cash and cash equivalents, at carrying value 39,096,562 69,160,466
Marketable securities, current 9,848,804
Working capital $ 22,639,376  
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF ESTIMATED USEFUL LIVES (Details)
12 Months Ended
Dec. 31, 2022
Computer Equipment [Member] | Minimum [Member]  
Property, Plant and Equipment [Line Items]  
Property plant and equipment, estimated useful lives 1 year
Computer Equipment [Member] | Maximum [Member]  
Property, Plant and Equipment [Line Items]  
Property plant and equipment, estimated useful lives 3 years
Furniture and Fixtures [Member] | Minimum [Member]  
Property, Plant and Equipment [Line Items]  
Property plant and equipment, estimated useful lives 2 years
Furniture and Fixtures [Member] | Maximum [Member]  
Property, Plant and Equipment [Line Items]  
Property plant and equipment, estimated useful lives 7 years
Machinery and Equipment [Member] | Minimum [Member]  
Property, Plant and Equipment [Line Items]  
Property plant and equipment, estimated useful lives 3 years
Machinery and Equipment [Member] | Maximum [Member]  
Property, Plant and Equipment [Line Items]  
Property plant and equipment, estimated useful lives 10 years
Leasehold Improvements [Member]  
Property, Plant and Equipment [Line Items]  
Property plant and equipment, estimated useful lives Shorter of useful or lease life
XML 48 R37.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE (Details) - shares
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Totals 7,546,982 7,942,973
Options to Purchase Common Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Totals 777,922 1,338,675
Restricted Stock Unvested [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Totals 660,562 450,000
Restricted Stock Vested Unissued [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Totals 43,000
Warrants Outstanding [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Totals 6,106,023 6,108,823
Preferred Stock Outstanding [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Totals 2,475 2,475
XML 49 R38.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Property, Plant and Equipment [Line Items]    
Marketable securities $ 9,848,804
Allowance for doubtful accounts 2,349 173,138
Cost of goods sold 6,043,506 4,774,784
Shipping expenses 442,932 393,231
Research and development expenses $ 6,845,451 $ 11,449,617
Minimum [Member]    
Property, Plant and Equipment [Line Items]    
Estimated useful life of intangible assets 3 years  
Maximum [Member]    
Property, Plant and Equipment [Line Items]    
Estimated useful life of intangible assets 10 years  
Cenntro Automotive Group Ltd [Member]    
Property, Plant and Equipment [Line Items]    
Inventory write down $ 1,317,289  
Cost of goods sold 621,097  
Fleet Inventory [Member]    
Property, Plant and Equipment [Line Items]    
Inventory write down 1,317,289  
Club Car Discount [Member]    
Property, Plant and Equipment [Line Items]    
Inventory write down 413,561  
Inventory reserves 124,375  
Impairment of inventory $ 2,476,322  
XML 50 R39.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF DISAGGREGATION OF REVENUE (Details) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Disaggregation of Revenue [Line Items]    
 Total Revenue $ 2,990,497 $ 2,683,597
Product [Member]    
Disaggregation of Revenue [Line Items]    
 Total Revenue 2,716,583 2,419,821
Shipping Revenue [Member]    
Disaggregation of Revenue [Line Items]    
 Total Revenue 229,027 227,089
Miscellaneous Income [Member]    
Disaggregation of Revenue [Line Items]    
 Total Revenue 44,887
Service Income [Member]    
Disaggregation of Revenue [Line Items]    
 Total Revenue $ 36,687
XML 51 R40.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF CONTRACT LIABILITIES (Details) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Revenue from Contract with Customer [Abstract]    
Balance, beginning of period $ 24,000
Additions
Transfer to revenue (24,000)
Balance, end of period
XML 52 R41.htm IDEA: XBRL DOCUMENT v3.23.1
REVENUES (Details Narrative) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Revenue from Contract with Customer [Abstract]    
Warranty reserves $ 410,017 $ 240,517
XML 53 R42.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF ACCOUNTS RECEIVABLE (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Credit Loss [Abstract]    
Trade receivables $ 512,420 $ 1,142,567
Less: Allowance for doubtful accounts (2,349) (173,138)
 Accounts receivable, net $ 510,071 $ 969,429
XML 54 R43.htm IDEA: XBRL DOCUMENT v3.23.1
ACCOUNTS RECEIVABLE, NET (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Credit Loss [Abstract]    
Changes in allowance for doubtful accounts receivable $ 170,789  
Bad debt expense $ 4,485 $ 99,309
XML 55 R44.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF INVENTORY (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Inventory Disclosure [Abstract]    
Raw materials $ 330,931 $ 3,481,614
Work-in-progress 51,441
Finished goods 639,450 210,982
 Total $ 970,381 $ 3,744,037
XML 56 R45.htm IDEA: XBRL DOCUMENT v3.23.1
INVENTORY, NET (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Inventory [Line Items]    
Depreciation expenses $ 580,445 $ 314,164
Fleet Inventory [Member]    
Inventory [Line Items]    
Depreciation expenses 87,586 $ 95,544
Inventory write down 1,317,289  
Club Car Discount [Member]    
Inventory [Line Items]    
Inventory write down 413,561  
Inventory reserve $ 124,375  
XML 57 R46.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]    
Prepaid final assembly services $ 439,660
Prepayments for inventory 1,174,466 1,622,617
Prepayments for insurance 118,434
Prepayments on advances on design 75,000
Prepayments on software 103,851
Prepaid other 7,094 213,901
Total Prepaid Expenses and Other Current Assets $ 1,478,845 $ 2,276,178
XML 58 R47.htm IDEA: XBRL DOCUMENT v3.23.1
PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Cost of goods sold $ 6,043,506 $ 4,774,784
Cenntro Automotive Group Ltd [Member]    
Prepaid expenses and accrued expenses, net   $ 602,016
Cost of goods sold $ 621,097  
XML 59 R48.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF PROPERTY AND EQUIPMENT, NET (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 3,702,617 $ 2,065,372
Less: Accumulated depreciation (1,510,280) (1,230,212)
Property and equipment, net 2,192,337 835,160
Computer And Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 1,970,001 853,695
Furniture and Fixtures [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 323,789 173,155
Leasehold Improvements [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 952,952 282,271
Prototypes [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 300,376
Computer Software [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 455,875 $ 455,875
XML 60 R49.htm IDEA: XBRL DOCUMENT v3.23.1
PROPERTY AND EQUIPMENT, NET (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Property, Plant and Equipment [Line Items]    
Depreciation $ 580,445 $ 314,164
Retiring Legacy Assets [Member]    
Property, Plant and Equipment [Line Items]    
Depreciation $ 101,581  
XML 61 R50.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF MARKETABLE SECURITIES (Details) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Net Investment Income [Line Items]    
Cost Basis $ 20,000,000  
Gross Realized Gains 160,990
Gross Unrealized Losses (1,713)
Transferred to Cash (10,310,473)  
Fair Value 9,848,804
Bonds [Member]    
Net Investment Income [Line Items]    
Cost Basis 12,235,258  
Gross Realized Gains 160,990  
Gross Unrealized Losses (1,713)  
Transferred to Cash (10,310,473)  
Fair Value 2,084,062  
US Treasury Securities [Member]    
Net Investment Income [Line Items]    
Cost Basis 7,764,742  
Gross Realized Gains  
Transferred to Cash  
Fair Value $ 7,764,742  
XML 62 R51.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF PAYMENT OF PREFERRED STOCK (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Convertible Preferred Stock Series H [Member]    
Class of Stock [Line Items]    
Number of Series H Preferred Stock outstanding as of December 31, 2022 8 8
Multiplied by the stated value $ 154  
Equals the gross stated value $ 1,232  
Divided by the conversion price $ 184.8  
Equals the convertible shares of Company Common Stock 6.66  
Multiplied by the fair market value of Company Common Stock as of December 31, 2022 $ 0.38  
Liquidation Value $ 2.66  
Convertible Preferred Stock Series H-3 [Member]    
Class of Stock [Line Items]    
Number of Series H Preferred Stock outstanding as of December 31, 2022 1,234 1,234
Multiplied by the stated value $ 138  
Equals the gross stated value $ 170,292  
Divided by the conversion price $ 165.6  
Equals the convertible shares of Company Common Stock 1,028  
Multiplied by the fair market value of Company Common Stock as of December 31, 2022 $ 0.38  
Liquidation Value $ 391  
Convertible Preferred Stock Series H-6 [Member]    
Class of Stock [Line Items]    
Number of Series H Preferred Stock outstanding as of December 31, 2022 50 50
Multiplied by the stated value $ 72  
Equals the gross stated value $ 3,600  
Divided by the conversion price $ 2.5  
Equals the convertible shares of Company Common Stock 1,440  
Multiplied by the fair market value of Company Common Stock as of December 31, 2022 $ 0.38  
Liquidation Value $ 547  
XML 63 R52.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF WARRANT ACTIVITY (Details) - $ / shares
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Equity [Abstract]    
Shares Underlying Warrants Outstanding 6,108,823 3,501,014
Weighted Average Exercise Price Outstanding $ 7.37 $ 8.03
Weighted Average Remaining Contractual Life 2 years 3 months 21 days 2 years 10 months 13 days
Shares Underlying Warrants Granted   3,873,711
Weighted Average Exercise Price Granted   $ 7.24
Shares Underlying Warrants Exercised   (13,642)
Weighted Average Exercise Price Exercised   $ 7.33
Shares Underlying Warrants Expired (2,800) (1,252,260)
Weighted Average Exercise Price Expired $ 165.60 $ 8.80
Shares underlying warrants outstanding 6,106,023 6,108,823
Weighted Average Exercise Price Outstanding $ 7.30 $ 7.37
Weighted Average Remaining Contractual Life 1 year 3 months 25 days  
XML 64 R53.htm IDEA: XBRL DOCUMENT v3.23.1
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Feb. 01, 2022
Mar. 17, 2021
Feb. 24, 2021
Feb. 11, 2021
Jan. 25, 2021
Nov. 22, 2020
Sep. 25, 2020
Jul. 21, 2020
Feb. 05, 2020
Feb. 28, 2021
Dec. 31, 2020
Dec. 31, 2022
Dec. 31, 2021
Jul. 22, 2020
Jul. 08, 2020
Jun. 19, 2020
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Common stock, par value                       $ 0.0001 $ 0.0001      
Offering price                       $ 0.84        
Shares issued for exercised stock options                         $ 1,506,999      
Preferred stock, shares authorized                       20,000,000 20,000,000      
Warrant exercise price                     $ 8.03 $ 7.30 $ 7.37      
Warrants outstanding                     3,501,014 6,106,023 6,108,823      
Share based compensation expenses                       $ 1,240,129 $ 7,556,282      
Series H Preferred Stock [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Preferred stock stated value                       $ 154.00        
Convertible conversion price increase                       $ 184.80        
Series H Preferred Stock [Member] | Affiliates [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Aggregate issued and outstanding shares percentage                       9.99%        
Series H-3 Preferred Stock [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Preferred stock stated value                       $ 138.00        
Series H-3 Preferred Stock [Member] | Affiliates [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Aggregate issued and outstanding shares percentage                       9.99%        
Series H-6 Convertible Preferred Stock [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Preferred stock stated value                 $ 72.00              
Convertible conversion price increase                 $ 3.60     $ 3.60        
Preferred stock, shares authorized                 50,000              
Preferred stock, conversion price description                 Each share of Series H-6 Preferred Stock is convertible at any time at the option of the holder thereof, into a number of shares of common stock of the Company determined by dividing the H-6 Stated Value by the initial conversion price of $3.60 per share, which was then further reduced to $2.50 under the anti-dilution adjustment provision, subject to a 9.99% blocker provision.              
Series H-6 Convertible Preferred Stock [Member] | Affiliates [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Aggregate issued and outstanding shares percentage                 9.99%              
Common Stock [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Shares issued for exercised stock options, shares                       555,004      
Shares issued for exercised stock options                         $ 55      
Preferred Stock [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Reverse stock split, description                       Upon closing of the Merger, the Company assumed the Series H, H-3 and H-6 preferred stock of DropCar, Inc., which respective conversion prices have been adjusted to reflect the May 2020 one-for-five reverse split.        
Preferred stock, shares authorized                       8,472,500        
Conversion of stock shares                       7,360,985        
Conversion of stock shares issued                       2,007,193        
Securities Purchase Agreement [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Proceeds from sale of common stock         $ 20,000,000.0     $ 1,512,500                
Shares issued for exercised stock options, shares                         555,004      
Shares issued for exercised stock options                   $ 100,000     $ 1,506,999      
Warrants to purchase common stock         233,334             3,566,668        
Warrant exercise price         $ 6.93                      
Securities Purchase Agreement [Member] | Investor [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Number of additional shares purchased               302,500                
Securities Purchase Agreement [Member] | Additional Shares [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Number of shares issued       4,400,001                        
Common stock, par value       $ 0.0001 0.0001     $ 0.0001                
Offering price       $ 9.50 $ 6.00     $ 5.00                
Proceeds from sale of common stock       $ 41,800,008                        
Offering expenses       $ 3,394,054                        
Purchase of additional shares description   (i) sell up to 5% of such stockholder’s holdings in the Company’s common stock on any trading day (with such 5% limitation to be measured as of the date of each sale) and (ii) allow for unlimited sales of the Company’s common stock for any sales made at $10.00 per share or greater.   Each purchaser was also granted an option to purchase, on or before February 16, 2022, additional shares of common stock equal to the full amount of 75% of the common stock it purchased at the initial closing, or an aggregate of 3,300,001 shares, at an exercise price of $11.50 per share.                        
Securities Purchase Agreement [Member] | Additional Shares [Member] | Investor [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Number of shares issued       3,300,001                        
Offering price       $ 11.50                        
Securities Purchase Agreement [Member] | Warrant [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Shares issued for exercised stock options, shares                   13,642            
January 2021 Offering [Member] | Securities Purchase Agreement [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Number of shares issued         3,333,334                      
Warrant exercise price         $ 6.93                      
January 2021 Offering [Member] | Securities Purchase Agreement [Member] | Additional Shares [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Number of shares issued         3,333,334                      
Common stock, par value         $ 0.0001                      
Offering price         $ 6.00                      
Proceeds from sale of common stock         $ 20,000,004                      
Offering expenses         $ 1,648,608                      
Restricted Stock [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Number of shares vested                       374,686 1,158,891      
Restricted Stock [Member] | Director [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Number of restricted shares 442,248                              
Share price $ 1.29                              
Restricted Stock [Member] | Director [Member] | 2020 Long-Term Incentive Plan [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Number of restricted shares 442,249   172,000                          
Share price $ 1.29   $ 7.66                          
Number of restricted shares issued and vested                       331,686        
Restricted Stock [Member] | Common Stock [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Common Stock, Shares Subscribed but Unissued                         43,000      
Series H-3 Warrants [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Conversion price per share                       $ 165.60        
Warrants to purchase common stock                       2,800        
Warrant exercise price                       $ 165.60        
Warrants outstanding                       2,800        
Warrants and rights outstanding term                       5 years        
Seed Warrants [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Warrants to purchase common stock                       461,647        
Warrant exercise price                       $ 7.33        
Warrants outstanding                       448,005        
Series I Warrants [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Warrants to purchase common stock                       14,636        
Warrant exercise price                       $ 69.00        
Warrants outstanding                         14,636      
Warrants description                       If at any time (i) the volume weighted average price (“VWAP”) of the Common Stock exceeds $138.00 for not less than the mandatory exercise measuring period; (ii) the daily average number of shares of Common Stock traded during the mandatory exercise measuring period equals or exceeds 25,000; and (iii) no equity conditions failure has occurred as of such date, then the Company shall have the right to require the holder to exercise all or any portion of the Series I Warrants still unexercised for a cash exercise.        
Warrant weighted average exercise price                       $ 138.00        
Series H-4 Warrants [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Warrant exercise price                       $ 15.60        
Warrants outstanding                       37,453        
Anti-dilution price protection price per share                       $ 15.60        
Series J Warrants [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Warrants to purchase common stock                       52,023        
Warrant exercise price                       $ 30.00        
Warrants outstanding                       52,023        
Warrants description                       If at any time (i) the VWAP of the Common Stock exceeds $9.00 for not less than the mandatory exercise measuring period; (ii) the daily average number of shares of Common Stock traded during the mandatory exercise measuring period equals or exceeds 25,000; and (iii) no equity conditions failure has occurred as of such date, then the Company shall have the right to require the holder to exercise all or any portion of the Series J Warrants still unexercised for a cash exercise.        
Exceeds warrant price per share                       $ 45.00        
Series H-5 Warrants [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Warrants to purchase common stock                       296,389        
Warrant exercise price                       $ 2.50        
Warrants outstanding                       348,476        
Warrants description                       The H-5 Warrants are entitled to certain anti-dilution adjustments if the Company issues shares of its common stock at a lower price per share than the applicable exercise price (subject to a floor of $0.792 per share). An anti-dilution adjustment was triggered resulting in an adjusted exercise price per share from $3.96 to $2.50, resulting in an issuance of an additional 173,091 warrants that are exercisable at $2.50 per share.        
Warrants and rights outstanding term                       5 years        
Series H-5 Warrants [Member] | Minimum [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Warrant exercise price                       $ 3.96        
Series H-5 Warrants [Member] | Maximum [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Warrant exercise price                       $ 2.50        
Number of warrants issued                       173,091        
June Finder Warrants [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Warrants to purchase common stock                               27,273
Warrant exercise price                               $ 2.75
Warrants outstanding                       27,273        
Warrants and rights outstanding term                               5 years
June Placement Agent Warrants [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Warrants to purchase common stock                     126,000         126,000
Warrant exercise price                               $ 2.875
July 8 Finder Warrants [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Warrants to purchase common stock                       71,770     71,770  
Warrant exercise price                             $ 5.225  
July 8 Placement Agent Warrants [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Warrants to purchase common stock                       147,368     147,368  
Warrant exercise price                             $ 5.4625  
Warrants and rights outstanding term                             5 years  
July 22 Placement Agent Warrants [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Warrants to purchase common stock                       129,500   129,500    
Warrant exercise price                           $ 5.750    
Warrants and rights outstanding term                           5 years    
September Warrant [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Warrants to purchase common stock             31,348         31,348        
Warrant exercise price             $ 3.19                  
Warrant expiration description             The September Warrant is immediately exercisable and expires on September 25, 2025.                  
Decrease in exercise price             $ 2.13                  
Share based compensation expenses                     $ 66,845          
Series A Warrants and Series B [Member] | Securities Purchase Agreement [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Value of common stock issued           $ 9,999,997                    
Series A Warrants [Member] | Securities Purchase Agreement [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Warrants to purchase common stock           1,237,624           0        
Warrant exercise price           $ 8.09                    
Warrant expiration date           May 24, 2021                    
Series B Warrants [Member] | Securities Purchase Agreement [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Warrants to purchase common stock           825,084           825,084        
Warrant exercise price           $ 8.90                    
November Finder Warrants [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Warrants to purchase common stock           56,256                    
Warrant exercise price           $ 6.6660                    
November Placement Agent Warrants [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Warrants to purchase common stock           57,756                    
Warrant exercise price           $ 6.9690                    
Warrants description           The November Finder Warrants and November Placement Agent Warrants terminate after a period of 5 years on November 22, 2025.                    
February Finder Warrants [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Warrants to purchase common stock       15,574               51,459        
Warrant exercise price       $ 10.925                        
February Finder Warrants [Member] | Common Stock [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Warrants to purchase common stock       35,885                        
Warrant exercise price       $ 10.45                        
February Placement Agent Warrants [Member]                                
Accumulated Other Comprehensive Income (Loss) [Line Items]                                
Warrants to purchase common stock       255,584               255,584        
Warrants and rights outstanding term       5 years                        
XML 65 R54.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF STOCK-BASED COMPENSATION (Details) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total $ 1,240,129 $ 7,556,282
Research And Development [Member]    
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total 21,922 73,447
Sales And Marketing [Member]    
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total 25,811 224,076
General And Administrative [Member]    
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total $ 1,192,396 $ 7,258,760
XML 66 R55.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF STOCK-BASED COMPENSATION, STOCK OPTIONS, ACTIVITY (Details) - Common Stock [Member] - $ / shares
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Number of Stock options outstanding, Beginning balance 1,338,675 1,920,269
Weighted Average Exercise Price Outstanding, Beginning balance $ 5.14 $ 4.40
Weighted average remaining contractual life 8 years 3 months 3 days 8 years 7 months 28 days
Number of Stock options, Exercised (555,004)
Weighted Average Exercise Price Outstanding, Exercised $ (2.72)
Number of Stock options, Forfeitures (734,253) (26,590)
Weighted Average Exercise Price Outstanding, Forfeitures $ 3.13 $ (2.52)
Number of Stock options, Granted 173,500  
Weighted Average Exercise Price Outstanding, Granted $ 0.97  
Number of Stock options outstanding, Ending balance 777,922 1,338,675
Weighted Average Exercise Price Outstanding, Ending balance $ 6.15 $ 5.14
Weighted average remaining contractual life 7 years 6 months 21 days  
XML 67 R56.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF STOCK-BASED PAYMENT AWARD, STOCK OPTIONS, VALUATION ASSUMPTIONS (Details)
12 Months Ended
Dec. 31, 2022
$ / shares
Share-Based Payment Arrangement [Abstract]  
Expected life (years) 6 years
Risk-free interest 3.04%
Expected volatility 128.67%
Share price $ 0.84
Exercise price $ 0.97
XML 68 R57.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF RESTRICTED STOCK ACTIVITY (Details) - Restricted Stock Units (RSUs) [Member] - $ / shares
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of shares, Outstanding, Beginning balance 450,000 1,072,503
Weighted Average Grant Price, Outstanding, Beginning balance $ 2.48 $ 5.30
Number of shares, Granted 542,248 622,000
Weighted Average Grant Price, Granted $ 1.06 $ 3.91
Number of shares, Vested (331,686) (1,201,891)
Weighted Average Grant Price, Vested $ 1.29 $ 5.71
Number of shares, Forfeited   (42,612)
Weighted Average Grant Price, Forfeited   $ 3.17
Number of shares, Outstanding, Ending balance 660,562 450,000
Weighted Average Grant Price, Outstanding, Ending balance $ 1.91 $ 2.48
XML 69 R58.htm IDEA: XBRL DOCUMENT v3.23.1
STOCK BASED COMPENSATION (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Aug. 23, 2022
May 06, 2022
Feb. 01, 2022
Feb. 24, 2021
Feb. 24, 2021
Sep. 30, 2021
Dec. 31, 2020
Sep. 30, 2020
Dec. 31, 2022
Dec. 31, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                    
Compensation expenses                 $ 1,240,129 $ 7,556,282
Volatility rate                 128.67%  
Share-Based Payment Arrangement, Option [Member]                    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                    
Number of options granted   173,000                
Number of shares vested                 612,963  
Aggregate intrinsic value of stock options vested and exercisable                 $ 0  
Compensation expenses                 65,291 $ 1,232,402
Cost not yet recognized                 $ 142,648  
Grant date fair value   $ 0.97                
Restricted Stock [Member]                    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                    
Number of shares vested                 374,686 1,158,891
Compensation expenses                 $ 522,958 $ 0
Cost not yet recognized                 42,788  
Restricted Stock [Member] | ThomasM Wittens Chlaeger [Member]                    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                    
Compensation expenses                 646,771 180,215
Cost not yet recognized                 $ 290,118  
Number of restricted stock units           450,000        
Share price           $ 2.48        
Volatility rate                 110.00%  
Restricted Stock [Member] | David E. Hollingsworth [Member]                    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                    
Compensation expenses                 $ 1,001 0
Restricted Stock [Member] | Directors [Member]                    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                    
Number of shares vested               15,115    
Compensation expenses                 0 699,527
Number of restricted stock units               436,368    
Restricted stock vesting description               vest in December 2020, which was subsequently modified to vest in full in May 2021.    
Restricted Stock [Member] | Keller Award [Member]                    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                    
Compensation expenses                 $ 0 4,126,618
Number of restricted stock units             651,250      
Restricted stock vesting description             the following vesting schedule: one-third vested on May 28, 2021, one-third was to vest on December 4, 2021 and one-third was to vest on December 4, 2022.      
Restricted stock shares vested but not issued           $ 434,166        
Restricted Stock [Member] | Director [Member]                    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                    
Number of restricted stock units     442,248              
Share price     $ 1.29              
Restricted Stock [Member] | David E. Hollingsworth [Member]                    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                    
Number of restricted stock units 100,000                  
Share price $ 0.03                  
2020 Long Term Incentive Plan [Member]                    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                    
Number of shares reserved                 4,089,650  
Number of options granted                 1,158,899  
2017 Long Term Incentive Plan [Member]                    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                    
Number of shares reserved                 477,983  
Options to purchase shares outstanding                 128,606  
Number of stock options available for grants                 0  
2014 Equity Incentive Plan [Member] | DropCar Inc [Member]                    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                    
Number of shares reserved                 141,326  
Number of stock options available for grants                 0  
2020 Long-Term Incentive Plan [Member] | Restricted Stock [Member] | Directors [Member]                    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                    
Compensation expenses                   $ 329,380
Number of restricted stock units         172,000          
Share price       $ 7.66 $ 7.66          
2020 Long-Term Incentive Plan [Member] | Restricted Stock [Member] | Director [Member]                    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                    
Number of restricted stock units     442,249 172,000            
Share price     $ 1.29 $ 7.66 $ 7.66          
Number of restricted shares issued and vested                 331,686  
XML 70 R59.htm IDEA: XBRL DOCUMENT v3.23.1
CONCENTRATIONS AND CREDIT RISK (Details Narrative)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Sales Revenue [Member] | Customer Concentration Risk [Member]    
Concentration Risk [Line Items]    
Concentration risk percentage 100.00%  
Sales Revenue [Member] | Customer Concentration Risk [Member] | Customer One [Member]    
Concentration Risk [Line Items]    
Concentration risk percentage   79.00%
Sales Revenue [Member] | Customer Concentration Risk [Member] | Customer Two [Member]    
Concentration Risk [Line Items]    
Concentration risk percentage   20.00%
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customer One [Member]    
Concentration Risk [Line Items]    
Concentration risk percentage 87.00%  
Cost of Goods and Service, Product and Service Benchmark [Member] | Supplier Concentration Risk [Member] | Supplier One [Member]    
Concentration Risk [Line Items]    
Concentration risk percentage 50.00% 62.00%
Cost of Goods and Service, Product and Service Benchmark [Member] | Supplier Concentration Risk [Member] | Supplier Two [Member]    
Concentration Risk [Line Items]    
Concentration risk percentage 19.00% 9.00%
Cost of Goods and Service, Product and Service Benchmark [Member] | Supplier Concentration Risk [Member] | Three Supplier [Member]    
Concentration Risk [Line Items]    
Concentration risk percentage 10.00%  
XML 71 R60.htm IDEA: XBRL DOCUMENT v3.23.1
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Related Party Transaction [Line Items]    
Due to related parties $ 15,000 $ 15,000
Board of Directors Chairman [Member]    
Related Party Transaction [Line Items]    
Due to related parties $ 60,000  
XML 72 R61.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF COMPONENTS OF LEASE EXPENSES (Details) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]    
Operating lease expense $ 409,543 $ 462,105
Short-term lease expense 153,572 8,296
Total lease cost $ 563,115 $ 470,401
XML 73 R62.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF OPERATING LEASES RIGHT OF USE ASSETS AND LIABILITIES (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]    
Operating lease – right-of-use asset $ 819,401 $ 1,012,884
Total lease assets 819,401 1,012,884
Lease obligation – operating lease 165,767 206,426
Lease obligation - operating lease, net of current portion 693,776 859,543
Total lease liability $ 859,543 $ 1,065,969
XML 74 R63.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF WEIGHTED- AVERAGE REMAINING LEASE TERM AND DISCOUNT RATE (Details)
Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
Weighted average remaining lease term (in years) - operating lease 4 years 3 months
Weighted average discount rate - operating lease 10.41%
XML 75 R64.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF CASH FLOW INFORMATION (Details) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]    
Operating cash flows for operating leases $ 306,689 $ 180,404
Supplemental non-cash amounts of lease liabilities arising from obtaining right of use assets $ 120,440
XML 76 R65.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]    
2023 $ 247,533  
2024 254,277  
2025 261,223  
2026 268,378  
2027 44,929  
Total minimum lease payments 1,076,340  
Less effects of discounting (216,797)  
Present value of future minimum lease payments $ 859,543 $ 1,065,969
XML 77 R66.htm IDEA: XBRL DOCUMENT v3.23.1
COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Sep. 25, 2020
Jan. 02, 2019
Mar. 31, 2021
Dec. 31, 2022
Dec. 31, 2021
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Share based compensation       $ 1,240,129 $ 7,556,282
Operating expense       20,223,897 31,037,683
Termination fee       750,000  
Cost of goods sold       $ 6,043,506 4,774,784
Operating sub lease, expansion description     Company subleased additional office space to support the Company’s expansion plan. The term is for 16 months with no lease obligation remaining as of December 31, 2022.    
Remaining term of lease       4 years 3 months  
Lease liabilities       $ 859,543 1,065,969
Other accrued liabilities, current         476,280
Cenntro Automotive Group Ltd [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Prepaid balance       0 602,016
Cost of goods sold       621,097  
Inventory written-off       1,317,289  
DropCar Operating, Inc. [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Settlement of multiple employment disputes   $ 232,000      
Remaning accounts payable and accrued liabilities         3,500
Legal fees       45,000  
Master Manufacturing Services Agreement [Member] | Karma Automotive, LLC [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Share based compensation $ 1,160,800        
Master Manufacturing Services Agreement [Member] | Karma Automotive, LLC [Member] | Advisor [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Repayments of related party debt 66,845        
Master Manufacturing Services Agreement [Member] | Karma Automotive, LLC [Member] | First Production Level Builds [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Repayments of related party debt 440,000        
Operating expense         641,140
Settlement of multiple employment disputes       468,480  
Pre-production costs       $ 73,333  
Master Manufacturing Services Agreement [Member] | Karma Automotive, LLC [Member] | Setup Costs [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Repayments of related party debt $ 80,000        
New Lease Agreement [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Incremental borrowing rate for the lease     10.41%    
Remaining term of lease       4 years 3 months  
Lease liabilities       $ 306,689 $ 180,404
XML 78 R67.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF RECONCILIATION STATUTORY FEDERAL INCOME TAX RATE (Details) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Income Tax Disclosure [Abstract]    
Income tax benefit at statutory U.S. federal rate $ (4,816,424) $ (6,946,677)
Permanent differences - equity based compensation 51,381 310,384
Income tax benefit attributable to U.S. states (936,810) (965,708)
Permanent difference - non-deductible compensation 765,339
Basis adjustments 70,544
Change in valuation allowance 5,701,853 6,766,118
Total income tax expense
XML 79 R68.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF DEFERRED TAX (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Income Tax Disclosure [Abstract]    
Net operating losses $ 15,843,010 $ 11,733,274
Intangible assets 99,566 85,758
Capitalized research and development expense 1,490,870
Equity based compensation 743,567 569,350
Warrants 156,851 156,851
Accrued compensation 1,467 33,147
Property and equipment 1,492 73,646
Lease liability 210,195 260,674
Other 113,487 93,268
Deferred tax assets 18,660,505 13,005,968
ROU asset (200,379) (247,695)
Deferred tax liabilities (200,379) (247,695)
Valuation allowance 18,460,126 12,758,273
Net deferred tax asset/(liability)
XML 80 R69.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF INCOME TAX EXAMINATION (Details)
12 Months Ended
Dec. 31, 2022
GEORGIA, REPUBLIC OF  
Operating Loss Carryforwards [Line Items]  
Income tax examiation year 2019 to 2022
Domestic Tax Authority [Member]  
Operating Loss Carryforwards [Line Items]  
Income tax examiation year 2016 to 2022
XML 81 R70.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAXES (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Operating Loss Carryforwards [Line Items]    
Deferred tax assets, operating loss carryforward $ 15,843,010 $ 11,733,274
Operating loss carryforwards maturity description 20-year carry forward, with a portion beginning to expire in 2036.  
Capitalization of research and development costs $ 6,845,451 11,449,617
Tax Cuts And Jobs Act [Member]    
Operating Loss Carryforwards [Line Items]    
Capitalization of research and development costs 6,729,353  
Domestic Tax Authority [Member]    
Operating Loss Carryforwards [Line Items]    
Deferred tax assets, operating loss carryforward 64,332,435 48,152,539
Net operating loss carryforwards 995,801  
Operating loss indefinite carryforwards 63,336,634  
State and Local Jurisdiction [Member]    
Operating Loss Carryforwards [Line Items]    
Net operating loss carryforwards $ 48,091,426 $ 34,824,332
XML 82 R71.htm IDEA: XBRL DOCUMENT v3.23.1
SUBSEQUENT EVENTS (Details Narrative)
Jan. 27, 2023
shares
Restricted Stock [Member] | Subsequent Event [Member]  
Subsequent Event [Line Items]  
Issuance of common stock upon vesting of restrcited stock 110,562
XML 83 form10-k_htm.xml IDEA: XBRL DOCUMENT 0001086745 2022-01-01 2022-12-31 0001086745 2022-06-30 0001086745 2023-03-22 0001086745 2021-01-01 2021-12-31 0001086745 2022-12-31 0001086745 2021-12-31 0001086745 AYRO:ConvertiblePreferredStockSeriesHMember 2022-12-31 0001086745 AYRO:ConvertiblePreferredStockSeriesHMember 2021-12-31 0001086745 AYRO:ConvertiblePreferredStockSeriesHThreeMember 2022-12-31 0001086745 AYRO:ConvertiblePreferredStockSeriesHThreeMember 2021-12-31 0001086745 AYRO:ConvertiblePreferredStockSeriesHSixMember 2022-12-31 0001086745 AYRO:ConvertiblePreferredStockSeriesHSixMember 2021-12-31 0001086745 us-gaap:SeriesHPreferredStockMember us-gaap:PreferredStockMember 2020-12-31 0001086745 AYRO:SeriesHThreePreferredStockMember us-gaap:PreferredStockMember 2020-12-31 0001086745 AYRO:SeriesHSixPreferredStockMember us-gaap:PreferredStockMember 2020-12-31 0001086745 us-gaap:CommonStockMember 2020-12-31 0001086745 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001086745 us-gaap:RetainedEarningsMember 2020-12-31 0001086745 2020-12-31 0001086745 us-gaap:SeriesHPreferredStockMember us-gaap:PreferredStockMember 2021-12-31 0001086745 AYRO:SeriesHThreePreferredStockMember us-gaap:PreferredStockMember 2021-12-31 0001086745 AYRO:SeriesHSixPreferredStockMember us-gaap:PreferredStockMember 2021-12-31 0001086745 us-gaap:CommonStockMember 2021-12-31 0001086745 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001086745 us-gaap:RetainedEarningsMember 2021-12-31 0001086745 us-gaap:SeriesHPreferredStockMember us-gaap:PreferredStockMember 2021-01-01 2021-12-31 0001086745 AYRO:SeriesHThreePreferredStockMember us-gaap:PreferredStockMember 2021-01-01 2021-12-31 0001086745 AYRO:SeriesHSixPreferredStockMember us-gaap:PreferredStockMember 2021-01-01 2021-12-31 0001086745 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001086745 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001086745 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001086745 us-gaap:SeriesHPreferredStockMember us-gaap:PreferredStockMember 2022-01-01 2022-12-31 0001086745 AYRO:SeriesHThreePreferredStockMember us-gaap:PreferredStockMember 2022-01-01 2022-12-31 0001086745 AYRO:SeriesHSixPreferredStockMember us-gaap:PreferredStockMember 2022-01-01 2022-12-31 0001086745 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001086745 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001086745 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001086745 us-gaap:SeriesHPreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001086745 AYRO:SeriesHThreePreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001086745 AYRO:SeriesHSixPreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001086745 us-gaap:CommonStockMember 2022-12-31 0001086745 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001086745 us-gaap:RetainedEarningsMember 2022-12-31 0001086745 AYRO:FleetInventoryMember 2022-01-01 2022-12-31 0001086745 AYRO:CenntroAutomotiveGroupLtdMember 2022-01-01 2022-12-31 0001086745 AYRO:ClubCarDiscountMember 2022-01-01 2022-12-31 0001086745 AYRO:ClubCarDiscountMember 2022-12-31 0001086745 srt:MinimumMember 2022-01-01 2022-12-31 0001086745 srt:MaximumMember 2022-01-01 2022-12-31 0001086745 srt:MinimumMember us-gaap:ComputerEquipmentMember 2022-01-01 2022-12-31 0001086745 srt:MaximumMember us-gaap:ComputerEquipmentMember 2022-01-01 2022-12-31 0001086745 srt:MinimumMember us-gaap:FurnitureAndFixturesMember 2022-01-01 2022-12-31 0001086745 srt:MaximumMember us-gaap:FurnitureAndFixturesMember 2022-01-01 2022-12-31 0001086745 srt:MinimumMember us-gaap:MachineryAndEquipmentMember 2022-01-01 2022-12-31 0001086745 srt:MaximumMember us-gaap:MachineryAndEquipmentMember 2022-01-01 2022-12-31 0001086745 us-gaap:LeaseholdImprovementsMember 2022-01-01 2022-12-31 0001086745 AYRO:OptionsToPurchaseCommonStockMember 2022-01-01 2022-12-31 0001086745 AYRO:OptionsToPurchaseCommonStockMember 2021-01-01 2021-12-31 0001086745 AYRO:RestrictedStockUnvestedMember 2022-01-01 2022-12-31 0001086745 AYRO:RestrictedStockUnvestedMember 2021-01-01 2021-12-31 0001086745 AYRO:RestrictedStockVestedUnissuedMember 2022-01-01 2022-12-31 0001086745 AYRO:RestrictedStockVestedUnissuedMember 2021-01-01 2021-12-31 0001086745 AYRO:WarrantsOutstandingMember 2022-01-01 2022-12-31 0001086745 AYRO:WarrantsOutstandingMember 2021-01-01 2021-12-31 0001086745 AYRO:PreferredStockOutstandingMember 2022-01-01 2022-12-31 0001086745 AYRO:PreferredStockOutstandingMember 2021-01-01 2021-12-31 0001086745 us-gaap:ProductMember 2022-01-01 2022-12-31 0001086745 us-gaap:ProductMember 2021-01-01 2021-12-31 0001086745 AYRO:ShippingRevenueMember 2022-01-01 2022-12-31 0001086745 AYRO:ShippingRevenueMember 2021-01-01 2021-12-31 0001086745 AYRO:MiscellaneousIncomeMember 2022-01-01 2022-12-31 0001086745 AYRO:MiscellaneousIncomeMember 2021-01-01 2021-12-31 0001086745 AYRO:ServiceIncomeMember 2022-01-01 2022-12-31 0001086745 AYRO:ServiceIncomeMember 2021-01-01 2021-12-31 0001086745 AYRO:FleetInventoryMember 2021-01-01 2021-12-31 0001086745 AYRO:CenntroAutomotiveGroupLtdMember 2021-12-31 0001086745 AYRO:ComputerAndEquipmentMember 2022-12-31 0001086745 AYRO:ComputerAndEquipmentMember 2021-12-31 0001086745 us-gaap:FurnitureAndFixturesMember 2022-12-31 0001086745 us-gaap:FurnitureAndFixturesMember 2021-12-31 0001086745 us-gaap:LeaseholdImprovementsMember 2022-12-31 0001086745 us-gaap:LeaseholdImprovementsMember 2021-12-31 0001086745 AYRO:PrototypesMember 2022-12-31 0001086745 AYRO:PrototypesMember 2021-12-31 0001086745 AYRO:ComputerSoftwareMember 2022-12-31 0001086745 AYRO:ComputerSoftwareMember 2021-12-31 0001086745 AYRO:RetiringLegacyAssetsMember 2022-01-01 2022-12-31 0001086745 us-gaap:BondsMember 2022-12-31 0001086745 us-gaap:BondsMember 2022-01-01 2022-12-31 0001086745 us-gaap:USTreasurySecuritiesMember 2022-12-31 0001086745 us-gaap:USTreasurySecuritiesMember 2022-01-01 2022-12-31 0001086745 AYRO:JanuaryTwentyTwentyOneOfferingMember AYRO:AdditionalSharesMember AYRO:SecuritiesPurchaseAgreementMember 2021-01-24 2021-01-25 0001086745 AYRO:JanuaryTwentyTwentyOneOfferingMember AYRO:AdditionalSharesMember AYRO:SecuritiesPurchaseAgreementMember 2021-01-25 0001086745 AYRO:AdditionalSharesMember AYRO:SecuritiesPurchaseAgreementMember 2021-02-10 2021-02-11 0001086745 AYRO:AdditionalSharesMember AYRO:SecuritiesPurchaseAgreementMember 2021-02-11 0001086745 us-gaap:InvestorMember AYRO:AdditionalSharesMember AYRO:SecuritiesPurchaseAgreementMember 2021-02-10 2021-02-11 0001086745 us-gaap:InvestorMember AYRO:AdditionalSharesMember AYRO:SecuritiesPurchaseAgreementMember 2021-02-11 0001086745 AYRO:AdditionalSharesMember AYRO:SecuritiesPurchaseAgreementMember 2021-03-16 2021-03-17 0001086745 us-gaap:InvestorMember AYRO:SecuritiesPurchaseAgreementMember 2020-07-20 2020-07-21 0001086745 AYRO:AdditionalSharesMember AYRO:SecuritiesPurchaseAgreementMember 2020-07-21 0001086745 AYRO:SecuritiesPurchaseAgreementMember 2020-07-20 2020-07-21 0001086745 us-gaap:WarrantMember AYRO:SecuritiesPurchaseAgreementMember 2021-02-01 2021-02-28 0001086745 AYRO:SecuritiesPurchaseAgreementMember 2021-02-01 2021-02-28 0001086745 AYRO:SecuritiesPurchaseAgreementMember 2021-01-01 2021-12-31 0001086745 us-gaap:RestrictedStockMember 2021-01-01 2021-12-31 0001086745 us-gaap:RestrictedStockMember 2022-01-01 2022-12-31 0001086745 srt:DirectorMember us-gaap:RestrictedStockMember AYRO:TwoThousandAndTwentyLongTermIncentivePlanMember 2021-02-20 2021-02-24 0001086745 srt:DirectorMember us-gaap:RestrictedStockMember AYRO:TwoThousandAndTwentyLongTermIncentivePlanMember 2021-02-24 0001086745 us-gaap:RestrictedStockMember us-gaap:CommonStockMember 2021-12-31 0001086745 srt:DirectorMember us-gaap:RestrictedStockMember AYRO:TwoThousandAndTwentyLongTermIncentivePlanMember 2022-01-29 2022-02-01 0001086745 srt:DirectorMember us-gaap:RestrictedStockMember AYRO:TwoThousandAndTwentyLongTermIncentivePlanMember 2022-02-01 0001086745 srt:DirectorMember us-gaap:RestrictedStockMember AYRO:TwoThousandAndTwentyLongTermIncentivePlanMember 2022-01-01 2022-12-31 0001086745 us-gaap:PreferredStockMember 2022-01-01 2022-12-31 0001086745 us-gaap:SeriesHPreferredStockMember 2022-12-31 0001086745 us-gaap:SeriesHPreferredStockMember 2022-01-01 2022-12-31 0001086745 AYRO:AffiliatesMember us-gaap:SeriesHPreferredStockMember 2022-12-31 0001086745 AYRO:SeriesHThreePreferredStockMember 2022-12-31 0001086745 AYRO:SeriesHThreeWarrantsMember 2022-12-31 0001086745 AYRO:AffiliatesMember AYRO:SeriesHThreePreferredStockMember 2022-12-31 0001086745 AYRO:SeriesHSixConvertibePreferredStockMember 2020-02-05 0001086745 AYRO:SeriesHSixConvertibePreferredStockMember 2020-02-04 2020-02-05 0001086745 AYRO:SeriesHSixConvertibePreferredStockMember 2022-01-01 2022-12-31 0001086745 AYRO:AffiliatesMember AYRO:SeriesHSixConvertibePreferredStockMember 2020-02-05 0001086745 us-gaap:PreferredStockMember 2022-12-31 0001086745 AYRO:SeedWarrantsMember 2022-12-31 0001086745 AYRO:SeriesIWarrantsMember 2022-12-31 0001086745 AYRO:SeriesIWarrantsMember 2022-01-01 2022-12-31 0001086745 AYRO:SeriesIWarrantsMember 2021-12-31 0001086745 AYRO:SeriesHFourWarrantsMember 2022-12-31 0001086745 AYRO:SeriesJWarrantsMember 2022-12-31 0001086745 AYRO:SeriesJWarrantsMember 2022-01-01 2022-12-31 0001086745 AYRO:SeriesHFiveWarrantsMember 2022-12-31 0001086745 AYRO:SeriesHFiveWarrantsMember 2022-01-01 2022-12-31 0001086745 srt:MinimumMember AYRO:SeriesHFiveWarrantsMember 2022-12-31 0001086745 srt:MaximumMember AYRO:SeriesHFiveWarrantsMember 2022-12-31 0001086745 srt:MaximumMember AYRO:SeriesHFiveWarrantsMember 2022-01-01 2022-12-31 0001086745 AYRO:JuneFinderWarrantsMember 2020-06-19 0001086745 AYRO:JunePlacementAgentWarrantsMember 2020-06-19 0001086745 AYRO:JunePlacementAgentWarrantsMember 2020-12-31 0001086745 AYRO:JuneFinderWarrantsMember 2022-12-31 0001086745 AYRO:JulyEightFinderWarrantsMember 2020-07-08 0001086745 AYRO:JulyEightPlacementAgentWarrantsMember 2020-07-08 0001086745 AYRO:JulyEightFinderWarrantsMember 2022-12-31 0001086745 AYRO:JulyEightPlacementAgentWarrantsMember 2022-12-31 0001086745 AYRO:JulyTwentyTwoPlacementAgentWarrantsMember 2020-07-22 0001086745 AYRO:JulyTwentyTwoPlacementAgentWarrantsMember 2022-12-31 0001086745 AYRO:SeptemberWarrantMember 2020-09-25 0001086745 AYRO:SeptemberWarrantMember 2020-09-24 2020-09-25 0001086745 AYRO:SeptemberWarrantMember 2020-10-01 2020-12-31 0001086745 AYRO:SeptemberWarrantMember 2022-12-31 0001086745 AYRO:SeriesAWarrantsAndSeriesBMember AYRO:SecuritiesPurchaseAgreementMember 2020-11-21 2020-11-22 0001086745 AYRO:SeriesAWarrantsMember AYRO:SecuritiesPurchaseAgreementMember 2020-11-22 0001086745 AYRO:SeriesBWarrantsMember AYRO:SecuritiesPurchaseAgreementMember 2020-11-22 0001086745 AYRO:SeriesAWarrantsMember AYRO:SecuritiesPurchaseAgreementMember 2022-12-31 0001086745 AYRO:SeriesBWarrantsMember AYRO:SecuritiesPurchaseAgreementMember 2022-12-31 0001086745 AYRO:NovemberFinderWarrantsMember 2020-11-22 0001086745 AYRO:NovemberPlacementAgentWarrantsMember 2020-11-22 0001086745 AYRO:NovemberPlacementAgentWarrantsMember 2020-11-21 2020-11-22 0001086745 AYRO:JanuaryTwentyTwentyOneOfferingMember AYRO:SecuritiesPurchaseAgreementMember 2021-01-24 2021-01-25 0001086745 AYRO:AdditionalSharesMember AYRO:SecuritiesPurchaseAgreementMember 2021-01-25 0001086745 AYRO:SecuritiesPurchaseAgreementMember 2021-01-24 2021-01-25 0001086745 AYRO:JanuaryTwentyTwentyOneOfferingMember AYRO:SecuritiesPurchaseAgreementMember 2021-01-25 0001086745 AYRO:SecuritiesPurchaseAgreementMember 2021-01-25 0001086745 AYRO:SecuritiesPurchaseAgreementMember 2022-12-31 0001086745 AYRO:FebruaryFinderWarrantsMember 2021-02-11 0001086745 AYRO:FebruaryFinderWarrantsMember us-gaap:CommonStockMember 2021-02-11 0001086745 AYRO:FebruaryPlacementAgentWarrantsMember 2021-02-11 0001086745 AYRO:FebruaryFinderWarrantsMember 2022-12-31 0001086745 AYRO:FebruaryPlacementAgentWarrantsMember 2022-12-31 0001086745 AYRO:SeriesHConvertiblePreferredStockMember 2022-01-01 2022-12-31 0001086745 AYRO:ConvertiblePreferredStockSeriesHThreeMember 2022-01-01 2022-12-31 0001086745 AYRO:SeriesHSixConvertiblePreferredStockMember 2022-01-01 2022-12-31 0001086745 AYRO:TwoThousandTwentyLongTermIncentivePlanMember 2022-12-31 0001086745 AYRO:TwoThousandTwentyLongTermIncentivePlanMember 2022-01-01 2022-12-31 0001086745 AYRO:TwoThousandSeventeenLongTermIncentivePlanMember 2022-12-31 0001086745 AYRO:TwoThousandFourteenEquityIncentivePlanMember AYRO:DropCarIncMember 2022-12-31 0001086745 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0001086745 us-gaap:EmployeeStockOptionMember 2022-12-31 0001086745 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-12-31 0001086745 us-gaap:EmployeeStockOptionMember 2022-05-05 2022-05-06 0001086745 AYRO:DirectorsMember us-gaap:RestrictedStockMember 2020-09-01 2020-09-30 0001086745 AYRO:DirectorsMember us-gaap:RestrictedStockMember 2022-01-01 2022-12-31 0001086745 AYRO:DirectorsMember us-gaap:RestrictedStockMember 2021-01-01 2021-12-31 0001086745 AYRO:KellerAwardMember us-gaap:RestrictedStockMember 2020-12-01 2020-12-31 0001086745 AYRO:KellerAwardMember us-gaap:RestrictedStockMember 2021-09-01 2021-09-30 0001086745 AYRO:KellerAwardMember us-gaap:RestrictedStockMember 2022-01-01 2022-12-31 0001086745 AYRO:KellerAwardMember us-gaap:RestrictedStockMember 2021-01-01 2021-12-31 0001086745 AYRO:DirectorsMember us-gaap:RestrictedStockMember AYRO:TwoThousandAndTwentyLongTermIncentivePlanMember 2021-02-23 2021-02-24 0001086745 AYRO:DirectorsMember us-gaap:RestrictedStockMember AYRO:TwoThousandAndTwentyLongTermIncentivePlanMember 2021-02-24 0001086745 AYRO:DirectorsMember us-gaap:RestrictedStockMember AYRO:TwoThousandAndTwentyLongTermIncentivePlanMember 2021-01-01 2021-12-31 0001086745 us-gaap:RestrictedStockMember AYRO:ThomasMWittenschlaegerMember 2021-09-01 2021-09-30 0001086745 us-gaap:RestrictedStockMember AYRO:ThomasMWittenschlaegerMember 2021-09-30 0001086745 us-gaap:RestrictedStockMember AYRO:ThomasMWittenschlaegerMember 2022-01-01 2022-12-31 0001086745 us-gaap:RestrictedStockMember AYRO:ThomasMWittenschlaegerMember 2021-01-01 2021-12-31 0001086745 us-gaap:RestrictedStockMember AYRO:ThomasMWittenschlaegerMember 2022-12-31 0001086745 srt:DirectorMember us-gaap:RestrictedStockMember 2022-01-29 2022-02-01 0001086745 srt:DirectorMember us-gaap:RestrictedStockMember 2022-02-01 0001086745 us-gaap:RestrictedStockMember 2022-12-31 0001086745 AYRO:DavidEHollingsworthMember us-gaap:RestrictedStockMember 2022-08-23 2022-08-23 0001086745 AYRO:DavidEHollingsworthMember us-gaap:RestrictedStockMember 2022-08-23 0001086745 us-gaap:RestrictedStockMember AYRO:DavidEHollingsworthMember 2022-01-01 2022-12-31 0001086745 us-gaap:RestrictedStockMember AYRO:DavidEHollingsworthMember 2021-01-01 2021-12-31 0001086745 AYRO:ResearchAndDevelopmentMember 2022-01-01 2022-12-31 0001086745 AYRO:ResearchAndDevelopmentMember 2021-01-01 2021-12-31 0001086745 AYRO:SalesAndMarketingMember 2022-01-01 2022-12-31 0001086745 AYRO:SalesAndMarketingMember 2021-01-01 2021-12-31 0001086745 AYRO:GeneralAndAdministrativeMember 2022-01-01 2022-12-31 0001086745 AYRO:GeneralAndAdministrativeMember 2021-01-01 2021-12-31 0001086745 us-gaap:RestrictedStockUnitsRSUMember 2020-12-31 0001086745 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-12-31 0001086745 us-gaap:RestrictedStockUnitsRSUMember 2021-12-31 0001086745 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0001086745 us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001086745 AYRO:SalesRevenueMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001086745 AYRO:OneCustomerMember AYRO:SalesRevenueMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001086745 AYRO:TwoCustomerMember AYRO:SalesRevenueMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001086745 AYRO:OneCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001086745 AYRO:OneSupplierMember us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember 2022-01-01 2022-12-31 0001086745 AYRO:OneSupplierMember us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember 2021-01-01 2021-12-31 0001086745 AYRO:TwoSupplierMember us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember 2022-01-01 2022-12-31 0001086745 AYRO:TwoSupplierMember us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember 2021-01-01 2021-12-31 0001086745 AYRO:ThreeSupplierMember us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember 2022-01-01 2022-12-31 0001086745 srt:BoardOfDirectorsChairmanMember 2022-12-31 0001086745 AYRO:MasterManufacturingServicesAgreementMember AYRO:KarmaAutomotiveLLCMember 2020-09-24 2020-09-25 0001086745 AYRO:FirstProductionLevelBuildsMember AYRO:MasterManufacturingServicesAgreementMember AYRO:KarmaAutomotiveLLCMember 2020-09-24 2020-09-25 0001086745 AYRO:SetupCostsMember AYRO:MasterManufacturingServicesAgreementMember AYRO:KarmaAutomotiveLLCMember 2020-09-24 2020-09-25 0001086745 AYRO:AdvisorMember AYRO:MasterManufacturingServicesAgreementMember AYRO:KarmaAutomotiveLLCMember 2020-09-24 2020-09-25 0001086745 AYRO:FirstProductionLevelBuildsMember AYRO:MasterManufacturingServicesAgreementMember AYRO:KarmaAutomotiveLLCMember 2021-01-01 2021-12-31 0001086745 AYRO:FirstProductionLevelBuildsMember AYRO:MasterManufacturingServicesAgreementMember AYRO:KarmaAutomotiveLLCMember 2022-01-01 2022-12-31 0001086745 AYRO:FirstProductionLevelBuildsMember AYRO:MasterManufacturingServicesAgreementMember AYRO:KarmaAutomotiveLLCMember 2022-12-31 0001086745 AYRO:CenntroAutomotiveGroupLtdMember 2022-12-31 0001086745 2021-03-01 2021-03-31 0001086745 AYRO:NewLeaseAgreementMember 2021-03-01 2021-03-31 0001086745 AYRO:NewLeaseAgreementMember 2022-12-31 0001086745 AYRO:NewLeaseAgreementMember 2021-12-31 0001086745 AYRO:DropCarOperatingIncMember 2019-01-01 2019-01-02 0001086745 AYRO:DropCarOperatingIncMember 2021-12-31 0001086745 AYRO:DropCarOperatingIncMember 2022-01-01 2022-12-31 0001086745 us-gaap:DomesticCountryMember 2022-12-31 0001086745 us-gaap:DomesticCountryMember 2021-12-31 0001086745 us-gaap:StateAndLocalJurisdictionMember 2022-12-31 0001086745 us-gaap:StateAndLocalJurisdictionMember 2021-12-31 0001086745 AYRO:TaxCutsAndJobsActMember 2022-01-01 2022-12-31 0001086745 us-gaap:DomesticCountryMember 2022-01-01 2022-12-31 0001086745 country:GE 2022-01-01 2022-12-31 0001086745 us-gaap:RestrictedStockMember us-gaap:SubsequentEventMember 2023-01-26 2023-01-27 iso4217:USD shares iso4217:USD shares pure 0001086745 false FY 10-K true 2022-12-31 --12-31 2022 false 001-34643 AYRO, INC. DE 98-0204758 900 E. Old Settlers Boulevard Suite 100 Round Rock TX 78664 (512) 994-4917 Common Stock, par value $0.0001 per share AYRO NASDAQ No No No No Yes Yes Non-accelerated Filer true false false false 30220995 37352203 Portions of the definitive Proxy Statement of AYRO, Inc., relating to the Annual Meeting of Stockholders to be filed within 120 days after the end of the fiscal year covered by this Form 10-K, are incorporated into Part III of this Form 10-K by reference. 688 711 Marcum LLP East Hanover, New Jersey Friedman LLP East Hanover, New Jersey 39096562 69160466 9848804 510071 969429 970381 3744037 1478845 2276178 51904663 76150110 2192337 835160 819401 1012884 73683 129610 54990084 78127764 1107215 647050 964937 2990513 165767 206426 2237919 3843989 693776 859543 2931695 4703532 20000000 20000000 0.0001 0.0001 8500 8500 8 8 8 8 0.0001 0.0001 8461 8461 1234 1234 1234 1234 0.0001 0.0001 50000 50000 50 50 50 50 0.0001 0.0001 100000000 100000000 37241642 37241642 36866956 36866956 3724 3687 133224249 131654776 -81169584 -58234231 52058389 73424232 54990084 78127764 2990497 2683597 6043506 4774784 -3053009 -2091187 6845451 11449617 1874658 2419168 11503788 17168898 20223897 31037683 -23276906 -33128870 182276 51768 2312 160990 -1713 341553 49456 -22935353 -33079414 -22935353 -33079414 -0.62 -0.94 37048975 35171935 8 1234 50 27088584 2709 64509724 -25154817 39357616 15000 2 42298 42300 8035835 804 58269025 58269829 13642 1 99999 100000 555004 55 1506944 1506999 7226902 7226902 1158891 116 -116 -33079414 -33079414 8 1234 50 36866956 3687 131654776 -58234231 73424232 8 1234 50 36866956 3687 131654776 -58234231 73424232 65291 65291 374686 37 1504182 1504219 -22935353 -22935353 8 1234 50 37241642 3724 133224249 -81169584 52058389 8 1234 50 37241642 3724 133224249 -81169584 52058389 -22935353 -33079414 762206 527584 1240129 7556282 193483 206375 4485 99309 160990 -1713 2476322 -454873 302887 -830845 2666327 581846 667416 -18797 18797 445165 -120155 -1272046 2038365 -24000 -206426 -180404 -18728643 -26631485 1588689 538012 9689526 57046 62351 -11335261 -600363 21611 100000 1506999 58269829 59855217 -30063904 32623369 69160466 36537097 39096562 69160466 1971 329380 329380 348932 120440 <p id="xdx_804_eus-gaap--NatureOfOperations_zaSfyI6R63nd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1. <span id="xdx_829_z5VropUUR0sl">ORGANIZATION AND NATURE OF OPERATIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AYRO, Inc. (“AYRO” or the “Company”), a Delaware corporation formerly known as DropCar, Inc. (“DropCar”), a corporation headquartered outside Austin, Texas, is the merger successor discussed below of AYRO Operating Company, Inc., which was formed under the laws of the State of Texas on May 17, 2016 as Austin PRT Vehicle, Inc. and subsequently changed its name to Austin EV, Inc. under an Amended and Restated Certificate of Formation filed with the State of Texas on March 9, 2017. On July 24, 2019, the Company changed its name to AYRO, Inc. and converted its corporate domicile to Delaware. The Company was founded on the basis of promoting resource sustainability. The Company, and its wholly-owned subsidiaries, are principally engaged in manufacturing and sales of environmentally-conscious, minimal-footprint electric vehicles. The all-electric vehicles are typically sold both directly to customers and to dealers in the United States.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Merger</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 28, 2020, pursuant to the previously announced Agreement and Plan of Merger, dated December 19, 2019 (the “Merger Agreement”), by and among AYRO, Inc., a Delaware corporation previously known as DropCar, Inc., ABC Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Company (“Merger Sub”), and AYRO Operating Company (“AYRO Operating”), a Delaware corporation previously known as AYRO, Inc., Merger Sub was merged with and into AYRO Operating, with AYRO Operating continuing after the merger as the surviving entity and a wholly owned subsidiary of the Company (the “Merger”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><i>Strategic Review</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following the hiring of the Company’s current Chief Executive Officer in the third quarter of 2021, the Company initiated a strategic review of their product development strategy, as they focus on creating value within the electric vehicle, last-mile delivery, and smart payload and enabling infrastructure markets. In connection with the strategic review, the Company canceled development of its planned next-generation three-wheeled high speed vehicle.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December of 2021 the Company began research and development on the Vanish, including updates on their supply chain evolution, offshoring/onshoring mix, manufacturing strategy, and annual model year refresh program.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_806_ecustom--LiquidityAndOtherUncertainitiesTextBlock_zaZCx5m5Tae6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2. <span id="xdx_820_zbgdqd2wgUfl">LIQUIDITY AND OTHER UNCERTAINTIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Liquidity and Other Uncertainties</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States (“GAAP”), which contemplates continuation of the Company as a going concern. The Company is subject to a number of risks similar to those of earlier stage commercial companies, including dependence on key individuals and products, the difficulties inherent in the development of a commercial market, the potential need to obtain additional capital, competition from larger companies, other technology companies and other technologies. The Company has a limited operating history and the sales and income potential of its business and market are unproven. The Company incurred net losses of $<span id="xdx_90F_eus-gaap--NetIncomeLoss_iN_di_c20220101__20221231_zp1YqaOByeTc" title="Net losses">22,935,353</span> for the year ended December 31, 2022, and negative cash flows from operations of $<span id="xdx_906_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pp0d_di_c20220101__20221231_zCGprR1kzTn2" title="Net cash provided by (used in) operating activities">18,728,643</span> for the year ended December 31, 2022. At December 31, 2022, the Company had cash balances totaling $<span id="xdx_90B_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20221231_zL7GiAJoqg71" title="Cash and cash equivalents, at carrying value">39,096,562</span> and $<span id="xdx_90D_eus-gaap--MarketableSecuritiesCurrent_iI_c20221231_ztrLUfJHRtO5" title="Marketable securities, current">9,848,804</span> in marketable securities. In addition, overall working capital decreased by $<span id="xdx_901_ecustom--WorkingCapital_iI_c20221231_zYlKBJDERQqk" title="Working capital">22,639,376</span> during the year ended December 31, 2022. Management believes that the existing cash at December 31, 2022 will be sufficient to fund operations for at least the next twelve months following the issuance of these consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AYRO, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company may experience increases in the cost or a sustained interruption in the supply or shortage of raw materials, including lithium-ion battery cells, semiconductors, and integrated circuits. Any such increase or supply interruption could materially negatively impact the business, prospects, financial condition and operating results. Currently, the Company is experiencing supply chain shortages, including with respect to lithium-ion battery cells, integrated circuits, vehicle control chips, and displays. Certain production-ready components may be delayed in shipment to company facilities which has and may continue to cause delays in validation and testing for these components, which would in turn create a delay in the availability of saleable vehicles.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company uses various raw materials, including aluminum, steel, carbon fiber, non-ferrous metals (such as copper), and cobalt. The prices for these raw materials fluctuate depending on market conditions, and global demand and could adversely affect business and operating results. For instance, the Company is exposed to multiple risks relating to price fluctuations for lithium-ion cells. These risks include:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the inability or unwillingness of current battery manufacturers to build or operate battery cell manufacturing plants to supply the numbers of lithium-ion cells required to support the growth of the electric vehicle industry as demand for such cells increases;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">disruption in the supply of cells due to quality issues or recalls by the battery cell manufacturers; and</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an increase in the cost of raw materials, such as cobalt, used in lithium-ion cells.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any disruption in the supply of lithium-ion battery cells, semiconductors, or integrated circuits could temporarily disrupt production of the Company’s vehicles until a different supplier is fully qualified. Moreover, battery cell manufacturers may refuse to supply electric vehicle manufacturers if they determine that the vehicles are not sufficiently safe. Furthermore, fluctuations or shortages in petroleum and other economic conditions may cause the Company to experience significant increases in freight charges and raw material costs. Substantial increases in the prices for our raw materials would increase operating costs and could reduce our margins if the increased costs cannot be recouped through increased electric vehicle prices. There can be no assurance that the Company will be able to recoup increasing costs of raw materials by increasing vehicle prices.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have made certain indemnities, under which we may be required to make payments to an indemnified party, in relation to certain transactions. We indemnify our directors and officers to the maximum extent permitted under the laws of the State of Delaware. In connection with our facility leases, we have indemnified our lessors for certain claims arising from the use of the facilities. The duration of the indemnities vary and, in many cases, are indefinite. These indemnities do not provide for any limitation of the maximum potential future payments we could be obligated to make. Historically, we have not been obligated to make any payments for these obligations and no liabilities have been recorded for these indemnities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 3, 2022, AYRO, Inc. (the “Company”) received a letter from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) indicating that, based upon the closing bid price of the Company’s common stock for the 30 consecutive business day period between August 19, 2022 and September 30, 2022, the Company did not meet the minimum bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2). The letter also indicated that the Company will be provided with a compliance period of 180 calendar days, or until April 3, 2023 (the “Compliance Period”), in which to regain compliance pursuant to Nasdaq Listing Rule 5810(c)(3)(A).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AYRO, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> -22935353 -18728643 39096562 9848804 22639376 <p id="xdx_80E_eus-gaap--SignificantAccountingPoliciesTextBlock_z1e4PWi3Rzg9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3. <span id="xdx_82F_zOiZ0MwUrvr4">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--ConsolidationPolicyTextBlock_zb2lnprPww7j" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_zH55zj6ENpbf">Basis of Presentation and Principles of Consolidation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements represent the consolidation of the accounts of the Company and its subsidiary in conformity with GAAP. All intercompany accounts and transactions have been eliminated in consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_843_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_z1peRiOO8mRh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zjHnzSNvR2uj">Reclassification</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain 2021 amounts were classified to conform to the current year presentation. Intangible assets were included into other assets on the consolidated balance sheet for current and prior year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_841_eus-gaap--UseOfEstimates_z5F4CM2h3yxc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_864_zBOdQGcCqXe9">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the consolidated financial statements, in conformity with GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenue and expenses during the reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zLMaflQdSwL8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_zg8EaWEcFQTb">Cash and Cash Equivalents</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company considers all highly-liquid investments purchased with a maturity of three months or less at the time of purchase to be cash equivalents. The Company maintains total cash balances in one account which exceeds the federally insured limits. Management does not believe this results in any significant credit risk. The Company has no cash equivalents as of December 31, 2022 and 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--MarketableSecuritiesPolicy_zB24GWLvTnM1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_za3Ch14r1SZ1">Marketable Securities</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marketable securities include investment in fixed income bonds and U.S. Treasury securities that are considered to be highly liquid and easily tradeable. The marketable securities are considered trading securities and are measured at fair value and are accounted for in accordance with ASC 320. The marketable securities are valued using inputs observable in active markets for identical securities and are therefore classified as Level 1 within the Company’s fair value hierarchy. The Company held $<span id="xdx_90C_eus-gaap--MarketableSecuritiesCurrent_iI_c20221231_zapeDCKq38Q5" title="Marketable securities">9,848,804</span> in marketable securities as of December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zLVpbW96kaQa" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_zf8pIM3ZIZDa">Fair Value Measurements</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company applies Accounting Standards Codification (“ASC”) 820, <i>Fair Value Measurement </i>(“ASC 820”), which establishes a framework for measuring fair value and clarifies the definition of fair value within that framework. ASC 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company’s principal or most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established in ASC 820 generally requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity’s own assumptions based on market data and the entity’s judgments about the assumptions that market participants would use in pricing the asset or liability and are to be developed based on the best information available in the circumstances.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The carrying amounts of financial instruments reported in the accompanying consolidated financial statements for current assets and current liabilities approximate the fair value because of the immediate or short-term maturities of the financial instruments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AYRO, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The valuation hierarchy is composed of three levels. The classification within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The levels within the valuation hierarchy are described below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1 — Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2 — Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3 — Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The marketable securities are considered trading securities and are measured at fair value and are accounted for in accordance with ASC 320. The marketable securities are valued using inputs observable in active markets for identical securities and are therefore classified as Level 1 within the Company’s fair value hierarchy.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_840_eus-gaap--ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_zSw1qEHvwZIc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zz98dCQRHbX">Accounts Receivable, Net</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the normal course of business, the Company extends credit to customers. Accounts receivable, less the allowance for doubtful accounts, reflect the net realizable value of receivables and approximate fair value. An allowance for doubtful accounts is maintained and reflects the best estimate of probable losses determined principally on the basis of historical experience and specific allowances for known troubled accounts. All accounts or portions thereof that are deemed to be uncollectible or that require an excessive collection cost are written off to the allowance for doubtful accounts. As of December 31, 2022 and 2021, the Company had reserved an allowance for doubtful accounts of $<span id="xdx_90D_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_c20221231_zjCdmJc0DNd5" title="Allowance for doubtful accounts">2,349</span> and $<span id="xdx_908_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_c20211231_zh3HI8PdkCBk" title="Allowance for doubtful accounts">173,138</span>, respectively. All account receivables are made on an unsecured basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--InventoryPolicyTextBlock_zDe9jzWeNyug" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_zYODmDFQo8Ka">Inventory</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory consists of purchased chassis, cabs, batteries, truck beds and component parts which includes cost of raw materials, freight, direct labor, and related production overhead and are stated at the lower of cost or net realizable value, as determined using a first-in, first-out method. Inventory also includes a fleet of internally manufactured vehicles that serve demonstration and other purposes, the balance of which is being depreciated over their useful lives. Management compares the cost of inventory with the net realizable value and, if applicable, an allowance is made for writing down the inventory to its net realizable value, if lower than cost. On an ongoing basis, inventory is reviewed for potential write-down for estimated obsolescence or unmarketable inventory based upon forecasts for future demand and market conditions. At June 30, 2022, we determined that testing of obsolescence was required for inventory due to the quality of certain purchased components from Cenntro’s lithium-ion (“NCM”) line. 17 vehicles tested in the second quarter of 2022 were determined to have 49 unique failures. An inspection of the remaining NCM units revealed a 100% failure rate. As a result, all inventory associated with Cenntro’s NCM line was written off for $<span id="xdx_903_eus-gaap--InventoryWriteDown_c20220101__20221231__us-gaap--PublicUtilitiesInventoryAxis__custom--FleetInventoryMember_zCzVSuijrLvg" title="Inventory written-off">1,317,289</span> to cost of goods sold. As of December 31, 2022, there was no longer a balance. The remainder of the balance was expensed through cost of goods sold for $<span id="xdx_905_eus-gaap--CostOfGoodsAndServicesSold_c20220101__20221231__dei--LegalEntityAxis__custom--CenntroAutomotiveGroupLtdMember_zp0Iry8BpTKj" title="Cost of goods sold">621,097</span>. During the year ended December 31, 2022, a $<span id="xdx_904_eus-gaap--InventoryWriteDown_c20220101__20221231__us-gaap--PublicUtilitiesInventoryAxis__custom--ClubCarDiscountMember_zC0EEhx1abj4" title="Inventory write down">413,561</span> net realizable value adjustment was recorded due to the Club Car Discount (as defined below), spare inventory for the 411x was written off, net with the inventory reserve of $<span id="xdx_905_eus-gaap--InventoryValuationReserves_iI_c20221231__us-gaap--PublicUtilitiesInventoryAxis__custom--ClubCarDiscountMember_zqkUSkdUf8ig" title="Inventory reserves">124,375</span>, and $<span id="xdx_90F_eus-gaap--ProductionRelatedImpairmentsOrCharges_c20220101__20221231__us-gaap--PublicUtilitiesInventoryAxis__custom--ClubCarDiscountMember_zSIpNYufqTbk" title="Impairment of inventory">2,476,322</span> was expensed for impairment of inventory.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_z2U0X4NQapS5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_864_z9XinSFY2nX9">Property and Equipment, Net</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment, net, are stated at cost, less accumulated depreciation. Depreciation is recorded over the shorter of the estimated useful life, of one to ten years, or the lease term of the applicable assets using the straight-line method beginning on the date an asset is placed in service. The Company regularly evaluates the estimated remaining useful lives of the Company’s property and equipment, net, to determine whether events or changes in circumstances warrant a revision to the remaining period of depreciation. Maintenance and repairs are charged to expense when incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AYRO, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_892_ecustom--ScheduleOfEstimatedUsefulLivesTableTextBlock_zF4n8Yb4u812" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The estimated useful lives for significant property and equipment categories are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_zLjvzmjCbjIc" style="display: none">SCHEDULE OF ESTIMATED USEFUL LIVES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; width: 70%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer Equipment and Software </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MinimumMember_zJyg2IzuSzU7" title="Property plant and equipment, estimated useful lives">1</span> – <span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MaximumMember_z1T2V1M9CN37" title="Property plant and equipment, estimated useful lives">3</span> years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and Fixtures</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_z1QpT6gv03ei" title="Property plant and equipment, estimated useful lives">2</span> – <span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_ziOIecwuNt2b" title="Property plant and equipment, estimated useful lives">7</span> years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Machinery and Equipment </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MinimumMember_zF9bWyVAWr7g" title="Property plant and equipment, estimated useful lives">3</span> – <span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MaximumMember_zCaboujnsURk" title="Property plant and equipment, estimated useful lives">10</span> years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold Improvements</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zc86LanJQ5zb" title="Property plant and equipment, estimated useful lives">Shorter of useful or lease life</span></span></td></tr> </table> <p id="xdx_8A0_zhVtK9NWBkH4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_zjjSqAqLvn7l" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_864_zsz769bskuef">Long-Lived Assets, Including Definite-Lived Intangible Assets</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets are stated at cost less accumulated amortization. Amortization is generally recorded on a straight-line basis over estimated useful life of <span id="xdx_909_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zXToMOGNL5zb" title="Estimated useful life of intangible assets">3</span>-<span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zSaQTzvMbZW5" title="Estimated useful life of intangible assets">10</span> years. The Company periodically reviews the estimated useful lives of intangible assets and makes adjustments when events indicate that a shorter life is appropriate.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-lived assets are evaluated for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable through the estimated undiscounted future cash flows derived from such assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Factors that the Company considers in deciding when to perform an impairment review include significant changes in the Company’s forecasted projections for the asset or asset group for reasons including, but not limited to, significant under-performance of a product in relation to expectations, significant changes, or planned changes in the Company’s use of the assets, significant negative industry or economic trends, and new or competing products that enter the marketplace. The impairment test is based on a comparison of the undiscounted cash flows expected to be generated from the use of the asset group. If impairment is indicated, the asset is written down by the amount by which the carrying value of the asset exceeds the related fair value of the asset with the related impairment charge recognized within the statements of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--LesseeLeasesPolicyTextBlock_zNeOgAt0zdV" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zr195uWT02L6">Leases</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating lease assets are included within operating lease right-of-use assets, and the corresponding operating lease obligation on the consolidated balance sheets as of December 31, 2022 and 2021 in accordance with ASC 842, <i>Leases</i>. The Company has elected not to present short-term leases as these leases have a lease term of 12 months or less at lease inception and do not contain purchase options or renewal terms that the Company is reasonably certain to exercise. All other lease assets and lease liabilities are recognized based on the present value of lease payments over the lease term at commencement date. Because most of the Company’s leases do not provide an implicit rate of return, the Company used an incremental borrowing rate based on the information available at adoption date in determining the present value of lease payments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--RevenueRecognitionPolicyTextBlock_zSjTrHfM4Mwd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_zCrrDJOFfy0e">Revenue Recognition</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes revenue in accordance with ASC 606, <i>Revenue from Contracts with Customers</i>, the core principle of which is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to receive in exchange for those goods or services.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To achieve this core principle, five basic criteria must be met before revenue can be recognized: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to performance obligations in the contract; and (5) recognize revenue when or as the Company satisfies a performance obligation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Nature of goods and services</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following is a description of the Company’s products and services from which the Company generates revenue, as well as the nature, timing of satisfaction of performance obligations, and significant payment terms for each:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Product revenue</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Product revenue from customer contracts is recognized on the sale of each electric vehicle as vehicles are shipped to customers. The majority of the Company’s vehicle sales orders generally have only one performance obligation: sale and delivery of complete vehicles. Ownership and risk of loss transfers to the customer based on FOB shipping point and freight charges are the responsibility of the customer. Revenue is typically recognized at the point control transfers or in accordance with payment terms customary to the business. The Company provides product warranties to assure that the product assembly complies with agreed upon specifications. The Company’s product warranty is similar in all material respects to the product warranties provided by the Company’s suppliers, therefore minimizing the warranty liability to the standard labor rates associated with the defective part replacement. Customers do not have the option to purchase a warranty separately; as such, warranty is not accounted for as a separate performance obligation. The Company’s policy is to exclude taxes collected from a customer from the transaction price of automotive contracts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AYRO, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shipping revenue</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts billed to customers related to shipping and handling are classified as shipping revenue. The Company has elected to recognize the cost for freight and shipping when control over vehicles has transferred to the customer as an operating expense. The Company has reported shipping expenses of $<span id="xdx_909_ecustom--ShippingExpenses_c20220101__20221231_zlAF8XdfasG" title="Shipping expenses">442,932</span> and $<span id="xdx_90E_ecustom--ShippingExpenses_c20210101__20211231_zxkWUPWkD8yk" title="Shipping expenses">393,231</span> for years ended December 31, 2022 and 2021, respectively, included in General and Administrative Expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Services and other revenue</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Services and other revenue consist of non-warranty after-sales vehicle services. Revenue is typically recognized at a point in time when services and replacement parts are provided.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Miscellaneous income</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Miscellaneous income consists of late fees charged for receivables not paid within the terms of the customer agreement based upon the outstanding customer receivable balance. This revenue is earned when a customer’s receivable balance becomes delinquent and its collection is reasonably assured and is calculated using a stated late fee rate multiplied by the outstanding balance that is subject to a late fee charge.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zW0NzYLgCt2e" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_z4h73wVuyHV8">Segment Reporting</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company operates in one business segment which focuses on the manufacturing and sales of environmentally-conscious, minimal-footprint electric vehicles. The Company’s business offerings have similar economic and other characteristics, including the nature of products, manufacturing, types of customers, and distribution methods. The chief operating decision maker (CODM) reviews profit and loss information on a consolidated basis to assess performance and make overall operating decisions. The consolidated financial statements reflect the financial results of the Company’s one reportable operating segment. The Company has no significant revenues or tangible assets outside of the United States.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eus-gaap--IncomeTaxPolicyTextBlock_zzsf8OeGgIf4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_860_zNEgywyqM87h">Income Taxes</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for income tax using an asset and liability approach, which allows for the recognition of deferred tax benefits in future years. Under the asset and liability approach, deferred taxes are provided for the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The accounting for deferred income tax calculation represents management’s best estimate on the most likely future tax consequences of events that have been recognized in the consolidated financial statements or tax returns and related future anticipation. A valuation allowance is provided for deferred tax assets if it is more likely than not these items will either expire before the Company is able to realize their benefits, or that future realization is uncertain. As of December 31, 2022 and 2021, there were no accruals for uncertain tax positions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_ecustom--WarrantsAndPreferredSharesPolicyTextBlock_z2bw48DwdxS6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_864_zfpjvj7K3mAj">Warrants and Preferred Shares</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accounting treatment of warrants and preferred share series issued is determined pursuant to the guidance provided by ASC 470, <i>Debt</i>, ASC 480, <i>Distinguishing Liabilities from Equity</i>, and ASC 815, <i>Derivatives and Hedging</i>, as applicable. Each feature of a freestanding financial instruments including, without limitation, any rights relating to subsequent dilutive issuances, dividend issuances, equity sales, rights offerings, forced conversions, optional redemptions, automatic monthly conversions, dividends and exercise are assessed with determinations made regarding the proper classification in the Company’s consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zHukTlpzzY4g" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><i><span id="xdx_860_zhvt44tkTNi6">Stock-Based Compensation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for stock-based compensation in accordance with ASC 718, Compensation-Stock Compensation (“ASC 718”). The Company recognizes all employee and non-employee share-based compensation as an expense in the financial statements on a straight-line basis over the requisite service period, based on the terms of the awards. Equity-classified awards principally related to stock options, restricted stock awards (“RSAs”) and equity-based compensation, are measured at the grant date fair value of the award. The Company determines grant date fair value of stock option awards using the Black-Scholes option-pricing model. The fair value of RSAs is determined using the closing price of the Company’s common stock on the grant date. For service based vesting grants, expense is recognized ratably over the requisite service period based on the number of options or shares. For value-based vesting grants, expense is recognized via straight line expense over the expected period per grant as determined by outside valuation experts. Stock-based compensation is reversed for forfeitures in the period of forfeiture.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We estimate the fair value of stock-based and cash unit awards containing a market condition using a Monte Carlo simulation model. Key inputs and assumptions used in the Monte Carlo simulation model include the stock price of the award on the grant date, the expected term, the risk-free interest rate over the expected term, the expected annual dividend yield and the expected stock price volatility. The expected volatility is based on a combination of the historical and implied volatility of the Company’s publicly traded, near-the-money stock options, and the valuation period is based on the vesting period of the awards. The risk-free interest rate is derived from the U.S. Treasury yield curve in effect at the time of grant and, since the Company does not currently pay or plan to pay a dividend on its common stock, the expected dividend yield was zero.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock options and warrants issued as compensation for services provided to the Company are accounted for based upon the fair value of the underlying equity instrument. The attribution of the fair value of the equity instrument is charged directly to compensation expense over the period during which services are rendered.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AYRO, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--EarningsPerSharePolicyTextBlock_zCwChZosxyyh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_zVMdXIdngUJh">Basic and Diluted Loss Per Share</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted net loss per share is determined by dividing net loss by the weighted average ordinary shares outstanding during the period. For all periods presented with a net loss, the shares underlying the ordinary share options and warrants have been excluded from the calculation because their effect would be anti-dilutive. Therefore, the weighted-average shares outstanding used to calculate both basic and diluted loss per share are the same for periods with a net loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zDiPbU6Jt1Sk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following potentially dilutive securities have been excluded from the computation of diluted weighted average shares outstanding as they would be anti-dilutive:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zqbIBd4sVmGl" style="display: none">SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the Years Ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Options to purchase common stock</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--OptionsToPurchaseCommonStockMember_zzyiC97tGoI9" style="width: 14%; text-align: right" title="Totals"><span style="font-family: Times New Roman, Times, Serif">777,922</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--OptionsToPurchaseCommonStockMember_zShg40lY9Dj1" style="width: 14%; text-align: right" title="Totals"><span style="font-family: Times New Roman, Times, Serif">1,338,675</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Restricted stock unvested</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RestrictedStockUnvestedMember_zw6UjDEVEm1c" style="text-align: right" title="Totals"><span style="font-family: Times New Roman, Times, Serif">660,562</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RestrictedStockUnvestedMember_z9ccnPqs4tmg" style="text-align: right" title="Totals"><span style="font-family: Times New Roman, Times, Serif">450,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Restricted stock vested - unissued</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RestrictedStockVestedUnissuedMember_zh50eNL8cWRe" style="text-align: right" title="Totals"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0665">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RestrictedStockVestedUnissuedMember_zPNWPIuzxCac" style="text-align: right" title="Totals"><span style="font-family: Times New Roman, Times, Serif">43,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Warrants outstanding</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--WarrantsOutstandingMember_zHhG8qypQyS" style="text-align: right" title="Totals"><span style="font-family: Times New Roman, Times, Serif">6,106,023</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--WarrantsOutstandingMember_zuKn9SMWsiWc" style="text-align: right" title="Totals"><span style="font-family: Times New Roman, Times, Serif">6,108,823</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Preferred stock outstanding</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--PreferredStockOutstandingMember_zJTmSN0H19la" style="border-bottom: Black 1.5pt solid; text-align: right" title="Totals"><span style="font-family: Times New Roman, Times, Serif">2,475</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--PreferredStockOutstandingMember_zGNh43zRZDhj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Totals"><span style="font-family: Times New Roman, Times, Serif">2,475</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Totals</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231_z4nhvOpnc8vf" style="border-bottom: Black 2.5pt double; text-align: right" title="Totals"><span style="font-family: Times New Roman, Times, Serif">7,546,982</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231_zbd6JJ2Eeqa3" style="border-bottom: Black 2.5pt double; text-align: right" title="Totals"><span style="font-family: Times New Roman, Times, Serif">7,942,973</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8AA_zWNSK4yZIB44" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--ResearchAndDevelopmentExpensePolicy_zaCKjNoPDlkk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zjABbb9UKqEd">Research and development costs</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Costs are incurred in connection with research and development programs that are expected to contribute to future earnings. Such costs include labor, stock-based compensation, training, software subscriptions, and consulting. These amounts are charged to the consolidated statement of operations as incurred. Total research and development expenses included were $<span id="xdx_903_eus-gaap--ResearchAndDevelopmentExpense_c20220101__20221231_zZpJrbXRArAg" title="Research and development expenses">6,845,451</span> and $<span id="xdx_904_eus-gaap--ResearchAndDevelopmentExpense_c20210101__20211231_z6kQkwk4Htvg" title="Research and development expenses">11,449,617</span> for the years ended December 31, 2022 and 2021, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zQYygPrJQp6c" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_860_zYa1J57A71j4">Recent Accounting Pronouncements</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In June 2016, the FASB issued ASU 2016-13 “Financial Instruments -Credit Losses” (ASC 326) “Measurement of Credit Losses on Financial Instruments: and subsequent amendment to the guidance, ASU 2018-19 in November 2018. The standard significantly changes how entities will measure credit losses for most financial assets, including trade receivables. The standard will replace historic incurred loss” approach with an “expected loss” model for instruments measured at amortized cost. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements.</span></p> <p id="xdx_85D_zFWUHzPxM8G5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AYRO, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--ConsolidationPolicyTextBlock_zb2lnprPww7j" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_zH55zj6ENpbf">Basis of Presentation and Principles of Consolidation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements represent the consolidation of the accounts of the Company and its subsidiary in conformity with GAAP. All intercompany accounts and transactions have been eliminated in consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_843_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_z1peRiOO8mRh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zjHnzSNvR2uj">Reclassification</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain 2021 amounts were classified to conform to the current year presentation. Intangible assets were included into other assets on the consolidated balance sheet for current and prior year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_841_eus-gaap--UseOfEstimates_z5F4CM2h3yxc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_864_zBOdQGcCqXe9">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the consolidated financial statements, in conformity with GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenue and expenses during the reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zLMaflQdSwL8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_zg8EaWEcFQTb">Cash and Cash Equivalents</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company considers all highly-liquid investments purchased with a maturity of three months or less at the time of purchase to be cash equivalents. The Company maintains total cash balances in one account which exceeds the federally insured limits. Management does not believe this results in any significant credit risk. The Company has no cash equivalents as of December 31, 2022 and 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--MarketableSecuritiesPolicy_zB24GWLvTnM1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_za3Ch14r1SZ1">Marketable Securities</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marketable securities include investment in fixed income bonds and U.S. Treasury securities that are considered to be highly liquid and easily tradeable. The marketable securities are considered trading securities and are measured at fair value and are accounted for in accordance with ASC 320. The marketable securities are valued using inputs observable in active markets for identical securities and are therefore classified as Level 1 within the Company’s fair value hierarchy. The Company held $<span id="xdx_90C_eus-gaap--MarketableSecuritiesCurrent_iI_c20221231_zapeDCKq38Q5" title="Marketable securities">9,848,804</span> in marketable securities as of December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 9848804 <p id="xdx_843_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zLVpbW96kaQa" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_zf8pIM3ZIZDa">Fair Value Measurements</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company applies Accounting Standards Codification (“ASC”) 820, <i>Fair Value Measurement </i>(“ASC 820”), which establishes a framework for measuring fair value and clarifies the definition of fair value within that framework. ASC 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company’s principal or most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established in ASC 820 generally requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity’s own assumptions based on market data and the entity’s judgments about the assumptions that market participants would use in pricing the asset or liability and are to be developed based on the best information available in the circumstances.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The carrying amounts of financial instruments reported in the accompanying consolidated financial statements for current assets and current liabilities approximate the fair value because of the immediate or short-term maturities of the financial instruments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AYRO, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The valuation hierarchy is composed of three levels. The classification within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The levels within the valuation hierarchy are described below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1 — Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2 — Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3 — Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The marketable securities are considered trading securities and are measured at fair value and are accounted for in accordance with ASC 320. The marketable securities are valued using inputs observable in active markets for identical securities and are therefore classified as Level 1 within the Company’s fair value hierarchy.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_840_eus-gaap--ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_zSw1qEHvwZIc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zz98dCQRHbX">Accounts Receivable, Net</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the normal course of business, the Company extends credit to customers. Accounts receivable, less the allowance for doubtful accounts, reflect the net realizable value of receivables and approximate fair value. An allowance for doubtful accounts is maintained and reflects the best estimate of probable losses determined principally on the basis of historical experience and specific allowances for known troubled accounts. All accounts or portions thereof that are deemed to be uncollectible or that require an excessive collection cost are written off to the allowance for doubtful accounts. As of December 31, 2022 and 2021, the Company had reserved an allowance for doubtful accounts of $<span id="xdx_90D_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_c20221231_zjCdmJc0DNd5" title="Allowance for doubtful accounts">2,349</span> and $<span id="xdx_908_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_c20211231_zh3HI8PdkCBk" title="Allowance for doubtful accounts">173,138</span>, respectively. All account receivables are made on an unsecured basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 2349 173138 <p id="xdx_842_eus-gaap--InventoryPolicyTextBlock_zDe9jzWeNyug" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_zYODmDFQo8Ka">Inventory</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory consists of purchased chassis, cabs, batteries, truck beds and component parts which includes cost of raw materials, freight, direct labor, and related production overhead and are stated at the lower of cost or net realizable value, as determined using a first-in, first-out method. Inventory also includes a fleet of internally manufactured vehicles that serve demonstration and other purposes, the balance of which is being depreciated over their useful lives. Management compares the cost of inventory with the net realizable value and, if applicable, an allowance is made for writing down the inventory to its net realizable value, if lower than cost. On an ongoing basis, inventory is reviewed for potential write-down for estimated obsolescence or unmarketable inventory based upon forecasts for future demand and market conditions. At June 30, 2022, we determined that testing of obsolescence was required for inventory due to the quality of certain purchased components from Cenntro’s lithium-ion (“NCM”) line. 17 vehicles tested in the second quarter of 2022 were determined to have 49 unique failures. An inspection of the remaining NCM units revealed a 100% failure rate. As a result, all inventory associated with Cenntro’s NCM line was written off for $<span id="xdx_903_eus-gaap--InventoryWriteDown_c20220101__20221231__us-gaap--PublicUtilitiesInventoryAxis__custom--FleetInventoryMember_zCzVSuijrLvg" title="Inventory written-off">1,317,289</span> to cost of goods sold. As of December 31, 2022, there was no longer a balance. The remainder of the balance was expensed through cost of goods sold for $<span id="xdx_905_eus-gaap--CostOfGoodsAndServicesSold_c20220101__20221231__dei--LegalEntityAxis__custom--CenntroAutomotiveGroupLtdMember_zp0Iry8BpTKj" title="Cost of goods sold">621,097</span>. During the year ended December 31, 2022, a $<span id="xdx_904_eus-gaap--InventoryWriteDown_c20220101__20221231__us-gaap--PublicUtilitiesInventoryAxis__custom--ClubCarDiscountMember_zC0EEhx1abj4" title="Inventory write down">413,561</span> net realizable value adjustment was recorded due to the Club Car Discount (as defined below), spare inventory for the 411x was written off, net with the inventory reserve of $<span id="xdx_905_eus-gaap--InventoryValuationReserves_iI_c20221231__us-gaap--PublicUtilitiesInventoryAxis__custom--ClubCarDiscountMember_zqkUSkdUf8ig" title="Inventory reserves">124,375</span>, and $<span id="xdx_90F_eus-gaap--ProductionRelatedImpairmentsOrCharges_c20220101__20221231__us-gaap--PublicUtilitiesInventoryAxis__custom--ClubCarDiscountMember_zSIpNYufqTbk" title="Impairment of inventory">2,476,322</span> was expensed for impairment of inventory.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1317289 621097 413561 124375 2476322 <p id="xdx_84D_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_z2U0X4NQapS5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_864_z9XinSFY2nX9">Property and Equipment, Net</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment, net, are stated at cost, less accumulated depreciation. Depreciation is recorded over the shorter of the estimated useful life, of one to ten years, or the lease term of the applicable assets using the straight-line method beginning on the date an asset is placed in service. The Company regularly evaluates the estimated remaining useful lives of the Company’s property and equipment, net, to determine whether events or changes in circumstances warrant a revision to the remaining period of depreciation. Maintenance and repairs are charged to expense when incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AYRO, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_892_ecustom--ScheduleOfEstimatedUsefulLivesTableTextBlock_zF4n8Yb4u812" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The estimated useful lives for significant property and equipment categories are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_zLjvzmjCbjIc" style="display: none">SCHEDULE OF ESTIMATED USEFUL LIVES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; width: 70%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer Equipment and Software </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MinimumMember_zJyg2IzuSzU7" title="Property plant and equipment, estimated useful lives">1</span> – <span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MaximumMember_z1T2V1M9CN37" title="Property plant and equipment, estimated useful lives">3</span> years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and Fixtures</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_z1QpT6gv03ei" title="Property plant and equipment, estimated useful lives">2</span> – <span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_ziOIecwuNt2b" title="Property plant and equipment, estimated useful lives">7</span> years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Machinery and Equipment </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MinimumMember_zF9bWyVAWr7g" title="Property plant and equipment, estimated useful lives">3</span> – <span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MaximumMember_zCaboujnsURk" title="Property plant and equipment, estimated useful lives">10</span> years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold Improvements</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zc86LanJQ5zb" title="Property plant and equipment, estimated useful lives">Shorter of useful or lease life</span></span></td></tr> </table> <p id="xdx_8A0_zhVtK9NWBkH4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_892_ecustom--ScheduleOfEstimatedUsefulLivesTableTextBlock_zF4n8Yb4u812" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The estimated useful lives for significant property and equipment categories are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_zLjvzmjCbjIc" style="display: none">SCHEDULE OF ESTIMATED USEFUL LIVES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; width: 70%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer Equipment and Software </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MinimumMember_zJyg2IzuSzU7" title="Property plant and equipment, estimated useful lives">1</span> – <span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MaximumMember_z1T2V1M9CN37" title="Property plant and equipment, estimated useful lives">3</span> years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and Fixtures</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_z1QpT6gv03ei" title="Property plant and equipment, estimated useful lives">2</span> – <span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_ziOIecwuNt2b" title="Property plant and equipment, estimated useful lives">7</span> years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Machinery and Equipment </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MinimumMember_zF9bWyVAWr7g" title="Property plant and equipment, estimated useful lives">3</span> – <span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MaximumMember_zCaboujnsURk" title="Property plant and equipment, estimated useful lives">10</span> years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold Improvements</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zc86LanJQ5zb" title="Property plant and equipment, estimated useful lives">Shorter of useful or lease life</span></span></td></tr> </table> P1Y P3Y P2Y P7Y P3Y P10Y Shorter of useful or lease life <p id="xdx_849_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_zjjSqAqLvn7l" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_864_zsz769bskuef">Long-Lived Assets, Including Definite-Lived Intangible Assets</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets are stated at cost less accumulated amortization. Amortization is generally recorded on a straight-line basis over estimated useful life of <span id="xdx_909_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zXToMOGNL5zb" title="Estimated useful life of intangible assets">3</span>-<span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zSaQTzvMbZW5" title="Estimated useful life of intangible assets">10</span> years. The Company periodically reviews the estimated useful lives of intangible assets and makes adjustments when events indicate that a shorter life is appropriate.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-lived assets are evaluated for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable through the estimated undiscounted future cash flows derived from such assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Factors that the Company considers in deciding when to perform an impairment review include significant changes in the Company’s forecasted projections for the asset or asset group for reasons including, but not limited to, significant under-performance of a product in relation to expectations, significant changes, or planned changes in the Company’s use of the assets, significant negative industry or economic trends, and new or competing products that enter the marketplace. The impairment test is based on a comparison of the undiscounted cash flows expected to be generated from the use of the asset group. If impairment is indicated, the asset is written down by the amount by which the carrying value of the asset exceeds the related fair value of the asset with the related impairment charge recognized within the statements of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> P3Y P10Y <p id="xdx_84E_eus-gaap--LesseeLeasesPolicyTextBlock_zNeOgAt0zdV" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zr195uWT02L6">Leases</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating lease assets are included within operating lease right-of-use assets, and the corresponding operating lease obligation on the consolidated balance sheets as of December 31, 2022 and 2021 in accordance with ASC 842, <i>Leases</i>. The Company has elected not to present short-term leases as these leases have a lease term of 12 months or less at lease inception and do not contain purchase options or renewal terms that the Company is reasonably certain to exercise. All other lease assets and lease liabilities are recognized based on the present value of lease payments over the lease term at commencement date. Because most of the Company’s leases do not provide an implicit rate of return, the Company used an incremental borrowing rate based on the information available at adoption date in determining the present value of lease payments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--RevenueRecognitionPolicyTextBlock_zSjTrHfM4Mwd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_zCrrDJOFfy0e">Revenue Recognition</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes revenue in accordance with ASC 606, <i>Revenue from Contracts with Customers</i>, the core principle of which is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to receive in exchange for those goods or services.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To achieve this core principle, five basic criteria must be met before revenue can be recognized: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to performance obligations in the contract; and (5) recognize revenue when or as the Company satisfies a performance obligation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Nature of goods and services</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following is a description of the Company’s products and services from which the Company generates revenue, as well as the nature, timing of satisfaction of performance obligations, and significant payment terms for each:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Product revenue</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Product revenue from customer contracts is recognized on the sale of each electric vehicle as vehicles are shipped to customers. The majority of the Company’s vehicle sales orders generally have only one performance obligation: sale and delivery of complete vehicles. Ownership and risk of loss transfers to the customer based on FOB shipping point and freight charges are the responsibility of the customer. Revenue is typically recognized at the point control transfers or in accordance with payment terms customary to the business. The Company provides product warranties to assure that the product assembly complies with agreed upon specifications. The Company’s product warranty is similar in all material respects to the product warranties provided by the Company’s suppliers, therefore minimizing the warranty liability to the standard labor rates associated with the defective part replacement. Customers do not have the option to purchase a warranty separately; as such, warranty is not accounted for as a separate performance obligation. The Company’s policy is to exclude taxes collected from a customer from the transaction price of automotive contracts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AYRO, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shipping revenue</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts billed to customers related to shipping and handling are classified as shipping revenue. The Company has elected to recognize the cost for freight and shipping when control over vehicles has transferred to the customer as an operating expense. The Company has reported shipping expenses of $<span id="xdx_909_ecustom--ShippingExpenses_c20220101__20221231_zlAF8XdfasG" title="Shipping expenses">442,932</span> and $<span id="xdx_90E_ecustom--ShippingExpenses_c20210101__20211231_zxkWUPWkD8yk" title="Shipping expenses">393,231</span> for years ended December 31, 2022 and 2021, respectively, included in General and Administrative Expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Services and other revenue</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Services and other revenue consist of non-warranty after-sales vehicle services. Revenue is typically recognized at a point in time when services and replacement parts are provided.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Miscellaneous income</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Miscellaneous income consists of late fees charged for receivables not paid within the terms of the customer agreement based upon the outstanding customer receivable balance. This revenue is earned when a customer’s receivable balance becomes delinquent and its collection is reasonably assured and is calculated using a stated late fee rate multiplied by the outstanding balance that is subject to a late fee charge.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 442932 393231 <p id="xdx_84E_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zW0NzYLgCt2e" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_z4h73wVuyHV8">Segment Reporting</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company operates in one business segment which focuses on the manufacturing and sales of environmentally-conscious, minimal-footprint electric vehicles. The Company’s business offerings have similar economic and other characteristics, including the nature of products, manufacturing, types of customers, and distribution methods. The chief operating decision maker (CODM) reviews profit and loss information on a consolidated basis to assess performance and make overall operating decisions. The consolidated financial statements reflect the financial results of the Company’s one reportable operating segment. The Company has no significant revenues or tangible assets outside of the United States.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eus-gaap--IncomeTaxPolicyTextBlock_zzsf8OeGgIf4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_860_zNEgywyqM87h">Income Taxes</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for income tax using an asset and liability approach, which allows for the recognition of deferred tax benefits in future years. Under the asset and liability approach, deferred taxes are provided for the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The accounting for deferred income tax calculation represents management’s best estimate on the most likely future tax consequences of events that have been recognized in the consolidated financial statements or tax returns and related future anticipation. A valuation allowance is provided for deferred tax assets if it is more likely than not these items will either expire before the Company is able to realize their benefits, or that future realization is uncertain. As of December 31, 2022 and 2021, there were no accruals for uncertain tax positions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_ecustom--WarrantsAndPreferredSharesPolicyTextBlock_z2bw48DwdxS6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_864_zfpjvj7K3mAj">Warrants and Preferred Shares</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accounting treatment of warrants and preferred share series issued is determined pursuant to the guidance provided by ASC 470, <i>Debt</i>, ASC 480, <i>Distinguishing Liabilities from Equity</i>, and ASC 815, <i>Derivatives and Hedging</i>, as applicable. Each feature of a freestanding financial instruments including, without limitation, any rights relating to subsequent dilutive issuances, dividend issuances, equity sales, rights offerings, forced conversions, optional redemptions, automatic monthly conversions, dividends and exercise are assessed with determinations made regarding the proper classification in the Company’s consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zHukTlpzzY4g" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><i><span id="xdx_860_zhvt44tkTNi6">Stock-Based Compensation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for stock-based compensation in accordance with ASC 718, Compensation-Stock Compensation (“ASC 718”). The Company recognizes all employee and non-employee share-based compensation as an expense in the financial statements on a straight-line basis over the requisite service period, based on the terms of the awards. Equity-classified awards principally related to stock options, restricted stock awards (“RSAs”) and equity-based compensation, are measured at the grant date fair value of the award. The Company determines grant date fair value of stock option awards using the Black-Scholes option-pricing model. The fair value of RSAs is determined using the closing price of the Company’s common stock on the grant date. For service based vesting grants, expense is recognized ratably over the requisite service period based on the number of options or shares. For value-based vesting grants, expense is recognized via straight line expense over the expected period per grant as determined by outside valuation experts. Stock-based compensation is reversed for forfeitures in the period of forfeiture.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We estimate the fair value of stock-based and cash unit awards containing a market condition using a Monte Carlo simulation model. Key inputs and assumptions used in the Monte Carlo simulation model include the stock price of the award on the grant date, the expected term, the risk-free interest rate over the expected term, the expected annual dividend yield and the expected stock price volatility. The expected volatility is based on a combination of the historical and implied volatility of the Company’s publicly traded, near-the-money stock options, and the valuation period is based on the vesting period of the awards. The risk-free interest rate is derived from the U.S. Treasury yield curve in effect at the time of grant and, since the Company does not currently pay or plan to pay a dividend on its common stock, the expected dividend yield was zero.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock options and warrants issued as compensation for services provided to the Company are accounted for based upon the fair value of the underlying equity instrument. The attribution of the fair value of the equity instrument is charged directly to compensation expense over the period during which services are rendered.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AYRO, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--EarningsPerSharePolicyTextBlock_zCwChZosxyyh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_zVMdXIdngUJh">Basic and Diluted Loss Per Share</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted net loss per share is determined by dividing net loss by the weighted average ordinary shares outstanding during the period. For all periods presented with a net loss, the shares underlying the ordinary share options and warrants have been excluded from the calculation because their effect would be anti-dilutive. Therefore, the weighted-average shares outstanding used to calculate both basic and diluted loss per share are the same for periods with a net loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zDiPbU6Jt1Sk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following potentially dilutive securities have been excluded from the computation of diluted weighted average shares outstanding as they would be anti-dilutive:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zqbIBd4sVmGl" style="display: none">SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the Years Ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Options to purchase common stock</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--OptionsToPurchaseCommonStockMember_zzyiC97tGoI9" style="width: 14%; text-align: right" title="Totals"><span style="font-family: Times New Roman, Times, Serif">777,922</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--OptionsToPurchaseCommonStockMember_zShg40lY9Dj1" style="width: 14%; text-align: right" title="Totals"><span style="font-family: Times New Roman, Times, Serif">1,338,675</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Restricted stock unvested</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RestrictedStockUnvestedMember_zw6UjDEVEm1c" style="text-align: right" title="Totals"><span style="font-family: Times New Roman, Times, Serif">660,562</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RestrictedStockUnvestedMember_z9ccnPqs4tmg" style="text-align: right" title="Totals"><span style="font-family: Times New Roman, Times, Serif">450,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Restricted stock vested - unissued</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RestrictedStockVestedUnissuedMember_zh50eNL8cWRe" style="text-align: right" title="Totals"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0665">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RestrictedStockVestedUnissuedMember_zPNWPIuzxCac" style="text-align: right" title="Totals"><span style="font-family: Times New Roman, Times, Serif">43,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Warrants outstanding</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--WarrantsOutstandingMember_zHhG8qypQyS" style="text-align: right" title="Totals"><span style="font-family: Times New Roman, Times, Serif">6,106,023</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--WarrantsOutstandingMember_zuKn9SMWsiWc" style="text-align: right" title="Totals"><span style="font-family: Times New Roman, Times, Serif">6,108,823</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Preferred stock outstanding</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--PreferredStockOutstandingMember_zJTmSN0H19la" style="border-bottom: Black 1.5pt solid; text-align: right" title="Totals"><span style="font-family: Times New Roman, Times, Serif">2,475</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--PreferredStockOutstandingMember_zGNh43zRZDhj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Totals"><span style="font-family: Times New Roman, Times, Serif">2,475</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Totals</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231_z4nhvOpnc8vf" style="border-bottom: Black 2.5pt double; text-align: right" title="Totals"><span style="font-family: Times New Roman, Times, Serif">7,546,982</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231_zbd6JJ2Eeqa3" style="border-bottom: Black 2.5pt double; text-align: right" title="Totals"><span style="font-family: Times New Roman, Times, Serif">7,942,973</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8AA_zWNSK4yZIB44" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zDiPbU6Jt1Sk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following potentially dilutive securities have been excluded from the computation of diluted weighted average shares outstanding as they would be anti-dilutive:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zqbIBd4sVmGl" style="display: none">SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the Years Ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Options to purchase common stock</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--OptionsToPurchaseCommonStockMember_zzyiC97tGoI9" style="width: 14%; text-align: right" title="Totals"><span style="font-family: Times New Roman, Times, Serif">777,922</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--OptionsToPurchaseCommonStockMember_zShg40lY9Dj1" style="width: 14%; text-align: right" title="Totals"><span style="font-family: Times New Roman, Times, Serif">1,338,675</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Restricted stock unvested</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RestrictedStockUnvestedMember_zw6UjDEVEm1c" style="text-align: right" title="Totals"><span style="font-family: Times New Roman, Times, Serif">660,562</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RestrictedStockUnvestedMember_z9ccnPqs4tmg" style="text-align: right" title="Totals"><span style="font-family: Times New Roman, Times, Serif">450,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Restricted stock vested - unissued</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RestrictedStockVestedUnissuedMember_zh50eNL8cWRe" style="text-align: right" title="Totals"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0665">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RestrictedStockVestedUnissuedMember_zPNWPIuzxCac" style="text-align: right" title="Totals"><span style="font-family: Times New Roman, Times, Serif">43,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Warrants outstanding</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--WarrantsOutstandingMember_zHhG8qypQyS" style="text-align: right" title="Totals"><span style="font-family: Times New Roman, Times, Serif">6,106,023</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--WarrantsOutstandingMember_zuKn9SMWsiWc" style="text-align: right" title="Totals"><span style="font-family: Times New Roman, Times, Serif">6,108,823</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Preferred stock outstanding</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--PreferredStockOutstandingMember_zJTmSN0H19la" style="border-bottom: Black 1.5pt solid; text-align: right" title="Totals"><span style="font-family: Times New Roman, Times, Serif">2,475</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--PreferredStockOutstandingMember_zGNh43zRZDhj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Totals"><span style="font-family: Times New Roman, Times, Serif">2,475</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Totals</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231_z4nhvOpnc8vf" style="border-bottom: Black 2.5pt double; text-align: right" title="Totals"><span style="font-family: Times New Roman, Times, Serif">7,546,982</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231_zbd6JJ2Eeqa3" style="border-bottom: Black 2.5pt double; text-align: right" title="Totals"><span style="font-family: Times New Roman, Times, Serif">7,942,973</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 777922 1338675 660562 450000 43000 6106023 6108823 2475 2475 7546982 7942973 <p id="xdx_842_eus-gaap--ResearchAndDevelopmentExpensePolicy_zaCKjNoPDlkk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zjABbb9UKqEd">Research and development costs</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Costs are incurred in connection with research and development programs that are expected to contribute to future earnings. Such costs include labor, stock-based compensation, training, software subscriptions, and consulting. These amounts are charged to the consolidated statement of operations as incurred. Total research and development expenses included were $<span id="xdx_903_eus-gaap--ResearchAndDevelopmentExpense_c20220101__20221231_zZpJrbXRArAg" title="Research and development expenses">6,845,451</span> and $<span id="xdx_904_eus-gaap--ResearchAndDevelopmentExpense_c20210101__20211231_z6kQkwk4Htvg" title="Research and development expenses">11,449,617</span> for the years ended December 31, 2022 and 2021, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 6845451 11449617 <p id="xdx_843_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zQYygPrJQp6c" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_860_zYa1J57A71j4">Recent Accounting Pronouncements</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In June 2016, the FASB issued ASU 2016-13 “Financial Instruments -Credit Losses” (ASC 326) “Measurement of Credit Losses on Financial Instruments: and subsequent amendment to the guidance, ASU 2018-19 in November 2018. The standard significantly changes how entities will measure credit losses for most financial assets, including trade receivables. The standard will replace historic incurred loss” approach with an “expected loss” model for instruments measured at amortized cost. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements.</span></p> <p id="xdx_805_eus-gaap--RevenueFromContractWithCustomerTextBlock_z1ogjiFrBhoe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 4. <span id="xdx_82A_zu9mBMr4xqP2">REVENUES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Disaggregation of Revenue</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eus-gaap--DisaggregationOfRevenueTableTextBlock_zt6Wkjk83qUl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue by type consists of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zRwZ243Oa5X3" style="display: none">SCHEDULE OF DISAGGREGATION OF REVENUE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49A_20220101__20221231_zl6d4vpFkRXe" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_497_20210101__20211231_zP80DXOZ7D51" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Years Ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Revenue type</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__us-gaap--ProductMember_zDartjdA7gF9" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Product revenue</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,716,583</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,419,821</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--ShippingRevenueMember_zqgdAZGtUKI8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Shipping revenue</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">229,027</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">227,089</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--MiscellaneousIncomeMember_zFJWeFdNyZ36" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Miscellaneous Income</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">44,887</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0700">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--ServiceIncomeMember_z71cV3QAVfjd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Service income</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0702">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">36,687</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_z3YqQmBKVqh1" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif"> <span style="font-size: 10pt">Total Revenue</span></span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,990,497</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,683,597</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8AC_zya5x8aV6bxd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Contract Liabilities</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes a contract liability when a consideration is received, or if the Company has the unconditional right to receive consideration, in advance of satisfying the performance obligation. A contract liability is the Company’s obligation to transfer goods or services to a customer for which the Company has received consideration, or an amount of consideration is due from the customer. The table below details the activity in the Company’s contract liabilities as of December 31, 2022 and 2021. The balance at the end of each period is reported as contract liability in the Company’s consolidated balance sheet.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_892_eus-gaap--ContractWithCustomerAssetAndLiabilityTableTextBlock_z1YZhPiaJbU7" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BE_zUpEQGdYQJz3" style="display: none">SCHEDULE OF CONTRACT LIABILITIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_497_20220101__20221231_ztn2ChaTT515" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49B_20210101__20211231_z0opVeGAowO8" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_eus-gaap--ContractWithCustomerLiabilityCurrent_iS_pp0p0_zv0rTIS5Qfwb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%"><span style="font-family: Times New Roman, Times, Serif">Balance, beginning of period</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0710">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">24,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_ecustom--AdditionsToContractLiability_zbuxWxvxpLG3" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Additions</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0713">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0714">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_ecustom--TransferToRevenue_iN_pp0p0_di_zjOuHoC6izj9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Transfer to revenue</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0716">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(24,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_406_eus-gaap--ContractWithCustomerLiabilityCurrent_iE_pp0p0_zC6jqkFlLQb8" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Balance, end of period</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">        <span style="-sec-ix-hidden: xdx2ixbrl0719">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0720">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A6_zRkOcnaOTwj1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Warranty Reserve</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company records a reserve for warranty repairs upon the initial delivery of vehicles to its dealer network. The Company provides a product warranty on each vehicle including powertrain, battery pack and electronics package. Such warranty matches the product warranty provided by its supply chain for warranty parts for all unaltered vehicles and is not considered a separate performance obligation. The supply chain warranty does not cover warranty-based labor needed to replace a part under warranty. Warranty reserves include management’s best estimate of the projected cost of labor to repair/replace all items under warranty. The Company reserves a percentage of all dealer-based sales to cover an industry-standard warranty fund to support dealer labor warranty repairs. Such percentage is recorded as a component of cost of revenues in the statement of operations. As of December 31, 2022 and 2021, warranty reserves were recorded within accrued expenses of $<span id="xdx_905_ecustom--WarrantyReserves_iI_pp0p0_c20221231_z0qOg8wyTsJ1" title="Warranty reserves">410,017</span> and $<span id="xdx_906_ecustom--WarrantyReserves_iI_pp0p0_c20211231_zoCT9hKl6ac4" title="Warranty reserves">240,517</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AYRO, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eus-gaap--DisaggregationOfRevenueTableTextBlock_zt6Wkjk83qUl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue by type consists of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zRwZ243Oa5X3" style="display: none">SCHEDULE OF DISAGGREGATION OF REVENUE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49A_20220101__20221231_zl6d4vpFkRXe" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_497_20210101__20211231_zP80DXOZ7D51" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Years Ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Revenue type</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__us-gaap--ProductMember_zDartjdA7gF9" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Product revenue</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,716,583</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,419,821</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--ShippingRevenueMember_zqgdAZGtUKI8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Shipping revenue</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">229,027</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">227,089</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--MiscellaneousIncomeMember_zFJWeFdNyZ36" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Miscellaneous Income</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">44,887</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0700">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--ServiceIncomeMember_z71cV3QAVfjd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Service income</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0702">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">36,687</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_z3YqQmBKVqh1" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif"> <span style="font-size: 10pt">Total Revenue</span></span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,990,497</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,683,597</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 2716583 2419821 229027 227089 44887 36687 2990497 2683597 <p id="xdx_892_eus-gaap--ContractWithCustomerAssetAndLiabilityTableTextBlock_z1YZhPiaJbU7" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BE_zUpEQGdYQJz3" style="display: none">SCHEDULE OF CONTRACT LIABILITIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_497_20220101__20221231_ztn2ChaTT515" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49B_20210101__20211231_z0opVeGAowO8" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_eus-gaap--ContractWithCustomerLiabilityCurrent_iS_pp0p0_zv0rTIS5Qfwb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%"><span style="font-family: Times New Roman, Times, Serif">Balance, beginning of period</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0710">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">24,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_ecustom--AdditionsToContractLiability_zbuxWxvxpLG3" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Additions</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0713">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0714">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_ecustom--TransferToRevenue_iN_pp0p0_di_zjOuHoC6izj9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Transfer to revenue</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0716">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(24,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_406_eus-gaap--ContractWithCustomerLiabilityCurrent_iE_pp0p0_zC6jqkFlLQb8" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Balance, end of period</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">        <span style="-sec-ix-hidden: xdx2ixbrl0719">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0720">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 24000 24000 410017 240517 <p id="xdx_808_eus-gaap--AccountsAndNontradeReceivableTextBlock_zTCgLYsxOnB7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 5. <span id="xdx_82E_zy1pldaQyxod">ACCOUNTS RECEIVABLE, NET</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_zwODLfVVBIK1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Accounts receivable, net consists of amounts due from invoiced customers and product deliveries and were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_z6piGL36ywOj" style="display: none">SCHEDULE OF ACCOUNTS RECEIVABLE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_495_20221231_zJBdeDTDmo2j" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_493_20211231_zSE96V5yMOT5" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_eus-gaap--AccountsReceivableGrossCurrent_iI_pp0p0_maARNzKXJ_zAYhPleygd9k" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Trade receivables</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">512,420</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,142,567</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40F_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iNI_pp0p0_di_msARNzKXJ_z7a17swEHx13" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Less: Allowance for doubtful accounts</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,349</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(173,138</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_40D_eus-gaap--AccountsReceivableNetCurrent_iTI_pp0p0_mtARNzKXJ_zSwMHK39uGT4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif"> <span style="font-size: 10pt">Accounts receivable, net</span></span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">510,071</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">969,429</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A9_zXa3V2eEQf29" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company reduced allowance for doubtful accounts by $<span id="xdx_903_eus-gaap--AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_pp0p0_c20220101__20221231_zPExZeadkXF7" title="Changes in allowance for doubtful accounts receivable">170,789</span> for the year ended December 31, 2022, due to collecting on past due accounts, and recorded $<span id="xdx_907_eus-gaap--ProvisionForDoubtfulAccounts_pp0p0_c20220101__20221231_z1eJBuIKA9gb" title="Bad debt expense">4,485</span> of bad debt expense of direct write off for the year ended December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_zwODLfVVBIK1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Accounts receivable, net consists of amounts due from invoiced customers and product deliveries and were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_z6piGL36ywOj" style="display: none">SCHEDULE OF ACCOUNTS RECEIVABLE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_495_20221231_zJBdeDTDmo2j" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_493_20211231_zSE96V5yMOT5" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_eus-gaap--AccountsReceivableGrossCurrent_iI_pp0p0_maARNzKXJ_zAYhPleygd9k" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Trade receivables</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">512,420</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,142,567</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40F_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iNI_pp0p0_di_msARNzKXJ_z7a17swEHx13" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Less: Allowance for doubtful accounts</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,349</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(173,138</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_40D_eus-gaap--AccountsReceivableNetCurrent_iTI_pp0p0_mtARNzKXJ_zSwMHK39uGT4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif"> <span style="font-size: 10pt">Accounts receivable, net</span></span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">510,071</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">969,429</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 512420 1142567 2349 173138 510071 969429 170789 4485 <p id="xdx_807_eus-gaap--InventoryDisclosureTextBlock_zM1oiQm3WLY" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 6. <span id="xdx_823_zmbVDa5BgIS3">INVENTORY, NET</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zKy3DLyIDPgg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory, net consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_z1zL57Y3ZePc" style="display: none">SCHEDULE OF INVENTORY</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_497_20221231_znHikHeX2A49" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49E_20211231_zbkRMooGmF1l" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_407_eus-gaap--InventoryRawMaterialsAndSupplies_iI_maINzAyV_maINzu39_zFC29CYGCCEh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Raw materials</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">330,931</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,481,614</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_eus-gaap--InventoryWorkInProcess_iI_maINzAyV_maINzu39_zM6B57ycoe86" style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Work-in-progress</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0750">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">51,441</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40C_eus-gaap--InventoryFinishedGoods_iI_maINzAyV_maINzu39_zV2eiETc6r2j" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Finished goods</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">639,450</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">210,982</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40F_eus-gaap--InventoryNet_iTI_mtINzu39_zLG6MKY1SB5h" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif"> <span style="font-size: 10pt">Total</span></span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">970,381</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,744,037</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A8_zHOStS9kqYq8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended December 31, 2022 and 2021, depreciation recorded for fleet inventory was $<span id="xdx_90F_eus-gaap--Depreciation_c20220101__20221231__us-gaap--PublicUtilitiesInventoryAxis__custom--FleetInventoryMember_zxkQTN44bpE9" title="Depreciation expenses">87,586</span> and $<span id="xdx_904_eus-gaap--Depreciation_c20210101__20211231__us-gaap--PublicUtilitiesInventoryAxis__custom--FleetInventoryMember_zPCmDm4L0b49" title="Depreciation expenses">95,544</span>. The Company determined that testing of obsolescence was required for inventory due to the quality of certain purchased components from Cenntro’s lithium-ion line (“NCM”). 17 vehicles tested in the second quarter of 2022 were determined to have 49 unique failures. An inspection of the remaining NCM units discovered a 100% failure rate. As a result, all inventory associated with Cenntro’s NCM line was written off to cost of goods sold for $<span id="xdx_90A_eus-gaap--InventoryWriteDown_c20220101__20221231__us-gaap--PublicUtilitiesInventoryAxis__custom--FleetInventoryMember_zsvyYHfJFOk3" title="Inventory written-off">1,317,289</span>. The Club Car Discount during the years ended December 31, 2022 required a $<span id="xdx_90C_eus-gaap--InventoryWriteDown_c20220101__20221231__us-gaap--PublicUtilitiesInventoryAxis__custom--ClubCarDiscountMember_zGmWqOm0eeh6" title="Inventory write down">413,561</span> net realizable value adjustment, necessitating the value of inventory to be written down, spare inventory for the 411x was written off, net with the inventory reserve of $<span id="xdx_909_eus-gaap--InventoryValuationReserves_iI_c20221231__us-gaap--PublicUtilitiesInventoryAxis__custom--ClubCarDiscountMember_zjRfhomiNjr7" title="Inventory reserve">124,375</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zKy3DLyIDPgg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory, net consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_z1zL57Y3ZePc" style="display: none">SCHEDULE OF INVENTORY</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_497_20221231_znHikHeX2A49" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49E_20211231_zbkRMooGmF1l" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_407_eus-gaap--InventoryRawMaterialsAndSupplies_iI_maINzAyV_maINzu39_zFC29CYGCCEh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Raw materials</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">330,931</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,481,614</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_eus-gaap--InventoryWorkInProcess_iI_maINzAyV_maINzu39_zM6B57ycoe86" style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Work-in-progress</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0750">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">51,441</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40C_eus-gaap--InventoryFinishedGoods_iI_maINzAyV_maINzu39_zV2eiETc6r2j" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Finished goods</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">639,450</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">210,982</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40F_eus-gaap--InventoryNet_iTI_mtINzu39_zLG6MKY1SB5h" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif"> <span style="font-size: 10pt">Total</span></span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">970,381</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,744,037</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 330931 3481614 51441 639450 210982 970381 3744037 87586 95544 1317289 413561 124375 <p id="xdx_803_eus-gaap--OtherCurrentAssetsTextBlock_zkvVtLXH0E48" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 7. <span id="xdx_82F_z9zN2Nld8Rai">PREPAID EXPENSES AND OTHER CURRENT ASSETS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span> </span></b></span></p> <p id="xdx_893_eus-gaap--ScheduleOfOtherCurrentAssetsTableTextBlock_zBHf1JpEcrTa" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_zMa3GBof0Yr5" style="display: none">SCHEDULE OF PREPAID EXPENSES AND OTHER CURRENT ASSETS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49F_20221231_zE0jsZpfyUol" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49F_20211231_zxk2KUnlpZ4d" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40F_ecustom--PrepaidFinalAssemblyServices_iI_maPEAOAzbRy_zO4EHdAHHya8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Prepaid final assembly services</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0773">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">439,660</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_ecustom--PrepaymentsForInventory_iI_maPEAOAzbRy_z9nQximFyjgd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Prepayments for inventory</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,174,466</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,622,617</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_408_eus-gaap--PrepaidInsurance_iI_maPEAOAzbRy_zKPV5MdnXkRl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Prepayments for insurance</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">118,434</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0780">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_ecustom--PrepaymentsOnAdvancesOnDesign_iI_maPEAOAzbRy_zFNNqEmSf449" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Prepayments on advances on design</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">75,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0783">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40B_ecustom--PrepaidOnSoftware_iI_maPEAOAzbRy_zsnNGbljUY1c" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Prepayments on software</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">103,851</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0786">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_eus-gaap--OtherPrepaidExpenseCurrent_iI_maPEAOAzbRy_zWLhgXvr9WWl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Prepaid other</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,094</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">213,901</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iTI_mtPEAOAzbRy_zumVXBJJTbge" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif">Total Prepaid Expenses and Other Current Assets</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,478,845</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,276,178</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8AE_zL21HcbFTX8l" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2021 the balance of prepaid expenses and accrued expenses, net with Cenntro was $<span id="xdx_90A_ecustom--PrepaidExpenseAndOtherAccruedExpensesNet_iI_c20211231__dei--LegalEntityAxis__custom--CenntroAutomotiveGroupLtdMember_zGPfqh9dO6Q7" title="Prepaid expenses and accrued expenses, net">602,016</span>. As of December 31, 2022, there was no longer a balance. Impairments of prepaid expenses led to a write-down, netted with the balance in accrued expenses. The remainder of the balance was expensed through cost of goods sold for $<span id="xdx_90A_eus-gaap--CostOfGoodsAndServicesSold_c20220101__20221231__dei--LegalEntityAxis__custom--CenntroAutomotiveGroupLtdMember_zoXRA80kboog" title="Cost of goods sold">621,097</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AYRO, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_893_eus-gaap--ScheduleOfOtherCurrentAssetsTableTextBlock_zBHf1JpEcrTa" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_zMa3GBof0Yr5" style="display: none">SCHEDULE OF PREPAID EXPENSES AND OTHER CURRENT ASSETS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49F_20221231_zE0jsZpfyUol" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49F_20211231_zxk2KUnlpZ4d" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40F_ecustom--PrepaidFinalAssemblyServices_iI_maPEAOAzbRy_zO4EHdAHHya8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Prepaid final assembly services</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0773">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">439,660</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_ecustom--PrepaymentsForInventory_iI_maPEAOAzbRy_z9nQximFyjgd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Prepayments for inventory</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,174,466</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,622,617</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_408_eus-gaap--PrepaidInsurance_iI_maPEAOAzbRy_zKPV5MdnXkRl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Prepayments for insurance</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">118,434</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0780">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_ecustom--PrepaymentsOnAdvancesOnDesign_iI_maPEAOAzbRy_zFNNqEmSf449" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Prepayments on advances on design</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">75,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0783">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40B_ecustom--PrepaidOnSoftware_iI_maPEAOAzbRy_zsnNGbljUY1c" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Prepayments on software</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">103,851</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0786">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_eus-gaap--OtherPrepaidExpenseCurrent_iI_maPEAOAzbRy_zWLhgXvr9WWl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Prepaid other</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,094</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">213,901</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iTI_mtPEAOAzbRy_zumVXBJJTbge" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif">Total Prepaid Expenses and Other Current Assets</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,478,845</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,276,178</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 439660 1174466 1622617 118434 75000 103851 7094 213901 1478845 2276178 602016 621097 <p id="xdx_806_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zgB2JpmRtCY2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 8. <span id="xdx_827_zkYqcX21EMd2">PROPERTY AND EQUIPMENT, NET</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--PropertyPlantAndEquipmentTextBlock_zY1DehbOvOh9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment, net consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zsedjKaoEmY2" style="display: none">SCHEDULE OF PROPERTY AND EQUIPMENT, NET</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_495_20221231_z438ioT0TAC5" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_493_20211231_zb8bZOBZA0Mf" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40C_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndEquipmentMember_zpxD3ZQ4hMl8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Computer and equipment</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,970,001</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">853,695</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40C_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zU0hIa0Sf636" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Furniture and fixtures</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">323,789</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">173,155</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zB1OaQGLdl7j" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Lease improvements</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">952,952</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">282,271</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40B_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PrototypesMember_zfoGOOtJVQ8a" style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Prototypes</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0811">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">300,376</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerSoftwareMember_zEKP1Tzaihdc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Computer software</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">455,875</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">455,875</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_407_eus-gaap--PropertyPlantAndEquipmentGross_iI_maPPAENzjOM_zzx8qD5qGs3a" style="vertical-align: bottom; background-color: White"> <td><span style="display: none; font-family: Times New Roman, Times, Serif">Property and equipment, gross</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,702,617</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,065,372</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENzjOM_z4lBxAv7q9yg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Less: Accumulated depreciation</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,510,280</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,230,212</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_408_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENzjOM_zLhidX1oacw7" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif">Property and equipment, net</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,192,337</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">835,160</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A8_zVfd4N051bn7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation expense for the years ended December 31, 2022 and 2021 was $<span id="xdx_907_eus-gaap--Depreciation_c20220101__20221231_zlKBhJol5pzi" title="Depreciation expense">580,445</span>, of which $<span id="xdx_905_eus-gaap--Depreciation_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RetiringLegacyAssetsMember_zxQ6LKkD26Y" title="Depreciation expense">101,581</span> was related to retiring legacy assets, and $<span id="xdx_909_eus-gaap--Depreciation_c20210101__20211231_zSbMYc9BKmc1" title="Depreciation">314,164</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AYRO, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--PropertyPlantAndEquipmentTextBlock_zY1DehbOvOh9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment, net consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zsedjKaoEmY2" style="display: none">SCHEDULE OF PROPERTY AND EQUIPMENT, NET</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_495_20221231_z438ioT0TAC5" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_493_20211231_zb8bZOBZA0Mf" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40C_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndEquipmentMember_zpxD3ZQ4hMl8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Computer and equipment</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,970,001</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">853,695</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40C_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zU0hIa0Sf636" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Furniture and fixtures</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">323,789</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">173,155</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zB1OaQGLdl7j" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Lease improvements</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">952,952</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">282,271</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40B_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PrototypesMember_zfoGOOtJVQ8a" style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Prototypes</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0811">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">300,376</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerSoftwareMember_zEKP1Tzaihdc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Computer software</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">455,875</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">455,875</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_407_eus-gaap--PropertyPlantAndEquipmentGross_iI_maPPAENzjOM_zzx8qD5qGs3a" style="vertical-align: bottom; background-color: White"> <td><span style="display: none; font-family: Times New Roman, Times, Serif">Property and equipment, gross</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,702,617</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,065,372</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENzjOM_z4lBxAv7q9yg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Less: Accumulated depreciation</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,510,280</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,230,212</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_408_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENzjOM_zLhidX1oacw7" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif">Property and equipment, net</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,192,337</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">835,160</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 1970001 853695 323789 173155 952952 282271 300376 455875 455875 3702617 2065372 1510280 1230212 2192337 835160 580445 101581 314164 <p id="xdx_80C_eus-gaap--CashCashEquivalentsAndMarketableSecuritiesTextBlock_zxRjxB7VQ0g5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 9. <span id="xdx_82E_zJqVVpW4hz0e">MARKETABLE SECURITIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--MarketableSecuritiesTextBlock_zx6V4GRpZ0ei" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marketable securities purchased in 2022 consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/><span id="xdx_8BE_zcErp5xOhQ7b" style="display: none">SCHEDULE OF MARKETABLE SECURITIES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td colspan="21" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31, 2022</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Realized</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Unrealized</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Transferred</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Cost Basis</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Gains</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Loss</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">to Cash</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%"><span style="font-family: Times New Roman, Times, Serif">Bonds</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--DebtSecuritiesTradingAndEquitySecuritiesFvNiCost_iI_c20221231__us-gaap--InvestmentTypeAxis__us-gaap--BondsMember_zDrKmgj0vo33" style="width: 9%; text-align: right" title="Cost Basis"><span style="font-family: Times New Roman, Times, Serif">12,235,258</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments_c20220101__20221231__us-gaap--InvestmentTypeAxis__us-gaap--BondsMember_zIVkwUmvK6Ad" style="width: 9%; text-align: right" title="Gross Realized Gains"><span style="font-family: Times New Roman, Times, Serif">160,990</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_c20220101__20221231__us-gaap--InvestmentTypeAxis__us-gaap--BondsMember_zGn4WXjythl8" style="width: 9%; text-align: right" title="Gross Unrealized Losses"><span style="font-family: Times New Roman, Times, Serif">(1,713</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--MarketableSecuritiesTransferredToCash_iI_c20221231__us-gaap--InvestmentTypeAxis__us-gaap--BondsMember_zcqrkP5HRnE4" style="width: 9%; text-align: right" title="Transferred to Cash"><span style="font-family: Times New Roman, Times, Serif">(10,310,473</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--MarketableSecuritiesCurrent_iI_c20221231__us-gaap--InvestmentTypeAxis__us-gaap--BondsMember_z0LP8pHojph2" style="width: 9%; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif">2,084,062</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">US Treasury securities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_981_eus-gaap--DebtSecuritiesTradingAndEquitySecuritiesFvNiCost_iI_c20221231__us-gaap--InvestmentTypeAxis__us-gaap--USTreasurySecuritiesMember_zy7HjQEK0IO7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Cost Basis"><span style="font-family: Times New Roman, Times, Serif">7,764,742</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eus-gaap--MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments_c20220101__20221231__us-gaap--InvestmentTypeAxis__us-gaap--USTreasurySecuritiesMember_zv5luBCxTRL2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Gross Realized Gains"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0848">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eus-gaap--MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments_c20220101__20221231__us-gaap--InvestmentTypeAxis__us-gaap--USTreasurySecuritiesMember_zYOQLisKvKXj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Gross Realized Gains"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0850">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_ecustom--MarketableSecuritiesTransferredToCash_iI_c20221231__us-gaap--InvestmentTypeAxis__us-gaap--USTreasurySecuritiesMember_zCqy2lrmPPx5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Transferred to Cash"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0852">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eus-gaap--MarketableSecuritiesCurrent_iI_c20221231__us-gaap--InvestmentTypeAxis__us-gaap--USTreasurySecuritiesMember_z0SNgYsWiWs3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif">7,764,742</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--DebtSecuritiesTradingAndEquitySecuritiesFvNiCost_iI_c20221231_z3zRFExmbOY" style="border-bottom: Black 2.5pt double; text-align: right" title="Cost Basis"><span style="font-family: Times New Roman, Times, Serif">20,000,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments_c20220101__20221231_znXRURGSENqg" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross Realized Gains"><span style="font-family: Times New Roman, Times, Serif">160,990</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_c20220101__20221231_zGHEpprzuxKh" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross Unrealized Losses"><span style="font-family: Times New Roman, Times, Serif">(1,713</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_ecustom--MarketableSecuritiesTransferredToCash_iI_c20221231_zNyuebXeADnc" style="border-bottom: Black 2.5pt double; text-align: right" title="Transferred to Cash"><span style="font-family: Times New Roman, Times, Serif">(10,310,473</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--MarketableSecuritiesCurrent_iI_c20221231_zbzoYUkJRtni" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif">9,848,804</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A6_zJS11LZRpb8j" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AYRO, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_897_eus-gaap--MarketableSecuritiesTextBlock_zx6V4GRpZ0ei" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marketable securities purchased in 2022 consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/><span id="xdx_8BE_zcErp5xOhQ7b" style="display: none">SCHEDULE OF MARKETABLE SECURITIES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td colspan="21" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31, 2022</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Realized</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Unrealized</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Transferred</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Cost Basis</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Gains</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Loss</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">to Cash</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%"><span style="font-family: Times New Roman, Times, Serif">Bonds</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--DebtSecuritiesTradingAndEquitySecuritiesFvNiCost_iI_c20221231__us-gaap--InvestmentTypeAxis__us-gaap--BondsMember_zDrKmgj0vo33" style="width: 9%; text-align: right" title="Cost Basis"><span style="font-family: Times New Roman, Times, Serif">12,235,258</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments_c20220101__20221231__us-gaap--InvestmentTypeAxis__us-gaap--BondsMember_zIVkwUmvK6Ad" style="width: 9%; text-align: right" title="Gross Realized Gains"><span style="font-family: Times New Roman, Times, Serif">160,990</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_c20220101__20221231__us-gaap--InvestmentTypeAxis__us-gaap--BondsMember_zGn4WXjythl8" style="width: 9%; text-align: right" title="Gross Unrealized Losses"><span style="font-family: Times New Roman, Times, Serif">(1,713</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--MarketableSecuritiesTransferredToCash_iI_c20221231__us-gaap--InvestmentTypeAxis__us-gaap--BondsMember_zcqrkP5HRnE4" style="width: 9%; text-align: right" title="Transferred to Cash"><span style="font-family: Times New Roman, Times, Serif">(10,310,473</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--MarketableSecuritiesCurrent_iI_c20221231__us-gaap--InvestmentTypeAxis__us-gaap--BondsMember_z0LP8pHojph2" style="width: 9%; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif">2,084,062</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">US Treasury securities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_981_eus-gaap--DebtSecuritiesTradingAndEquitySecuritiesFvNiCost_iI_c20221231__us-gaap--InvestmentTypeAxis__us-gaap--USTreasurySecuritiesMember_zy7HjQEK0IO7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Cost Basis"><span style="font-family: Times New Roman, Times, Serif">7,764,742</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eus-gaap--MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments_c20220101__20221231__us-gaap--InvestmentTypeAxis__us-gaap--USTreasurySecuritiesMember_zv5luBCxTRL2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Gross Realized Gains"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0848">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eus-gaap--MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments_c20220101__20221231__us-gaap--InvestmentTypeAxis__us-gaap--USTreasurySecuritiesMember_zYOQLisKvKXj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Gross Realized Gains"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0850">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_ecustom--MarketableSecuritiesTransferredToCash_iI_c20221231__us-gaap--InvestmentTypeAxis__us-gaap--USTreasurySecuritiesMember_zCqy2lrmPPx5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Transferred to Cash"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0852">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eus-gaap--MarketableSecuritiesCurrent_iI_c20221231__us-gaap--InvestmentTypeAxis__us-gaap--USTreasurySecuritiesMember_z0SNgYsWiWs3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif">7,764,742</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--DebtSecuritiesTradingAndEquitySecuritiesFvNiCost_iI_c20221231_z3zRFExmbOY" style="border-bottom: Black 2.5pt double; text-align: right" title="Cost Basis"><span style="font-family: Times New Roman, Times, Serif">20,000,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments_c20220101__20221231_znXRURGSENqg" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross Realized Gains"><span style="font-family: Times New Roman, Times, Serif">160,990</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_c20220101__20221231_zGHEpprzuxKh" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross Unrealized Losses"><span style="font-family: Times New Roman, Times, Serif">(1,713</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_ecustom--MarketableSecuritiesTransferredToCash_iI_c20221231_zNyuebXeADnc" style="border-bottom: Black 2.5pt double; text-align: right" title="Transferred to Cash"><span style="font-family: Times New Roman, Times, Serif">(10,310,473</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--MarketableSecuritiesCurrent_iI_c20221231_zbzoYUkJRtni" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif">9,848,804</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 12235258 160990 -1713 -10310473 2084062 7764742 7764742 20000000 160990 -1713 -10310473 9848804 <p id="xdx_804_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_z7yp4ALqxIJg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>NOTE 10. <span id="xdx_829_zGO4MEqGGf9d">STOCKHOLDERS’ EQUITY</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Common Stock</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 25, 2021, AYRO entered into a Securities Purchase Agreement with certain institutional and accredited investors, pursuant to which AYRO agreed to issue and sell in a registered direct offering (the “January 2021 Offering”) an aggregate of <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210124__20210125__us-gaap--AwardTypeAxis__custom--JanuaryTwentyTwentyOneOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--AdditionalSharesMember_z4tvpYAXlep2" title="Number of shares issued">3,333,334</span> shares of common stock of AYRO, par value $<span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20210125__us-gaap--StatementEquityComponentsAxis__custom--AdditionalSharesMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--AwardTypeAxis__custom--JanuaryTwentyTwentyOneOfferingMember_zVp9ijd8Sztk" title="Common stock, par value">0.0001</span> per share, at an offering price of $<span id="xdx_906_eus-gaap--SharePrice_iI_c20210125__us-gaap--StatementEquityComponentsAxis__custom--AdditionalSharesMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--AwardTypeAxis__custom--JanuaryTwentyTwentyOneOfferingMember_zQWAnVN99h64" title="Offering price">6.00</span> per share, for gross proceeds of $<span id="xdx_904_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20210124__20210125__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--AwardTypeAxis__custom--JanuaryTwentyTwentyOneOfferingMember__us-gaap--StatementEquityComponentsAxis__custom--AdditionalSharesMember_z0zxt6zhvPf9" title="Sale of stock consideration received on transaction">20,000,004</span> before the deduction of fees and offering expenses of $<span id="xdx_909_eus-gaap--PaymentsOfStockIssuanceCosts_c20210124__20210125__us-gaap--AwardTypeAxis__custom--JanuaryTwentyTwentyOneOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--AdditionalSharesMember_zWEi2cmaIyml" title="Offering expenses">1,648,608</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 11, 2021, AYRO entered into a Securities Purchase Agreement with certain institutional and accredited investors, pursuant to which AYRO agreed to issue and sell in a registered direct offering (the “February 2021 Offering”) an aggregate of <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210210__20210211__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--AdditionalSharesMember_zpky73rb3KK5" title="Number of shares issued">4,400,001</span> shares of common stock of AYRO, par value $<span id="xdx_909_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20210211__us-gaap--StatementEquityComponentsAxis__custom--AdditionalSharesMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zZr1XvGgQmlb" title="Common stock, par value">0.0001</span> per share, at an offering price of $<span id="xdx_90B_eus-gaap--SharePrice_iI_c20210211__us-gaap--StatementEquityComponentsAxis__custom--AdditionalSharesMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_ztPmXmkfsrF2" title="Offering price">9.50</span> per share, for gross proceeds of $<span id="xdx_90D_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20210210__20210211__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--AdditionalSharesMember_zoRmUvM5yBg3" title="Proceeds from sale of common stock">41,800,008</span> before the deduction of fees and offering expenses of $<span id="xdx_90E_eus-gaap--PaymentsOfStockIssuanceCosts_c20210210__20210211__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--AdditionalSharesMember_zX6G72BZswXd" title="Offering expenses">3,394,054</span>. <span id="xdx_906_eus-gaap--SaleOfStockDescriptionOfTransaction_c20210210__20210211__us-gaap--StatementEquityComponentsAxis__custom--AdditionalSharesMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zhYdwvNgIlXk" title="Purchase of additional shares description">Each purchaser was also granted an option to purchase, on or before February 16, 2022, additional shares of common stock equal to the full amount of 75% of the common stock it purchased at the initial closing, or an aggregate of <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210210__20210211__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--AdditionalSharesMember_zeGuXL5djdfa" title="Number of shares issued">3,300,001</span> shares, at an exercise price of $<span id="xdx_900_eus-gaap--SharePrice_iI_c20210211__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--StatementEquityComponentsAxis__custom--AdditionalSharesMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zUwAo2hsR0M1" title="Offering price">11.50</span> per share.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 17, 2021, in connection with that certain Agreement and Plan of Merger dated December 19, 2019, whereby certain former stockholders of AYRO Operating entered into lock-up agreements (collectively, the “May Lock-Up Agreements”) pursuant to which they agreed to certain restrictions on the transfer or sale of shares of the Company’s common stock for the one-year period following the Merger, AYRO modified the May Lock-Up Agreements to allow each stockholder party to a May Lock-Up Agreement to <span id="xdx_906_eus-gaap--SaleOfStockDescriptionOfTransaction_c20210316__20210317__us-gaap--StatementEquityComponentsAxis__custom--AdditionalSharesMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z16eVHtC9EQ1" title="Purchase of additional shares description">(i) sell up to 5% of such stockholder’s holdings in the Company’s common stock on any trading day (with such 5% limitation to be measured as of the date of each sale) and (ii) allow for unlimited sales of the Company’s common stock for any sales made at $10.00 per share or greater.</span> As of May 28, 2021, all of the May Lock-up Agreements were expired.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to the Securities Purchase Agreement dated July 21, 2020, during the year ended December 31, 2021 investors purchased <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_c20200720__20200721__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zLkUs57kuTv4" title="Number of additional shares purchased">302,500</span> of the Additional Shares of common stock of AYRO, par value $<span id="xdx_903_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20200721__us-gaap--StatementEquityComponentsAxis__custom--AdditionalSharesMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zwLNsuBlIvyk" title="Common stock, par value">0.0001</span> per share, at an offering price of $<span id="xdx_904_eus-gaap--SharePrice_iI_c20200721__us-gaap--StatementEquityComponentsAxis__custom--AdditionalSharesMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zXphvAVrF7Rg" title="Offering price">5.00</span> per share, for gross proceeds of $<span id="xdx_900_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20200720__20200721__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zFS0ampLGw9e" title="Proceeds from sale of common stock">1,512,500</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During February 2021, the Company issued <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20210201__20210228__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zF7ZqtiBn762" title="Shares issued for exercised stock options, shares">13,642</span> shares of common stock upon the exercise of warrants and received cash proceeds of $<span id="xdx_903_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_c20210201__20210228__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zlZU181hbZW3" title="Shares issued for exercised stock options">100,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2021, the Company issued <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20210101__20211231__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zRvDu8Pqkf9a" title="Shares issued for exercised stock options, shares">555,004</span> shares of common stock upon the exercise of stock options and received cash proceeds of $<span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_c20210101__20211231__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zMmfftMONk8b" title="Shares issued for exercised stock options">1,506,999</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AYRO, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2021, the Company issued <span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z845MgsmFESd" title="Number of shares vested">1,158,891</span> shares of common stock upon the vesting of restricted stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2022, the Company issued <span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zXMBIJK2p9Jb" title="Number of shares vested">374,686</span> shares of common stock upon the vesting of restricted stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Restricted Stock</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On February 24, 2021, pursuant to the AYRO, Inc. 2020 Long-Term Incentive Plan, the Company granted <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20210220__20210224__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyLongTermIncentivePlanMember_zesurzgAlIeh" title="Number of restricted stock units">172,000</span> shares of restricted stock to non-executive directors at a value of $<span id="xdx_902_eus-gaap--SharesIssuedPricePerShare_iI_c20210224__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyLongTermIncentivePlanMember_zq7N0LoDuuW7" title="Offering price">7.66</span> per share. <span id="xdx_901_eus-gaap--CommonStockSharesSubscribedButUnissued_iI_c20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zNWgPUBVse92" title="Common Stock, Shares Subscribed but Unissued">43,000</span> shares of common stock remained unissued as of December 31, 2021; these shares were issued during the years ended December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 1, 2022, pursuant to the AYRO, Inc. 2020 Long-Term Incentive Plan, the Company granted <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_pid_c20220129__20220201__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyLongTermIncentivePlanMember_zfGyRCWhy3Ya" title="Number of restricted shares">442,249</span> shares of restricted stock to non-executive directors at a value of $<span id="xdx_90C_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20220201__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyLongTermIncentivePlanMember_z87DV73WUow2" title="Share price">1.29</span> per share. During the years ended December 31, 2022, <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_pid_c20220101__20221231__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyLongTermIncentivePlanMember_z8PcRArL2Tvj" title="Number of restricted shares issued and vested">331,686</span> shares were issued and vested.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Preferred Stock</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--StockholdersEquityReverseStockSplit_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zLhQq2T3QIK4" title="Reverse stock split, description">Upon closing of the Merger, the Company assumed the Series H, H-3 and H-6 preferred stock of DropCar, Inc., which respective conversion prices have been adjusted to reflect the May 2020 one-for-five reverse split.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Series H Convertible Preferred Stock</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the terms of the Series H Certificate of Designation, each share of the Company’s Series H Convertible Preferred Stock (the “Series H Preferred Stock”) has a stated value of $<span id="xdx_901_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_zRuTGBzXMxg9" title="Preferred stock stated value">154.00</span> and is convertible into shares of the Company’s Common Stock, equal to the stated value divided by the conversion price of $<span id="xdx_909_eus-gaap--PreferredStockConvertibleConversionPriceIncrease_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_zov5dp8uPaN2" title="Preferred stock, conversion price">184.80</span> per share (subject to adjustment in the event of stock splits or dividends). The Company is prohibited from effecting the conversion of the Series H Preferred Stock to the extent that, as a result of such conversion, the holder would beneficially own more than <span id="xdx_900_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AffiliatesMember_zq6lwzgmP5M3" title="Aggregate issued and outstanding shares percentage">9.99</span>%, in the aggregate, of the issued and outstanding shares of the Company’s common stock calculated immediately after giving effect to the issuance of shares of common stock upon such conversion. In the event of liquidation, the holders of the Series H Preferred Stock are entitled, pari passu with the holders of common stock, to receive a payment in the amount the holder would receive if such holder converted the Series H Preferred Stock into common stock immediately prior to the date of such payment. As of December 31, 2022, such payment would be calculated as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_ecustom--ScheduleOfPaymentOfPreferredStockTableTextBlock_hus-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zLZ1CO2fDYIe" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zUzpXrNKBuq5" style="display: none">SCHEDULE OF PAYMENT OF PREFERRED STOCK</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49D_20221231__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesHMember_z2IBa7HHcOx3" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--PreferredStockSharesOutstanding_iI_zXSODJZMafL" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 82%"><span style="font-family: Times New Roman, Times, Serif">Number of Series H Preferred Stock outstanding as of December 31, 2022</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_ecustom--StatedValueOfPreferredStockSeries_iI_zNgsnPDfZQba" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Multiplied by the stated value</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">154</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_ecustom--GrossStateValueOfPreferredStock_iI_zgIA4UEN9sYe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Equals the gross stated value</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,232</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40B_eus-gaap--PreferredStockConvertibleConversionPrice_iI_z45UR5jgLyUc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Divided by the conversion price</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">184.8</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_ziAfQJb3YSHe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Equals the convertible shares of Company Common Stock</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6.66</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_eus-gaap--SharesIssuedPricePerShare_iI_zAnjHezqH5Ak" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Multiplied by the fair market value of Company Common Stock as of December 31, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.38</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40F_eus-gaap--PreferredStockLiquidationPreference_iI_zi3gLwkIxY5a" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Liquidation Value</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.66</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A8_zgg2uNjuRxA9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AYRO, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Series H-3 Convertible Preferred Stock</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to the Series H-3 Certificate of Designation (as defined below), the holders of the Company’s Series H-3 Convertible Preferred Stock (the “Series H-3 Preferred Stock”) are entitled to elect up to two members of a seven-member Board, subject to certain step downs; pursuant to the Series H-3 securities purchase agreement, the Company agreed to effectuate the appointment of the designees specified by the Series H-3 investors as directors of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the terms of the Series H-3 Certificate of Designation, each share of the Series H-3 Preferred Stock has a stated value of $<span id="xdx_90A_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesHThreePreferredStockMember_z8KDrgynHtUg" title="Preferred stock stated value">138.00</span> and is convertible into shares of common stock, equal to the stated value divided by the conversion price of $<span id="xdx_905_ecustom--ConversionPriceOfShare_iI_c20221231__us-gaap--AwardTypeAxis__custom--SeriesHThreeWarrantsMember_z0xSpeaAElH8" title="Conversion price per share">165.60</span> per share (subject to adjustment in the event of stock splits and dividends). The Company is prohibited from effecting the conversion of the Series H-3 Preferred Stock to the extent that, as a result of such conversion, the holder or any of its affiliates would beneficially own more than <span id="xdx_90F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesHThreePreferredStockMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AffiliatesMember_zbhP9qS37xJ6" title="Aggregate issued and outstanding shares percentage">9.99</span>%, in the aggregate, of the issued and outstanding shares of common stock calculated immediately after giving effect to the issuance of shares of common stock upon the conversion of the Series H-3 Preferred Stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the event of liquidation, the holders of the Series H-3 Preferred Stock are entitled, pari passu with the holders of common stock, to receive a payment in the amount the holder would receive if such holder converted the Series H-3 Preferred Stock into common stock immediately prior to the date of such payment. As of <span style="background-color: white">December 31, 2022</span>, such payment would be calculated as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89D_ecustom--ScheduleOfPaymentOfPreferredStockTableTextBlock_hus-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesHThreeMember_zZiBmIzCMn95" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_z3udqGCjjxSl" style="display: none">SCHEDULE OF PAYMENT OF PREFERRED STOCK</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_496_20221231__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesHThreeMember_z0WTAZBkowm7" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--PreferredStockSharesOutstanding_iI_zzRN5Gg1TUMl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 82%"><span style="font-family: Times New Roman, Times, Serif">Number of Series H-3 Preferred Stock outstanding as of December 31, 2022</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,234</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40C_ecustom--StatedValueOfPreferredStockSeries_iI_z9citqDXFdOe" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Multiplied by the stated value</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">138</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_ecustom--GrossStateValueOfPreferredStock_iI_zscQU7qskLr2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Equals the gross stated value</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">170,292</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_407_eus-gaap--PreferredStockConvertibleConversionPrice_iI_zzrAdC15io0i" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Divided by the conversion price</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">165.6</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_408_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_zMs8NYDCXL09" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Equals the convertible shares of Company Common Stock</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,028</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_eus-gaap--SharesIssuedPricePerShare_iI_zTrg8tYRTKRi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Multiplied by the fair market value of Company Common Stock as of December 31, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.38</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_eus-gaap--PreferredStockLiquidationPreferenceValue_iI_ztNoeY9saNQe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Liquidation Value</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">391</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A2_zAx3Z11tYRd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Series H-6 Convertible Preferred Stock</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 5, 2020, the Company filed the Certificate of Designations, Preferences and Rights of the Series H-6 Preferred Stock (the “Series H-6 Certificate of Designation”) with the Secretary of State of the State of Delaware, establishing and designating the rights, powers and preferences of the Series H-6 Preferred Stock. The Company designated up to <span id="xdx_909_eus-gaap--PreferredStockSharesAuthorized_iI_c20200205__us-gaap--StatementClassOfStockAxis__custom--SeriesHSixConvertibePreferredStockMember_z7ct2L6ywhVl" title="Preferred stock, designated">50,000</span> shares of Series H-6 Preferred Stock and each share has a stated value of $<span id="xdx_902_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20200205__us-gaap--StatementClassOfStockAxis__custom--SeriesHSixConvertibePreferredStockMember_z7p2YsldlFE4" title="Preferred stock stated value">72.00</span> (the “H-6 Stated Value”). <span id="xdx_90F_eus-gaap--PreferredStockConversionBasis_c20200204__20200205__us-gaap--StatementClassOfStockAxis__custom--SeriesHSixConvertibePreferredStockMember_z9kxQOGQoruc" title="Preferred stock, conversion price description">Each share of Series H-6 Preferred Stock is convertible at any time at the option of the holder thereof, into a number of shares of common stock of the Company determined by dividing the H-6 Stated Value by the initial conversion price of $<span id="xdx_907_eus-gaap--PreferredStockConvertibleConversionPriceIncrease_c20200204__20200205__us-gaap--StatementClassOfStockAxis__custom--SeriesHSixConvertibePreferredStockMember_zaQTntz5oR94" title="Preferred stock, conversion price">3.60</span> per share, which was then further reduced to $2.50 under the anti-dilution adjustment provision, subject to a 9.99% blocker provision.</span> The Series H-6 Preferred Stock has the same dividend rights as the common stock, except as provided for in the Series H-6 Certificate of Designation or as otherwise required by law. The Series H-6 Preferred Stock also has the same voting rights as the common stock, except that in no event shall a holder of Series H-6 Preferred Stock be permitted to exercise a greater number of votes than such holder would have been entitled to cast if the Series H-6 Preferred Stock had immediately been converted into shares of common stock at a conversion price equal to $<span id="xdx_908_eus-gaap--PreferredStockConvertibleConversionPriceIncrease_c20220101__20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesHSixConvertibePreferredStockMember_z8JOYJjju3Lc" title="Preferred stock, conversion price">3.60</span>. In addition, a holder (together with its affiliates) may not be permitted to vote Series H-6 Preferred Stock held by such holder to the extent that such holder would beneficially own more than <span id="xdx_90C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_c20200205__us-gaap--StatementClassOfStockAxis__custom--SeriesHSixConvertibePreferredStockMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AffiliatesMember_zj9e2Retaqo" title="Aggregate issued and outstanding shares percentage">9.99</span>% of our common stock. In the event of any liquidation or dissolution, the Series H-6 Preferred Stock ranks senior to the common stock in the distribution of assets, to the extent legally available for distribution.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AYRO, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The holders of Series H-6 Preferred Stock are entitled to certain anti-dilution adjustments if the Company issues shares of its common stock at a lower price per share than the applicable conversion price of the Series H-6 Preferred Stock. If any such dilutive issuance occurs prior to the conversion of the Series H-6 Preferred Stock, the conversion price will be adjusted downward to a price that cannot be less than 20% of the exercise price of $<span id="xdx_903_eus-gaap--PreferredStockConvertibleConversionPriceIncrease_c20220101__20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesHSixConvertibePreferredStockMember_zbbPCMYyqDM3" title="Convertible conversion price increase">3.60</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the event of liquidation, the holders of the Series H-6 Preferred Stock are entitled, pari passu with the holders of common stock, to receive a payment in the amount the holder would receive if such holder converted the Series H-6 Preferred Stock into common stock immediately prior to the date of such payment. As of <span style="background-color: white">December 31, 2022,</span> such payment would be calculated as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_ecustom--ScheduleOfPaymentOfPreferredStockTableTextBlock_hus-gaap--StatementClassOfStockAxis__custom--SeriesHSixConvertiblePreferredStockMember_z3JYjbc7phv9" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_z9N8pQMyvGFl" style="display: none">SCHEDULE OF PAYMENT OF PREFERRED STOCK</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49A_20221231__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesHSixMember_zcWvNf2XQBa8" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--PreferredStockSharesOutstanding_iI_zrm5RownvJe2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 82%"><span style="font-family: Times New Roman, Times, Serif">Number of Series H-6 Preferred Stock outstanding as of December 31, 2022</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">50</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_eus-gaap--PreferredStockSharesOutstanding_iI_zfLBR0ZO3hXb" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Number of Series H Preferred Stock outstanding as of December 31, 2022</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">50</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_ecustom--StatedValueOfPreferredStockSeries_iI_zuYebJKz8Np5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Multiplied by the stated value</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">72</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_ecustom--GrossStateValueOfPreferredStock_iI_zDmI2DdSzgg9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Equals the gross stated value</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,600</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_eus-gaap--PreferredStockConvertibleConversionPrice_iI_zisCvqIWoqQ9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Divided by the conversion price</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.5</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_zbxMbAqSIOr8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Equals the convertible shares of Company Common Stock</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,440</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eus-gaap--SharesIssuedPricePerShare_iI_z8ClFemME3ij" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Multiplied by the fair market value of Company Common Stock as of December 31, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.38</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_407_eus-gaap--PreferredStockLiquidationPreferenceValue_iI_zwx4KDGaUsU7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Liquidation Value</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">547</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8AF_zy1SwbSOvSzd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>AYRO Series Seed Preferred Stock</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior to the Merger, the Company was authorized to issue <span id="xdx_902_eus-gaap--PreferredStockSharesAuthorized_iI_c20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_z5lNrljeB5ca" title="Preferred stock, shares authorized">8,472,500</span> shares of preferred stock, no par value, of which all were designated as Series Seed Preferred Stock. As of <span style="background-color: white">December 31, 2022 and 2021,</span> no shares of Series Seed Preferred Stock were issued and outstanding. In conjunction with the Merger, all <span id="xdx_904_eus-gaap--ConversionOfStockSharesConverted1_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_z7kpxhjoJ3lg" title="Conversion of stock shares">7,360,985</span> shares of AYRO Series Seed Preferred Stock were converted into approximately <span id="xdx_905_eus-gaap--ConversionOfStockSharesIssued1_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zT28MxIm3Mzj" title="Conversion of stock shares issued">2,007,193</span> shares of the Company Common Stock after taking into account the Exchange Ratio, Reverse Stock Split and Stock Dividend.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AYRO, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrants</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>AYRO Seed Warrants</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior to the Merger, the Company issued <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20221231__us-gaap--AwardTypeAxis__custom--SeedWarrantsMember_zV39PFkZBQ17">461,647</span> warrants (the “AYRO Seed Warrants”) with an exercise price $<span id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20221231__us-gaap--AwardTypeAxis__custom--SeedWarrantsMember_zabOfTo1HWf3">7.33</span>. The AYRO Seed Warrants terminate five years from the grant date. <span style="background-color: white">As of December 31, 2022, there were <span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20221231__us-gaap--AwardTypeAxis__custom--SeedWarrantsMember_zLe8kJOcskzj">448,005</span> AYRO Seed Warrants outstanding.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Series I Warrants</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a result of the Merger, <span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20221231__us-gaap--AwardTypeAxis__custom--SeriesIWarrantsMember_zLC0EhfLeW52" title="Warrants to purchase common stock">14,636</span> Series I Warrants transferred to AYRO and have an exercise price of $<span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20221231__us-gaap--AwardTypeAxis__custom--SeriesIWarrantsMember_zSAHA6423L56" title="Warrant exercise price">69.00</span> per share. <span id="xdx_904_eus-gaap--ClassOfWarrantOrRightReasonForIssuingToNonemployees_c20220101__20221231__us-gaap--AwardTypeAxis__custom--SeriesIWarrantsMember_zgEOkCPU5n35" title="Warrants description">If at any time (i) the volume weighted average price (“VWAP”) of the Common Stock exceeds $<span id="xdx_90D_ecustom--WarrantWeightedAverageExercisePrice_iI_pp0p0_c20221231__us-gaap--AwardTypeAxis__custom--SeriesIWarrantsMember_zy8crcrZwuV1" title="Warrant weighted average exercise price">138.00</span> for not less than the mandatory exercise measuring period; (ii) the daily average number of shares of Common Stock traded during the mandatory exercise measuring period equals or exceeds 25,000; and (iii) no equity conditions failure has occurred as of such date, then the Company shall have the right to require the holder to exercise all or any portion of the Series I Warrants still unexercised for a cash exercise.</span> During the year ended December 31, 2021, all <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20211231__us-gaap--AwardTypeAxis__custom--SeriesIWarrantsMember_z5ppUgdFMaGh" title="Warrant outstanding">14,636</span> Series I Warrants expired<span style="background-color: white">.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Series H-3 Warrants</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a result of the Merger, <span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20221231__us-gaap--AwardTypeAxis__custom--SeriesHThreeWarrantsMember_zMZB2YiKUlyj" title="Warrants to purchase common stock">2,800</span> Series H-3 Warrants transferred to AYRO and have an exercise price of $<span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20221231__us-gaap--AwardTypeAxis__custom--SeriesHThreeWarrantsMember_zIpqHggf9Xya" title="Warrant exercise price">165.60</span> per share, subject to adjustments (the “Series H-3 Warrants”). Subject to certain ownership limitations, the Series H-3 Warrants are immediately exercisable from the issuance date and will be exercisable for a period of five (<span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20221231__us-gaap--AwardTypeAxis__custom--SeriesHThreeWarrantsMember_zTv73XgGIFB" title="Warrants term">5</span>) years from the issuance date. <span style="background-color: white">As of December 31, 2022, all <span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20221231__us-gaap--AwardTypeAxis__custom--SeriesHThreeWarrantsMember_zmkWPi9wvK6c" title="Warrant outstanding">2,800</span> Series H-3 Warrants expired.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Series H-4 Warrants</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a result of the Merger, <span id="xdx_909_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20221231__us-gaap--AwardTypeAxis__custom--SeriesHFourWarrantsMember_zMDQTxdMIDe1" title="Warrant outstanding">37,453</span> Series H-4 Warrants transferred to AYRO and have an exercise price of $<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20221231__us-gaap--AwardTypeAxis__custom--SeriesHFourWarrantsMember_zVKRnPkj9Agf" title="Warrant exercise price">15.60</span>. The Series H-4 Warrants contain an anti-dilution price protection and the warrants cannot be less than $<span id="xdx_907_ecustom--AntidilutionPriceProtectionPricePerShare_iI_c20221231__us-gaap--AwardTypeAxis__custom--SeriesHFourWarrantsMember_zibWlIeidOW5" title="Anti-dilution price protection price per share">15.60</span> per share. <span style="background-color: white">As of December 31, 2022, there were <span id="xdx_909_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20221231__us-gaap--AwardTypeAxis__custom--SeriesHFourWarrantsMember_zarvxk3XBa6h" title="Warrant outstanding">37,453</span> Series H-4 Warrants outstanding.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AYRO, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Series J Warrants</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a result of the Merger, <span id="xdx_905_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20221231__us-gaap--AwardTypeAxis__custom--SeriesJWarrantsMember_zKYfACOjuEo" title="Warrant outstanding">52,023</span> Series J Warrants transferred to AYRO. The terms of the Series J Warrants are substantially identical to the terms of the Series H-4 Warrants except that (i) the exercise price is equal to $<span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20221231__us-gaap--AwardTypeAxis__custom--SeriesJWarrantsMember_zVbMVwQ2Os3g" title="Warrant exercise price">30.00</span> per share, (ii) the Series J Warrants may be exercised at all times beginning on the 6-month anniversary of the issuance date on a cash basis and also on a cashless basis, (iii) the Series J Warrants do not contain any provisions for anti-dilution adjustment and (iv) the Company has the right to require the Holders to exercise all or any portion of the Series J Warrants still unexercised for a cash exercise if the volume-weighted average price (VWAP) (as defined in the Series J Warrant) for the Company’s common stock equals or exceeds $<span id="xdx_907_ecustom--ExceedsWarrantPricePerShare_iI_c20221231__us-gaap--AwardTypeAxis__custom--SeriesJWarrantsMember_zMjbTwJgUDSb" title="Exceeds warrant price per share">45.00</span> for not less than ten consecutive trading days.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--ClassOfWarrantOrRightReasonForIssuingToNonemployees_c20220101__20221231__us-gaap--AwardTypeAxis__custom--SeriesJWarrantsMember_zSxh6Y3sRDR8" title="Warrants description">If at any time (i) the VWAP of the Common Stock exceeds $9.00 for not less than the mandatory exercise measuring period; (ii) the daily average number of shares of Common Stock traded during the mandatory exercise measuring period equals or exceeds 25,000; and (iii) no equity conditions failure has occurred as of such date, then the Company shall have the right to require the holder to exercise all or any portion of the Series J Warrants still unexercised for a cash exercise.</span> <span style="background-color: white">As of December 31, 2022, there were <span id="xdx_900_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20221231__us-gaap--AwardTypeAxis__custom--SeriesJWarrantsMember_zF5mkseIJRa2" title="Warrants to purchase common stock">52,023</span> Series J Warrants outstanding.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Series H-5 Warrants</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a result of the Merger, <span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20221231__us-gaap--AwardTypeAxis__custom--SeriesHFiveWarrantsMember_zZpXg4AM3r5a" title="Warrants to purchase common stock">296,389</span> Series H-5 Warrants were transferred to AYRO and have an exercise price of $<span id="xdx_902_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20221231__us-gaap--AwardTypeAxis__custom--SeriesHFiveWarrantsMember_zF2TzFazc3Od" title="Warrant exercise price">2.50</span> per share. Subject to certain ownership limitations, the H-5 Warrants will be exercisable beginning six months from the issuance date and will be exercisable for a period of <span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dc_c20221231__us-gaap--AwardTypeAxis__custom--SeriesHFiveWarrantsMember_zPnWBJ1HKFUb" title="Warrants term">five years</span> from the initial issuance date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightReasonForIssuingToNonemployees_c20220101__20221231__us-gaap--AwardTypeAxis__custom--SeriesHFiveWarrantsMember_z2zucToNbiKi" title="Warrants description">The H-5 Warrants are entitled to certain anti-dilution adjustments if the Company issues shares of its common stock at a lower price per share than the applicable exercise price (subject to a floor of $0.792 per share). An anti-dilution adjustment was triggered resulting in an adjusted exercise price per share from $<span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20221231__us-gaap--AwardTypeAxis__custom--SeriesHFiveWarrantsMember__srt--RangeAxis__srt--MinimumMember_zmyf80jpiVE1" title="Warrant exercise price">3.96</span> to $<span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20221231__us-gaap--AwardTypeAxis__custom--SeriesHFiveWarrantsMember__srt--RangeAxis__srt--MaximumMember_zjvVYswEvQo5" title="Warrant exercise price">2.50</span>, resulting in an issuance of an additional <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20220101__20221231__us-gaap--AwardTypeAxis__custom--SeriesHFiveWarrantsMember__srt--RangeAxis__srt--MaximumMember_zXJuDl7pBzfb" title="Number of warrants issued">173,091</span> warrants that are exercisable at $<span id="xdx_902_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20221231__us-gaap--AwardTypeAxis__custom--SeriesHFiveWarrantsMember_zZ0V1p2Whqqa" title="Warrant exercise price">2.50</span> per share.</span> As of December 31, 2022, there were <span id="xdx_909_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20221231__us-gaap--AwardTypeAxis__custom--SeriesHFiveWarrantsMember_zW6og9lXO8U3" title="Warrant outstanding">348,476</span> Series H-5 Warrants outstanding.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Series H-1, H-4, J and H-5 Warrants expire through the years 2023-2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AYRO, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other AYRO Warrants</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 19, 2020, the Company agreed to issue finder warrants (the “June Finder Warrants”) to purchase <span id="xdx_904_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20200619__us-gaap--AwardTypeAxis__custom--JuneFinderWarrantsMember_z17hZbxLnd42" title="Warrants to purchase common stock">27,273</span> shares of the Company’s common stock at an exercise price of $<span id="xdx_902_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20200619__us-gaap--AwardTypeAxis__custom--JuneFinderWarrantsMember_zOdFSb23NZO5" title="Warrant exercise price">2.75</span> per share to a finder or its designees, and the Company agreed to issue warrants to Palladium (the “June Placement Agent Warrants”) to purchase <span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20200619__us-gaap--AwardTypeAxis__custom--JunePlacementAgentWarrantsMember_ztFvvi6ajR1b" title="Warrants to purchase common stock">126,000</span> shares of the Company’s common stock at an exercise price of $<span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20200619__us-gaap--AwardTypeAxis__custom--JunePlacementAgentWarrantsMember_zJ1DO6RkP7r4" title="Warrant exercise price">2.875</span> per share. The June Finder Warrants and June Placement Agent Warrants terminate after a period of <span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20200619__us-gaap--AwardTypeAxis__custom--JuneFinderWarrantsMember_zc9HfyMteO1a" title="Warrants term">5</span> years on June 19, 2025. As of December 31, 2020, <span id="xdx_907_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20201231__us-gaap--AwardTypeAxis__custom--JunePlacementAgentWarrantsMember_zGNlmaLAdRe6">126,000</span> of the June Placement Agent Warrants had been exercised. As of December 31, 2022, the <span id="xdx_904_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20221231__us-gaap--AwardTypeAxis__custom--JuneFinderWarrantsMember_zHmIhjjxlaZd" title="Warrants outstanding">27,273</span> June Finder Warrants were outstanding.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 8, 2020, the Company agreed to issue finder warrants (the “July 8 Finder Warrants”) to purchase <span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20200708__us-gaap--AwardTypeAxis__custom--JulyEightFinderWarrantsMember_z0mYHCRk6c8c" title="Warrants to purchase common stock">71,770</span> shares of the Company’s common stock at an exercise price of $<span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20200708__us-gaap--AwardTypeAxis__custom--JulyEightFinderWarrantsMember_zxSgyFtHMSAa" title="Warrant exercise price">5.225</span> per share to a finder or its designees, and the Company agreed to issue warrants to Palladium (the “July 8 Placement Agent Warrants”) to purchase <span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20200708__us-gaap--AwardTypeAxis__custom--JulyEightPlacementAgentWarrantsMember_zRMPxBAfo4rl" title="Warrants to purchase common stock">147,368</span> shares of the Company’s common stock at an exercise price of $<span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20200708__us-gaap--AwardTypeAxis__custom--JulyEightPlacementAgentWarrantsMember_zAN5AwDG6Oz8" title="Warrant exercise price">5.4625</span> per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The July 8 Finder Warrants and July 8 Placement Agent Warrants terminate after a period of <span id="xdx_90B_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20200708__us-gaap--AwardTypeAxis__custom--JulyEightPlacementAgentWarrantsMember_zPBHubNwx1mc" title="Warrants term">5</span> years on July 8, 2025. As of December 31, 2022, there were <span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20221231__us-gaap--AwardTypeAxis__custom--JulyEightFinderWarrantsMember_zQfSe2HFMLze" title="Warrants to purchase common stock">71,770</span> July 8 Finder Warrants and <span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20221231__us-gaap--AwardTypeAxis__custom--JulyEightPlacementAgentWarrantsMember_zTEOcSbHJe3l" title="Warrants to purchase common stock">147,368</span> July 8 Placement Agent Warrants were outstanding.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 22, 2020, the Company agreed to issue warrants to Palladium (the “July 22 Placement Agent Warrants”) to purchase <span id="xdx_907_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20200722__us-gaap--AwardTypeAxis__custom--JulyTwentyTwoPlacementAgentWarrantsMember_zbPOqYmzUrTd" title="Warrants to purchase common stock">129,500</span> shares of the Company’s common stock at an exercise price of $<span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20200722__us-gaap--AwardTypeAxis__custom--JulyTwentyTwoPlacementAgentWarrantsMember_zKw1lRRITI4" title="Warrant exercise price">5.750</span> per share. The July 22 Placement Agent Warrants terminate after a period of <span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20200722__us-gaap--AwardTypeAxis__custom--JulyTwentyTwoPlacementAgentWarrantsMember_zQcJ12V1GvPb" title="Warrants term">5</span> years on July 22, 2025. As of December 31, 2022, there were <span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20221231__us-gaap--AwardTypeAxis__custom--JulyTwentyTwoPlacementAgentWarrantsMember_z52x94IDz39g" title="Warrants to purchase common stock">129,500</span> July 22 Placement Agent Warrants outstanding.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AYRO, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 25, 2020, the Company issued a warrant (the “September Warrant”) to purchase <span id="xdx_905_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20200925__us-gaap--AwardTypeAxis__custom--SeptemberWarrantMember_zwMwLZU2cwwh" title="Warrants to purchase common stock">31,348</span> shares of the Company’s common stock at an exercise price of $<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20200925__us-gaap--AwardTypeAxis__custom--SeptemberWarrantMember_zzCHallSdy2k" title="Warrant exercise price">3.19</span> per share to a vendor for facilitating a manufacturing agreement. <span id="xdx_900_ecustom--WarrantExpirationDescription_c20200924__20200925__us-gaap--AwardTypeAxis__custom--SeptemberWarrantMember_zaEi3iPSq7uh" title="Warrant expiration description">The September Warrant is immediately exercisable and expires on September 25, 2025.</span> The September Warrant was classified as equity and the estimated fair value of $<span id="xdx_90A_eus-gaap--WarrantExercisePriceDecrease_c20200924__20200925__us-gaap--AwardTypeAxis__custom--SeptemberWarrantMember_zHwQODNeONhi" title="Decrease in exercise price">2.13</span> per share was computed as of September 25, 2020, using the Black-Scholes model. The Company recorded $<span id="xdx_907_eus-gaap--ShareBasedCompensation_pp0p0_c20201001__20201231__us-gaap--AwardTypeAxis__custom--SeptemberWarrantMember_zWOo7cDYYBfl" title="Share based compensation expenses">66,845</span> as stock-based compensation expense during the fourth quarter of 2020 for the total fair value of the September Warrant. As of December 31, 2022, there were <span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20221231__us-gaap--AwardTypeAxis__custom--SeptemberWarrantMember_zDkuOpxFT5g9" title="Warrants to purchase common stock">31,348</span> September Warrants outstanding.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 22, 2020, the Company entered into a Securities Purchase Agreement with new and current stockholders of the Company, pursuant to which such stockholders agreed to purchase shares of AYRO’s Common Stock, Series A Warrants and Series B Warrants to purchase AYRO’s Common Stock for an aggregate purchase price of $<span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20201121__20201122__us-gaap--AwardTypeAxis__custom--SeriesAWarrantsAndSeriesBMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zSyegx5iJ8k3" title="Value of common stock issued">9,999,997</span>. Each purchaser additionally purchased and received Series A Warrants and Series B Warrants equal to 75% and 50% of the purchased shares, for a total of <span id="xdx_909_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20201122__us-gaap--AwardTypeAxis__custom--SeriesAWarrantsMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zy4Dda1qL8T7" title="Warrants to purchase common stock">1,237,624</span> Series A Warrants and <span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20201122__us-gaap--AwardTypeAxis__custom--SeriesBWarrantsMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zIVPeV15Cg95" title="Warrants to purchase common stock">825,084</span> Series B Warrants. The Series A Warrants were immediately exercisable, in whole or in part at a strike price of $<span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20201122__us-gaap--AwardTypeAxis__custom--SeriesAWarrantsMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zuXpGI46aw6g" title="Warrant exercise price">8.09</span> and expired on <span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20201122__us-gaap--AwardTypeAxis__custom--SeriesAWarrantsMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zQYdKTjKhxZ6" title="Warrant expiration date">May 24, 2021</span>. The Series B Warrants are immediately exercisable, in whole or in part, at a strike price of $<span id="xdx_902_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20201122__us-gaap--AwardTypeAxis__custom--SeriesBWarrantsMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zFF8XQZGdjX4" title="Warrant exercise price">8.90</span>, and terminate five years from the date issuance on November 24, 2025. As of December 31, 2022, there were <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_do_c20221231__us-gaap--AwardTypeAxis__custom--SeriesAWarrantsMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zNMEalSjN4se" title="Warrants to purchase common stock">no</span> Series A Warrants and <span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20221231__us-gaap--AwardTypeAxis__custom--SeriesBWarrantsMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zD2jgaS4z1M1" title="Warrants to purchase common stock">825,084</span> Series B Warrants outstanding.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 22, 2020, the Company agreed to issue finder warrants (the “November Finder Warrants”) to purchase <span id="xdx_900_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20201122__us-gaap--AwardTypeAxis__custom--NovemberFinderWarrantsMember_ztX90fCyfuj7" title="Warrants to purchase common stock">56,256</span> shares of the Company’s common stock at an exercise price of $<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20201122__us-gaap--AwardTypeAxis__custom--NovemberFinderWarrantsMember_zuWu29P7UCV4" title="Warrant exercise price">6.6660</span> per share to a finder or its designees, and the Company agreed to issue warrants to Palladium (the “November Placement Agent Warrants”) to purchase <span id="xdx_905_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20201122__us-gaap--AwardTypeAxis__custom--NovemberPlacementAgentWarrantsMember_zn1evEWxtbX7" title="Warrants to purchase common stock">57,756</span> shares of the Company’s common stock at an exercise price of $<span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20201122__us-gaap--AwardTypeAxis__custom--NovemberPlacementAgentWarrantsMember_z3E4ZOMzVlS5" title="Warrant exercise price">6.9690</span> per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightReasonForIssuingToNonemployees_c20201121__20201122__us-gaap--AwardTypeAxis__custom--NovemberPlacementAgentWarrantsMember_zOLSLFyDwaT3" title="Warrants description">The November Finder Warrants and November Placement Agent Warrants terminate after a period of 5 years on November 22, 2025.</span> As of December 31, 2022, there were <span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20201122__us-gaap--AwardTypeAxis__custom--NovemberFinderWarrantsMember_zX2XFz5E3mf4" title="Warrants to purchase common stock">56,256</span> November Finder Warrants and <span id="xdx_902_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20201122__us-gaap--AwardTypeAxis__custom--NovemberPlacementAgentWarrantsMember_zXa8h7N2X3Kh" title="Warrants to purchase common stock">57,756</span> November Placement Agent Warrants outstanding.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 25, 2021, AYRO entered into a Securities Purchase Agreement with certain institutional and accredited investors, pursuant to which AYRO agreed to issue and sell in the January 2021 Offering an aggregate of <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210124__20210125__us-gaap--AwardTypeAxis__custom--JanuaryTwentyTwentyOneOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zY84Bv8SpGcc" title="Number of shares issued">3,333,334</span> shares of common stock of AYRO, par value $<span id="xdx_900_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20210125__us-gaap--StatementEquityComponentsAxis__custom--AdditionalSharesMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z7gc5YqgU2Jl" title="Common stock, par value">0.0001</span> per share, at an offering price of $<span id="xdx_901_eus-gaap--SharePrice_iI_c20210125__us-gaap--StatementEquityComponentsAxis__custom--AdditionalSharesMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zUaarF1eLRe6" title="Offering price">6.00</span> per share, for gross proceeds of approximately $<span id="xdx_902_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pn5n6_c20210124__20210125__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zT4nrL92ZAe5">20.0</span> million before the deduction of fees and offering expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each purchaser was also granted a warrant to purchase, between July 26, 2021 and July 26, 2023, additional shares of common stock equal to the full amount of the common stock it purchased at the initial closing, or an aggregate of <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210124__20210125__us-gaap--AwardTypeAxis__custom--JanuaryTwentyTwentyOneOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z4WosWH6hUL5" title="Number of shares issued">3,333,334</span> shares at an exercise price of $<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20210125__us-gaap--AwardTypeAxis__custom--JanuaryTwentyTwentyOneOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zvo7DCRlf6Dd" title="Warrant exercise price">6.93</span> per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 25, 2021, the Company agreed to issue warrants to Palladium, the placement agent for the January 2021 offering to purchase <span id="xdx_905_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20210125__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zavtIvZoasZ5" title="Warrant purchase price">233,334</span> shares of the Company’s common stock at an exercise price of $<span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20210125__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z0suFZCC8XJc" title="Warrant exercise price">6.93</span> per share. The warrants are exercisable six months following issuance and terminate on July 23, 2023. As of December 31, 2022 all <span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20221231__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zXGAVU3S7Tgl" title="Warrants to purchase common stock">3,566,668</span> warrants are outstanding.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 11, 2021, the Company agreed to issue warrants to Spartan Capital Securities, LLC and its affiliates (the “February Finder Warrants”) to purchase <span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20210211__us-gaap--AwardTypeAxis__custom--FebruaryFinderWarrantsMember_zPMBXs5bWhj1" title="Warrants to purchase common stock">15,574</span> shares of the Company’s common stock at an exercise price of $<span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20210211__us-gaap--AwardTypeAxis__custom--FebruaryFinderWarrantsMember_z2IV6EyPjAoj" title="Warrant exercise price">10.925</span> per share and to purchase <span id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20210211__us-gaap--AwardTypeAxis__custom--FebruaryFinderWarrantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zY8iXkniCxf3" title="Warrants to purchase common stock">35,885</span> shares of the Company’s common stock at an exercise price of $<span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20210211__us-gaap--AwardTypeAxis__custom--FebruaryFinderWarrantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zOLVnX21Cxia" title="Warrant exercise price">10.45</span> per share to a finder or its designees. In addition, the Company agreed to issue warrants to Palladium (the “February Placement Agent Warrants”) to purchase <span id="xdx_902_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20210211__us-gaap--AwardTypeAxis__custom--FebruaryPlacementAgentWarrantsMember_zJ5qdqQFOj8" title="Warrants to purchase common stock">255,584</span> shares of the Company’s common stock at an exercise price of $<span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20210211__us-gaap--AwardTypeAxis__custom--FebruaryFinderWarrantsMember_zH118r7xCa89" title="Warrant exercise price">10.925</span> per share. The February Finder Warrants and February Placement Agent Warrants terminate after a period of <span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20210211__us-gaap--AwardTypeAxis__custom--FebruaryPlacementAgentWarrantsMember_zNBQnUw3GSJc" title="Warrants and rights outstanding term">5</span> years on February 26, 2026. As of December 31, 2022, there were <span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20221231__us-gaap--AwardTypeAxis__custom--FebruaryFinderWarrantsMember_zGYAKPxYlG" title="Warrants to purchase common stock">51,459</span> February Finder Warrants and <span id="xdx_902_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20221231__us-gaap--AwardTypeAxis__custom--FebruaryPlacementAgentWarrantsMember_z4h9Pmck0Lr7" title="Warrants to purchase common stock">255,584</span> February Placement Agent Warrants were outstanding.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--ScheduleOfProductWarrantyLiabilityTableTextBlock_zHLZsWKAL0Q7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of the Company’s warrants to purchase common stock activity is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_zbLogxAA9Kkl" style="display: none">SCHEDULE OF WARRANT ACTIVITY</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Shares Underlying Warrants</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average Exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Remaining Contractual</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Term (in years)</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding at December 31, 2020</span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_c20210101__20211231_zEVsMpPxaLji" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right" title="Shares Underlying Warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif">3,501,014</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_c20210101__20211231_zWjjqwLlAjF6" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right" title="Weighted Average Exercise Price Outstanding"><span style="font-family: Times New Roman, Times, Serif">8.03</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingBeginningWeightedAverageRemainingContractualTerms_dtY_c20210101__20211231_zIXnmpWMDPk8" title="Weighted Average Remaining Contractual Life">2.87</span></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_ecustom--ClassOfWarrantOrRightGranted_c20210101__20211231_z5fEWyUx7di8" style="text-align: right" title="Shares Underlying Warrants Granted"><span style="font-family: Times New Roman, Times, Serif">3,873,711</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_ecustom--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsGranted_c20210101__20211231_zXZcLlTrwYRa" style="text-align: right" title="Weighted Average Exercise Price Granted"><span style="font-family: Times New Roman, Times, Serif">7.24</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_ecustom--ClassOfWarrantOrRightExercised_c20210101__20211231_zoY2P8boyJH" style="text-align: right" title="Shares Underlying Warrants Exercised"><span style="font-family: Times New Roman, Times, Serif">(13,642</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExercised_c20210101__20211231_zMhrvNkPUoVh" style="text-align: right" title="Weighted Average Exercise Price Exercised"><span style="font-family: Times New Roman, Times, Serif">7.33</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_ecustom--ClassOfWarrantOrRightExpired_c20210101__20211231_zZ0ab5yTGSn" style="border-bottom: Black 1.5pt solid; text-align: right" title="Shares Underlying Warrants Expired"><span style="font-family: Times New Roman, Times, Serif">(1,252,260</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExpired_c20210101__20211231_zCCFycFvk4te" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price Expired"><span style="font-family: Times New Roman, Times, Serif">8.80</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding at December 31, 2021</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_c20220101__20221231_z0F6tXBJEEYg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Shares Underlying Warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif">6,108,823</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_c20220101__20221231_z2aDe4hu9JAl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price Outstanding"><span style="font-family: Times New Roman, Times, Serif">7.37</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingBeginningWeightedAverageRemainingContractualTerms_dtY_c20220101__20221231_z7yCDeEzmpVf" title="Weighted Average Remaining Contractual Life">2.31</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_ecustom--ClassOfWarrantOrRightExpired_c20220101__20221231_zTR5FWLpk8h7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Shares Underlying Warrants Expired"><span style="font-family: Times New Roman, Times, Serif">(2,800</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_ecustom--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExpired_c20220101__20221231_z55wx5wyHhlk" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price Expired"><span style="font-family: Times New Roman, Times, Serif">165.60</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding at December 31,2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_c20220101__20221231_zOnyMRTC8hu" style="border-bottom: Black 1.5pt solid; text-align: right" title="Shares underlying warrants outstanding"><span style="font-family: Times New Roman, Times, Serif">6,106,023</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_c20220101__20221231_zZfiWDertzH6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price Outstanding"><span style="font-family: Times New Roman, Times, Serif">7.30</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingEndingWeightedAverageRemainingContractualTerms_dtY_c20220101__20221231_zAIhZctR23wd" title="Weighted Average Remaining Contractual Life">1.32</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A3_zxGyvn78YHD3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AYRO, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 3333334 0.0001 6.00 20000004 1648608 4400001 0.0001 9.50 41800008 3394054 Each purchaser was also granted an option to purchase, on or before February 16, 2022, additional shares of common stock equal to the full amount of 75% of the common stock it purchased at the initial closing, or an aggregate of 3,300,001 shares, at an exercise price of $11.50 per share. 3300001 11.50 (i) sell up to 5% of such stockholder’s holdings in the Company’s common stock on any trading day (with such 5% limitation to be measured as of the date of each sale) and (ii) allow for unlimited sales of the Company’s common stock for any sales made at $10.00 per share or greater. 302500 0.0001 5.00 1512500 13642 100000 555004 1506999 1158891 374686 172000 7.66 43000 442249 1.29 331686 Upon closing of the Merger, the Company assumed the Series H, H-3 and H-6 preferred stock of DropCar, Inc., which respective conversion prices have been adjusted to reflect the May 2020 one-for-five reverse split. 154.00 184.80 0.0999 <p id="xdx_898_ecustom--ScheduleOfPaymentOfPreferredStockTableTextBlock_hus-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zLZ1CO2fDYIe" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zUzpXrNKBuq5" style="display: none">SCHEDULE OF PAYMENT OF PREFERRED STOCK</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49D_20221231__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesHMember_z2IBa7HHcOx3" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--PreferredStockSharesOutstanding_iI_zXSODJZMafL" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 82%"><span style="font-family: Times New Roman, Times, Serif">Number of Series H Preferred Stock outstanding as of December 31, 2022</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_ecustom--StatedValueOfPreferredStockSeries_iI_zNgsnPDfZQba" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Multiplied by the stated value</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">154</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_ecustom--GrossStateValueOfPreferredStock_iI_zgIA4UEN9sYe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Equals the gross stated value</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,232</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40B_eus-gaap--PreferredStockConvertibleConversionPrice_iI_z45UR5jgLyUc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Divided by the conversion price</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">184.8</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_ziAfQJb3YSHe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Equals the convertible shares of Company Common Stock</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6.66</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_eus-gaap--SharesIssuedPricePerShare_iI_zAnjHezqH5Ak" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Multiplied by the fair market value of Company Common Stock as of December 31, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.38</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40F_eus-gaap--PreferredStockLiquidationPreference_iI_zi3gLwkIxY5a" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Liquidation Value</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.66</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 8 154 1232 184.8 6.66 0.38 2.66 138.00 165.60 0.0999 <p id="xdx_89D_ecustom--ScheduleOfPaymentOfPreferredStockTableTextBlock_hus-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesHThreeMember_zZiBmIzCMn95" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_z3udqGCjjxSl" style="display: none">SCHEDULE OF PAYMENT OF PREFERRED STOCK</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_496_20221231__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesHThreeMember_z0WTAZBkowm7" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--PreferredStockSharesOutstanding_iI_zzRN5Gg1TUMl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 82%"><span style="font-family: Times New Roman, Times, Serif">Number of Series H-3 Preferred Stock outstanding as of December 31, 2022</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,234</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40C_ecustom--StatedValueOfPreferredStockSeries_iI_z9citqDXFdOe" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Multiplied by the stated value</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">138</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_ecustom--GrossStateValueOfPreferredStock_iI_zscQU7qskLr2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Equals the gross stated value</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">170,292</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_407_eus-gaap--PreferredStockConvertibleConversionPrice_iI_zzrAdC15io0i" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Divided by the conversion price</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">165.6</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_408_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_zMs8NYDCXL09" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Equals the convertible shares of Company Common Stock</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,028</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_eus-gaap--SharesIssuedPricePerShare_iI_zTrg8tYRTKRi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Multiplied by the fair market value of Company Common Stock as of December 31, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.38</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_eus-gaap--PreferredStockLiquidationPreferenceValue_iI_ztNoeY9saNQe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Liquidation Value</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">391</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 1234 138 170292 165.6 1028 0.38 391 50000 72.00 Each share of Series H-6 Preferred Stock is convertible at any time at the option of the holder thereof, into a number of shares of common stock of the Company determined by dividing the H-6 Stated Value by the initial conversion price of $3.60 per share, which was then further reduced to $2.50 under the anti-dilution adjustment provision, subject to a 9.99% blocker provision. 3.60 3.60 0.0999 3.60 <p id="xdx_897_ecustom--ScheduleOfPaymentOfPreferredStockTableTextBlock_hus-gaap--StatementClassOfStockAxis__custom--SeriesHSixConvertiblePreferredStockMember_z3JYjbc7phv9" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_z9N8pQMyvGFl" style="display: none">SCHEDULE OF PAYMENT OF PREFERRED STOCK</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49A_20221231__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesHSixMember_zcWvNf2XQBa8" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--PreferredStockSharesOutstanding_iI_zrm5RownvJe2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 82%"><span style="font-family: Times New Roman, Times, Serif">Number of Series H-6 Preferred Stock outstanding as of December 31, 2022</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">50</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_eus-gaap--PreferredStockSharesOutstanding_iI_zfLBR0ZO3hXb" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Number of Series H Preferred Stock outstanding as of December 31, 2022</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">50</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_ecustom--StatedValueOfPreferredStockSeries_iI_zuYebJKz8Np5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Multiplied by the stated value</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">72</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_ecustom--GrossStateValueOfPreferredStock_iI_zDmI2DdSzgg9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Equals the gross stated value</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,600</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_eus-gaap--PreferredStockConvertibleConversionPrice_iI_zisCvqIWoqQ9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Divided by the conversion price</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.5</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_zbxMbAqSIOr8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Equals the convertible shares of Company Common Stock</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,440</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eus-gaap--SharesIssuedPricePerShare_iI_z8ClFemME3ij" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Multiplied by the fair market value of Company Common Stock as of December 31, 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.38</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_407_eus-gaap--PreferredStockLiquidationPreferenceValue_iI_zwx4KDGaUsU7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Liquidation Value</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">547</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 50 50 72 3600 2.5 1440 0.38 547 8472500 7360985 2007193 461647 7.33 448005 14636 69.00 If at any time (i) the volume weighted average price (“VWAP”) of the Common Stock exceeds $138.00 for not less than the mandatory exercise measuring period; (ii) the daily average number of shares of Common Stock traded during the mandatory exercise measuring period equals or exceeds 25,000; and (iii) no equity conditions failure has occurred as of such date, then the Company shall have the right to require the holder to exercise all or any portion of the Series I Warrants still unexercised for a cash exercise. 138.00 14636 2800 165.60 P5Y 2800 37453 15.60 15.60 37453 52023 30.00 45.00 If at any time (i) the VWAP of the Common Stock exceeds $9.00 for not less than the mandatory exercise measuring period; (ii) the daily average number of shares of Common Stock traded during the mandatory exercise measuring period equals or exceeds 25,000; and (iii) no equity conditions failure has occurred as of such date, then the Company shall have the right to require the holder to exercise all or any portion of the Series J Warrants still unexercised for a cash exercise. 52023 296389 2.50 P5Y The H-5 Warrants are entitled to certain anti-dilution adjustments if the Company issues shares of its common stock at a lower price per share than the applicable exercise price (subject to a floor of $0.792 per share). An anti-dilution adjustment was triggered resulting in an adjusted exercise price per share from $3.96 to $2.50, resulting in an issuance of an additional 173,091 warrants that are exercisable at $2.50 per share. 3.96 2.50 173091 2.50 348476 27273 2.75 126000 2.875 P5Y 126000 27273 71770 5.225 147368 5.4625 P5Y 71770 147368 129500 5.750 P5Y 129500 31348 3.19 The September Warrant is immediately exercisable and expires on September 25, 2025. 2.13 66845 31348 9999997 1237624 825084 8.09 2021-05-24 8.90 0 825084 56256 6.6660 57756 6.9690 The November Finder Warrants and November Placement Agent Warrants terminate after a period of 5 years on November 22, 2025. 56256 57756 3333334 0.0001 6.00 20000000.0 3333334 6.93 233334 6.93 3566668 15574 10.925 35885 10.45 255584 10.925 P5Y 51459 255584 <p id="xdx_89F_eus-gaap--ScheduleOfProductWarrantyLiabilityTableTextBlock_zHLZsWKAL0Q7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of the Company’s warrants to purchase common stock activity is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_zbLogxAA9Kkl" style="display: none">SCHEDULE OF WARRANT ACTIVITY</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Shares Underlying Warrants</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average Exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Remaining Contractual</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Term (in years)</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding at December 31, 2020</span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_c20210101__20211231_zEVsMpPxaLji" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right" title="Shares Underlying Warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif">3,501,014</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_c20210101__20211231_zWjjqwLlAjF6" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right" title="Weighted Average Exercise Price Outstanding"><span style="font-family: Times New Roman, Times, Serif">8.03</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingBeginningWeightedAverageRemainingContractualTerms_dtY_c20210101__20211231_zIXnmpWMDPk8" title="Weighted Average Remaining Contractual Life">2.87</span></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_ecustom--ClassOfWarrantOrRightGranted_c20210101__20211231_z5fEWyUx7di8" style="text-align: right" title="Shares Underlying Warrants Granted"><span style="font-family: Times New Roman, Times, Serif">3,873,711</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_ecustom--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsGranted_c20210101__20211231_zXZcLlTrwYRa" style="text-align: right" title="Weighted Average Exercise Price Granted"><span style="font-family: Times New Roman, Times, Serif">7.24</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_ecustom--ClassOfWarrantOrRightExercised_c20210101__20211231_zoY2P8boyJH" style="text-align: right" title="Shares Underlying Warrants Exercised"><span style="font-family: Times New Roman, Times, Serif">(13,642</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExercised_c20210101__20211231_zMhrvNkPUoVh" style="text-align: right" title="Weighted Average Exercise Price Exercised"><span style="font-family: Times New Roman, Times, Serif">7.33</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_ecustom--ClassOfWarrantOrRightExpired_c20210101__20211231_zZ0ab5yTGSn" style="border-bottom: Black 1.5pt solid; text-align: right" title="Shares Underlying Warrants Expired"><span style="font-family: Times New Roman, Times, Serif">(1,252,260</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExpired_c20210101__20211231_zCCFycFvk4te" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price Expired"><span style="font-family: Times New Roman, Times, Serif">8.80</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding at December 31, 2021</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_c20220101__20221231_z0F6tXBJEEYg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Shares Underlying Warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif">6,108,823</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_c20220101__20221231_z2aDe4hu9JAl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price Outstanding"><span style="font-family: Times New Roman, Times, Serif">7.37</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingBeginningWeightedAverageRemainingContractualTerms_dtY_c20220101__20221231_z7yCDeEzmpVf" title="Weighted Average Remaining Contractual Life">2.31</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_ecustom--ClassOfWarrantOrRightExpired_c20220101__20221231_zTR5FWLpk8h7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Shares Underlying Warrants Expired"><span style="font-family: Times New Roman, Times, Serif">(2,800</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_ecustom--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExpired_c20220101__20221231_z55wx5wyHhlk" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price Expired"><span style="font-family: Times New Roman, Times, Serif">165.60</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding at December 31,2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_c20220101__20221231_zOnyMRTC8hu" style="border-bottom: Black 1.5pt solid; text-align: right" title="Shares underlying warrants outstanding"><span style="font-family: Times New Roman, Times, Serif">6,106,023</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_c20220101__20221231_zZfiWDertzH6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price Outstanding"><span style="font-family: Times New Roman, Times, Serif">7.30</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingEndingWeightedAverageRemainingContractualTerms_dtY_c20220101__20221231_zAIhZctR23wd" title="Weighted Average Remaining Contractual Life">1.32</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 3501014 8.03 P2Y10M13D 3873711 7.24 -13642 7.33 -1252260 8.80 6108823 7.37 P2Y3M21D -2800 165.60 6106023 7.30 P1Y3M25D <p id="xdx_80E_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_z2P3iX2hkrVe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>NOTE 11. <span id="xdx_822_z9aSTsrZYV98">STOCK BASED COMPENSATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>AYRO 2020 Long Term Incentive Plan</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 28, 2020, the Company’s shareholders approved the AYRO, Inc. 2020 Long Term Incentive Plan for future grants of incentive stock options, nonqualified stock, stock appreciation rights, restricted stock, restricted stock units, performance and other awards.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has reserved a total of <span id="xdx_90C_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyLongTermIncentivePlanMember_zHWxqMYCCEF8" title="Number of shares reserved">4,089,650</span> shares of its common stock pursuant to the AYRO, Inc. 2020 Long-Term Incentive Plan, including shares of restricted stock that have been issued. The Company has <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyLongTermIncentivePlanMember_zCwssB2BZpBk" title="Number of stock options available for grants">1,158,899</span> stock options, restricted stock and warrants remaining under this plan as of December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>AYRO 2017 Long Term Incentive Plan</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has reserved a total of <span id="xdx_908_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_pid_c20221231__us-gaap--PlanNameAxis__custom--TwoThousandSeventeenLongTermIncentivePlanMember_zctBqla4p1dc" title="Common stock shares reserves for issuance">477,983</span> shares of its common stock pursuant to the AYRO, Inc. 2017 Long-Term Incentive Plan. The Company had <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20221231__us-gaap--PlanNameAxis__custom--TwoThousandSeventeenLongTermIncentivePlanMember_zGblT3LuUEj" title="Options to purchase shares outstanding">128,606</span> shares of common stock outstanding under the plan at December 31, 2022. At December 31, 2022, <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_pid_do_c20221231__us-gaap--PlanNameAxis__custom--TwoThousandSeventeenLongTermIncentivePlanMember_zeIWt2OxPnWk" title="Number of stock options available for grants">no</span> shares remained available for grant under future awards under the 2017 Long-Term Incentive Plan. In conjunction with the 2020 incentive plan, the remaining unissued amounts were cancelled.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>DropCar Amended and Restated 2014 Equity Incentive Plan</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s equity incentive plan created in 2014 (the “2014 Plan”) was amended in 2018 to increase the number of shares of Company common stock available for issuance. Pursuant to the 2014 Plan, <span id="xdx_900_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20221231__us-gaap--PlanNameAxis__custom--TwoThousandFourteenEquityIncentivePlanMember__dei--LegalEntityAxis__custom--DropCarIncMember_zeGmHsct6Mri" title="Number of shares reserved">141,326</span> shares of common stock were reserved for issuance. As of December 31, 2022, there were <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_do_c20221231__us-gaap--PlanNameAxis__custom--TwoThousandFourteenEquityIncentivePlanMember__dei--LegalEntityAxis__custom--DropCarIncMember_zK2VV4CZWsWb" title="Number of stock options available for grants">no</span> shares available for grant under the 2014 Plan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_zWdoniW1nTZh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock-based compensation, including stock options, and restricted stock, expense is included in the consolidated statement of operations as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B6_z9oe8SbLZBW1" style="display: none">SCHEDULE OF STOCK-BASED COMPENSATION</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49A_20220101__20221231_zk0oZuP7AAd4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_494_20210101__20211231_zHaE3v42ZSrj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Years Ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__custom--ResearchAndDevelopmentMember_zOn0RqVVvH1d" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Research and development</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">21,922</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">73,447</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__custom--SalesAndMarketingMember_zq3gwLzHjbQa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Sales and marketing</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">25,811</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">224,076</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__custom--GeneralAndAdministrativeMember_zOOl4w5lhvB5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">General and administrative</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,192,396</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,258,760</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_407_eus-gaap--AllocatedShareBasedCompensationExpense_zgLpyDk5CVMl" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,240,129</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,556,282</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8AC_ziCXX0ftchB3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AYRO, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Options</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_89E_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_z8hOFv00iTX8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The following table reflects the stock option activity:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B9_zQ4NxmF7kN3i" style="display: none">SCHEDULE OF STOCK-BASED COMPENSATION, STOCK OPTIONS, ACTIVITY</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Contractual</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Life (Years)</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding at December 31, 2020</span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zcS4vxZdwMfc" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right" title="Number of Stock options outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif">1,920,269</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zJWAzNwGJvX4" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right" title="Weighted Average Exercise Price Outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif">4.40</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zgZZiZHIK4y3" title="Weighted average remaining contractual life">8.66</span></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zJXNCheGloA" style="text-align: right" title="Number of Stock options, Exercised"><span style="font-family: Times New Roman, Times, Serif">(555,004</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_iN_di_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zUWsPAvTwjUg" style="text-align: right" title="Weighted Average Exercise Price Outstanding, Excercised"><span style="font-family: Times New Roman, Times, Serif">(2.72</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Forfeitures</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zplYlxa22eXf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Stock options, Forfeitures"><span style="font-family: Times New Roman, Times, Serif">(26,590</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_iN_di_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zoMt32MhTG3j" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price. Forfeitures"><span style="font-family: Times New Roman, Times, Serif">(2.52</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Outstanding at December 31, 2021</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z85Eq1VztYjl" style="text-align: right" title="Number of Stock options outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif">1,338,675</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zPDnSvaZRfQ1" style="text-align: right" title="Weighted Average Exercise Price Outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif">5.14</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_908_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zhESwuHK2bK4" title="Weighted average remaining contractual life">8.26</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_981_ecustom--StockIssuedDuringPeriodSharesStockOptionsGranted_iN_di_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zbsLvesE9QNc" style="text-align: right" title="Number of Stock options, Granted"><span style="font-family: Times New Roman, Times, Serif">173,500</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageGranted_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zBxnWmKT0rw6" style="text-align: right" title="Weighted Average Exercise Price Outstanding, Granted"><span style="font-family: Times New Roman, Times, Serif">0.97</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zQjkvCToWgZ4" style="text-align: right" title="Number of Stock options, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1273">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_iN_di_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zQwUgiKfeb7e" style="text-align: right" title="Weighted Average Exercise Price Outstanding, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1275">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Forfeitures</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zJfRTiudGjJ1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Stock options, Forfeitures"><span style="font-family: Times New Roman, Times, Serif">(734,253</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_iN_di_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zB7WCXnPV687" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price Outstanding, Forfeitures"><span style="font-family: Times New Roman, Times, Serif">3.13</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding at December 31, 2022</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zudIEAcB5BNc" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Stock options outstanding, Ending balance"><span style="font-family: Times New Roman, Times, Serif">777,922</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z0kBKck6cQSb" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price Outstanding, Ending balance"><span style="font-family: Times New Roman, Times, Serif">6.15</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zu9LaMYBrB62" title="Weighted average remaining contractual life">7.56</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8AB_zI7OmqqGMvwb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Of the outstanding options, <span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z6a3yFgsEi61" title="Number of stock options vested and exercisable">612,963</span> were vested and exercisable as of December 31, 2022. At December 31, 2022 the aggregate intrinsic value of stock options vested and exercisable was $<span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iI_c20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zoPObNe4z9si" title="Aggregate intrinsic value of stock options vested and exercisable">0</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognized $<span id="xdx_90B_eus-gaap--AllocatedShareBasedCompensationExpense_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zY0Q1YUl8t31" title="Share-based Compensation">65,291</span> and $<span id="xdx_906_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zrU0IeQ2Enfi" title="Share-based Compensation">1,232,402</span> of stock option expense for the years ended December 31, 2022 and 2021, respectively. Total compensation cost related to non-vested stock option awards not yet recognized as of December 31, 2022 was $<span id="xdx_903_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_c20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zxGBckylTKu7" title="Share-based payment arrangement, nonvested award, option, cost not yet recognized, amount">142,648</span> <span style="background-color: white">a</span>nd will be recognized on a straight-line basis through the end of the vesting periods through April 2025. The amount of future stock option compensation expense could be affected by any future option grants or by any forfeitures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Determining the appropriate fair value of the stock-based awards requires the input of subjective assumptions, including the fair value of the Company’s common stock, and for stock options, the expected life of the option, and the expected stock price volatility. The Company uses the Black-Scholes option pricing model to value its stock option awards. The assumptions used in calculating the fair value of stock-based awards represent management’s best estimates and involve inherent uncertainties and the application of management’s judgment. The Company granted <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220505__20220506__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zkmzU9IWChU8" title="Number of options granted">173,000</span> shares on May 6, 2022, at a grant date fair value of $<span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20220505__20220506__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z6RfdUY19V69" title="Grant date fair value">0.97</span>. As a result, if factors change and management uses different assumptions, stock-based compensation expense could be materially different for future awards.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AYRO, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_891_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_z054zP96CRm5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company uses the following inputs when valuing stock-based awards.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zKla208Rz8Df" style="display: none">SCHEDULE OF STOCK-BASED PAYMENT AWARD, STOCK OPTIONS, VALUATION ASSUMPTIONS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the Years Ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected life (years)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231_z0KaINec0l3c" title="Expected life (years)">6</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">n/a</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Risk-free interest rate</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20220101__20221231_zQ9bQmjCPa67" title="Risk-free interest">3.04</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">n/a</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected volatility</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_uPure_c20220101__20221231_zR46YLX7Naq8" title="Expected volatility">128.67</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">n/a</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Stock Price</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90F_eus-gaap--SharePrice_iI_uUSDPShares_c20221231_zQL5U3A5rr19" title="Share price">0.84</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">n/a</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Exercise Price</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_uUSDPShares_c20221231_z0rehWnj6P0b" title="Exercise price">0.97</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">n/a</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A0_z5fUSOMuDRyl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The expected life of the employee stock options was estimated using the “simplified method,” as the Company has no historical information to develop reasonable expectations about future exercise patterns and employment duration for its stock option grants. The simplified method is based on the average of the vesting tranches and the contractual life of each grant. The expected life of awards that vest immediately use the contractual maturity since they are vested when issued. For stock price volatility, the Company uses public company comparable data and in periods prior to the Merger historical private placement data as a basis for its expected volatility to calculate the fair value of option grants. The risk-free interest rate is based on U.S. Treasury notes with a term approximating the expected life of the option at the grant-date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Restricted Stock</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_899_eus-gaap--ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_zV96Dn6CUfF4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table reflects the restricted stock activity:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_ze7xj4a4M6nf" style="display: none">SCHEDULE OF RESTRICTED STOCK ACTIVITY</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number of Shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average Grant</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding at December 31, 2020</span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z8RvaVDZq8uj" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Number of shares, Outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif">1,072,503</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zxQF52LTQT57" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Weighted Average Grant Price, Outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif">5.30</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_ze7XJgUgksM4" style="text-align: right" title="Number of shares, Granted"><span style="font-family: Times New Roman, Times, Serif">622,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zYGcHQN0jAQ4" style="text-align: right" title="Weighted Average Grant Price, Granted"><span style="font-family: Times New Roman, Times, Serif">3.91</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Vested</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zQ3v6ZpXyB65" style="text-align: right" title="Number of shares, Vested"><span style="font-family: Times New Roman, Times, Serif">(1,201,891</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue1_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zE86bK8QDWag" style="text-align: right" title="Weighted Average Grant Price, Vested"><span style="font-family: Times New Roman, Times, Serif">5.71</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Forfeitures</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_di_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zBeXo4G3zpjd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of shares, Forfeited"><span style="font-family: Times New Roman, Times, Serif">(42,612</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zn1JkA6gr7c8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Grant Price, Forfeited"><span style="font-family: Times New Roman, Times, Serif">3.17</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Outstanding at December 31, 2021</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zwAToCc2UWTg" style="text-align: right" title="Number of shares, Outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif">450,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zUtDaCMxOlq7" style="text-align: right" title="Weighted Average Grant Price, Outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif">2.48</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zMOBEwvhLUQg" style="text-align: right" title="Number of shares, Granted"><span style="font-family: Times New Roman, Times, Serif">542,248</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zPFkqBF8Hql7" style="text-align: right" title="Weighted Average Grant Price, Granted"><span style="font-family: Times New Roman, Times, Serif">1.06</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Vested</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zhrt7Z7ml9f6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of shares, Vested"><span style="font-family: Times New Roman, Times, Serif">(331,686</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue1_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zcC9ygsgvhaj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Grant Price, Vested"><span style="font-family: Times New Roman, Times, Serif">1.29</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Outstanding at December 31, 2022</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zdNiKAc1hNCl" style="text-align: right" title="Number of shares, Outstanding, Ending balance"><span style="font-family: Times New Roman, Times, Serif">660,562</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_ztiQUjGldiYe" style="text-align: right" title="Weighted Average Grant Price, Outstanding, Ending balance"><span style="font-family: Times New Roman, Times, Serif">1.91</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A7_zegMaRXPhGvl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In September 2020, the Company issued <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20200901__20200930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zGRGAdqW9Hzj" title="Number of restricted stock units">436,368</span> shares of restricted stock to current directors, of which <span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20200901__20200930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zmy2c5pJaLja" title="Number of shares vested">15,115</span> immediately vested and the remainder to <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights_c20200901__20200930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zBXfgO4TesWl" title="Restricted stock vesting description">vest in December 2020, which was subsequently modified to vest in full in May 2021.</span> The Company recognized compensation expense during the year ended <span style="background-color: white">December 31, 2022 and 2021</span> of $<span id="xdx_90B_eus-gaap--AllocatedShareBasedCompensationExpense_c20220101__20221231__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zcT3woDAwygc" title="Share-based Compensation">0</span> and $<span id="xdx_900_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20211231__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zMHXPfWhy8Fd" title="Share-based Compensation">699,527</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2020, based on objectives achieved, the Company issued <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20201201__20201231__srt--TitleOfIndividualAxis__custom--KellerAwardMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z8VivCUjx3f4" title="Number of restricted stock units">651,250</span> shares of restricted stock to Rodney C. Keller, Jr. that vest according to <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights_c20201201__20201231__srt--TitleOfIndividualAxis__custom--KellerAwardMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zLjL0crcyaMd" title="Restricted stock vesting description">the following vesting schedule: one-third vested on May 28, 2021, one-third was to vest on December 4, 2021 and one-third was to vest on December 4, 2022.</span> In September 2021 all <span id="xdx_900_ecustom--RestrictedStockForServiceVestedNotIssued_c20210901__20210930__srt--TitleOfIndividualAxis__custom--KellerAwardMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z8mV5yRWJRmg" title="Restricted stock shares vested but not issued">434,166</span> unvested shares of Keller Restricted Stock vested pursuant to Mr. Keller’s separation agreement. Compensation expense recognized for the Keller Restricted Stock for the years ended December 31, 2022 and 2021 was $<span id="xdx_903_eus-gaap--AllocatedShareBasedCompensationExpense_c20220101__20221231__srt--TitleOfIndividualAxis__custom--KellerAwardMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z45s8Vdn9HNl" title="Share-based Compensation">0</span> and $<span id="xdx_907_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20211231__srt--TitleOfIndividualAxis__custom--KellerAwardMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zRF4ZnZfF7Za" title="Share-based Compensation">4,126,618</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AYRO, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 24, 2021, pursuant to the AYRO, Inc. 2020 Long-Term Incentive Plan, the Company issued <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20210223__20210224__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyLongTermIncentivePlanMember_zn4EZwkP1Rg3" title="Number of restricted stock units">172,000</span> shares of restricted stock to non-executive directors at a value of $<span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_c20210224__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyLongTermIncentivePlanMember_z1F1XH8JjMla" title="Share price">7.66</span> per share. All awards vested during the year ended December 31, 2021. The Company recognized compensation expense during the year ended December 31, 2021 of $<span id="xdx_909_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20211231__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyLongTermIncentivePlanMember_z3JTlnpvjVwg">329,380</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In September 2021, pursuant to the employment agreement with Thomas M. Wittenschlaeger, the Company issued <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20210901__20210930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThomasMWittenschlaegerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zIWWDktP5ZX" title="Number of restricted stock units">450,000</span> shares of restricted stock at a value of $<span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_c20210930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThomasMWittenschlaegerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zAtYPpdvyMKl" title="Share price">2.48</span> per share. Vesting will occur as predetermined value-based targets are met. We estimate the fair value of stock-based and cash unit awards containing a market condition using a Monte Carlo simulation model. Key inputs and assumptions used in the Monte Carlo simulation model include the stock price of the award on the grant date, the expected term, the risk-free interest rate over the expected term, the expected annual dividend yield and the expected stock price volatility. The Company does not currently pay or plan to pay a dividend on its common stock, the expected dividend yield was zero. Volatility was determined using a three-year lookback with a <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThomasMWittenschlaegerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zIbrzDSbFtjh" title="Volatility rate">110</span>% determination. The expected term is December 27, 2023 for the fifth and final tranche. During the year ended December 31, 2022 and 2021 the Company recognized $<span id="xdx_90E_eus-gaap--AllocatedShareBasedCompensationExpense_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThomasMWittenschlaegerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z5meDz1CJeuk" title="Compensation expense">646,771</span> and $<span id="xdx_909_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThomasMWittenschlaegerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zpzOArYd5aNi" title="Compensation expense">180,215</span> respectively. Total compensation cost related to non-vested restricted stock not yet recognized as of December 31, 2022 was $<span id="xdx_906_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThomasMWittenschlaegerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zEHyXqm3JTu5" title="Cost not yet recognized">290,118</span> and will be recognized on a straight-line basis per target through the end of each vesting period through December 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 1, 2022, pursuant to the AYRO, Inc. 2020 Long-Term Incentive Plan, the Company issued <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_pid_c20220129__20220201__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zj7X08UE1cK4" title="Number of restricted stock units">442,248</span> shares of restricted stock to non-executive directors at a value of $<span id="xdx_901_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20220201__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zqXlP3cdV0vf" title="Share price">1.29</span> per share. <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_pid_c20220101__20221231__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyLongTermIncentivePlanMember_zbU4P5pJXwf1" title="Number of restricted shares issued and vested">331,686</span> shares vested during the year ended December 31, 2022. The remainder vested in full in January 2023. The Company recognized compensation expense during the year ended December 31, 2022 and 2021 of $<span id="xdx_90A_eus-gaap--AllocatedShareBasedCompensationExpense_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zB4FKoqtRCT1" title="Compensation expense">522,958</span> and $<span id="xdx_90D_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z5VrbTiJXTl6" title="Compensation expense">0</span> respectively. $<span id="xdx_903_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_c20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zXMJtFDrnlg2" title="Cost not yet recognized">42,788</span> remained unrecognized as of December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 23, 2022, pursuant to the employment agreement with David E. Hollingsworth, the Company issued <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_pid_c20220823__20220823__srt--TitleOfIndividualAxis__custom--DavidEHollingsworthMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zLobi9j33Ixb" title="Number of restricted stock units">100,000</span> shares of restricted stock at a value of $<span id="xdx_90B_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20220823__srt--TitleOfIndividualAxis__custom--DavidEHollingsworthMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zhqw70I8lIwb" title="Share price">0.03</span> per share. Vesting will occur as predetermined value-based targets are met. We estimate the fair value of stock-based and cash unit awards containing a market condition using a Monte Carlo simulation model. During the year ended December 31, 2022 and 2021 the Company recognized $<span id="xdx_90D_eus-gaap--AllocatedShareBasedCompensationExpense_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DavidEHollingsworthMember_zCbigbkTmjal" title="Compensation expenses">1,001</span> and $<span id="xdx_900_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DavidEHollingsworthMember_zzENDNdZJHCg" title="Compensation expenses">0</span> respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AYRO, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 4089650 1158899 477983 128606 0 141326 0 <p id="xdx_89F_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_zWdoniW1nTZh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock-based compensation, including stock options, and restricted stock, expense is included in the consolidated statement of operations as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B6_z9oe8SbLZBW1" style="display: none">SCHEDULE OF STOCK-BASED COMPENSATION</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49A_20220101__20221231_zk0oZuP7AAd4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_494_20210101__20211231_zHaE3v42ZSrj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Years Ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__custom--ResearchAndDevelopmentMember_zOn0RqVVvH1d" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Research and development</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">21,922</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">73,447</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__custom--SalesAndMarketingMember_zq3gwLzHjbQa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Sales and marketing</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">25,811</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">224,076</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__custom--GeneralAndAdministrativeMember_zOOl4w5lhvB5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">General and administrative</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,192,396</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,258,760</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_407_eus-gaap--AllocatedShareBasedCompensationExpense_zgLpyDk5CVMl" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,240,129</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,556,282</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 21922 73447 25811 224076 1192396 7258760 1240129 7556282 <p id="xdx_89E_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_z8hOFv00iTX8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The following table reflects the stock option activity:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B9_zQ4NxmF7kN3i" style="display: none">SCHEDULE OF STOCK-BASED COMPENSATION, STOCK OPTIONS, ACTIVITY</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Contractual</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Life (Years)</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding at December 31, 2020</span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zcS4vxZdwMfc" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right" title="Number of Stock options outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif">1,920,269</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zJWAzNwGJvX4" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right" title="Weighted Average Exercise Price Outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif">4.40</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zgZZiZHIK4y3" title="Weighted average remaining contractual life">8.66</span></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zJXNCheGloA" style="text-align: right" title="Number of Stock options, Exercised"><span style="font-family: Times New Roman, Times, Serif">(555,004</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_iN_di_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zUWsPAvTwjUg" style="text-align: right" title="Weighted Average Exercise Price Outstanding, Excercised"><span style="font-family: Times New Roman, Times, Serif">(2.72</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Forfeitures</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zplYlxa22eXf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Stock options, Forfeitures"><span style="font-family: Times New Roman, Times, Serif">(26,590</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_iN_di_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zoMt32MhTG3j" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price. Forfeitures"><span style="font-family: Times New Roman, Times, Serif">(2.52</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Outstanding at December 31, 2021</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z85Eq1VztYjl" style="text-align: right" title="Number of Stock options outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif">1,338,675</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zPDnSvaZRfQ1" style="text-align: right" title="Weighted Average Exercise Price Outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif">5.14</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_908_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zhESwuHK2bK4" title="Weighted average remaining contractual life">8.26</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_981_ecustom--StockIssuedDuringPeriodSharesStockOptionsGranted_iN_di_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zbsLvesE9QNc" style="text-align: right" title="Number of Stock options, Granted"><span style="font-family: Times New Roman, Times, Serif">173,500</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageGranted_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zBxnWmKT0rw6" style="text-align: right" title="Weighted Average Exercise Price Outstanding, Granted"><span style="font-family: Times New Roman, Times, Serif">0.97</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zQjkvCToWgZ4" style="text-align: right" title="Number of Stock options, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1273">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_iN_di_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zQwUgiKfeb7e" style="text-align: right" title="Weighted Average Exercise Price Outstanding, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1275">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Forfeitures</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zJfRTiudGjJ1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Stock options, Forfeitures"><span style="font-family: Times New Roman, Times, Serif">(734,253</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_iN_di_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zB7WCXnPV687" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price Outstanding, Forfeitures"><span style="font-family: Times New Roman, Times, Serif">3.13</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding at December 31, 2022</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zudIEAcB5BNc" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Stock options outstanding, Ending balance"><span style="font-family: Times New Roman, Times, Serif">777,922</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z0kBKck6cQSb" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price Outstanding, Ending balance"><span style="font-family: Times New Roman, Times, Serif">6.15</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zu9LaMYBrB62" title="Weighted average remaining contractual life">7.56</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 1920269 4.40 P8Y7M28D 555004 2.72 26590 2.52 1338675 5.14 P8Y3M3D -173500 0.97 734253 -3.13 777922 6.15 P7Y6M21D 612963 0 65291 1232402 142648 173000 0.97 <p id="xdx_891_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_z054zP96CRm5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company uses the following inputs when valuing stock-based awards.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zKla208Rz8Df" style="display: none">SCHEDULE OF STOCK-BASED PAYMENT AWARD, STOCK OPTIONS, VALUATION ASSUMPTIONS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the Years Ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected life (years)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231_z0KaINec0l3c" title="Expected life (years)">6</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">n/a</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Risk-free interest rate</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20220101__20221231_zQ9bQmjCPa67" title="Risk-free interest">3.04</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">n/a</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected volatility</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_uPure_c20220101__20221231_zR46YLX7Naq8" title="Expected volatility">128.67</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">n/a</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Stock Price</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90F_eus-gaap--SharePrice_iI_uUSDPShares_c20221231_zQL5U3A5rr19" title="Share price">0.84</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">n/a</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Exercise Price</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_uUSDPShares_c20221231_z0rehWnj6P0b" title="Exercise price">0.97</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">n/a</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> P6Y 0.0304 1.2867 0.84 0.97 <p id="xdx_899_eus-gaap--ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_zV96Dn6CUfF4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table reflects the restricted stock activity:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_ze7xj4a4M6nf" style="display: none">SCHEDULE OF RESTRICTED STOCK ACTIVITY</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number of Shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average Grant</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding at December 31, 2020</span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z8RvaVDZq8uj" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Number of shares, Outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif">1,072,503</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zxQF52LTQT57" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Weighted Average Grant Price, Outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif">5.30</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_ze7XJgUgksM4" style="text-align: right" title="Number of shares, Granted"><span style="font-family: Times New Roman, Times, Serif">622,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zYGcHQN0jAQ4" style="text-align: right" title="Weighted Average Grant Price, Granted"><span style="font-family: Times New Roman, Times, Serif">3.91</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Vested</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zQ3v6ZpXyB65" style="text-align: right" title="Number of shares, Vested"><span style="font-family: Times New Roman, Times, Serif">(1,201,891</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue1_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zE86bK8QDWag" style="text-align: right" title="Weighted Average Grant Price, Vested"><span style="font-family: Times New Roman, Times, Serif">5.71</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Forfeitures</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_di_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zBeXo4G3zpjd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of shares, Forfeited"><span style="font-family: Times New Roman, Times, Serif">(42,612</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zn1JkA6gr7c8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Grant Price, Forfeited"><span style="font-family: Times New Roman, Times, Serif">3.17</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Outstanding at December 31, 2021</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zwAToCc2UWTg" style="text-align: right" title="Number of shares, Outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif">450,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zUtDaCMxOlq7" style="text-align: right" title="Weighted Average Grant Price, Outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif">2.48</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zMOBEwvhLUQg" style="text-align: right" title="Number of shares, Granted"><span style="font-family: Times New Roman, Times, Serif">542,248</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zPFkqBF8Hql7" style="text-align: right" title="Weighted Average Grant Price, Granted"><span style="font-family: Times New Roman, Times, Serif">1.06</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Vested</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zhrt7Z7ml9f6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of shares, Vested"><span style="font-family: Times New Roman, Times, Serif">(331,686</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue1_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zcC9ygsgvhaj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Grant Price, Vested"><span style="font-family: Times New Roman, Times, Serif">1.29</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Outstanding at December 31, 2022</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zdNiKAc1hNCl" style="text-align: right" title="Number of shares, Outstanding, Ending balance"><span style="font-family: Times New Roman, Times, Serif">660,562</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_ztiQUjGldiYe" style="text-align: right" title="Weighted Average Grant Price, Outstanding, Ending balance"><span style="font-family: Times New Roman, Times, Serif">1.91</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 1072503 5.30 622000 3.91 1201891 5.71 42612 3.17 450000 2.48 542248 1.06 331686 1.29 660562 1.91 436368 15115 vest in December 2020, which was subsequently modified to vest in full in May 2021. 0 699527 651250 the following vesting schedule: one-third vested on May 28, 2021, one-third was to vest on December 4, 2021 and one-third was to vest on December 4, 2022. 434166 0 4126618 172000 7.66 329380 450000 2.48 1.10 646771 180215 290118 442248 1.29 331686 522958 0 42788 100000 0.03 1001 0 <p id="xdx_808_eus-gaap--ConcentrationRiskDisclosureTextBlock_zBir1rzJ5348" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 12. <span id="xdx_82B_zNgtKxb0hZ2b">CONCENTRATIONS AND CREDIT RISK</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Revenues</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">One customer accounted for approximately <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zdygAJDEYna7" title="Concentration risk percentage">100</span>% , respectively, of the Company’s revenues for the year ended December 31, 2022 and for two customers <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__srt--MajorCustomersAxis__custom--OneCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zwDQbiiJRpVi" title="Concentration risk percentage">79</span>% and <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__srt--MajorCustomersAxis__custom--TwoCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SalesRevenueMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zMlZQ0Os33" title="Concentration risk percentage">20</span>%, respectively, for the year ended December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Accounts Receivable</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022 one customer accounted for 100% of the Company’s net accounts receivable. As of December 31, 2021 two customers accounted for more than 10% of the Company’s net accounts receivable. One customer accounted for approximately <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__srt--MajorCustomersAxis__custom--OneCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z3W5sf59wrWa" title="Concentration risk percentage">87</span>% of the Company’s gross account receivable and a second customer accounted for approximately 10% of the Company’s gross account receivable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Purchasing</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company places orders with various suppliers. During the years ended December 31, 2022 and 2021, three suppliers accounted for more than 10% of the Company’s raw materials. One supplier, Cenntro Automotive Group (“Cenntro”), a related party – see Note 14 – accounted for approximately <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsProductLineMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneSupplierMember_zM2LTZU17yD3">50</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% and <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsProductLineMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneSupplierMember_zgEfbkaE0QBh">62</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%, respectively, of the Company’s purchases of raw materials during the years ended December 31, 2022 and 2021. The second supplier accounted for <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsProductLineMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoSupplierMember_zs4RH9dsAWK3">19</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% and <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsProductLineMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoSupplierMember_zTTy920vQq52">9</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%, respectively, of the Company’s purchases of raw materials during the years ended December 31, 2022 and 2021. The third supplier accounted for <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsProductLineMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeSupplierMember_zS3cQkxwueml">10</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of the Company’s purchases of raw materials during the year ended December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Manufacturing</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 31, 2022, the Company received a letter from Cenntro purporting to terminate all agreements and contracts between the Company and Cenntro. Although the Company does not believe Cenntro’s termination of the Cenntro MLA is valid, the Company has determined to cease production of the AYRO 411x and focus its resources on the development and launch of the Vanish. The Company has canceled all purchase orders and future builds with Cenntro and currently intends to only order replacement parts for vehicles from Cenntro in the future. The Company is in discussions with Cenntro concerning the potential repurchase by Cenntro of unsaleable inventory due to quality concerns. AYRO expects to lose its exclusive license under the Cenntro MLA, in which case Cenntro could sell similar products through other companies or directly to the Company’s customers, which could have a material adverse effect on its results of operations and financial condition.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AYRO, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1 0.79 0.20 0.87 0.50 0.62 0.19 0.09 0.10 <p id="xdx_807_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_z7xllhxqdFyh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 13. <span id="xdx_821_zg94bEvulBch">RELATED PARTY TRANSACTIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company had received short-term expense advances from its founders. For the years ended December 31, 2022 and 2021, the amounts outstanding were $<span id="xdx_906_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_c20221231_zzcsGQkscTa2" title="Due to related parties"><span id="xdx_903_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_c20211231_zLtMSTGMWNeb" title="Due to related parties">15,000</span></span> for each year and recorded as a component of accounts payable on the accompanying consolidated balance sheets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2022, the Company paid $<span id="xdx_904_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--BoardOfDirectorsChairmanMember_zJAQhRmwNSv7" title="Due to related parties">60,000</span> to a member of the Board of Directors for approved consulting services.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 15000 15000 60000 <p id="xdx_80E_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_za3p0GPgGQSi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>NOTE 14. <span id="xdx_82E_zjvhfpzpaBRc">COMMITMENTS AND CONTINGENCIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Manufacturing Agreements</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 25, 2020, AYRO entered into a Master Manufacturing Services Agreement (the “Karma Agreement”) with Karma Automotive, LLC (“Karma”). The Karma Agreement expired in September 2022. Pursuant to the agreement Karma agreed to provide certain manufacturing services, starting in 2021, under an attached statement of work including final assembly, raw material storage and logistical support of our vehicles in return for compensation of $<span id="xdx_909_eus-gaap--ShareBasedCompensation_c20200924__20200925__us-gaap--TypeOfArrangementAxis__custom--MasterManufacturingServicesAgreementMember__dei--LegalEntityAxis__custom--KarmaAutomotiveLLCMember_zyZwm24xNJNj" title="Share based compensation">1,160,800</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company paid Karma an amount of $<span id="xdx_903_eus-gaap--RepaymentsOfRelatedPartyDebt_c20200924__20200925__us-gaap--RelatedPartyTransactionAxis__custom--FirstProductionLevelBuildsMember__us-gaap--TypeOfArrangementAxis__custom--MasterManufacturingServicesAgreementMember__dei--LegalEntityAxis__custom--KarmaAutomotiveLLCMember_zeNYdyVfK5rd" title="Repayments of related party">440,000</span> for the first production level builds and $<span id="xdx_905_eus-gaap--RepaymentsOfRelatedPartyDebt_c20200924__20200925__us-gaap--RelatedPartyTransactionAxis__custom--SetupCostsMember__us-gaap--TypeOfArrangementAxis__custom--MasterManufacturingServicesAgreementMember__dei--LegalEntityAxis__custom--KarmaAutomotiveLLCMember_zGzGE3NK5gQ9" title="Repayments of related party debt">80,000</span> for setup costs. In addition, the Company issued warrants to an advisor to the transaction with a fair value of $<span id="xdx_902_eus-gaap--RepaymentsOfRelatedPartyDebt_c20200924__20200925__srt--TitleOfIndividualAxis__custom--AdvisorMember__us-gaap--TypeOfArrangementAxis__custom--MasterManufacturingServicesAgreementMember__dei--LegalEntityAxis__custom--KarmaAutomotiveLLCMember_zdyR3lVfgrK3" title="Repayments of related party debt">66,845</span> due at signing of the contract, which amount was expensed in the prior year. The payment was recorded as prepaid expense as of December 31, 2020. For the year ended December 31, 2021, the Company recorded expense of $<span id="xdx_90E_eus-gaap--OperatingExpenses_c20210101__20211231__us-gaap--TypeOfArrangementAxis__custom--MasterManufacturingServicesAgreementMember__us-gaap--RelatedPartyTransactionAxis__custom--FirstProductionLevelBuildsMember__dei--LegalEntityAxis__custom--KarmaAutomotiveLLCMember_zXpzgiHEE7be" title="Operating expense">641,140</span> related to the Karma Agreement for the assembly of the AYRO 411 and 411x vehicles (the “AYRO 411 Fleet”), of which $<span id="xdx_909_eus-gaap--LitigationSettlementExpense_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--MasterManufacturingServicesAgreementMember__us-gaap--RelatedPartyTransactionAxis__custom--FirstProductionLevelBuildsMember__dei--LegalEntityAxis__custom--KarmaAutomotiveLLCMember_zCFmZLs6pUZb" title="Litigation settlement expense">468,480</span> was recorded to reduce the total remaining prepaid expense to match the expected number of 411x vehicles to be built in 2022. This amount was recorded against cost of goods for direct labor as part of the first production level builds, and $<span id="xdx_90F_eus-gaap--PreproductionCostsRelatedToLongTermSupplyArrangementsCostsCapitalized_iI_c20221231__us-gaap--TypeOfArrangementAxis__custom--MasterManufacturingServicesAgreementMember__us-gaap--RelatedPartyTransactionAxis__custom--FirstProductionLevelBuildsMember__dei--LegalEntityAxis__custom--KarmaAutomotiveLLCMember_zqx1uYo2ZZX3" title="Pre-production costs">73,333</span> was recorded for pre-production costs. No prepaid balance remained as of December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 28, 2022, the Company partnered with Linamar Corporation (“Linamar”) a Canadian manufacturer, in a manufacturing agreement (the “Linamar MLA”) to provide certain sub assembly and assembly parts, including the cabin frame and skate for the Vanish (collectively, the “Products”). During the term of the Linamar MLA, Linamar has the exclusive right to supply the Products to the Company, subject to certain exceptions. The Linamar MLA has an initial term of three years and will automatically renew for successive two-year terms unless either party has given at least 12 months’ written notice of nonrenewal. Either party may terminate the Linamar MLA at any time upon 12 months’ written notice, and in the event of a change in control of the Company prior to the end of the initial term, the Company may terminate upon written notice within three days of completion of such change in control.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the event the Company terminates the Linamar MLA prior to its expiration, whether following a change in control or otherwise, the Company must purchase any remaining raw material inventory, finished goods inventory and work in progress and any unamortized capital equipment used in production and testing of the Products and pay a termination fee of $<span id="xdx_907_ecustom--TerminationFee_c20220101__20221231_zH2A3OjJi75i" title="Termination fee">750,000</span>, subject to certain adjustments. The Company is dependent on the Linamar MLA, and in the event of its termination the Company’s manufacturing operations and customer deliveries would be materially impacted.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the Linamar MLA, the Company must commit to certain minimum purchase requirements, to be determined by AYRO on a quarterly basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Supply Chain Agreements</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In 2017, the Company executed a supply chain contract with Cenntro, which has historically been the Company’s primary supplier. Prior to the Merger, Cenntro was a significant shareholder in AYRO Operating. Cenntro owns the design of the AYRO 411 Fleet vehicles and has granted the Company an exclusive license to purchase the AYRO 411 Fleet vehicles for sale in North America. The Company purchased 100% of its vehicle chassis, cabs and wheels for AYRO 411 Fleet Vehicles through this supply chain relationship with Cenntro. The Company must sell a minimum number of units in order to maintain its exclusive supply chain contract. See Note 12 for concentration amounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2021 the net balance between prepaid expenses and accrued expenses with Cenntro was a prepaid balance of $<span id="xdx_905_eus-gaap--PrepaidExpenseCurrent_iI_c20211231__dei--LegalEntityAxis__custom--CenntroAutomotiveGroupLtdMember_zcghSnxcQaua" title="Prepaid balance">602,016</span>. As of December 31, 2022 the balance was <span id="xdx_90E_eus-gaap--PrepaidExpenseCurrent_iI_dc_c20221231__dei--LegalEntityAxis__custom--CenntroAutomotiveGroupLtdMember_zc656HpcUWda" title="Prepaid balance">zero</span>. Impairments of prepaid expenses led to a write-down, netted with the balance in accrued expenses. The remainder of the balance was expensed through cost of goods sold for $<span id="xdx_906_eus-gaap--CostOfGoodsAndServicesSold_c20220101__20221231__dei--LegalEntityAxis__custom--CenntroAutomotiveGroupLtdMember_zOwJJtXAC0D1" title="Cost of goods sold">621,097</span>. Additionally, all inventory associated with Cenntro’s NCM line was written off to cost of goods sold for $<span id="xdx_901_eus-gaap--InventoryWriteDown_c20220101__20221231__dei--LegalEntityAxis__custom--CenntroAutomotiveGroupLtdMember_z5UkEVRUxlj7" title="Inventory written-off">1,317,289</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has canceled all purchase orders and future builds with Cenntro and currently intends to only order replacement parts from Cenntro in the future.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><i>Lease Agreements</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In 2019 the Company entered into a new lease agreement for office and manufacturing space. The lease commencement date was January 16, 2020. Prior to the commencement date of the new lease agreement, the Company leased other office and manufacturing space on a short-term basis. The Company determined if an arrangement is a lease at inception of the contract and whether a contract is or contains a lease by determining whether it conveys the right to control the use of identified asset for a period of time. The contact provides the right to substantially all the economic benefits from the use of the identified asset and the right to direct use of the identified asset, as such, the contract is, or contains, a lease. In connection with the adoption of ASC 842, <i>Leases</i>, the Company has elected to treat the lease and non-lease components as a single component.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During March 2021, the <span id="xdx_90C_eus-gaap--LesseeOperatingSubleaseOptionToExtend_c20210301__20210331_zaUWStbOK6R9" title="Operating sub lease, expansion description">Company subleased additional office space to support the Company’s expansion plan. The term is for 16 months with no lease obligation remaining as of December 31, 2022.</span> In connection with the adoption of ASC 842, <i>Leases</i>, the Company has elected to treat the lease and non-lease components as a single component.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leases were classified as an operating lease at inception. An operating lease results in the recognition of a Right-of-Use (“ROU”) assets and lease liability on the balance sheet. ROU assets and operating lease liabilities are recognized based on the present value of lease payments over the lease term as of the commencement date. Because the lease does not provide an explicit or implicit rate of return, the Company determines an incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments on an individual lease basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The incremental borrowing rate for a lease is the rate of interest the Company would have to pay on a collateralized basis to borrow an amount equal to the lease payments for the asset under similar term, which is <span id="xdx_90A_ecustom--IncrementalBorrowingRateForLease_pid_dp_uPure_c20210301__20210331__us-gaap--TypeOfArrangementAxis__custom--NewLeaseAgreementMember_zcHDNVPmuQXa" title="Incremental borrowing rate for the lease">10.41</span>%. Lease expense for the lease is recognized on a straight-line basis over the lease term.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AYRO, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s leases do not contain any residual value guarantees or material restrictive covenants. Leases with a lease term of 12 months or less are not recorded on the balance sheet and lease expense is recognized on a straight-line basis over the lease term. The remaining term for the Company’s lease as of December 31, 2022 is <span id="xdx_90B_eus-gaap--LesseeOperatingLeaseRemainingLeaseTerm_iI_dtY_c20221231__us-gaap--TypeOfArrangementAxis__custom--NewLeaseAgreementMember_z2OpVgE5nF6h" title="Remaining term of lease">4.25</span> years. The Company currently has no finance leases.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the years ended December 31, 2022 and 2021, cash paid for amounts included in the measurement of lease liabilities- operating cash flows from operating lease was $<span id="xdx_907_eus-gaap--OperatingLeaseLiability_iI_c20221231__us-gaap--TypeOfArrangementAxis__custom--NewLeaseAgreementMember_z7M8lrZ4BqJ" title="Lease liabilities">306,689</span> and $<span id="xdx_903_eus-gaap--OperatingLeaseLiability_iI_c20211231__us-gaap--TypeOfArrangementAxis__custom--NewLeaseAgreementMember_z0aR0ttSD2Ui" title="Lease liabilities">180,404</span> respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--LeaseCostTableTextBlock_ztOydncTZyT4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The components of lease expense consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_zuT1c9i5EmP9" style="display: none">SCHEDULE OF COMPONENTS OF LEASE EXPENSES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_492_20220101__20221231_zcIG5spv6Bc5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49E_20210101__20211231_zYRKcft0nHY7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Years Ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_eus-gaap--OperatingLeaseCost_maLCz0OR_z6VsnbWLOXsi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating lease expense</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">409,543</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">462,105</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eus-gaap--ShortTermLeaseCost_maLCz0OR_zLaZjIuCAjd9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Short-term lease expense</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">153,572</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,296</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_eus-gaap--LeaseCost_iT_pp0p0_mtLCz0OR_zEUMWA9fNM0k" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total lease cost</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">563,115</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">470,401</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A8_zqndJIATxwr8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_ecustom--ScheduleOfOperatingLeasesRightOfUseAssetsAndLiabilitiesTableTextBlock_zXtYibKjytBl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance sheet information related to leases consists of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zCHFRkr5QJ4d" style="display: none">SCHEDULE OF OPERATING LEASES RIGHT OF USE ASSETS AND LIABILITIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_494_20221231_zV0NBONppHOf" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31, 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_492_20211231_zRjs30vZxIl8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Assets</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_ecustom--OperatingLeaseRightOfUseAssetCurrent_iI_pp0p0_maOLROUzzC2_zO0L4A0mN6zc" style="vertical-align: bottom; background-color: White"> <td style="width: 64%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Operating lease – right-of-use asset</span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">819,401</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,012,884</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_eus-gaap--OperatingLeaseRightOfUseAsset_iTI_pp0p0_mtOLROUzzC2_zeM7l5CYNCel" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total lease assets</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">819,401</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,012,884</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current liabilities:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_407_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pp0p0_maOLLzNKG_zJK1ZLQOXAEb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Lease obligation – operating lease</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">165,767</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">206,426</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Noncurrent liabilities:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0_maOLLzNKG_z1Ce0B27cafh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Lease obligation - operating lease, net of current portion</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">693,776</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">859,543</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_eus-gaap--OperatingLeaseLiability_iTI_pp0p0_mtOLLzNKG_zCpRoGV0Rzhh" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total lease liability</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">859,543</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,065,969</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8AC_zStM4p4O4W62" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_892_ecustom--ScheduleOfWeightedaverageRemainingLeaseTermAndDiscountRateTableTextBlock_zO2w03ZCzSye" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The weighted-average remaining lease term and discount rate is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_zZkALV4293gk" style="display: none">SCHEDULE OF WEIGHTED- AVERAGE REMAINING LEASE TERM AND DISCOUNT RATE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 82%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Weighted average remaining lease term (in years) – operating lease</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_eus-gaap--LesseeOperatingLeaseRemainingLeaseTerm_iI_dtY_c20221231_zA2vFEQy5Ync" title="Weighted average remaining lease term (in years) - operating lease">4.25</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Weighted average discount rate – operating lease</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_902_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_uPure_c20221231_zDSE74G9k3Zf" title="Weighted average discount rate - operating lease">10.41</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> </table> <p id="xdx_8AC_z4Ang0ToYaL" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AYRO, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_89C_eus-gaap--ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_zZw6oA44cChf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash flow information related to leases consists of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_z8WMYsn9J7Qe" style="display: none">SCHEDULE OF CASH FLOW INFORMATION</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_499_20220101__20221231_zDvyEtvcfmE3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31, 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_492_20210101__20211231_z1lColXVoESf" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_eus-gaap--OperatingLeasePayments_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating cash flows for operating leases</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">306,689</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">180,404</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_eus-gaap--RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_i_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Supplemental non-cash amounts of lease liabilities arising from obtaining right of use assets</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1502">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">120,440</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A6_zW2KDyoa0pCk" style="margin-top: 0; margin-bottom: 0">  </p> <p id="xdx_898_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_ztDwp0PLqAF8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future minimum lease payment under non-cancellable lease as of December 31, 2022 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zSOJ1Mncm1ge" style="display: none">SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">As of December 31, 2022</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_493_20221231_z6rpRxi5sowd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Operating Leases</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maLOLLPzjgl_zCau2YWzyKb3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">247,533</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_maLOLLPzjgl_zVDdRiEsBBS" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">254,277</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pp0p0_maLOLLPzjgl_zlgMNS037vwd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">2025</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">261,223</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pp0p0_maLOLLPzjgl_zXe5xtfOqdQk" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">2026</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">268,378</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueFiveAndAfterFive_iI_pp0p0_maLOLLPzjgl_zbqdbzO6Afal" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">2027</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">44,929</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_408_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPzjgl_zOSro9VtNwz8" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Total minimum lease payments</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,076,340</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_408_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_zgiiN78KpMs9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Less effects of discounting</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(216,797</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Present value of future minimum lease payments</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">859,543</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A4_zV43oEB2Voog" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Litigation</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is subject to various legal proceedings and claims, either asserted or unasserted, which arise in the ordinary course of business, that it believes are incidental to the operation of its business. While the outcome of these claims cannot be predicted with certainty, management does not believe that the outcome of any of these legal matters will have a material adverse effect on its results of operations, financial positions or cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AYRO, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 12, 2021, the Company entered into an agreement with Arcimoto, Inc. to settle certain patent infringement claims (the “Arcimoto Settlement”) for a de minimis amount, pursuant to which the Company agreed to cease the production, importation and sale of the AYRO 311, among other things. Accordingly, the Company would not be contractually permitted to resume production of the AYRO 311.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of January 1, 2019, DropCar had accrued approximately $<span id="xdx_905_eus-gaap--LitigationSettlementExpense_pp0p0_c20190101__20190102__dei--LegalEntityAxis__custom--DropCarOperatingIncMember_z5negVzooFCc" title="Settlement of multiple employment disputes">232,000</span> for the settlement of multiple employment disputes. As of December 31, 2021 the accrual balance was $<span id="xdx_906_ecustom--RemaningAccountsPayableAndAccruedLiabilities_iI_pp0p0_c20211231__dei--LegalEntityAxis__custom--DropCarOperatingIncMember_zmy2BURLA7T1" title="Remaning accounts payable and accrued liabilities">3,500</span>, as of December 31, 2022 the remainder has been paid.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 23, 2018, DropCar was made aware of an audit being conducted by the New York State Department of Labor (“DOL”) regarding a claim filed by an employee. The DOL is investigating whether DropCar properly paid overtime for which DropCar has raised several defenses. In addition, the DOL is conducting its audit to determine whether the Company owes spread of hours pay (an hour’s pay for each day an employee worked or was scheduled for a period over ten hours in a day). Management believes the case has no merit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DropCar was a defendant in a class action lawsuit which resulted in a judgement entered into whereby the Company is required to pay legal fees in the amount of $<span id="xdx_906_eus-gaap--LegalFees_c20220101__20221231__dei--LegalEntityAxis__custom--DropCarOperatingIncMember_zSNXiOWSDEr8" title="Legal fees">45,000</span> to the plaintiff’s counsel. As of December 31, 2022 there is no balance due.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DropCar was audited by the New York State Department of Taxation and Finance (“DOTF”) for its sales tax paid over the period of 2017 – 2020. The DOTF believes DropCar owes additional sales tax plus interest. Management is investigating the details this audit. As of December 31, 2021, the Company has accrued $<span id="xdx_90B_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_c20211231_zZigZMqkHCW2" title="Other accrued liabilities, current">476,280</span> in expense for such additional sales tax and interest and paid as of December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AYRO, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1160800 440000 80000 66845 641140 468480 73333 750000 602016 0 621097 1317289 Company subleased additional office space to support the Company’s expansion plan. The term is for 16 months with no lease obligation remaining as of December 31, 2022. 0.1041 P4Y3M 306689 180404 <p id="xdx_89A_eus-gaap--LeaseCostTableTextBlock_ztOydncTZyT4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The components of lease expense consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_zuT1c9i5EmP9" style="display: none">SCHEDULE OF COMPONENTS OF LEASE EXPENSES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_492_20220101__20221231_zcIG5spv6Bc5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49E_20210101__20211231_zYRKcft0nHY7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Years Ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_eus-gaap--OperatingLeaseCost_maLCz0OR_z6VsnbWLOXsi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating lease expense</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">409,543</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">462,105</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eus-gaap--ShortTermLeaseCost_maLCz0OR_zLaZjIuCAjd9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Short-term lease expense</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">153,572</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,296</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_eus-gaap--LeaseCost_iT_pp0p0_mtLCz0OR_zEUMWA9fNM0k" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total lease cost</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">563,115</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">470,401</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 409543 462105 153572 8296 563115 470401 <p id="xdx_89C_ecustom--ScheduleOfOperatingLeasesRightOfUseAssetsAndLiabilitiesTableTextBlock_zXtYibKjytBl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance sheet information related to leases consists of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zCHFRkr5QJ4d" style="display: none">SCHEDULE OF OPERATING LEASES RIGHT OF USE ASSETS AND LIABILITIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_494_20221231_zV0NBONppHOf" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31, 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_492_20211231_zRjs30vZxIl8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Assets</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_ecustom--OperatingLeaseRightOfUseAssetCurrent_iI_pp0p0_maOLROUzzC2_zO0L4A0mN6zc" style="vertical-align: bottom; background-color: White"> <td style="width: 64%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Operating lease – right-of-use asset</span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">819,401</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,012,884</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_eus-gaap--OperatingLeaseRightOfUseAsset_iTI_pp0p0_mtOLROUzzC2_zeM7l5CYNCel" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total lease assets</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">819,401</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,012,884</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current liabilities:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_407_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pp0p0_maOLLzNKG_zJK1ZLQOXAEb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Lease obligation – operating lease</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">165,767</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">206,426</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Noncurrent liabilities:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0_maOLLzNKG_z1Ce0B27cafh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Lease obligation - operating lease, net of current portion</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">693,776</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">859,543</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_eus-gaap--OperatingLeaseLiability_iTI_pp0p0_mtOLLzNKG_zCpRoGV0Rzhh" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total lease liability</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">859,543</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,065,969</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 819401 1012884 819401 1012884 165767 206426 693776 859543 859543 1065969 <p id="xdx_892_ecustom--ScheduleOfWeightedaverageRemainingLeaseTermAndDiscountRateTableTextBlock_zO2w03ZCzSye" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The weighted-average remaining lease term and discount rate is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_zZkALV4293gk" style="display: none">SCHEDULE OF WEIGHTED- AVERAGE REMAINING LEASE TERM AND DISCOUNT RATE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 82%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Weighted average remaining lease term (in years) – operating lease</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_eus-gaap--LesseeOperatingLeaseRemainingLeaseTerm_iI_dtY_c20221231_zA2vFEQy5Ync" title="Weighted average remaining lease term (in years) - operating lease">4.25</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Weighted average discount rate – operating lease</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_902_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_uPure_c20221231_zDSE74G9k3Zf" title="Weighted average discount rate - operating lease">10.41</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> </table> P4Y3M 0.1041 <p id="xdx_89C_eus-gaap--ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_zZw6oA44cChf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash flow information related to leases consists of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_z8WMYsn9J7Qe" style="display: none">SCHEDULE OF CASH FLOW INFORMATION</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_499_20220101__20221231_zDvyEtvcfmE3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31, 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_492_20210101__20211231_z1lColXVoESf" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_eus-gaap--OperatingLeasePayments_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating cash flows for operating leases</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">306,689</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">180,404</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_eus-gaap--RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_i_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Supplemental non-cash amounts of lease liabilities arising from obtaining right of use assets</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1502">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">120,440</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 306689 180404 120440 <p id="xdx_898_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_ztDwp0PLqAF8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future minimum lease payment under non-cancellable lease as of December 31, 2022 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zSOJ1Mncm1ge" style="display: none">SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">As of December 31, 2022</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_493_20221231_z6rpRxi5sowd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Operating Leases</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maLOLLPzjgl_zCau2YWzyKb3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">247,533</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_maLOLLPzjgl_zVDdRiEsBBS" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">254,277</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pp0p0_maLOLLPzjgl_zlgMNS037vwd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">2025</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">261,223</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pp0p0_maLOLLPzjgl_zXe5xtfOqdQk" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">2026</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">268,378</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueFiveAndAfterFive_iI_pp0p0_maLOLLPzjgl_zbqdbzO6Afal" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">2027</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">44,929</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_408_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPzjgl_zOSro9VtNwz8" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Total minimum lease payments</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,076,340</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_408_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_zgiiN78KpMs9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Less effects of discounting</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(216,797</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Present value of future minimum lease payments</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">859,543</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 247533 254277 261223 268378 44929 1076340 216797 859543 232000 3500 45000 476280 <p id="xdx_800_eus-gaap--IncomeTaxDisclosureTextBlock_z3ujd5spRyN3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 15. <span id="xdx_824_zrrJCQf6dzH8">INCOME TAXES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zEgCOxEjmbEj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following is a reconciliation of the statutory federal income tax rate applied to pre-tax net loss compared to the income taxes in the statement of operations as of December 31, 2022 and 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B9_zrpqt2hLQVIe" style="display: none">SCHEDULE OF RECONCILIATION STATUTORY FEDERAL INCOME TAX RATE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49F_20220101__20221231_zEcIp7V2Hf7g" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">December 31, 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_495_20210101__20211231_zhLhl6InkQh9" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">December 31, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_zgNGqmFLM5wg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Income tax benefit at statutory U.S. federal rate</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,816,424</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(6,946,677</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_402_ecustom--IncomeTaxReconciliationEquityBasedCompensationExpense_zTw7z9lpBYF" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Permanent differences - equity based compensation</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">51,381</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">310,384</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_zmxfS8jkUCC3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Income tax benefit attributable to U.S. states</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(936,810</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(965,708</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">) </span></td></tr> <tr id="xdx_40B_eus-gaap--IncomeTaxReconciliationNondeductibleExpense_z7dazWy6fqP3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Permanent difference - non-deductible compensation</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1544">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">765,339</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_407_eus-gaap--IncomeTaxReconciliationOtherAdjustments_zsDeNtsMa3V1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basis adjustments</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1547">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">70,544</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_zcN5IcZdmAMh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in valuation allowance</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,701,853</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,766,118</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_eus-gaap--IncomeTaxExpenseBenefit_zbWizE1R70h6" style="vertical-align: bottom; background-color: White"> <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total income tax expense</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1553">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1554">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8AC_z8MxCeLoiRy8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zZBlpbhpAg3k" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred income taxes reflect the net effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The following table sets forth deferred income tax assets and liabilities as of the date shown:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_zEUxjWo6Dqfa" style="display: none">SCHEDULE OF DEFERRED TAX</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_492_20221231_z7Xd8Rwx0wN1" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31, 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_492_20211231_zBSKskCQNun5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred tax assets:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_maDTAGzHF7_zE8d6ZLxPpuc" style="vertical-align: bottom; background-color: White"> <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net operating losses</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">15,843,010</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,733,274</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsGoodwillAndIntangibleAssets_iI_pp0p0_maDTAGzHF7_z07Wjm9GCqJ8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Intangible assets</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">99,566</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">85,758</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_ecustom--DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpense_iI_maDTAGzHF7_zMl8wMi24CN8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Capitalized research and development expense</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,490,870</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1565">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_iI_maDTANzp5q_maDTAGzHF7_zSGsPr2vYwZ6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Equity based compensation</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">743,567</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">569,350</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_ecustom--DeferredTaxAssetsWarrants_iI_maDTAGzHF7_z6jTNUtGkf99" style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Warrants</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">156,851</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">156,851</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_ecustom--DeferredTaxAssetsCompensation_iI_maDTAGzHF7_zsgejp4kZvLf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accrued compensation</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,467</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">33,147</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_407_ecustom--DeferredTaxAssetsDepreciation_iI_maDTAGzHF7_znT96L68ivu2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Property and equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,492</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">73,646</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsDeferredGainOnSaleLeasebackTransaction_iI_pp0p0_maDTAGzHF7_zYhpYhrQQwKl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Lease liability</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">210,195</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">260,674</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsOther_iI_pp0p0_maDTAGzHF7_zxDlS4sibUab" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Other</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">113,487</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">93,268</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAGzHF7_msDTLzJxa_zIMGfA0BnxS3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred tax assets</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">18,660,505</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">13,005,968</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred tax liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_eus-gaap--DeferredTaxLiabilitiesLeasingArrangements_iNI_pp0p0_di_maDITLzRu6_zpZCjUP2GO2g" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">ROU asset</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(200,379</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(247,695</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_eus-gaap--DeferredIncomeTaxLiabilities_iNTI_di_mtDITLzRu6_maDTLzJxa_zNhdhkp0ziU" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred tax liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(200,379</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(247,695</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_pp0p0_maDTLzJxa_zHQwNqbfWMWd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Valuation allowance</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">18,460,126</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">12,758,273</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_eus-gaap--DeferredTaxLiabilities_iTI_pp0p0_mtDTLzJxa_zqxqz7nQvLv" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Net deferred tax asset/(liability)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1597">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1598">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8AB_zlMgUIXtM87e" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income, and projections for future taxable income over periods in which the deferred tax assets are deductible. Management believes it is more likely than not that the Company will not realize the benefits of these deductible differences. A valuation allowance has been applied to the amount of deferred tax assets Management expects will be unrealized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management does not believe that there are significant uncertain tax positions in 2022. There are no interest and penalties related to uncertain tax positions in 2022. The Company has federal net operating loss carryforwards of $<span id="xdx_90A_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_c20221231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zmTExd4985Y6" title="Deferred tax assets, operating loss carryforward">64,332,435</span> and $<span id="xdx_90F_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_c20211231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zqepWL7XDVwj" title="Deferred tax assets, operating loss carryforward">48,152,539</span> as of December 31, 2022 and 2021, respectively. $<span id="xdx_905_eus-gaap--OperatingLossCarryforwards_iI_c20221231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zP5EvGBYeSaf" title="Operating loss carryforwards">995,801</span> of the federal net operating loss is subject to a <span id="xdx_908_ecustom--OperatingLossCarryforwardsMaturityDescription_c20220101__20221231_zWjL8yKiRMh9" title="Operating loss carryforwards maturity description">20-year carry forward, with a portion beginning to expire in 2036.</span> $<span id="xdx_900_ecustom--OperatingLossIndefiniteCarryforwards_iI_c20221231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zkiPGoscW3H2" title="Operating loss indefinite carryforwards">63,336,634</span> of the federal net operating loss has an indefinite carry forward period subjected to 80% of taxable income. The Company had state net operating loss carryforwards totaling $<span id="xdx_90B_eus-gaap--OperatingLossCarryforwards_iI_c20221231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_zLAwTLkDeU24" title="Net operating loss carryforwards">48,091,426</span> and $<span id="xdx_903_eus-gaap--OperatingLossCarryforwards_iI_c20211231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_zfFRM4tZ6iz8" title="Net operating loss carryforwards">34,824,332</span> at December 31, 2022 and 2021. The Company has various state net operating loss carryforwards. The determination of the state net operating loss carryforwards is dependent upon apportionment percentages and state laws that can change from year to year and impact the amount of such carryforwards. If such net operating loss carryforwards are not utilized, they will begin to expire in 2031.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AYRO, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--SummaryOfIncomeTaxExaminationsTextBlock_zMqbndOd5nBf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets for the tax years subject to examination for the major jurisdictions where the Company conducts business as of December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_zWiNE1CDdaG6" style="display: none">SCHEDULE OF INCOME TAX EXAMINATION</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 25%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Federal</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--IncomeTaxExaminationDescription_c20220101__20221231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_ztQ6FjbqJGge" title="Income tax examiation year">2016 to 2022</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Georgia</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--IncomeTaxExaminationDescription_c20220101__20221231__srt--StatementGeographicalAxis__country--GE_zylXbDAIEdB5" title="Income tax examiation year">2019 to 2022</span></span></td></tr> </table> <p id="xdx_8AD_zbj4Nvjn1wT" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Federal and state laws impose substantial restrictions on the utilization of NOL carryforwards in the event of an ownership change for income tax purposes, as defined in Section 382 of the Internal Revenue Code (“IRC”). Pursuant to IRC Section 382, annual use of the Company’s NOL carryforwards may be limited in the event a cumulative change in ownership of more than 50% occurs within a three-year period. The Company has not completed an IRC Section 382 analysis regarding the limitation of NOL carryforwards.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">However, it is possible that past ownership changes will result in the inability to utilize a significant portion of the Company’s NOL carryforward that was generated prior to any change of control. The Company’s ability to use its remaining NOL carryforwards may be further limited if the Company experiences an IRC Section 382 ownership change in connection with future changes in the Company’s stock ownership.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain deferred tax assets from DropCar, such as NOL carryforwards and capital loss carryforwards are not included in the Company’s deferred tax assets as they are expected to be fully limited under IRC Section 382 as a result of the merger.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Tax Cuts and Jobs Act (“TCJA”) requires taxpayers to capitalize and amortize research and experimental expenditures under IRC Section 174 for tax years beginning after December 31, 2021. This rule became effective for this Company during the year ended December 31, 2022 and resulted in the capitalization of research and development costs of $<span id="xdx_901_eus-gaap--ResearchAndDevelopmentExpense_c20220101__20221231__us-gaap--IncomeTaxAuthorityNameAxis__custom--TaxCutsAndJobsActMember_zYkrK5N8FNy8" title="Capitalization of research and development costs">6,729,353</span>. Before the TCJA, businesses have had the option of deducting Section 174 expenses in the year incurred or capitalizing and amortizing the costs over five years. The Company will amortize these costs for tax purposes over five years if the research and development was performed in the U.S. and over 15 years if research and development was performed outside the U.S.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 16, 2022, the Inflation Reduction Act was enacted into law. This Act includes a 15.0 percent book minimum tax on the adjusted financial statement income of applicable corporations, a number of clean-energy tax credits, and a 1.0 percent excise tax on certain stock buybacks. The Company does not expect these changes to have a material impact on the provision for income taxes or the financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_89C_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zEgCOxEjmbEj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following is a reconciliation of the statutory federal income tax rate applied to pre-tax net loss compared to the income taxes in the statement of operations as of December 31, 2022 and 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B9_zrpqt2hLQVIe" style="display: none">SCHEDULE OF RECONCILIATION STATUTORY FEDERAL INCOME TAX RATE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49F_20220101__20221231_zEcIp7V2Hf7g" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">December 31, 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_495_20210101__20211231_zhLhl6InkQh9" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">December 31, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_zgNGqmFLM5wg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Income tax benefit at statutory U.S. federal rate</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,816,424</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(6,946,677</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_402_ecustom--IncomeTaxReconciliationEquityBasedCompensationExpense_zTw7z9lpBYF" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Permanent differences - equity based compensation</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">51,381</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">310,384</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_zmxfS8jkUCC3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Income tax benefit attributable to U.S. states</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(936,810</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(965,708</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">) </span></td></tr> <tr id="xdx_40B_eus-gaap--IncomeTaxReconciliationNondeductibleExpense_z7dazWy6fqP3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Permanent difference - non-deductible compensation</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1544">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">765,339</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_407_eus-gaap--IncomeTaxReconciliationOtherAdjustments_zsDeNtsMa3V1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basis adjustments</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1547">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">70,544</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_zcN5IcZdmAMh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in valuation allowance</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,701,853</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,766,118</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_eus-gaap--IncomeTaxExpenseBenefit_zbWizE1R70h6" style="vertical-align: bottom; background-color: White"> <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total income tax expense</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1553">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1554">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> -4816424 -6946677 51381 310384 -936810 -965708 765339 70544 5701853 6766118 <p id="xdx_894_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zZBlpbhpAg3k" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred income taxes reflect the net effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The following table sets forth deferred income tax assets and liabilities as of the date shown:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_zEUxjWo6Dqfa" style="display: none">SCHEDULE OF DEFERRED TAX</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_492_20221231_z7Xd8Rwx0wN1" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31, 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_492_20211231_zBSKskCQNun5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31, 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred tax assets:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_maDTAGzHF7_zE8d6ZLxPpuc" style="vertical-align: bottom; background-color: White"> <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net operating losses</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">15,843,010</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,733,274</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsGoodwillAndIntangibleAssets_iI_pp0p0_maDTAGzHF7_z07Wjm9GCqJ8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Intangible assets</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">99,566</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">85,758</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_ecustom--DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpense_iI_maDTAGzHF7_zMl8wMi24CN8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Capitalized research and development expense</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,490,870</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1565">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_iI_maDTANzp5q_maDTAGzHF7_zSGsPr2vYwZ6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Equity based compensation</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">743,567</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">569,350</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_ecustom--DeferredTaxAssetsWarrants_iI_maDTAGzHF7_z6jTNUtGkf99" style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Warrants</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">156,851</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">156,851</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_ecustom--DeferredTaxAssetsCompensation_iI_maDTAGzHF7_zsgejp4kZvLf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accrued compensation</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,467</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">33,147</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_407_ecustom--DeferredTaxAssetsDepreciation_iI_maDTAGzHF7_znT96L68ivu2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Property and equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,492</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">73,646</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsDeferredGainOnSaleLeasebackTransaction_iI_pp0p0_maDTAGzHF7_zYhpYhrQQwKl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Lease liability</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">210,195</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">260,674</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsOther_iI_pp0p0_maDTAGzHF7_zxDlS4sibUab" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Other</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">113,487</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">93,268</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAGzHF7_msDTLzJxa_zIMGfA0BnxS3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred tax assets</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">18,660,505</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">13,005,968</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred tax liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_eus-gaap--DeferredTaxLiabilitiesLeasingArrangements_iNI_pp0p0_di_maDITLzRu6_zpZCjUP2GO2g" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">ROU asset</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(200,379</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(247,695</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40E_eus-gaap--DeferredIncomeTaxLiabilities_iNTI_di_mtDITLzRu6_maDTLzJxa_zNhdhkp0ziU" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred tax liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(200,379</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(247,695</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_pp0p0_maDTLzJxa_zHQwNqbfWMWd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Valuation allowance</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">18,460,126</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">12,758,273</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_eus-gaap--DeferredTaxLiabilities_iTI_pp0p0_mtDTLzJxa_zqxqz7nQvLv" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Net deferred tax asset/(liability)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1597">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1598">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 15843010 11733274 99566 85758 1490870 743567 569350 156851 156851 1467 33147 1492 73646 210195 260674 113487 93268 18660505 13005968 200379 247695 200379 247695 18460126 12758273 64332435 48152539 995801 20-year carry forward, with a portion beginning to expire in 2036. 63336634 48091426 34824332 <p id="xdx_897_eus-gaap--SummaryOfIncomeTaxExaminationsTextBlock_zMqbndOd5nBf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets for the tax years subject to examination for the major jurisdictions where the Company conducts business as of December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_zWiNE1CDdaG6" style="display: none">SCHEDULE OF INCOME TAX EXAMINATION</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 25%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Federal</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--IncomeTaxExaminationDescription_c20220101__20221231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_ztQ6FjbqJGge" title="Income tax examiation year">2016 to 2022</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Georgia</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--IncomeTaxExaminationDescription_c20220101__20221231__srt--StatementGeographicalAxis__country--GE_zylXbDAIEdB5" title="Income tax examiation year">2019 to 2022</span></span></td></tr> </table> 2016 to 2022 2019 to 2022 6729353 <p id="xdx_802_eus-gaap--SubsequentEventsTextBlock_ztTOGAGvFogj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 16. <span id="xdx_829_zts87IIFpo4j">SUBSEQUENT EVENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c20230126__20230127__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_ztTLHWHmBd3l" title="Issuance of common stock upon vesting of restrcited stock">110,562</span> shares of common stock upon the vesting of restricted stock on January 27, 2023.</span></p> 110562 EXCEL 84 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

#_F#4O8;W*,*H.Q[LLN6@MMVVC&?< MFHH8,?!*"C G0LFJY>$]B[+%4YHS2(-''N!)I78D:31CXP4 M+6"N\/F$RSI?@!4I#=Q36/O1^A]^M-; 5@W\<<6UAN^F3GC!IYD&IM]=8CV> M/IS6?C'.^ )'@=UR(SOP CBF:62W@\B.XAB.K7N.S:8@4]-L.N62%PGZX03X MSS+3;Z8%I<9GV!FK*(2N[;=<--[!9[";D);9I-14WN1FP\GX5,%1VX^0C8-, MCMI1:,=.:P\+)%&(X@3KN\1>2E!;-$X@1G'?;UN73%&VI,_8ORAH1#]V[# ( MK-Z,%4\48WAA>6D$+48IQD@!:7?M5NA#9,=19+MNRQH+O9U0_)5TDAM/S.] ML85UL86?+K;^X&HP&@WZE 6["ND@TNY"ZG/T(&:XM97:>/S0V61RGHJ!HY\3 M;1(:YC@4ZP2G6&8GAR MPS0KT,$992!'9(V2UJ*4"Z%X)4"8:ZB2,HRD-IR^WGP*V!7@O2M4*67THH2> MT8EH;-T4WD/,%*]%FE,J"S43R^)LJV W8_&I8EQ[>D/MF76+SEWU#&1,/0>5 M?P$WM%N!;SN8^CAQ[=CW;2^F^M&8HR:_5\3;;3N,(FAA>H8MJ\<6&:9D]@^J MH1 SF) BP[C F$EWBVT$KAC:Z)6KMIZ7A!;$>H_7BOX)[MW]8=!-X["#(*D)'K1>!Z M%"X,J6\R(/T/_^91[8+CSW23J.XFT:>[R<:),OC1O1G>FJ-G5U\YC+E]%F]7 MG2E>LNH-&>L?+3>.&?/.'HN9:;2+*F.T27&FYNW/3J, MBS=,L(*Z/#:=4B$5]?&HK8MP^X3=;:YUM3K^/,>-+.1%@M;O'+\E,D:+[?7B M+N\W-VZWK@W8K*J+;KU:?R9TJ]OQ^_;J&^.&H4:T-^=3%'5.8VSF MLKJW5Q,M%N:N/!$:;]YF.,-/'2YI [Z?"J'7$U)0?SQU_@502P,$% @ M(#AW5J\#]!4W P T @ !D !X;"]W;W)K&UL MK99_;_(V$,??BI5-4RMUS4],Z" 2A4X/TAZ>KBU[M#]-]^UP<7\9[+EYE#J#0][)@=AMR24.+N'@N\G MCN^\+SS1;:[,@IN,*[*%9U"KZE'HF=NJ9+0$)BEG2,!FXDS]NUEL[*W!'Q3V M\FB,#,F:\U>@=%+>2'M/]HWMCAR4%I+QGM!J.7MX>IDNEB^+AV=T M-0=%:"'1D@A!3-&OT<]H]3Q'5S]>CUVEDS!2;GH(>-\$#"X$] /TF3.52_3 M,L@^"K@Z^Q8A>$>X#WH5YY#>HM"_08$7!!T)S?Z]N]^33MA6-+1ZX:6*TF\U MS:AZ0U.6H2\J!X%6+ 6AJ\@4!=E5LT8RZI8T;_*=K$@*$T>_JA+$#ISDIQ]\ M[/W2Q?L_B7V@CUKZJ$\]6>J#I^!2=F,VO@/K:\Z771($HW"@?V-W=XQP;AB& MWG 4^5%K^"&]09O>X!_32XG,427XCNK]A]9OZ*J6>D#9-=*'H]GB;-L<+_32 MXVJ"X*/T_'@8Q#@ZY3@W## ._2@>='/@E@/W"SO,*1-\(#')P G!OBD=XJ$<;= ,,68-@+\)F(5WVNK M M$M):V%+?Z!-/"(W1E?+P+)-1',6Q%YUDW!NW>_>CGHT?MT!Q+]!7W:U,R5-2 M446*+H*X8_?CJFMAIH>T" M4EM 10(-&J:S#ZM]<),+L2:.,[936FD_?NT$$F;4F@Y#A@=B.[[G'M\<6+Q*I*O_1NII['GHH*I06?!-L&'"655?ZM"G$3D#8>26 M; )(R;M*5+(<4DT'/2G62-K9!LTVRJ66T88+V[O1\'XZ M0A_':+3X/)E=?QX-T?UB-+Z?HNGDRVB!_AR"IBQ5'WJ^-AEMG!]MT&\J=/(* M.B9H)C*=*#3*8HB_!_ -U9HOV?*](4[$(42G*,0GB 2$./#">OUAB7?V"MZM MX'FA0:+1MX+E1FX:_3,#_@#R7_0?FK&,\8+70R]5P(EO-]65RFD$?<_L&@7R M$;S!'^]Q)_C+P?ZL9G]6HH>OL)]+LSVE?CY!\Y0:ZC2+=Q;%O]["O%F>/ BN.@<82@1;5LP(],?L?.\&\1S)XT9*]B,&DH MDU_5S!O>+^XDA]:]L5$ M- M2_$(EJQR2L2->&B5&T\EI$6)D#:\E#1>2MS?I$>3B#O-(A'2?-*\0^8GEELT M(5%J'[>!7<)+R_%W#ALXR%5YI*)0)(I,5^<.]6A];'-='58TTZLSGQF5*Y8I MDW!I0H/3KG$C61VC5!TM\O+HXD%H+7C93(#&(.T$TH1JLD* QTTS!L/41^I/6[R=Z,]KLDYH$? MX1D%+ Y#1/^[PP$Y]#2HO6_,_N>-H"W0]B1 (B#0"() M'C\R4"U_IPP\?GY'OT^2%\F\((:')/CFK_BVI[4UL,)K% =\3@X/.$NH*?$\ M$K#D/SAD9PT->#'C),R"!8/0C])/])8)<10 [0L!9A9@G@8T+@1868"5))HR M2](:(8[Z74H.@,K3 DT^)-HDT2(;/Y)E=#D5W_HBCO?=X8,S6CXZ8'H/!D^+ M\6C\N%R,GQW@.L/E?+P8.RYP_AD^+D?."-S/IQ,PG$YFR\5@,9X^R2!G,'\: M/_WM@IDS!^[#8.Z WT>8(S]@?X"_ -LBBEE7YX*K?*/N9;SN4E[F!5[0!!,2 M\2T#3K3"JS* +I+,,S7?,[TSE8@C[-T "_X)3,,T*P@-?ST<*NA8N?!6@F== MP!M$W%_Y02Q=#%SLQ=3G/A;IOGE!+#(&:TI","3A+N8H<3Q9 P?1R(\V#,PP M!:Z4%GQ_%,!@S''(_JV2.671J&8A+XE;MD,>[FGB%F"8[K'6__(;M(VO51+5 M!%82K)$+UE"A]Q>$HZ#226FEMQJ*_@^P>$+II7E44)?6YZ:P$HJ MV+D*]J?PLUVG8#6!E01KY8*U/NCGUKE/6ZV.>6KG\V/0LMIVJUEMYW;.JZWD M-<>,4]_CHF2I?9?17FR)IUVY5X5Q>N)K1R]D5+!IN?P^VU]F]UH95%*SHXJ.QW M5&ZWS^]Q:-B&:9U>Y)4'VVWS0H\-BVX)JMNEF?AYCRG-+_)?MK42]NH*U816 M%J%HS6#[<]BZUG:N+K2R:$5#!Y7MC\K6G3.WFHVC_CFC_Y-3*2W]: 838KI) M1E,,>"2.>#JDR'?S\=<@&?J<[-_)L5@RVRE@TIG:!-&-+WYH!G@M((V;EK@N M:#JF2A><[)))SPOAG(3)XQ:C%:;R@/A^30A_7\@7Y,/"_O]02P,$% @ M(#AW5DK,5-T !0 ;AD !D !X;"]W;W)K&UL MM5EK;^(X%/TK%KM:S4BS)79" EV*1-/'(I46E>FN5J/]8(@!JTFPX0ODX7ON/=>^-R=.?\/XLU@1(L%+X(?BHK62,CIOM\5\10(LSEA$ M0G5GP7B I3KER[:(.,%>:A3X;608=CO -&P-^NFU"1_T62Q]&I()!R(. LQ? M+XG/-A/CX#WBX =/1[?WH9N0. M[[^#H>L^/-U_']W?@LG#W<@=74_!ERLB,?4%N,>P&/Q3"YB7_6A.8M#6;]NPS(YA[\2X/\YR',OI6O5! M.D60CC;(Z8I&$0V7@+RHQY*H7Q;.OF\+]4RT$^+^,%,-,F%]A-TBPJXVPD>U M@C"?K]+B]4"::0JNF8NMA#K4S?RTD M5=*&>" 6).E./EV0I W04.)P29,FC(4@]>WJ W 3O*I:J+-T]9;'TD8E;?3! M(^;EPP6OASAXGAM"JQ(NE04\I;2 C6J+IM"JJ2C5!=3+B_^YY/7@T-"L^2-T MR,>\2S4"]7+$)6$H.0/#6+TBL$2-@UO.X@C<24]?"%K<@V>_(;1J%DJ5 ^U3 M%H)60QV0G^A4G^A4^HOU*C^:@JMFHI2?R&]1/KTJK;VW^.A MV;%W7XKU[HZE4\HJI)=5)9T7S"G4$2K5$=)O HV""%.> MKLE4$.?4:AG9>ZH 68YMHMU]%KW+0RFUMW:N \*7Z8:^ &D[R39^BZO%1X-A MNE6^<_T2GKO9UG\)DWV)&&.^I*$ /EDH2./,41QYMKF?G4@6I?OC,R:5E$X/ M5P1[A"<#U/T%8_+M)'%0?&(9_ =02P,$% @ (#AW5N@4976+ P Z1 M !D !X;"]W;W)K&ULM9AM;]I($,>_RLIWJEKI M&C^!L5.PE !-D9HF@J3WHKH7&WLPJ]I>=W>!WK?OKFT,)H[;(/,FV.N9W\[, M_G%F&&XI^\Y7 +]3.*4C[25$-FEKO-@!0GF%S2#5#Y94I9@(6]9I/., 0YS MIR36+<-P] 235/.'^=H]\X=T+6*2PCU#?)TDF/U_#3'=CC13VRW,2;02:D'W MAQF.8 'B,;MG\DZO*"%)(.6$IHC!*)./X44*U:D_E>'B]HW_,DY?)/&$.8QK_2T*Q M&FFNAD)8XG4LYG3[""@UTZV'FB161Y6A,LL#]D=(N8LI8T=9'7)O>6V9!4'>-" M,/F42#_A+\:?II/'SU-T]Q%-9HNKFYOY].;J87;W1:W,IU^G7QZGZ.T$!"8Q M?X?>H\?%!+W]^]U0%W)[!=&#/AO?\CRCYPV&^N8POP8[Q[7[!W:UT/M5 MZ/VVT/U[1L-U(-"W6TB>@#6>4ROAM>?4$:R6K%,EZYQ)JDZ7)>@(5BO!H"K! MX&Q2+PVS5[2WA@6S8< ITS=$L#6C2KMUVWFM/KBM:/7MKG[UU)OV6X*[*T!&M M7H9]DV2>W(#\7L'V,V7V>J[[3, G1(#:DMNW/V9K_^,O)(P$\$?:/KF3:CS4 MCFCUO/>]D]D_E[8[[:FZHM7+L.^JS),[EM]K^P0T:JR!\ZQ!MAW'/6Z/]8.A M,0$6Y;,T1P%=IZ(8P:K5:EZ_RJ?4H_5K-4_P(<(M91%*.8EA*I'$Q MD#&Q8JXN;@3-\M'TB0HYZ.:7*\ A,&4@GR\I%;L;M4'UZX;_"U!+ P04 M" @.'=66,66',4" !H" &0 'AL+W=O$_%GC!G? M#IV6LQ^8T56JS( ;# JRPCFJA^)>Z)Y;46*:(Y.4,Q"8#)U1ZR+LF_EVPG>* M6WG0!N-DR?FCZ4SCH>.9@###2!D"T7\;##'+#$B'\7O'=*HEC?"PO:=?6>_: MRY)(#'GV@\8J'3I?'(@Q(>M,S?CV&G=^NH87\4S:7]B6<[MM!Z*U5#S?B74$ M.67E/WG:[<.!H-4[(O!W O^EH'-$T-X)VM9H&9FU-2&*! /!MR#,;$TS#;LW M5JW=4&9.<:Z$?DJU3@7S\/IR\G!S"7=7$-Y]6\Q&X0)NIJ/Q]&:ZF%[.X62" MBM!,?H8S>)A/X.3CYX&K],I&[T:[5<;E*OZ155H^W'*F4@F7+,;X.<#5(5=Q M^_NXQWXC<8+1.;1;I^![OE\34/AZ>:LAG':UC6W+:Q_AS7"#;(V0")Y#J*T* M?3_U4:H40GN(*.#G:"GM^*^Z#2SYG7J^>9M[7 M.O/_"?9L*SK55G2:Z,&89(1%> I+7%'&*%L!3Z! 07E<9[R15A\KU'DN.5W+ M,;EK$_@=S_,&[J;&3+>:M5WGK-7I;",)D MHB^FXCH?V_M;Y[(1\@:7):=W<#YG#0?4KTST7W?;D,7-]ZR1\P8?[^>41MV# MI*W3P\K6,@D17S-5YL%JM"J7(ULE7HR/=1DMJ]X_3%F#;XG0KZ"$#!.-],[[ M^J:)LJZ5'<4+6QJ67.D<99NI_A1 82;HYPGG:M\Q"U0?%\%?4$L#!!0 ( M " X=U8"9MO")0( % 9 >&PO=V]R:W-H965T[";QQWD?G_?X(VJ$?%(%@$;/):]4C NMZQDA*BN@I&HD:JC,3"YD M2;7IRCU1M02ZUT$>//&.T@IP>N5Z+Y!IV?B>5E@BOW14T;.YYBE!V4%F4G-AF4K&K_]+FK MPT#@CR\(@DX0O%40=@)7.=)FYFS-J:9))$6#I(TV--MPM7%JXX95=A?76II9 M9G0Z62T>%O>;Q1I=S4%3QA6ZIU)26]MK] EMUG-T]?XZ(MJL914DZ[AW+3>X MP)U#-D*A_Q$%7A"^.:A7FB0-H ,Y\+ MH4\=>POZ1R_Y U!+ P04 " @.'=6E(]7UH@" !P!@ &0 'AL+W=O MVT[-_/3D(4(" T[4OCL^^]>\_I7<(]%P]R"Z#08\9R M.;&V2A5CVY;)%C(B3W@!N3Y9-F[I9JO,AAV%!=G M2RN!$ZLEN6E&:0 M2\IS)& ]L:;N. Y,?I5P3V$O.VMDG*PX?S#!93JQ'",(&"3*,!#]V$$,C!DB M+>-WPVFU)0VPNWYB/Z^\:R\K(B'F[ =-U79BG5HHA34IF;KE^PMH_%0"$\YD M]8OV=6Z +9244O&L 6L%&3\]T]L',U"$,GF(CM%R,4,'GP]#6^G"!FXG39&SN@A^H\@,DA/DN4<( M.QCWP../P]WG<%O;;3WCUC.N^+PW^&(!*57HBDN)?DY74@G]9_K59ZOF\?MY M3(.-94$2F%BZ@R2('5C1ET_NP/G:9_(_D3VS[+66O??8HSM!4M!=EP#=D14# MV>>VI@@J"M/]NRAPL8^=T-YU?;Q. 52CM&4Z;E" M\@20GE HY>5*K4NFNSWA9:YZ9=>T@XZ>8^SYHQ>J>[+=ZI_VJ@U9U\*^O M;=IH[ES[$J[><8;N"Q.OTT:#D8]'+SS8G7E@9O$W(C8TEXC!6@.= MDZ%F$/5\JP/%BVI$K+C2 Z=:;O4G 81)T.=KSM538*9.^Y&)_@)02P,$% M @ (#AW5EH../J; @ A08 !D !X;"]W;W)K&ULK55K3]LP%/TK5C9-3&+DU?!:&JE-.PT)&*+ /DS[X"2WC85C9[;3LG\_ MVTE#@;::IGUI_+CWW'-N>D_B%1>/L@10Z*FB3 Z=4JGZW'5E7D*%Y1&O@>F; M.1<55GHK%JZL!>#")E74#3SOV*TP84X2V[,;D<2\490PN!%(-E6%Q>\Q4+X: M.KZS/K@EBU*9 S>):[R &:C[^D;HG=NC%*0")@EG2,!\Z(S\\S0R\3;@@K76O) ML(24T^^D4.70.750 7/<4'7+5U^ATV,)YIQ*^XM6;6P4.2AOI.)5EZP95(2U M3_S4]6$CP3_>D1!T"<'KA,&.A+!+"*W0EIF5-<$*)['@*R1,M$8S"]L;FZW5 M$&;>XDP)?4MTGDI&:?KM_OINAFZGZ?3B832^G!ZBZ^D=.IB PH1*=(V%P*;7 M']$G=#^;H(/W'V-7Z=H&P*J @"EUR*=&/42:5T/_0 MG]L:U>(,MN.8J3V7-1:CO + >DC045O,G4O*%Z2'/>,"7UO.= ECBCL*TC;9G(EC&VLTS\ M$^_D]"QVEYM:][+Y1ZU1KS7:JW6,"^T.F4+PI U4;I41O9$Q&)Q&KT2\#3H[ M"[UGJ2T[=V.B*Q +:W02V6ZV(]*?]EXZLA;RZGRL/;:UQ&>8UJ"OL%@0)A&% MN8;TCDXT)]&:7KM1O+:^D7&E7<@N2_V= &$"]/V<<[7>F +]ER?Y U!+ P04 M " @.'=6N6'6JI0" #!P &0 'AL+W=OS,-J3] M][.3$$%)437M2^+'/F M9^9<9%CIKEC8,A> TQ*44=MSG,C.,&%6W"_'[D30JR[!XO0#* MBX'E6IN!"5DLE1FPXWZ.%S %]9#?"=VS&Y:49, DX0P)F ^L<_=L&)GX,N"1 M0"&WVL@XF7'^;#K7ZE= M>YEA"4-.GTBJE@.K:Z$4YGA%U8075U#["0U?PJDLOZBH8@//0LE**I[58*T@ M(ZSZXY/ES?WMY.?Z&@$"A,JC]$)>IB.T-'G MX[ZM]'(&9"HU3KV2SW^' M[YJM@2DN7M&(R(1RN1* ?IW/I!+Z+/UN\U<1!NV$IK[.9(X3&%BZ@"2(-5CQ MET]NY'QK<_N?R':\^XUW_Q![/,&%/C0*!,%4MCFMX&$)-X6_CGW?Z?DZ[^MM M#RUA0=>-W*")VY$7-/*"@_*>=*6?$':2"[[0YEL5'F1H3Q]JVX:*)]JR$+I! MX+8;"!L#X4$#8\*(KL$4+3A/6^6'>\M&?B\(G3<)W@_S7*?7]=KE18V\Z%\/ MUSU7F+8)CO:VNM=Q_.[;$[$?YG>"P/$[;Q3;6U>4>1Y^8+$@3"(*0P !D !X;"]W;W)K&UL MK9=K;]HP%(;_BI5-4RMU39P;T %2"ZU6:655;],T[8-)#A UB9EMH/WWLYT0 M H2HK?(%8L?G\?O:Q\E)=T79,Y\!"/22Q"GO&3,AYF>FR8,9)(2?TCFD\LZ$ MLH0(V613D\\9D% ');%I6Y9O)B1*C7Y7]]VR?ILU_4J; MEV;&A,. QK^B4,QZ1MM (4S((A9W=/4=X@4TYOH7K;*QKF>@8,$%3?)@ MJ2")TNR?O.0+40K _H$ .P^P=P/< P%.'N!HHYDR;6M(!.EW&5TAID9+FKK0 M:Z.CI9LH5=MX+YB\&\DXT;\>/5V.'G[>_3Y!H\L'=#0$0:*8HQ%AC*@5/D9? MT>/]$!U]/NZ:0LZHXLP@IU]D=/L '=OHAJ9BQM%E&D*X#3"EU$*OO=9[8=<2 MAQ"<(@>?(-NR[0I!@[>'XQHY3K%\CN8YAY8O74(J*'M%?W[(6^A:0,+_5BU4 MQG&K.>JPGO$Y":!GR-/(@2W!Z'_YA'WK6Y7)AF!;EMW"LEM'ETLHH4%$]"F$ M%_D\X<"K'&<83V/4TV39]]J6ZWI=F]6],0;,NT7YCV&\I&OTG+#<&V++<*RZUFLC'#^*4T:[>\ MMK^3C*V]9.QXGGL@%]N%QG:MQLVVK%@D (5TE59);.])Q YNV>W.CLC:V3ZX MWIW"2Z?6RR!>C-& ,#2,>$ 7J:@]6;6L]Z990[ MV]C:O">MALY6#FK(=5.T M;=NE\@ WDKLYIIR\+G8\'^_D;OUT'[5C;^S8;[23TRN]V'M/ 6R[3FOWS54_ MUWN]F*4B+@$VU;4M1_J09?51T5O4S^>Z:MSIOU!UM2X.-YBL*+\A;!JE',4P MD4CKM"4MLJS.S1J"SG6I.*9"%I[Z&ULK59MCYLX$/XK%CV=6FF[O ;(7H*4$JJMU.Y&8;=WTJD?')@D5@%3 MVTEV^^MK \ME$V^:E>X+C&'FF><9VV./=I1]YVL @1[*HN)C8RU$?66:/%M# MB?DEK:&2?Y:4E5C((5N9O&: \R:H+$S'LGRSQ*0RHE'S;<:B$=V(@E0P8XAO MRA*SQP]0T-W8L(VG#W.R6@OUP8Q&-5Y!"N*^GC$Y,GN4G)10<4(KQ& Y-B;V M53Q4_HW#5P([OFN#GL!MO="@-,%..<&N%V VPAMF36RIEC@:,3H#C'E M+=&4T=2FB99J2*5F,15,_B4R3D1I?)U,[S\GZ/8CFLV3V>33%"7_S)*;-$G1 MY&:*;N^NDSF*[^?SY.8.3=(TN4O1VRD(3 K^#KU']^D4O?WCW<@4DHX"-;,N M]8;LHB])5P^DHX#9[[(MX2&(,A6K(&A"><@.)H2GA64;QB@?R<++IA_KL:K->\1IG,#;D;N3 MF!$?[ZQ?>LO76G^)[!GA7+[0KFGT*.N%FA) M*EP@+,M0+HI'I-*0#+A.^TE /5VDD]WB#!H<.?=\:F5N-(*\7Y/U> MT*-L37(Z95]$I-I*F[)'G906RM^C8-N!Y_E^SZ&EJO'S'<>W SW70<]U\$JN MBG^V%-70\ZW2T=@Y<+*J=)+\(TG! MP+*L T4G$[]>4= K"EZCB-.EV&&FG9K@>&HL-QS8!T).YGN]D+ 7$IZUQ:GJ M=#KZX?$T6,/#=77LY-CNT++U.V#8Y'9'95=^:L@H>9#W&2Y7S7^-.=[( M-EZ)KD'KV ^/VHCM!6'H#0X$'/LY3B"W<'B@P-P[?]7=YPMF*[DQ40%+&6E= M!A*"M?>)=B!HW1S)"RKD =^8:WD% Z8)IH$[Y_E(7_0)02P,$% M @ (#AW5D#40-G! @ :@< !D !X;"]W;W)K&ULK55M;]HP$/XKIVR:.JEK7@BAZR 2+]E::66(M-ND:1],YUM8PS19+J0UVV"W) F.4M^6$JYG=H*19@51DC +'><_JNQ?#0/L;A^\9 MKL7.&+22&6-W>G*5]BQ'$\(<$ZD1B/JM<(AYKH$4C3\;3*M)J0-WQUOTST:[ MTC(C HMH:+V&Y,%]8U[X=SX*D$I(5FV#% MH,AH_2?WFSKL!+C!@0!O$^ ]#? /!+0V 2TCM&9F9(V()&&7LS5P[:W0],#4 MQD0K-1G5NQA+KE8S%2?#R32:]*]&$/V<1.,XBJ$_'L&WF\MH"L/;Z30:WT _ MCJ.;&$Y&*$F6"Q@3SHDN_GOX +?Q"$[>ON_:4I'1D':R23RH$WL'$KL>7#,J MEP(BFF+Z&,!6*AHIWE;*P#N*.,+D#%KN*7B.Y^TA-/S_[BM2C=$V&/K&K<+ \5MM)^C:JUWNS_W\3L?OG/N-WR.2 M?D/2/TX2*96<0;]2!XWI384OG%4E?)4I_+K&8H;\]S[>1V%UZ[D0)4FP9ZG> M(I"OT K?O7$#Y].^C7DEL$<5:#<5:!^MP(1C2;(4\%XU1H$""$U5X1P&SW-[KO.Q\^08'DWUTIVR=]I6 M@7QANKF A%54UM>^L38/1M_TR2?V@7I(ZK[_ %._0M>$+S(J(,>Y@G3..DHA MKSM[/9&L-,UQQJ2Z 6:X5(\A,R>U$)VB>U_ ?4$L#!!0 ( " X M=U:L!3)4!00 #(4 9 >&PO=V]R:W-H965T*2;1.HDJ:92V\DV[8Q6J_W@$B=! YBQ3=+^^[&! M\D@(G51$BA(#]Q[.O1R;$P^VE/W@:T($> Z#B ^UM1#QA:YS;TU"S,]I3")Y M94E9B(4\9"N=QXS@19H4!CHR#%L/L1]IHT%Z;L9& YJ(P(_(C &>A"%F+Y]) M0+=##6JO)^[]U5JH$_IH$.,5F1/Q&,^8/-(+E(4?DHC[- *,+(?:);P8(T,E MI!'??++EE3%0I3Q1^D,=7"^&FJ$8D8!X0D%@^;,A8Q($"DGR^)F#:L4]56)U M_(I^E18OBWG"G(QI\-U?B/50;K^0O"!+X7DTX.DWV&:QMJ$! M+^&"AGFR9!#Z4?:+G_-&5!)@[T "RA/0[R:8>8*9%IHQ2\N:8(%' T:W@*EH MB:8&:6_2;%F-'ZG'.!=,7O5EGAC-QU^FD\>;*?AZ!6;W7V?3^X=_P>7=!$S_ M>;R>W4[O'L[ W?0!?)@0@?V ?P2?P.-\ C[\^7&@"TE P>A>?K//VUHZ)VE.*9!_!F3,X&)E[.P"S D0 X6H#I MS\2/I4P%^.]&AH-K04+^?U.I&7:O&5O-O@L>8X\,-3F].&$;HHW^^@/:QM]- MA7<$5FN#6;3!;$,OVI#63U[K/P,K1CEOJCR#LU(XM4QL1J9C(!LZ WU3+6H_ M#AFV93JHB*OQ[15\>ZU\;PCG%^#2\Y(P"; @"SEM95L\'ZN%H8EPAF=7B'R" M%C20:^PP;@I$IE3; B8F9@M[K-\:J"-)'IN/T=W3;$ M0<>$U@'APM*"P-97NWR920^ZIL$"7(+=]^N]"TD/[OBW8]#+D(./"#>TM7 -VV-H.(E M?F.M;4B78ZD'>(=AW>!K06+BSOVP; MANG8!Q1=^A[8;GP*[SNG2['%TE&T"KL5[.BGV1%:O?320\'^*87=J:'J"JV^ M+5 Z*M1J4XX7=HY7_:O;LRS7L796XK?C,L9Z94-'[:;=8K;R(PX"LI2)QKDC M$5BV094="!JG>SQ/5 @:IL,UP0O"5("\OJ14O!ZH;:-BFW#T"U!+ P04 M" @.'=6]%$22L$" !U" &0 'AL+W=OS M'<>\^)G9MHR?B#F %(]%3D5+2LF93EI6V+9 8%%N>L!*J> M3!DOL%13GMFBY(!3 RIRVW.IXTW =P)+ ML3%&6LF$L0<]N4I;EJ,+@AP2J1FPNBV@"WFNB509CRM.JTZI@9OC-?MGHUUI MF6 !79;_(*FPGP]P :*T##"*TJ,[)Z6.(XXFR)N(Y6;'I@O#%H MI890_19O)%=/B<+)>#3^.NJ/;W^B]K"'^M_NKD:#_O#V# W[M^BD!Q*37* A MYAQKNT_11W1WTT,G[T\C6ZKTFL1.5JDZ52IO3RK70P-&Y4R@/DTAW2:P5=UU M\=ZZ^(YWD+$'R3EJN&?([!\IIU%XV#%]CGY=<'2XNG\_0*,=4 M(DQ3U'^HGNKU4XNI)0B%^[S*NX_=W<^C!?BA(GT++4:17 %V#%']ZY MH?-IE_ CD6W9X-!W6 M<'TW].NPK>*"NKC@8'%CD(03FJ%KR'#RC-I"@!3H?@#%!/C.%W.0\*TOYDAD M6]K#6GOX'_=G>$P;CD2V94.SMJ'Y3_NS^6KCN8X;7+@O]N?!)&^58&]\P0O@ MF6EL B5L3F7U/:Q7Z][9-BWCQ7I']=2J!?ZAJ1KR /.,4(%RF"I*Y[RI%/*J MR543R4K3)R9,JJYCAC/U7P!J(3U'\:\6]02P,$% @ (#AW M5ML)&ULM9AK M<^(V%(;_BL;M='9GNK$E#(84F F7[#)-MAD(VP\[_:#8!_"L;5%)P&Y__<1Y:/WU%[P_@WL0"0Z'L81*)C+*11 O20H#$QB60TSI'YD=-O)N2?>;;.5#/P(GC@2JS"D_$!'+/-)\B ZK&>RP*1_$>;]-ZZ;2!W M)20+LV!50>A'Z2_]GDW$3@!NO!) L@!R&/!:AEH64$M T\H2K &5M-OF;(-X M?+=2BP^2N4FB%8T?Q8]Q(KFZZJLXV9WT/PT'TX/=Z-_QP^W_74:#+L M3\>CY]%P@MX-0%(_$._1!S2=#-"[7]^W3:E2QP*FFZ7II6G(*VDP08\LD@N! MAI$'WKZ J6K."R?;PGM$JS@ ]P;5\.^(6(24%-0_/QQKRJGE\UA+]&JOZ'U6 M;]PH6H.0:HW'ARX+ 7U]4+>AD810_%,V::FF7:X9O\&W8DE=Z!CJ%17 UV!T M?_L%-ZP_RH"O)+:';^?XMDZ]VV="HAX5OBC#3&/K26S<5]9=U662O[:YWD70 M)JF(4,\1ZEJ$CYP)@<9 _\_\-!'U0)+85*5Q@Z,*J#5.D31)BM'01J*1D[1 M.(-B&O$MQX,:0RE(XPCD W9P[8!#F^YR#B?G<+0ZIS]$7&JR@C*%YQ-!JVLVF91\0:'-<_B1: M>?$M;?$]%GD"?7V$\ 5X:1?3QE_:Q:XDMH>*K>)K:+U!&\]$KS0#UU+;GX(= M0X#_1RO/@O?:'R&U.JDW#Y:K/DU5#%)@D*NT\TSF9#_7IZN*4]@+K/U\7]+7 M,Z53C5V?L"I081BPWC& SE7,ZO#YA5:#"/F"]?] W>7QL&XC5M*T&.:2H M8!Q.4Q3V >O]PW2"GM4:$RO^ TW 77%?^J!O_WK%B[O?E=3V^0O;@9VW^ !< MR5UD4_ 67@479@7KW2R5233G8W\;+X%=I=L_!R<[^';?KJ15,H M1IYN5:4#R9;);L\+DY*%R>$"J <\OD%=GS$FMX,X0;YAV/T)4$L#!!0 ( M " X=U8\@0$_O00 +X; 9 >&PO=V]R:W-H965T8AE:OHZ^->*_#UM*G(1EQ(-9!@/G+ M-?'9MFM!Z_7" UTL973![G56>$'&1#ZN1ER=V8G*C 8D%)2%@)-YU_H(K_JH M%07H)[Y1LA698Q!9F3#V%)U\FG4M)ZJ(^&0J(PFL_C:D3WP_4E)U/,>B5I(S M"LP>OZK?://*S 0+TF?^/W0FEUVK98$9F>.U+Q_8]I;$AAJ1WI3Y0O^";?RL M8X'I6D@6Q,&J@H"&NW_\(VZ(3 "L'PE <0 Z-<"- UQM=%>9MC7 $O3J+E5QLC?NWPX'CW=#\.4&C#[^>S_\_%4?/@QO MA@\/PP$8?_W2_QN\&Q")J2_>@P_@<3P [WY_W[&ERA^IV-,XU_4N%SJ2:T"F M->#"/P%R$#H0WC\]'.;#;>4ZL8X2ZTCKU8_H]5FX(5S2B4_ 2 T>PCF9@;%D MTRZPE?"P$8//8_/<[=1]\DB00!WV[5?JN2"SGNY[XKAM'P.=U MU+?:^&M_%P>"6OF$Q.&,A@N =1NI8:B'A&DD7^_R>CIOM))N>JV.O7;(Z4BB*J$ 5@I!56EEO>>5LIYD SYYR/!K%@;BO=6X',6UBX1@ MSEO65TH]T(P])2 A5LQ1@M>H[:VTEV ?F,(/---/9: 0Y\E-$P?M#<]+0!%, MJ0B:L>@7L4)E&(/,F//2;#@ MF=\:5(0[\6N#2\ 32N$)P2IA 54*2E6IY;UG7A^9WQ]=#A;BQ-GUK>$4)H+Y MF;REE'^0F7_.!X58,#MIF\7]U)RT;#^E](/,]',V)Z!]^'$]9Z\#+D$_**4? M9*:?$I00*V8I =4:15N7@!^4P@\Z^9W/SS%"G"?'"/7Z7B=>@HA02D3(3$2_ MB!'B*MY@!'.M9=LBY25DYJ63&"'6R$[-1KU9-%(I[-B9CRO1EZU[S!$1P^H^W/&Y.M)] DG^637^Q]0 M2P,$% @ (#AW5NA0R=_. P Y@X !D !X;"]W;W)K&ULK5=M;^(X$/XK5NZTNI-N2>Q 2'N 1"E[6VE?*MIN=5K=!S<9 M(-HD9FT#Y=^O[8000I)=VN,#B9V9Q\\S?AG/8,OX-[$$D.@YB5,QM)92KBYM M6P1+2*CHL!6DZLN<\81*U>0+6ZPXT- X);%-',>S$QJEUFA@^F[Y:,#6,HY2 MN.5(K).$\MT5Q&P[M+"U[YA%BZ74'?9HL*(+N /YL+KEJF47*&&40"HBEB(. M\Z$UQI<3W-,.QN)+!%M1>D=:RA-CWW3C)AQ:CF8$,0120U#UV, $XE@C*1[? M"7FB0J8L/@Q"N5R:/D6"F%.U[&U[R 49@@&+A?E' MV\RV1RP4K(5D2>ZL&"11FCWI3Z\?/DS1YW?H<3R;C3_= MH_'D_N;+S?V_Z(]KD#2*Q9_H+?H=V4@L*0P([7=0FVW#7UT9Y8!>E!SR>-=E"[0(^6:R7^:#8UA&B\ :X.*31]!AY$ M M MCP+X&?L,W"^QZG?.>)F($^KO4T3-0FT\MO M36/T(9I#G8AV<()V0+E +DJR#4LP"NFN;L]/?@T).WLH[-9 '86@7X2@_](% M^(]^5(^83'DKYKG[KW^Z0OV^V\>X?G+]0IG_JA7:(J\5^%QY?LU2)PV[[Z+0 M=O'26=NKK!76BGJNL(N3>7N+7:]+ZJ5AYY!&G5=-7*O"=NQS)>9HE7/*;5!8 MNBC@ET_?*N(-TO!IP(GO.)53L\X,DQXAGM/ FQQXDU?.3#-YEZSDG2K3<\RL['Y _W M!=Q^87AEWLW1*PNZRK[6J-] _7!CP&=>&<[+MC]!QR9)EK)MKS';MB.=>^.S M2Q5# GQA"BF! K9.978++WJ+8FUL2I1*_Y4NXDPE5VJ0A2X-E#?YXS)?4,/4)2VHQ]02P,$% M @ (#AW5G!/!J7R-@ BRH$ !D !X;"]W;W)K&ULQ=UI<]O(H>[Q]_X4*&=.:J;*(Y/@GEFJ)H/&WD CSE*W3MT7L 1)3"A2 M 4E[?"H?_@(4*2RDFH3/?W3G14++Q*])47Z$I1_TCY]7^;_6]UFV,7Y[6"S7 M/[V]WVP>__3^_?KZ/GM(UU>KQVQ9_,WM*G](-\4?\[OWZ\<\2V]V&STLWIN] MWOC]0SI?OOWYQ]W75/[SCZOM9C%?9BHWUMN'AS3_\N=LL?K\T]O^V\,7_C*_ MN]^47WC_\X^/Z5WV(=O\[5'EQ9_>/RLW\X=LN9ZOED:>W?[T]I?^GQ*S9Y9; M[)[R]WGV>5U[;)3OY>-J]:_R#][-3V][Y4O*%MGUIC32XO\^9;]FBT5)%2_D MWWOU[?.@Y8;UQP?=WKW[XMU\3-?9KZO%/^8WF_N?WD[?&C?9;;I=;/ZR^NQF M^WP<-\^?3_Z6_[[T1M@_[PA0W, M_09F:X,71QCL-QA<.L)PO\'PTA%&^PU&[1%&+VPPWF\POG2$R7Z#R:4;3/<; M3"]]T[/]!K-+1^CW#I]<[]*WW7_^L(\^[1;'=YN&=_4 .^+;]OS]\X\?._^ M;&I%._MX9?3Z[XPBA,T3+^A7_>8RS:^,_F2W>?_$YM8%HYO#%S<7%VS>[[^X MN:W?W$^7Q>BC%S=W])M'JT_%YN9N\]Z)S5W]YA^RQ^?13VWNG7GQVT6Q>?_% MS?U+/O>71P\N^>"F+W[K0OWF5G9]90Q>?O'R\LU/_=!&EV]^ZL7'EWSG7_[< MU06;]Z8O;IZW/3FW>"(#!^7Z^OMPW:1;K(;(][<9[GQ MZ^JAV!F\+_?2/F6&M[Q>/63&M^%JO?[.^.^PV-SP-MG#^O^>>.U_?AIK>'JL MF2"R!L$:ZC9[3;:1-M_CV-LOGRSOC,9]?GPPU[?9=0XW$ M+!(3)&:3F$-B+HEY).:36$!B(8G))VS:2*OIL!5IY(@QB2D22R"L$7SCY^ ; M:X/OPWU:H,9\O=X61\FWJ]S(?LORZ_FZ^--N7\]8/9:7(]:G,E%+=\U$$K-( M3)"836(.B;DDYI&83V(!B84D)DDL>L)&M8#MCWKCV6S6VA\D!U4DED!8(Q8G MS[$XT<:BRK-BAS _A. [8_V4D^EV<[_*Y_]S\@K'G[5FUSPD,8O$!(G9).:0 MF$MB'HGY)!:06$AB\@D;UR+,[#W]U]I/O/2),?GR%(DE$-8(N^ESV$VU8?>/ M\@+RMTZN>.:O_ MU\P<>;S%Y&K0"K"3SYFTPHM\'XK$$@AKA-?L.;QFEX37VEAM-^M-NKR9+^]. M19=6Z1I=)&:1F" QF\0<$G-)S",QG\0"$@MG1WM)@U&OW^NWSKK)X^>-^[UQ MSVR'ULGG3:?MY\7DFU DED!8([?ZO>?@*F=V-L^4ZW1>:YPQ,X>]OMG: MH8M./'$R&HW-J=D*/O3U*51+**V9?;5IS7U]]F7Y/%L;KE&=:/NPN]KPWS)[ M^)CE)V?@Z:CFHUJ :B&J252+4"U&-85J M":4UX[6JC_2U$ZK;%X&+_]TE[8OSGO5NK+[_< MW>7979&NAU)@NKRI3ZX\5&$>L_PZ6V[2N].'^F@7!M4L5!.H9J.:@VHNJGFH MYJ-:@&HAJLF]UN_7CO5[5[VCB><1.FR,:@K5$DIK)F95G^GK^S.'@_WO!]VF M,Z%M&E2S4$V@FHUJ#JJYJ.:AFH]J :J%J"91+4*U&-44JB64ULS1JLG3G[WF M@3W:^$$U"]4$JMFHYJ":BVH>JOFH%J!:B&H2U2)4BU%-H5I":JOFH%J!:B&H2 MU2)4BU%-H5I":'39&-85J":4U$[-J+Q4/+SK<'QOU(E.7*_?Z$3K'):E9J"90 MS48U!]5<5/-0S4>U -5"5).H%J%:C&H*U1)*:V9J57J\:3J5^DI_.5>[33A&H6 MJ@E4LU'-0347U3Q4\\WCQ68FK9MA!NB((:I)5(M0+48UA6H)I35CL6HJF?JF MTE??AT3O=LY'M)R$:@+5;%1S4,U%-0_5_+U6OSO'X&K<#DBT[1QZ:-T(U02JV:CFH)J+:AZJ^7NMOC[$ MZ'A)K@ =-$0UB6H1JL6HIE MH;1F/E8](E._)-!1/A[M'-YDZ^M\OEO8]F14 MHM4A5+-03:":C6H.JKFHYJ&:?^;G6:37]T^_XXW5K5&[?MF^9CE?[W_4=\=$ M;]*-D2Z_&)OY0V84CS?WV7XQYY(I_W2_6MQD>?DPSU:W[XICILW*2(WEMKSR M63YIOV-1/+I>/3P4&^Z7A'[:O#S'7PYPDVVR_*%XT3?&Q^)/\T_SWELU=_+LU7E$\JOSY?SS3Q='/_++.AOBEW+7CEAY6GX=\;G^WGQ#?B< MKLM-E\;M-M]=8BC>]_:Z@(O7_(UY->H9V^7^W11O>S/__F:^V.[>;7KSS^UZ M\Y M-V\>\]6G>3EJ"90 MS48U!]5<5/-0S=]K9R?I!^BP(:I)5(M0+48UA6H)I343LRIP#?0%KE^?3JR= M+QWHGRWXJC]OGZN8;P=#%Y?9A_=C)5T2H7JEFH)E#-1C4' MU5Q4\U#-1[4 U4)4DU^C&2<#=70\3V\TZO5:RZO&Z,M7J)906C,JJW[60-_/ MNC@J3T8D6M9"-0O5!*K9J.:@FHMJ'JKYJ!:@6HAJ$M6BP7');31J9R1:UD*U MA-*:&5F5M0;ZLM9+JOFH%J!:B&H2U2)4 MBU%-H5I":'N*H^+^>;=N8Z8GNPJOFH%J!:B&KRS#_6OSVNEF^N%ZMU.9UPWT2367Z7Y>\:K;1TO=X^ ME/6PXFL?]OV:=[M5/LHYB675YK%U6Z4"L_+5XZ]I(15[5%>'YEGQFA^SZTVY MH]7NJZW?W*?%ES]FV:%F]E1(*^3%KEQ6OKCTBV'VS)ZQ6F;?WZ[R[V]+*3]D M3IDVIWIF$?I=C5%-H5I":8WX'U;MJV&GA;$NO)^"'NWZ"P#5+%03J&:CFH-J M+JIYJ.:C6H!J(:K)O5:_(C4=3LQ1^]X1$3ILC&H*U1)*:R9DU9H:ZI?(^K7Z MM5>VPI]VDU^\Z*_'.BK, ]H-1\4IJ%JH)5+-1S4$U%]4\5/-1 M+4"U$-4DJD6H%J.:0K6$TIKQ6A6>AOK"D\I7UUEVLS9N\]6#L4X76?O&ER=C M%&TXH9J%:@+5[+U6GTYM]I[^:QZJ.>BX+JIY)]Y%?]0_OE3AH\,&J!:BFD2U M"-5B5%.HEE!:,_VJ#M,0ZC#IZI[Z,3J'(=IE0C6!:C:J.:CFHIJ':CZJ!:@6 MHII$M6BOG>U\HJ,J5$LHK9F759]IJ.\S_:\ZGWJ[:CFHUJPUQH[O2=VW$-T5(EJT:GW,.J-CV[Y%Z/#*E1+**T9@54K::A?A^H? M:9ZGR\VZG/#Z>+BV<_9X&2T?H9J%:@+5[.'QSS1\YJWZ%RO:[\Z> M[/+HWON*A_A"-5U*S4$V@FHUJ#JJYJ.:AFH]J :J% MJ"91+4*U&-44JB64UHS7JNE[?//-$!WUY+JIY%[Y9 M'QTU0+40U22J1:@6HYI"M832FE%6=7-&^FY.?'N;Y>7MH5^C=GP=MR'&[>!"RS*HYIUX^:-V9J$-&%0+44VB6H1J,:HI5$LH MK9E959EFI"_3?-W=)_1HYQQ#VS2H)O9:_=_XL#\MCU"G[3!#E^E!-1?5/%3S M42U M1#5)*I%J!:CFD*UA-*:$5F5;D;ZTLWS;EWVVV.V7)^^!87>Z)R(:-\& MU<1>JR?B8# ;]D;#=B"B2^Z@FHMJ'JKYJ!:@6HAJ$M4B5(M13:%:0FF-0!Q7 ME9OQF85K#K-P3DY;/+. F=[N&I1G7NFW\^^,=;98&-O'LBT^^J_=Y9?M]?W3 MKNW]:G&3Y7_\P]3L3WY8ORG_6.3\VI@OZTLZ'?Z^L5=L% _*Y9XV>5IN8]RD M7XQO/\\W]T]\,=)B_C#?I.6WH1SZ8V8\9.EZ6R[WDZX/"TC=I)O==S%+RY=4 M['Q_]Z9<)>K;>?&ZT\6B^&#*.WQLESNKO,-'\93GC;4OK]RN?'U/6SRD-YF1 M;HQO^N69->,QRY\^+:-XUEV>%:\B/[46E(5^6.+,AR7*;\)ATFMN?"Z^3>EB MO2I>8+HLWWRZW-_;I%[\?U=^$,6[^)@5[SA[8V;\HF3IY^9\F\:V\PWU?S<\CM;/F&^ M+ 9*%X=5PMX9N\_ 2.^*;_'=_I,>O!OT>N]ZO?[^Q;PK-RZ>U&STEL_\IM^_ M&M4^JU,?D(U^0 ZJN:CFH9J/:@&JA:@F42U"M1C5%*HEE-;\'5OUKL;ZI8^ M2:^7=E[UKZ3S;V2TE(5J M5L5'-0S44U#]5\5 M0+40UB6H1JL6HIE MH;1F M]II5]CX5&EYG(NP8;6JAFH5J M5L5'-0S44U#]5\5 M0+40UB6H1JL6HIE M MH;1FO%9]KK&^S]5A(JQ>ZIR=:$<+U<1>:[0U!ZE-M$R% M:A:J"52S4JY_,[@_&0[.U4!,ZJ$2U"-5B5%.H MEE!:,RZK MI87T#ST^5NPJ;9,_O&\SG0VC'^92<#3H8HVE)#-0O5!*K9J.:@ MFHMJ'JKYJ!:@6HAJ$M4B5(M13:%:0FG-K*V:;./9:Q[YHY4W5+-03:":C6H. MJKFHYJ&:CVH!JH6H)E$M0K48U12J)936B-=)U8N;Z M,'28VZ:6NV8EJ%JH) M5+/W6G.:U*GU2-%A753S4,U'M0#50E23J!:A6HQJ"M422FO&8E5EFNBK3)U -5"5).H%J%: MC&H*U1)*:\9KU6DJ'E)G1+52Y^PD-0O5!*K9>^V",Z+DL"ZJ>:CFHUJ :B&J M252+4"U&-85J":4U8['J-TWT_:8.:Y[HIK M%$7R#ZNB59]&CG;$0; M0Z@F4,V>'"_B9/9V_QT=0*-M(%3S4,U'M0#50E23J!:A6HQJ"M422FM&9%4: MFNA+0Q#@=MU>\C7J/I+MMX41\WE9>P/NXZY=A806MQ!-0O5!*K9 MJ.:@FHMJ'JKYJ!:@6HAJ$M4B5(M13:%:0FF-])Q6Q9UI[Q5G 4W1;@^J6:@F M4,U&-0?57%3S4,U'M0#50E23J!:A6HQJ"M422FO&:U4 FNH+0$>S@,I%B4[/ M M)+G;,3;0"AFD U&]4<5'-1S4,U']4"5 M13>ZUQCRQR7 \;5T(C$X\K]\? M3:>SULR)&'UY"M422FL&GED%GK[>\^+1N/$?PYKGV?6Y)=GT?N<81'LZJ"90 MS48U!]5<5/-0S4>U -5"5).H%J%:C&H*U1)*:R9JU=.9OF9/9XKV=%#-0C6! M:C:J.:CFHIJ':CZJ!:@6HII$M0C58E13J)906C->JYY.\?"R(_2\VG5]^>[$ M>ZU^C# NYS>OK#:@+5;%1S4,U%-0_5?%0+ M4"U$-8EJ$:K%J*90+:&T9JJ:5:J:KWC19H;V@5#-0C6!:C:J.:CFHIJ':CZJ M!:@6HII$M0C58E13J)906C->JS[03#LA_N?ZCNF[P\IG'[8?U]?Y_&,1N1^W M&^-ORY=7F]#SG0,5;0"AFD U&]4<5'-1S4,U']4"5 M13:):M-<:5UL'1Y<] M8W10A6H)I363LJKV% ^UEWJRO%Q%TOU^8.P7XM4O$:GG.B.U*A;-],6B7U?+3UF^GA='\[OY M2,9CD;"[2_4GXQ,M!Z&:A6H"U6Q4,1+?>@FD U M&]4<5'-1S4,U']4"5 M13>ZU^HE(<]H^#QFA8\:HIE MH;1F.E:EG9F^M+-/ M1R/[+1>.[O'B)9Z M4$VA6D)IS4RL2CTS?:GG>8]QM=VL-^GR9KZ\.YF(Z/(_J&:AFD U&]4<5'-1 MS4,U']4"5 M13>ZU<;MF),M9+"=8SF8YA^5Y@.5"EI/G_O&.C"]9FI^Z"4/$ MOI*8Y13+)1C7BM%^+4;U%:$/679SV>RA,U+WX$2;0"PG6,YF.8?E7);S6,YG MN8#E0I:3+!>Q7,QRBN42C&N%J5D+T]=L!AU&PP(7[0:QG& YF^4\;]\7#2.F7*CANSG&*Y!.-:B3FL)>80NKI^1NH> MDR1GL9Q@.9OE')9S6N.:]$0>#HY D1XU93K%<@G&MD!S5 M0E*_,M"EE]O/.-TC$NW\L)Q@.9OE')9S6N.9MN:>]WN@H M)-%B#\LIEDLPKA62XUI(ZML]'Y[:Y]ZE5X_0>@_+62PG6,YF.8?E7);S6,YG MN8#E0I:3+!>Q7,QRBN42C&L%ZJ06J*^Y&-!A-"QPT<80RPF6LUG.83F7Y3R6 M\UDN8+F0Y23+12P7LYQBN03C6H$[K07N14VCKE>/T-81RUDL)UC.9CF'Y5R6 M\UC.9[F Y4*6DP>NL2C6<#QH%Y#886.64RR78%PK,&>UP+RHAG31Q2.TB<1R M%LL)EK-9SF$YE^4\EO-9+F"YD.7D@1O54G(\.XI(M)/$KK.T?/&7F3E3=U?]S,5\O3&7GU8?[=F\U]9GQ:+;;%'S]G9?.Z7'/Q4Y:G M=_LC0N/;/_YA:IJ]'_[^CU_4[F'_A^_*)1O++1L+CV6_76?9S=KXIC^87O5Z MQNTJ-Y:KC;'(UNOBV>ERM\E#L1^5;E;YE^K(\R%+U]N\V+EZ\YCE\]7-#\4K MFW^W>_9-.E]\>7Y!R^?U(O>+1!:/&B]ADZAC.R?V_318'E MA[?PQAR]Z_5Z/^SZZ,5K*5[,UWE[?%Z]^D[TK7\;R\-UZ++_YQ8M?+(J-/F6[+^\*[^5YR[P< M(7_ZXOUJ<9/E;XJO/K_NS(MG;Y>'C6]VGT9J M7*?K^V?QZO0O1K9FAG**Y1*,:_W^-&N_/[6]BN?3,$?_^"XX+Z.GN_]*93ME M*"=8SF8YA^5Y@.5"EI,'KGY>IOC]UCXQ@PX:LYQBN03C6J%9JXKU M]56Q#X?%4H873EC3>]V3DFV)H9Q@.9OE')9S6RG,=R M/LL%+!>RG#QP]2D3@\EP='2# W38F.44RR48U\K(6M6LKU^!ZI?E9O[]S7RQ MW=06Y\M7F^QZ<^%J?6=&Z)Z>;+T,Y03+V2SGL)S+]CL16SU#.8CG!Z MIR3;64,YP7(VRSDLY[*>%R5>=N?*!WNFRG,=R/LL%+!>RG#SW MC]6[?=.Z\<&N-U_>TD!_*X/9U]W(P#A](X,WKWTC ^/4C0S>_'^XD8%Q?".# M-R_?R,!';F2 _HC%+*=8+L&XUN_#6H&L>*S[)R;V/W&?]Z=7+IEWIB>[_VHD M.8OE!,O9+.>PG,MR'LOY+!>P7,AR\L#5SZ\,CY;;0<>,64ZQ7()QK:RL=;], M???KP^'^!:,+YYWIO>Y!R3; 4$ZPG,UR#LNY+.>QG,]R SG,-R+LMY+.>S7,!R(WXU?2U]?%S,K]./B_92(\:WZ^W'?V;7 MNYE[*^.7EU^U\3E=&YM\?G>7E7/)BE>Z76S* M)7YV[W3_Q.(O6F,_Z\9MOGHPOAE'T[ M]6E"6[HP^I/!N]ZL?YB.M)NWMWGZWC^-6+[S7*68N[286-XP%CD^4/IW_?L7T]E+-83K"Q7,QRBN42C&NE M;*T'.!B\YL2S =L61#F+Y03+V2SGL)S+R_DL%[!M^?+\OZ4E]V'2P]V3TNV=89R@N5LEG-8SF4YC^5\ ME@M8+F0YR7(1R\4LIU@NP;AFI@YKW;1A[S5/B0[9!AO*62PG6,YF.8?E7);S M6,YGN8#E0I:3+!>Q7,QRBN42C&L%;JTL-;RP+-7I/EQZM'NNLDTIE!,L9[.< MPW(NRWDLY[-ZIR3;?D(YP7(VRSDLY[*N;G;N/EQZIWM$LGTEE!,L9[.5=E?AU:)X=;O[AOUR5_[O99?C M]7+W(&4;2B@G6,YF.8?E7);S6,YGN8#E0I:3+!>Q7,QRBN42C&N%:ZVA-'S5 MAM*0;2BAG,5R@N5LEG-8SF4YC^5\E@M8+F0YR7(1R\4LIU@NP;A6X-8:2L/? M8UDL/=H]5]FR$LH)EK-9SF$YE^4\EO-9+F"Y\, UILV;XUZOUSSO*=EQ(Y:+ M64ZQ7'+!-[F5A;4FTA!;\$HO=0] MH:$M4BTH@M(J&RG,=R/LL%+!>RG#QP]7-\D_YDTFO/'T6'C5E.7?@N$FS85A*:M23$ M&D9ZJ7O\L0TCE!,L9[.6D4:UC--)WC/;G/;]NZJ?>[AZ<;.\(Y03+V2SGL)S+Q7,QRBN42C&L%;JW(--(7F;[R!"C;84(YB^4$R]DLY["R_DL M%[!PG,MR'LOY+!>P7,ARDN4BEHL/7&OZ^V1TE)+LR MG,=R/LL%+!>RG&2YB.5BEE,LEV!<*U!K+:3B\2M>.MJ/A@4NR5DL)UC.9CF' MY5R6\UC.9[F Y4*6DRP7L5S,K1[KK(M))03+&>S MG,-R[H&K7S<8] ?#5F7$8X?U62Y@N9#EY(7?XX@=-F8YQ7()QK62L-9!&F,= M)+W4/?[8#A+*"9:S6SG&*Y M!.-:(5EK((TO:B 5(?DXS]/-O-A+O,G6U_G\L7Q\.BS9[A'*62PG6,YF.8?E MW',_*W^]SXSC$^3S]9OYPT-V,T\WV>++X;=M^G&1[:Y%[GZPLK51_&!5VYJC M=X;9,T=7IX_=V]0='>ZUL(0GE I8+64ZR7,1R,

  •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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 86 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 87 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 246 342 1 false 102 0 false 4 false false R1.htm 00000001 - Document - Cover Sheet http://ayro.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Consolidated Balance Sheets Sheet http://ayro.com/role/BalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://ayro.com/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Consolidated Statements of Operations Sheet http://ayro.com/role/StatementsOfOperations Consolidated Statements of Operations Statements 4 false false R5.htm 00000005 - Statement - Consolidated Statements of Changes in Stockholders' Equity Sheet http://ayro.com/role/StatementsOfChangesInStockholdersEquity Consolidated Statements of Changes in Stockholders' Equity Statements 5 false false R6.htm 00000006 - Statement - Consolidated Statements of Cash Flows Sheet http://ayro.com/role/StatementsOfCashFlows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 00000007 - Disclosure - ORGANIZATION AND NATURE OF OPERATIONS Sheet http://ayro.com/role/OrganizationAndNatureOfOperations ORGANIZATION AND NATURE OF OPERATIONS Notes 7 false false R8.htm 00000008 - Disclosure - LIQUIDITY AND OTHER UNCERTAINTIES Sheet http://ayro.com/role/LiquidityAndOtherUncertainties LIQUIDITY AND OTHER UNCERTAINTIES Notes 8 false false R9.htm 00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://ayro.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 9 false false R10.htm 00000010 - Disclosure - REVENUES Sheet http://ayro.com/role/Revenues REVENUES Notes 10 false false R11.htm 00000011 - Disclosure - ACCOUNTS RECEIVABLE, NET Sheet http://ayro.com/role/AccountsReceivableNet ACCOUNTS RECEIVABLE, NET Notes 11 false false R12.htm 00000012 - Disclosure - INVENTORY, NET Sheet http://ayro.com/role/InventoryNet INVENTORY, NET Notes 12 false false R13.htm 00000013 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS Sheet http://ayro.com/role/PrepaidExpensesAndOtherCurrentAssets PREPAID EXPENSES AND OTHER CURRENT ASSETS Notes 13 false false R14.htm 00000014 - Disclosure - PROPERTY AND EQUIPMENT, NET Sheet http://ayro.com/role/PropertyAndEquipmentNet PROPERTY AND EQUIPMENT, NET Notes 14 false false R15.htm 00000015 - Disclosure - MARKETABLE SECURITIES Sheet http://ayro.com/role/MarketableSecurities MARKETABLE SECURITIES Notes 15 false false R16.htm 00000016 - Disclosure - STOCKHOLDERS??? EQUITY Sheet http://ayro.com/role/StockholdersEquity STOCKHOLDERS??? EQUITY Notes 16 false false R17.htm 00000017 - Disclosure - STOCK BASED COMPENSATION Sheet http://ayro.com/role/StockBasedCompensation STOCK BASED COMPENSATION Notes 17 false false R18.htm 00000018 - Disclosure - CONCENTRATIONS AND CREDIT RISK Sheet http://ayro.com/role/ConcentrationsAndCreditRisk CONCENTRATIONS AND CREDIT RISK Notes 18 false false R19.htm 00000019 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://ayro.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 19 false false R20.htm 00000020 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://ayro.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 20 false false R21.htm 00000021 - Disclosure - INCOME TAXES Sheet http://ayro.com/role/IncomeTaxes INCOME TAXES Notes 21 false false R22.htm 00000022 - Disclosure - SUBSEQUENT EVENTS Sheet http://ayro.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 22 false false R23.htm 00000023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://ayro.com/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 23 false false R24.htm 00000024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://ayro.com/role/SummaryOfSignificantAccountingPoliciesTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://ayro.com/role/SummaryOfSignificantAccountingPolicies 24 false false R25.htm 00000025 - Disclosure - REVENUES (Tables) Sheet http://ayro.com/role/RevenuesTables REVENUES (Tables) Tables http://ayro.com/role/Revenues 25 false false R26.htm 00000026 - Disclosure - ACCOUNTS RECEIVABLE, NET (Tables) Sheet http://ayro.com/role/AccountsReceivableNetTables ACCOUNTS RECEIVABLE, NET (Tables) Tables http://ayro.com/role/AccountsReceivableNet 26 false false R27.htm 00000027 - Disclosure - INVENTORY, NET (Tables) Sheet http://ayro.com/role/InventoryNetTables INVENTORY, NET (Tables) Tables http://ayro.com/role/InventoryNet 27 false false R28.htm 00000028 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS (Tables) Sheet http://ayro.com/role/PrepaidExpensesAndOtherCurrentAssetsTables PREPAID EXPENSES AND OTHER CURRENT ASSETS (Tables) Tables http://ayro.com/role/PrepaidExpensesAndOtherCurrentAssets 28 false false R29.htm 00000029 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables) Sheet http://ayro.com/role/PropertyAndEquipmentNetTables PROPERTY AND EQUIPMENT, NET (Tables) Tables http://ayro.com/role/PropertyAndEquipmentNet 29 false false R30.htm 00000030 - Disclosure - MARKETABLE SECURITIES (Tables) Sheet http://ayro.com/role/MarketableSecuritiesTables MARKETABLE SECURITIES (Tables) Tables http://ayro.com/role/MarketableSecurities 30 false false R31.htm 00000031 - Disclosure - STOCKHOLDERS??? EQUITY (Tables) Sheet http://ayro.com/role/StockholdersEquityTables STOCKHOLDERS??? EQUITY (Tables) Tables http://ayro.com/role/StockholdersEquity 31 false false R32.htm 00000032 - Disclosure - STOCK BASED COMPENSATION (Tables) Sheet http://ayro.com/role/StockBasedCompensationTables STOCK BASED COMPENSATION (Tables) Tables http://ayro.com/role/StockBasedCompensation 32 false false R33.htm 00000033 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables) Sheet http://ayro.com/role/CommitmentsAndContingenciesTables COMMITMENTS AND CONTINGENCIES (Tables) Tables http://ayro.com/role/CommitmentsAndContingencies 33 false false R34.htm 00000034 - Disclosure - INCOME TAXES (Tables) Sheet http://ayro.com/role/IncomeTaxesTables INCOME TAXES (Tables) Tables http://ayro.com/role/IncomeTaxes 34 false false R35.htm 00000035 - Disclosure - LIQUIDITY AND OTHER UNCERTAINTIES (Details Narrative) Sheet http://ayro.com/role/LiquidityAndOtherUncertaintiesDetailsNarrative LIQUIDITY AND OTHER UNCERTAINTIES (Details Narrative) Details http://ayro.com/role/LiquidityAndOtherUncertainties 35 false false R36.htm 00000036 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIVES (Details) Sheet http://ayro.com/role/ScheduleOfEstimatedUsefulLivesDetails SCHEDULE OF ESTIMATED USEFUL LIVES (Details) Details 36 false false R37.htm 00000037 - Disclosure - SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE (Details) Sheet http://ayro.com/role/ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE (Details) Details 37 false false R38.htm 00000038 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://ayro.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Details http://ayro.com/role/SummaryOfSignificantAccountingPoliciesTables 38 false false R39.htm 00000039 - Disclosure - SCHEDULE OF DISAGGREGATION OF REVENUE (Details) Sheet http://ayro.com/role/ScheduleOfDisaggregationOfRevenueDetails SCHEDULE OF DISAGGREGATION OF REVENUE (Details) Details 39 false false R40.htm 00000040 - Disclosure - SCHEDULE OF CONTRACT LIABILITIES (Details) Sheet http://ayro.com/role/ScheduleOfContractLiabilitiesDetails SCHEDULE OF CONTRACT LIABILITIES (Details) Details 40 false false R41.htm 00000041 - Disclosure - REVENUES (Details Narrative) Sheet http://ayro.com/role/RevenuesDetailsNarrative REVENUES (Details Narrative) Details http://ayro.com/role/RevenuesTables 41 false false R42.htm 00000042 - Disclosure - SCHEDULE OF ACCOUNTS RECEIVABLE (Details) Sheet http://ayro.com/role/ScheduleOfAccountsReceivableDetails SCHEDULE OF ACCOUNTS RECEIVABLE (Details) Details 42 false false R43.htm 00000043 - Disclosure - ACCOUNTS RECEIVABLE, NET (Details Narrative) Sheet http://ayro.com/role/AccountsReceivableNetDetailsNarrative ACCOUNTS RECEIVABLE, NET (Details Narrative) Details http://ayro.com/role/AccountsReceivableNetTables 43 false false R44.htm 00000044 - Disclosure - SCHEDULE OF INVENTORY (Details) Sheet http://ayro.com/role/ScheduleOfInventoryDetails SCHEDULE OF INVENTORY (Details) Details 44 false false R45.htm 00000045 - Disclosure - INVENTORY, NET (Details Narrative) Sheet http://ayro.com/role/InventoryNetDetailsNarrative INVENTORY, NET (Details Narrative) Details http://ayro.com/role/InventoryNetTables 45 false false R46.htm 00000046 - Disclosure - SCHEDULE OF PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details) Sheet http://ayro.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails SCHEDULE OF PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details) Details 46 false false R47.htm 00000047 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details Narrative) Sheet http://ayro.com/role/PrepaidExpensesAndOtherCurrentAssetsDetailsNarrative PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details Narrative) Details http://ayro.com/role/PrepaidExpensesAndOtherCurrentAssetsTables 47 false false R48.htm 00000048 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT, NET (Details) Sheet http://ayro.com/role/ScheduleOfPropertyAndEquipmentNetDetails SCHEDULE OF PROPERTY AND EQUIPMENT, NET (Details) Details 48 false false R49.htm 00000049 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details Narrative) Sheet http://ayro.com/role/PropertyAndEquipmentNetDetailsNarrative PROPERTY AND EQUIPMENT, NET (Details Narrative) Details http://ayro.com/role/PropertyAndEquipmentNetTables 49 false false R50.htm 00000050 - Disclosure - SCHEDULE OF MARKETABLE SECURITIES (Details) Sheet http://ayro.com/role/ScheduleOfMarketableSecuritiesDetails SCHEDULE OF MARKETABLE SECURITIES (Details) Details 50 false false R51.htm 00000051 - Disclosure - SCHEDULE OF PAYMENT OF PREFERRED STOCK (Details) Sheet http://ayro.com/role/ScheduleOfPaymentOfPreferredStockDetails SCHEDULE OF PAYMENT OF PREFERRED STOCK (Details) Details 51 false false R52.htm 00000052 - Disclosure - SCHEDULE OF WARRANT ACTIVITY (Details) Sheet http://ayro.com/role/ScheduleOfWarrantActivityDetails SCHEDULE OF WARRANT ACTIVITY (Details) Details 52 false false R53.htm 00000053 - Disclosure - STOCKHOLDERS??? EQUITY (Details Narrative) Sheet http://ayro.com/role/StockholdersEquityDetailsNarrative STOCKHOLDERS??? EQUITY (Details Narrative) Details http://ayro.com/role/StockholdersEquityTables 53 false false R54.htm 00000054 - Disclosure - SCHEDULE OF STOCK-BASED COMPENSATION (Details) Sheet http://ayro.com/role/ScheduleOfStock-basedCompensationDetails SCHEDULE OF STOCK-BASED COMPENSATION (Details) Details 54 false false R55.htm 00000055 - Disclosure - SCHEDULE OF STOCK-BASED COMPENSATION, STOCK OPTIONS, ACTIVITY (Details) Sheet http://ayro.com/role/ScheduleOfStock-basedCompensationStockOptionsActivityDetails SCHEDULE OF STOCK-BASED COMPENSATION, STOCK OPTIONS, ACTIVITY (Details) Details 55 false false R56.htm 00000056 - Disclosure - SCHEDULE OF STOCK-BASED PAYMENT AWARD, STOCK OPTIONS, VALUATION ASSUMPTIONS (Details) Sheet http://ayro.com/role/ScheduleOfStock-basedPaymentAwardStockOptionsValuationAssumptionsDetails SCHEDULE OF STOCK-BASED PAYMENT AWARD, STOCK OPTIONS, VALUATION ASSUMPTIONS (Details) Details 56 false false R57.htm 00000057 - Disclosure - SCHEDULE OF RESTRICTED STOCK ACTIVITY (Details) Sheet http://ayro.com/role/ScheduleOfRestrictedStockActivityDetails SCHEDULE OF RESTRICTED STOCK ACTIVITY (Details) Details 57 false false R58.htm 00000058 - Disclosure - STOCK BASED COMPENSATION (Details Narrative) Sheet http://ayro.com/role/StockBasedCompensationDetailsNarrative STOCK BASED COMPENSATION (Details Narrative) Details http://ayro.com/role/StockBasedCompensationTables 58 false false R59.htm 00000059 - Disclosure - CONCENTRATIONS AND CREDIT RISK (Details Narrative) Sheet http://ayro.com/role/ConcentrationsAndCreditRiskDetailsNarrative CONCENTRATIONS AND CREDIT RISK (Details Narrative) Details http://ayro.com/role/ConcentrationsAndCreditRisk 59 false false R60.htm 00000060 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) Sheet http://ayro.com/role/RelatedPartyTransactionsDetailsNarrative RELATED PARTY TRANSACTIONS (Details Narrative) Details http://ayro.com/role/RelatedPartyTransactions 60 false false R61.htm 00000061 - Disclosure - SCHEDULE OF COMPONENTS OF LEASE EXPENSES (Details) Sheet http://ayro.com/role/ScheduleOfComponentsOfLeaseExpensesDetails SCHEDULE OF COMPONENTS OF LEASE EXPENSES (Details) Details 61 false false R62.htm 00000062 - Disclosure - SCHEDULE OF OPERATING LEASES RIGHT OF USE ASSETS AND LIABILITIES (Details) Sheet http://ayro.com/role/ScheduleOfOperatingLeasesRightOfUseAssetsAndLiabilitiesDetails SCHEDULE OF OPERATING LEASES RIGHT OF USE ASSETS AND LIABILITIES (Details) Details 62 false false R63.htm 00000063 - Disclosure - SCHEDULE OF WEIGHTED- AVERAGE REMAINING LEASE TERM AND DISCOUNT RATE (Details) Sheet http://ayro.com/role/ScheduleOfWeighted-AverageRemainingLeaseTermAndDiscountRateDetails SCHEDULE OF WEIGHTED- AVERAGE REMAINING LEASE TERM AND DISCOUNT RATE (Details) Details 63 false false R64.htm 00000064 - Disclosure - SCHEDULE OF CASH FLOW INFORMATION (Details) Sheet http://ayro.com/role/ScheduleOfCashFlowInformationDetails SCHEDULE OF CASH FLOW INFORMATION (Details) Details 64 false false R65.htm 00000065 - Disclosure - SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES (Details) Sheet http://ayro.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES (Details) Details 65 false false R66.htm 00000066 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative) Sheet http://ayro.com/role/CommitmentsAndContingenciesDetailsNarrative COMMITMENTS AND CONTINGENCIES (Details Narrative) Details http://ayro.com/role/CommitmentsAndContingenciesTables 66 false false R67.htm 00000067 - Disclosure - SCHEDULE OF RECONCILIATION STATUTORY FEDERAL INCOME TAX RATE (Details) Sheet http://ayro.com/role/ScheduleOfReconciliationStatutoryFederalIncomeTaxRateDetails SCHEDULE OF RECONCILIATION STATUTORY FEDERAL INCOME TAX RATE (Details) Details 67 false false R68.htm 00000068 - Disclosure - SCHEDULE OF DEFERRED TAX (Details) Sheet http://ayro.com/role/ScheduleOfDeferredTaxDetails SCHEDULE OF DEFERRED TAX (Details) Details 68 false false R69.htm 00000069 - Disclosure - SCHEDULE OF INCOME TAX EXAMINATION (Details) Sheet http://ayro.com/role/ScheduleOfIncomeTaxExaminationDetails SCHEDULE OF INCOME TAX EXAMINATION (Details) Details 69 false false R70.htm 00000070 - Disclosure - INCOME TAXES (Details Narrative) Sheet http://ayro.com/role/IncomeTaxesDetailsNarrative INCOME TAXES (Details Narrative) Details http://ayro.com/role/IncomeTaxesTables 70 false false R71.htm 00000071 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) Sheet http://ayro.com/role/SubsequentEventsDetailsNarrative SUBSEQUENT EVENTS (Details Narrative) Details http://ayro.com/role/SubsequentEvents 71 false false All Reports Book All Reports [dq-0542-Deprecated-Concept] Concept PropertyPlantAndEquipmentEstimatedUsefulLives in us-gaap/2022 used in 1 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. form10-k.htm 11372 [dq-0542-Deprecated-Concept] Concept DueToRelatedPartiesCurrentAndNoncurrent in us-gaap/2022 used in 3 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. form10-k.htm 13377, 13382 [dqc-0033-Document-Period-End-Date-Context] The ending date of 2021-12-31 used for AuditorFirmId must be the same as the Document Period End Date, 2022-12-31. The properties of this AuditorFirmId fact are Context: From2021-01-012021-12-31, Unit: (none), Rule Element Id: 2. form10-k.htm 9824 [dqc-0033-Document-Period-End-Date-Context] The ending date of 2021-12-31 used for AuditorLocation must be the same as the Document Period End Date, 2022-12-31. The properties of this AuditorLocation fact are Context: From2021-01-012021-12-31, Unit: (none), Rule Element Id: 2. form10-k.htm 10044 [dqc-0033-Document-Period-End-Date-Context] The ending date of 2021-12-31 used for AuditorName must be the same as the Document Period End Date, 2022-12-31. The properties of this AuditorName fact are Context: From2021-01-012021-12-31, Unit: (none), Rule Element Id: 2. form10-k.htm 10035 form10-k.htm ayro-20221231.xsd ayro-20221231_cal.xml ayro-20221231_def.xml ayro-20221231_lab.xml ayro-20221231_pre.xml ex23-1.htm ex23-2.htm ex31-1.htm ex31-2.htm ex32-1.htm http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 90 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form10-k.htm": { "axisCustom": 0, "axisStandard": 24, "baseTaxonomies": { "http://fasb.org/us-gaap/2022": 768, "http://xbrl.sec.gov/dei/2022": 43 }, "contextCount": 246, "dts": { "calculationLink": { "local": [ "ayro-20221231_cal.xml" ] }, "definitionLink": { "local": [ "ayro-20221231_def.xml" ] }, "inline": { "local": [ "form10-k.htm" ] }, "labelLink": { "local": [ "ayro-20221231_lab.xml" ] }, "presentationLink": { "local": [ "ayro-20221231_pre.xml" ] }, "schema": { "local": [ "ayro-20221231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 579, "entityCount": 1, "hidden": { "http://ayro.com/20221231": 9, "http://fasb.org/us-gaap/2022": 71, "http://xbrl.sec.gov/dei/2022": 3, "total": 83 }, "keyCustom": 53, "keyStandard": 289, "memberCustom": 72, "memberStandard": 29, "nsprefix": "AYRO", "nsuri": "http://ayro.com/20221231", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://ayro.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - REVENUES", "menuCat": "Notes", "order": "10", "role": "http://ayro.com/role/Revenues", "shortName": "REVENUES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsAndNontradeReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - ACCOUNTS RECEIVABLE, NET", "menuCat": "Notes", "order": "11", "role": "http://ayro.com/role/AccountsReceivableNet", "shortName": "ACCOUNTS RECEIVABLE, NET", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsAndNontradeReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - INVENTORY, NET", "menuCat": "Notes", "order": "12", "role": "http://ayro.com/role/InventoryNet", "shortName": "INVENTORY, NET", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherCurrentAssetsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS", "menuCat": "Notes", "order": "13", "role": "http://ayro.com/role/PrepaidExpensesAndOtherCurrentAssets", "shortName": "PREPAID EXPENSES AND OTHER CURRENT ASSETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherCurrentAssetsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - PROPERTY AND EQUIPMENT, NET", "menuCat": "Notes", "order": "14", "role": "http://ayro.com/role/PropertyAndEquipmentNet", "shortName": "PROPERTY AND EQUIPMENT, NET", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - MARKETABLE SECURITIES", "menuCat": "Notes", "order": "15", "role": "http://ayro.com/role/MarketableSecurities", "shortName": "MARKETABLE SECURITIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - STOCKHOLDERS\u2019 EQUITY", "menuCat": "Notes", "order": "16", "role": "http://ayro.com/role/StockholdersEquity", "shortName": "STOCKHOLDERS\u2019 EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - STOCK BASED COMPENSATION", "menuCat": "Notes", "order": "17", "role": "http://ayro.com/role/StockBasedCompensation", "shortName": "STOCK BASED COMPENSATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - CONCENTRATIONS AND CREDIT RISK", "menuCat": "Notes", "order": "18", "role": "http://ayro.com/role/ConcentrationsAndCreditRisk", "shortName": "CONCENTRATIONS AND CREDIT RISK", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - RELATED PARTY TRANSACTIONS", "menuCat": "Notes", "order": "19", "role": "http://ayro.com/role/RelatedPartyTransactions", "shortName": "RELATED PARTY TRANSACTIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - Consolidated Balance Sheets", "menuCat": "Statements", "order": "2", "role": "http://ayro.com/role/BalanceSheets", "shortName": "Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "lang": null, "name": "us-gaap:AssetsCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - COMMITMENTS AND CONTINGENCIES", "menuCat": "Notes", "order": "20", "role": "http://ayro.com/role/CommitmentsAndContingencies", "shortName": "COMMITMENTS AND CONTINGENCIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - INCOME TAXES", "menuCat": "Notes", "order": "21", "role": "http://ayro.com/role/IncomeTaxes", "shortName": "INCOME TAXES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - SUBSEQUENT EVENTS", "menuCat": "Notes", "order": "22", "role": "http://ayro.com/role/SubsequentEvents", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "menuCat": "Policies", "order": "23", "role": "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "AYRO:ScheduleOfEstimatedUsefulLivesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "menuCat": "Tables", "order": "24", "role": "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesTables", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "AYRO:ScheduleOfEstimatedUsefulLivesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - REVENUES (Tables)", "menuCat": "Tables", "order": "25", "role": "http://ayro.com/role/RevenuesTables", "shortName": "REVENUES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "us-gaap:AccountsAndNontradeReceivableTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000026 - Disclosure - ACCOUNTS RECEIVABLE, NET (Tables)", "menuCat": "Tables", "order": "26", "role": "http://ayro.com/role/AccountsReceivableNetTables", "shortName": "ACCOUNTS RECEIVABLE, NET (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:AccountsAndNontradeReceivableTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000027 - Disclosure - INVENTORY, NET (Tables)", "menuCat": "Tables", "order": "27", "role": "http://ayro.com/role/InventoryNetTables", "shortName": "INVENTORY, NET (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "us-gaap:OtherCurrentAssetsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000028 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS (Tables)", "menuCat": "Tables", "order": "28", "role": "http://ayro.com/role/PrepaidExpensesAndOtherCurrentAssetsTables", "shortName": "PREPAID EXPENSES AND OTHER CURRENT ASSETS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:OtherCurrentAssetsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000029 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)", "menuCat": "Tables", "order": "29", "role": "http://ayro.com/role/PropertyAndEquipmentNetTables", "shortName": "PROPERTY AND EQUIPMENT, NET (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - Consolidated Balance Sheets (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://ayro.com/role/BalanceSheetsParenthetical", "shortName": "Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "lang": null, "name": "us-gaap:CommonStockSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MarketableSecuritiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000030 - Disclosure - MARKETABLE SECURITIES (Tables)", "menuCat": "Tables", "order": "30", "role": "http://ayro.com/role/MarketableSecuritiesTables", "shortName": "MARKETABLE SECURITIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MarketableSecuritiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000031 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Tables)", "menuCat": "Tables", "order": "31", "role": "http://ayro.com/role/StockholdersEquityTables", "shortName": "STOCKHOLDERS\u2019 EQUITY (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000032 - Disclosure - STOCK BASED COMPENSATION (Tables)", "menuCat": "Tables", "order": "32", "role": "http://ayro.com/role/StockBasedCompensationTables", "shortName": "STOCK BASED COMPENSATION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000033 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)", "menuCat": "Tables", "order": "33", "role": "http://ayro.com/role/CommitmentsAndContingenciesTables", "shortName": "COMMITMENTS AND CONTINGENCIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000034 - Disclosure - INCOME TAXES (Tables)", "menuCat": "Tables", "order": "34", "role": "http://ayro.com/role/IncomeTaxesTables", "shortName": "INCOME TAXES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000035 - Disclosure - LIQUIDITY AND OTHER UNCERTAINTIES (Details Narrative)", "menuCat": "Details", "order": "35", "role": "http://ayro.com/role/LiquidityAndOtherUncertaintiesDetailsNarrative", "shortName": "LIQUIDITY AND OTHER UNCERTAINTIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "AYRO:LiquidityAndOtherUncertainitiesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "lang": null, "name": "AYRO:WorkingCapital", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "AYRO:ScheduleOfEstimatedUsefulLivesTableTextBlock", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_us-gaap_ComputerEquipmentMember_srt_MinimumMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000036 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIVES (Details)", "menuCat": "Details", "order": "36", "role": "http://ayro.com/role/ScheduleOfEstimatedUsefulLivesDetails", "shortName": "SCHEDULE OF ESTIMATED USEFUL LIVES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "AYRO:ScheduleOfEstimatedUsefulLivesTableTextBlock", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_us-gaap_ComputerEquipmentMember_srt_MinimumMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000037 - Disclosure - SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE (Details)", "menuCat": "Details", "order": "37", "role": "http://ayro.com/role/ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails", "shortName": "SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:MarketableSecuritiesCurrent", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000038 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "menuCat": "Details", "order": "38", "role": "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:RevenueRecognitionPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "lang": null, "name": "AYRO:ShippingExpenses", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000039 - Disclosure - SCHEDULE OF DISAGGREGATION OF REVENUE (Details)", "menuCat": "Details", "order": "39", "role": "http://ayro.com/role/ScheduleOfDisaggregationOfRevenueDetails", "shortName": "SCHEDULE OF DISAGGREGATION OF REVENUE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_us-gaap_ProductMember", "decimals": "0", "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - Consolidated Statements of Operations", "menuCat": "Statements", "order": "4", "role": "http://ayro.com/role/StatementsOfOperations", "shortName": "Consolidated Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "lang": null, "name": "us-gaap:GrossProfit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ContractWithCustomerLiabilityCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000040 - Disclosure - SCHEDULE OF CONTRACT LIABILITIES (Details)", "menuCat": "Details", "order": "40", "role": "http://ayro.com/role/ScheduleOfContractLiabilitiesDetails", "shortName": "SCHEDULE OF CONTRACT LIABILITIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ContractWithCustomerLiabilityCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "AYRO:WarrantyReserves", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000041 - Disclosure - REVENUES (Details Narrative)", "menuCat": "Details", "order": "41", "role": "http://ayro.com/role/RevenuesDetailsNarrative", "shortName": "REVENUES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "AYRO:WarrantyReserves", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "us-gaap:AccountsAndNontradeReceivableTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccountsReceivableGrossCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000042 - Disclosure - SCHEDULE OF ACCOUNTS RECEIVABLE (Details)", "menuCat": "Details", "order": "42", "role": "http://ayro.com/role/ScheduleOfAccountsReceivableDetails", "shortName": "SCHEDULE OF ACCOUNTS RECEIVABLE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "us-gaap:AccountsAndNontradeReceivableTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccountsReceivableGrossCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:AccountsAndNontradeReceivableTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000043 - Disclosure - ACCOUNTS RECEIVABLE, NET (Details Narrative)", "menuCat": "Details", "order": "43", "role": "http://ayro.com/role/AccountsReceivableNetDetailsNarrative", "shortName": "ACCOUNTS RECEIVABLE, NET (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:AccountsAndNontradeReceivableTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterialsAndSupplies", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000044 - Disclosure - SCHEDULE OF INVENTORY (Details)", "menuCat": "Details", "order": "44", "role": "http://ayro.com/role/ScheduleOfInventoryDetails", "shortName": "SCHEDULE OF INVENTORY (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterialsAndSupplies", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000045 - Disclosure - INVENTORY, NET (Details Narrative)", "menuCat": "Details", "order": "45", "role": "http://ayro.com/role/InventoryNetDetailsNarrative", "shortName": "INVENTORY, NET (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_custom_FleetInventoryMember", "decimals": "0", "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "us-gaap:OtherCurrentAssetsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "AYRO:PrepaidFinalAssemblyServices", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000046 - Disclosure - SCHEDULE OF PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details)", "menuCat": "Details", "order": "46", "role": "http://ayro.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails", "shortName": "SCHEDULE OF PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "us-gaap:OtherCurrentAssetsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "AYRO:PrepaidFinalAssemblyServices", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000047 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details Narrative)", "menuCat": "Details", "order": "47", "role": "http://ayro.com/role/PrepaidExpensesAndOtherCurrentAssetsDetailsNarrative", "shortName": "PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:OtherCurrentAssetsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31_custom_CenntroAutomotiveGroupLtdMember", "decimals": "0", "lang": null, "name": "AYRO:PrepaidExpenseAndOtherAccruedExpensesNet", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000048 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT, NET (Details)", "menuCat": "Details", "order": "48", "role": "http://ayro.com/role/ScheduleOfPropertyAndEquipmentNetDetails", "shortName": "SCHEDULE OF PROPERTY AND EQUIPMENT, NET (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000049 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details Narrative)", "menuCat": "Details", "order": "49", "role": "http://ayro.com/role/PropertyAndEquipmentNetDetailsNarrative", "shortName": "PROPERTY AND EQUIPMENT, NET (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_custom_RetiringLegacyAssetsMember", "decimals": "0", "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-12-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - Consolidated Statements of Changes in Stockholders' Equity", "menuCat": "Statements", "order": "5", "role": "http://ayro.com/role/StatementsOfChangesInStockholdersEquity", "shortName": "Consolidated Statements of Changes in Stockholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-12-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:MarketableSecuritiesTextBlock", "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DebtSecuritiesTradingAndEquitySecuritiesFvNiCost", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000050 - Disclosure - SCHEDULE OF MARKETABLE SECURITIES (Details)", "menuCat": "Details", "order": "50", "role": "http://ayro.com/role/ScheduleOfMarketableSecuritiesDetails", "shortName": "SCHEDULE OF MARKETABLE SECURITIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:MarketableSecuritiesTextBlock", "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DebtSecuritiesTradingAndEquitySecuritiesFvNiCost", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "us-gaap:PreferredStockSharesIssued", "span", "span", "span", "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31_custom_ConvertiblePreferredStockSeriesHMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockSharesOutstanding", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000051 - Disclosure - SCHEDULE OF PAYMENT OF PREFERRED STOCK (Details)", "menuCat": "Details", "order": "51", "role": "http://ayro.com/role/ScheduleOfPaymentOfPreferredStockDetails", "shortName": "SCHEDULE OF PAYMENT OF PREFERRED STOCK (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "AYRO:ScheduleOfPaymentOfPreferredStockTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31_custom_ConvertiblePreferredStockSeriesHMember", "decimals": "INF", "lang": null, "name": "AYRO:StatedValueOfPreferredStockSeries", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000052 - Disclosure - SCHEDULE OF WARRANT ACTIVITY (Details)", "menuCat": "Details", "order": "52", "role": "http://ayro.com/role/ScheduleOfWarrantActivityDetails", "shortName": "SCHEDULE OF WARRANT ACTIVITY (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "lang": "en-US", "name": "AYRO:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingBeginningWeightedAverageRemainingContractualTerms", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000053 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Details Narrative)", "menuCat": "Details", "order": "53", "role": "http://ayro.com/role/StockholdersEquityDetailsNarrative", "shortName": "STOCKHOLDERS\u2019 EQUITY (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31_us-gaap_SeriesHPreferredStockMember", "decimals": "INF", "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000054 - Disclosure - SCHEDULE OF STOCK-BASED COMPENSATION (Details)", "menuCat": "Details", "order": "54", "role": "http://ayro.com/role/ScheduleOfStock-basedCompensationDetails", "shortName": "SCHEDULE OF STOCK-BASED COMPENSATION (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_custom_ResearchAndDevelopmentMember", "decimals": "0", "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31_us-gaap_CommonStockMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000055 - Disclosure - SCHEDULE OF STOCK-BASED COMPENSATION, STOCK OPTIONS, ACTIVITY (Details)", "menuCat": "Details", "order": "55", "role": "http://ayro.com/role/ScheduleOfStock-basedCompensationStockOptionsActivityDetails", "shortName": "SCHEDULE OF STOCK-BASED COMPENSATION, STOCK OPTIONS, ACTIVITY (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-12-31_us-gaap_CommonStockMember", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000056 - Disclosure - SCHEDULE OF STOCK-BASED PAYMENT AWARD, STOCK OPTIONS, VALUATION ASSUMPTIONS (Details)", "menuCat": "Details", "order": "56", "role": "http://ayro.com/role/ScheduleOfStock-basedPaymentAwardStockOptionsValuationAssumptionsDetails", "shortName": "SCHEDULE OF STOCK-BASED PAYMENT AWARD, STOCK OPTIONS, VALUATION ASSUMPTIONS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31_us-gaap_RestrictedStockUnitsRSUMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000057 - Disclosure - SCHEDULE OF RESTRICTED STOCK ACTIVITY (Details)", "menuCat": "Details", "order": "57", "role": "http://ayro.com/role/ScheduleOfRestrictedStockActivityDetails", "shortName": "SCHEDULE OF RESTRICTED STOCK ACTIVITY (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-12-31_us-gaap_RestrictedStockUnitsRSUMember", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000058 - Disclosure - STOCK BASED COMPENSATION (Details Narrative)", "menuCat": "Details", "order": "58", "role": "http://ayro.com/role/StockBasedCompensationDetailsNarrative", "shortName": "STOCK BASED COMPENSATION (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-05-052022-05-06_us-gaap_EmployeeStockOptionMember", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_custom_SalesRevenueMember_us-gaap_CustomerConcentrationRiskMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000059 - Disclosure - CONCENTRATIONS AND CREDIT RISK (Details Narrative)", "menuCat": "Details", "order": "59", "role": "http://ayro.com/role/ConcentrationsAndCreditRiskDetailsNarrative", "shortName": "CONCENTRATIONS AND CREDIT RISK (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_custom_SalesRevenueMember_us-gaap_CustomerConcentrationRiskMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - Consolidated Statements of Cash Flows", "menuCat": "Statements", "order": "6", "role": "http://ayro.com/role/StatementsOfCashFlows", "shortName": "Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "lang": null, "name": "us-gaap:DepreciationAndAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "span", "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DueToRelatedPartiesCurrentAndNoncurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000060 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)", "menuCat": "Details", "order": "60", "role": "http://ayro.com/role/RelatedPartyTransactionsDetailsNarrative", "shortName": "RELATED PARTY TRANSACTIONS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DueToRelatedPartiesCurrentAndNoncurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000061 - Disclosure - SCHEDULE OF COMPONENTS OF LEASE EXPENSES (Details)", "menuCat": "Details", "order": "61", "role": "http://ayro.com/role/ScheduleOfComponentsOfLeaseExpensesDetails", "shortName": "SCHEDULE OF COMPONENTS OF LEASE EXPENSES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "AYRO:ScheduleOfOperatingLeasesRightOfUseAssetsAndLiabilitiesTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "AYRO:OperatingLeaseRightOfUseAssetCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000062 - Disclosure - SCHEDULE OF OPERATING LEASES RIGHT OF USE ASSETS AND LIABILITIES (Details)", "menuCat": "Details", "order": "62", "role": "http://ayro.com/role/ScheduleOfOperatingLeasesRightOfUseAssetsAndLiabilitiesDetails", "shortName": "SCHEDULE OF OPERATING LEASES RIGHT OF USE ASSETS AND LIABILITIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "AYRO:ScheduleOfOperatingLeasesRightOfUseAssetsAndLiabilitiesTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "AYRO:OperatingLeaseRightOfUseAssetCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "AYRO:ScheduleOfWeightedaverageRemainingLeaseTermAndDiscountRateTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseRemainingLeaseTerm", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000063 - Disclosure - SCHEDULE OF WEIGHTED- AVERAGE REMAINING LEASE TERM AND DISCOUNT RATE (Details)", "menuCat": "Details", "order": "63", "role": "http://ayro.com/role/ScheduleOfWeighted-AverageRemainingLeaseTermAndDiscountRateDetails", "shortName": "SCHEDULE OF WEIGHTED- AVERAGE REMAINING LEASE TERM AND DISCOUNT RATE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "AYRO:ScheduleOfWeightedaverageRemainingLeaseTermAndDiscountRateTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "lang": null, "name": "us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000064 - Disclosure - SCHEDULE OF CASH FLOW INFORMATION (Details)", "menuCat": "Details", "order": "64", "role": "http://ayro.com/role/ScheduleOfCashFlowInformationDetails", "shortName": "SCHEDULE OF CASH FLOW INFORMATION (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000065 - Disclosure - SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES (Details)", "menuCat": "Details", "order": "65", "role": "http://ayro.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails", "shortName": "SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensation", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000066 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)", "menuCat": "Details", "order": "66", "role": "http://ayro.com/role/CommitmentsAndContingenciesDetailsNarrative", "shortName": "COMMITMENTS AND CONTINGENCIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "lang": null, "name": "AYRO:TerminationFee", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000067 - Disclosure - SCHEDULE OF RECONCILIATION STATUTORY FEDERAL INCOME TAX RATE (Details)", "menuCat": "Details", "order": "67", "role": "http://ayro.com/role/ScheduleOfReconciliationStatutoryFederalIncomeTaxRateDetails", "shortName": "SCHEDULE OF RECONCILIATION STATUTORY FEDERAL INCOME TAX RATE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000068 - Disclosure - SCHEDULE OF DEFERRED TAX (Details)", "menuCat": "Details", "order": "68", "role": "http://ayro.com/role/ScheduleOfDeferredTaxDetails", "shortName": "SCHEDULE OF DEFERRED TAX (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "lang": null, "name": "us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:SummaryOfIncomeTaxExaminationsTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_country_GE", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxExaminationDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000069 - Disclosure - SCHEDULE OF INCOME TAX EXAMINATION (Details)", "menuCat": "Details", "order": "69", "role": "http://ayro.com/role/ScheduleOfIncomeTaxExaminationDetails", "shortName": "SCHEDULE OF INCOME TAX EXAMINATION (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:SummaryOfIncomeTaxExaminationsTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_country_GE", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxExaminationDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000007 - Disclosure - ORGANIZATION AND NATURE OF OPERATIONS", "menuCat": "Notes", "order": "7", "role": "http://ayro.com/role/OrganizationAndNatureOfOperations", "shortName": "ORGANIZATION AND NATURE OF OPERATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000070 - Disclosure - INCOME TAXES (Details Narrative)", "menuCat": "Details", "order": "70", "role": "http://ayro.com/role/IncomeTaxesDetailsNarrative", "shortName": "INCOME TAXES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "lang": "en-US", "name": "AYRO:OperatingLossCarryforwardsMaturityDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2023-01-262023-01-27_us-gaap_RestrictedStockMember_us-gaap_SubsequentEventMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000071 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)", "menuCat": "Details", "order": "71", "role": "http://ayro.com/role/SubsequentEventsDetailsNarrative", "shortName": "SUBSEQUENT EVENTS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2023-01-262023-01-27_us-gaap_RestrictedStockMember_us-gaap_SubsequentEventMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "AYRO:LiquidityAndOtherUncertainitiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - LIQUIDITY AND OTHER UNCERTAINTIES", "menuCat": "Notes", "order": "8", "role": "http://ayro.com/role/LiquidityAndOtherUncertainties", "shortName": "LIQUIDITY AND OTHER UNCERTAINTIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "AYRO:LiquidityAndOtherUncertainitiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "menuCat": "Notes", "order": "9", "role": "http://ayro.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 102, "tag": { "AYRO_AccruedFixedAssets": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued fixed assets.", "label": "Accrued Fixed Assets" } } }, "localname": "AccruedFixedAssets", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AYRO_AdditionalSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Additional Shares [Member]", "label": "Additional Shares [Member]" } } }, "localname": "AdditionalSharesMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_AdditionsToContractLiability": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Additions.", "label": "Additions" } } }, "localname": "AdditionsToContractLiability", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/ScheduleOfContractLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "AYRO_AdvisorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Advisor [Member]", "label": "Advisor [Member]" } } }, "localname": "AdvisorMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_AffiliatesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Affiliates [Member]", "label": "Affiliates [Member]" } } }, "localname": "AffiliatesMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_AntidilutionPriceProtectionPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Anti-dilution price protection price per share.", "label": "Anti-dilution price protection price per share" } } }, "localname": "AntidilutionPriceProtectionPricePerShare", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "AYRO_CenntroAutomotiveGroupLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cenntro Automotive Group Ltd [Member]", "label": "Cenntro Automotive Group Ltd [Member]" } } }, "localname": "CenntroAutomotiveGroupLtdMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://ayro.com/role/PrepaidExpensesAndOtherCurrentAssetsDetailsNarrative", "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights exercised.", "label": "Weighted Average Exercise Price Exercised" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExercised", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "perShareItemType" }, "AYRO_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExpired": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrant or right expired erercise price expired.", "label": "Weighted Average Exercise Price Expired" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExpired", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "perShareItemType" }, "AYRO_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights granted.", "label": "Weighted Average Exercise Price Granted" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsGranted", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "perShareItemType" }, "AYRO_ClassOfWarrantOrRightExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights exercised.", "label": "Shares Underlying Warrants Exercised" } } }, "localname": "ClassOfWarrantOrRightExercised", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "sharesItemType" }, "AYRO_ClassOfWarrantOrRightExpired": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrant or right expired.", "label": "Shares Underlying Warrants Expired" } } }, "localname": "ClassOfWarrantOrRightExpired", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "sharesItemType" }, "AYRO_ClassOfWarrantOrRightGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights granted.", "label": "Shares Underlying Warrants Granted" } } }, "localname": "ClassOfWarrantOrRightGranted", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "sharesItemType" }, "AYRO_ClubCarDiscountMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Club Car Discount [Member]", "label": "Club Car Discount [Member]" } } }, "localname": "ClubCarDiscountMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/InventoryNetDetailsNarrative", "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_ComputerAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Computer And Equipment [Member]", "label": "Computer And Equipment [Member]" } } }, "localname": "ComputerAndEquipmentMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/ScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "AYRO_ComputerSoftwareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Computer Software [Member]", "label": "Computer Software [Member]" } } }, "localname": "ComputerSoftwareMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/ScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "AYRO_ConversionPriceOfShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Conversion Price of Share.", "label": "Conversion price per share" } } }, "localname": "ConversionPriceOfShare", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "AYRO_ConvertiblePreferredStockSeriesHMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Preferred Stock Series H [Member]", "label": "Convertible Preferred Stock Series H [Member]" } } }, "localname": "ConvertiblePreferredStockSeriesHMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/BalanceSheets", "http://ayro.com/role/BalanceSheetsParenthetical", "http://ayro.com/role/ScheduleOfPaymentOfPreferredStockDetails" ], "xbrltype": "domainItemType" }, "AYRO_ConvertiblePreferredStockSeriesHSixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Preferred Stock Series H-6 [Member]", "label": "Convertible Preferred Stock Series H-6 [Member]" } } }, "localname": "ConvertiblePreferredStockSeriesHSixMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/BalanceSheets", "http://ayro.com/role/BalanceSheetsParenthetical", "http://ayro.com/role/ScheduleOfPaymentOfPreferredStockDetails" ], "xbrltype": "domainItemType" }, "AYRO_ConvertiblePreferredStockSeriesHThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Preferred Stock Series H-3 [Member]", "label": "Convertible Preferred Stock Series H-3 [Member]" } } }, "localname": "ConvertiblePreferredStockSeriesHThreeMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/BalanceSheets", "http://ayro.com/role/BalanceSheetsParenthetical", "http://ayro.com/role/ScheduleOfPaymentOfPreferredStockDetails", "http://ayro.com/role/StockholdersEquityTables" ], "xbrltype": "domainItemType" }, "AYRO_DavidEHollingsworthMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "David E. Hollingsworth [Member]", "label": "David E. Hollingsworth [Member]" } } }, "localname": "DavidEHollingsworthMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpense": { "auth_ref": [], "calculation": { "http://ayro.com/role/ScheduleOfDeferredTaxDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred tax assets capitalized research and development expense.", "label": "Capitalized research and development expense" } } }, "localname": "DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpense", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/ScheduleOfDeferredTaxDetails" ], "xbrltype": "monetaryItemType" }, "AYRO_DeferredTaxAssetsCompensation": { "auth_ref": [], "calculation": { "http://ayro.com/role/ScheduleOfDeferredTaxDetails": { "order": 6.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred tax assets compensation.", "label": "Accrued compensation" } } }, "localname": "DeferredTaxAssetsCompensation", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/ScheduleOfDeferredTaxDetails" ], "xbrltype": "monetaryItemType" }, "AYRO_DeferredTaxAssetsDepreciation": { "auth_ref": [], "calculation": { "http://ayro.com/role/ScheduleOfDeferredTaxDetails": { "order": 7.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred tax assets depreciation.", "label": "Property and equipment" } } }, "localname": "DeferredTaxAssetsDepreciation", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/ScheduleOfDeferredTaxDetails" ], "xbrltype": "monetaryItemType" }, "AYRO_DeferredTaxAssetsWarrants": { "auth_ref": [], "calculation": { "http://ayro.com/role/ScheduleOfDeferredTaxDetails": { "order": 5.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred tax assets warrants.", "label": "Warrants" } } }, "localname": "DeferredTaxAssetsWarrants", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/ScheduleOfDeferredTaxDetails" ], "xbrltype": "monetaryItemType" }, "AYRO_DirectorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Directors [Member]", "label": "Directors [Member]" } } }, "localname": "DirectorsMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_DisclosureLiquidityAndOtherUncertaintiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liquidity And Other Uncertainties" } } }, "localname": "DisclosureLiquidityAndOtherUncertaintiesAbstract", "nsuri": "http://ayro.com/20221231", "xbrltype": "stringItemType" }, "AYRO_DropCarIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "DropCar Inc [Member]", "label": "DropCar Inc [Member]" } } }, "localname": "DropCarIncMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_DropCarOperatingIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "DropCar Operating, Inc. [Member]", "label": "DropCar Operating, Inc. [Member]" } } }, "localname": "DropCarOperatingIncMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_ExceedsWarrantPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exceeds warrant price per share.", "label": "Exceeds warrant price per share" } } }, "localname": "ExceedsWarrantPricePerShare", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "AYRO_FebruaryFinderWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "February Finder Warrants [Member]", "label": "February Finder Warrants [Member]" } } }, "localname": "FebruaryFinderWarrantsMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_FebruaryPlacementAgentWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "February Placement Agent Warrants [Member]", "label": "February Placement Agent Warrants [Member]" } } }, "localname": "FebruaryPlacementAgentWarrantsMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_FirstProductionLevelBuildsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First Production Level Builds [Member]", "label": "First Production Level Builds [Member]" } } }, "localname": "FirstProductionLevelBuildsMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_FleetInventoryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fleet Inventory [Member]", "label": "Fleet Inventory [Member]" } } }, "localname": "FleetInventoryMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/InventoryNetDetailsNarrative", "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_GeneralAndAdministrativeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "General And Administrative [Member]" } } }, "localname": "GeneralAndAdministrativeMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/ScheduleOfStock-basedCompensationDetails" ], "xbrltype": "domainItemType" }, "AYRO_GrossStateValueOfPreferredStock": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equals the gross stated value.", "label": "Equals the gross stated value" } } }, "localname": "GrossStateValueOfPreferredStock", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/ScheduleOfPaymentOfPreferredStockDetails" ], "xbrltype": "monetaryItemType" }, "AYRO_ImpairmentOfinventoryAndPrepaid": { "auth_ref": [], "calculation": { "http://ayro.com/role/StatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Impairment of inventory and prepaid.", "label": "Impairment of inventory and prepaid" } } }, "localname": "ImpairmentOfinventoryAndPrepaid", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AYRO_IncomeTaxReconciliationEquityBasedCompensationExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Income tax reconciliation equity based compensation expense", "label": "Permanent differences - equity based compensation" } } }, "localname": "IncomeTaxReconciliationEquityBasedCompensationExpense", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/ScheduleOfReconciliationStatutoryFederalIncomeTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "AYRO_IncrementalBorrowingRateForLease": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Incremental borrowing rate for the lease.", "label": "Incremental borrowing rate for the lease" } } }, "localname": "IncrementalBorrowingRateForLease", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "AYRO_JanuaryTwentyTwentyOneOfferingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "January 2021 Offering [Member]", "label": "January 2021 Offering [Member]" } } }, "localname": "JanuaryTwentyTwentyOneOfferingMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_JulyEightFinderWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "July 8 Finder Warrants [Member]", "label": "July 8 Finder Warrants [Member]" } } }, "localname": "JulyEightFinderWarrantsMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_JulyEightPlacementAgentWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "July 8 Placement Agent Warrants [Member]", "label": "July 8 Placement Agent Warrants [Member]" } } }, "localname": "JulyEightPlacementAgentWarrantsMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_JulyTwentyTwoPlacementAgentWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "July 22 Placement Agent Warrants [Member]", "label": "July 22 Placement Agent Warrants [Member]" } } }, "localname": "JulyTwentyTwoPlacementAgentWarrantsMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_JuneFinderWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "June Finder Warrants [Member]", "label": "June Finder Warrants [Member]" } } }, "localname": "JuneFinderWarrantsMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_JunePlacementAgentWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "June Placement Agent Warrants [Member]", "label": "June Placement Agent Warrants [Member]" } } }, "localname": "JunePlacementAgentWarrantsMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_KarmaAutomotiveLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Karma Automotive, LLC [Member]", "label": "Karma Automotive, LLC [Member]" } } }, "localname": "KarmaAutomotiveLLCMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_KellerAwardMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Keller Award [Member]", "label": "Keller Award [Member]" } } }, "localname": "KellerAwardMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_LesseeOperatingLeaseLiabilityPaymentsDueFiveAndAfterFive": { "auth_ref": [], "calculation": { "http://ayro.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in five fiscal year and thereafter following current fiscal year.", "label": "2027" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueFiveAndAfterFive", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "AYRO_LiquidityAndOtherUncertainitiesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Liquidity and other uncertainities [text block]", "label": "LIQUIDITY AND OTHER UNCERTAINTIES" } } }, "localname": "LiquidityAndOtherUncertainitiesTextBlock", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/LiquidityAndOtherUncertainties" ], "xbrltype": "textBlockItemType" }, "AYRO_MarketableSecuritiesTransferredToCash": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Marketable securities transferred to cash.", "label": "Transferred to Cash" } } }, "localname": "MarketableSecuritiesTransferredToCash", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/ScheduleOfMarketableSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "AYRO_MasterManufacturingServicesAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Master Manufacturing Services Agreement [Member]", "label": "Master Manufacturing Services Agreement [Member]" } } }, "localname": "MasterManufacturingServicesAgreementMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_MiscellaneousIncomeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Miscellaneous Income [Member]", "label": "Miscellaneous Income [Member]" } } }, "localname": "MiscellaneousIncomeMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "domainItemType" }, "AYRO_NewLeaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "New Lease Agreement [Member]", "label": "New Lease Agreement [Member]" } } }, "localname": "NewLeaseAgreementMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_NovemberFinderWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "November Finder Warrants [Member]", "label": "November Finder Warrants [Member]" } } }, "localname": "NovemberFinderWarrantsMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_NovemberPlacementAgentWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "November Placement Agent Warrants [Member]", "label": "November Placement Agent Warrants [Member]" } } }, "localname": "NovemberPlacementAgentWarrantsMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_OneCustomerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer One [Member]", "label": "Customer One [Member]" } } }, "localname": "OneCustomerMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/ConcentrationsAndCreditRiskDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_OneSupplierMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Supplier One [Member]", "label": "Supplier One [Member]" } } }, "localname": "OneSupplierMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/ConcentrationsAndCreditRiskDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_OperatingLeaseRightOfUseAssetCurrent": { "auth_ref": [], "calculation": { "http://ayro.com/role/ScheduleOfOperatingLeasesRightOfUseAssetsAndLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_OperatingLeaseRightOfUseAsset", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating lease - right-of-use asset, net", "verboseLabel": "Operating lease \u2013 right-of-use asset" } } }, "localname": "OperatingLeaseRightOfUseAssetCurrent", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/ScheduleOfOperatingLeasesRightOfUseAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "AYRO_OperatingLossCarryforwardsMaturityDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Operating loss carryforwards maturity description.", "label": "Operating loss carryforwards maturity description" } } }, "localname": "OperatingLossCarryforwardsMaturityDescription", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "AYRO_OperatingLossIndefiniteCarryforwards": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Operating loss indefinite carry forwards.", "label": "Operating loss indefinite carryforwards" } } }, "localname": "OperatingLossIndefiniteCarryforwards", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "AYRO_OptionsToPurchaseCommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Options to Purchase Common Stock [Member]", "label": "Options to Purchase Common Stock [Member]" } } }, "localname": "OptionsToPurchaseCommonStockMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" ], "xbrltype": "domainItemType" }, "AYRO_PreferredStockOutstandingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred Stock Outstanding [Member]", "label": "Preferred Stock Outstanding [Member]" } } }, "localname": "PreferredStockOutstandingMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" ], "xbrltype": "domainItemType" }, "AYRO_PrepaidExpenseAndOtherAccruedExpensesNet": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Prepaid expense and other accrued expenses, net.", "label": "Prepaid expenses and accrued expenses, net" } } }, "localname": "PrepaidExpenseAndOtherAccruedExpensesNet", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/PrepaidExpensesAndOtherCurrentAssetsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "AYRO_PrepaidFinalAssemblyServices": { "auth_ref": [], "calculation": { "http://ayro.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Prepaid final assembly services.", "label": "Prepaid final assembly services" } } }, "localname": "PrepaidFinalAssemblyServices", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "AYRO_PrepaidOnSoftware": { "auth_ref": [], "calculation": { "http://ayro.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails": { "order": 5.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Prepayments on software.", "label": "Prepayments on software" } } }, "localname": "PrepaidOnSoftware", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "AYRO_PrepaymentsForInventory": { "auth_ref": [], "calculation": { "http://ayro.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Prepayments for inventory.", "label": "Prepayments for inventory" } } }, "localname": "PrepaymentsForInventory", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "AYRO_PrepaymentsOnAdvancesOnDesign": { "auth_ref": [], "calculation": { "http://ayro.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails": { "order": 4.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Prepayments on advances on design.", "label": "Prepayments on advances on design" } } }, "localname": "PrepaymentsOnAdvancesOnDesign", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "AYRO_PrototypesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Prototypes [Member]", "label": "Prototypes [Member]" } } }, "localname": "PrototypesMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/ScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "AYRO_RemaningAccountsPayableAndAccruedLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Remaning accounts payable and accrued liabilities.", "label": "Remaning accounts payable and accrued liabilities" } } }, "localname": "RemaningAccountsPayableAndAccruedLiabilities", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "AYRO_ResearchAndDevelopmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Research And Development [Member]" } } }, "localname": "ResearchAndDevelopmentMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/ScheduleOfStock-basedCompensationDetails" ], "xbrltype": "domainItemType" }, "AYRO_RestrictedStockForServiceVestedNotIssued": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Restricted stock for service vested not issued.", "label": "Restricted stock shares vested but not issued" } } }, "localname": "RestrictedStockForServiceVestedNotIssued", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "AYRO_RestrictedStockUnvestedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted Stock Unvested [Member]", "label": "Restricted Stock Unvested [Member]" } } }, "localname": "RestrictedStockUnvestedMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" ], "xbrltype": "domainItemType" }, "AYRO_RestrictedStockVestedUnissuedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted Stock Vested Unissued [Member]", "label": "Restricted Stock Vested Unissued [Member]" } } }, "localname": "RestrictedStockVestedUnissuedMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" ], "xbrltype": "domainItemType" }, "AYRO_RetiringLegacyAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Retiring Legacy Assets [Member]", "label": "Retiring Legacy Assets [Member]" } } }, "localname": "RetiringLegacyAssetsMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/PropertyAndEquipmentNetDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_SalesAndMarketingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Sales And Marketing [Member]" } } }, "localname": "SalesAndMarketingMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/ScheduleOfStock-basedCompensationDetails" ], "xbrltype": "domainItemType" }, "AYRO_SalesRevenueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sales Revenue [Member]", "label": "Sales Revenue [Member]" } } }, "localname": "SalesRevenueMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/ConcentrationsAndCreditRiskDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_ScheduleOfEstimatedUsefulLivesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of estimated useful lives [Table text block]", "label": "SCHEDULE OF ESTIMATED USEFUL LIVES" } } }, "localname": "ScheduleOfEstimatedUsefulLivesTableTextBlock", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "AYRO_ScheduleOfOperatingLeasesRightOfUseAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of operating leases right of use assets and liabilities [Table Text Block].", "label": "SCHEDULE OF OPERATING LEASES RIGHT OF USE ASSETS AND LIABILITIES" } } }, "localname": "ScheduleOfOperatingLeasesRightOfUseAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/CommitmentsAndContingenciesTables" ], "xbrltype": "textBlockItemType" }, "AYRO_ScheduleOfPaymentOfPreferredStockTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Payment Of Preferred Stock [Table Text Block]", "label": "SCHEDULE OF PAYMENT OF PREFERRED STOCK" } } }, "localname": "ScheduleOfPaymentOfPreferredStockTableTextBlock", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "AYRO_ScheduleOfWeightedaverageRemainingLeaseTermAndDiscountRateTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of weighted average remaining lease term and discount rate [Table Text Block].", "label": "SCHEDULE OF WEIGHTED- AVERAGE REMAINING LEASE TERM AND DISCOUNT RATE" } } }, "localname": "ScheduleOfWeightedaverageRemainingLeaseTermAndDiscountRateTableTextBlock", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/CommitmentsAndContingenciesTables" ], "xbrltype": "textBlockItemType" }, "AYRO_SecuritiesPurchaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Securities Purchase Agreement [Member]", "label": "Securities Purchase Agreement [Member]" } } }, "localname": "SecuritiesPurchaseAgreementMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_SeedWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Seed Warrants [Member]", "label": "Seed Warrants [Member]" } } }, "localname": "SeedWarrantsMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_SeptemberWarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "September Warrant [Member]", "label": "September Warrant [Member]" } } }, "localname": "SeptemberWarrantMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_SeriesAWarrantsAndSeriesBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series A Warrants and Series B [Member]", "label": "Series A Warrants and Series B [Member]" } } }, "localname": "SeriesAWarrantsAndSeriesBMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_SeriesAWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series A Warrants [Member]", "label": "Series A Warrants [Member]" } } }, "localname": "SeriesAWarrantsMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_SeriesBWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series B Warrants [Member]", "label": "Series B Warrants [Member]" } } }, "localname": "SeriesBWarrantsMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_SeriesHConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Series H Convertible Preferred Stock [Member]" } } }, "localname": "SeriesHConvertiblePreferredStockMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/StockholdersEquityTables" ], "xbrltype": "domainItemType" }, "AYRO_SeriesHFiveWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series H-5 Warrants [Member]", "label": "Series H-5 Warrants [Member]" } } }, "localname": "SeriesHFiveWarrantsMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_SeriesHFourWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series H-4 Warrants [Member]", "label": "Series H-4 Warrants [Member]" } } }, "localname": "SeriesHFourWarrantsMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_SeriesHSixConvertibePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series H-6 Convertible Preferred Stock [Member]", "label": "Series H-6 Convertible Preferred Stock [Member]" } } }, "localname": "SeriesHSixConvertibePreferredStockMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_SeriesHSixConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Series H Six Convertible Preferred Stock [Member]" } } }, "localname": "SeriesHSixConvertiblePreferredStockMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/StockholdersEquityTables" ], "xbrltype": "domainItemType" }, "AYRO_SeriesHSixPreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series H-6 Preferred Stock [Member]", "label": "Series H-6 Preferred Stock [Member]" } } }, "localname": "SeriesHSixPreferredStockMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "AYRO_SeriesHThreePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series H-3 Preferred Stock [Member]", "label": "Series H-3 Preferred Stock [Member]" } } }, "localname": "SeriesHThreePreferredStockMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/StatementsOfChangesInStockholdersEquity", "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_SeriesHThreeWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series H-3 Warrants [Member]", "label": "Series H-3 Warrants [Member]" } } }, "localname": "SeriesHThreeWarrantsMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_SeriesIWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series I Warrants [Member]", "label": "Series I Warrants [Member]" } } }, "localname": "SeriesIWarrantsMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_SeriesJWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series J Warrants [Member]", "label": "Series J Warrants [Member]" } } }, "localname": "SeriesJWarrantsMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_ServiceIncomeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Service Income [Member]", "label": "Service Income [Member]" } } }, "localname": "ServiceIncomeMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "domainItemType" }, "AYRO_SetupCostsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Setup Costs [Member]", "label": "Setup Costs [Member]" } } }, "localname": "SetupCostsMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingBeginningWeightedAverageRemainingContractualTerms": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Remaining Contractual Life, Beginning.", "label": "Weighted Average Remaining Contractual Life" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingBeginningWeightedAverageRemainingContractualTerms", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "durationItemType" }, "AYRO_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingEndingWeightedAverageRemainingContractualTerms": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Remaining Contractual Life, Ending.", "label": "Weighted Average Remaining Contractual Life, Ending", "verboseLabel": "Weighted Average Remaining Contractual Life" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingEndingWeightedAverageRemainingContractualTerms", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "durationItemType" }, "AYRO_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangements by share based payment award options exercises in period weighted average granted.", "label": "Weighted Average Exercise Price Outstanding, Granted" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageGranted", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/ScheduleOfStock-basedCompensationStockOptionsActivityDetails" ], "xbrltype": "perShareItemType" }, "AYRO_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award options outstanding weighted average remaining contractual term1.", "label": "Weighted average remaining contractual life" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/ScheduleOfStock-basedCompensationStockOptionsActivityDetails" ], "xbrltype": "durationItemType" }, "AYRO_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award options vested weighted average grant date fairvalue1.", "label": "Weighted Average Grant Price, Vested" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue1", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/ScheduleOfRestrictedStockActivityDetails" ], "xbrltype": "perShareItemType" }, "AYRO_ShippingExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Shipping expenses.", "label": "Shipping expenses" } } }, "localname": "ShippingExpenses", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "AYRO_ShippingRevenueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shipping Revenue [Member]", "label": "Shipping Revenue [Member]" } } }, "localname": "ShippingRevenueMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "domainItemType" }, "AYRO_StatedValueOfPreferredStockSeries": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Multiplied by the stated value.", "label": "Multiplied by the stated value" } } }, "localname": "StatedValueOfPreferredStockSeries", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/ScheduleOfPaymentOfPreferredStockDetails" ], "xbrltype": "perShareItemType" }, "AYRO_StockIssuedDuringPeriodShareExerciseOfWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock issued during period share exercise of warrants.", "label": "Exercise of Warrants net , shares" } } }, "localname": "StockIssuedDuringPeriodShareExerciseOfWarrants", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "AYRO_StockIssuedDuringPeriodSharesStockOptionsGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock issued during period shares stock options granted.", "label": "StockIssuedDuringPeriodSharesStockOptionsGranted", "negatedLabel": "Number of Stock options, Granted" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsGranted", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/ScheduleOfStock-basedCompensationStockOptionsActivityDetails" ], "xbrltype": "sharesItemType" }, "AYRO_StockIssuedDuringPeriodValueExerciseOfWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock issued during period value exercise of warrants.", "label": "Exercise of warrants, net of fees" } } }, "localname": "StockIssuedDuringPeriodValueExerciseOfWarrants", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "AYRO_TaxCutsAndJobsActMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tax Cuts And Jobs Act [Member]", "label": "Tax Cuts And Jobs Act [Member]" } } }, "localname": "TaxCutsAndJobsActMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_TerminationFee": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Termination fee" } } }, "localname": "TerminationFee", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "AYRO_ThomasMWittenschlaegerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ThomasM Wittens Chlaeger [Member]", "label": "ThomasM Wittens Chlaeger [Member]" } } }, "localname": "ThomasMWittenschlaegerMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_ThreeSupplierMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Three Supplier [Member]", "label": "Three Supplier [Member]" } } }, "localname": "ThreeSupplierMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/ConcentrationsAndCreditRiskDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_TransferToRevenue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Transfer to revenue.", "label": "Weighted average exercise price exercised/forfeited", "negatedLabel": "Transfer to revenue" } } }, "localname": "TransferToRevenue", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/ScheduleOfContractLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "AYRO_TwoCustomerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer Two [Member]", "label": "Customer Two [Member]" } } }, "localname": "TwoCustomerMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/ConcentrationsAndCreditRiskDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_TwoSupplierMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Supplier Two [Member]", "label": "Supplier Two [Member]" } } }, "localname": "TwoSupplierMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/ConcentrationsAndCreditRiskDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_TwoThousandAndTwentyLongTermIncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2020 Long-Term Incentive Plan [Member]", "label": "2020 Long-Term Incentive Plan [Member]" } } }, "localname": "TwoThousandAndTwentyLongTermIncentivePlanMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/StockBasedCompensationDetailsNarrative", "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_TwoThousandFourteenEquityIncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two Thousand Fourteen Equity Incentive Plan [Member]", "label": "2014 Equity Incentive Plan [Member]" } } }, "localname": "TwoThousandFourteenEquityIncentivePlanMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_TwoThousandSeventeenLongTermIncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2017 Long Term Incentive Plan [Member]", "label": "2017 Long Term Incentive Plan [Member]" } } }, "localname": "TwoThousandSeventeenLongTermIncentivePlanMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_TwoThousandTwentyLongTermIncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2020 Long Term Incentive Plan [Member]", "label": "2020 Long Term Incentive Plan [Member]" } } }, "localname": "TwoThousandTwentyLongTermIncentivePlanMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_WarrantExpirationDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant expiration description.", "label": "Warrant expiration description" } } }, "localname": "WarrantExpirationDescription", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "AYRO_WarrantWeightedAverageExercisePrice": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Warrant weighted average exercise price.", "label": "Warrant weighted average exercise price" } } }, "localname": "WarrantWeightedAverageExercisePrice", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "AYRO_WarrantsAndPreferredSharesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants and preferred shares [Policy text block]", "label": "Warrants and Preferred Shares" } } }, "localname": "WarrantsAndPreferredSharesPolicyTextBlock", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "AYRO_WarrantsOutstandingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants Outstanding [Member]", "label": "Warrants Outstanding [Member]" } } }, "localname": "WarrantsOutstandingMember", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" ], "xbrltype": "domainItemType" }, "AYRO_WarrantyReserves": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Warranty reserves.", "label": "Warranty reserves" } } }, "localname": "WarrantyReserves", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/RevenuesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "AYRO_WorkingCapital": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Working capital.", "label": "Working capital" } } }, "localname": "WorkingCapital", "nsuri": "http://ayro.com/20221231", "presentation": [ "http://ayro.com/role/LiquidityAndOtherUncertaintiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "country_GE": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "GEORGIA, REPUBLIC OF" } } }, "localname": "GE", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://ayro.com/role/ScheduleOfIncomeTaxExaminationDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r526" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r526" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r523", "r525", "r526" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r523", "r525", "r526" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r523", "r525", "r526" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r525" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r523", "r525", "r526" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r524" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r512" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r525" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r525" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r527" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r515" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r518" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r514" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://ayro.com/role/PrepaidExpensesAndOtherCurrentAssetsDetailsNarrative", "http://ayro.com/role/StockBasedCompensationDetailsNarrative", "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r514" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r531" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r514" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r528" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r526" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r514" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r514" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r514" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r514" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r529" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_IcfrAuditorAttestationFlag": { "auth_ref": [ "r523", "r525", "r526" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag" } } }, "localname": "IcfrAuditorAttestationFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://ayro.com/role/PrepaidExpensesAndOtherCurrentAssetsDetailsNarrative", "http://ayro.com/role/StockBasedCompensationDetailsNarrative", "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r525" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r519" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r520" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r513" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r517" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r516" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r521" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r522" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r530" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "booleanItemType" }, "srt_BoardOfDirectorsChairmanMember": { "auth_ref": [ "r555" ], "lang": { "en-us": { "role": { "label": "Board of Directors Chairman [Member]" } } }, "localname": "BoardOfDirectorsChairmanMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ayro.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_DirectorMember": { "auth_ref": [ "r555" ], "lang": { "en-us": { "role": { "label": "Director [Member]" } } }, "localname": "DirectorMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ayro.com/role/StockBasedCompensationDetailsNarrative", "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_EquityMethodInvesteeNameDomain": { "auth_ref": [], "localname": "EquityMethodInvesteeNameDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r240", "r498", "r569", "r624" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ayro.com/role/ConcentrationsAndCreditRiskDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r262", "r263", "r264", "r265", "r315", "r420", "r441", "r478", "r479", "r495", "r505", "r511", "r565", "r615", "r616", "r617", "r618", "r619", "r620" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ayro.com/role/ScheduleOfEstimatedUsefulLivesDetails", "http://ayro.com/role/StockholdersEquityDetailsNarrative", "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r262", "r263", "r264", "r265", "r315", "r420", "r441", "r478", "r479", "r495", "r505", "r511", "r565", "r615", "r616", "r617", "r618", "r619", "r620" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ayro.com/role/ScheduleOfEstimatedUsefulLivesDetails", "http://ayro.com/role/StockholdersEquityDetailsNarrative", "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r240", "r498", "r569", "r624" ], "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ayro.com/role/ConcentrationsAndCreditRiskDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r237", "r423", "r496", "r509", "r560", "r561", "r569", "r623" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ayro.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r237", "r423", "r496", "r509", "r560", "r561", "r569", "r623" ], "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ayro.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r262", "r263", "r264", "r265", "r313", "r315", "r345", "r346", "r347", "r419", "r420", "r441", "r478", "r479", "r495", "r505", "r511", "r559", "r565", "r616", "r617", "r618", "r619", "r620" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ayro.com/role/ScheduleOfEstimatedUsefulLivesDetails", "http://ayro.com/role/StockholdersEquityDetailsNarrative", "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r262", "r263", "r264", "r265", "r313", "r315", "r345", "r346", "r347", "r419", "r420", "r441", "r478", "r479", "r495", "r505", "r511", "r559", "r565", "r616", "r617", "r618", "r619", "r620" ], "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ayro.com/role/ScheduleOfEstimatedUsefulLivesDetails", "http://ayro.com/role/StockholdersEquityDetailsNarrative", "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "auth_ref": [ "r245" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Axis]" } } }, "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r238", "r239", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r497", "r510", "r569" ], "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ayro.com/role/ScheduleOfIncomeTaxExaminationDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r238", "r239", "r463", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r497", "r510", "r569" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ayro.com/role/ScheduleOfIncomeTaxExaminationDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r555", "r611" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ayro.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://ayro.com/role/StockBasedCompensationDetailsNarrative", "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ayro.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://ayro.com/role/StockBasedCompensationDetailsNarrative", "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsAndNontradeReceivableTextBlock": { "auth_ref": [ "r244", "r250" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts receivable, contract receivable, receivable held-for-sale, and nontrade receivable.", "label": "ACCOUNTS RECEIVABLE, NET" } } }, "localname": "AccountsAndNontradeReceivableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/AccountsReceivableNet" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r14", "r508" ], "calculation": { "http://ayro.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableGrossCurrent": { "auth_ref": [ "r160", "r241", "r242", "r483" ], "calculation": { "http://ayro.com/role/ScheduleOfAccountsReceivableDetails": { "order": 1.0, "parentTag": "us-gaap_AccountsReceivableNetCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Trade receivables" } } }, "localname": "AccountsReceivableGrossCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfAccountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableMember": { "auth_ref": [ "r464" ], "lang": { "en-us": { "role": { "documentation": "Due from customers or clients for goods or services that have been delivered or sold.", "label": "Accounts Receivable [Member]" } } }, "localname": "AccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ConcentrationsAndCreditRiskDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r241", "r242" ], "calculation": { "http://ayro.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://ayro.com/role/ScheduleOfAccountsReceivableDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts receivable, net", "totalLabel": "Accounts receivable, net" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/BalanceSheets", "http://ayro.com/role/ScheduleOfAccountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r16" ], "calculation": { "http://ayro.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued expenses" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r71", "r155" ], "calculation": { "http://ayro.com/role/ScheduleOfPropertyAndEquipmentNetDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Less: Accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [ "r169", "r170", "r389", "r390", "r391", "r392", "r393", "r394" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r6", "r508" ], "calculation": { "http://ayro.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r353", "r354", "r355", "r550", "r551", "r552", "r602" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r102", "r103", "r317" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "Stock based compensation" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r349" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Total", "verboseLabel": "Compensation expenses" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfStock-basedCompensationDetails", "http://ayro.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r161", "r243", "r248" ], "calculation": { "http://ayro.com/role/ScheduleOfAccountsReceivableDetails": { "order": 2.0, "parentTag": "us-gaap_AccountsReceivableNetCurrent", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "Allowance for doubtful accounts", "negatedLabel": "Less: Allowance for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfAccountsReceivableDetails", "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease": { "auth_ref": [ "r557" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in allowance for credit loss on accounts receivable.", "label": "Changes in allowance for doubtful accounts receivable" } } }, "localname": "AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/AccountsReceivableNetDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r206" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Totals" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r51" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r51" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r127", "r137", "r156", "r183", "r222", "r231", "r235", "r246", "r266", "r267", "r269", "r270", "r271", "r272", "r273", "r275", "r276", "r380", "r382", "r388", "r508", "r563", "r564", "r613" ], "calculation": { "http://ayro.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r150", "r165", "r183", "r246", "r266", "r267", "r269", "r270", "r271", "r272", "r273", "r275", "r276", "r380", "r382", "r388", "r508", "r563", "r564", "r613" ], "calculation": { "http://ayro.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r320", "r321", "r322", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r344", "r345", "r346", "r347", "r348" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfRestrictedStockActivityDetails", "http://ayro.com/role/StockBasedCompensationDetailsNarrative", "http://ayro.com/role/StockholdersEquityDetailsNarrative", "http://ayro.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BondsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt security, in which the authorized issuer owes the holder a debt and is obliged to repay the principal and interest (the coupon).", "label": "Bonds [Member]" } } }, "localname": "BondsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfMarketableSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CapitalLeaseObligationsIncurred": { "auth_ref": [ "r44", "r45" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in lease obligation from new lease.", "label": "Supplemental non-cash amounts of lease liabilities arising from obtaining right of use assets" } } }, "localname": "CapitalLeaseObligationsIncurred", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents [Abstract]" } } }, "localname": "CashAndCashEquivalentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r42", "r153", "r481" ], "calculation": { "http://ayro.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash", "verboseLabel": "Cash and cash equivalents, at carrying value" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/BalanceSheets", "http://ayro.com/role/LiquidityAndOtherUncertaintiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r43" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock": { "auth_ref": [ "r65" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of cash, cash equivalents, and debt and equity securities, including any unrealized or realized gain (loss).", "label": "MARKETABLE SECURITIES" } } }, "localname": "CashCashEquivalentsAndMarketableSecuritiesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/MarketableSecurities" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r37", "r42", "r47" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "periodEndLabel": "Cash, end of year", "periodStartLabel": "Cash, beginning of year" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r37", "r122" ], "calculation": { "http://ayro.com/role/StatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net change in cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r157", "r158", "r159", "r183", "r200", "r201", "r203", "r205", "r210", "r211", "r246", "r266", "r269", "r270", "r271", "r275", "r276", "r277", "r278", "r282", "r286", "r295", "r388", "r480", "r532", "r547", "r553" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/BalanceSheets", "http://ayro.com/role/BalanceSheetsParenthetical", "http://ayro.com/role/ScheduleOfPaymentOfPreferredStockDetails", "http://ayro.com/role/StatementsOfChangesInStockholdersEquity", "http://ayro.com/role/StockholdersEquityDetailsNarrative", "http://ayro.com/role/StockholdersEquityTables" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfPaymentOfPreferredStockDetails", "http://ayro.com/role/StockholdersEquityTables" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r296" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Warrant exercise price", "periodEndLabel": "Weighted Average Exercise Price Outstanding", "periodStartLabel": "Weighted Average Exercise Price Outstanding" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfWarrantActivityDetails", "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "auth_ref": [ "r296" ], "lang": { "en-us": { "role": { "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "Warrants to purchase common stock" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights outstanding.", "label": "Warrants outstanding", "periodEndLabel": "Shares underlying warrants outstanding", "periodStartLabel": "Shares Underlying Warrants Outstanding" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfWarrantActivityDetails", "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of reason for issuing warrant or right.", "label": "Warrants description" } } }, "localname": "ClassOfWarrantOrRightReasonForIssuingToNonemployees", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]" } } }, "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r18", "r131", "r141" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r74", "r260", "r261", "r465", "r562" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Aggregate number of common shares reserved for future issuance.", "label": "Number of shares reserved" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r550", "r551", "r602" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfStock-basedCompensationStockOptionsActivityDetails", "http://ayro.com/role/StatementsOfChangesInStockholdersEquity", "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/BalanceSheetsParenthetical", "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r5", "r79" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesSubscribedButUnissued": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Amount of common stock allocated to investors to buy shares of a new issue of common stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds.", "label": "Common Stock, Shares Subscribed but Unissued" } } }, "localname": "CommonStockSharesSubscribedButUnissued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r5", "r508" ], "calculation": { "http://ayro.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, ($0.0001 par value; authorized \u2013 100,000,000 shares; issued and outstanding \u2013 37,241,642 and 36,866,956 as of December 31, 2022 and 2021, respectively)" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComputerEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.", "label": "Computer Equipment [Member]" } } }, "localname": "ComputerEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfEstimatedUsefulLivesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r55", "r56", "r119", "r120", "r240", "r464" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ConcentrationsAndCreditRiskDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r55", "r56", "r119", "r120", "r240", "r447", "r464" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ConcentrationsAndCreditRiskDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r55", "r56", "r119", "r120", "r240", "r464", "r625" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ConcentrationsAndCreditRiskDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskDisclosureTextBlock": { "auth_ref": [ "r61" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.", "label": "CONCENTRATIONS AND CREDIT RISK" } } }, "localname": "ConcentrationRiskDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ConcentrationsAndCreditRisk" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Concentration Risk [Line Items]" } } }, "localname": "ConcentrationRiskLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ConcentrationsAndCreditRiskDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r55", "r56", "r119", "r120", "r240" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration risk percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ConcentrationsAndCreditRiskDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTable": { "auth_ref": [ "r53", "r55", "r56", "r57", "r119", "r121", "r464" ], "lang": { "en-us": { "role": { "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Concentration Risk [Table]" } } }, "localname": "ConcentrationRiskTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ConcentrationsAndCreditRiskDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r55", "r56", "r119", "r120", "r240", "r464" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ConcentrationsAndCreditRiskDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r116", "r486" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Basis of Presentation and Principles of Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": { "auth_ref": [ "r568" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.", "label": "SCHEDULE OF CONTRACT LIABILITIES" } } }, "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/RevenuesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "auth_ref": [ "r298", "r299", "r310" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.", "label": "Contract with Customer, Liability, Current", "periodEndLabel": "Balance, end of period", "periodStartLabel": "Balance, beginning of period" } } }, "localname": "ContractWithCustomerLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfContractLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConversionOfStockSharesConverted1": { "auth_ref": [ "r44", "r45", "r46" ], "lang": { "en-us": { "role": { "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Conversion of stock shares" } } }, "localname": "ConversionOfStockSharesConverted1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ConversionOfStockSharesIssued1": { "auth_ref": [ "r44", "r45", "r46" ], "lang": { "en-us": { "role": { "documentation": "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Conversion of stock shares issued" } } }, "localname": "ConversionOfStockSharesIssued1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion": { "auth_ref": [ "r3", "r4", "r80", "r83", "r290" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued for each share of convertible preferred stock that is converted.", "label": "Equals the convertible shares of Company Common Stock" } } }, "localname": "ConvertiblePreferredStockSharesIssuedUponConversion", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfPaymentOfPreferredStockDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r27", "r423" ], "calculation": { "http://ayro.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of goods sold" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://ayro.com/role/PrepaidExpensesAndOtherCurrentAssetsDetailsNarrative", "http://ayro.com/role/StatementsOfOperations", "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfGoodsProductLineMember": { "auth_ref": [ "r554" ], "lang": { "en-us": { "role": { "documentation": "Cost of product sold and service rendered from specified product or service, when it serves as benchmark in concentration of risk calculation.", "label": "Cost of Goods and Service, Product and Service Benchmark [Member]" } } }, "localname": "CostOfGoodsProductLineMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ConcentrationsAndCreditRiskDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_CreditLossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Credit Loss [Abstract]" } } }, "localname": "CreditLossAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r54", "r240" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ConcentrationsAndCreditRiskDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_DebtSecuritiesTradingAndEquitySecuritiesFvNiCost": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cost of investment in debt investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security with change in fair value recognized in net income (FV-NI). Excludes equity method investment and investment in equity security without readily determinable fair value.", "label": "Cost Basis" } } }, "localname": "DebtSecuritiesTradingAndEquitySecuritiesFvNiCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfMarketableSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]" } } }, "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DeferredIncomeTaxLiabilities": { "auth_ref": [ "r1", "r2", "r128", "r136", "r365" ], "calculation": { "http://ayro.com/role/ScheduleOfDeferredTaxDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.", "label": "Deferred Tax Liabilities, Gross", "negatedTotalLabel": "Deferred tax liabilities" } } }, "localname": "DeferredIncomeTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfDeferredTaxDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsDeferredGainOnSaleLeasebackTransaction": { "auth_ref": [ "r113", "r600" ], "calculation": { "http://ayro.com/role/ScheduleOfDeferredTaxDetails": { "order": 8.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from a gain reported for tax purposes on sale and leaseback transactions in accordance with enacted tax laws.", "label": "Lease liability" } } }, "localname": "DeferredTaxAssetsDeferredGainOnSaleLeasebackTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfDeferredTaxDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets": { "auth_ref": [], "calculation": { "http://ayro.com/role/ScheduleOfDeferredTaxDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.", "label": "Intangible assets" } } }, "localname": "DeferredTaxAssetsGoodwillAndIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfDeferredTaxDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r366" ], "calculation": { "http://ayro.com/role/ScheduleOfDeferredTaxDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Gross", "totalLabel": "Deferred tax assets" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfDeferredTaxDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r113", "r600" ], "calculation": { "http://ayro.com/role/ScheduleOfDeferredTaxDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Net operating losses", "verboseLabel": "Deferred tax assets, operating loss carryforward" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/IncomeTaxesDetailsNarrative", "http://ayro.com/role/ScheduleOfDeferredTaxDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOther": { "auth_ref": [ "r113", "r600" ], "calculation": { "http://ayro.com/role/ScheduleOfDeferredTaxDetails": { "order": 9.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.", "label": "Other" } } }, "localname": "DeferredTaxAssetsOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfDeferredTaxDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits": { "auth_ref": [ "r113", "r600" ], "calculation": { "http://ayro.com/role/ScheduleOfDeferredTaxDetails": { "order": 4.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs.", "label": "Equity based compensation" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfDeferredTaxDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r367" ], "calculation": { "http://ayro.com/role/ScheduleOfDeferredTaxDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Valuation allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfDeferredTaxDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilities": { "auth_ref": [ "r105", "r599" ], "calculation": { "http://ayro.com/role/ScheduleOfDeferredTaxDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.", "label": "Deferred Tax Liabilities, Net", "totalLabel": "Net deferred tax asset/(liability)" } } }, "localname": "DeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfDeferredTaxDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": { "auth_ref": [ "r113", "r600" ], "calculation": { "http://ayro.com/role/ScheduleOfDeferredTaxDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.", "label": "Deferred Tax Liabilities, Leasing Arrangements", "negatedLabel": "ROU asset" } } }, "localname": "DeferredTaxLiabilitiesLeasingArrangements", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfDeferredTaxDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepositAssets": { "auth_ref": [ "r534" ], "calculation": { "http://ayro.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The carrying amount of the asset transferred to a third party to serve as a deposit, which typically serves as security against failure by the transferor to perform under terms of an agreement.", "label": "Deposits and other assets" } } }, "localname": "DepositAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r40", "r69" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation expenses", "verboseLabel": "Depreciation" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/InventoryNetDetailsNarrative", "http://ayro.com/role/PropertyAndEquipmentNetDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAndAmortization": { "auth_ref": [ "r40", "r69" ], "calculation": { "http://ayro.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.", "label": "Depreciation and amortization" } } }, "localname": "DepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation of Revenue [Line Items]" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [ "r309", "r496", "r497", "r498", "r499", "r500", "r501", "r502" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r569" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "SCHEDULE OF DISAGGREGATION OF REVENUE" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/RevenuesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r319", "r350", "r351", "r352", "r357", "r506" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "STOCK BASED COMPENSATION" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StockBasedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DomesticCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.", "label": "Domestic Tax Authority [Member]" } } }, "localname": "DomesticCountryMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/IncomeTaxesDetailsNarrative", "http://ayro.com/role/ScheduleOfIncomeTaxExaminationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DueToRelatedPartiesCurrentAndNoncurrent": { "auth_ref": [ "r130", "r142", "r268", "r269", "r270", "r274", "r275", "r276", "r413", "r549" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties.", "label": "Due to related parties" } } }, "localname": "DueToRelatedPartiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r173", "r191", "r192", "r193", "r194", "r195", "r199", "r200", "r203", "r204", "r205", "r207", "r386", "r387", "r436", "r439", "r491" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Net loss per share, basic and diluted" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r51", "r52" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Basic and Diluted Loss Per Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]" } } }, "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfStock-basedCompensationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "auth_ref": [ "r596" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.", "label": "Cost not yet recognized" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Share-Based Payment Arrangement, Option [Member]" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r79", "r148", "r169", "r170", "r171", "r186", "r187", "r188", "r190", "r196", "r198", "r209", "r247", "r297", "r353", "r354", "r355", "r371", "r372", "r385", "r389", "r390", "r391", "r392", "r393", "r394", "r409", "r442", "r443", "r444" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfStock-basedCompensationStockOptionsActivityDetails", "http://ayro.com/role/StatementsOfChangesInStockholdersEquity", "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r66" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Aggregate issued and outstanding shares percentage" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Fair Value Measurements" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Estimated useful life of intangible assets" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture and Fixtures [Member]" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfEstimatedUsefulLivesDetails", "http://ayro.com/role/ScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r29" ], "calculation": { "http://ayro.com/role/StatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r25", "r183", "r222", "r230", "r234", "r236", "r246", "r266", "r267", "r269", "r270", "r271", "r272", "r273", "r275", "r276", "r388", "r493", "r563" ], "calculation": { "http://ayro.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross loss" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.", "label": "Long-Lived Assets, Including Definite-Lived Intangible Assets" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r22", "r126", "r132", "r144", "r222", "r230", "r234", "r236", "r437", "r493" ], "calculation": { "http://ayro.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Net loss prior to provision for income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r258", "r259" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfStock-basedCompensationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r259" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement." } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfStock-basedCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxAuthorityAxis": { "auth_ref": [ "r108" ], "lang": { "en-us": { "role": { "documentation": "Information by tax jurisdiction.", "label": "Income Tax Authority [Axis]" } } }, "localname": "IncomeTaxAuthorityAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/IncomeTaxesDetailsNarrative", "http://ayro.com/role/ScheduleOfIncomeTaxExaminationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes." } } }, "localname": "IncomeTaxAuthorityDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/IncomeTaxesDetailsNarrative", "http://ayro.com/role/ScheduleOfIncomeTaxExaminationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxAuthorityNameAxis": { "auth_ref": [ "r108" ], "lang": { "en-us": { "role": { "documentation": "Information by name of taxing authority.", "label": "Income Tax Authority, Name [Axis]" } } }, "localname": "IncomeTaxAuthorityNameAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes." } } }, "localname": "IncomeTaxAuthorityNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r184", "r362", "r363", "r369", "r373", "r375", "r377", "r378", "r379" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "INCOME TAXES" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExaminationDescription": { "auth_ref": [ "r107" ], "lang": { "en-us": { "role": { "documentation": "A brief description of status of the tax examination, significant findings to date, and the entity's position with respect to the findings.", "label": "Income tax examiation year" } } }, "localname": "IncomeTaxExaminationDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfIncomeTaxExaminationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r185", "r197", "r198", "r221", "r360", "r374", "r376", "r440" ], "calculation": { "http://ayro.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Provision for income taxes", "verboseLabel": "Total income tax expense" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfReconciliationStatutoryFederalIncomeTaxRateDetails", "http://ayro.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r168", "r358", "r359", "r363", "r364", "r368", "r370" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r598" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.", "label": "Change in valuation allowance" } } }, "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfReconciliationStatutoryFederalIncomeTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r361" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Income tax benefit at statutory U.S. federal rate" } } }, "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfReconciliationStatutoryFederalIncomeTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationNondeductibleExpense": { "auth_ref": [ "r598" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.", "label": "Permanent difference - non-deductible compensation" } } }, "localname": "IncomeTaxReconciliationNondeductibleExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfReconciliationStatutoryFederalIncomeTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationOtherAdjustments": { "auth_ref": [ "r598" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.", "label": "Basis adjustments" } } }, "localname": "IncomeTaxReconciliationOtherAdjustments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfReconciliationStatutoryFederalIncomeTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": { "auth_ref": [ "r598" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).", "label": "Income tax benefit attributable to U.S. states" } } }, "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfReconciliationStatutoryFederalIncomeTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r39" ], "calculation": { "http://ayro.com/role/StatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "verboseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r39" ], "calculation": { "http://ayro.com/role/StatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r39" ], "calculation": { "http://ayro.com/role/StatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Increase (Decrease) in Accrued Liabilities", "verboseLabel": "Accrued expenses" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "auth_ref": [ "r421", "r545" ], "calculation": { "http://ayro.com/role/StatementsOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Contract liability" } } }, "localname": "IncreaseDecreaseInContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDepositOtherAssets": { "auth_ref": [ "r39" ], "calculation": { "http://ayro.com/role/StatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in moneys or securities given as security including, but not limited to, contract, escrow, or earnest money deposits, retainage (if applicable), deposits with clearing organizations and others, collateral, or margin deposits.", "label": "Increase (Decrease) in Deposit Assets", "negatedLabel": "Deposits" } } }, "localname": "IncreaseDecreaseInDepositOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r39" ], "calculation": { "http://ayro.com/role/StatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventory" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Change in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "auth_ref": [ "r545", "r606" ], "calculation": { "http://ayro.com/role/StatementsOfCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation for operating lease.", "label": "Lease obligations - operating leases" } } }, "localname": "IncreaseDecreaseInOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r39" ], "calculation": { "http://ayro.com/role/StatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaid expenses and other current assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r123", "r134", "r172", "r220", "r396" ], "calculation": { "http://ayro.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r176", "r178", "r179" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Cash paid for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryCurrentTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about inventory expected to be sold or consumed within one year or operating cycle, if longer.", "label": "Inventory, Current [Table]" } } }, "localname": "InventoryCurrentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/InventoryNetDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r254" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "INVENTORY, NET" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/InventoryNet" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoods": { "auth_ref": [ "r537" ], "calculation": { "http://ayro.com/role/ScheduleOfInventoryDetails": { "order": 3.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.", "label": "Finished goods" } } }, "localname": "InventoryFinishedGoods", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Inventory [Line Items]" } } }, "localname": "InventoryLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/InventoryNetDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r163", "r482", "r508" ], "calculation": { "http://ayro.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://ayro.com/role/ScheduleOfInventoryDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory", "totalLabel": "Total" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/BalanceSheets", "http://ayro.com/role/ScheduleOfInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryPolicyTextBlock": { "auth_ref": [ "r152", "r162", "r208", "r251", "r253", "r254", "r422", "r487" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.", "label": "Inventory, Policy [Policy Text Block]", "verboseLabel": "Inventory" } } }, "localname": "InventoryPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryRawMaterialsAndSupplies": { "auth_ref": [ "r540" ], "calculation": { "http://ayro.com/role/ScheduleOfInventoryDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed.", "label": "Raw materials" } } }, "localname": "InventoryRawMaterialsAndSupplies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryValuationReserves": { "auth_ref": [ "r67", "r540" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of valuation reserve for inventory.", "label": "Inventory reserves", "verboseLabel": "Inventory reserve" } } }, "localname": "InventoryValuationReserves", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/InventoryNetDetailsNarrative", "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcess": { "auth_ref": [ "r538" ], "calculation": { "http://ayro.com/role/ScheduleOfInventoryDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.", "label": "Work-in-progress" } } }, "localname": "InventoryWorkInProcess", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWriteDown": { "auth_ref": [ "r252" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.", "label": "Inventory write down", "verboseLabel": "Inventory written-off" } } }, "localname": "InventoryWriteDown", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://ayro.com/role/InventoryNetDetailsNarrative", "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentTypeAxis": { "auth_ref": [ "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462" ], "lang": { "en-us": { "role": { "documentation": "Information by type of investments.", "label": "Investment Type [Axis]" } } }, "localname": "InvestmentTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfMarketableSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentTypeCategorizationMember": { "auth_ref": [ "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462" ], "lang": { "en-us": { "role": { "documentation": "Asset obtained to generate income or appreciate in value." } } }, "localname": "InvestmentTypeCategorizationMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfMarketableSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InvestorMember": { "auth_ref": [ "r609", "r610" ], "lang": { "en-us": { "role": { "documentation": "Business entity or individual that puts money, by purchase or expenditure, in something offering potential profitable returns, such as interest income or appreciation in value.", "label": "Investor [Member]" } } }, "localname": "InvestorMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_LeaseCost": { "auth_ref": [ "r407", "r507" ], "calculation": { "http://ayro.com/role/ScheduleOfComponentsOfLeaseExpensesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease cost recognized by lessee for lease contract.", "label": "Lease, Cost", "totalLabel": "Total lease cost" } } }, "localname": "LeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfComponentsOfLeaseExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r607" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "SCHEDULE OF COMPONENTS OF LEASE EXPENSES" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/CommitmentsAndContingenciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r70" ], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfEstimatedUsefulLivesDetails", "http://ayro.com/role/ScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LegalFees": { "auth_ref": [ "r28" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.", "label": "Legal fees" } } }, "localname": "LegalFees", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r400" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "Leases" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r608" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/CommitmentsAndContingenciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r408" ], "calculation": { "http://ayro.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "totalLabel": "Total minimum lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r408" ], "calculation": { "http://ayro.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r408" ], "calculation": { "http://ayro.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2026" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r408" ], "calculation": { "http://ayro.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r408" ], "calculation": { "http://ayro.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r408" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "negatedLabel": "Less effects of discounting" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": { "auth_ref": [ "r605" ], "lang": { "en-us": { "role": { "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Weighted average remaining lease term (in years) - operating lease", "verboseLabel": "Remaining term of lease" } } }, "localname": "LesseeOperatingLeaseRemainingLeaseTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://ayro.com/role/ScheduleOfWeighted-AverageRemainingLeaseTermAndDiscountRateDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LesseeOperatingSubleaseOptionToExtend": { "auth_ref": [ "r401" ], "lang": { "en-us": { "role": { "documentation": "Description of terms and conditions of option to extend operating sublease.", "label": "Operating sub lease, expansion description" } } }, "localname": "LesseeOperatingSubleaseOptionToExtend", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r15", "r183", "r246", "r266", "r267", "r269", "r270", "r271", "r272", "r273", "r275", "r276", "r381", "r382", "r383", "r388", "r492", "r563", "r613", "r614" ], "calculation": { "http://ayro.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r10", "r129", "r139", "r508", "r548", "r556", "r604" ], "calculation": { "http://ayro.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and stockholders\u2019 equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r17", "r151", "r183", "r246", "r266", "r267", "r269", "r270", "r271", "r272", "r273", "r275", "r276", "r381", "r382", "r383", "r388", "r508", "r563", "r613", "r614" ], "calculation": { "http://ayro.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LitigationSettlementExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.", "label": "Settlement of multiple employment disputes" } } }, "localname": "LitigationSettlementExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_MachineryAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.", "label": "Machinery and Equipment [Member]" } } }, "localname": "MachineryAndEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfEstimatedUsefulLivesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MarketableSecuritiesCurrent": { "auth_ref": [], "calculation": { "http://ayro.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in marketable security, classified as current.", "label": "Marketable securities", "terseLabel": "Fair Value", "verboseLabel": "Marketable securities, current" } } }, "localname": "MarketableSecuritiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/BalanceSheets", "http://ayro.com/role/LiquidityAndOtherUncertaintiesDetailsNarrative", "http://ayro.com/role/ScheduleOfMarketableSecuritiesDetails", "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_MarketableSecuritiesPolicy": { "auth_ref": [ "r135" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for investment classified as marketable security.", "label": "Marketable Securities" } } }, "localname": "MarketableSecuritiesPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments": { "auth_ref": [], "calculation": { "http://ayro.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://ayro.com/role/StatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of realized gain (loss) on investment in marketable security, excluding other-than-temporary impairment (OTTI).", "label": "Realized gain on marketable securities", "negatedLabel": "Realized gain on marketable securities", "verboseLabel": "Gross Realized Gains" } } }, "localname": "MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfMarketableSecuritiesDetails", "http://ayro.com/role/StatementsOfCashFlows", "http://ayro.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_MarketableSecuritiesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.", "label": "SCHEDULE OF MARKETABLE SECURITIES" } } }, "localname": "MarketableSecuritiesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/MarketableSecuritiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_MarketableSecuritiesUnrealizedGainLoss": { "auth_ref": [ "r24" ], "calculation": { "http://ayro.com/role/StatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://ayro.com/role/StatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) on investment in marketable security.", "label": "Unrealized loss on marketable securities", "negatedLabel": "Unrealized loss on marketable securities", "verboseLabel": "Gross Unrealized Losses" } } }, "localname": "MarketableSecuritiesUnrealizedGainLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfMarketableSecuritiesDetails", "http://ayro.com/role/StatementsOfCashFlows", "http://ayro.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NatureOfOperations": { "auth_ref": [ "r212", "r217" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.", "label": "ORGANIZATION AND NATURE OF OPERATIONS" } } }, "localname": "NatureOfOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/OrganizationAndNatureOfOperations" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r177" ], "calculation": { "http://ayro.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM FINANCING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r177" ], "calculation": { "http://ayro.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM INVESTING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r37", "r38", "r41" ], "calculation": { "http://ayro.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "negatedLabel": "Net cash provided by (used in) operating activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/LiquidityAndOtherUncertaintiesDetailsNarrative", "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM OPERATING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r23", "r41", "r133", "r143", "r149", "r166", "r167", "r171", "r183", "r189", "r191", "r192", "r193", "r194", "r197", "r198", "r202", "r222", "r230", "r234", "r236", "r246", "r266", "r267", "r269", "r270", "r271", "r272", "r273", "r275", "r276", "r387", "r388", "r493", "r563" ], "calculation": { "http://ayro.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://ayro.com/role/StatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Loss", "negatedLabel": "Net losses", "totalLabel": "Net loss", "verboseLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/LiquidityAndOtherUncertaintiesDetailsNarrative", "http://ayro.com/role/StatementsOfCashFlows", "http://ayro.com/role/StatementsOfChangesInStockholdersEquity", "http://ayro.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r31" ], "calculation": { "http://ayro.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Total other income (expense), net" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other income (expense):" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://ayro.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating expense", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://ayro.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r222", "r230", "r234", "r236", "r493" ], "calculation": { "http://ayro.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r402", "r507" ], "calculation": { "http://ayro.com/role/ScheduleOfComponentsOfLeaseExpensesDetails": { "order": 1.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating lease expense" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfComponentsOfLeaseExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r398" ], "calculation": { "http://ayro.com/role/ScheduleOfOperatingLeasesRightOfUseAssetsAndLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Present value of future minimum lease payments", "totalLabel": "Total lease liability", "verboseLabel": "Lease liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://ayro.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails", "http://ayro.com/role/ScheduleOfOperatingLeasesRightOfUseAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r398" ], "calculation": { "http://ayro.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://ayro.com/role/ScheduleOfOperatingLeasesRightOfUseAssetsAndLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Current portion lease obligation \u2013 operating lease", "verboseLabel": "Lease obligation \u2013 operating lease" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/BalanceSheets", "http://ayro.com/role/ScheduleOfOperatingLeasesRightOfUseAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r398" ], "calculation": { "http://ayro.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 }, "http://ayro.com/role/ScheduleOfOperatingLeasesRightOfUseAssetsAndLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Lease obligation - operating lease, net of current portion" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/BalanceSheets", "http://ayro.com/role/ScheduleOfOperatingLeasesRightOfUseAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r399", "r404" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating cash flows for operating leases" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r397" ], "calculation": { "http://ayro.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://ayro.com/role/ScheduleOfOperatingLeasesRightOfUseAssetsAndLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating lease \u2013 right-of-use asset", "totalLabel": "Total lease assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/BalanceSheets", "http://ayro.com/role/ScheduleOfOperatingLeasesRightOfUseAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": { "auth_ref": [ "r546" ], "calculation": { "http://ayro.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense for right-of-use asset from operating lease.", "label": "Amortization of right-of-use asset" } } }, "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r406", "r507" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Weighted average discount rate - operating lease" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfWeighted-AverageRemainingLeaseTermAndDiscountRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r111" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Net operating loss carryforwards" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwardsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Operating Loss Carryforwards [Line Items]" } } }, "localname": "OperatingLossCarryforwardsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/IncomeTaxesDetailsNarrative", "http://ayro.com/role/ScheduleOfIncomeTaxExaminationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLossCarryforwardsTable": { "auth_ref": [ "r112" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.", "label": "Operating Loss Carryforwards [Table]" } } }, "localname": "OperatingLossCarryforwardsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/IncomeTaxesDetailsNarrative", "http://ayro.com/role/ScheduleOfIncomeTaxExaminationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r16" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other accrued liabilities, current" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCurrentAssetsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for other current assets.", "label": "PREPAID EXPENSES AND OTHER CURRENT ASSETS" } } }, "localname": "OtherCurrentAssetsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/PrepaidExpensesAndOtherCurrentAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherNonoperatingIncome": { "auth_ref": [ "r175" ], "calculation": { "http://ayro.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income related to nonoperating activities, classified as other.", "label": "Interest income" } } }, "localname": "OtherNonoperatingIncome", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherPrepaidExpenseCurrent": { "auth_ref": [ "r541", "r558" ], "calculation": { "http://ayro.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails": { "order": 6.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid other" } } }, "localname": "OtherPrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfStockIssuanceCosts": { "auth_ref": [ "r36" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.", "label": "Offering expenses" } } }, "localname": "PaymentsOfStockIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "auth_ref": [ "r33" ], "calculation": { "http://ayro.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.", "label": "Payments to Acquire Intangible Assets", "negatedLabel": "Purchase of intangible assets" } } }, "localname": "PaymentsToAcquireIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireMarketableSecurities": { "auth_ref": [ "r64" ], "calculation": { "http://ayro.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for purchase of marketable security.", "label": "Payments to Acquire Marketable Securities", "negatedLabel": "Purchase of marketable securities, net" } } }, "localname": "PaymentsToAcquireMarketableSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r33" ], "calculation": { "http://ayro.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchase of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r570", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r593", "r594", "r595" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StockBasedCompensationDetailsNarrative", "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [ "r570", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r593", "r594", "r595" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement." } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StockBasedCompensationDetailsNarrative", "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockConversionBasis": { "auth_ref": [ "r4", "r80" ], "lang": { "en-us": { "role": { "documentation": "Describe the conversion features of preferred stock if preferred stock is convertible. That is, shares of preferred stock into which another convertible security was converted, or shares of preferred stock into which another class of preferred stock was converted.", "label": "Preferred stock, conversion price description" } } }, "localname": "PreferredStockConversionBasis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PreferredStockConvertibleConversionPrice": { "auth_ref": [ "r279" ], "lang": { "en-us": { "role": { "documentation": "Per share conversion price of preferred stock.", "label": "Divided by the conversion price" } } }, "localname": "PreferredStockConvertibleConversionPrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfPaymentOfPreferredStockDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockConvertibleConversionPriceIncrease": { "auth_ref": [ "r288", "r296" ], "lang": { "en-us": { "role": { "documentation": "Per share increase in conversion price of convertible preferred stock. Excludes change due to standard antidilution provision.", "label": "Convertible conversion price increase" } } }, "localname": "PreferredStockConvertibleConversionPriceIncrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockLiquidationPreference": { "auth_ref": [ "r4", "r80", "r81", "r547", "r566" ], "lang": { "en-us": { "role": { "documentation": "The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share.", "label": "Liquidation Value" } } }, "localname": "PreferredStockLiquidationPreference", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfPaymentOfPreferredStockDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockLiquidationPreferenceValue": { "auth_ref": [ "r181", "r282" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of the difference between preference in liquidation and the par or stated values of the preferred shares.", "label": "Preferred Stock, Liquidation Preference, Value", "verboseLabel": "Liquidation Value" } } }, "localname": "PreferredStockLiquidationPreferenceValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfPaymentOfPreferredStockDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfChangesInStockholdersEquity", "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r4", "r277" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred stock, par value", "verboseLabel": "Preferred stock stated value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/BalanceSheetsParenthetical", "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/BalanceSheetsParenthetical", "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r4", "r277" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred stock, shares outstanding", "verboseLabel": "Number of Series H Preferred Stock outstanding as of December 31, 2022" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/BalanceSheetsParenthetical", "http://ayro.com/role/ScheduleOfPaymentOfPreferredStockDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r4", "r508" ], "calculation": { "http://ayro.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred stock, value" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r542" ], "calculation": { "http://ayro.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://ayro.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid expenses and other current assets", "totalLabel": "Total Prepaid Expenses and Other Current Assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/BalanceSheets", "http://ayro.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r164", "r255", "r256", "r484" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid balance" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidInsurance": { "auth_ref": [ "r485", "r494", "r558" ], "calculation": { "http://ayro.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails": { "order": 3.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepayments for insurance" } } }, "localname": "PrepaidInsurance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreproductionCostsRelatedToLongTermSupplyArrangementsCostsCapitalized": { "auth_ref": [ "r257" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The carrying amount as of the balance sheet date of capitalized preproduction costs incurred on long-term supply arrangements, including recoverable costs to design and develop products.", "label": "Pre-production costs" } } }, "localname": "PreproductionCostsRelatedToLongTermSupplyArrangementsCostsCapitalized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PriorPeriodReclassificationAdjustmentDescription": { "auth_ref": [ "r533" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.", "label": "Reclassification" } } }, "localname": "PriorPeriodReclassificationAdjustmentDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r34" ], "calculation": { "http://ayro.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from issuance of Common Stock, net of fees and expenses" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r34", "r100" ], "calculation": { "http://ayro.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Proceeds from exercise of stock options" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromWarrantExercises": { "auth_ref": [ "r543" ], "calculation": { "http://ayro.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants.", "label": "Proceeds from exercise of warrants, net of fees" } } }, "localname": "ProceedsFromWarrantExercises", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductMember": { "auth_ref": [ "r496" ], "lang": { "en-us": { "role": { "documentation": "Article or substance produced by nature, labor or machinery.", "label": "Product [Member]" } } }, "localname": "ProductMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProductionRelatedImpairmentsOrCharges": { "auth_ref": [ "r26" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Nonrecurring impairment charges related to the write-off of production-related equipment and inventory. This tag is used when an Entity charges this cost to cost of goods sold.", "label": "Impairment of inventory" } } }, "localname": "ProductionRelatedImpairmentsOrCharges", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r72" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/PropertyAndEquipmentNetDetailsNarrative", "http://ayro.com/role/ScheduleOfEstimatedUsefulLivesDetails", "http://ayro.com/role/ScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r73", "r466", "r467", "r468" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "PROPERTY AND EQUIPMENT, NET" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/PropertyAndEquipmentNet" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives": { "auth_ref": [ "r68" ], "lang": { "en-us": { "role": { "documentation": "Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).", "label": "Property, Plant and Equipment, Estimated Useful Lives", "verboseLabel": "Property plant and equipment, estimated useful lives" } } }, "localname": "PropertyPlantAndEquipmentEstimatedUsefulLives", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfEstimatedUsefulLivesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r70", "r154" ], "calculation": { "http://ayro.com/role/ScheduleOfPropertyAndEquipmentNetDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property and equipment, gross" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/PropertyAndEquipmentNetDetailsNarrative", "http://ayro.com/role/ScheduleOfEstimatedUsefulLivesDetails", "http://ayro.com/role/ScheduleOfPropertyAndEquipmentNetDetails", "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r72", "r140", "r438", "r508" ], "calculation": { "http://ayro.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://ayro.com/role/ScheduleOfPropertyAndEquipmentNetDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property and equipment, net", "totalLabel": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/BalanceSheets", "http://ayro.com/role/ScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r72", "r466", "r467" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property and Equipment, Net" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r72" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "SCHEDULE OF PROPERTY AND EQUIPMENT, NET" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/PropertyAndEquipmentNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r70" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/PropertyAndEquipmentNetDetailsNarrative", "http://ayro.com/role/ScheduleOfEstimatedUsefulLivesDetails", "http://ayro.com/role/ScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property plant and equipment, estimated useful lives" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfEstimatedUsefulLivesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r174", "r249" ], "calculation": { "http://ayro.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "Bad debt expense" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/AccountsReceivableNetDetailsNarrative", "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PublicUtilitiesInventoryAxis": { "auth_ref": [ "r539" ], "lang": { "en-us": { "role": { "documentation": "Information by type of inventory held.", "label": "Inventory [Axis]" } } }, "localname": "PublicUtilitiesInventoryAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/InventoryNetDetailsNarrative", "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PublicUtilitiesInventoryTypeDomain": { "auth_ref": [ "r539" ], "lang": { "en-us": { "role": { "documentation": "Tangible personal property that is held for sale in the ordinary course of business, in process of production for such sale or is to be currently consumed in the production of goods or services to be available for sale." } } }, "localname": "PublicUtilitiesInventoryTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/InventoryNetDetailsNarrative", "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy": { "auth_ref": [ "r62" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.", "label": "Accounts Receivable, Net" } } }, "localname": "ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r314", "r412", "r413" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/RelatedPartyTransactionsDetailsNarrative", "http://ayro.com/role/StockBasedCompensationDetailsNarrative", "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r147", "r412", "r413", "r612" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r147" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party." } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r314", "r412", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r612" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/RelatedPartyTransactionsDetailsNarrative", "http://ayro.com/role/StockBasedCompensationDetailsNarrative", "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r410", "r411", "r413", "r414", "r415" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "RELATED PARTY TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfDebt": { "auth_ref": [ "r544" ], "calculation": { "http://ayro.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.", "label": "Repayments of Debt", "negatedLabel": "Repayments of debt" } } }, "localname": "RepaymentsOfDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfRelatedPartyDebt": { "auth_ref": [ "r35" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.", "label": "Repayments of related party debt" } } }, "localname": "RepaymentsOfRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r104", "r146", "r621" ], "calculation": { "http://ayro.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and development", "terseLabel": "Capitalization of research and development costs", "verboseLabel": "Research and development expenses" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/IncomeTaxesDetailsNarrative", "http://ayro.com/role/StatementsOfOperations", "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "auth_ref": [ "r104" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.", "label": "Research and development costs" } } }, "localname": "ResearchAndDevelopmentExpensePolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r51" ], "lang": { "en-us": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted Stock [Member]" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StockBasedCompensationDetailsNarrative", "http://ayro.com/role/StockholdersEquityDetailsNarrative", "http://ayro.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfRestrictedStockActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r7", "r87", "r138", "r445", "r446", "r508" ], "calculation": { "http://ayro.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r148", "r186", "r187", "r188", "r190", "r196", "r198", "r247", "r353", "r354", "r355", "r371", "r372", "r385", "r442", "r444" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r218", "r219", "r229", "r232", "r233", "r237", "r238", "r240", "r308", "r309", "r423" ], "calculation": { "http://ayro.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue", "verboseLabel": "Total Revenue" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfDisaggregationOfRevenueDetails", "http://ayro.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r311", "r312" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "REVENUES" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/Revenues" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r488", "r489" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue Recognition" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "auth_ref": [ "r405", "r507" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "verboseLabel": "Supplemental non-cash amounts of lease liabilities arising from obtaining right of use assets" } } }, "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RisksAndUncertaintiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Risks and Uncertainties [Abstract]" } } }, "localname": "RisksAndUncertaintiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash received on stock transaction after deduction of issuance costs.", "label": "Proceeds from sale of common stock" } } }, "localname": "SaleOfStockConsiderationReceivedOnTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockDescriptionOfTransaction": { "auth_ref": [ "r115", "r117", "r118" ], "lang": { "en-us": { "role": { "documentation": "Description of stock transaction which may include details of the offering (IPO, private placement), a description of the stock sold, percentage of subsidiary's or equity investee's stock sold, a description of the investors and whether the stock was issued in a business combination.", "label": "Purchase of additional shares description" } } }, "localname": "SaleOfStockDescriptionOfTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": { "auth_ref": [ "r21" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.", "label": "SCHEDULE OF ACCOUNTS RECEIVABLE" } } }, "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/AccountsReceivableNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r51" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r51" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.", "label": "SCHEDULE OF CASH FLOW INFORMATION" } } }, "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/CommitmentsAndContingenciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "auth_ref": [ "r601" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]" } } }, "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r110" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "SCHEDULE OF DEFERRED TAX" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r106" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "SCHEDULE OF RECONCILIATION STATUTORY FEDERAL INCOME TAX RATE" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "auth_ref": [ "r98", "r101" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfStock-basedCompensationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r0", "r11", "r12", "r13" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "SCHEDULE OF INVENTORY" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/InventoryNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Net Investment Income [Line Items]" } } }, "localname": "ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfMarketableSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable": { "auth_ref": [ "r30", "r32", "r145" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about investment income, including, but not limited to, interest and dividend income and amortization of discount (premium) derived from debt and equity securities. Excludes realized and unrealized gain (loss) on investments.", "label": "Investment Income [Table]" } } }, "localname": "ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfMarketableSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": { "auth_ref": [ "r93" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units.", "label": "SCHEDULE OF RESTRICTED STOCK ACTIVITY" } } }, "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amounts of other current assets.", "label": "SCHEDULE OF PREPAID EXPENSES AND OTHER CURRENT ASSETS" } } }, "localname": "ScheduleOfOtherCurrentAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/PrepaidExpensesAndOtherCurrentAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": { "auth_ref": [ "r75" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.", "label": "SCHEDULE OF WARRANT ACTIVITY" } } }, "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r72" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/PropertyAndEquipmentNetDetailsNarrative", "http://ayro.com/role/ScheduleOfEstimatedUsefulLivesDetails", "http://ayro.com/role/ScheduleOfPropertyAndEquipmentNetDetails", "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r124", "r125" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock": { "auth_ref": [ "r93", "r94", "r95" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.", "label": "SCHEDULE OF STOCK-BASED COMPENSATION" } } }, "localname": "ScheduleOfShareBasedCompensationActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r316", "r318", "r320", "r321", "r322", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r344", "r345", "r346", "r347", "r348" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfRestrictedStockActivityDetails", "http://ayro.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r91", "r94", "r95" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "SCHEDULE OF STOCK-BASED COMPENSATION, STOCK OPTIONS, ACTIVITY" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r97" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "SCHEDULE OF STOCK-BASED PAYMENT AWARD, STOCK OPTIONS, VALUATION ASSUMPTIONS" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r76", "r77", "r78", "r80", "r81", "r82", "r84", "r85", "r86", "r87", "r157", "r158", "r159", "r210", "r277", "r278", "r280", "r282", "r286", "r293", "r295", "r495", "r532", "r547" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfPaymentOfPreferredStockDetails", "http://ayro.com/role/StockholdersEquityTables" ], "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "auth_ref": [ "r223", "r224", "r225", "r226", "r227", "r228", "r238" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for segment reporting.", "label": "Segment Reporting" } } }, "localname": "SegmentReportingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingAndMarketingExpense": { "auth_ref": [], "calculation": { "http://ayro.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.", "label": "Sales and marketing" } } }, "localname": "SellingAndMarketingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_SeriesHPreferredStockMember": { "auth_ref": [ "r535", "r536", "r567" ], "lang": { "en-us": { "role": { "documentation": "Series H preferred stock.", "label": "Series H Preferred Stock [Member]" } } }, "localname": "SeriesHPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfChangesInStockholdersEquity", "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r39" ], "calculation": { "http://ayro.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Stock-based compensation", "terseLabel": "Share based compensation", "verboseLabel": "Share based compensation expenses" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://ayro.com/role/StatementsOfCashFlows", "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights": { "auth_ref": [ "r90" ], "lang": { "en-us": { "role": { "documentation": "Description of service or performance condition required to be met for earning right to award under share-based payment arrangement. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Restricted stock vesting description" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r337" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "negatedLabel": "Number of shares, Forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfRestrictedStockActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r335" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Number of shares, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfRestrictedStockActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r332", "r333" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Number of shares, Outstanding, Ending balance", "periodStartLabel": "Number of shares, Outstanding, Beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfRestrictedStockActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r336" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Number of restricted shares issued and vested", "negatedLabel": "Number of shares, Vested", "verboseLabel": "Issuance of common stock upon vesting of restrcited stock" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfRestrictedStockActivityDetails", "http://ayro.com/role/StockBasedCompensationDetailsNarrative", "http://ayro.com/role/StockholdersEquityDetailsNarrative", "http://ayro.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.", "label": "Exercise price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfStock-basedPaymentAwardStockOptionsValuationAssumptionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r345" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Expected volatility", "verboseLabel": "Volatility rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfStock-basedPaymentAwardStockOptionsValuationAssumptionsDetails", "http://ayro.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r347" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Risk-free interest" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfStock-basedPaymentAwardStockOptionsValuationAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfRestrictedStockActivityDetails", "http://ayro.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": { "auth_ref": [ "r92" ], "lang": { "en-us": { "role": { "documentation": "Net number of non-option equity instruments granted to participants.", "label": "Number of warrants issued" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "auth_ref": [ "r99" ], "lang": { "en-us": { "role": { "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.", "label": "Number of stock options available for grants" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r330" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period", "negatedLabel": "Number of Stock options, Forfeitures" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfStock-basedCompensationStockOptionsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r328" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Number of options granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Weighted Average Grant Price, Granted", "verboseLabel": "Grant date fair value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfRestrictedStockActivityDetails", "http://ayro.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r324", "r325" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Options to purchase shares outstanding", "periodEndLabel": "Number of Stock options outstanding, Ending balance", "periodStartLabel": "Number of Stock options outstanding, Beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfStock-basedCompensationStockOptionsActivityDetails", "http://ayro.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r324", "r325" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Weighted Average Exercise Price Outstanding, Ending balance", "periodStartLabel": "Weighted Average Exercise Price Outstanding, Beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfStock-basedCompensationStockOptionsActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": { "auth_ref": [ "r341" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Aggregate intrinsic value of stock options vested and exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward": { "auth_ref": [ "r597" ], "lang": { "en-us": { "role": { "documentation": "Number of shares purchased for issuance under share-based payment arrangement.", "label": "Number of additional shares purchased" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r320", "r321", "r322", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r344", "r345", "r346", "r347", "r348" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfRestrictedStockActivityDetails", "http://ayro.com/role/StockBasedCompensationDetailsNarrative", "http://ayro.com/role/StockholdersEquityDetailsNarrative", "http://ayro.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r329" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "negatedLabel": "Weighted Average Exercise Price Outstanding, Exercised" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfStock-basedCompensationStockOptionsActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r330" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price", "negatedLabel": "Weighted Average Exercise Price Outstanding, Forfeitures" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfStock-basedCompensationStockOptionsActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r323", "r342", "r343", "r344", "r345", "r348", "r356", "r357" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Stock-Based Compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Offering price", "verboseLabel": "Share price" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfStock-basedPaymentAwardStockOptionsValuationAssumptionsDetails", "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r344" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Expected life (years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfStock-basedPaymentAwardStockOptionsValuationAssumptionsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant-date fair value of non-vested options forfeited.", "label": "Weighted Average Grant Price, Forfeited" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfRestrictedStockActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant-date fair value of non-vested options outstanding.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price", "periodEndLabel": "Weighted Average Grant Price, Outstanding, Ending balance", "periodStartLabel": "Weighted Average Grant Price, Outstanding, Beginning balance" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfRestrictedStockActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r96" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "verboseLabel": "Weighted average remaining contractual life" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfStock-basedCompensationStockOptionsActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of options vested.", "label": "Number of shares vested" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StockBasedCompensationDetailsNarrative", "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Multiplied by the fair market value of Company Common Stock as of December 31, 2022", "verboseLabel": "Share price" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfPaymentOfPreferredStockDetails", "http://ayro.com/role/StockBasedCompensationDetailsNarrative", "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Ending balance, shares", "periodStartLabel": "Beginning balance, shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermLeaseCost": { "auth_ref": [ "r403", "r507" ], "calculation": { "http://ayro.com/role/ScheduleOfComponentsOfLeaseExpensesDetails": { "order": 2.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.", "label": "Short-term lease expense" } } }, "localname": "ShortTermLeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfComponentsOfLeaseExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r48", "r180" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StateAndLocalJurisdictionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.", "label": "State and Local Jurisdiction [Member]" } } }, "localname": "StateAndLocalJurisdictionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r157", "r158", "r159", "r183", "r200", "r201", "r203", "r205", "r210", "r211", "r246", "r266", "r269", "r270", "r271", "r275", "r276", "r277", "r278", "r282", "r286", "r295", "r388", "r480", "r532", "r547", "r553" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/BalanceSheets", "http://ayro.com/role/BalanceSheetsParenthetical", "http://ayro.com/role/ScheduleOfPaymentOfPreferredStockDetails", "http://ayro.com/role/StatementsOfChangesInStockholdersEquity", "http://ayro.com/role/StockholdersEquityDetailsNarrative", "http://ayro.com/role/StockholdersEquityTables" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r20", "r79", "r148", "r169", "r170", "r171", "r186", "r187", "r188", "r190", "r196", "r198", "r209", "r247", "r297", "r353", "r354", "r355", "r371", "r372", "r385", "r389", "r390", "r391", "r392", "r393", "r394", "r409", "r442", "r443", "r444" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfStock-basedCompensationStockOptionsActivityDetails", "http://ayro.com/role/StatementsOfChangesInStockholdersEquity", "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/BalanceSheets", "http://ayro.com/role/BalanceSheetsParenthetical", "http://ayro.com/role/PrepaidExpensesAndOtherCurrentAssetsDetailsNarrative", "http://ayro.com/role/ScheduleOfStock-basedCompensationStockOptionsActivityDetails", "http://ayro.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r186", "r187", "r188", "r209", "r423" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/BalanceSheets", "http://ayro.com/role/BalanceSheetsParenthetical", "http://ayro.com/role/PrepaidExpensesAndOtherCurrentAssetsDetailsNarrative", "http://ayro.com/role/ScheduleOfStock-basedCompensationStockOptionsActivityDetails", "http://ayro.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssued1": { "auth_ref": [ "r44", "r45", "r46" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value of stock issued in noncash financing activities.", "label": "Restricted Stock issued previously accrued" } } }, "localname": "StockIssued1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Issuance of common stock for services, shares" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r4", "r5", "r79", "r87" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Number of shares issued" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesOther": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued attributable to transactions classified as other.", "label": "Sale of common stock, net of fees, shares" } } }, "localname": "StockIssuedDuringPeriodSharesOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": { "auth_ref": [ "r79", "r87" ], "lang": { "en-us": { "role": { "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.", "label": "Number of restricted shares", "verboseLabel": "Number of restricted stock units" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StockBasedCompensationDetailsNarrative", "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": { "auth_ref": [ "r4", "r5", "r79", "r87" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.", "label": "Vested restricted stock , shares" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r4", "r5", "r79", "r87", "r329" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Exercise of stock options, shares", "negatedLabel": "Number of Stock options, Exercised", "verboseLabel": "Shares issued for exercised stock options, shares" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfStock-basedCompensationStockOptionsActivityDetails", "http://ayro.com/role/StatementsOfChangesInStockholdersEquity", "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.", "label": "Issuance of common stock for services" } } }, "localname": "StockIssuedDuringPeriodValueIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r4", "r5", "r79", "r87" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Value of common stock issued" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of shares of stock issued attributable to transactions classified as other.", "label": "Sale of common stock, net of fees" } } }, "localname": "StockIssuedDuringPeriodValueOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": { "auth_ref": [ "r79", "r87" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.", "label": "Vested Restricted Stock" } } }, "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r20", "r79", "r87" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Exercise of stock options", "verboseLabel": "Shares issued for exercised stock options" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfChangesInStockholdersEquity", "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r5", "r8", "r9", "r63", "r508", "r548", "r556", "r604" ], "calculation": { "http://ayro.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Ending balance,", "periodStartLabel": "Beginning balance", "totalLabel": "Total stockholders\u2019 equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/BalanceSheets", "http://ayro.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r89", "r182", "r278", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r289", "r291", "r292", "r294", "r297", "r384" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_StockholdersEquityReverseStockSplit": { "auth_ref": [ "r88" ], "lang": { "en-us": { "role": { "documentation": "Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.", "label": "Reverse stock split, description" } } }, "localname": "StockholdersEquityReverseStockSplit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r395", "r417" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r395", "r417" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r395", "r417" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r395", "r417" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r416", "r418" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SummaryOfIncomeTaxExaminationsTextBlock": { "auth_ref": [ "r109", "r114" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of income tax examinations that an enterprise is currently subject to or that have been completed in the current period typically including a description of the examination, the jurisdiction conducting the examination, the tax year(s) under examination, the likelihood of an unfavorable settlement, the range of possible losses, the liability recorded, the increase or decrease in the liability from the prior period, and any penalties and interest that have been recorded.", "label": "SCHEDULE OF INCOME TAX EXAMINATION" } } }, "localname": "SummaryOfIncomeTaxExaminationsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental disclosure of cash and non-cash transactions:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_SupplierConcentrationRiskMember": { "auth_ref": [ "r54" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that purchases in the period from one or more significant suppliers is to cost of goods or services, as defined by the entity, such as total cost of sales or services, product line cost of sales or services, segment cost of sales or services. Risk is the materially adverse effects of loss of a material supplier or a supplier of critically needed goods or services.", "label": "Supplier Concentration Risk [Member]" } } }, "localname": "SupplierConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ConcentrationsAndCreditRiskDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r601" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_USTreasurySecuritiesMember": { "auth_ref": [ "r490", "r503", "r504", "r622" ], "lang": { "en-us": { "role": { "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years).", "label": "US Treasury Securities [Member]" } } }, "localname": "USTreasurySecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/ScheduleOfMarketableSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r58", "r59", "r60", "r213", "r214", "r215", "r216" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WarrantExercisePriceDecrease": { "auth_ref": [ "r296" ], "lang": { "en-us": { "role": { "documentation": "Per share decrease in exercise price of warrant. Excludes change due to standard antidilution provision.", "label": "Decrease in exercise price" } } }, "localname": "WarrantExercisePriceDecrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsOutstandingMaturityDate": { "auth_ref": [ "r603" ], "lang": { "en-us": { "role": { "documentation": "Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format.", "label": "Warrant expiration date" } } }, "localname": "WarrantsAndRightsOutstandingMaturityDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "auth_ref": [ "r603" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Warrants and rights outstanding term" } } }, "localname": "WarrantsAndRightsOutstandingTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_WeightedAverageNumberOfSharesIssuedBasic": { "auth_ref": [ "r49", "r50" ], "lang": { "en-us": { "role": { "documentation": "This element represents the weighted average total number of shares issued throughout the period including the first (beginning balance outstanding) and last (ending balance outstanding) day of the period before considering any reductions (for instance, shares held in treasury) to arrive at the weighted average number of shares outstanding. Weighted average relates to the portion of time within a reporting period that common shares have been issued and outstanding to the total time in that period. Such concept is used in determining the weighted average number of shares outstanding for purposes of calculating earnings per share (basic).", "label": "Basic and diluted weighted average Common Stock outstanding" } } }, "localname": "WeightedAverageNumberOfSharesIssuedBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ayro.com/role/StatementsOfOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "217", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126976462&loc=d3e36027-109320", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569655-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(3),(4))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62652-112803", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(15)(b)(2))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.17)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04.2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(7)(d))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "270", "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.3,4)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(7)(c))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "310", "URI": "https://asc.fasb.org/topic&trid=2196771", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "326", "URI": "https://asc.fasb.org/topic&trid=82887179", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "https://asc.fasb.org/topic&trid=2126998", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=122040515&loc=d3e105117-122735", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(a),(b))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "https://asc.fasb.org/topic&trid=49130388", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(l)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(2)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=126938201&loc=d3e55415-109406", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "330", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column A))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column B))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column C))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column D))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r48": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)(1)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2646-109256", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r512": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r513": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r514": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r515": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r516": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r517": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r518": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r519": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r521": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r522": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r523": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r524": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r525": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r526": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r527": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r528": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r529": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r531": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r562": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(l)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r61": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5144-111524", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(b)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r65": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "320", "URI": "https://asc.fasb.org/topic&trid=2196928", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.BB)", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905813&loc=d3e1205-110223", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r73": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "https://asc.fasb.org/topic&trid=2155823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r74": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.C)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" } }, "version": "2.2" } ZIP 91 0001493152-23-008631-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-23-008631-xbrl.zip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ʹ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